Clustering O 0 0.0004145932907704264
of O 0 6.912314711371437e-05
missense O 0 0.0002220436290372163
mutations O 0 2.3693124603596516e-05
in O 0 9.190560376737267e-06
the O 0 5.9546691772993654e-05
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999905824661255
telangiectasia I-Disease 1 0.9999973773956299
gene O 0 1.5027972040115856e-05
in O 0 4.688620265369536e-06
a O 0 1.349951980955666e-05
sporadic B-Disease 0 0.000835617131087929
T I-Disease 1 0.999091386795044
- I-Disease 1 0.9193450212478638
cell I-Disease 1 0.5121096968650818
leukaemia I-Disease 1 0.9995331764221191
. O 0 0.0002914156357292086

Ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999732971191406
telangiectasia I-Disease 1 0.9999995231628418
( O 0 0.3565530776977539
A B-Disease 1 0.9999971389770508
- I-Disease 1 0.9999545812606812
T I-Disease 1 0.9999728202819824
) O 0 4.380393875180744e-06
is O 0 1.5078901469678385e-06
a O 0 5.54220196136157e-06
recessive B-Disease 0 6.459811993408948e-05
multi I-Disease 1 0.9563775062561035
- I-Disease 1 0.9994909763336182
system I-Disease 1 0.8562822937965393
disorder I-Disease 1 0.9999994039535522
caused O 0 0.2555902600288391
by O 0 2.706940222196863e-06
mutations O 0 2.301500444445992e-06
in O 0 1.8295004338142462e-06
the O 0 3.8715229493391234e-06
ATM O 0 6.242422387003899e-05
gene O 0 4.461867320060264e-06
at O 0 1.32207815113361e-05
11q22 O 0 0.0002964069426525384
- O 0 6.844707968411967e-05
q23 O 0 0.00015121139585971832
( O 0 1.049101229000371e-05
ref O 0 0.00010803081386256963
. O 0 5.566078925767215e-06
3 O 0 3.494138945825398e-05
) O 0 2.299374136782717e-05
. O 0 5.3345025662565604e-05

The O 0 9.599077020538971e-05
risk O 0 9.761146793607622e-05
of O 0 0.0008021764224395156
cancer B-Disease 1 0.9999938011169434
, O 0 5.798849088023417e-05
especially O 0 8.44752648845315e-05
lymphoid B-Disease 1 0.9995166063308716
neoplasias I-Disease 1 0.9258908629417419
, O 0 4.105694642930757e-06
is O 0 3.826389274763642e-06
substantially O 0 8.209425686800387e-06
elevated O 0 7.447756070178002e-05
in O 0 9.072122338693589e-06
A B-Disease 1 0.9999793767929077
- I-Disease 1 0.999996542930603
T I-Disease 1 0.9999997615814209
patients O 0 5.6693737860769033e-05
and O 0 3.0674520985485287e-06
has O 0 2.978767042804975e-06
long O 0 5.600017175311223e-06
been O 0 3.2192879189096857e-06
associated O 0 5.117290129419416e-06
with O 0 1.3589784430223517e-05
chromosomal O 1 0.9999840259552002
instability O 1 0.9999991655349731
. O 0 0.004102486185729504

By O 0 0.0001835369475884363
analysing O 0 0.0006648736307397485
tumour B-Disease 1 0.999997615814209
DNA O 0 8.034671191126108e-05
from O 0 1.3541165571950842e-05
patients O 0 1.1945214282604866e-05
with O 0 4.124869974475587e-06
sporadic B-Disease 0 0.0056667448952794075
T I-Disease 1 0.999312162399292
- I-Disease 0 0.13861620426177979
cell I-Disease 0 0.1265168935060501
prolymphocytic I-Disease 1 0.996906578540802
leukaemia I-Disease 1 0.9999743700027466
( O 0 0.0013411663239821792
T B-Disease 1 0.9998025298118591
- I-Disease 0 0.033817242830991745
PLL I-Disease 1 0.9982230067253113
) O 0 3.0869969123159535e-06
, O 0 1.065213041329116e-06
a O 0 1.8032196749118157e-06
rare O 0 8.666131179779768e-06
clonal B-Disease 0 0.0010019210167229176
malignancy I-Disease 0 0.147286057472229
with O 0 2.1354776436055545e-06
similarities O 0 5.395143944042502e-06
to O 0 2.0347258669062285e-06
a O 0 8.842450370138977e-06
mature B-Disease 0 5.450448952615261e-05
T I-Disease 0 0.3940965533256531
- I-Disease 0 0.0008212864631786942
cell I-Disease 0 0.00031992257572710514
leukaemia I-Disease 0 0.33424776792526245
seen O 0 1.061986040440388e-05
in O 0 7.564317456854042e-06
A B-Disease 1 0.9655258059501648
- I-Disease 1 0.9268691539764404
T I-Disease 1 0.983002245426178
, O 0 2.383537776040612e-06
we O 0 7.670747095289698e-07
demonstrate O 0 3.327401373098837e-06
a O 0 1.5453000514753512e-06
high O 0 2.300372443642118e-06
frequency O 0 2.1892672066314844e-06
of O 0 3.635531356849242e-06
ATM O 0 0.0001278314448427409
mutations O 0 1.3107418453728314e-05
in O 0 2.8546455723699182e-05
T B-Disease 1 0.6207894086837769
- I-Disease 0 0.02254081331193447
PLL I-Disease 1 0.9986763596534729
. O 0 0.00016437169688288122

In O 0 0.00010246415331494063
marked O 0 9.286549902753904e-05
contrast O 0 1.6690148186171427e-05
to O 0 3.5152907003066503e-06
the O 0 6.747716270183446e-06
ATM O 0 0.00021369714522734284
mutation O 0 1.5574998542433605e-05
pattern O 0 2.214160303992685e-05
in O 0 1.1575594726309646e-05
A B-Disease 1 0.999871015548706
- I-Disease 1 0.9996435642242432
T I-Disease 1 0.999875545501709
, O 0 2.346338305869722e-06
the O 0 1.8200507838628255e-06
most O 0 8.252191037172452e-07
frequent O 0 2.0862639757979196e-06
nucleotide O 0 4.156436716584722e-06
changes O 0 1.363730461889645e-06
in O 0 2.001496113734902e-06
this O 0 4.5965616664034314e-06
leukaemia B-Disease 1 0.9266524314880371
were O 0 3.222673694835976e-05
missense O 0 0.00038403752841986716
mutations O 0 7.603986887261271e-05
. O 0 0.0001407646486768499

These O 0 2.709283035073895e-05
clustered O 0 7.559797813883051e-05
in O 0 7.115712378436001e-06
the O 0 3.4156503261328908e-06
region O 0 4.628753231372684e-06
corresponding O 0 1.6998816363411606e-06
to O 0 1.2382686236378504e-06
the O 0 2.058011887129396e-06
kinase O 0 7.881531928433105e-06
domain O 0 2.6264308417012217e-06
, O 0 5.922692025706056e-07
which O 0 2.4147610133695707e-07
is O 0 5.455437985801836e-07
highly O 0 1.5933071608742466e-06
conserved O 0 3.3101773624366615e-06
in O 0 3.087727236561477e-06
ATM O 0 0.00017500779358670115
- O 0 2.2287038518697955e-05
related O 0 4.348942638898734e-06
proteins O 0 1.9141352822771296e-06
in O 0 3.190037432432291e-06
mouse O 0 1.2484157196013257e-05
, O 0 2.963401357192197e-06
yeast O 0 1.5911107766442e-05
and O 0 1.0277725777996238e-05
Drosophila O 0 0.00013690874038729817
. O 0 6.916957499925047e-05

The O 0 8.299648470710963e-05
resulting O 0 7.588029257021844e-05
amino O 0 4.678201730712317e-05
- O 0 5.5891159718157724e-05
acid O 0 1.1874725714733358e-05
substitutions O 0 5.3243156798998825e-06
are O 0 6.212185894582944e-07
predicted O 0 2.269625383632956e-06
to O 0 7.081742410264269e-07
interfere O 0 3.1087467959878268e-06
with O 0 2.4611770186311333e-06
ATP O 0 0.006931413430720568
binding O 0 4.821502443519421e-06
or O 0 5.3307685448089615e-06
substrate O 0 3.434613245190121e-05
recognition O 0 4.998507574782707e-05
. O 0 9.314415365224704e-05

Two O 0 4.337004429544322e-05
of O 0 5.848848741152324e-05
seventeen O 0 0.0003465080226305872
mutated O 0 0.0003876399714499712
T B-Disease 0 0.24138282239437103
- I-Disease 0 0.00014335797459352762
PLL I-Disease 0 0.08475411683320999
samples O 0 3.1070455861481605e-06
had O 0 2.7358521492715226e-06
a O 0 3.0251303542172536e-06
previously O 0 5.864927970833378e-06
reported O 0 1.4592367733712308e-05
A B-Disease 0 0.07023369520902634
- I-Disease 1 0.7662426233291626
T I-Disease 1 0.9994145631790161
allele O 0 0.00013610847236122936
. O 0 7.749057112960145e-05

In O 0 8.182048622984439e-05
contrast O 0 5.1050184993073344e-05
, O 0 1.3429908904072363e-05
no O 0 4.915191311738454e-06
mutations O 0 3.815209765889449e-06
were O 0 2.733533619903028e-06
detected O 0 4.465929123398382e-06
in O 0 1.2613503486136324e-06
the O 0 2.6674169930629432e-06
p53 O 0 8.376762707484886e-06
gene O 0 1.8923800553238834e-06
, O 0 1.1501276730996324e-06
suggesting O 0 2.1653017938660923e-06
that O 0 6.650657837781182e-07
this O 0 4.084360170963919e-06
tumour B-Disease 1 0.9999998807907104
suppressor O 0 0.016648247838020325
is O 0 1.7502690070614335e-06
not O 0 4.851668222727312e-07
frequently O 0 1.2817539527532062e-06
altered O 0 3.388624008948682e-06
in O 0 2.963658516819123e-06
this O 0 1.6949063137872145e-05
leukaemia B-Disease 1 0.9984726309776306
. O 0 0.00039200775790959597

Occasional O 0 0.0008150921203196049
missense O 0 0.000548465468455106
mutations O 0 6.125795334810391e-05
in O 0 2.122628029610496e-05
ATM O 0 0.00016030138067435473
were O 0 5.864989361725748e-06
also O 0 2.2485637600766495e-06
found O 0 1.0385606401541736e-06
in O 0 3.058641595998779e-06
tumour B-Disease 1 0.9999721050262451
DNA O 0 8.81791038409574e-06
from O 0 2.713081130423234e-06
patients O 0 2.1121873032825533e-06
with O 0 1.8447111642672098e-06
B B-Disease 1 0.774109959602356
- I-Disease 0 0.3403887152671814
cell I-Disease 0 0.011817490682005882
non I-Disease 0 0.00012365737347863615
- I-Disease 1 0.9685639142990112
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9999725818634033
( O 0 2.7859650799655356e-05
B B-Disease 0 0.004849900025874376
- I-Disease 0 1.6470021364511922e-05
NHL I-Disease 0 2.064947875624057e-05
) O 0 1.4497243228106527e-06
and O 0 1.2567637668325915e-06
a O 0 5.995575975248357e-06
B B-Disease 0 0.00036521832225844264
- I-Disease 0 0.00013115005276631564
NHL I-Disease 0 0.0018868964398279786
cell O 0 0.00022343017917592078
line O 0 0.000137203314807266
. O 0 6.437808042392135e-05

The O 0 4.817513035959564e-05
evidence O 0 1.6660316759953275e-05
of O 0 8.916059414332267e-06
a O 0 7.227167316159466e-06
significant O 0 5.9683070503524505e-06
proportion O 0 3.6611631912819576e-06
of O 0 9.558764759276528e-06
loss O 0 0.3736240863800049
- O 0 0.0006695230258628726
of O 0 3.5335589927854016e-05
- O 0 0.00012917391723021865
function O 0 2.0194981971144443e-06
mutations O 0 9.721471769807977e-07
and O 0 3.8023807746867533e-07
a O 0 1.3791004676022567e-06
complete O 0 4.25103644374758e-06
absence O 0 5.249254172667861e-06
of O 0 3.5105701954307733e-06
the O 0 2.16819648812816e-06
normal O 0 1.7844173498815508e-06
copy O 0 2.3912812139315065e-06
of O 0 2.013855237237294e-06
ATM O 0 2.8785821996279992e-05
in O 0 1.554072582621302e-06
the O 0 1.9897479432984255e-06
majority O 0 3.232480139558902e-06
of O 0 1.4935703802620992e-05
mutated O 0 0.00037473664269782603
tumours B-Disease 1 0.9999635219573975
establishes O 0 6.813214713474736e-05
somatic O 0 7.484508387278765e-05
inactivation O 0 0.0002682881022337824
of O 0 5.50911909158458e-06
this O 0 1.143770532507915e-06
gene O 0 1.6856913589435862e-06
in O 0 1.0823355296452064e-06
the O 0 3.7409074593597325e-06
pathogenesis O 1 0.7184379696846008
of O 0 3.376960739842616e-05
sporadic B-Disease 1 0.9293367266654968
T I-Disease 1 0.9999834299087524
- I-Disease 0 0.22622188925743103
PLL I-Disease 1 0.9963604807853699
and O 0 2.9621751309605315e-06
suggests O 0 3.6062522212887416e-06
that O 0 6.068270295145339e-07
ATM O 0 2.3778849936206825e-05
acts O 0 4.429750788403908e-06
as O 0 1.1601146070461255e-05
a O 0 0.0001749545626807958
tumour B-Disease 1 0.9999998807907104
suppressor O 1 0.9166119694709778
. O 0 0.0003468889626674354

As O 0 8.882704423740506e-05
constitutional O 0 3.663328607217409e-05
DNA O 0 1.6210291505558416e-05
was O 0 1.1417377208999824e-05
not O 0 4.6211391691031167e-07
available O 0 4.28535230412308e-07
, O 0 1.013233031699201e-06
a O 0 5.113016413815785e-06
putative O 0 0.0002153178065782413
hereditary O 1 0.9998626708984375
predisposition O 1 0.9999854564666748
to O 0 0.005536123178899288
T B-Disease 1 0.9999983310699463
- I-Disease 1 0.7843834757804871
PLL I-Disease 1 0.9720793962478638
will O 0 2.0460295218072133e-06
require O 0 1.0670645451682503e-06
further O 0 3.56182908944902e-06
investigation O 0 1.7828400814323686e-05
. O 0 1.3360430784814525e-05
. O 0 6.802561256336048e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 0.018360570073127747
kinase O 0 0.000220670917769894
is O 0 9.117405170400161e-06
involved O 0 3.2360981094825547e-06
in O 0 1.0729166888268082e-06
the O 0 1.8727175756794168e-06
modulation O 0 6.808264515711926e-06
of O 0 3.6120484310231404e-06
the O 0 6.485715857706964e-06
Ca2 O 0 9.883932943921536e-05
+ O 0 7.062425720505416e-05
homeostasis O 0 0.00016623726696707308
in O 0 2.0802281142096035e-05
skeletal O 1 0.9991533756256104
muscle O 0 0.47747182846069336
cells O 0 0.00014683647896163166
. O 0 9.728864097269252e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999830722808838
DM B-Disease 1 1.0
) O 0 9.71531990217045e-05
, O 0 8.4051380326855e-06
the O 0 4.534414074441884e-06
most O 0 8.032933692447841e-06
prevalent O 1 0.9883193969726562
muscular B-Disease 1 0.9999998807907104
disorder I-Disease 1 0.9999998807907104
in O 0 0.0023406948894262314
adults O 0 3.177608596161008e-05
, O 0 3.2313025712937815e-06
is O 0 2.6678112590161618e-06
caused O 0 8.025935130717698e-06
by O 0 2.2749823074263986e-06
( O 0 8.552753570256755e-06
CTG O 0 0.19544009864330292
) O 0 3.5217226468375884e-06
n O 0 9.106352081289515e-06
- O 0 6.1016071413178e-06
repeat O 0 3.7976656130922493e-06
expansion O 0 4.6853033381921705e-06
in O 0 5.925811024098948e-07
a O 0 7.682526188546035e-07
gene O 0 6.144123858575767e-07
encoding O 0 6.9180504169708e-07
a O 0 2.449812654958805e-06
protein O 0 6.342342658172129e-06
kinase O 0 1.723071727610659e-05
( O 0 6.95393509886344e-06
DM B-Disease 1 0.9999717473983765
protein O 0 1.4209320397640113e-05
kinase O 0 1.6158846847247332e-05
; O 0 2.1869761894777184e-06
DMPK O 0 0.00012666925613302737
) O 0 1.2866320275861653e-06
and O 0 5.992878300276061e-07
involves O 0 1.3675569334736792e-06
changes O 0 1.022205651679542e-06
in O 0 2.5232668576791184e-06
cytoarchitecture O 0 0.00012474492541514337
and O 0 1.6187612345675007e-05
ion O 0 0.00037273572525009513
homeostasis O 0 0.0010969561990350485
. O 0 8.645816706120968e-05

To O 0 2.4128323275363073e-05
obtain O 0 1.660161797190085e-05
clues O 0 1.2664063433476258e-05
to O 0 1.550928004689922e-06
the O 0 1.227818302140804e-06
normal O 0 1.634700993236038e-06
biological O 0 4.198626811557915e-06
role O 0 3.460470907157287e-06
of O 0 4.8466454245499335e-06
DMPK O 1 0.9685197472572327
in O 0 6.0531192502821796e-06
cellular O 0 5.490319381351583e-05
ion O 0 7.621148688485846e-05
homeostasis O 0 7.113692845450714e-05
, O 0 1.192749778056168e-06
we O 0 6.054974051039608e-07
have O 0 2.3468388121727912e-07
compared O 0 7.85650286161399e-07
the O 0 1.5809290516699548e-06
resting O 0 3.3973687095567584e-05
[ O 0 9.775834769243374e-06
Ca2 O 0 2.1009287593187764e-05
+ O 0 1.3256814781925641e-05
] O 0 6.652689535258105e-06
i O 0 1.9544906990631716e-06
, O 0 3.2999702170855016e-07
the O 0 3.656271019281121e-07
amplitude O 0 2.7034807317249943e-06
and O 0 1.2284074273338774e-06
shape O 0 4.141053977946285e-06
of O 0 4.237464963807724e-06
depolarization O 0 0.00020089397730771452
- O 0 0.00013494362065102905
induced O 0 0.0008882364491000772
Ca2 O 0 4.197061571176164e-05
+ O 0 1.4681745597044937e-05
transients O 0 9.392719221068546e-06
, O 0 4.864037919105613e-07
and O 0 3.008937881077145e-07
the O 0 6.359856001836306e-07
content O 0 1.4657491647085408e-06
of O 0 5.264168521534884e-06
ATP O 0 0.03192967176437378
- O 0 7.79035544837825e-05
driven O 0 2.8401291274349205e-05
ion O 0 3.3009891922120005e-05
pumps O 0 1.2171206435596105e-05
in O 0 3.912543888873188e-06
cultured O 0 6.140119512565434e-05
skeletal O 0 0.06483099609613419
muscle O 0 6.930287781869993e-05
cells O 0 4.715498107543681e-06
of O 0 3.793676569330273e-06
wild O 0 7.88238048698986e-06
- O 0 9.97048664430622e-06
type O 0 5.660195256496081e-06
and O 0 3.2648433716531144e-06
DMPK O 1 0.9809984564781189
[ O 0 6.478245632024482e-05
- O 0 6.596018647542223e-05
/ O 0 0.0003620685019996017
- O 0 0.00023851101286709309
] O 0 0.00018935180560220033
knockout O 0 0.09594269841909409
mice O 0 0.0003193350858055055
. O 0 7.92157297837548e-05

In O 0 0.0002410058950772509
vitro O 0 0.0004892528522759676
- O 0 0.000501721806358546
differentiated O 0 0.00031481918995268643
DMPK O 1 0.9956128597259521
[ O 0 0.0003434155078139156
- O 0 0.0003218413039576262
/ O 0 0.0029615783132612705
- O 0 0.00019653182243928313
] O 0 6.204919191077352e-05
myotubes O 0 5.7429802836850286e-05
exhibit O 0 7.388675840047654e-06
a O 0 2.999814569193404e-06
higher O 0 3.8052899071772117e-06
resting O 0 2.0761774067068473e-05
[ O 0 1.198767677124124e-05
Ca2 O 0 2.3920223611639813e-05
+ O 0 2.2412106773117557e-05
] O 0 1.0225830010313075e-05
i O 0 1.5131048485272913e-06
than O 0 4.933901891490677e-07
do O 0 9.795008963919827e-07
wild O 0 4.212122348690173e-06
- O 0 1.1347202416800428e-05
type O 0 6.4192336139967665e-06
myotubes O 0 5.263349521555938e-05
because O 0 8.422369432992127e-07
of O 0 1.1858109019158292e-06
an O 0 1.162655735242879e-06
altered O 0 2.4770879463176243e-06
open O 0 1.3968933672003914e-06
probability O 0 1.1281964589215931e-06
of O 0 3.209120677638566e-06
voltage O 0 3.147191455354914e-05
- O 0 2.5834493499132805e-05
dependent O 0 8.696722943568602e-06
l O 0 2.1667250621248968e-05
- O 0 1.402132329531014e-05
type O 0 5.873525424249237e-06
Ca2 O 0 1.5565819921903312e-05
+ O 0 1.2034251994919032e-05
and O 0 5.161411081644474e-06
Na O 0 0.00035180061240680516
+ O 0 4.665802407544106e-05
channels O 0 4.524076939560473e-05
. O 0 5.9103560488438234e-05

The O 0 0.00031534972367808223
mutant O 0 0.0013239621184766293
myotubes O 0 0.0032880015205591917
exhibit O 0 6.421480065910146e-05
smaller O 0 7.628779258084251e-06
and O 0 2.1169546471355716e-06
slower O 0 8.898052328731865e-06
Ca2 O 0 1.2834595509048086e-05
+ O 0 5.093607796879951e-06
responses O 0 1.085174744730466e-06
upon O 0 2.6094908207596745e-06
triggering O 0 1.179842911369633e-05
by O 0 3.138344482067623e-06
acetylcholine O 0 2.230179416073952e-05
or O 0 3.4886531921074493e-06
high O 0 2.1213048967183568e-05
external O 0 2.2378852008841932e-05
K O 0 0.00017270191165152937
+ O 0 0.00016559276264160872
. O 0 9.857350960373878e-05

In O 0 6.232138548512012e-05
addition O 0 2.2141730369185098e-05
, O 0 6.323861271084752e-06
we O 0 1.6383170304834493e-06
observed O 0 1.3761443824478192e-06
that O 0 4.2185078541479015e-07
these O 0 6.442542144213803e-07
Ca2 O 0 2.214574305980932e-05
+ O 0 1.9265489754616283e-05
transients O 0 3.035568443010561e-05
partially O 0 3.52145411852689e-06
result O 0 9.267786253985832e-07
from O 0 1.069890231519821e-06
an O 0 1.5020932551124133e-06
influx O 0 6.193172794155544e-06
of O 0 2.6184825401287526e-06
extracellular O 0 1.0925205060630105e-05
Ca2 O 0 1.1421199815231375e-05
+ O 0 5.257380962575553e-06
through O 0 1.2921839243063005e-06
the O 0 3.3705557598295854e-06
l O 0 3.8425205275416374e-05
- O 0 2.9359125619521365e-05
type O 0 2.7130809030495584e-05
Ca2 O 0 9.782084816833958e-05
+ O 0 7.321663724724203e-05
channel O 0 0.00013312595547176898
. O 0 0.00010136734636034817

Neither O 0 0.00016976342885755002
the O 0 2.4301165467477404e-05
content O 0 1.3537847735278774e-05
nor O 0 8.213270120904781e-06
the O 0 2.8253145956114167e-06
activity O 0 4.884108875558013e-06
of O 0 6.294733339018421e-06
Na O 0 0.29793187975883484
+ O 0 4.864708171226084e-05
/ O 0 3.2912070309976116e-05
K O 0 3.3656695450190455e-05
+ O 0 1.9424369384068996e-05
ATPase O 0 2.025317917286884e-05
and O 0 2.535982730478281e-06
sarcoplasmic O 0 3.420906432438642e-05
reticulum O 0 3.06635738525074e-05
Ca2 O 0 2.5159399228869006e-05
+ O 0 2.1388823370216414e-05
- O 0 1.5961777535267174e-05
ATPase O 0 2.9067634386592545e-05
are O 0 1.1343880714775878e-06
affected O 0 6.44338706479175e-06
by O 0 1.4246335013012867e-05
DMPK O 0 0.2773800492286682
absence O 0 0.0005058154347352684
. O 0 0.000237682179431431

In O 0 6.291169120231643e-05
conclusion O 0 3.1546402169624344e-05
, O 0 7.595168881380232e-06
our O 0 2.012354116232018e-06
data O 0 2.516840368116391e-06
suggest O 0 2.435326223348966e-06
that O 0 1.4627872815253795e-06
DMPK O 0 0.020007848739624023
is O 0 2.3968589175638044e-06
involved O 0 1.5259018937285873e-06
in O 0 1.0547717010922497e-06
modulating O 0 8.827022611512803e-06
the O 0 2.4749390377110103e-06
initial O 0 2.100540314131649e-06
events O 0 1.7418832385374117e-06
of O 0 4.38740471508936e-06
excitation O 0 6.0970178310526535e-05
- O 0 0.0002235940919490531
contraction O 0 0.0005392722086980939
coupling O 0 0.00010377461148891598
in O 0 2.7694017262547277e-05
skeletal O 1 0.9997562766075134
muscle O 0 0.006438877433538437
. O 0 3.714388731168583e-05
. O 0 7.060256757540628e-05

Constitutional O 0 0.0023861851077526808
RB1 O 1 0.9997023940086365
- O 0 0.0029635950922966003
gene O 0 4.912764416076243e-05
mutations O 0 1.2943401998199988e-05
in O 0 6.484701771114487e-06
patients O 0 1.2066429007973056e-05
with O 0 7.2876305239333306e-06
isolated O 0 0.00042620720341801643
unilateral B-Disease 0 0.0002890869800467044
retinoblastoma I-Disease 1 0.9982554316520691
. O 0 0.0003956725122407079

In O 0 0.00012311697355471551
most O 0 1.9394565242691897e-05
patients O 0 2.619728365971241e-05
with O 0 9.938041330315173e-06
isolated O 0 0.0009886824991554022
unilateral B-Disease 0 0.00017129594925791025
retinoblastoma I-Disease 1 0.9999923706054688
, O 0 0.0036074486561119556
tumor B-Disease 1 0.9999765157699585
development O 0 2.0703406335087493e-05
is O 0 2.690202336452785e-06
initiated O 0 8.552141480322462e-06
by O 0 1.2744357036353904e-06
somatic O 0 1.2775272807630245e-05
inactivation O 0 8.982988219941035e-05
of O 0 8.698249985172879e-06
both O 0 3.557524451025529e-06
alleles O 0 3.913820364687126e-06
of O 0 1.2308688383200206e-05
the O 0 7.146989810280502e-05
RB1 O 1 0.9994334578514099
gene O 0 8.70231888256967e-05
. O 0 0.00014151347568258643

However O 0 9.93184294202365e-05
, O 0 7.515522156609222e-06
some O 0 1.413596692145802e-06
of O 0 2.591176780697424e-06
these O 0 1.0498603160158382e-06
patients O 0 5.307808805810055e-06
can O 0 2.3701957161392784e-06
transmit O 0 2.5470870241406374e-05
retinoblastoma B-Disease 0 0.1461273431777954
predisposition O 0 0.011279636062681675
to O 0 2.026165930146817e-05
their O 0 3.254279727116227e-05
offspring O 0 0.0003054933622479439
. O 0 0.0001666487951297313

To O 0 2.1802683477289975e-05
determine O 0 5.973824954708107e-06
the O 0 4.214541604596889e-06
frequency O 0 3.955678948841523e-06
and O 0 1.2345803952484857e-06
nature O 0 3.466264161033905e-06
of O 0 7.080235718603944e-06
constitutional O 0 9.875302930595353e-05
RB1 O 1 0.9999903440475464
- O 0 0.0006593142752535641
gene O 0 5.0651879064389504e-06
mutations O 0 2.466522801114479e-06
in O 0 2.928044523287099e-06
patients O 0 3.6586850455933018e-06
with O 0 2.4721696263441117e-06
isolated O 0 5.927176243858412e-05
unilateral B-Disease 0 9.931456588674337e-06
retinoblastoma I-Disease 0 0.0008592206286266446
, O 0 1.5659478549423511e-06
we O 0 5.828673579344468e-07
analyzed O 0 2.1878333882341394e-06
DNA O 0 2.3246934688359033e-06
from O 0 2.5619226562412223e-06
peripheral O 0 0.0018245478859171271
blood O 0 1.6057383618317544e-05
and O 0 5.3873031902185176e-06
from O 0 6.678164209006354e-05
tumor B-Disease 1 0.9999973773956299
tissue O 0 0.10719797015190125
. O 0 0.00010456332529429346

The O 0 4.722865196526982e-05
analysis O 0 1.731802876747679e-05
of O 0 3.748235758394003e-05
tumors B-Disease 1 0.9992710947990417
from O 0 9.087249054573476e-06
54 O 0 1.5028072994027752e-05
( O 0 2.6587363208818715e-06
71 O 0 9.873914677882567e-06
% O 0 2.426470473437803e-06
) O 0 1.2682111218964565e-06
of O 0 2.1635737539327238e-06
76 O 0 1.9522962247719988e-05
informative O 0 1.3106593542033806e-05
patients O 0 4.021793301944854e-06
showed O 0 7.033007022982929e-06
loss O 0 1.5137360605876893e-05
of O 0 1.1091357919212896e-05
constitutional O 0 0.00012096043064957485
heterozygosity O 1 0.9996592998504639
( O 0 0.00017833607853390276
LOH O 1 0.9999935626983643
) O 0 2.872505137929693e-05
at O 0 9.488150681136176e-05
intragenic O 0 0.006590695586055517
loci O 0 0.0002168816572520882
. O 0 0.00010817553265951574

Three O 0 9.77481176960282e-05
of O 0 6.907241913722828e-05
13 O 0 0.0002769040293060243
uninformative O 1 0.8243996500968933
patients O 0 0.00020848930580541492
had O 0 6.708085129503161e-05
constitutional O 0 0.00015632616123184562
deletions O 0 0.0005485569126904011
. O 0 0.00019061732746195048

For O 0 4.3559928599279374e-05
39 O 0 6.050322554074228e-05
randomly O 0 1.3559515537053812e-05
selected O 0 2.3171804059529677e-05
tumors B-Disease 1 0.9996567964553833
, O 0 2.413844777038321e-05
SSCP O 1 0.9995263814926147
, O 0 2.0361785573186353e-05
hetero O 0 0.007670003455132246
- O 0 3.744323839782737e-05
duplex O 0 6.264283729251474e-05
analysis O 0 2.1610744624922518e-06
, O 0 1.2441920489436598e-06
sequencing O 0 3.1041727197589353e-06
, O 0 9.391566777594562e-07
and O 0 4.6394384867198823e-07
Southern O 0 3.0381756914721336e-06
blot O 0 8.45949944050517e-06
analysis O 0 8.744925708015217e-07
were O 0 1.2083355613867752e-06
used O 0 1.1462645943538519e-06
to O 0 1.5877918713158579e-06
identify O 0 9.256752491637599e-06
mutations O 0 3.296138675068505e-05
. O 0 8.550567872589454e-05

Mutations O 0 7.570524758193642e-05
were O 0 1.8814153008861467e-05
detected O 0 1.98646193894092e-05
in O 0 4.0804043237585574e-06
21 O 0 8.305758456117474e-06
( O 0 2.1508067220565863e-06
91 O 0 6.63545552015421e-06
% O 0 2.99061957775848e-06
) O 0 1.7784253714125953e-06
of O 0 9.558664714859333e-06
23 O 0 0.017756471410393715
tumors B-Disease 1 0.9999983310699463
with O 0 0.00030231178971007466
LOH O 1 0.9999997615814209
. O 0 0.00044581765541806817

In O 0 6.592113641090691e-05
6 O 0 5.167920971871354e-05
( O 0 1.4089726391830482e-05
38 O 0 1.1961937161686365e-05
% O 0 5.892848093935754e-06
) O 0 4.374027867015684e-06
of O 0 1.0237519745714962e-05
16 O 0 0.017580373212695122
tumors B-Disease 1 0.999998927116394
without O 0 3.845221726805903e-05
LOH O 1 0.9999529123306274
, O 0 3.843985723506194e-06
one O 0 2.3808818241377594e-06
mutation O 0 2.3680154299654532e-06
was O 0 1.2757448530464899e-05
detected O 0 6.835432486695936e-06
, O 0 1.4388679119292647e-06
and O 0 4.857779458689038e-07
in O 0 7.913230319900322e-07
9 O 0 4.698664270108566e-06
( O 0 1.2215522247061017e-06
56 O 0 2.672756636457052e-06
% O 0 1.5136157571760123e-06
) O 0 7.875902383602806e-07
of O 0 3.0739706744498108e-06
the O 0 2.349057285755407e-05
tumors B-Disease 1 0.9999992847442627
without O 0 3.2857944461284205e-05
LOH O 1 0.9999904632568359
, O 0 4.873658326687291e-06
both O 0 1.934719648488681e-06
mutations O 0 4.440092197910417e-06
were O 0 6.502566975541413e-06
found O 0 1.82074054464465e-05
. O 0 6.349591421894729e-05

Thus O 0 0.00011606279440457001
, O 0 1.0610161552904174e-05
a O 0 5.508867161552189e-06
total O 0 2.4143405426002573e-06
of O 0 2.8710937840514816e-06
45 O 0 5.7431921050010715e-06
mutations O 0 2.2087176603236003e-06
were O 0 2.0327652237028815e-06
identified O 0 2.836919065885013e-06
in O 0 4.0863201320462395e-06
tumors B-Disease 1 0.9997965693473816
of O 0 6.916812708368525e-05
36 O 0 0.000518595043104142
patients O 0 0.00032416684553027153
. O 0 0.0001873597502708435

Thirty O 0 0.001144017674960196
- O 0 0.00012938250438310206
nine O 0 1.881521166069433e-05
of O 0 9.712255632621236e-06
the O 0 7.215632649604231e-06
mutations O 0 7.260714482981712e-06
- O 0 8.318513209815137e-06
including O 0 2.135701606675866e-06
34 O 0 8.807532140053809e-06
small O 0 3.5423136068857275e-06
mutations O 0 2.4104799649649067e-06
, O 0 1.0708538411563495e-06
2 O 0 4.285072918719379e-06
large O 0 3.061344159505097e-06
structural O 0 8.516122761648148e-05
alterations O 0 2.111514004354831e-05
, O 0 1.9859071471728384e-06
and O 0 1.8680781295188353e-06
hypermethylation O 0 0.0004395914147607982
in O 0 6.605616817978444e-06
3 O 0 0.007837112061679363
tumors O 1 0.9999974966049194
- O 0 1.0431980626890436e-05
were O 0 1.0689917644413072e-06
not O 0 2.948191877294448e-07
detected O 0 1.699567064861185e-06
in O 0 8.902542276700842e-07
the O 0 3.20644994644681e-06
corresponding O 0 1.4366505638463423e-05
peripheral O 0 0.055196333676576614
blood O 0 0.00012723921099677682
DNA O 0 0.00011592341616051272
. O 0 5.839140430907719e-05

In O 0 0.00013221270637586713
6 O 0 8.567511395085603e-05
( O 0 1.7104051948990673e-05
17 O 0 1.1427279787312727e-05
% O 0 3.838567408820381e-06
) O 0 1.4250397271098336e-06
of O 0 1.3834580840921262e-06
the O 0 2.5886229195748456e-06
36 O 0 7.898733201727737e-06
patients O 0 2.2688418539473787e-06
, O 0 1.5148938246056787e-06
a O 0 2.674863026186358e-06
mutation O 0 2.660080554051092e-06
was O 0 7.408425062749302e-06
detected O 0 2.531874542910373e-06
in O 0 8.472349577459681e-07
constitutional O 0 2.95345853373874e-06
DNA O 0 3.2999776067299535e-06
, O 0 7.402707637993444e-07
and O 0 3.09917169261098e-07
1 O 0 1.7497850421932526e-06
of O 0 1.412956407875754e-06
these O 0 6.626688104915957e-07
mutations O 0 2.0228076209605206e-06
is O 0 1.2236743032190134e-06
known O 0 1.4008742255100515e-06
to O 0 5.747459113081277e-07
be O 0 4.655296095279482e-07
associated O 0 1.7241317209482077e-06
with O 0 4.616999376594322e-06
reduced O 0 8.657613943796605e-05
expressivity O 0 0.04247735068202019
. O 0 0.00013424953795038164

The O 0 0.00011202506721019745
presence O 0 2.7072785087511875e-05
of O 0 1.1808257113443688e-05
a O 0 1.2169117326266132e-05
constitutional O 0 7.76548586145509e-06
mutation O 0 4.527535111265024e-06
was O 0 8.203110155591276e-06
not O 0 7.893159477134759e-07
associated O 0 8.556650072932825e-07
with O 0 4.4515127228805795e-07
an O 0 1.5766651131343679e-06
early O 0 1.573385816300288e-05
age O 0 4.791850005858578e-05
at O 0 0.0004110297013539821
treatment O 0 0.001733401557430625
. O 0 0.0001882662472780794

In O 0 0.00010196599760092795
1 O 0 0.00010504933015909046
patient O 0 9.686291741672903e-05
, O 0 1.4064995411899872e-05
somatic O 0 0.0004910352872684598
mosaicism O 1 0.9903969764709473
was O 0 6.354563811328262e-05
demonstrated O 0 1.0047038813354447e-05
by O 0 1.4796574987485656e-06
molecular O 0 2.251121259178035e-06
analysis O 0 6.595354307137313e-07
of O 0 1.465155264668283e-06
DNA O 0 5.388500539993402e-06
and O 0 2.1775961158709833e-06
RNA O 0 2.356371442147065e-05
from O 0 1.3475646483129822e-05
peripheral O 0 0.00792328454554081
blood O 0 0.00012416329991538078
. O 0 9.437707922188565e-05

In O 0 8.897446969058365e-05
2 O 0 0.00012679831706918776
patients O 0 1.841800258262083e-05
without O 0 6.066851256036898e-06
a O 0 1.0060193744720891e-05
detectable O 0 5.131526631885208e-05
mutation O 0 9.239191967935767e-06
in O 0 8.679266102262773e-06
peripheral O 1 0.8400439023971558
blood O 0 0.00016519124619662762
, O 0 1.4528797692037188e-05
mosaicism O 1 0.9910872578620911
was O 0 6.201985524967313e-05
suggested O 0 2.084633479171316e-06
because O 0 3.4699280604399974e-07
1 O 0 1.3084198826618376e-06
of O 0 1.5581121033392265e-06
the O 0 6.831157861597603e-06
patients O 0 0.0040903594344854355
showed O 1 0.9706906676292419
multifocal O 1 1.0
tumors B-Disease 1 0.9999998807907104
and O 0 3.7131126191525254e-06
the O 0 3.21467064168246e-06
other O 0 1.272908889404789e-06
later O 0 1.3267715985421091e-05
developed O 0 3.91092398785986e-05
bilateral B-Disease 0 0.0003446321643423289
retinoblastoma I-Disease 1 0.6972941756248474
. O 0 0.0002729539410211146

In O 0 5.2116312872385606e-05
conclusion O 0 2.9839628041372634e-05
, O 0 9.745432180352509e-06
our O 0 2.800816446324461e-06
results O 0 1.8942920405606856e-06
emphasize O 0 6.206765647220891e-06
that O 0 9.20456159292371e-07
the O 0 2.880459533116664e-06
manifestation O 0 0.00015427981270477176
and O 0 5.508005415322259e-06
transmissibility O 0 0.00959742534905672
of O 0 1.614630855328869e-05
retinoblastoma B-Disease 0 0.007390798535197973
depend O 0 3.303113771835342e-06
on O 0 2.2952360723138554e-06
the O 0 1.3025099860897171e-06
nature O 0 1.2212157116664457e-06
of O 0 8.511773899044783e-07
the O 0 1.3296672705109813e-06
first O 0 2.6452180463820696e-06
mutation O 0 9.171527040052752e-07
, O 0 3.177605094606406e-07
its O 0 4.762794674206816e-07
time O 0 8.13253166143113e-07
in O 0 9.348076446258347e-07
development O 0 2.742934611887904e-06
, O 0 9.953358812708757e-07
and O 0 2.43172138425507e-07
the O 0 4.346751723005582e-07
number O 0 3.922598637018382e-07
and O 0 4.7603290909137286e-07
types O 0 7.689321250836656e-07
of O 0 3.2014086173148826e-06
cells O 0 4.123021426494233e-06
that O 0 7.579297971460619e-07
are O 0 6.900214089000656e-07
affected O 0 3.6064618598175002e-06
. O 0 9.02744159247959e-06
. O 0 3.267234569648281e-05

Hereditary B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999998807907104
of I-Disease 0 0.1386479288339615
the I-Disease 0 0.0003574324073269963
fifth I-Disease 0 0.09585612267255783
component I-Disease 0 8.317537867696956e-05
of I-Disease 0 1.2610577869054396e-05
complement I-Disease 0 2.1690260837203823e-05
in O 0 1.5189419173111673e-05
man O 0 0.00012434861855581403
. O 0 6.086717621656135e-05

I O 0 0.01813746616244316
. O 0 0.0014126732712611556

Clinical O 0 0.013425961136817932
, O 0 0.0003357999084983021
immunochemical O 0 0.2687530815601349
, O 0 3.0640159820904955e-05
and O 0 1.1106568308605347e-05
family O 0 4.047983748023398e-05
studies O 0 3.5581218980951235e-05
. O 0 6.653684249613434e-05

The O 0 0.00011484714923426509
first O 0 5.75949416088406e-05
recognized O 0 3.972865306423046e-05
human O 0 1.734574652800802e-05
kindred O 0 0.02501654624938965
with O 0 7.320491567952558e-05
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.999392032623291
the I-Disease 0 0.03428032249212265
fifth I-Disease 0 0.11824364215135574
component I-Disease 0 4.8184821935137734e-05
of I-Disease 0 7.827964509488083e-06
complement I-Disease 0 2.518652763683349e-05
( O 0 1.3316937838681042e-05
C5 O 1 0.9913499355316162
) O 0 6.31810462436988e-06
is O 0 6.969178230065154e-06
described O 0 3.681058660731651e-05
. O 0 5.5913173127919436e-05

The O 0 0.00022576846822630614
proband O 0 0.00168614462018013
, O 0 3.103321068920195e-05
a O 0 2.3597447579959407e-05
20 O 0 2.4519520593457855e-05
- O 0 3.265851046307944e-05
year O 0 1.518878161732573e-05
- O 0 7.466701208613813e-05
old O 0 0.00022884004283696413
black O 0 7.368916703853756e-05
female O 0 5.174509351490997e-05
with O 0 0.006421089172363281
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9993840456008911
age O 0 0.33576613664627075
11 O 0 0.0002912594936788082
, O 0 1.4852396816422697e-05
lacked O 0 0.0018594301072880626
serum O 1 0.7198657393455505
hemolytic O 1 0.9999936819076538
complement O 0 4.400307443575002e-05
activity O 0 9.254006727132946e-06
, O 0 2.8011904760205653e-06
even O 0 3.1915344607114093e-06
during O 0 2.938811667263508e-05
remission O 0 0.0008584914612583816
. O 0 0.00019648947636596859

C5 O 1 0.9990039467811584
was O 0 0.0010127138812094927
undetectable O 0 0.0002787832054309547
in O 0 1.0152970389754046e-05
her O 0 9.531173418508843e-06
serum O 0 1.78237405634718e-05
by O 0 3.4181334740424063e-06
both O 0 6.251182185224025e-06
immunodiffusion O 0 0.15541070699691772
and O 0 4.413701390149072e-05
hemolytic O 1 0.9999847412109375
assays O 0 0.0003883936442434788
. O 0 0.0002338188060093671

Other O 0 2.480109287716914e-05
complement O 0 4.2365016270196065e-05
components O 0 2.344929816899821e-05
were O 0 6.03247690378339e-06
normal O 0 3.990963705291506e-06
during O 0 1.188435544463573e-05
remission O 0 0.004124278202652931
of O 0 0.002170872176066041
lupus O 1 0.9999997615814209
, O 0 4.349687515059486e-05
but O 0 8.287560376629699e-06
C1 O 1 0.9999620914459229
, O 0 9.208805568050593e-05
C4 O 1 0.9999978542327881
, O 0 2.320110252185259e-05
C2 O 1 0.9557801485061646
, O 0 7.245649157994194e-06
and O 0 7.568690762127517e-06
C3 O 1 0.9979721903800964
levels O 0 4.158919909968972e-05
fell O 0 0.009468823671340942
during O 0 0.00012217120092827827
exacerbations O 0 0.12280285358428955
. O 0 0.00023078381491359323

A O 0 0.0010134188923984766
younger O 0 0.00021922455925960094
half O 0 5.826330743730068e-05
- O 0 0.0001370315148960799
sister O 0 6.058533108443953e-05
, O 0 3.910745817847783e-06
who O 0 4.427305611898191e-06
had O 0 8.903755770006683e-06
no O 0 1.3180130736145657e-05
underlying O 1 0.9998385906219482
disease O 1 0.9999902248382568
, O 0 1.6972291632555425e-05
was O 0 0.00028014046256430447
also O 0 1.8199727946921485e-06
found O 0 1.1462361726444215e-06
to O 0 1.245249677594984e-06
lack O 0 3.418763662921265e-05
immunochemically O 1 0.9481601715087891
detectable O 0 0.3892393410205841
C5 O 1 0.9991218447685242
. O 0 0.0002889833995141089

By O 0 0.0005893911002203822
hemolytic O 1 0.9999452829360962
assay O 0 0.0002143973542843014
, O 0 3.0753566534258425e-05
she O 0 1.1697397894749884e-05
exhibited O 0 1.2442403203749564e-05
1 O 0 1.0969346476485953e-05
- O 0 7.631209882674739e-06
2 O 0 4.067292138643097e-06
% O 0 1.4032971193955746e-06
of O 0 2.3817062810849166e-06
the O 0 3.418192363824346e-06
normal O 0 5.918755960010458e-06
serum O 0 6.122582999523729e-05
C5 O 0 0.002302230801433325
level O 0 5.61496926820837e-06
and O 0 8.146698178279621e-07
normal O 0 1.4396530332305701e-06
concentrations O 0 2.052960326182074e-06
of O 0 1.5098788708201027e-06
other O 0 2.0657100776588777e-06
complement O 0 1.7178215784952044e-05
components O 0 5.1834187615895644e-05
. O 0 0.00010532917076488957

C5 O 1 0.9198817610740662
levels O 0 7.882292266003788e-05
of O 0 2.2648451704299077e-05
other O 0 3.671960939755081e-06
family O 0 4.4434218580136076e-06
members O 0 9.256339126295643e-07
were O 0 1.0830138990058913e-06
either O 0 6.805686325606075e-07
normal O 0 1.1047284260712331e-06
or O 0 9.920663615048397e-07
approximately O 0 4.98757754030521e-06
half O 0 6.032419605617179e-06
- O 0 9.159149158222135e-06
normal O 0 2.0366692297102418e-06
, O 0 1.196384005197615e-06
consistent O 0 1.9927181256207405e-06
with O 0 1.3704579941986594e-06
autosomal O 0 5.7213885156670585e-05
codominant O 1 0.7514879107475281
inheritance O 0 5.3786468924954534e-05
of O 0 1.4469963389274199e-05
the O 0 2.066050910798367e-05
gene O 0 5.2274292102083564e-05
determining O 0 0.002150943037122488
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.027086926624178886

Normal O 0 0.0023984210565686226
hemolytic O 1 0.9999860525131226
titers O 0 0.009723791852593422
were O 0 5.712082565878518e-05
restored O 0 9.578119352227077e-05
to O 0 5.585504368355032e-06
both O 0 8.708667337486986e-06
homozygous O 0 0.00035176007077097893
C5 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999227523803711
deficient I-Disease 1 0.9999963045120239
( O 0 0.0008559169946238399
C5D B-Disease 1 0.9999998807907104
) O 0 8.021957000892144e-06
sera O 0 2.180035698984284e-05
by O 0 6.275949431255867e-07
addition O 0 1.217110138895805e-06
of O 0 3.1098438739718404e-06
highly O 0 2.061968552879989e-05
purified O 0 0.0001337626890745014
human O 0 3.8411355490097776e-05
C5 O 1 0.8481512069702148
. O 0 0.0001232224312843755

In O 0 0.0001165656722150743
specific O 0 4.192092819721438e-05
C5 O 1 0.9997239708900452
titrations O 0 0.0027144302148371935
, O 0 7.642323907930404e-06
however O 0 3.106601070612669e-06
, O 0 1.9355391032149782e-06
it O 0 6.775242695766792e-07
was O 0 4.658001671487e-06
noted O 0 1.237359697370266e-06
that O 0 2.038825215322504e-07
when O 0 4.5321385755414667e-07
limited O 0 4.695635595908243e-07
amounts O 0 7.298762056962005e-07
of O 0 3.3741673632903257e-06
C5 O 0 0.13973967730998993
were O 0 3.6685341910924762e-06
assayed O 0 1.0506071703275666e-05
in O 0 1.001523969534901e-06
the O 0 8.134144309224212e-07
presence O 0 1.7611961311558844e-06
of O 0 2.467061449351604e-06
low O 0 1.0011362974182703e-05
dilutions O 0 2.6353116481914185e-05
of O 0 7.158525022532558e-06
either O 0 1.5018157682789024e-05
C5D B-Disease 1 0.9999967813491821
serum O 0 0.00026128595345653594
, O 0 5.869907909072936e-06
curving O 0 8.093358701444231e-06
rather O 0 1.0244209533993853e-06
than O 0 4.90822174015193e-07
linear O 0 4.796965185960289e-06
dose O 0 1.28038745970116e-05
- O 0 8.10595702205319e-06
response O 0 1.5683525589338387e-06
plots O 0 2.4287694486702094e-06
were O 0 1.5026705568743637e-06
consistently O 0 2.4600435608590487e-06
obtained O 0 1.7338186353299534e-06
, O 0 2.619696488181944e-06
suggesting O 0 6.953577212698292e-06
some O 0 2.932532652266673e-06
inhibitory O 0 6.786512676626444e-05
effect O 0 8.21699941297993e-05
. O 0 0.00010284278687322512

Further O 0 0.00013163141557015479
studies O 0 3.423256202950142e-05
suggested O 0 1.2039395187457558e-05
that O 0 2.6485729449632345e-06
low O 0 1.0482891411811579e-05
dilutions O 0 0.0001087580676539801
of O 0 2.9723185434704646e-05
C5D B-Disease 1 0.9999985694885254
serum O 0 0.00017606325855012983
contain O 0 5.167069957678905e-06
a O 0 5.165665697859367e-06
factor O 0 3.541340674928506e-06
( O 0 1.6539198668397148e-06
or O 0 9.715326996229123e-07
factors O 0 1.8257181864100858e-06
) O 0 1.1000962558682659e-06
interfering O 0 2.450999772918294e-06
at O 0 2.7842752388096415e-06
some O 0 8.00609711859579e-07
step O 0 2.3704803879809333e-06
in O 0 1.0155448535442702e-06
the O 0 5.083164523966843e-06
hemolytic O 1 0.9999312162399292
assay O 0 3.2912572351051494e-05
of O 0 6.398795812856406e-05
C5 O 1 0.9978798627853394
, O 0 3.7023526147095254e-06
rather O 0 9.017597903948626e-07
than O 0 5.560406179938582e-07
a O 0 2.290351176270633e-06
true O 0 1.829017674026545e-05
C5 O 1 0.9997133612632751
inhibitor O 0 0.0005617249989882112
or O 0 4.187658123555593e-05
inactivator O 0 0.002307478804141283
. O 0 0.00023311517725232989

Of O 0 0.00011317672760924324
clinical O 0 0.00014411605661734939
interest O 0 1.3831420801579952e-05
are O 0 7.814843456799281e-07
( O 0 1.5254188383551082e-06
a O 0 1.7944945511771948e-06
) O 0 8.907314850148396e-07
the O 0 1.2253887007318554e-06
documentation O 0 9.589204637450166e-06
of O 0 0.0003868236090056598
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 1 0.9887722134590149
vasculitis B-Disease 1 1.0
, O 0 0.023102743551135063
and O 0 0.0014204042963683605
arthritis B-Disease 1 1.0
in O 0 4.028678813483566e-05
an O 0 1.3155255146557465e-05
individual O 0 7.158012522268109e-06
lacking O 0 0.03863745182752609
C5 O 1 0.9999433755874634
( O 0 2.8386727990437066e-06
and O 0 1.01584225831175e-06
its O 0 1.0450363561176346e-06
biologic O 0 2.1547793949139304e-05
functions O 0 7.384030595858349e-07
) O 0 7.027248329904978e-07
, O 0 4.0555497093919257e-07
and O 0 3.5697181033356173e-07
( O 0 9.994221272791037e-07
b O 0 4.446032562555047e-06
) O 0 1.162897547146713e-06
a O 0 2.048157284662011e-06
remarkable O 0 1.0173694136028644e-05
propensity O 0 4.216473826090805e-05
to O 0 4.706840627477504e-06
bacterial B-Disease 1 0.9992772936820984
infections I-Disease 1 0.9396815896034241
in O 0 9.059127478394657e-06
the O 0 1.579445779498201e-05
proband O 0 0.0009896239498630166
, O 0 2.4127800770656904e-06
even O 0 6.972355777179473e-07
during O 0 2.7534574655874167e-06
periods O 0 3.0222672648960724e-06
of O 0 3.4635943393368507e-06
low O 0 1.8138016457669437e-05
- O 0 1.7462063624407165e-05
dose O 0 8.439707926299889e-06
or O 0 1.8814569102687528e-06
alternate O 0 5.7352776821062434e-06
- O 0 2.650967326189857e-05
day O 0 2.933637188107241e-05
corticosteroid O 0 0.1426810920238495
therapy O 0 0.0028561304789036512
. O 0 0.0001377783337375149

Other O 0 3.4980897908098996e-05
observations O 0 2.8734093575621955e-05
indicate O 0 2.7210280677536502e-05
that O 0 3.7473669181053992e-06
the O 0 8.58996372699039e-06
C5D B-Disease 1 0.9999372959136963
state O 0 5.28134114574641e-06
is O 0 2.001925622607814e-06
compatible O 0 2.5196718524966855e-06
with O 0 5.862623879693274e-07
normal O 0 2.7059415970143164e-06
coagulation O 0 6.022105662850663e-05
function O 0 2.2126139356259955e-06
and O 0 1.0641144854162121e-06
the O 0 1.6405607539127232e-06
capacity O 0 6.983289040363161e-06
to O 0 2.433183453831589e-06
mount O 0 0.00019953250011894852
a O 0 4.1727493226062506e-05
neutrophilic O 1 0.9953885078430176
leukocytosis O 1 0.5669594407081604
during O 0 0.00036918430123478174
pyogenic B-Disease 1 0.9680892825126648
infection I-Disease 0 0.0005213362746872008
. O 0 2.448891245876439e-05
. O 0 4.7288049245253205e-05

Susceptibility O 1 0.9983512163162231
to O 0 0.18920640647411346
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.0012091173557564616
twins O 0 0.00033581978641450405
: O 0 5.019778200221481e-06
the O 0 2.8994404601689894e-06
role O 0 3.2044079034676543e-06
of O 0 3.545270828908542e-06
genes O 0 4.499178430705797e-06
, O 0 6.952728199394187e-06
HLA O 1 0.9986018538475037
, O 0 6.37859102425864e-06
and O 0 3.691986421472393e-06
the O 0 1.7533415302750655e-05
environment O 0 4.833472121390514e-05
. O 0 8.405797416344285e-05

OBJECTIVE O 0 0.00042581252637319267
To O 0 1.2257147318450734e-05
determine O 0 6.963757186895236e-06
the O 0 6.0171478253323585e-06
relative O 0 1.254022845387226e-05
effects O 0 9.928055987984408e-06
of O 0 5.027434326621005e-06
genetic O 0 2.366665648878552e-05
and O 0 1.9296448954264633e-06
environmental O 0 7.56703047954943e-06
factors O 0 2.2933149921300355e-06
in O 0 3.173808863721206e-06
susceptibility O 0 0.2503524124622345
to O 0 0.026088522747159004
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9281221032142639
AS B-Disease 1 0.9995001554489136
) O 0 0.00011025461571989581
. O 0 0.00014524537255056202

METHODS O 0 0.0003817963879555464
Twins O 0 0.00019550201250240207
with O 0 1.0787694009195548e-05
AS B-Disease 0 0.0044328137300908566
were O 0 7.1457020567322616e-06
identified O 0 5.125358256918844e-06
from O 0 2.10117946153332e-06
the O 0 3.720680524565978e-06
Royal O 0 0.001183254411444068
National O 1 0.7683187127113342
Hospital O 1 0.9999990463256836
for O 1 0.9872102737426758
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 1 0.9584795236587524
. O 0 0.0005393641768023372

Clinical O 0 0.0008891873876564205
and O 0 3.9951177313923836e-05
radiographic O 0 0.0002275031729368493
examinations O 0 3.0209273973014206e-05
were O 0 5.991294528939761e-06
performed O 0 8.720992809685413e-06
to O 0 2.5819217626121826e-06
establish O 0 1.301837164646713e-05
diagnoses O 0 0.00028932769782841206
, O 0 1.3303977539180778e-05
and O 0 1.8676397303352132e-05
disease O 1 0.9989420771598816
severity O 0 0.02558758854866028
was O 0 0.004479270428419113
assessed O 0 7.34212017050595e-06
using O 0 1.2867191117038601e-06
a O 0 2.7455230338091496e-06
combination O 0 4.427065050549572e-06
of O 0 6.008580839989008e-06
validated O 0 3.587556420825422e-05
scoring O 0 6.294176273513585e-05
systems O 0 0.00014643043687101454
. O 0 0.00011201865709153935

HLA O 1 0.995818555355072
typing O 0 0.0011284584179520607
for O 0 0.0001955362968146801
HLA O 1 0.9999669790267944
- O 0 0.22739046812057495
B27 O 1 0.5466709733009338
, O 0 6.476923590525985e-05
HLA O 1 0.9998457431793213
- O 0 0.000830229779239744
B60 O 0 0.0014929297612980008
, O 0 1.131205317506101e-05
and O 0 1.018527564156102e-05
HLA O 1 0.9999881982803345
- O 0 0.40764597058296204
DR1 O 1 0.9996283054351807
was O 0 3.152294812025502e-05
performed O 0 5.11905182065675e-06
by O 0 1.7773672880139202e-06
polymerase O 0 1.8697945051826537e-05
chain O 0 5.4832989917485975e-06
reaction O 0 1.2459731806302443e-06
with O 0 8.07815979442239e-07
sequence O 0 2.7688224690791685e-06
- O 0 4.4180642362334765e-06
specific O 0 7.835701012481877e-07
primers O 0 9.707310709927697e-06
, O 0 2.550980525484192e-06
and O 0 2.236885848105885e-06
zygosity O 0 6.112176197348163e-05
was O 0 2.3374706870527007e-05
assessed O 0 1.2616712410817854e-05
using O 0 1.5241947039612569e-05
microsatellite O 0 0.0005620907759293914
markers O 0 0.00036109297070652246
. O 0 0.00013410225801635534

Genetic O 0 0.000312165793729946
and O 0 1.2583522220666055e-05
environmental O 0 1.3542896340368316e-05
variance O 0 3.6223457300366135e-06
components O 0 6.064623903512256e-06
were O 0 1.574459361108893e-06
assessed O 0 2.4720566216274165e-06
with O 0 8.21487788016384e-07
the O 0 2.981446868943749e-06
program O 0 4.0034901758190244e-06
Mx O 0 2.9456918127834797e-05
, O 0 6.041119604560663e-07
using O 0 1.6613579134627798e-07
data O 0 2.3040691132791835e-07
from O 0 2.6302708988623635e-07
this O 0 2.1208940381711727e-07
and O 0 4.428376882970042e-07
previous O 0 1.2556411093100905e-06
studies O 0 1.6400163076468743e-06
of O 0 3.81992458642344e-06
twins O 0 2.992557710967958e-05
with O 0 6.817470875830622e-06
AS B-Disease 1 0.555596113204956
. O 0 0.000115496754006017

RESULTS O 0 0.00016106039402075112
Six O 0 4.841032568947412e-05
of O 0 4.8649868404027075e-05
8 O 0 0.0002020619867835194
monozygotic O 0 0.005865705665200949
( O 0 8.085884473985061e-05
MZ O 1 0.9997097849845886
) O 0 1.3071541616227478e-05
twin O 0 2.592116652522236e-05
pairs O 0 5.689842510037124e-06
were O 0 7.206521786429221e-06
disease O 0 0.017512714490294456
concordant O 0 0.0001121362074627541
, O 0 5.030100510339253e-06
compared O 0 3.62545256393787e-06
with O 0 1.4610570815420942e-06
4 O 0 9.114206477534026e-06
of O 0 9.048921128851362e-06
15 O 0 1.9754046661546454e-05
B27 O 0 0.00018166440713685006
- O 0 3.0066457838984206e-05
positive O 0 6.89228909322992e-06
dizygotic O 0 0.00020504345593508333
( O 0 1.7783366274670698e-05
DZ O 0 0.07770660519599915
) O 0 8.809463906800374e-06
twin O 0 1.5087292013049591e-05
pairs O 0 1.726843606775219e-06
( O 0 1.6058771734606125e-06
27 O 0 5.527338089450495e-06
% O 0 1.8252846984978532e-06
) O 0 1.039626795318327e-06
and O 0 9.440758503842517e-07
4 O 0 4.753755092679057e-06
of O 0 8.079577128228266e-06
32 O 0 4.303173045627773e-05
DZ O 1 0.61113041639328
twin O 0 4.738745337817818e-05
pairs O 0 5.78824710828485e-06
overall O 0 7.799842933309264e-06
( O 0 3.145781647617696e-06
12 O 0 5.582196990872035e-06
. O 0 1.018619627757289e-06
5 O 0 4.466295649763197e-06
% O 0 8.008533768588677e-06
) O 0 2.2670536054647528e-05
. O 0 6.798703543609008e-05

Nonsignificant O 0 0.4195006489753723
increases O 0 0.00011094666842836887
in O 0 1.809810237318743e-05
similarity O 0 1.884286575659644e-05
with O 0 2.711055913096061e-06
regard O 0 4.957705641572829e-06
to O 0 2.213289235442062e-06
age O 0 6.239679350983351e-05
at O 1 0.9168733358383179
disease O 1 0.9999980926513672
onset O 1 0.9999934434890747
and O 0 4.528929821390193e-06
all O 0 9.067268820217578e-07
of O 0 6.9794336923223455e-06
the O 0 5.3082771046319976e-05
disease O 1 0.9719433784484863
severity O 0 4.977211574441753e-05
scores O 0 5.836382570123533e-06
assessed O 0 6.494356057373807e-06
were O 0 2.224983973064809e-06
noted O 0 4.9134382607007865e-06
in O 0 7.6641754276352e-06
disease O 1 0.9988580942153931
- O 0 0.4559400677680969
concordant O 1 0.9953808784484863
MZ O 1 0.9999958276748657
twins O 0 0.00021708052372559905
compared O 0 1.797938602976501e-05
with O 0 2.125873652403243e-05
concordant O 0 0.08118996769189835
DZ O 1 0.99996018409729
twins O 0 0.004282512702047825
. O 0 0.00017396129260305315

HLA O 1 0.9999936819076538
- O 1 0.8553352355957031
B27 O 0 0.24342350661754608
and O 0 1.4685119822388515e-05
B60 O 0 0.00013573700562119484
were O 0 2.6185875867668074e-06
associated O 0 1.7263955669477582e-06
with O 0 1.1760444067476783e-06
the O 0 2.6955982320941985e-05
disease O 1 0.9999122619628906
in O 0 1.6641055481159128e-05
probands O 1 0.9770366549491882
, O 0 1.7086910020225332e-06
and O 0 4.276008098713646e-07
the O 0 9.816976671572775e-07
rate O 0 2.1418329652078683e-06
of O 0 7.858340723032597e-06
disease O 1 0.9175358414649963
concordance O 0 7.177623047027737e-05
was O 0 5.4401047236751765e-05
significantly O 0 7.876993549871258e-06
increased O 0 4.760324372909963e-06
among O 0 5.2085538300161716e-06
DZ O 1 0.9453411102294922
twin O 0 1.7730973922880366e-05
pairs O 0 9.611210316506913e-07
in O 0 9.774685167940333e-07
which O 0 6.79971776662569e-07
the O 0 3.397801037863246e-06
co O 0 9.791259071789682e-05
- O 0 3.392479629837908e-05
twin O 0 1.612142841622699e-05
was O 0 1.0950940122711472e-05
positive O 0 1.7008237591653597e-06
for O 0 2.1202499738137703e-06
both O 0 7.84203439252451e-06
B27 O 0 0.0005466629518195987
and O 0 7.22836994100362e-05
DR1 O 1 0.8718027472496033
. O 0 0.00023961965052876621

Additive O 0 0.0007119477377273142
genetic O 0 0.00019036377489101142
effects O 0 6.81670499034226e-05
were O 0 1.3833544471708592e-05
estimated O 0 7.844293577363715e-06
to O 0 1.4858554777674726e-06
contribute O 0 3.90007926398539e-06
97 O 0 1.0867471246456262e-05
% O 0 2.936806367870304e-06
of O 0 4.165675363765331e-06
the O 0 8.149292625603266e-06
population O 0 9.939793926605489e-06
variance O 0 2.263454553030897e-05
. O 0 4.7630110202590004e-05

CONCLUSION O 0 0.0005670667160302401
Susceptibility O 0 0.0012718356447294354
to O 0 1.1772578545787837e-05
AS B-Disease 0 0.003440250875428319
is O 0 3.4887593756138813e-06
largely O 0 5.638870788970962e-06
genetically O 0 2.5050253498193342e-06
determined O 0 1.2312398212088738e-06
, O 0 6.430051371353329e-07
and O 0 4.530712374162249e-07
the O 0 1.7363072402076796e-06
environmental O 0 7.251345323311398e-06
trigger O 0 5.137465450388845e-06
for O 0 1.3368206737141008e-06
the O 0 1.6945006791502237e-05
disease O 1 0.9997836947441101
is O 0 2.394994407950435e-05
probably O 0 6.900578591739759e-05
ubiquitous O 0 0.00015237480693031102
. O 0 5.79309489694424e-05

HLA O 1 0.9999692440032959
- O 0 0.007134170737117529
B27 O 0 0.0003745152207557112
accounts O 0 5.14698922415846e-06
for O 0 1.804389512471971e-06
a O 0 3.3511328183521982e-06
minority O 0 2.5585432013031095e-06
of O 0 2.924717819041689e-06
the O 0 6.6127709033025894e-06
overall O 0 4.282711961423047e-05
genetic O 0 0.00019971045549027622
susceptibility O 0 0.0006005283212289214
to O 0 2.826371019182261e-05
AS B-Disease 0 0.2087639570236206
. O 0 0.00016351255180779845

Cell O 0 0.005047408398240805
cycle O 0 0.00037757903919555247
- O 0 0.0001192756972159259
dependent O 0 2.1970119632896967e-05
colocalization O 0 0.00037130116834305227
of O 0 2.3021497327135876e-05
BARD1 O 1 0.9954643845558167
and O 0 8.672340300108772e-06
BRCA1 O 0 6.202340591698885e-05
proteins O 0 5.061291176389204e-06
in O 0 3.372311084604007e-06
discrete O 0 1.664768933551386e-05
nuclear O 0 0.00017813687736634165
domains O 0 0.00013118606875650585
. O 0 9.716486965771765e-05

Germ O 1 0.9999747276306152
- O 0 0.0009455893305130303
line O 0 4.0675524360267445e-05
mutations O 0 4.979683126293821e-06
of O 0 6.363020020216936e-06
the O 0 1.0840734830708243e-05
BRCA1 O 0 0.004167431499809027
gene O 0 1.2574310858326498e-05
predispose O 0 2.2198413716978393e-05
women O 0 1.7077753682315233e-06
to O 0 1.2288995776543743e-06
early O 0 9.991533261199947e-06
- O 0 0.0012228015111759305
onset O 1 0.9999995231628418
breast B-Disease 1 1.0
and I-Disease 1 0.9999700784683228
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 2.5850267775240354e-05
compromising O 0 0.000145076381159015
the O 0 1.0307732736691833e-05
genes O 0 5.867747859156225e-06
presumptive O 0 0.0005165733164176345
function O 0 1.1081852790084668e-05
as O 0 1.3421343282971065e-05
a O 0 9.114818385569379e-05
tumor B-Disease 1 0.9999396800994873
suppressor O 0 0.12204084545373917
. O 0 0.00015888613415881991

Although O 0 4.0698341763345525e-05
the O 0 2.5492427084827796e-05
biochemical O 0 9.186686656903476e-05
properties O 0 2.5385803382960148e-05
of O 0 2.4220791601692326e-05
BRCA1 O 0 0.0011742578353732824
polypeptides O 0 1.0140738595509902e-05
are O 0 5.615198119812703e-07
not O 0 4.99764894357213e-07
understood O 0 2.447561200824566e-06
, O 0 8.067765975283692e-07
their O 0 5.383423058447079e-07
expression O 0 3.2955745155049954e-06
pattern O 0 5.365072411223082e-06
and O 0 2.211061428170069e-06
subcellular O 0 1.8717264538281597e-05
localization O 0 1.5132307453313842e-05
suggest O 0 2.0950765247107483e-06
a O 0 2.782977162496536e-06
role O 0 7.90747617429588e-06
in O 0 9.158398825093172e-06
cell O 0 9.985620272345841e-05
- O 0 6.300228415057063e-05
cycle O 0 7.822500629117712e-05
regulation O 0 7.164015551097691e-05
. O 0 6.191130523802713e-05

When O 0 0.000285356305539608
resting O 0 0.009920209646224976
cells O 0 2.5708364773890935e-05
are O 0 2.4148978354787687e-06
induced O 0 2.8995098546147346e-05
to O 0 5.12581800649059e-06
proliferate O 0 1.7076537915272638e-05
, O 0 1.8330001694266684e-06
the O 0 2.084359039145056e-06
steady O 0 2.7317271815263666e-05
- O 0 3.2443238069390645e-06
state O 0 7.379376825156214e-07
levels O 0 1.0327382824470988e-06
of O 0 2.558796950324904e-06
BRCA1 O 0 1.2709651855402626e-05
increase O 0 2.074538770102663e-06
in O 0 1.6229698758252198e-06
late O 0 1.0103400200023316e-05
G1 O 0 0.00014866174024064094
and O 0 2.104524583046441e-06
reach O 0 3.3872186122607673e-06
a O 0 2.915797949754051e-06
maximum O 0 6.5705708038876764e-06
during O 0 2.7618056265055202e-05
S O 0 0.0003298016672488302
phase O 0 0.00030983382021076977
. O 0 0.0001487444096710533

Moreover O 0 0.00023916889040265232
, O 0 2.48629912675824e-05
in O 0 1.1598866876738612e-05
S O 0 0.00025959720369428396
phase O 0 0.0014112143544480205
cells O 0 1.8884114979300648e-05
, O 0 4.6751219997531734e-06
BRCA1 O 0 2.2996329789748415e-05
polypeptides O 0 4.623467702913331e-06
are O 0 4.959603074894403e-07
hyperphosphorylated O 0 2.2831849491922185e-05
and O 0 1.7810102690418717e-06
accumulate O 0 7.3473661359457765e-06
into O 0 5.1248307499918155e-06
discrete O 0 7.784526133036707e-06
subnuclear O 0 0.00020713242702186108
foci O 0 0.0001692668884061277
termed O 0 5.8208552218275145e-05
" O 0 3.905266203219071e-05
BRCA1 O 0 0.000195909189642407
nuclear O 0 0.00033576562418602407
dots O 0 0.00024101209419313818
. O 0 0.00012446263281162828

" O 0 0.0009155457373708487
BRCA1 O 0 0.004438570700585842
associates O 0 0.0003581807832233608
in O 0 2.222608236479573e-05
vivo O 0 4.912084841635078e-05
with O 0 2.873550783988321e-06
a O 0 1.0644143912941217e-05
structurally O 0 0.00013339291035663337
related O 0 2.165675505239051e-05
protein O 0 6.067367212381214e-05
termed O 0 0.000242374197114259
BARD1 O 1 0.9977515339851379
. O 0 0.0002272432466270402

Here O 0 0.0002625726046971977
we O 0 2.5200870368280448e-05
show O 0 1.0516577276575845e-05
that O 0 2.238131855847314e-06
the O 0 3.5201210266677663e-06
steady O 0 3.2045310945250094e-05
- O 0 6.185747224662919e-06
state O 0 1.354817186438595e-06
levels O 0 2.3172563032858307e-06
of O 0 5.42214684173814e-06
BARD1 O 1 0.9771594405174255
, O 0 2.0942895844200393e-06
unlike O 0 1.0219326895821723e-06
those O 0 5.552521429308399e-07
of O 0 3.5834302707371535e-06
BRCA1 O 0 6.708712317049503e-05
, O 0 3.1472459340875503e-06
remain O 0 3.6455928693612805e-06
relatively O 0 2.6121201699425e-06
constant O 0 8.613867976237088e-06
during O 0 2.5043944333447143e-05
cell O 0 0.0002619359875097871
cycle O 0 0.00015694103785790503
progression O 0 0.005370425526052713
. O 0 0.00013847692753188312

However O 0 0.00021524165640585124
, O 0 7.498488412238657e-05
immunostaining O 0 0.0014969361945986748
revealed O 0 5.204429180594161e-05
that O 0 6.251235845411429e-06
BARD1 O 0 0.48200124502182007
resides O 0 4.164341589785181e-05
within O 0 7.191019903984852e-06
BRCA1 O 0 9.107546793529764e-05
nuclear O 0 6.666730041615665e-05
dots O 0 1.544686710985843e-05
during O 0 1.2079532098141499e-05
S O 0 2.253787715744693e-05
phase O 0 9.117457011598162e-06
of O 0 3.5620601011032704e-06
the O 0 4.503123363974737e-06
cell O 0 9.64419450610876e-06
cycle O 0 3.927651050616987e-06
, O 0 9.816742476687068e-07
but O 0 3.655308944416902e-07
not O 0 3.2132595606526593e-07
during O 0 3.987795025750529e-06
the O 0 1.7778687833924778e-05
G1 O 1 0.5994317531585693
phase O 0 0.0010934454621747136
. O 0 0.00025749107589945197

Nevertheless O 0 0.000889632327016443
, O 0 0.00011358800838934258
BARD1 O 0 0.48450642824172974
polypeptides O 0 4.1561925172572955e-05
are O 0 1.7240577108168509e-06
found O 0 2.8989261409151368e-06
exclusively O 0 2.878125542338239e-06
in O 0 1.9140807125950232e-06
the O 0 3.0181654437910765e-06
nuclear O 0 2.259902066725772e-05
fractions O 0 6.563186616403982e-06
of O 0 4.214191903884057e-06
both O 0 5.084066742711002e-06
G1 O 0 0.02632402814924717
- O 0 5.625106496154331e-05
and O 0 9.670719919085968e-06
S O 0 0.0003552765119820833
- O 0 8.834831533022225e-05
phase O 0 0.000557943363673985
cells O 0 6.944107008166611e-05
. O 0 4.275647734175436e-05

Therefore O 0 0.00018695929611567408
, O 0 3.1219326046993956e-05
progression O 0 0.00013716067769564688
to O 0 9.624807717045769e-06
S O 0 0.00013434430002234876
phase O 0 3.6499241105047986e-05
is O 0 5.089772002975224e-06
accompanied O 0 5.943558790022507e-06
by O 0 6.097566256357823e-07
the O 0 1.8914199699793244e-06
aggregation O 0 7.82030929258326e-06
of O 0 8.658588740217965e-06
nuclear O 0 0.0005516670062206686
BARD1 O 1 0.7192980647087097
polypeptides O 0 2.4144248527591117e-05
into O 0 1.0781307537399698e-05
BRCA1 O 0 0.00011635301052592695
nuclear O 0 0.0002879506500903517
dots O 0 0.00029103635461069643
. O 0 9.200458589475602e-05

This O 0 0.00018256893963553011
cell O 0 0.0003462928580120206
cycle O 0 0.00012525197234936059
- O 0 8.754381269682199e-05
dependent O 0 1.9989336578873917e-05
colocalization O 0 0.00023416909971274436
of O 0 3.6827266740147024e-05
BARD1 O 1 0.9994871616363525
and O 0 1.0217095223197248e-05
BRCA1 O 0 4.415520015754737e-05
indicates O 0 1.4064526112633757e-05
a O 0 4.282434019842185e-06
role O 0 5.385978056438034e-06
for O 0 4.072780484420946e-06
BARD1 O 1 0.9108102321624756
in O 0 3.533087146934122e-05
BRCA1 O 0 0.33180010318756104
- O 1 0.678891658782959
mediated O 1 0.9957296252250671
tumor B-Disease 1 0.9999804496765137
suppression O 1 0.710480272769928
. O 0 0.00040564144728705287

Ethnic O 0 0.00035020746872760355
differences O 0 9.698787471279502e-05
in O 0 3.324721546960063e-05
the O 0 6.326315633486956e-05
HFE O 1 0.807969331741333
codon O 0 0.00017331080744042993
282 O 0 0.0002965409366879612
( O 0 0.0001242396974703297
Cys O 1 0.9994584918022156
/ O 0 0.04429391771554947
Tyr O 0 0.02368813566863537
) O 0 0.00012168776447651908
polymorphism O 0 0.0003276395727880299
. O 0 0.0002517199900466949

Recent O 0 6.998019671300426e-05
studies O 0 1.4141160136205144e-05
have O 0 2.1941166323813377e-06
shown O 0 5.505390618054662e-06
that O 0 7.97908433014527e-06
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 1 0.9999990463256836
HH B-Disease 1 1.0
) O 0 2.986675826832652e-05
is O 0 1.8175097693529096e-06
likely O 0 6.422966407626518e-07
to O 0 4.116623131267261e-07
be O 0 5.10576796841633e-07
caused O 0 3.791408971665078e-06
by O 0 1.252235392712464e-06
homozygosity O 0 6.411072536138818e-05
for O 0 2.543166147006559e-06
a O 0 1.0165226740355138e-05
Cys282Tyr O 0 0.0008366809342987835
mutation O 0 6.143939572211821e-06
in O 0 2.981498255394399e-06
the O 0 7.846987500670366e-06
HFE O 0 0.3744339942932129
gene O 0 2.5960202037822455e-05
located O 0 7.120351801859215e-05
4 O 0 8.816702757030725e-05
. O 0 8.849148434819654e-05

5 O 0 0.0007476531318388879
Mb O 0 0.006979320663958788
telomeric O 0 0.001645406475290656
to O 0 0.00017039719386957586
HLA O 1 0.9997580647468567
- O 0 0.009805580601096153
A O 0 0.004524317570030689
. O 0 0.00017102893616538495

Population O 0 5.381525625125505e-05
studies O 0 1.2393257748044562e-05
of O 0 6.768023922631983e-06
this O 0 2.5494944111414952e-06
polymorphism O 0 1.838744901760947e-05
are O 0 1.497901735092455e-06
facilitated O 0 6.582073183380999e-06
by O 0 1.0915831580859958e-06
the O 0 2.2196243207872612e-06
fact O 0 1.424897050128493e-06
that O 0 4.6327576797011716e-07
the O 0 1.9291608168714447e-06
Cys282Tyr O 0 0.02448223903775215
mutation O 0 6.641393611062085e-06
creates O 0 1.067572975443909e-05
a O 0 1.6322506780852564e-05
Rsal O 0 0.0009693731553852558
restriction O 0 3.5652308724820614e-05
site O 0 0.00011927376181120053
. O 0 8.077560778474435e-05

We O 0 5.5895048717502505e-05
have O 0 7.334099791478366e-06
studied O 0 2.8354148525977507e-05
the O 0 1.1617630661930889e-05
codon O 0 5.9459314798004925e-05
282 O 0 0.00013567051792051643
( O 0 9.603425132809207e-05
Cys O 1 0.9994400143623352
/ O 0 0.013164717704057693
Tyr O 0 0.0005477749509736896
) O 0 1.049569618771784e-05
polymorphism O 0 1.0111555639014114e-05
in O 0 2.9750819976470666e-06
different O 0 1.06675020106195e-06
ethnic O 0 1.3970097825222183e-05
groups O 0 1.6466017768834718e-05
. O 0 5.8105790230911225e-05

In O 0 4.053561860928312e-05
agreement O 0 1.752990465320181e-05
with O 0 5.8522450672171544e-06
previous O 0 5.409760888142046e-06
observations O 0 9.266070264857262e-06
the O 0 9.527511792839505e-06
Tyr O 0 0.00020911921455990523
allele O 0 1.015310590446461e-05
appeared O 0 7.197922059276607e-06
to O 0 1.4267667438616627e-06
be O 0 1.1676048643494141e-06
rare O 0 3.388591721886769e-06
or O 0 3.1680360734753776e-06
absent O 0 1.9124576283502392e-05
in O 0 9.470478289586026e-06
Asiatic O 0 0.0009846845641732216
( O 0 1.387090469506802e-05
Indian O 0 2.09446698136162e-05
, O 0 6.84617134538712e-06
Chinese O 0 2.0457351638469845e-05
) O 0 1.004463410936296e-05
populations O 0 2.08748006116366e-05
. O 0 4.498110865824856e-05

The O 0 9.011129441205412e-05
highest O 0 4.9818609113572165e-05
allele O 0 9.068688086699694e-06
frequency O 0 6.817015673732385e-06
( O 0 4.958159479429014e-06
7 O 0 6.453478363255272e-06
. O 0 1.536825834591582e-06
5 O 0 2.631221832416486e-06
% O 0 2.5943963919417e-06
) O 0 3.0587439141527284e-06
was O 0 1.313577467954019e-05
found O 0 2.9859259029763052e-06
in O 0 6.89046828483697e-06
Swedes O 0 0.00023247126955538988
. O 0 0.00011979717965004966

Saamis O 0 0.0032395320013165474
( O 0 0.00010013540304498747
2 O 0 6.752750050509349e-05
% O 0 2.6024576072813943e-05
) O 0 7.055606147332583e-06
and O 0 2.598358150862623e-06
Mordvinians O 0 8.424060797551647e-05
( O 0 3.404463086553733e-06
1 O 0 3.9353676584141795e-06
. O 0 1.125124640566355e-06
8 O 0 2.2520853235619143e-06
% O 0 1.6713072454876965e-06
) O 0 1.1507903536767117e-06
had O 0 2.813331320794532e-06
significantly O 0 2.7139585654367693e-06
lower O 0 2.4999085326271597e-06
frequencies O 0 2.345045231777476e-06
of O 0 4.475004971027374e-06
the O 0 1.277811225008918e-05
Tyr O 0 0.0007471228018403053
allele O 0 9.72414345596917e-05
. O 0 0.0001205286753247492

Comparisons O 0 8.148807683028281e-05
with O 0 1.695857099548448e-05
allele O 0 1.4319958609121386e-05
frequencies O 0 5.957786015642341e-06
based O 0 4.204196102364222e-06
on O 0 5.06157130075735e-06
prevalence O 0 1.5211031495709904e-05
estimates O 0 4.324384462961461e-06
of O 0 1.1403873941162601e-05
HH B-Disease 1 0.9999041557312012
showed O 0 2.7573190891416743e-05
some O 0 1.9518288354447577e-06
disagreements O 0 9.22454273677431e-06
with O 0 1.3730324326388654e-06
the O 0 7.113025276339613e-06
RFLP O 0 5.805455657537095e-05
data O 0 6.276863587117987e-06
, O 0 5.812298240925884e-06
particularly O 0 8.608300049672835e-06
in O 0 1.2596226042660419e-05
Finns O 0 0.0006523475749418139
. O 0 0.0001488851848989725

The O 0 0.00033666699891909957
newly O 0 0.0008940573898144066
described O 0 0.0004061696236021817
HFE O 1 0.9979210495948792
marker O 0 0.00019265706941951066
provides O 0 7.869154615036678e-06
a O 0 3.860145625367295e-06
new O 0 8.558486683796218e-07
approach O 0 1.2870774526163586e-06
to O 0 3.097590592915367e-07
the O 0 1.1789001064244076e-06
screening O 0 3.877278686559293e-06
of O 0 7.932051630632486e-06
HH B-Disease 1 0.9999474287033081
as O 0 5.4109268603497185e-06
well O 0 1.1015932841473841e-06
as O 0 9.548473371978616e-07
studies O 0 4.757338274430367e-07
of O 0 6.326511652332556e-07
the O 0 1.5000661051089992e-06
relationship O 0 2.8486201699706726e-06
between O 0 5.648520982504124e-06
the O 0 2.3149827029556036e-05
HFE O 1 0.9999715089797974
Tyr O 0 0.0033211756963282824
allele O 0 5.494951892615063e-06
and O 0 2.0259371922293212e-06
different O 0 2.0314028006396256e-06
disorders O 1 0.9999972581863403
including O 1 0.9124024510383606
cancer B-Disease 1 0.9999998807907104

Autosomal B-Disease 1 0.9998459815979004
dominant I-Disease 1 0.9999693632125854
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999794960021973
associated O 0 4.403258571983315e-05
with O 0 1.1358592928445432e-05
a O 0 1.5326135326176882e-05
missense O 0 5.944247095612809e-05
mutation O 0 9.176879757433198e-06
encoding O 0 1.9841349057969637e-05
Gly23 O 0 0.0036955135874450207
- O 0 0.00010345705959480256
- O 0 0.0001065033720806241
> O 0 0.00012223937665112317
Val O 0 0.0007332090754061937
in O 0 5.406983109423891e-05
neurophysin O 1 0.9454410076141357
II O 1 0.9999847412109375
. O 0 0.0003750869364012033

Autosomal B-Disease 1 0.9999222755432129
dominant I-Disease 1 0.9999955892562866
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9152284860610962
ADNDI B-Disease 1 0.9999985694885254
) O 0 1.2522554243332706e-05
is O 0 3.356310799063067e-06
an O 0 2.868896808649879e-05
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.9999997615814209
by O 1 0.9385892748832703
progressive O 1 1.0
degeneration O 1 1.0
of O 1 0.7487024068832397
the O 0 0.18555407226085663
magnocellular O 1 0.9999791383743286
neurons O 0 6.969102832954377e-05
of O 0 6.911047876201337e-06
the O 0 1.0700396160245873e-05
hypothalamus O 0 6.477022543549538e-05
leading O 0 4.889985120826168e-06
to O 0 7.964463861753757e-07
decreased O 0 4.230649210512638e-06
ability O 0 6.639124308094324e-07
to O 0 3.949768938582565e-07
produce O 0 9.489194781053811e-07
the O 0 3.371038246768876e-06
hormone O 0 1.947158671100624e-05
arginine O 0 2.246770600322634e-05
vasopressin O 0 7.749944052193314e-05
( O 0 2.8376789487083443e-05
AVP O 0 0.007664496544748545
) O 0 3.554045542841777e-05
. O 0 8.547860488761216e-05

Affected O 0 0.00012193110887892544
individuals O 0 1.1949451618420426e-05
are O 0 1.968628794202232e-06
not O 0 1.8553815834820853e-06
symptomatic O 0 0.004417899996042252
at O 0 6.310721801128238e-05
birth O 0 4.777330832439475e-05
, O 0 3.2257664770440897e-06
but O 0 1.3534920526581118e-06
usually O 0 1.8913876829174114e-06
develop O 0 3.094676139880903e-05
diabetes B-Disease 1 0.9997840523719788
insipidus I-Disease 1 0.9458694458007812
at O 0 7.217577513074502e-05
1 O 0 0.00012382515706121922
- O 0 6.636024045292288e-05
6 O 0 6.562771159224212e-05
yr O 0 0.0009211825090460479
of O 0 2.724172009038739e-05
age O 0 0.0001541433302918449
. O 0 9.797899110708386e-05

The O 0 8.675688150105998e-05
genetic O 0 6.25095926807262e-05
locus O 0 4.077047560713254e-05
of O 0 2.4842114726197906e-05
the O 0 7.821694453014061e-05
disease O 1 0.9996070265769958
is O 0 1.7818407286540605e-05
the O 0 5.1353152230149135e-05
AVP O 1 0.9999949932098389
- O 1 0.694025993347168
neurophysin O 1 0.9998021721839905
II O 1 0.9999996423721313
( O 0 4.290887954994105e-05
NPII O 1 0.9973107576370239
) O 0 1.8541645658842754e-06
gene O 0 1.8664291019376833e-06
, O 0 9.370506859340821e-07
and O 0 5.848496016369609e-07
mutations O 0 1.5694133708166191e-06
that O 0 1.0177855074289255e-06
cause O 0 1.5480522051802836e-05
ADNDI B-Disease 1 0.9636464715003967
have O 0 1.0501837550691562e-06
been O 0 9.331037631454819e-07
found O 0 5.386180532696017e-07
in O 0 4.6133408204696025e-07
both O 0 5.185084432923759e-07
the O 0 2.006859403991257e-06
signal O 0 1.0132656825589947e-05
peptide O 0 9.15602231543744e-06
of O 0 3.3604487725824583e-06
the O 0 1.110904759116238e-05
prepro O 1 0.9870748519897461
- O 0 0.27599307894706726
AVP O 1 0.9999656677246094
- O 0 0.030662404373288155
NPII O 1 0.999447762966156
precursor O 0 0.00011417049245210364
and O 0 6.6941465775016695e-06
within O 0 1.7535237930133007e-05
NPII O 0 0.3852075934410095
itself O 0 0.00013770005898550153
. O 0 0.00012726856220979244

An O 0 0.00015634419105481356
affected O 0 6.7693974415306e-05
girl O 0 6.899578147567809e-05
who O 0 6.635259069298627e-06
presented O 0 7.67855908634374e-06
at O 0 6.0467550611065235e-06
9 O 0 7.067203114274889e-06
months O 0 3.128175876554451e-06
of O 0 3.504505457385676e-06
age O 0 9.914573638525326e-06
and O 0 2.7732012313208543e-06
her O 0 5.341404630598845e-06
similarly O 0 4.619192623067647e-06
affected O 0 3.166978558510891e-06
younger O 0 1.0738035598478746e-05
brother O 0 1.8308044673176482e-05
and O 0 1.2011088301733253e-06
father O 0 5.865470939170336e-06
were O 0 7.805502946212073e-07
all O 0 3.325398267861601e-07
found O 0 4.0009990698308684e-07
to O 0 3.4648354585442576e-07
have O 0 5.585577014244336e-07
a O 0 2.034171075138147e-06
novel O 0 4.240403995936504e-06
missense O 0 1.4092399396758992e-05
mutation O 0 3.974173068854725e-06
( O 0 4.4370699470164254e-06
G1758 O 0 0.00011889472807524726
- O 0 3.296377690276131e-05
- O 0 2.000337372010108e-05
> O 0 1.892359614430461e-05
T O 0 1.3712377040064894e-05
) O 0 6.484179948529345e-07
encoding O 0 9.343896181235323e-07
the O 0 1.3930831528341514e-06
amino O 0 3.1790161756362068e-06
acid O 0 4.870471002504928e-06
substitution O 0 1.7766791643225588e-05
Gly23 O 0 0.0022560658399015665
- O 0 0.00011658579751383513
- O 0 0.0001023339937091805
> O 0 0.00012699957005679607
Val O 0 0.0009090083185583353
within O 0 9.77110248641111e-05
NPII O 0 0.2741515636444092
. O 0 0.0002484098367858678

The O 0 0.0001387592637911439
mutation O 0 4.6800349082332104e-05
was O 0 6.331953045446426e-05
confirmed O 0 1.412188976246398e-05
by O 0 4.771828571392689e-06
restriction O 0 2.909323484345805e-05
endonuclease O 0 0.00012889904610347003
analysis O 0 4.627472662832588e-05
. O 0 0.00010102187661686912

A O 0 0.006491976790130138
T1 O 1 0.9997562766075134
- O 0 0.00030239889747463167
weighted O 0 4.256011743564159e-05
magnetic O 0 3.808211113209836e-05
resonance O 0 2.549964665377047e-05
imaging O 0 1.814248025766574e-05
of O 0 1.1312755304970779e-05
the O 0 4.607292066793889e-05
fathers O 0 0.006021886132657528
pituitary O 1 0.9996567964553833
gland O 1 0.8783645629882812
demonstrates O 0 0.0001781328028300777
an O 0 2.665073589014355e-05
attenuated O 0 0.14387419819831848
posterior O 1 0.629027247428894
pituitary O 1 0.9998400211334229
bright O 0 0.008950288407504559
spot O 0 0.0008345759124495089
. O 0 0.0002482653653714806

This O 0 3.575318987714127e-05
mutation O 0 2.6470492230146192e-05
may O 0 8.712579983694013e-06
be O 0 2.3462196168111404e-06
valuable O 0 9.438091183255892e-06
for O 0 3.7035181321698474e-06
developing O 0 1.1184691175003536e-05
models O 0 5.064521246822551e-06
of O 0 2.016997132159304e-05
dominantly B-Disease 1 0.9999876022338867
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 3.539531826390885e-05
as O 0 2.8767340154445264e-06
the O 0 2.240852836621343e-06
early O 0 4.317033472034382e-06
age O 0 6.0595421018661e-06
of O 0 1.170831274066586e-05
onset O 1 0.9999767541885376
of O 0 0.1229131743311882
symptoms O 1 0.9999150037765503
suggests O 0 3.6676734453067183e-05
that O 0 9.89538762041775e-07
this O 0 5.822056436954881e-07
mutation O 0 1.2960418871443835e-06
may O 0 1.228251562679361e-06
be O 0 7.910047088444117e-07
particularly O 0 2.2294339032669086e-06
deleterious O 0 1.0860778274945915e-05
to O 0 5.788291218777886e-06
the O 0 2.1978963559377007e-05
magnocellular O 1 0.8096001744270325
neuron O 0 0.00041636524838395417
. O 0 1.9958633856731467e-05
. O 0 6.346625013975427e-05

Frequent O 0 0.0005889067542739213
inactivation O 0 0.027486518025398254
of O 0 0.0019720690324902534
PTEN O 1 0.9999970197677612
/ O 1 0.9984637498855591
MMAC1 O 1 0.999958872795105
in O 0 0.00014185892359819263
primary O 1 0.999860405921936
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.008448762819170952

Sporadic B-Disease 1 0.9999901056289673
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.035044219344854355
the O 0 6.398576078936458e-05
most O 0 7.637165253981948e-06
common O 0 1.748314025462605e-05
male B-Disease 0 0.0006843542214483023
cancer I-Disease 1 0.6834268569946289
in O 0 5.347454134607688e-06
the O 0 8.773412446316797e-06
Western O 0 2.1291216398822144e-05
world O 0 3.8012167351553217e-06
, O 0 8.932094601732388e-07
yet O 0 3.9501685478171567e-07
many O 0 1.4089974342823552e-07
of O 0 5.586387032963103e-07
the O 0 1.038481286741444e-06
major O 0 1.799583696993068e-05
genetic O 0 6.059114639356267e-06
events O 0 1.4167277413434931e-06
involved O 0 1.7362079915983486e-06
in O 0 8.402881803704076e-07
the O 0 1.6110864180518547e-06
progression O 0 0.0003678143839351833
of O 0 4.085548425791785e-06
this O 0 1.6157547406692174e-06
often O 0 2.2562110189028317e-06
fatal O 1 0.8763236403465271
cancer B-Disease 1 0.7862616181373596
remain O 0 1.8200047634309158e-05
to O 0 5.75606736674672e-06
be O 0 1.4751130038348492e-05
elucidated O 0 0.0007185527356341481
. O 0 0.00016464527288917452

Numerous O 0 0.0006314166821539402
cytogenetic O 0 0.04917694255709648
and O 0 8.238836016971618e-05
allelotype O 0 0.2287416160106659
studies O 0 1.3115420188114513e-05
have O 0 2.215536142102792e-06
reported O 0 3.439735792198917e-06
frequent O 0 3.8171024243638385e-06
loss O 0 3.5827459214488044e-05
of O 0 2.8669441235251725e-05
heterozygosity O 1 0.988247811794281
on O 0 5.118404078530148e-05
chromosomal O 0 0.17475923895835876
arm O 0 0.07425960898399353
10q O 0 0.06622365117073059
in O 0 5.458677696879022e-05
sporadic B-Disease 1 0.9997714161872864
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.06166141480207443

Deletion O 0 0.00036529527278617024
mapping O 0 9.933092951541767e-05
studies O 0 1.610899380466435e-05
have O 0 2.7444600618764525e-06
unambiguously O 0 1.898107075248845e-05
identified O 0 3.4726699595921673e-06
a O 0 2.838118007275625e-06
region O 0 6.448156909755198e-06
of O 0 5.837362095917342e-06
chromosome O 0 2.2343263481161557e-05
10q23 O 0 2.612999378470704e-05
to O 0 1.0677282489268691e-06
be O 0 6.680299406980339e-07
the O 0 1.8128513374904287e-06
minimal O 0 1.2896040061605163e-05
area O 0 1.7287866285187192e-05
of O 0 3.0659801268484443e-05
loss O 1 0.8140971660614014
. O 0 0.00033696452737785876

A O 0 0.0005303359357640147
new O 0 8.004547271411866e-05
tumor B-Disease 1 0.9998637437820435
suppressor O 0 0.10206864774227142
gene O 0 1.533473187009804e-05
, O 0 1.2730200069199782e-05
PTEN O 1 0.99834144115448
/ O 0 0.03289083018898964
MMAC1 O 1 0.9987704157829285
, O 0 4.643347892852034e-06
was O 0 1.227067787112901e-05
isolated O 0 5.417866759671597e-06
recently O 0 2.3320078526012367e-06
at O 0 2.1787011519336374e-06
this O 0 8.592082281211333e-07
region O 0 3.2855764402484056e-06
of O 0 2.7649987259792397e-06
chromosome O 0 1.419087675458286e-05
10q23 O 0 2.792287887132261e-05
and O 0 4.995204108126927e-07
found O 0 3.2750014611337974e-07
to O 0 2.825196929734375e-07
be O 0 4.086130331870663e-07
inactivated O 0 5.605055775959045e-06
by O 0 7.141316018532962e-07
mutation O 0 1.622575268811488e-06
in O 0 3.043650622203131e-06
three O 0 4.848220487474464e-05
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9998544454574585
lines O 0 0.0007458242471329868
. O 0 0.00016281726129818708

We O 0 0.00012337975203990936
screened O 0 0.000221525551751256
80 O 0 0.0005916525260545313
prostate B-Disease 1 0.9999996423721313
tumors I-Disease 1 0.9999969005584717
by O 0 1.3630330613523256e-05
microsatellite O 0 0.0003131043922621757
analysis O 0 3.674234449135838e-06
and O 0 1.7456616205890896e-06
found O 0 3.585149670470855e-06
chromosome O 0 1.0640013897500467e-05
10q23 O 0 3.2392872526543215e-05
to O 0 2.036333398791612e-06
be O 0 2.804991709126625e-06
deleted O 0 1.4217534953786526e-05
in O 0 7.17492139301612e-06
23 O 0 4.5450025936588645e-05
cases O 0 2.817296626744792e-05
. O 0 0.00010162740363739431

We O 0 7.426366937579587e-05
then O 0 2.792958912323229e-05
proceeded O 0 3.0614279239671305e-05
with O 0 1.3946170156486914e-06
sequence O 0 2.232772203569766e-06
analysis O 0 1.748148861224763e-06
of O 0 3.7610932395182317e-06
the O 0 1.0169726010644808e-05
entire O 0 0.0003400611749384552
PTEN O 1 0.9998726844787598
/ O 0 0.1294092983007431
MMAC1 O 1 0.9869153499603271
coding O 0 4.26459992013406e-05
region O 0 1.2212984074722044e-05
and O 0 2.1096086584293516e-06
tested O 0 3.0055705337872496e-06
for O 0 1.1761924270103918e-06
homozygous O 0 4.9852092161017936e-06
deletion O 0 8.901726687327027e-06
with O 0 3.0853634598315693e-06
new O 0 5.8162127061223146e-06
intragenic O 0 0.003851501038298011
markers O 0 1.509507819719147e-05
in O 0 2.3689979116170434e-06
these O 0 7.689277481404133e-07
23 O 0 6.28626821708167e-06
cases O 0 2.0595375644916203e-06
with O 0 5.617921033262974e-06
10q23 O 0 0.04044971987605095
loss O 0 0.02713141031563282
of O 0 0.00046363327419385314
heterozygosity O 1 0.9998924732208252
. O 0 0.00035212928196415305

The O 0 6.747998850187287e-05
identification O 0 2.35505049204221e-05
of O 0 1.67325579241151e-05
the O 0 8.91575291461777e-06
second O 0 2.934535405074712e-05
mutational O 0 0.00011126568278996274
event O 0 1.2104162124160212e-05
in O 0 1.8896441815741127e-06
10 O 0 2.3030549982649973e-06
( O 0 1.22850110528816e-06
43 O 0 4.835468189412495e-06
% O 0 7.354642548307311e-06
) O 0 4.6842502342769876e-05
tumors B-Disease 1 0.999996542930603
establishes O 0 0.018254194408655167
PTEN O 1 0.9999407529830933
/ O 0 0.06325497478246689
MMAC1 O 0 0.47592905163764954
as O 0 5.0951234698004555e-06
a O 0 4.622867891157512e-06
main O 0 6.561428108398104e-06
inactivation O 0 4.204600918455981e-05
target O 0 3.90179775422439e-06
of O 0 7.938620910863392e-06
10q O 0 0.0002651019021868706
loss O 0 0.00013759768626186997
in O 0 3.2569685572525486e-05
sporadic B-Disease 1 0.9998511075973511
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0004154252528678626
. O 0 0.0001669637276791036

Risk O 0 0.0006973106064833701
reversals O 0 0.00043159836786799133
in O 0 3.098609886365011e-05
predictive O 0 8.888771117199212e-05
testing O 0 9.85275546554476e-05
for O 0 0.00026439360226504505
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.016808493062853813

The O 0 4.685568273998797e-05
first O 0 1.850308763096109e-05
predictive O 0 1.558420990477316e-05
testing O 0 1.2363201676635072e-05
for O 0 1.808716478990391e-05
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 8.225945202866569e-05
HD B-Disease 0 0.034327976405620575
) O 0 1.5250435581037891e-06
was O 0 3.0693627195432782e-06
based O 0 3.1029128422233043e-07
on O 0 5.214246812101919e-07
analysis O 0 3.9353949432552326e-07
of O 0 1.7900744069265784e-06
linked O 0 7.801249012118205e-06
polymorphic O 0 9.663997843745165e-06
DNA O 0 5.3427443162945565e-06
markers O 0 5.029774456488667e-06
to O 0 6.727090635649802e-07
estimate O 0 8.507602728968777e-07
the O 0 6.195029982336564e-07
likelihood O 0 1.97120061784517e-06
of O 0 2.170319248762098e-06
inheriting O 0 2.793854037008714e-05
the O 0 4.101714239368448e-06
mutation O 0 8.579435416322667e-06
for O 0 1.0988799658662174e-05
HD B-Disease 0 0.002229352481663227
. O 0 6.674751784885302e-05

Limits O 0 4.9349833716405556e-05
to O 0 8.764179256104399e-06
accuracy O 0 9.110869541473221e-06
included O 0 4.344217359175673e-06
recombination O 0 6.217376267159125e-06
between O 0 3.1050551569933305e-06
the O 0 2.1781631858175388e-06
DNA O 0 6.291132194746751e-06
markers O 0 6.188396582729183e-06
and O 0 1.3162331242710934e-06
the O 0 1.8642747363628587e-06
mutation O 0 4.013658781332197e-06
, O 0 2.7512314773048274e-06
pedigree O 0 1.148358660429949e-05
structure O 0 4.936791810905561e-06
, O 0 1.3006516610403196e-06
and O 0 4.2516430198702437e-07
whether O 0 6.973286872380413e-07
DNA O 0 1.7778351093511446e-06
samples O 0 9.093456583286752e-07
were O 0 1.0504691090318374e-06
available O 0 1.1598605169638176e-06
from O 0 5.1634983719850425e-06
family O 0 2.4075296096270904e-05
members O 0 2.325430978089571e-05
. O 0 6.422540172934532e-05

With O 0 5.044045246904716e-05
direct O 0 1.2013199011562392e-05
tests O 0 4.63701553599094e-06
for O 0 3.5980315260530915e-06
the O 0 8.502228411089163e-06
HD B-Disease 0 0.0002655483840499073
mutation O 0 7.1212857619684655e-06
, O 0 1.6563869849051116e-06
we O 0 7.001708013376629e-07
have O 0 2.2682178268951247e-07
assessed O 0 7.339245939874672e-07
the O 0 4.7431268512809766e-07
accuracy O 0 9.699857628220343e-07
of O 0 1.0140631729882443e-06
results O 0 1.0399143093309249e-06
obtained O 0 1.863990405581717e-06
by O 0 1.2839708460887778e-06
linkage O 0 9.724933079269249e-06
approaches O 0 2.7908897664019605e-06
when O 0 1.0675520343284006e-06
requested O 0 8.923222480916593e-07
to O 0 3.042667628960771e-07
do O 0 4.1806606532190926e-07
so O 0 2.799887113269506e-07
by O 0 3.4157181971750106e-07
the O 0 1.2693897133431165e-06
test O 0 8.641382009955123e-06
individuals O 0 1.2245452126080636e-05
. O 0 7.267059845617041e-05

For O 0 3.911304520443082e-05
six O 0 1.5498559150728397e-05
such O 0 2.4959922484413255e-06
individuals O 0 2.120820226991782e-06
, O 0 2.9864440875826403e-06
there O 0 2.519993813621113e-06
was O 0 3.146162271150388e-05
significant O 0 1.2202540347061586e-05
disparity O 0 0.00024349296290893108
between O 0 1.706971670500934e-05
the O 0 2.3117681848816574e-05
tests O 0 5.506716115633026e-05
. O 0 0.00012233536108396947

Three O 0 5.341701034922153e-05
went O 0 4.660452395910397e-05
from O 0 5.075210992799839e-06
a O 0 8.674689524923451e-06
decreased O 0 3.3751126466086134e-05
risk O 0 2.248662440251792e-06
to O 0 5.467084065458039e-07
an O 0 1.2869129477621755e-06
increased O 0 3.557195213943487e-06
risk O 0 4.303833975427551e-06
, O 0 1.1733155815818463e-06
while O 0 8.517505989402707e-07
in O 0 5.7212315596189e-07
another O 0 2.260964492961648e-06
three O 0 1.5495796787945437e-06
the O 0 6.706300155201461e-06
risk O 0 4.016062666778453e-05
was O 0 0.002642393810674548
decreased O 0 0.0020159012638032436
. O 0 0.00010529634892009199

Knowledge O 0 0.00022661473485641181
of O 0 4.655139855458401e-05
the O 0 2.12505656236317e-05
potential O 0 2.0916766516165808e-05
reasons O 0 3.565492761481437e-06
for O 0 9.417064461558766e-07
these O 0 3.734932647603273e-07
changes O 0 5.924849801886012e-07
in O 0 6.497941171801358e-07
results O 0 1.092096454158309e-06
and O 0 1.0774632528409711e-06
impact O 0 3.851662313536508e-06
of O 0 2.3678010165895103e-06
these O 0 1.3554090401157737e-06
risk O 0 6.61057038087165e-06
reversals O 0 4.668734618462622e-05
on O 0 2.5499105049675563e-06
both O 0 1.0020714853453683e-06
patients O 0 2.0574211703205947e-06
and O 0 7.768601335556014e-07
the O 0 1.273921725442051e-06
counseling O 0 8.704714673513081e-06
team O 0 2.6260049708071165e-06
can O 0 4.357925433851051e-07
assist O 0 1.164643322226766e-06
in O 0 7.926296916593856e-07
the O 0 1.3378243011175073e-06
development O 0 3.9207839108712506e-06
of O 0 3.0952894576330436e-06
strategies O 0 2.4536961973353755e-06
for O 0 1.1151929584229947e-06
the O 0 3.928809292119695e-06
prevention O 0 4.753953544422984e-05
and O 0 1.0817875590873882e-06
, O 0 8.310555017487786e-07
where O 0 1.1205606824660208e-06
necessary O 0 1.0121552804776002e-06
, O 0 7.790681593178306e-07
management O 0 2.0305408270360203e-06
of O 0 2.1684736566385254e-06
a O 0 6.883945843583206e-06
risk O 0 5.147592673893087e-06
reversal O 0 1.0552572348387912e-05
in O 0 1.9805809188255807e-06
any O 0 2.3561731268273434e-06
predictive O 0 7.089397968229605e-06
testing O 0 6.001491328788688e-06
program O 0 1.1050128705392126e-05
. O 0 7.183411526057171e-06
. O 0 4.4796393922297284e-05

A O 0 0.0008903692360036075
novel O 0 0.00021002521680202335
common O 0 3.109699173364788e-05
missense O 0 0.0001328158105025068
mutation O 0 3.054674016311765e-05
G301C O 0 9.252130257664248e-05
in O 0 5.045887974119978e-06
the O 0 8.165893632394727e-06
N O 0 0.00011931027984246612
- O 0 6.85131672071293e-05
acetylgalactosamine O 0 0.00276873167604208
- O 0 4.204103606753051e-05
6 O 0 8.345027163159102e-05
- O 0 0.00020175223471596837
sulfate O 0 0.0036159565206617117
sulfatase O 0 0.017627330496907234
gene O 0 2.61098648479674e-05
in O 0 3.2443269446957856e-05
mucopolysaccharidosis B-Disease 0 0.3109923303127289
IVA I-Disease 1 0.9991905093193054
. O 0 0.00023947740555740893

Mucopolysaccharidosis B-Disease 1 0.9999772310256958
IVA I-Disease 1 0.9999992847442627
( O 0 0.024288851767778397
MPS B-Disease 1 0.9999182224273682
IVA I-Disease 1 1.0
) O 0 2.0254936316632666e-05
is O 0 3.1672716431785375e-06
an O 0 4.104485014977399e-06
autosomal B-Disease 1 0.5878009796142578
recessive I-Disease 1 0.9999977350234985
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.99699866771698
by O 0 1.3283681255416013e-05
a O 0 9.309087181463838e-05
genetic B-Disease 1 0.9897956252098083
defect I-Disease 1 0.9998345375061035
in O 0 3.0070787033764645e-05
N O 0 0.021049341186881065
- O 0 0.00037303968565538526
acetylgalactosamine O 0 0.13059693574905396
- O 0 0.00010051290882984176
6 O 0 0.0001674384984653443
- O 0 0.0006347373127937317
sulfate O 0 0.16244807839393616
sulfatase O 1 0.8765884637832642
( O 0 9.170136763714254e-05
GALNS O 1 0.8599856495857239
) O 0 6.497771391877905e-05
. O 0 9.203785157296807e-05

In O 0 5.542710277950391e-05
previous O 0 1.959819383046124e-05
studies O 0 1.2352784324320965e-05
, O 0 2.666839691300993e-06
we O 0 1.0188061878579902e-06
have O 0 3.310046565729863e-07
found O 0 3.629021705364721e-07
two O 0 3.849569338854053e-07
common O 0 1.23543543395499e-06
mutations O 0 3.085737262153998e-06
in O 0 3.932085292035481e-06
Caucasians O 0 9.193697769660503e-05
and O 0 6.728785592713393e-06
Japanese O 0 0.00018379840184934437
, O 0 2.4442526409984566e-05
respectively O 0 5.925265941186808e-05
. O 0 7.507811824325472e-05

To O 0 5.301493001752533e-05
characterize O 0 0.00010695149103412405
the O 0 2.466149271640461e-05
mutational O 0 0.0009192634024657309
spectrum O 0 3.742760236491449e-05
in O 0 3.018459210579749e-06
various O 0 8.033078984226449e-07
ethnic O 0 2.196000423282385e-06
groups O 0 6.951846103220305e-07
, O 0 8.393455459554389e-07
mutations O 0 1.0096380265167682e-06
in O 0 1.2877920880782767e-06
the O 0 2.7813932774733985e-06
GALNS O 1 0.984897792339325
gene O 0 3.522686938595143e-06
in O 0 3.5149721497873543e-06
Colombian O 0 6.95839844411239e-05
MPS B-Disease 1 0.9328488707542419
IVA I-Disease 1 1.0
patients O 0 3.4745080483844504e-05
were O 0 3.6924689084116835e-06
investigated O 0 7.912658475106582e-06
, O 0 1.1797965271398425e-06
and O 0 9.592265541868983e-07
genetic O 0 3.218017354811309e-06
backgrounds O 0 1.777535203473235e-06
were O 0 1.0055196071334649e-06
extensively O 0 2.2384392650565132e-06
analyzed O 0 7.956151080179552e-07
to O 0 2.4782664809208654e-07
identify O 0 6.558085487995413e-07
racial O 0 3.000192464241991e-06
origin O 0 1.334245325779193e-06
, O 0 7.881146757426905e-07
based O 0 7.357704703281343e-07
on O 0 2.4070732251857407e-06
mitochondrial O 0 4.309481028030859e-06
DNA O 0 5.951199000264751e-06
( O 0 4.3767654460680205e-06
mtDNA O 0 1.2457742741389666e-05
) O 0 1.216570490214508e-05
lineages O 0 7.542356615886092e-05
. O 0 7.795944839017466e-05

Three O 0 0.00011182291927980259
novel O 0 0.0001213307841680944
missense O 0 0.00023616821272298694
mutations O 0 1.806061845854856e-05
never O 0 1.0830854989762884e-05
identified O 0 3.264102360844845e-06
previously O 0 1.691506440693047e-06
in O 0 4.82651671518397e-07
other O 0 2.879861256133154e-07
populations O 0 4.364759149666497e-07
and O 0 3.850068708288745e-07
found O 0 3.889764741416002e-07
in O 0 6.138243406894617e-07
16 O 0 2.2084357169660507e-06
out O 0 1.0546771136432653e-06
of O 0 3.5140269574185368e-06
19 O 0 2.293907709827181e-05
Colombian O 0 5.502474232343957e-05
MPS B-Disease 0 0.1019965410232544
IVA I-Disease 1 0.9999960660934448
unrelated O 0 3.076703069382347e-05
alleles O 0 5.798390702693723e-06
account O 0 5.695819709217176e-06
for O 0 6.116270924394485e-06
84 O 0 0.00018831671332009137
. O 0 0.00010482778452569619

2 O 0 0.00017602781008463353
% O 0 3.469299554126337e-05
of O 0 1.8339360394747928e-05
the O 0 9.067865903489292e-06
alleles O 0 6.704483894282021e-06
in O 0 6.561152986250818e-06
this O 0 1.0442352504469454e-05
study O 0 3.9799982914701104e-05
. O 0 8.123784937197343e-05

The O 0 0.00038847976247780025
G301C O 0 0.0013985111145302653
and O 0 2.916804442065768e-05
S162F O 0 0.0003251238667871803
mutations O 0 2.8500648113549687e-05
account O 0 2.1119974917382933e-05
for O 0 2.094598676194437e-05
68 O 0 0.000312342366669327
. O 0 0.0001840969198383391

4 O 0 0.0007577235228382051
% O 0 0.0001888372644316405
and O 0 8.58420244185254e-05
10 O 0 0.00017451588064432144
. O 0 0.00015366873412858695

5 O 0 0.0001128034055000171
% O 0 3.959646346629597e-05
of O 0 1.560110285936389e-05
mutations O 0 8.566239557694644e-06
, O 0 3.2558573366259225e-06
respectively O 0 4.238075234752614e-06
, O 0 1.1746243444576976e-06
whereas O 0 1.0577191460470203e-06
the O 0 1.5980109537849785e-06
remaining O 0 1.5130503925320227e-05
F69V O 1 0.5674355626106262
is O 0 3.445645461397362e-06
limited O 0 1.8520863704907242e-06
to O 0 1.5694208741479088e-06
a O 0 9.113128726312425e-06
single O 0 1.595213143446017e-05
allele O 0 4.300900036469102e-05
. O 0 5.6661850976524875e-05

The O 0 0.00022773192904423922
skewed O 0 0.00024930312065407634
prevalence O 0 0.00015645961684640497
of O 0 3.9793190808268264e-05
G301C O 0 0.00043140319758094847
in O 0 5.281502126308624e-06
only O 0 2.208408204751322e-06
Colombian O 0 1.4584451491828077e-05
patients O 0 5.07086633660947e-06
and O 0 1.18036598450999e-06
haplotype O 0 9.002199476526584e-06
analysis O 0 1.6144700794029632e-06
by O 0 1.4206459582055686e-06
restriction O 0 3.1598076475347625e-06
fragment O 0 6.92040612193523e-06
length O 0 2.6208135750493966e-06
polymorphisms O 0 3.731724746103282e-06
in O 0 1.5181376511463895e-06
the O 0 3.2545844987907913e-06
GALNS O 1 0.981269359588623
gene O 0 2.774261929516797e-06
suggest O 0 2.0221018530719448e-06
that O 0 7.312410730264673e-07
G301C O 0 2.7860609407071024e-05
originated O 0 5.965165655652527e-06
from O 0 3.2913656013988657e-06
a O 0 1.117727060773177e-05
common O 0 1.4878085494274274e-05
ancestor O 0 0.00045646989019587636
. O 0 0.00017337262397632003

Investigation O 0 0.00012760417303070426
of O 0 2.6844592866837047e-05
the O 0 1.751608397171367e-05
genetic O 0 2.0855735783698037e-05
background O 0 5.682510163751431e-06
by O 0 2.785345714073628e-06
means O 0 3.7542524751188466e-06
of O 0 3.462223730821279e-06
mtDNA O 0 4.5691449486184865e-06
lineages O 0 4.0820664253260475e-06
indicate O 0 1.784721916919807e-06
that O 0 4.1514275039844506e-07
all O 0 4.0971303860715125e-07
our O 0 1.3907998663853505e-06
patients O 0 1.6003122027541394e-06
are O 0 3.5769730288848223e-07
probably O 0 3.900867795891827e-06
of O 0 5.527580469788518e-06
native O 0 4.090900984010659e-05
American O 0 9.274655167246237e-05
descent O 0 0.0009279957157559693

Low O 0 0.00015273514145519584
frequency O 0 2.602864697109908e-05
of O 0 3.957090666517615e-05
BRCA1 O 0 0.0002185333432862535
germline O 0 0.00016629848687443882
mutations O 0 6.7658620537258685e-06
in O 0 5.4312858992489055e-06
45 O 0 2.276086888741702e-05
German O 1 0.9388324618339539
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.06054381653666496
. O 0 0.000802615366410464

In O 0 7.31647087377496e-05
this O 0 9.504976333118975e-06
study O 0 6.327613846224267e-06
we O 0 2.184414142902824e-06
investigated O 0 5.186451289773686e-06
45 O 0 8.247161531471647e-06
German O 1 0.969934344291687
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.06182773783803e-05
for O 0 1.1515180631249677e-05
germline O 0 0.004753747023642063
mutations O 0 7.441805337293772e-06
in O 0 6.193580702529289e-06
the O 0 2.0004936231998727e-05
BRCA1 O 0 0.0005634806584566832
gene O 0 7.189735333668068e-05
. O 0 7.856155571062118e-05

We O 0 4.121078745811246e-05
identified O 0 1.5555642676190473e-05
four O 0 5.289607543090824e-06
germline O 0 9.182711073663086e-05
mutations O 0 5.340696134226164e-06
in O 0 2.3492914351663785e-06
three O 0 7.545750577264698e-06
breast B-Disease 1 0.9999693632125854
cancer I-Disease 1 0.995269238948822
families O 0 3.0440569389611483e-06
and O 0 1.2671218883042457e-06
in O 0 2.2780129711463815e-06
one O 0 3.1785086321178824e-05
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.12626913189888
. O 0 1.5024728554635658e-06
among O 0 6.122003242126084e-07
these O 0 2.2732204740805173e-07
were O 0 8.538358429177606e-07
one O 0 1.183171207230771e-06
frameshift O 0 2.9260989322210662e-05
mutation O 0 3.3804576560214628e-06
, O 0 1.943711367857759e-06
one O 0 1.661535293351335e-06
nonsense O 0 1.7194017345900647e-05
mutation O 0 2.969413117170916e-06
, O 0 1.6675882079653093e-06
one O 0 1.2669515854213387e-06
novel O 0 5.235785465629306e-06
splice O 0 1.3684356417797972e-05
site O 0 5.906993010285078e-06
mutation O 0 3.804147127084434e-06
, O 0 2.6468380838196026e-06
and O 0 1.9385613541089697e-06
one O 0 5.945310931565473e-06
missense O 0 9.615392627893016e-05
mutation O 0 9.223975212080404e-05
. O 0 0.00011749402619898319

The O 0 0.0001191922347061336
missense O 0 0.00039136072155088186
mutation O 0 7.763702888041735e-05
was O 0 0.00011321515921736136
also O 0 7.403184554277686e-06
found O 0 4.673045168601675e-06
in O 0 1.043837983161211e-05
2 O 0 0.00014876866771373898
. O 0 0.0001157783844973892

8 O 0 0.0002541489084251225
% O 0 2.897934064094443e-05
of O 0 2.0511621187324636e-05
the O 0 1.0603606824588496e-05
general O 0 1.0321296031179372e-05
population O 0 3.161981339872e-06
, O 0 1.7561577578817378e-06
suggesting O 0 1.8674137436391902e-06
that O 0 3.5059957781413686e-07
it O 0 3.7067368907628406e-07
is O 0 1.7281895452470053e-06
not O 0 2.3445554688805714e-06
disease O 0 0.07040131837129593
associated O 0 6.761706754332408e-05
. O 0 0.00012192134454380721

The O 0 0.00010487156396266073
average O 0 5.1733990403590724e-05
age O 0 0.00011923351121367887
of O 0 0.0026867466513067484
disease O 1 0.9999977350234985
onset O 1 0.9999984502792358
in O 0 0.00011722746421582997
those O 0 1.0435044714540709e-05
families O 0 2.3519445676356554e-05
harbouring O 1 0.9821236729621887
causative O 0 0.017594190314412117
mutations O 0 4.9821272114058957e-05
was O 0 0.0001263519807253033
between O 0 6.800208211643621e-05
32 O 0 0.0001525181287433952
. O 0 0.0001297484413953498

3 O 0 0.0008793845190666616
and O 0 0.000171498759300448
37 O 0 0.0008069905452430248
. O 0 0.0004970831796526909

4 O 0 0.0004234780208207667
years O 0 7.799320883350447e-05
, O 0 1.5709807485109195e-05
whereas O 0 7.662407369934954e-06
the O 0 6.029025826137513e-06
family O 0 2.2037098460714333e-05
harbouring O 0 0.007465234957635403
the O 0 1.1448212717368733e-05
missense O 0 5.450334356282838e-05
mutation O 0 4.692489255830878e-06
had O 0 3.6531030218611704e-06
an O 0 1.4314497320810915e-06
average O 0 3.0535529731423594e-06
age O 0 4.223066753183957e-06
of O 0 1.1182708476553671e-05
onset O 1 0.7909751534461975
of O 0 0.00029438850469887257
51 O 0 0.0022889168467372656
. O 0 0.00018972085672430694

2 O 0 0.0037174569442868233
years O 0 0.0015696812188252807
. O 0 0.000854738405905664

These O 0 1.9209113816032186e-05
findings O 0 3.292805195087567e-05
show O 0 1.7019197912304662e-05
that O 0 4.629759587260196e-06
BRCA1 O 0 4.866025847150013e-05
is O 0 4.558790806186153e-06
implicated O 0 9.098356713366229e-06
in O 0 1.562357397233427e-06
a O 0 1.4135764558886876e-06
small O 0 9.217948786499619e-07
fraction O 0 1.964252078323625e-06
of O 0 1.099496421375079e-05
breast B-Disease 1 0.9999996423721313
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.402397826197557e-05
suggesting O 0 1.117010924645001e-05
the O 0 3.0392247936106287e-06
involvement O 0 7.152103989938041e-06
of O 0 4.7482549234700855e-06
another O 0 9.288010915042832e-06
susceptibility O 0 8.604157483205199e-05
gene O 0 1.6185358617804013e-05
( O 0 1.7763773939805105e-05
s O 0 0.00021656572062056512
) O 0 0.0001444821828044951

Paternal O 1 0.8932995200157166
transmission O 1 0.9980176687240601
of O 1 0.9999674558639526
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9996341466903687

We O 0 3.312985791126266e-05
report O 0 8.007877113413997e-06
a O 0 6.389154350472381e-06
rare O 0 3.934936103178188e-06
case O 0 6.504856173705775e-06
of O 0 6.0361464420566335e-05
paternally O 1 0.9999996423721313
transmitted O 1 0.9999996423721313
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999995231628418
DM B-Disease 1 1.0
) O 0 0.00206722947768867
. O 0 0.0004098947683814913

The O 0 0.0003473122196737677
proband O 0 0.0013854270800948143
is O 0 1.7431930245948024e-05
a O 0 1.016081660054624e-05
23 O 0 1.868209983513225e-05
year O 0 8.888679985830095e-06
old O 0 0.00029080838430672884
, O 0 0.0003474393452052027
mentally B-Disease 1 0.9999998807907104
retarded I-Disease 1 0.9999996423721313
male O 1 0.720991313457489
who O 0 0.21680930256843567
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9655948281288147

He O 0 0.00018459981947671622
presented O 0 0.00010981372179230675
with O 0 0.00011577849363675341
respiratory O 1 0.9999992847442627
and O 0 0.0003839279233943671
feeding O 0 0.008648199029266834
difficulties O 1 0.6329306364059448
at O 0 0.06429784744977951
birth O 0 0.005550554022192955
. O 0 0.00019529910059645772

His O 0 0.0005426024436019361
two O 0 0.00011055738286813721
sibs O 1 0.999138355255127
suffer O 0 0.26724064350128174
from O 0 0.0004099338548257947
childhood O 1 0.9999973773956299
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 0.27310633659362793

Their O 0 9.324226266471669e-05
late O 0 0.0001268690830329433
father O 0 7.52385167288594e-05
had O 0 8.79713934409665e-06
the O 0 4.14005080529023e-06
adult O 0 4.533804712991696e-06
type O 0 6.66133610138786e-06
of O 0 2.524279261706397e-05
DM B-Disease 1 0.9999998807907104
, O 0 1.3379148185777012e-05
with O 0 4.071285729878582e-06
onset O 1 0.9714930057525635
around O 0 3.1193194445222616e-05
30 O 0 3.995655424660072e-05
years O 0 8.257530862465501e-05
. O 0 0.00014178887067828327

Only O 0 5.872971087228507e-05
six O 0 1.721422995615285e-05
other O 0 2.1158384697628208e-06
cases O 0 1.5765974694659235e-06
of O 0 8.04736373538617e-06
paternal O 1 0.6354657411575317
transmission O 1 0.9944526553153992
of O 1 0.9999645948410034
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.00034242335823364556
been O 0 4.424721191753633e-05
reported O 0 3.7515648728003725e-05
recently O 0 8.409797737840563e-05
. O 0 7.909948180895299e-05

We O 0 3.315470166853629e-05
review O 0 1.1452394574007485e-05
the O 0 7.211368028947618e-06
sex O 0 8.532280844519846e-06
related O 0 9.302621037932113e-06
effects O 0 6.419833516702056e-05
on O 0 5.375278487917967e-05
transmission O 0 0.32270270586013794
of O 1 0.9294551610946655
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9848330616950989

Decreased O 0 0.00209498661570251
fertility O 0 0.00024859365657903254
of O 0 2.9439504942274652e-05
males O 0 1.2840423551097047e-05
with O 0 7.1943668444873765e-06
adult O 0 9.410818893229589e-05
onset O 1 0.9999994039535522
DM B-Disease 1 1.0
and O 0 8.388612332055345e-05
contraction O 0 0.0003033300454262644
of O 0 7.299274784600129e-06
the O 0 5.777305887022521e-06
repeat O 0 1.721734952297993e-05
upon O 0 9.42950737226056e-06
male O 0 8.477396477246657e-06
transmission O 0 7.2761313276714645e-06
contribute O 0 2.1561338598985458e-06
to O 0 6.312397431429417e-07
the O 0 2.0231857433827827e-06
almost O 0 2.7475948627397884e-06
absent O 0 5.875738679606002e-06
occurrence O 0 3.796676992351422e-06
of O 0 8.463760423182976e-06
paternal O 0 0.002357560209929943
transmission O 0 0.2978772521018982
of O 1 0.9933172464370728
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9876789450645447

Also O 0 9.761844557942823e-05
the O 0 3.0467632313957438e-05
fathers O 0 3.981577538070269e-05
of O 0 1.255207371286815e-05
the O 0 2.634118209243752e-05
reported O 0 9.742632391862571e-05
congenitally O 0 0.08243532478809357
affected O 0 1.1538275430211797e-05
children O 0 4.774796707351925e-06
showed O 0 9.031592526298482e-06
, O 0 1.9376998352527153e-06
on O 0 1.5970283584465506e-06
average O 0 3.567727389963693e-06
, O 0 3.8413545553339645e-06
shorter O 0 1.6418271115981042e-05
CTG O 0 0.00744986766949296
repeat O 0 1.3650545042764861e-05
lengths O 0 2.2730153432348743e-05
and O 0 1.969635377463419e-06
hence O 0 3.7432307635754114e-06
less O 0 3.5582065720518585e-06
severe O 0 0.01111436914652586
clinical O 0 0.25207793712615967
symptoms O 1 0.9100775718688965
than O 0 2.550012368374155e-06
the O 0 1.0268055120832287e-05
mothers O 0 2.055576078419108e-05
of O 0 9.17482338991249e-06
children O 0 3.744516652659513e-05
with O 0 0.06861519813537598
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.999291181564331

We O 0 7.477810140699148e-05
conclude O 0 6.329102325253189e-05
that O 0 8.967464054876473e-06
paternal O 0 0.000410008302424103
transmission O 0 0.1550927758216858
of O 1 0.9993379712104797
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 1 0.7847993969917297
rare O 0 5.290321496431716e-05
and O 0 2.387316499152803e-06
preferentially O 0 3.369572596056969e-06
occurs O 0 1.1086270887972205e-06
with O 0 1.2534480902104406e-06
onset O 1 0.9509646892547607
of O 0 0.02940388023853302
DM B-Disease 1 1.0
past O 0 3.290921449661255e-05
30 O 0 6.469919298979221e-06
years O 0 4.424393409863114e-06
in O 0 3.790526761804358e-06
the O 0 1.48389062815113e-05
father O 0 9.911661618389189e-05
. O 0 2.432593100820668e-05
. O 0 6.796706293243915e-05

The O 0 0.0003295684000477195
RB1 O 1 0.9808381199836731
gene O 0 4.0087463275995106e-05
mutation O 0 1.1402307791286148e-05
in O 0 6.6257357502763625e-06
a O 0 1.2197398064017761e-05
child O 0 3.490045855869539e-05
with O 0 4.296964834793471e-05
ectopic B-Disease 1 0.9999713897705078
intracranial I-Disease 1 0.9999998807907104
retinoblastoma I-Disease 1 0.9999923706054688
. O 0 0.0035553560592234135

The O 0 0.0003575611917767674
RB1 O 1 0.9940978288650513
gene O 0 3.4483542549423873e-05
mutation O 0 1.334166245214874e-05
was O 0 2.246869189548306e-05
investigated O 0 1.0565209777269047e-05
in O 0 3.316468337288825e-06
a O 0 9.48993238125695e-06
child O 0 2.673912422324065e-05
with O 0 2.219534508185461e-05
ectopic B-Disease 1 0.9998058676719666
intracranial I-Disease 1 0.9999961853027344
retinoblastoma I-Disease 0 0.21771380305290222
using O 0 2.870603566407226e-06
DNA O 0 3.082354623984429e-06
obtained O 0 1.8272266970598139e-06
from O 0 1.3827630027662963e-06
both O 0 1.1905111705345917e-06
the O 0 8.870449164533056e-06
pineal B-Disease 1 0.9977529644966125
and I-Disease 0 9.732029138831422e-05
retinal I-Disease 1 0.9999985694885254
tumours I-Disease 1 0.9999997615814209
of O 0 0.0030358387157320976
the O 0 0.002102241152897477
patient O 0 0.037844181060791016
. O 0 0.0002493259671609849

A O 0 0.0007495085592381656
nonsense O 0 0.0004168064333498478
mutation O 0 3.3992873795796186e-05
in O 0 1.734459146973677e-05
exon O 0 0.00011839828948723152
17 O 0 2.9089293093420565e-05
( O 0 5.197081918595359e-06
codon O 0 6.344012035697233e-06
556 O 0 1.1562574400159065e-05
) O 0 1.8500544456401258e-06
of O 0 2.670249614311615e-06
the O 0 1.2184248589619529e-05
RB1 O 1 0.9500311613082886
gene O 0 7.796325007802807e-06
was O 0 8.906320545065682e-06
found O 0 1.005964691103145e-06
to O 0 4.377535844923841e-07
be O 0 4.188266586879763e-07
present O 0 1.412717892890214e-06
homozygously O 0 2.6159066692343913e-05
in O 0 1.6981624639811344e-06
both O 0 1.1723815305231255e-06
the O 0 5.720485205529258e-06
retinal B-Disease 1 0.9682305455207825
and I-Disease 0 1.1611018635449e-05
the I-Disease 0 0.0009339769603684545
pineal I-Disease 1 0.9999985694885254
tumours I-Disease 1 0.9999998807907104
. O 0 0.0002133878879249096

The O 0 8.694058487890288e-05
same O 0 2.563746238593012e-05
mutation O 0 2.1341817046049982e-05
was O 0 3.09912720695138e-05
present O 0 1.0181302968703676e-05
heterozygously O 0 6.93399560987018e-05
in O 0 2.0487591427809093e-06
the O 0 2.5362608084833482e-06
DNA O 0 3.4249728741997387e-06
from O 0 1.266265371668851e-06
the O 0 2.5764588826859836e-06
constitutional O 0 5.834696366946446e-06
cells O 0 1.5920815030767699e-06
of O 0 1.5415288316944498e-06
the O 0 2.4523253614461282e-06
patient O 0 9.874564966594335e-06
, O 0 1.9567303297662875e-06
proving O 0 1.3835167919751257e-05
it O 0 8.375009201699868e-07
to O 0 8.633051038486883e-07
be O 0 1.5950829492794583e-06
of O 0 1.0357986866438296e-05
germline O 0 0.0003866329789161682
origin O 0 5.335519745131023e-05
. O 0 0.00011434896441642195

The O 0 5.919290197198279e-05
initial O 0 5.3137366194278e-05
mutation O 0 1.881928437796887e-05
was O 0 2.445406607876066e-05
shown O 0 2.759385324679897e-06
to O 0 9.714159432405722e-07
have O 0 1.0159449175262125e-06
occurred O 0 5.491599040396977e-06
in O 0 2.256492734886706e-06
the O 0 1.0859121175599284e-05
paternally O 0 0.00026689309743233025
derived O 0 5.1113216613885015e-05
RB1 O 0 0.06063563749194145
allele O 0 0.00010455513984197751
. O 0 0.00012767844600602984

The O 0 6.830636993981898e-05
mutation O 0 2.848861004167702e-05
is O 0 5.078348294773605e-06
in O 0 1.402267002958979e-06
an O 0 1.7342584897050983e-06
area O 0 4.608201379596721e-06
of O 0 1.5679562466175412e-06
the O 0 2.108288981617079e-06
gene O 0 9.967093319573905e-07
that O 0 3.253139766457025e-07
encodes O 0 1.6649788676659227e-06
the O 0 1.1577607210710994e-06
protein O 0 3.9506835491920356e-06
- O 0 5.5717723626003135e-06
binding O 0 1.299881660088431e-06
region O 0 4.7645485210523475e-06
known O 0 2.6907719075097702e-06
as O 0 1.8566171320344438e-06
the O 0 5.470230917126173e-06
pocket O 0 6.033878889866173e-05
region O 0 4.842233011004282e-06
and O 0 8.75013938639313e-07
has O 0 1.2324745739533682e-06
been O 0 1.438722392776981e-06
detected O 0 3.238018280171673e-06
in O 0 1.0356804978073342e-06
other O 0 5.696676907973597e-07
cases O 0 2.415056542304228e-06
of O 0 2.840914748958312e-05
retinoblastoma B-Disease 1 0.9395977258682251
. O 0 5.962687646388076e-05
. O 0 9.695329936221242e-05

Low O 0 0.0002557583211455494
levels O 0 3.2111696782521904e-05
of O 0 2.134098394890316e-05
beta O 0 7.254852971527725e-05
hexosaminidase O 0 0.0005852910690009594
A O 0 2.7802932891063392e-05
in O 0 5.016456725570606e-06
healthy O 0 7.158968401199672e-06
individuals O 0 9.881873666017782e-07
with O 0 3.7474526379810413e-06
apparent O 1 0.9940436482429504
deficiency O 1 0.9999998807907104
of O 0 0.3244504928588867
this O 0 5.506584420800209e-05
enzyme O 0 0.00011109743354609236
. O 0 8.353035809705034e-05

Appreciable O 0 0.0020999088883399963
beta O 0 0.0008039847598411143
hexosaminidase O 0 0.039714712649583817
A O 0 0.0001505131513113156
( O 0 2.031049007200636e-05
hex O 0 0.00011377261398592964
A O 0 2.0786479581147432e-05
) O 0 1.8937555523734773e-06
activity O 0 2.7826058612845372e-06
has O 0 1.2567062412927044e-06
been O 0 1.5173402516666101e-06
detected O 0 7.4088916335313115e-06
in O 0 6.450475666497368e-06
cultured O 0 0.002040801104158163
skin O 0 0.07383456826210022
fibroblasts O 0 0.0035549812018871307
and O 0 3.956419459427707e-05
melanoma B-Disease 1 0.9999998807907104
tissue O 1 0.7840467095375061
from O 0 1.6008669263101183e-05
healthy O 0 1.5773535778862424e-05
individuals O 0 8.246574338954815e-07
previously O 0 4.077973244420718e-06
reported O 0 3.2924392598943086e-06
as O 0 2.895646275646868e-06
having O 0 0.0001758610742399469
deficiency B-Disease 1 0.9999966621398926
of I-Disease 0 0.043277639895677567
hex I-Disease 1 0.734224796295166
A I-Disease 0 4.764632467413321e-05
activity O 0 3.829243723885156e-06
indistinguishable O 0 3.0240632895583985e-06
from O 0 5.450876869872445e-07
that O 0 3.887795401169569e-07
of O 0 2.778951284199138e-06
patients O 0 1.1886474567290861e-05
with O 0 0.0005721091292798519
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.19518321752548218
TSD B-Disease 1 0.9999946355819702
) O 0 5.0154576456407085e-05
. O 0 5.504290675162338e-05

Identification O 0 0.0002446912694722414
and O 0 6.575870793312788e-05
quantitation O 0 0.0007788797374814749
of O 0 0.00011720287147909403
hex O 0 0.0005904267309233546
A O 0 7.038108014967293e-05
, O 0 1.0356120583310258e-05
amounting O 0 2.9518612791434862e-05
to O 0 1.0886766176554374e-05
3 O 0 9.973419946618378e-05
. O 0 0.00010349110380047932

5 O 0 0.0006396106327883899
% O 0 0.00036862498382106423
- O 0 0.0007890125270932913
6 O 0 0.0007092924788594246
. O 0 0.0002519870176911354

9 O 0 0.00020589270570781082
% O 0 1.959092332981527e-05
of O 0 1.4145232853479683e-05
total O 0 1.7419515643268824e-05
beta O 0 5.9711084759328514e-05
hexosaminidase O 0 0.00015690304280724376
activity O 0 3.7960217014187947e-06
, O 0 9.177284709949163e-07
has O 0 3.7084905102346966e-07
been O 0 3.087560287440283e-07
obtained O 0 5.353657002160617e-07
by O 0 1.4936993011360755e-06
cellulose O 0 0.0003998784814029932
acetate O 0 0.000982519006356597
gel O 0 0.0002501356939319521
electrophoresis O 0 5.0923517846968025e-05
, O 0 7.465589533239836e-06
DEAE O 0 0.18507809937000275
- O 0 5.254869392956607e-05
cellulose O 0 0.0002573813544586301
ion O 0 6.978859892114997e-05
- O 0 4.116679701837711e-05
exchange O 0 2.6682344469008967e-05
chromatography O 0 0.0006255329353734851
, O 0 8.893047379388008e-06
radial O 0 0.0001276711409445852
immunodiffusion O 0 0.000642696802970022
, O 0 1.6024983779061586e-05
and O 0 1.6022842828533612e-05
radioimmunoassay O 0 0.002128294203430414
. O 0 0.00011478135274956003

Previous O 0 0.00013037821918260306
family O 0 4.522015296970494e-05
studies O 0 8.232483196479734e-06
suggested O 0 4.366147095424822e-06
that O 0 4.710656753559306e-07
these O 0 2.7173982175554556e-07
individuals O 0 3.285089462679025e-07
may O 0 1.4628069493483054e-06
be O 0 1.015766656564665e-06
compound O 0 9.725628842716105e-06
heterozygotes O 0 1.2698020327661652e-05
for O 0 1.7331375374851632e-06
the O 0 3.8003506688255584e-06
common O 0 7.247846951941028e-06
mutant O 0 0.00011065927537856624
TSD B-Disease 1 0.9699730277061462
gene O 0 6.236730314412853e-06
and O 0 1.6636314512652461e-06
a O 0 3.5491034395818133e-06
rare O 0 6.438835043809377e-06
( O 0 6.4515647864027414e-06
allelic O 0 9.058151772478595e-05
) O 0 1.866190359578468e-05
mutant O 0 9.284282714361325e-05
gene O 0 5.19125496794004e-05
. O 0 5.5831977078923956e-05

Thus O 0 0.0001115915656555444
, O 0 2.452726403134875e-05
the O 0 7.616275979671627e-06
postulated O 0 5.115588282933459e-05
rate O 0 6.719602879456943e-06
mutant O 0 1.7454054614063352e-05
gene O 0 1.8982996152772103e-06
appears O 0 1.3111616681271698e-06
to O 0 2.626325397159235e-07
code O 0 2.21344251372102e-07
for O 0 2.0807472367323498e-07
the O 0 8.122091230688966e-07
expression O 0 1.3756234693573788e-06
of O 0 3.280729515608982e-06
low O 0 1.1010735761374235e-05
amounts O 0 5.564805178437382e-06
of O 0 2.1342773834476247e-05
hex O 0 0.00030093122040852904
A O 0 0.0001563370315125212
. O 0 7.624056161148474e-05

Heterozygotes O 0 0.0011805163230746984
for O 0 4.563538095680997e-05
the O 0 2.8848422516603023e-05
rare O 0 3.608947736211121e-05
mutant O 0 5.106712706037797e-05
may O 0 4.359922058938537e-06
be O 0 1.367768163618166e-06
indistinguishable O 0 3.693169901453075e-06
from O 0 2.633822759889881e-06
heterozygotes O 0 2.156047776225023e-05
for O 0 3.6232161164662102e-06
the O 0 1.4829018255113624e-05
common O 0 6.14283126196824e-05
TSD B-Disease 1 0.9999767541885376
mutant O 0 0.0010649636387825012
. O 0 0.00015243612870108336

However O 0 9.961634350474924e-05
, O 0 2.349303940718528e-05
direct O 0 1.750915362208616e-05
visualization O 0 8.935086225392297e-05
and O 0 1.0813422704814002e-05
quantitation O 0 0.0002024021523538977
of O 0 2.093809780490119e-05
hex O 0 0.00014088860189076513
A O 0 1.568957850395236e-05
by O 0 1.6863151586221647e-06
the O 0 1.783779339348257e-06
methods O 0 1.4044766203369363e-06
described O 0 3.7085649182699854e-06
may O 0 1.798349217096984e-06
prevent O 0 4.704766979557462e-06
false O 0 4.975890078640077e-06
- O 0 2.349146961933002e-05
positive O 0 5.197176051296992e-06
prenatal O 0 8.812466694507748e-05
diagnosis O 0 0.00020073316409252584
of O 0 0.00012693430471699685
TSD B-Disease 1 0.9999905824661255
in O 0 3.0791481549385935e-05
fetuses O 0 5.275187868392095e-05
having O 0 1.0015745829150546e-05
the O 0 6.550062153110048e-06
incomplete O 0 3.801625280175358e-05
hex B-Disease 0 0.0036300194915384054
A I-Disease 0 0.07648731768131256
deficiency I-Disease 1 0.9999663829803467
of O 0 7.253586954902858e-05
the O 0 4.10537286370527e-05
type O 0 7.052276487229392e-05
described O 0 1.8557107978267595e-05
in O 0 3.647940047812881e-06
the O 0 1.380474895995576e-05
four O 0 3.463752364041284e-05
healthy O 0 0.00017597833357285708
individuals O 0 9.618776675779372e-05

The O 0 0.000779087538830936
tumor B-Disease 1 0.9999897480010986
suppressor O 1 0.7765425443649292
gene O 0 0.0001211217968375422
Smad4 O 1 0.9516578316688538
/ O 0 0.022970693185925484
Dpc4 O 0 0.005522991064935923
is O 0 2.876775397453457e-06
required O 0 1.500894768469152e-06
for O 0 2.1891692085773684e-06
gastrulation O 0 0.0001313846296397969
and O 0 2.3035665890347445e-06
later O 0 6.71369707561098e-06
for O 0 3.043375045308494e-06
anterior O 0 0.008360853418707848
development O 0 3.605518213589676e-05
of O 0 2.2343647287925705e-05
the O 0 6.212468724697828e-05
mouse O 0 0.000171816922375001
embryo O 0 0.00011890230962308124
. O 0 6.351667252602056e-05

Mutations O 0 0.00012190239067422226
in O 0 3.789774200413376e-05
the O 0 7.779636507621035e-05
SMAD4 O 1 0.9999991655349731
/ O 1 0.9999804496765137
DPC4 O 1 0.9999998807907104
tumor B-Disease 1 0.9999940395355225
suppressor O 0 0.0018992850091308355
gene O 0 5.366392542782705e-06
, O 0 1.8821926914824871e-06
a O 0 3.3260307645832654e-06
key O 0 8.029104719753377e-06
signal O 0 1.3564107575803064e-05
transducer O 0 2.1355110220611095e-05
in O 0 2.5095228011196014e-06
most O 0 3.945735898014391e-06
TGFbeta O 1 0.5540623664855957
- O 0 5.4412517783930525e-05
related O 0 4.209508006169926e-06
pathways O 0 4.688458830059972e-06
, O 0 5.716503324038058e-07
are O 0 1.52707386291695e-07
involved O 0 6.074477028050751e-07
in O 0 5.361976036510896e-07
50 O 0 2.565401018728153e-06
% O 0 6.259610927372705e-06
of O 0 0.0003148207033518702
pancreatic B-Disease 1 1.0
cancers I-Disease 1 0.9999961853027344
. O 0 0.0011205784976482391

Homozygous O 0 0.004548771306872368
Smad4 O 1 0.9296182990074158
mutant O 0 0.005382695700973272
mice O 0 0.0006874375976622105
die O 0 0.00016876599693205208
before O 0 4.1423161746934056e-05
day O 0 6.202890654094517e-05
7 O 0 0.00014390265278052539
. O 0 0.00010511936852708459

5 O 0 0.0006716813077218831
of O 0 0.0005587506457231939
embryogenesis O 0 0.032858770340681076
. O 0 0.0005236883298493922

Mutant O 0 0.0005254877032712102
embryos O 0 4.445755257620476e-05
have O 0 3.9333526729024015e-06
reduced O 0 5.2751142902707215e-06
size O 0 6.7020614551438484e-06
, O 0 2.99837870443298e-06
fail O 0 5.0342664508207235e-06
to O 0 2.1465812096721493e-06
gastrulate O 0 0.0001597515947651118
or O 0 3.0281091767392354e-06
express O 0 1.1585732863750309e-05
a O 0 1.3074197340756655e-05
mesodermal O 0 0.0005427136202342808
marker O 0 8.465298742521554e-05
, O 0 3.699924036482116e-06
and O 0 2.2096785414760234e-06
show O 0 1.0077977094624657e-05
abnormal O 0 7.873150752857327e-05
visceral O 0 0.0657040923833847
endoderm O 1 0.9081175923347473
development O 0 0.00040263758273795247
. O 0 0.00010862270573852584

Growth B-Disease 1 0.9994816184043884
retardation I-Disease 1 0.9999446868896484
of O 0 0.00037826813058927655
the O 0 0.0034602913074195385
Smad4 O 1 0.9999953508377075
- O 0 0.3128736615180969
deficient O 0 0.0002875060308724642
embryos O 0 3.5733116874325788e-06
results O 0 9.678529977463768e-07
from O 0 1.8526727671996923e-06
reduced O 0 1.317631085839821e-05
cell O 0 3.1000345188658684e-05
proliferation O 0 2.5237039153580554e-05
rather O 0 1.8537562027631793e-06
than O 0 1.6205092379095731e-06
increased O 0 2.008198862313293e-05
apoptosis O 0 0.00022019130119588226
. O 0 5.8905552577925846e-05

Aggregation O 0 0.000565744936466217
of O 0 0.0002671833208296448
mutant O 0 0.0011856501223519444
Smad4 O 1 0.9922630786895752
ES O 1 0.8279508948326111
cells O 0 1.3449711332214065e-05
with O 0 3.906407528120326e-06
wild O 0 2.4899225536501035e-05
- O 0 3.622001167968847e-05
type O 0 3.582626231946051e-05
tetraploid O 0 0.00029376440215855837
morulae O 0 0.0033449821639806032
rescues O 0 0.0003182816144544631
the O 0 7.273161463672295e-05
gastrulation B-Disease 1 0.933814525604248
defect I-Disease 1 0.5674855709075928
. O 0 0.0003509387606754899

These O 0 1.7706606740830466e-05
results O 0 1.431385589967249e-05
indicate O 0 1.1243265362281818e-05
that O 0 2.992996314787888e-06
Smad4 O 0 0.00021363524137996137
is O 0 1.5455357242899481e-06
initially O 0 1.948215412994614e-06
required O 0 3.676007622743782e-07
for O 0 4.479876167806651e-07
the O 0 9.010927328745311e-07
differentiation O 0 7.657002242922317e-06
of O 0 3.954294697905425e-06
the O 0 1.2063839676557109e-05
visceral O 0 0.4221732020378113
endoderm O 0 0.03432339429855347
and O 0 2.1483917862497037e-06
that O 0 1.3187360536903725e-06
the O 0 5.292291916703107e-06
gastrulation B-Disease 1 0.73005610704422
defect I-Disease 0 0.011162778362631798
in O 0 5.808230980619555e-06
the O 0 1.2505177437560633e-05
epiblast O 0 0.4836013913154602
is O 0 8.924260328058153e-06
secondary O 0 1.451017215003958e-05
and O 0 5.099080226500519e-06
non O 0 2.4302511519636028e-05
- O 0 0.00032612498034723103
cell O 0 0.00018708358402363956
autonomous O 0 0.00013053831935394555
. O 0 0.0001218030447489582

Rescued O 0 0.005854093935340643
embryos O 0 0.0004240439448039979
show O 0 0.0001797914446797222
severe O 0 0.4709260165691376
anterior O 1 0.9761859774589539
truncations O 1 0.917007565498352
, O 0 3.141281194984913e-05
indicating O 0 3.4011223760899156e-05
a O 0 1.278475519939093e-05
second O 0 9.229285751644056e-06
important O 0 4.494242602959275e-06
role O 0 7.897347131802235e-06
for O 0 4.651036761060823e-06
Smad4 O 1 0.9113550782203674
in O 0 2.3257371140061878e-05
anterior O 1 0.9451789855957031
patterning O 1 0.8269715309143066
during O 0 0.32864394783973694
embryogenesis O 1 0.9777347445487976
. O 0 0.00042813620530068874

Prevalence O 0 0.0026728876400738955
of O 0 0.0002939910627901554
p16 O 0 0.001693999976851046
and O 0 3.811607894022018e-05
CDK4 O 1 0.9970346689224243
germline O 0 0.0012455395190045238
mutations O 0 1.4644562725152355e-05
in O 0 1.8859351257560775e-05
48 O 0 0.0004310946387704462
melanoma B-Disease 1 0.9999995231628418
- O 1 0.7149829268455505
prone O 0 0.035967182368040085
families O 0 1.5862065993133e-05
in O 0 1.397998676111456e-05
France O 0 0.00011985567834926769
. O 0 8.96313795237802e-05

The O 0 0.0003968446690123528
French O 0 0.017064526677131653
Familial B-Disease 1 0.9999978542327881
Melanoma I-Disease 1 1.0
Study O 0 0.47799843549728394
Group O 0 0.0011704530334100127
. O 0 0.0002988130727317184

Germline O 0 0.012172875925898552
mutations O 0 6.66458799969405e-05
in O 0 1.907232217490673e-05
the O 0 2.448961095069535e-05
p16 O 0 0.0002349157730350271
and O 0 1.4030231795914005e-05
CDK4 O 1 0.9913803935050964
genes O 0 3.3540807180543197e-06
have O 0 1.1468036973383278e-06
been O 0 1.8631053535500541e-06
reported O 0 1.9930182588723255e-06
in O 0 1.0389637736807344e-06
a O 0 3.7841878111066762e-06
subset O 0 1.1485524737508968e-05
of O 0 3.3904325391631573e-05
melanoma B-Disease 1 0.9999984502792358
pedigrees O 0 0.00013335565745364875
, O 0 4.056805664731655e-06
but O 0 6.341565494949464e-07
their O 0 7.112498110473098e-07
prevalence O 0 1.5725890989415348e-05
is O 0 3.293004738225136e-06
not O 0 1.5189255009318003e-06
well O 0 4.243956027494278e-06
known O 0 2.9140021069906652e-05
. O 0 5.886669168830849e-05

We O 0 6.865751493023708e-05
searched O 0 5.577259071287699e-05
for O 0 7.044210178719368e-06
such O 0 4.7726434786454774e-06
germline O 0 0.00018891863874159753
mutations O 0 1.1288193491054699e-05
in O 0 8.851030543155503e-06
48 O 0 6.053294782759622e-05
French O 0 0.11036192625761032
melanoma B-Disease 1 0.9999997615814209
- O 1 0.7583613395690918
prone O 0 0.0023163778241723776
families O 0 3.4302031508559594e-06
selected O 0 4.131547029828653e-06
according O 0 1.353595280306763e-06
to O 0 7.771462264827278e-07
two O 0 1.28311398839287e-06
major O 0 4.343198270362336e-06
criteria O 0 1.8994205674971454e-06
families O 0 1.7658144315646496e-06
with O 0 1.2185992090962827e-06
at O 0 6.9891384555376135e-06
least O 0 1.3021796121392981e-06
three O 0 7.101477308424364e-07
affected O 0 9.944970997821656e-07
members O 0 8.269129239124595e-07
( O 0 1.2126691899538855e-06
n O 0 4.367163001006702e-06
= O 0 3.79725292987132e-06
20 O 0 1.3018616300541908e-06
) O 0 4.796040684595937e-07
or O 0 3.674174422485521e-07
families O 0 3.318916128591809e-07
with O 0 5.166967866898631e-07
two O 0 4.3599871446531324e-07
affected O 0 1.4591174704037257e-06
members O 0 6.545976134475495e-07
, O 0 5.594661161012482e-07
one O 0 2.55444206231914e-07
of O 0 5.875547799405467e-07
them O 0 3.938094152999838e-07
affected O 0 8.108949600682536e-07
before O 0 1.0988914027620922e-06
the O 0 5.868760126759298e-07
age O 0 2.0018510440422688e-06
of O 0 1.5462758256035158e-06
50 O 0 1.79592586846411e-06
( O 0 1.0225693358734134e-06
n O 0 2.9461220947268885e-06
= O 0 3.733155836016522e-06
28 O 0 3.3597086712688906e-06
) O 0 9.669829523772933e-07
, O 0 6.457613039856369e-07
and O 0 5.020415869694261e-07
one O 0 1.1359047675796319e-06
additional O 0 4.633227035810705e-06
minor O 0 8.695997530594468e-05
criterion O 0 0.00206676684319973
. O 0 0.00022272576461546123

Sixteen O 0 0.0003970096295233816
different O 0 1.2933457583130803e-05
p16 O 0 0.00025310181081295013
germline O 0 0.0001993182086152956
mutations O 0 9.480670087214094e-06
were O 0 3.66628160008986e-06
found O 0 1.24409473301057e-06
in O 0 1.2347911706456216e-06
21 O 0 4.001504748885054e-06
families O 0 1.2413948979883571e-06
, O 0 1.3814145631840802e-06
while O 0 1.6051453712861985e-06
one O 0 1.898430014080077e-06
germline O 0 4.1469083953415975e-05
mutation O 0 3.292809878985281e-06
, O 0 2.323270791748655e-06
Arg24His O 0 0.0002257234591525048
, O 0 2.0171498817944666e-06
was O 0 6.772072083549574e-06
detected O 0 4.542282567854272e-06
in O 0 1.9213248378946446e-06
the O 0 1.2838463590014726e-05
CDK4 O 1 0.9955829977989197
gene O 0 8.547942707082257e-05
. O 0 7.036658644210547e-05

The O 0 5.1232676923973486e-05
frequency O 0 1.6389330994570628e-05
of O 0 2.4730501536396332e-05
p16 O 0 5.70199299545493e-05
gene O 0 4.068363068654435e-06
mutation O 0 1.7846469972937484e-06
in O 0 7.705206712671497e-07
our O 0 5.618380214400531e-07
sample O 0 8.223092322623415e-07
( O 0 1.4807388879489736e-06
44 O 0 2.701287485251669e-06
% O 0 3.0961487027525436e-06
) O 0 2.1077100882394006e-06
is O 0 1.3392501614362118e-06
among O 0 7.321762041101465e-07
the O 0 9.069846669262915e-07
highest O 0 6.975507858442143e-06
rates O 0 1.957070253411075e-06
yet O 0 9.823241953199613e-07
reported O 0 1.428275140824553e-06
and O 0 7.279298301909876e-07
the O 0 2.8231977466930402e-06
CDK4 O 0 0.37786173820495605
mutation O 0 3.780317683776957e-06
is O 0 9.747224112288677e-07
the O 0 7.624042268616904e-07
second O 0 3.455019850662211e-06
mutation O 0 1.3542796750698471e-06
detected O 0 2.6544748834567145e-06
in O 0 1.4076962315812125e-06
this O 0 3.0463249913736945e-06
gene O 0 1.29034460769617e-05
worldwide O 0 2.419126576569397e-05
. O 0 6.859214045107365e-05

In O 0 8.213215915020555e-05
summary O 0 6.373401265591383e-05
, O 0 9.684119504527189e-06
our O 0 3.86405736207962e-06
results O 0 1.745936287989025e-06
show O 0 6.325441972876433e-06
frequent O 0 4.502427600527881e-06
involvement O 0 1.2568700185511261e-05
of O 0 5.468692506838124e-06
the O 0 9.883146958600264e-06
p16 O 0 0.00010390056559117511
gene O 0 5.384858468460152e-06
in O 0 3.6509438814391615e-06
familial B-Disease 1 0.9984172582626343
melanoma I-Disease 1 0.999997615814209
and O 0 3.869437477987958e-06
confirm O 0 1.5170796814345522e-06
the O 0 1.1330592997182976e-06
role O 0 1.7536390259920154e-06
of O 0 1.8315080296815722e-06
the O 0 3.523335180943832e-06
CDK4 O 1 0.998694121837616
gene O 0 3.106325493718032e-06
as O 0 3.0796543342148652e-06
a O 0 2.9162398277549073e-05
melanoma B-Disease 1 0.9999954700469971
- O 0 0.4203064739704132
predisposing O 0 0.0384405218064785
gene O 0 4.1908460843842477e-05
. O 0 2.1894487872486934e-05
. O 0 5.330175190465525e-05

Progression O 0 0.2515068054199219
of O 0 0.0005233883857727051
somatic O 0 0.31540316343307495
CTG O 1 0.9783339500427246
repeat O 0 0.00013672400382347405
length O 0 4.141486351727508e-05
heterogeneity O 0 4.088821879122406e-05
in O 0 8.357204933417961e-06
the O 0 1.4012406609253958e-05
blood O 0 0.00010859287431230769
cells O 0 9.429980127606541e-05
of O 0 0.13463473320007324
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9998360872268677
. O 0 0.0010290361242368817

The O 0 5.6970573496073484e-05
genetic O 0 5.136573963682167e-05
basis O 0 4.542190072243102e-05
of O 1 0.9590766429901123
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999880790710449
DM B-Disease 1 1.0
) O 0 2.134904389095027e-05
is O 0 2.7436228720034705e-06
the O 0 1.9618089481809875e-06
expansion O 0 1.139097184932325e-05
of O 0 6.5310377976857126e-06
an O 0 9.378522918268573e-06
unstable O 0 0.03604408726096153
CTG O 1 0.5949177742004395
repeat O 0 1.2679555766226258e-05
in O 0 3.090855898335576e-06
the O 0 3.884014404320624e-06
34 O 0 1.1774915037676692e-05
UTR O 0 0.00010354765981901437
of O 0 7.071706932038069e-06
the O 0 8.614106263848953e-06
DM B-Disease 1 0.999996542930603
protein O 0 2.036835030594375e-05
kinase O 0 1.6499940102221444e-05
gene O 0 4.8741417231212836e-06
on O 0 8.295167390315328e-06
chromosome O 0 5.354941094992682e-05
19 O 0 0.00010077501065097749
. O 0 0.0001114458791562356

One O 0 6.210277206264436e-05
of O 0 2.5290601115557365e-05
the O 0 1.4959509826439898e-05
principal O 0 2.5767691113287583e-05
features O 0 2.7251546725892695e-06
of O 0 4.083772182639223e-06
the O 0 1.885445999505464e-05
DM B-Disease 1 1.0
mutation O 0 8.944385626818985e-06
is O 0 1.798630592020345e-06
an O 0 7.812615763214126e-07
extraordinarily O 0 9.180731467495207e-06
high O 0 3.6750616345671006e-06
level O 0 2.684077344383695e-06
of O 0 5.3048379413667135e-06
somatic O 0 0.002006982220336795
mosaicism O 1 0.825925350189209
, O 0 1.8671715906748432e-06
due O 0 1.564126932862564e-06
to O 0 7.880914267843764e-07
an O 0 1.0562010857029236e-06
extremely O 0 2.8659642339334823e-06
high O 0 2.975388497361564e-06
degree O 0 5.038541075919056e-06
of O 0 5.2820914788753726e-06
somatic O 0 0.00013540685176849365
instability O 0 8.413376053795218e-05
both O 0 1.4631654039476416e-06
within O 0 1.677406999078812e-06
and O 0 1.2069592685293173e-06
between O 0 4.3750878830906e-06
different O 0 3.960189587814966e-06
tissues O 0 4.760704905493185e-05
. O 0 7.229865877889097e-05

This O 0 0.00013295964163262397
instability O 0 0.0009494812693446875
appears O 0 3.8925278204260394e-05
to O 0 3.0047219752304954e-06
be O 0 1.5691259704908589e-06
biased O 0 3.0513085675920593e-06
towards O 0 4.013880698039429e-06
further O 0 3.44753220815619e-06
expansion O 0 8.818020432954654e-06
and O 0 1.1635630698947352e-06
continuous O 0 4.964424078934826e-06
throughout O 0 2.269551487188437e-06
the O 0 2.5840649868769106e-06
life O 0 2.374512405367568e-06
of O 0 1.4789465012654546e-06
an O 0 1.5447842542926082e-06
individual O 0 5.214102429818013e-07
, O 0 1.2285830734981573e-06
features O 0 6.742408800164412e-07
that O 0 1.4963354999508738e-07
could O 0 2.000701186943843e-07
be O 0 2.1561039886819344e-07
associated O 0 4.0815967849994195e-07
with O 0 5.262519948701083e-07
the O 0 3.4833103654818842e-06
progressive O 0 0.016878532245755196
nature O 0 6.282384674705099e-06
of O 0 1.426154631190002e-05
the O 0 0.0007430167170241475
disease O 1 0.9999818801879883
. O 0 0.00027809853781946003

Although O 0 7.352870306931436e-05
increasing O 0 2.266044248244725e-05
measured O 0 1.3050293091509957e-05
allele O 0 5.591201443166938e-06
size O 0 5.525261713046348e-06
between O 0 8.583248927607201e-06
patients O 0 8.375372999580577e-06
clearly O 0 6.741014203726081e-06
correlates O 0 7.955203727760818e-06
with O 0 1.6062463146226946e-06
an O 0 2.0402851532708155e-06
increased O 0 6.16643364992342e-06
severity O 0 3.1299034162657335e-05
of O 0 2.8330794521025382e-05
symptoms O 0 0.19850312173366547
and O 0 2.008381443374674e-06
an O 0 1.4239311667552101e-06
earlier O 0 3.581735654734075e-06
age O 0 4.498465841606958e-06
of O 0 6.985880190768512e-06
onset O 1 0.9885287880897522
, O 0 2.70539703706163e-06
this O 0 4.396429744701891e-07
correlation O 0 1.3762795560978702e-06
is O 0 3.1128834621085844e-07
not O 0 1.0356512802900397e-07
precise O 0 2.1902728519762604e-07
and O 0 2.3935231752147956e-07
measured O 0 8.639022439638211e-07
allele O 0 4.07635695864883e-07
length O 0 4.6252660013124114e-07
cannot O 0 2.4891411953831266e-07
be O 0 1.469088033445587e-07
used O 0 1.8547257241152693e-07
as O 0 4.938901270179485e-07
an O 0 9.339851203549188e-07
accurate O 0 5.519636488315882e-06
predictor O 0 6.549574027303606e-05
of O 0 2.414919981674757e-05
age O 0 8.13563892734237e-05
of O 0 0.0001440295163774863
onset O 1 0.999879002571106
. O 0 0.0007275690441019833

In O 0 0.00010130443843081594
order O 0 1.9025923393201083e-05
to O 0 5.262943886918947e-06
further O 0 5.87213662583963e-06
characterize O 0 1.4393919627764262e-05
the O 0 7.780949090374634e-06
dynamics O 0 0.0003090084355790168
of O 0 0.0019553625024855137
DM B-Disease 1 1.0
CTG O 1 0.9999966621398926
repeat O 0 0.00046880400623194873
somatic O 0 0.000327666406519711
instability O 0 0.00012104696361348033
, O 0 2.2544427338289097e-06
we O 0 7.187702522060135e-07
have O 0 3.4383805314064375e-07
studied O 0 4.149798769503832e-06
repeat O 0 3.6481803817878244e-06
length O 0 1.310165544055053e-06
changes O 0 4.2357015672678244e-07
over O 0 8.593794973421609e-07
time O 0 1.873560790954798e-06
in O 0 6.192422915773932e-06
111 O 1 0.9999278783798218
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.006263707764446735
with O 0 6.9433854150702246e-06
varying O 0 6.987799224589253e-06
clinical O 0 0.0002763040829449892
severity O 0 0.0052785989828407764
and O 0 3.1683463021181524e-05
CTG O 1 0.8747411966323853
repeat O 0 1.537377102067694e-05
size O 0 3.409112423469196e-06
over O 0 1.074221131602826e-06
time O 0 1.7059164747479372e-06
intervals O 0 3.5344983189133927e-06
of O 0 4.124264251004206e-06
1 O 0 3.2682317396393046e-05
- O 0 5.5531749239889905e-05
7 O 0 7.19452800694853e-05
years O 0 5.5947737564565614e-05
. O 0 6.073937765904702e-05

We O 0 3.775176082854159e-05
have O 0 4.269197233952582e-06
found O 0 1.9602118754846742e-06
a O 0 2.664787871253793e-06
direct O 0 2.328612026758492e-06
progression O 0 3.70451198250521e-05
of O 0 4.140639248362277e-06
the O 0 5.171891643840354e-06
size O 0 3.426475586820743e-06
heterogeneity O 0 8.774876732786652e-06
over O 0 1.6511130525032058e-06
time O 0 2.22363269131165e-06
related O 0 1.2028157243548776e-06
to O 0 1.2230665333845536e-06
initial O 0 7.733455277048051e-06
CTG O 0 0.08346249163150787
repeat O 0 8.490778782288544e-06
size O 0 1.998808556891163e-06
and O 0 3.772319132622215e-07
the O 0 8.534963740203239e-07
time O 0 1.2720290669676615e-06
interval O 0 5.725145911128493e-06
and O 0 1.693725948825886e-06
always O 0 2.760069492069306e-06
biased O 0 3.863773599732667e-06
towards O 0 9.257767487724777e-06
further O 0 1.5623674698872492e-05
expansion O 0 0.00013846319052390754
. O 0 0.0001153805133071728

Attempts O 0 8.09757475508377e-05
to O 0 9.303516890213359e-06
mathematically O 0 3.465460395091213e-05
model O 0 9.838290679908823e-06
the O 0 5.370191502152011e-06
dynamics O 0 4.528942008619197e-05
have O 0 2.662643964868039e-06
proved O 0 1.615051405678969e-05
only O 0 1.96356472770276e-06
partially O 0 1.3928618500358425e-05
successful O 0 5.509865331987385e-06
suggesting O 0 3.795504198933486e-06
that O 0 2.583589377991302e-07
individual O 0 3.353238184899965e-07
specific O 0 4.7102525968512055e-07
genetic O 0 5.4858624025655445e-06
and O 0 3.536585381880286e-06
/ O 0 0.00144667224958539
or O 0 4.006067683803849e-06
environmental O 0 8.364134373550769e-06
factors O 0 2.1463806660904083e-06
also O 0 1.2161077620476135e-06
play O 0 1.8397953454041271e-06
a O 0 3.84550730814226e-06
role O 0 1.1403014468669426e-05
in O 0 1.5085406630532816e-05
somatic O 0 0.0013738927664235234
mosaicism O 1 0.9815369248390198
. O 0 8.418311335844919e-05
. O 0 0.00010426839435240254

Aspartylglucosaminuria B-Disease 1 0.9989375472068787
among O 0 0.0005686916410923004
Palestinian O 0 0.0008684186032041907
Arabs O 0 0.001511822221800685
. O 0 0.0006290421006269753

Aspartylglucosaminuria B-Disease 1 0.9999984502792358
( O 1 0.6802425980567932
AGU B-Disease 1 0.9999994039535522
) O 0 3.6288402043282986e-05
is O 0 6.886724349897122e-06
a O 0 9.912465429806616e-06
rare O 0 0.00011922089470317587
disorder B-Disease 1 0.9999988079071045
of I-Disease 1 0.9980864524841309
glycoprotein I-Disease 1 0.9999994039535522
metabolism I-Disease 1 0.9075095653533936
caused O 0 0.0012553498381748796
by O 0 3.7130773762328317e-06
the O 0 2.054239303106442e-05
deficiency B-Disease 1 0.9999619722366333
of I-Disease 0 9.345653234049678e-05
the I-Disease 0 0.0004282408917788416
lysosomal I-Disease 1 0.9999889135360718
enzyme I-Disease 0 0.00019975063332822174
aspartylglucosaminidase I-Disease 0 0.40318042039871216
( O 0 6.498118455056101e-05
AGA O 0 0.34434613585472107
) O 0 6.775474321329966e-05
. O 0 7.58902751840651e-05

AGU B-Disease 1 0.9999990463256836
is O 0 0.00025594906765036285
inherited O 1 0.978642463684082
as O 0 3.532322443788871e-05
an O 0 4.6820576244499534e-05
autosomal O 1 0.9985101819038391
recessive O 1 0.9999008178710938
trait O 1 0.993334174156189
and O 0 2.793427847791463e-05
occurs O 0 5.711120138585102e-06
with O 0 1.3652179404743947e-06
a O 0 4.387388344184728e-06
high O 0 6.749383373971796e-06
frequency O 0 1.5155686696743942e-06
in O 0 1.461476585973287e-06
Finland O 0 8.864783012541011e-06
because O 0 1.6113981473608874e-06
of O 0 6.9835750764468685e-06
a O 0 3.211344301234931e-05
founder O 0 0.0007052704459056258
effect O 0 5.592256275122054e-05
. O 0 8.159258140949532e-05

While O 0 9.884686005534604e-05
very O 0 2.6394518499728292e-05
few O 0 1.0888135875575244e-05
patients O 0 1.8515480405767448e-05
with O 0 1.2095417332602665e-05
AGU B-Disease 1 0.9999998807907104
have O 0 2.141332743121893e-06
been O 0 1.1225982916585053e-06
reported O 0 9.951639867722406e-07
from O 0 1.160737951977353e-06
non O 0 3.1521722121397033e-06
- O 0 9.808360118768178e-06
Finnish O 0 0.0001070371872629039
origin O 0 1.5825340824449086e-06
, O 0 1.4332117643789388e-06
we O 0 1.2715026969090104e-06
diagnosed O 0 0.48525577783584595
the O 0 1.206459910463309e-05
disorder O 1 0.9999427795410156
in O 0 2.5765995815163478e-05
8 O 0 0.0021134675480425358
patients O 0 6.083838343329262e-06
originating O 0 2.3367761059489567e-06
from O 0 1.92773745766317e-06
3 O 0 4.225500106258551e-06
unrelated O 0 3.260319090259145e-06
families O 0 1.0064608204629621e-06
, O 0 6.823063927186013e-07
all O 0 3.476138488167635e-07
Palestinian O 0 3.971562819060637e-06
Arabs O 0 7.770300726406276e-06
from O 0 3.818212917394703e-06
the O 0 6.279521585383918e-06
region O 0 3.365290831425227e-05
of O 0 4.551108577288687e-05
Jerusalem O 0 0.0006512352265417576
. O 0 0.00014994417142588645

The O 0 0.00017711696273181587
clinical O 0 0.3228774666786194
diagnosis O 1 0.999764621257782
of O 1 0.999414324760437
AGU B-Disease 1 1.0
is O 0 6.806792225688696e-05
often O 0 2.716047902140417e-06
difficult O 0 3.177088501615799e-06
, O 0 7.056151503093133e-07
in O 0 6.212150651663251e-07
particular O 0 6.198989126460219e-07
early O 0 2.2924971290194662e-06
in O 0 1.1403723192415782e-06
the O 0 2.055834556813352e-06
course O 0 5.648655132972635e-06
of O 0 2.773962933133589e-06
the O 0 2.3507380319642834e-05
disease O 1 0.9996411800384521
, O 0 2.0123886770306854e-06
and O 0 5.751001026510494e-07
most O 0 4.730681268938497e-07
of O 0 1.7278549648835906e-06
the O 0 4.267658368917182e-06
patients O 0 1.4427384485315997e-05
are O 0 8.930339845392155e-07
diagnosed O 0 0.12819448113441467
after O 0 1.236287243955303e-05
the O 0 7.879983968450688e-06
age O 0 2.2982341761235148e-05
of O 0 2.605226109153591e-05
5 O 0 5.2615738241001964e-05
years O 0 7.00599848642014e-05
. O 0 9.283830877393484e-05

However O 0 0.00013466415111906826
, O 0 1.9648234228952788e-05
since O 0 1.1592231203394476e-05
these O 0 2.5542035473336e-06
patients O 0 1.0592792023089714e-05
excrete O 0 3.4494398278184235e-05
early O 0 5.7463921621092595e-06
large O 0 2.3945972316141706e-06
amounts O 0 1.600480231900292e-06
of O 0 3.388249069757876e-06
aspartylglucosamine O 0 7.046105747576803e-05
in O 0 1.281076947634574e-06
urine O 0 3.1512165605818154e-06
, O 0 1.2016187156405067e-06
biochemical O 0 3.6861954413325293e-06
screening O 0 3.380867156010936e-06
is O 0 1.4864010609016987e-06
easy O 0 3.095209649472963e-06
by O 0 3.411119223528658e-06
urine O 0 2.2650870960205793e-05
chromatography O 0 0.0005478151724673808
. O 0 3.297235889476724e-05
. O 0 8.664229972055182e-05

Detection O 0 0.00023384335509035736
of O 0 5.523040454136208e-05
heterozygous O 0 3.0203826099750586e-05
carriers O 0 8.394645192311145e-06
of O 0 9.13699022930814e-06
the O 0 5.3872143325861543e-05
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999940395355225
telangiectasia I-Disease 1 0.9999990463256836
( O 0 0.00011311382695566863
ATM O 0 0.010483845137059689
) O 0 3.0726137083547655e-06
gene O 0 1.5537436865997734e-06
by O 0 1.6116149481604225e-06
G2 O 0 0.1102420836687088
phase O 0 0.0001876640599220991
chromosomal O 0 0.0015123391058295965
radiosensitivity O 0 0.09081864356994629
of O 0 0.00011795045429607853
peripheral O 1 0.9997144341468811
blood O 0 0.12746769189834595
lymphocytes O 0 0.0018671232974156737
. O 0 0.00013917600153945386

In O 0 0.001905238488689065
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999827146530151
telangiectasia I-Disease 1 0.9999997615814209
( O 0 0.49178773164749146
A B-Disease 1 0.9999990463256836
- I-Disease 1 0.9999939203262329
T I-Disease 1 0.9999990463256836
) O 0 1.0066354661830701e-05
patients O 0 3.518573748806375e-06
, O 0 1.2273441143406671e-06
mutations O 0 1.2461323422030546e-06
in O 0 7.507975965381775e-07
a O 0 2.013056473515462e-06
single O 0 2.0907652924506692e-06
gene O 0 1.3464191397360992e-06
, O 0 8.999555802802206e-07
ATM O 0 1.8570402971818112e-05
, O 0 6.240979928406887e-07
result O 0 8.851442885315919e-07
in O 0 1.174643330159597e-06
an O 0 0.0001010754713206552
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 0.04526529088616371
embraces O 0 0.0013428848469629884
a O 0 5.973488896415802e-06
variety O 0 1.5936034287733492e-06
of O 0 3.1490415040025255e-06
clinical O 0 0.00010199371172348037
features O 0 4.9075983952207025e-06
and O 0 2.4934015527833253e-06
manifests O 0 3.0438592148129828e-05
extreme O 0 7.020264456514269e-05
radiosensitivity O 0 0.015764275565743446
and O 0 4.947909928887384e-06
a O 0 8.303406502818689e-06
strong O 0 9.395630513608921e-06
pre O 0 8.159895514836535e-05
- O 0 0.00018148763047065586
disposition O 0 0.0005234470590949059
to O 0 4.937416815664619e-05
malignancy B-Disease 1 0.9988332390785217
. O 0 0.00023354253789875656

Heterozygotes O 0 0.0009689633152447641
for O 0 3.932285471819341e-05
the O 0 2.8215234124218114e-05
ATM O 0 0.0011709259124472737
gene O 0 7.089310201990884e-06
have O 0 6.255901325857849e-07
no O 0 1.0096533742398606e-06
clinical O 0 5.316639089869568e-06
expression O 0 3.2139598715730244e-06
of O 0 1.7478407244198024e-05
A B-Disease 1 0.9999963045120239
- I-Disease 1 0.9999680519104004
T I-Disease 1 0.9999915361404419
but O 0 1.958358325282461e-06
may O 0 3.6581302538252203e-06
be O 0 2.965951580335968e-06
cancer B-Disease 0 0.03130248188972473
prone O 0 5.2563224016921595e-05
with O 0 3.0257854177762056e-06
a O 0 1.6524676539120264e-05
moderate O 0 2.1890562493354082e-05
increase O 0 4.877508217759896e-06
in O 0 6.342730102915084e-06
in O 0 1.755056291585788e-05
vitro O 0 0.00022546791296917945
radiosensitivity O 0 0.0026314901188015938
. O 0 0.00015519028238486499

We O 0 9.45556239457801e-05
performed O 0 6.817303074058145e-05
a O 0 4.3614254536805674e-05
blind O 0 0.00013636310177389532
chromosomal O 0 6.74067996442318e-05
analysis O 0 1.146900740423007e-05
on O 0 2.342560765100643e-05
G2 O 1 0.9992431402206421
- O 0 8.249803067883477e-05
phase O 0 0.00010036043386207893
lymphocytes O 0 2.0201194274704903e-05
from O 0 2.978514203277882e-06
7 O 0 1.3758828572463244e-05
unrelated O 0 1.9588289433158934e-05
A B-Disease 1 0.9110170602798462
- I-Disease 1 0.9933551549911499
T I-Disease 1 0.9999675750732422
patients O 0 6.785862296965206e-06
, O 0 1.630441147426609e-06
13 O 0 5.072791736893123e-06
obligate O 0 1.3981747542857192e-05
A B-Disease 1 0.9751580357551575
- I-Disease 1 0.9909701347351074
T I-Disease 1 0.9999066591262817
heterozygotes O 0 4.047906622872688e-05
( O 0 1.6377531437683501e-06
parents O 0 8.640711826046754e-07
of O 0 1.3985808209326933e-06
the O 0 2.0111415324208792e-06
patients O 0 3.00885130855022e-06
) O 0 1.1888988638020237e-06
, O 0 7.648861810594099e-07
and O 0 4.390010701627034e-07
14 O 0 1.5933482018226641e-06
normal O 0 1.3529811440093908e-06
controls O 0 1.8536555899117957e-06
following O 0 2.154842832169379e-06
X O 0 2.4513909011147916e-05
- O 0 7.986057426023763e-06
irradiation O 0 4.359676950116409e-06
with O 0 1.08014432953496e-06
1 O 0 8.534046173735987e-06
Gy O 0 4.069512215210125e-05
in O 0 4.7203027975228906e-07
order O 0 3.448659242621943e-07
to O 0 1.980927351041828e-07
evaluate O 0 8.102718993541203e-07
this O 0 5.507682203642617e-07
cytogenetic O 0 7.5840080171474256e-06
method O 0 1.0056164683192037e-06
as O 0 8.352619147444784e-07
a O 0 1.2865399412476108e-06
tool O 0 4.056357283843681e-06
for O 0 1.2594728104886599e-06
detection O 0 1.6043759387684986e-05
of O 0 3.4656888601602986e-05
ATM O 0 0.0044121090322732925
carriers O 0 0.00015265648835338652
. O 0 0.00011859149526571855

Both O 0 0.0003227778652217239
A B-Disease 1 0.9997802376747131
- I-Disease 1 0.9999740123748779
T I-Disease 1 0.9999945163726807
homozygotes O 0 0.00517037371173501
and O 0 8.588996934122406e-06
heterozygotes O 0 3.973479397245683e-05
showed O 0 9.868097549770027e-06
significantly O 0 4.1658736336103175e-06
increased O 0 3.3417693430237705e-06
levels O 0 1.8668386019271566e-06
of O 0 7.884403203206602e-06
radiation O 1 0.5488945841789246
- O 0 0.014548707753419876
induced O 0 0.4632243812084198
chromatid O 0 0.16530266404151917
damage O 0 4.303575406083837e-05
relative O 0 4.754349447466666e-06
to O 0 1.0125066864929977e-06
that O 0 5.712208803743124e-07
of O 0 4.014531896245899e-06
normal O 0 1.4262415788834915e-05
controls O 0 2.4800643586786464e-05
. O 0 4.569330485537648e-05

These O 0 2.0446312191779725e-05
results O 0 1.307508227910148e-05
show O 0 1.0591903446766082e-05
that O 0 1.7571645685166004e-06
the O 0 1.069350037141703e-05
G2 O 1 0.9997648596763611
- O 0 0.000124966143630445
phase O 0 0.0004476078611332923
chromosomal O 0 0.00026463973335921764
radiosensitivity O 0 0.0001595629728399217
assay O 0 5.114879513712367e-06
can O 0 4.6009816401237913e-07
be O 0 4.0398737155555864e-07
used O 0 6.85803058786405e-07
for O 0 5.875149895473442e-07
the O 0 2.066857177851489e-06
detection O 0 1.2867280929640401e-05
of O 0 1.8471546354703605e-05
A B-Disease 1 0.9997863173484802
- I-Disease 1 0.9997645020484924
T I-Disease 1 0.9999845027923584
heterozygotes O 0 0.001895973109640181
. O 0 0.0001618043170310557

In O 0 6.52704547974281e-05
combination O 0 4.557024294626899e-05
with O 0 6.165399099700153e-06
molecular O 0 2.428652260277886e-05
genetic O 0 1.1296368029434234e-05
analyses O 0 2.818240091073676e-06
, O 0 1.1837207694043173e-06
this O 0 3.4193490705547447e-07
test O 0 7.01094904798083e-07
may O 0 4.855866677644372e-07
be O 0 1.5639494677088805e-07
of O 0 4.4520092501443287e-07
value O 0 5.673277314599545e-07
in O 0 6.380255967997073e-07
studies O 0 1.3548894912673859e-06
of O 0 5.0911503421957605e-06
familial B-Disease 0 0.15022341907024384
and I-Disease 0 1.514304858574178e-05
sporadic I-Disease 0 0.03523778170347214
cancers I-Disease 0 0.41408464312553406
aimed O 0 1.0513397683098447e-05
at O 0 6.686082087981049e-06
determination O 0 3.945946446037851e-06
of O 0 2.718190671657794e-06
the O 0 2.461456460878253e-06
potential O 0 5.953600066277431e-06
involvement O 0 1.1273165910097305e-05
of O 0 8.503420758643188e-06
ATM O 0 0.0167124904692173
mutations O 0 9.248413334717043e-06
in O 0 1.2544511264422908e-05
tumor B-Disease 1 0.9982231259346008
risk O 0 2.2091408027336e-05
or O 0 9.918119758367538e-06
development O 0 2.67987579718465e-05
. O 0 2.3559940018458292e-05
. O 0 6.399271660484374e-05

Ataxia B-Disease 1 1.0
- I-Disease 1 0.999937891960144
telangiectasia I-Disease 1 0.9999512434005737
: O 0 2.6144600269617513e-05
identification O 0 1.1560634447960183e-05
and O 0 4.278237156540854e-06
detection O 0 1.7273478079005145e-05
of O 0 2.1040443243691698e-05
founder O 0 0.06790732592344284
- O 0 2.4818507881718688e-05
effect O 0 2.124308139173081e-06
mutations O 0 1.8090656794811366e-06
in O 0 1.4158093790683779e-06
the O 0 3.83974656870123e-06
ATM O 0 9.40649479161948e-05
gene O 0 4.8957667786453385e-06
in O 0 3.07515529129887e-06
ethnic O 0 1.773426993167959e-05
populations O 0 2.773122650978621e-05
. O 0 7.01497629052028e-05

To O 0 5.8449739299248904e-05
facilitate O 0 2.704213147808332e-05
the O 0 1.3492479411070235e-05
evaluation O 0 1.7075839423341677e-05
of O 0 2.174601650040131e-05
ATM O 0 0.08372043073177338
heterozygotes O 0 0.00010653151548467577
for O 0 3.7346587760112016e-06
susceptibility O 0 5.3252570069162175e-05
to O 0 2.749542545643635e-06
other O 0 3.1487711567024235e-06
diseases O 1 0.9556097388267517
, O 0 2.794540932882228e-06
such O 0 1.4520129525408265e-06
as O 0 0.00012541713658720255
breast B-Disease 1 0.9999992847442627
cancer I-Disease 1 0.9999958276748657
, O 0 7.027113952062791e-06
we O 0 7.879749546191306e-07
have O 0 3.0433585607170244e-07
attempted O 0 2.2506619643536396e-06
to O 0 3.283767853190511e-07
define O 0 1.1247179827478249e-06
the O 0 8.247989740084449e-07
most O 0 7.663566634619201e-07
common O 0 9.977164836527663e-07
mutations O 0 1.1006293334503425e-06
and O 0 9.469261499361892e-07
their O 0 8.127274782054883e-07
frequencies O 0 3.528836487021181e-06
in O 0 1.0822027434187476e-05
ataxia B-Disease 1 0.9999982118606567
- I-Disease 1 0.9993807077407837
telangiectasia I-Disease 1 0.9999960660934448
( O 0 0.0007926613907329738
A B-Disease 1 0.9999758005142212
- I-Disease 1 0.9952044486999512
T I-Disease 1 0.9987881779670715
) O 0 5.456340659293346e-06
homozygotes O 0 2.388184111623559e-05
from O 0 3.2980142350425012e-06
10 O 0 8.738707947486546e-06
ethnic O 0 2.134647911589127e-05
populations O 0 3.096122600254603e-05
. O 0 0.00010502197983441874

Both O 0 8.821404480841011e-05
genomic O 0 9.869578934740275e-05
mutations O 0 1.894900378829334e-05
and O 0 4.1769885683606844e-06
their O 0 3.5111895613226807e-06
effects O 0 1.3165974451112561e-05
on O 0 1.3133807442500256e-05
cDNA O 0 3.875242327922024e-05
were O 0 1.3156033674022183e-05
characterized O 0 0.00010339955770177767
. O 0 8.27276599011384e-05

Protein O 0 0.0006157540483400226
- O 0 0.00012817075185012072
truncation O 0 0.00010509150160942227
testing O 0 9.852600669546518e-06
of O 0 5.23815788255888e-06
the O 0 5.354603672458325e-06
entire O 0 1.6969248463283293e-05
ATM O 0 6.482384924311191e-05
cDNA O 0 1.705503927951213e-05
detected O 0 3.1059671528055333e-06
92 O 0 5.6212702475022525e-06
( O 0 1.6186542097784695e-06
66 O 0 6.229900009202538e-06
% O 0 4.312823875807226e-06
) O 0 3.2032712624641135e-06
truncating O 0 2.3805370801710524e-05
mutations O 0 3.294823727628682e-06
in O 0 3.916748028132133e-06
140 O 0 1.3024456166021992e-05
mutant O 0 4.3347299651941285e-05
alleles O 0 3.105265932390466e-05
screened O 0 0.00026983293355442584
. O 0 0.00012013784726150334

The O 0 0.00016006965597625822
haplotyping O 0 0.015109914354979992
of O 0 3.5343746276339516e-05
patients O 0 3.663464667624794e-05
with O 0 2.4355374534934526e-06
identical O 0 8.27082203613827e-06
mutations O 0 6.3707375375088304e-06
indicates O 0 3.4539393709565047e-06
that O 0 3.060168864976731e-07
almost O 0 3.429495905038493e-07
all O 0 1.9762930492106534e-07
of O 0 6.940895787010959e-07
these O 0 2.9002180212955864e-07
represent O 0 1.228074779646704e-06
common O 0 1.0179991249970044e-06
ancestry O 0 3.721447001225897e-06
and O 0 1.254982635146007e-06
that O 0 7.803247399351676e-07
very O 0 1.3496921837941045e-06
few O 0 3.082913281104993e-06
spontaneously O 0 2.7974689146503806e-05
recurring O 0 0.0003382762661203742
ATM O 0 0.03726337105035782
mutations O 0 3.4495711588533595e-05
exist O 0 3.457567436271347e-05
. O 0 6.828363257227466e-05

Assays O 0 0.0001336279237875715
requiring O 0 2.299628613400273e-05
minimal O 0 1.9947177861467935e-05
amounts O 0 3.7357237943069777e-06
of O 0 3.7791785416629864e-06
genomic O 0 7.11730717739556e-06
DNA O 0 4.509474820224568e-06
were O 0 1.1463541795819765e-06
designed O 0 1.4776185253140284e-06
to O 0 5.291375941851584e-07
allow O 0 7.331991014325467e-07
rapid O 0 7.679892405576538e-06
screening O 0 3.2602040391793707e-06
for O 0 1.2104080724384403e-06
common O 0 3.147375082335202e-06
ethnic O 0 1.8647477190825157e-05
mutations O 0 6.445991311920807e-05
. O 0 0.00011942170385736972

These O 0 4.594130223267712e-05
rapid O 0 0.00014703796477988362
assays O 0 3.018542702193372e-05
detected O 0 1.820082798076328e-05
mutations O 0 3.8022826629457995e-06
in O 0 2.605842610137188e-06
76 O 0 1.2688120477832854e-05
% O 0 4.904936304228613e-06
of O 0 8.358767445315607e-06
Costa O 0 2.3352089556283318e-05
Rican O 0 6.158690666779876e-05
patients O 0 5.041337772127008e-06
( O 0 2.8189847398607526e-06
3 O 0 4.733037258120021e-06
) O 0 1.2956612636116915e-06
, O 0 4.965590392203012e-07
50 O 0 7.745138077552838e-07
% O 0 7.148913709897897e-07
of O 0 1.7030847629939672e-06
Norwegian O 0 2.0934585336362943e-05
patients O 0 3.7668078221031465e-06
( O 0 2.221148861281108e-06
1 O 0 5.46207775187213e-06
) O 0 1.37400820676703e-06
, O 0 5.002183343094657e-07
25 O 0 9.319547302766296e-07
% O 0 1.3506321465683868e-06
of O 0 3.8520406633324455e-06
Polish O 0 0.01250949315726757
patients O 0 7.783658475091215e-06
( O 0 1.4881683227940812e-06
4 O 0 4.456139777175849e-06
) O 0 9.818774060477153e-07
, O 0 3.404985307042807e-07
and O 0 2.1139251771273848e-07
14 O 0 7.114132358765346e-07
% O 0 5.734735282203474e-07
of O 0 2.3321190383285284e-06
Italian O 0 4.9054797273129225e-05
patients O 0 6.646684141742298e-06
( O 0 1.3194002121963422e-06
1 O 0 4.052761141792871e-06
) O 0 7.633259997419373e-07
, O 0 2.7969301186203666e-07
as O 0 3.175245524289494e-07
well O 0 3.5893978633794177e-07
as O 0 4.802274702342402e-07
in O 0 7.554733656434109e-07
patients O 0 3.4032880193990422e-06
of O 0 1.770268863765523e-05
Amish O 0 0.0721881091594696
/ O 0 0.021202655509114265
Mennonite O 0 0.0006533439736813307
and O 0 7.330045264097862e-06
Irish O 0 8.127853652695194e-05
English O 0 5.101397619000636e-05
backgrounds O 0 0.00012629054253920913
. O 0 0.0001456649333704263

Additional O 0 8.74954930623062e-05
mutations O 0 4.841609552386217e-05
were O 0 1.3620949175674468e-05
observed O 0 7.94414972915547e-06
in O 0 5.893359684705501e-06
Japanese O 0 4.363934203865938e-05
, O 0 8.128599802148528e-06
Utah O 0 5.950446575297974e-05
Mormon O 0 2.4406330339843407e-05
, O 0 2.307130671397317e-06
and O 0 3.044420054720831e-06
African O 0 2.5350313080707565e-05
American O 0 4.2867977754212916e-05
patients O 0 0.00010269530321238562
. O 0 9.435835818294436e-05

These O 0 1.93245941773057e-05
assays O 0 2.0276465875213034e-05
should O 0 3.8721877899661195e-06
facilitate O 0 6.552536888193572e-06
screening O 0 5.4365245887311175e-06
for O 0 5.227124347584322e-06
A B-Disease 1 0.9824008345603943
- I-Disease 1 0.9981141090393066
T I-Disease 1 0.9999446868896484
heterozygotes O 0 7.505535177187994e-05
in O 0 4.410036581248278e-06
the O 0 4.002135028713383e-06
populations O 0 8.582856025896035e-06
studied O 0 2.7700276405084878e-05
. O 0 1.8977088984684087e-05
. O 0 6.791413761675358e-05

The O 0 0.00024721212685108185
von B-Disease 1 0.9724279642105103
Hippel I-Disease 1 0.9999632835388184
- I-Disease 1 0.999738872051239
Lindau I-Disease 1 0.9999998807907104
tumor I-Disease 1 0.9999953508377075
suppressor O 0 0.00042484147707000375
gene O 0 2.0841919194936054e-06
is O 0 5.374138822844543e-07
required O 0 3.7371381722550723e-07
for O 0 1.3495840676114312e-06
cell O 0 1.1467094736872241e-05
cycle O 0 7.809732778696343e-06
exit O 0 1.2281343515496701e-05
upon O 0 1.2587986930157058e-05
serum O 0 0.00010823889169842005
withdrawal O 0 0.000181447685463354
. O 0 0.00010776690032798797

The O 0 0.0001366656069876626
inactivation O 0 0.0009292352478951216
of O 0 6.0774662415497005e-05
the O 0 4.3171108700335026e-05
von B-Disease 1 0.988856852054596
Hippel I-Disease 1 0.9999610185623169
- I-Disease 1 0.9824490547180176
Lindau I-Disease 1 0.9999954700469971
( I-Disease 0 0.0003339845279697329
VHL I-Disease 1 0.9999759197235107
) I-Disease 0 7.024536898825318e-05
tumor I-Disease 1 0.999940037727356
suppressor O 0 0.12997697293758392
gene O 0 9.957545444194693e-06
predisposes O 0 4.916447869618423e-05
affected O 0 2.524845740481396e-06
individuals O 0 8.374897220164712e-07
to O 0 1.620006969460519e-06
the O 0 1.3173533261578996e-05
human O 0 0.1856013387441635
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 3.13242053380236e-05
is O 0 3.6187891510053305e-06
associated O 0 1.5566685078738374e-06
with O 0 4.280212579033105e-06
sporadic B-Disease 1 0.9999555349349976
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 1 0.9972499012947083
RCC B-Disease 1 1.0
) O 0 4.369268208392896e-05
and O 0 2.3928048904053867e-05
brain B-Disease 0 0.05274536833167076
hemangioblastomas I-Disease 0 0.2806313931941986
. O 0 0.00014701540931127965

VHL O 1 0.992424488067627
- O 0 0.0009249317809008062
negative O 0 0.00010319585271645337
786 O 0 0.21932561695575714
- O 0 0.021180931478738785
0 O 0 0.026572417467832565
RCC B-Disease 1 0.9999997615814209
cells O 0 3.157303945044987e-05
are O 0 2.5328140509373043e-06
tumorigenic O 0 0.0001314189430559054
in O 0 1.1044417988159694e-05
nude O 0 7.446548261214048e-05
mice O 0 1.2157402125012595e-05
which O 0 1.29020997974294e-06
is O 0 1.956429969141027e-06
suppressed O 0 6.7956411839986686e-06
by O 0 2.0417101040948182e-06
the O 0 7.172622645157389e-06
reintroduction O 0 0.0002131011860910803
of O 0 0.0001753560791257769
VHL B-Disease 1 0.9989594221115112
. O 0 0.00028323777951300144

Remarkably O 0 0.0013767409836873412
, O 0 2.9998951504239812e-05
this O 0 9.515261808701325e-06
occurs O 0 7.884102160460316e-06
without O 0 3.2177104003494605e-06
affecting O 0 7.1503445724374615e-06
the O 0 5.262838840280892e-06
growth O 0 1.2949426491104532e-05
rate O 0 4.08515097660711e-06
and O 0 2.771995468719979e-06
cell O 0 1.134434569394216e-05
cycle O 0 5.132211299496703e-06
profile O 0 2.1808070869155927e-06
of O 0 2.427998197163106e-06
these O 0 1.4437667914535268e-06
cells O 0 5.3809267228643876e-06
in O 0 5.965956461295718e-06
culture O 0 5.944780059508048e-05
. O 0 9.329739987151697e-05

The O 0 0.00018324615666642785
786 O 0 0.05876531824469566
- O 0 0.00035576659138314426
0 O 0 0.00012223287194501609
cell O 0 0.0001157602746388875
line O 0 8.761606295593083e-06
, O 0 1.4914330677129328e-06
like O 0 1.1556912795640528e-06
many O 0 1.8260403749081888e-06
cancer B-Disease 1 0.8475305438041687
cells O 0 2.7698022222466534e-06
, O 0 7.672810511394346e-07
fails O 0 1.35797597522469e-06
to O 0 3.131418395696528e-07
exit O 0 3.0138137390167685e-06
the O 0 3.456380909483414e-06
cell O 0 1.0811567335622385e-05
cycle O 0 8.84495511854766e-06
upon O 0 8.21450066723628e-06
serum O 0 7.944684330141172e-05
withdrawal O 0 0.0001176236110040918
. O 0 0.00011780972999986261

Here O 0 0.00018366788572166115
, O 0 1.3318601304490585e-05
it O 0 2.332296844542725e-06
is O 0 1.5756430684632505e-06
shown O 0 1.5320348438763176e-06
that O 0 6.695664183098415e-07
reintroduction O 0 7.71666418586392e-06
of O 0 2.426620767437271e-06
the O 0 6.216682777449023e-06
wild O 0 1.9374894691281952e-05
- O 0 6.063966065994464e-05
type O 0 6.370473420247436e-05
VHL B-Disease 1 0.7143378257751465
gene O 0 4.891640855930746e-06
restores O 0 8.458434422209393e-06
the O 0 2.756439243967179e-06
ability O 0 2.6872532998822862e-06
of O 0 1.1241817446716595e-05
VHL O 1 0.9999339580535889
- O 0 0.05438398942351341
negative O 0 0.0005748267285525799
RCC B-Disease 1 1.0
cancer I-Disease 1 0.9854924082756042
cells O 0 2.3400432382914005e-06
to O 0 5.599016503765597e-07
exit O 0 5.273781425785273e-06
the O 0 3.7012512166256784e-06
cell O 0 1.3920093806518707e-05
cycle O 0 7.574365099571878e-06
and O 0 2.522857812436996e-06
enter O 0 1.3179540474084206e-05
G0 O 0 0.028478404507040977
/ O 0 0.00011498434469103813
quiescence O 0 0.0003499083104543388
in O 0 3.0703391530551016e-05
low O 0 0.00015817627718206495
serum O 0 0.0004918658523820341
. O 0 0.0001391777186654508

Both O 0 0.0004852224374189973
VHL O 1 0.9985803365707397
- O 0 0.0006645713583566248
positive O 0 4.4487707782536745e-05
and O 0 3.2307234505424276e-05
VHL O 1 0.9998306035995483
- O 0 0.0016763132298365235
negative O 0 4.075271135661751e-05
RCC B-Disease 1 0.999990701675415
cells O 0 8.310781595355365e-06
exit O 0 8.86354064277839e-06
the O 0 5.693636012438219e-06
cell O 0 1.3228335774329025e-05
cycle O 0 7.768596333335154e-06
by O 0 5.165074526303215e-06
contact O 0 3.854665192193352e-05
inhibition O 0 0.0002229919919045642
. O 0 0.00015380624972749501

The O 0 0.00027075005345977843
cyclin O 0 0.0036218329332768917
- O 0 0.00020302471239119768
dependent O 0 3.921070310752839e-05
kinase O 0 9.156635496765375e-05
inhibitor O 0 7.749397627776489e-05
, O 0 6.0706706790369935e-06
p27 O 0 3.5525714338291436e-05
, O 0 1.5868456557655009e-06
accumulates O 0 3.882037162838969e-06
upon O 0 1.6355055549865938e-06
serum O 0 5.3889375521976035e-06
withdrawal O 0 3.756755631911801e-06
, O 0 8.347984703505062e-07
only O 0 3.664299867978116e-07
in O 0 3.710733551542944e-07
the O 0 8.209787552004855e-07
presence O 0 1.8488885871192906e-06
of O 0 6.215271696419222e-06
VHL B-Disease 1 0.9348762631416321
, O 0 1.8592146489027073e-06
as O 0 8.910781161830528e-07
a O 0 1.0690620229070191e-06
result O 0 9.314242674918205e-07
of O 0 2.005407168326201e-06
the O 0 2.6554366741038393e-06
stabilization O 0 4.977852586307563e-05
of O 0 1.9714208974619396e-05
the O 0 4.865139999310486e-05
protein O 0 0.00010522446973482147
. O 0 0.00011505202564876527

We O 0 4.78858346468769e-05
propose O 0 2.2426816940424033e-05
that O 0 1.55067812102061e-06
the O 0 2.974951485157362e-06
loss O 0 3.002476842084434e-05
of O 0 2.1973641196382232e-05
wild O 0 0.00027410531765781343
- O 0 0.015366091392934322
type O 0 0.0003752929624170065
VHL B-Disease 1 0.9148381948471069
gene O 0 1.614322286513925e-06
results O 0 7.821158192200528e-07
in O 0 8.161076152646274e-07
a O 0 1.604989165571169e-06
specific O 0 1.014586473502277e-06
cellular O 0 1.949050056282431e-05
defect O 0 5.768200571765192e-05
in O 0 6.1696341617789585e-06
serum O 0 0.007576470263302326
- O 0 0.00014120331616140902
dependent O 0 6.439111530198716e-06
growth O 0 2.8973756798222894e-06
control O 0 2.013409812207101e-06
, O 0 9.421852382729412e-07
which O 0 1.1220696478630998e-06
may O 0 4.008406904176809e-06
initiate O 0 4.420718687470071e-05
tumor B-Disease 1 0.6072946190834045
formation O 0 0.0009565562941133976
. O 0 0.00027321092784404755

This O 0 4.115917909075506e-05
is O 0 1.3862837477063295e-05
corrected O 0 2.2970705686020665e-05
by O 0 2.2713836642651586e-06
the O 0 3.3856940717669204e-06
reintroduction O 0 2.265705006720964e-05
of O 0 9.676716217654757e-06
wild O 0 4.4387485104380175e-05
- O 0 0.002499462803825736
type O 0 0.030391164124011993
VHL B-Disease 1 0.9999780654907227
, O 0 1.4709297829540446e-05
implicating O 1 0.6073014140129089
VHL B-Disease 1 0.9751502275466919
as O 0 4.998109943699092e-06
the O 0 5.0097823987016454e-06
first O 0 3.120842666248791e-05
tumor B-Disease 1 0.9997947812080383
suppressor O 0 8.753529982641339e-05
involved O 0 2.6971224542648997e-06
in O 0 1.2051971225446323e-06
the O 0 1.797647996681917e-06
regulation O 0 3.23564427162637e-06
of O 0 8.005173185665626e-06
cell O 0 1.9417126168264076e-05
cycle O 0 7.4752356340468396e-06
exit O 0 5.200924533710349e-06
, O 0 1.226347308147524e-06
which O 0 2.557647462708701e-07
is O 0 3.270862691806542e-07
consistent O 0 4.49272846481108e-07
with O 0 3.114932383141422e-07
its O 0 1.3769872566626873e-06
gatekeeper O 0 0.0001247230393346399
function O 0 2.1703958736907225e-06
in O 0 2.6609227461449336e-06
the O 0 1.6852200133143924e-05
kidney O 1 0.9999116659164429
. O 0 4.013160287286155e-05
. O 0 9.315675561083481e-05

Piebaldism B-Disease 1 0.9999884366989136
with O 0 0.005341056268662214
deafness B-Disease 1 1.0
: O 0 0.0001566695427754894
molecular O 0 3.852011650451459e-05
evidence O 0 8.558172339689918e-06
for O 0 6.189854502736125e-06
an O 0 3.0450091799139045e-05
expanded O 0 0.08112703263759613
syndrome O 1 0.9999996423721313
. O 0 0.0012201813515275717

In O 0 0.00011408387217670679
a O 0 6.253940227907151e-05
South O 0 0.00019176743808202446
African O 0 5.156774932402186e-05
girl O 0 3.1137857149587944e-05
of O 0 9.43381655815756e-06
Xhosa O 1 0.9972639083862305
stock O 0 0.0001173474665847607
with O 0 6.547046268678969e-06
severe O 1 0.9999620914459229
piebaldism B-Disease 1 0.9999996423721313
and O 1 0.8764452338218689
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 0.13571827113628387
identified O 0 3.8696474803145975e-05
a O 0 1.0866289812838659e-05
novel O 0 7.092109626682941e-06
missense O 0 1.4912207007000688e-05
substitution O 0 7.7548720582854e-06
at O 0 1.0040564120572526e-05
a O 0 5.460338343254989e-06
highly O 0 5.592342404270312e-06
conserved O 0 7.597675448778318e-06
residue O 0 9.05657907424029e-06
in O 0 1.759951942403859e-06
the O 0 3.2059240311355097e-06
intracellular O 0 1.067839730239939e-05
kinase O 0 9.32259536057245e-06
domain O 0 3.787679133893107e-06
of O 0 4.138827080168994e-06
the O 0 1.4820450815022923e-05
KIT O 0 0.06523371487855911
proto O 0 0.019195016473531723
- O 0 0.00035034905886277556
oncogene O 0 0.007865267805755138
, O 0 3.810997077380307e-05
R796G O 0 0.0005292678251862526
. O 0 0.00011499519314384088

Though O 0 0.00038824486546218395
auditory B-Disease 1 0.7252015471458435
anomalies I-Disease 0 0.04424206539988518
have O 0 8.758815965848044e-06
been O 0 5.110588972456753e-06
observed O 0 4.172919943812303e-06
in O 0 3.922650193999289e-06
mice O 0 1.005858212010935e-05
with O 0 2.3594379854330327e-06
dominant O 0 0.00037277379306033254
white O 0 0.00011348343105055392
spotting O 0 0.12982197105884552
( O 0 1.8328519217902794e-05
W O 1 0.644952118396759
) O 0 1.499046447861474e-06
due O 0 2.447309270792175e-06
to O 0 1.771927713889454e-06
KIT O 1 0.5628018975257874
mutations O 0 2.0425653929123655e-05
, O 0 2.190123086620588e-05
deafness B-Disease 1 1.0
is O 0 7.723342605459038e-06
not O 0 1.82840847173793e-06
typical O 0 7.33343495085137e-06
in O 0 9.535810931993183e-06
human O 0 2.0804682208108716e-05
piebaldism B-Disease 0 0.00617996696382761
. O 0 0.00011198745778528973

Thus O 0 0.00012153480929555371
, O 0 1.1755962987081148e-05
the O 0 6.076445515645901e-06
occurrence O 0 2.799796493491158e-05
of O 0 0.3734636604785919
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 0.30268773436546326
this O 0 1.5841764252400026e-05
patient O 0 3.656494664028287e-05
extends O 0 1.2634773156605661e-05
considerably O 0 3.886615559167694e-06
the O 0 7.080459454300581e-07
phenotypic O 0 4.879271273239283e-06
range O 0 2.2999863631412154e-06
of O 0 4.0667259781912435e-06
piebaldism B-Disease 0 0.00018804808496497571
due O 0 4.542412625596626e-06
to O 0 2.451373575240723e-06
KIT O 0 0.0011818334460258484
gene O 0 2.5479171199549455e-06
mutation O 0 9.670955023466377e-07
in O 0 1.0547273632255383e-06
humans O 0 1.8786849977914244e-06
and O 0 9.896293704514392e-07
tightens O 0 4.405917024996597e-06
the O 0 1.681337266745686e-06
clinical O 0 7.5169273259234615e-06
similarity O 0 8.9131008280674e-06
between O 0 1.5136652109504212e-05
piebaldism B-Disease 0 0.06261584907770157
and O 0 1.1664239991659997e-06
the O 0 1.0673454653442604e-06
various O 0 7.055687660795229e-07
forms O 0 4.839057510253042e-06
of O 0 0.09906432777643204
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0006913468241691589
. O 0 0.00019815792620647699

Cycloheximide O 0 0.03266959264874458
facilitates O 0 0.00010575016494840384
the O 0 1.6191626855288632e-05
identification O 0 6.2028543652559165e-06
of O 0 9.35964362724917e-06
aberrant O 0 3.286038918304257e-05
transcripts O 0 2.0768486137967557e-05
resulting O 0 8.541863280697726e-06
from O 0 3.008125531778205e-06
a O 0 6.015220151311951e-06
novel O 0 1.5316831195377745e-05
splice O 0 4.4465865357778966e-05
- O 0 9.424149538972415e-06
site O 0 6.135111107141711e-06
mutation O 0 1.4873482996335952e-06
in O 0 1.6395346165154479e-06
COL17A1 O 0 0.007674780674278736
in O 0 2.6599916509439936e-06
a O 0 5.394650088419439e-06
patient O 0 1.5963270925567485e-05
with O 0 1.3272803698782809e-05
generalized O 1 0.9950850605964661
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999978542327881
. O 0 0.002324458211660385

Patients O 0 0.005445993971079588
with O 0 0.00019832767429761589
generalized O 1 0.9999357461929321
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999995231628418
often O 0 2.8268668756936677e-05
show O 0 1.1562498002604116e-05
decreased O 0 3.310339161544107e-05
expression O 0 9.18364730750909e-06
of O 0 1.1810554497060366e-05
type O 0 0.02136908657848835
XVII O 1 0.9999998807907104
collagen O 1 0.8558042049407959
, O 0 3.998197826149408e-06
a O 0 7.841219485271722e-06
transmembrane O 0 0.00014135285164229572
hemidesmosomal O 0 0.0002593246172182262
protein O 0 9.675941328168847e-06
encoded O 0 8.490228537993971e-06
by O 0 1.8192740753875114e-05
COL17A1 O 0 0.022070061415433884
. O 0 0.00010457887401571497

This O 0 7.820464088581502e-05
report O 0 1.79988237505313e-05
documents O 0 1.8902635929407552e-05
a O 0 1.7897291400004178e-05
novel O 0 2.258159474877175e-05
splice O 0 7.794353587087244e-05
- O 0 2.6370062187197618e-05
site O 0 1.0057967301690951e-05
mutation O 0 3.0868584417476086e-06
in O 0 3.393979795873747e-06
COL17A1 O 0 0.06444153934717178
in O 0 2.7877799766429234e-06
a O 0 7.662385542062111e-06
patient O 0 1.5532503311987966e-05
with O 0 7.038818239379907e-06
generalized O 1 0.9982569813728333
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999994039535522
, O 0 2.6494788471609354e-05
and O 0 2.225508296760381e-06
applies O 0 1.6498412378496141e-06
a O 0 9.657397868068074e-07
new O 0 5.378998935157142e-07
methodology O 0 1.1251921705479617e-06
to O 0 5.050925437899423e-07
define O 0 1.4138689721221454e-06
and O 0 1.202297312374867e-06
characterize O 0 5.849744866281981e-06
the O 0 3.2301873034157325e-06
resulting O 0 1.0160525562241673e-05
mRNA O 0 2.3953230993356556e-05
splice O 0 0.00010874198778765276
variants O 0 4.769169390783645e-05
. O 0 4.539778092294e-05

Mutational O 0 0.0017423663521185517
analysis O 0 5.7670564274303615e-05
of O 0 7.548415305791423e-05
COL17A1 O 1 0.7905852198600769
identified O 0 2.3518075977335684e-05
a O 0 2.1714911781600676e-05
maternally O 0 0.00022829978843219578
inherited O 1 0.9406785368919373
G O 0 0.3384130299091339
- O 0 0.00013863705680705607
to O 0 6.793016837036703e-06
- O 0 0.0001393509010085836
T O 0 0.000641897669993341
transversion O 0 5.8731391618493944e-05
at O 0 5.825416792504257e-06
the O 0 3.1719689559395192e-06
- O 0 8.739108125155326e-06
1 O 0 9.60868510446744e-06
position O 0 9.994038919103332e-06
of O 0 1.8407115931040607e-05
exon O 0 0.00019924258231185377
32 O 0 0.00012536501162685454
. O 0 0.00011923760030185804

This O 0 0.0001474401942687109
acceptor O 0 0.0002993699163198471
splice O 0 0.0007184849819168448
- O 0 0.00014750529953744262
site O 0 2.8335305614746176e-05
mutation O 0 6.673697498627007e-06
led O 0 5.619180228677578e-06
to O 0 1.125907147070393e-06
the O 0 3.3333151350234402e-06
formation O 0 1.728390998323448e-05
of O 0 9.035830771608744e-06
aberrant O 0 3.5636159736895934e-05
transcripts O 0 1.650193917157594e-05
present O 0 6.4225341702695005e-06
at O 0 1.7825577742769383e-05
extremely O 0 2.109396518790163e-05
low O 0 4.489591083256528e-05
levels O 0 3.661268419818953e-05
. O 0 5.0268059567315504e-05

Based O 0 6.844780000392348e-05
on O 0 1.527468702988699e-05
our O 0 4.8018582674558274e-06
recent O 0 2.945475898741279e-06
finding O 0 7.04460626366199e-06
that O 0 2.6356522084824974e-06
cycloheximide O 0 0.002557662082836032
stabilized O 0 0.0012051487574353814
mutant O 0 9.780330583453178e-05
COL17A1 O 0 0.019557563588023186
transcripts O 0 1.7624024621909484e-05
in O 0 4.024686404591193e-06
keratinocytes O 0 2.2496817109640688e-05
homozygous O 0 5.273927399684908e-06
for O 0 1.6513414493601886e-06
a O 0 8.249552593042608e-06
frameshift O 0 6.957356526982039e-05
mutation O 0 4.4463931772043e-06
, O 0 1.4520877584800473e-06
the O 0 1.4000061128172092e-06
effects O 0 3.1679694529884728e-06
of O 0 2.946756922028726e-06
the O 0 6.756125912943389e-06
splice O 0 5.8745063142850995e-05
- O 0 1.537204116175417e-05
site O 0 4.6592408580181655e-06
mutation O 0 1.2399265187923447e-06
on O 0 1.4168142570269993e-06
splicing O 0 3.0853898351779208e-06
of O 0 4.039267423650017e-06
COL17A1 O 0 0.0004518786445260048
transcripts O 0 6.370846222125692e-06
were O 0 1.329636802438472e-06
determined O 0 1.5566446336379158e-06
using O 0 1.4738973277417244e-06
reverse O 0 9.337383744423278e-06
transcriptase O 0 2.0722962290165015e-05
polymerase O 0 2.6755296858027577e-05
chain O 0 6.697032404190395e-06
reaction O 0 1.7188403944601305e-06
of O 0 2.1450750864460133e-06
total O 0 5.311353106662864e-06
RNA O 0 2.689876600925345e-05
from O 0 5.506603429239476e-06
keratinocytes O 0 2.623601358209271e-05
incubated O 0 3.743898923858069e-05
for O 0 8.240494935307652e-06
2 O 0 0.00011474546045064926
. O 0 0.00013311451766639948

5 O 0 0.0002854564518202096
h O 0 0.0001530158770037815
in O 0 7.39697406970663e-06
the O 0 4.234201242070412e-06
presence O 0 3.639433771240874e-06
or O 0 1.335526008006127e-06
absence O 0 7.6257315413386095e-06
of O 0 1.2934750884596724e-05
10 O 0 3.555140574462712e-05
microg O 0 0.01348610408604145
cycloheximide O 0 0.000913690309971571
per O 0 6.233731983229518e-05
ml O 0 0.0007246551685966551
. O 0 0.0001642286661081016

Using O 0 3.86063547921367e-05
this O 0 6.1463074416678865e-06
approach O 0 8.40500979393255e-06
, O 0 1.6225272929659695e-06
an O 0 2.5359777282574214e-06
abnormally O 0 3.627560363383964e-05
spliced O 0 2.3979722755029798e-05
transcript O 0 1.3511819815903436e-05
was O 0 7.695448402955662e-06
identified O 0 8.558323543184088e-07
that O 0 2.3838462936964788e-07
contains O 0 3.9021597331156954e-07
an O 0 5.133661602485518e-07
extra O 0 1.693120339041343e-06
264 O 0 6.002406735206023e-06
bases O 0 2.6828565751202404e-06
upstream O 0 6.428343112929724e-06
from O 0 3.854499027511338e-06
exon O 0 1.8494019968784414e-05
32 O 0 4.6794757508905604e-06
, O 0 1.6985576394290547e-06
resulting O 0 1.8025766621576622e-06
in O 0 2.2595611426368123e-06
a O 0 7.66570428822888e-06
premature O 0 3.6606958019547164e-05
termination O 0 7.032229768810794e-05
codon O 0 6.661398219875991e-05
27 O 0 4.9910577217815444e-05
bp O 0 4.28641724283807e-05
downstream O 0 2.9934768463135697e-05
from O 0 1.365593561786227e-05
the O 0 3.081163595197722e-05
cryptic O 0 0.0001788152294466272
splice O 0 0.00038693129317834973
site O 0 0.0004837040032725781
. O 0 0.00021149437816347927

Three O 0 4.043307853862643e-05
other O 0 7.321389148273738e-06
splice O 0 3.673074388643727e-05
variants O 0 5.821839749842184e-06
, O 0 1.8757078805720084e-06
including O 0 8.348796427526395e-07
one O 0 7.828889465599786e-07
derived O 0 9.619793672754895e-07
from O 0 9.348049161417293e-07
the O 0 1.9045793351324392e-06
skipping O 0 1.0832890438905451e-05
of O 0 2.8549243324960116e-06
exon O 0 2.5944955268641934e-05
32 O 0 6.4168102653638925e-06
, O 0 1.590944521012716e-06
were O 0 2.441353444737615e-06
also O 0 3.0588169011025457e-06
identified O 0 1.5140507457545027e-05
. O 0 3.906309211743064e-05

These O 0 1.5990895917639136e-05
results O 0 9.542433872411493e-06
indicate O 0 7.950348845042754e-06
the O 0 5.048323600931326e-06
usefulness O 0 2.7606627554632723e-05
of O 0 1.683192931523081e-05
cycloheximide O 0 0.09109541028738022
treatment O 0 1.387590600643307e-05
in O 0 2.829402319548535e-06
evaluating O 0 4.828118562727468e-06
the O 0 3.6411104247235926e-06
abnormal O 0 6.569587185367709e-06
processing O 0 4.2600868255249225e-06
of O 0 3.3095268463512184e-06
mRNA O 0 5.155965027370257e-06
due O 0 2.396177933405852e-06
to O 0 1.4787208328925772e-06
splice O 0 3.331469270051457e-05
- O 0 9.203953595715575e-06
site O 0 6.915530775586376e-06
mutations O 0 1.8817262343873153e-06
, O 0 1.2640091426874278e-06
because O 0 6.305826900643297e-07
( O 0 1.892296950245509e-06
i O 0 3.6464341519604204e-06
) O 0 1.8725354493653867e-06
aberrant O 0 7.045271559036337e-06
splicing O 0 5.475194484461099e-06
often O 0 1.2514606169133913e-06
generates O 0 3.4941167541546747e-06
a O 0 2.7545788725547027e-06
premature O 0 6.007388947182335e-06
termination O 0 1.080575293599395e-05
codon O 0 9.053366738953628e-06
, O 0 2.208123987657018e-06
( O 0 1.8430740738040186e-06
ii O 0 0.0002787199628073722
) O 0 1.3649757875100477e-06
transcripts O 0 2.975885081468732e-06
with O 0 1.2128878097428242e-06
premature O 0 1.1271833500359207e-05
termination O 0 1.4048427146917675e-05
codons O 0 7.417374490614748e-06
can O 0 6.55120970805001e-07
occur O 0 6.42948748463823e-07
at O 0 3.3277790407737484e-06
low O 0 5.122739366925089e-06
or O 0 2.3233526462718146e-06
undetectable O 0 2.3998711185413413e-05
levels O 0 2.243393055323395e-06
due O 0 3.361089738973533e-06
to O 0 1.7875343019113643e-06
nonsense O 0 2.4920416763052344e-05
- O 0 1.710740980342962e-05
mediated O 0 1.2902215530630201e-05
mRNA O 0 1.0608340744511224e-05
decay O 0 1.1265202374488581e-05
, O 0 9.429241458747128e-07
and O 0 5.8377185041536e-07
( O 0 1.6015764003896038e-06
iii O 0 4.793193511432037e-05
) O 0 6.567523769263062e-07
the O 0 5.341030373529065e-07
levels O 0 5.402179112934391e-07
of O 0 8.252804946096148e-07
these O 0 4.0832085801412177e-07
transcripts O 0 3.372173068783013e-06
can O 0 4.247249876243586e-07
be O 0 9.856009910436114e-07
increased O 0 3.71797045772837e-06
by O 0 6.3901352405082434e-06
cycloheximide O 0 0.0010139545192942023
. O 0 8.866439020493999e-05

A O 0 0.0006008266936987638
deletion O 0 0.0003884029283653945
mutation O 0 8.269926911452785e-05
in O 0 3.2936000934569165e-05
COL17A1 O 1 0.7434355020523071
in O 0 7.172574441938195e-06
five O 0 4.083421572431689e-06
Austrian O 0 7.374919368885458e-05
families O 0 4.211974101053784e-06
with O 0 8.102054380287882e-06
generalized O 1 0.9987431168556213
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999828338623047
represents O 0 0.00015003840962890536
propagation O 0 6.016239422024228e-05
of O 0 2.422589750494808e-05
an O 0 1.6734982636990026e-05
ancestral O 0 0.0006434948300011456
allele O 0 0.00019311904907226562
. O 0 0.0001993442274397239

Patients O 0 0.003501177066937089
with O 0 0.00012289598817005754
generalized O 1 0.9998188614845276
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999995231628418
, O 0 7.310209184652194e-05
a O 0 1.5003942280600313e-05
usually O 0 3.199256752850488e-06
nonlethal O 0 3.700417073559947e-05
form O 0 4.4210482883499935e-06
of O 0 0.00011499212996568531
junctional B-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999784231185913
, O 0 1.2944092304678634e-05
have O 0 1.432430053682765e-06
generalized O 0 2.1994706912664697e-05
blistering B-Disease 0 0.01477998960763216
, O 0 0.004618687089532614
nail B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
, O 0 0.16149091720581055
patchy B-Disease 1 0.999998927116394
alopecia I-Disease 1 1.0
, O 0 0.06001584231853485
and O 0 0.0018575874855741858
dental B-Disease 1 0.9999995231628418
abnormalities I-Disease 1 0.9999995231628418
. O 0 0.02444428578019142

Skin B-Disease 1 0.9996442794799805
fragility I-Disease 1 0.9992293119430542
in O 0 4.826387521461584e-05
most O 0 7.105770691850921e-06
cases O 0 2.6691218408814166e-06
is O 0 1.982035882974742e-06
due O 0 2.4409509933320805e-06
to O 0 7.294531769730384e-07
mutations O 0 7.291623660421465e-07
in O 0 5.024530196351407e-07
the O 0 1.4975161093389033e-06
gene O 0 3.079713223996805e-06
encoding O 0 6.928905804670649e-06
type O 0 0.00017859405488707125
XVII O 1 0.9999996423721313
collagen O 1 0.9993890523910522
( O 0 0.0001054488675436005
COL17A1 O 1 0.9987860321998596
) O 0 6.416271207854152e-05
. O 0 0.0001256599061889574

Recently O 0 0.00029767336673103273
, O 0 1.3498103726305999e-05
we O 0 2.656437345649465e-06
reported O 0 3.1810418477107305e-06
five O 0 3.1766371648700442e-06
Austrian O 0 3.529686000547372e-05
families O 0 6.140167442936217e-06
with O 0 1.0852754712686874e-05
generalized O 1 0.9985429048538208
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.999996542930603
who O 0 5.1592247473308817e-05
share O 0 1.471204905101331e-05
the O 0 1.836897718021646e-05
same O 0 4.014626028947532e-05
COL17A1 O 1 0.9935320615768433
mutation O 0 0.00025145732797682285
. O 0 0.0002520148700568825

Affected O 0 8.510057523380965e-05
individuals O 0 5.850202796864323e-06
in O 0 4.212282874505036e-06
three O 0 1.990662894968409e-06
families O 0 1.6503117876709439e-06
are O 0 3.6185053886583773e-07
homozygous O 0 1.5869213711994234e-06
for O 0 1.327346126345219e-06
4003delTC O 0 6.179846968734637e-05
, O 0 1.6335243344656192e-06
whereas O 0 1.77033666659554e-06
those O 0 3.314026173484308e-07
in O 0 1.575982651047525e-06
two O 0 1.7136306951215374e-06
others O 0 4.733258265332552e-06
are O 0 3.059785512959934e-06
compound O 0 0.0001168059025076218
heterozygotes O 0 0.0007445432129316032
. O 0 0.0001352477411273867

To O 0 4.63438373117242e-05
determine O 0 1.5563979104626924e-05
if O 0 4.293900019547436e-06
the O 0 6.51596974421409e-06
occurrence O 0 8.060905202000868e-06
of O 0 1.1911132787645329e-05
4003delTC O 0 0.00043223658576607704
in O 0 3.993480277131312e-06
these O 0 1.0007420314650517e-06
unrelated O 0 7.786939931975212e-06
families O 0 3.087105824306491e-06
signifies O 0 2.422180841676891e-05
propagation O 0 1.2997629710298497e-05
of O 0 4.452384473552229e-06
an O 0 6.030987151461886e-06
ancestral O 0 5.6813234550645575e-05
allele O 0 6.825042873970233e-06
or O 0 2.6489767606108217e-06
a O 0 8.026624527701642e-06
mutational O 0 0.0001378260349156335
hot O 0 3.218162237317301e-05
spot O 0 8.690612958162092e-06
, O 0 1.849179625423858e-06
haplotypes O 0 3.409320697755902e-06
were O 0 1.0309404387953691e-06
determined O 0 1.7061132666640333e-06
for O 0 9.596931249689078e-07
polymorphisms O 0 5.8881687436951324e-06
both O 0 2.223297769887722e-06
within O 0 9.578712706570514e-06
and O 0 1.7183228919748217e-05
flanking O 0 0.2809450328350067
COL17A1 O 1 0.9998862743377686
. O 0 0.0002995857794303447

Five O 0 0.0003276549105066806
intragenic O 0 0.0017145117744803429
polymorphisms O 0 0.00013436120934784412
were O 0 1.6055286323535256e-05
chosen O 0 1.3491283425537404e-05
based O 0 4.373147930891719e-06
on O 0 1.406125466019148e-05
their O 0 2.2191259631654248e-05
informativeness O 0 0.014535093680024147
. O 0 0.00016177624638658017

One O 0 5.6341043091379106e-05
of O 0 1.561569115438033e-05
these O 0 2.227085587946931e-06
, O 0 2.2686213014821988e-06
not O 0 4.6565708089474356e-07
previously O 0 2.6733330287243007e-06
reported O 0 1.8490437696527806e-06
, O 0 1.7840736745711183e-06
was O 0 1.9262586647528224e-05
2988 O 0 0.00013491581194102764
A O 0 1.5730194718344137e-05
or O 0 2.146100314348587e-06
C O 0 2.061372833850328e-05
that O 0 1.072519808076322e-06
introduces O 0 4.428855390870012e-06
a O 0 1.8338814697926864e-06
new O 0 1.2054121043547639e-06
restriction O 0 5.125280495121842e-06
site O 0 1.3429614227788989e-05
for O 0 1.187904035759857e-05
Eco0109 O 0 0.0008463165140710771
I O 0 0.0005103445146232843
. O 0 0.0001943146635312587

All O 0 3.760749677894637e-05
the O 0 2.7504906029207632e-05
4003delTC O 0 0.00013321559526957572
alleles O 0 1.4186018233885989e-05
showed O 0 1.4264362107496709e-05
the O 0 3.884785201080376e-06
same O 0 2.962457529065432e-06
haplotype O 0 1.1690806786646135e-05
for O 0 1.6750730083003873e-06
these O 0 1.230468683388608e-06
five O 0 5.525804226635955e-06
polymorphic O 0 6.403551378753036e-05
markers O 0 0.00024360697716474533
. O 0 0.0001155289210146293

Fourteen O 0 0.0017545534064993262
microsatellite O 0 0.0017459670780226588
polymorphisms O 0 0.00016342481831088662
were O 0 1.7397187548340298e-05
selected O 0 6.313051017059479e-06
based O 0 3.1716997455077944e-06
on O 0 4.298751264286693e-06
their O 0 2.2286792500381125e-06
high O 0 1.6582995158387348e-05
heterozygosity O 0 0.00015131552936509252
and O 0 2.5351944259455195e-06
their O 0 1.5688432313254452e-06
location O 0 8.847941899148282e-06
within O 0 8.077018719632179e-06
10q23 O 0 0.0002464651479385793
- O 0 9.240279905498028e-05
q25 O 0 0.0007045879028737545
near O 0 0.0009191519930027425
COL17A1 O 1 0.9339814782142639
. O 0 0.00022766811889596283

Three O 0 5.1063332648482174e-05
families O 0 2.2600121155846864e-05
shared O 0 4.023487417725846e-05
microsatellite O 0 0.0017561534186825156
polymorphisms O 0 3.653364910860546e-05
covering O 0 2.5077237296500243e-05
at O 0 1.2105328096367884e-05
most O 0 3.544912260622368e-06
19 O 0 1.7219679648405872e-05
cM O 0 2.1689824279746972e-05
, O 0 1.4025853261045995e-06
whereas O 0 1.1160461781400954e-06
the O 0 1.0991125236614607e-06
others O 0 1.2671024478549953e-06
shared O 0 2.4842515813361388e-06
smaller O 0 1.0413126574349008e-06
regions O 0 1.1550246199476533e-06
consistent O 0 1.509055437054485e-06
with O 0 8.651571192785923e-07
cross O 0 7.44520548323635e-06
- O 0 6.278419277805369e-06
over O 0 2.2777826416131575e-06
events O 0 1.9672306734719314e-06
during O 0 5.117665750731248e-06
passage O 0 4.892863671557279e-06
of O 0 1.193131993204588e-06
this O 0 1.3092037534079282e-06
mutation O 0 2.293529178132303e-06
through O 0 4.394444204081083e-06
several O 0 9.139604117081035e-06
generations O 0 8.702136256033555e-05
. O 0 0.00012536643771454692

These O 0 2.131498695234768e-05
results O 0 1.677230466157198e-05
indicate O 0 1.2802580386050977e-05
that O 0 4.743294084619265e-06
4003delTC O 0 6.231840961845592e-05
occurs O 0 4.129081389692146e-06
on O 0 3.4685326681938022e-06
a O 0 8.872089892975055e-06
single O 0 9.696374036138877e-06
ancestral O 0 6.907235365360975e-05
allele O 0 2.5079989427467808e-05
. O 0 1.8859243937185965e-05
. O 0 5.532739669433795e-05

The O 0 0.0007900718483142555
haptoglobin O 0 0.016308888792991638
- O 0 0.0005599277792498469
gene O 0 5.548411718336865e-05
deletion O 0 0.00010592555918265134
responsible O 0 5.5537839216412976e-05
for O 0 5.742317807744257e-05
anhaptoglobinemia B-Disease 0 0.4466448128223419
. O 0 0.00030566612258553505

We O 0 4.804396667168476e-05
have O 0 4.352668383944547e-06
found O 0 2.9308159810170764e-06
an O 0 2.170130983358831e-06
allelic O 0 2.2562739104614593e-05
deletion O 0 2.1194222426856868e-05
of O 0 1.808961314964108e-05
the O 0 2.866859722416848e-05
haptoglobin O 0 0.0012720983941107988
( O 0 9.694414075056557e-06
Hp O 0 1.911212530103512e-05
) O 0 3.4576867165014846e-06
gene O 0 1.6423264241893776e-06
from O 0 1.258049110219872e-06
an O 0 1.5479106423299527e-06
individual O 0 4.222334155201679e-06
with O 0 1.63242184498813e-05
anhaptoglobinemia B-Disease 1 0.7933670878410339
. O 0 0.00020328134996816516

The O 0 0.0001896047469926998
Hp O 0 0.0003297604853287339
gene O 0 2.0951001715729944e-05
cluster O 0 2.986732761200983e-05
consists O 0 5.152538960828679e-06
of O 0 4.975325282430276e-06
coding O 0 7.523497060901718e-06
regions O 0 2.4581206616858253e-06
of O 0 2.23521601583343e-06
the O 0 5.727516054321313e-06
alpha O 0 1.6909752957872115e-05
chain O 0 2.6948396225634497e-06
and O 0 5.679123660229379e-07
beta O 0 6.116568329161964e-06
chain O 0 2.8821962132496992e-06
of O 0 1.1080478543590289e-06
the O 0 3.400763944227947e-06
haptoglobin O 0 6.387456232914701e-05
gene O 0 2.6954048735206015e-06
( O 0 1.7275864365728921e-06
Hp O 0 9.307927939516958e-06
) O 0 8.127724413498072e-07
and O 0 3.321408144074667e-07
of O 0 1.128093231272942e-06
the O 0 2.6223410714010242e-06
alpha O 0 1.8119362721336074e-05
chain O 0 5.2703121582453605e-06
and O 0 9.704317562864162e-07
beta O 0 4.717139745480381e-06
chain O 0 3.154578052999568e-06
of O 0 2.1214493699517334e-06
the O 0 4.374912350613158e-06
haptoglobin O 0 0.0004875205340795219
- O 0 1.996761784539558e-05
related O 0 3.3022254228853853e-06
gene O 0 4.708155756816268e-06
( O 0 4.183849796390859e-06
Hpr O 0 4.902547880192287e-05
) O 0 3.4424463137838757e-06
, O 0 1.3526894235837972e-06
in O 0 2.388209168202593e-06
tandem O 0 2.0850367945968173e-05
from O 0 5.705252078769263e-06
the O 0 1.3608667359221727e-05
5 O 0 5.2162846259307116e-05
side O 0 0.00012513939873315394
. O 0 0.00010133265459444374

Southern O 0 0.0003797735262196511
blot O 0 0.00021844421280547976
and O 0 1.1727533092198428e-05
PCR O 0 2.341037725273054e-05
analyses O 0 4.300498403608799e-06
have O 0 8.62135209445114e-07
indicated O 0 1.4037790379006765e-06
that O 0 2.452009368880681e-07
the O 0 8.9073745357382e-07
individual O 0 5.746697411268542e-07
with O 0 1.545087798149325e-06
anhaptoglobinemia B-Disease 0 0.009744934737682343
was O 0 1.5234244528983254e-05
homozygous O 0 2.0211321043461794e-06
for O 0 5.098284532323305e-07
the O 0 9.96426138044626e-07
gene O 0 1.061868033502833e-06
deletion O 0 1.9128688109049108e-06
and O 0 5.273552687867777e-07
that O 0 2.0352371166154626e-07
the O 0 6.007945216879307e-07
gene O 0 1.1556493291209335e-06
deletion O 0 4.480197731027147e-06
was O 0 8.170146429620218e-06
included O 0 2.434065436318633e-06
at O 0 4.398217697598739e-06
least O 0 1.5412980474138749e-06
from O 0 2.150964519387344e-06
the O 0 4.733416062663309e-06
promoter O 0 0.00026836179313249886
region O 0 1.0082850167236757e-05
of O 0 5.327617145667318e-06
Hp O 0 1.580786738486495e-05
to O 0 1.4396035794561612e-06
Hpr O 0 3.7345387681853026e-05
alpha O 0 5.975522981316317e-06
but O 0 4.356790839210589e-07
not O 0 2.8964313969481736e-07
to O 0 1.0515908570596366e-06
Hpr O 0 5.423833863460459e-05
beta O 0 4.025809539598413e-05
( O 0 2.591310658317525e-05
Hpdel O 0 0.0008742885547690094
) O 0 6.428140477510169e-05
. O 0 6.859777204226702e-05

In O 0 6.412173388525844e-05
addition O 0 3.2711250241845846e-05
, O 0 7.344220648519695e-06
we O 0 2.100436176988296e-06
found O 0 1.4861133195154252e-06
seven O 0 1.3514103329725913e-06
individuals O 0 8.456285627289617e-07
with O 0 1.4286374607763719e-06
hypohaptoglobinemia B-Disease 0 0.008690179325640202
in O 0 2.6343077479396015e-06
three O 0 1.3499277429218637e-06
families O 0 1.7988620584219461e-06
, O 0 1.0345867167416145e-06
and O 0 4.77908770335489e-07
the O 0 1.4345970384965767e-06
genotypes O 0 4.9757286433305126e-06
of O 0 2.6315103696106235e-06
six O 0 1.479606680732104e-06
of O 0 1.6939474107857677e-06
the O 0 1.2373715208013891e-06
seven O 0 9.964071523427265e-07
individuals O 0 2.386355220096448e-07
were O 0 5.346865918909316e-07
found O 0 5.013884560867155e-07
to O 0 9.991895240091253e-07
be O 0 4.77130060971831e-06
Hp2 O 0 0.1859617829322815
/ O 0 0.044962428510189056
Hpdel O 1 0.8629910945892334
. O 0 0.00017381738871335983

The O 0 0.00016368743672501296
phenotypes O 0 0.00016034446889534593
and O 0 1.830491964938119e-05
genotypes O 0 3.790883783949539e-05
in O 0 8.181327757483814e-06
one O 0 3.0219327982194955e-06
of O 0 3.955290594603866e-06
these O 0 8.695841984263097e-07
three O 0 1.8355366364630754e-06
families O 0 1.8628709312906722e-06
showed O 0 4.120576704735868e-06
the O 0 2.6738173346529948e-06
father O 0 9.233890523319133e-06
to O 0 1.6907468989302288e-06
be O 0 2.3718100692349253e-06
hypohaptoglobinemic B-Disease 0 0.00015965446073096246
( O 0 7.857253876863979e-06
Hp2 O 0 0.000970430439338088
) O 0 7.985790944076143e-06
and O 0 6.654605840594741e-06
Hp2 O 0 0.2696163058280945
/ O 0 0.0008128010085783899
Hpdel O 0 0.001938404282554984
, O 0 2.7228738872508984e-06
the O 0 2.1723940335505176e-06
mother O 0 3.817189735855209e-06
to O 0 8.581067731938674e-07
be O 0 1.8522860045777634e-06
Hp2 O 0 0.00010652115452103317
- O 0 1.4925821233191527e-05
1 O 0 1.309805884375237e-05
and O 0 3.880245458276477e-06
Hp1 O 1 0.7780812978744507
/ O 0 0.000359842786565423
Hp2 O 0 0.0016243421705439687
, O 0 2.380282467129291e-06
one O 0 1.0088352837556158e-06
of O 0 1.1332127769492217e-06
the O 0 1.5119234149096883e-06
two O 0 7.170394837885397e-07
children O 0 9.979115702662966e-07
to O 0 9.449775006942218e-07
be O 0 1.2077698556822725e-06
hypohaptoglobinemic B-Disease 0 0.00011562590952962637
( O 0 5.3665921768697444e-06
Hp2 O 0 0.00057882972760126
) O 0 3.278533768025227e-06
and O 0 3.0452240480371984e-06
Hp2 O 1 0.7692030072212219
/ O 0 0.007958154194056988
Hpdel O 0 0.2453911453485489
, O 0 2.00953877538268e-06
and O 0 6.275141686273855e-07
the O 0 9.370988891532761e-07
other O 0 3.763501013054338e-07
child O 0 1.9625877030193806e-06
to O 0 7.157973413995933e-07
be O 0 1.322923026236822e-06
Hp1 O 0 0.0006361990817822516
and O 0 6.704317911498947e-06
Hp1 O 1 0.9459496736526489
/ O 0 0.013473850674927235
Hpdel O 0 0.031003020703792572
, O 0 2.678380496945465e-06
showing O 0 3.8130749544507125e-06
an O 0 2.2987958345765946e-06
anomalous O 0 3.890090010827407e-05
inheritance O 0 3.724896305357106e-05
of O 0 2.522628528822679e-05
Hp O 0 0.0005482231499627233
phenotypes O 0 1.1414361324568745e-05
in O 0 2.9014208848821e-06
the O 0 5.0937537707795855e-06
child O 0 1.5567558875773102e-05
with O 0 1.631331178941764e-05
Hp1 O 1 0.970658004283905
. O 0 0.00010954075696645305

The O 0 0.0005269404500722885
Hp2 O 1 0.9995899796485901
/ O 1 0.6340284943580627
Hpdel O 0 0.38571256399154663
individuals O 0 8.536960194760468e-06
had O 0 7.661209565412719e-06
an O 0 3.009052306879312e-06
extremely O 0 4.828984401683556e-06
low O 0 4.06083518100786e-06
level O 0 2.840817842297838e-06
of O 0 3.669797479233239e-06
Hp O 0 1.0558128451521043e-05
( O 0 2.062808334812871e-06
mean O 0 4.736084974865662e-06
+ O 0 1.2883527233498171e-05
/ O 0 2.0935463908244856e-05
- O 0 1.992379293369595e-05
SD O 0 0.00014548751641996205
= O 0 1.1779181477322709e-05
0 O 0 5.322691322362516e-06
. O 0 2.1846435629413463e-06
049 O 0 3.244599429308437e-05
+ O 0 1.1323106264171656e-05
/ O 0 1.3756505722994916e-05
- O 0 9.722680260892957e-06
0 O 0 5.962782779533882e-06
. O 0 3.029521849384764e-06
043 O 0 4.61100171378348e-05
mg O 0 3.206303881597705e-05
/ O 0 1.7644828403717838e-05
ml O 0 1.3074383787170518e-05
; O 0 7.191919735305419e-07
n O 0 3.255195906604058e-06
= O 0 3.0251246698753675e-06
6 O 0 2.302097527717706e-06
) O 0 4.741087309412251e-07
, O 0 2.9375158305811055e-07
compared O 0 3.0024338570910913e-07
with O 0 1.9087873681655765e-07
the O 0 5.923228627580102e-07
level O 0 1.976765361177968e-06
( O 0 6.377682666425244e-07
1 O 0 1.2184946172055788e-06
. O 0 4.4744021465703554e-07
64 O 0 2.794391775751137e-06
+ O 0 7.065673344186507e-06
/ O 0 1.1449991689005401e-05
- O 0 7.62950730859302e-06
1 O 0 9.97158986137947e-06
. O 0 4.030247964692535e-06
07 O 0 6.155139271868393e-05
mg O 0 8.828623685985804e-05
/ O 0 4.6593413571827114e-05
ml O 0 2.5434244889765978e-05
) O 0 2.3584482278238283e-06
obtained O 0 3.2237614959740313e-06
from O 0 3.7006088859925512e-06
52 O 0 1.9618519218056463e-05
healthy O 0 1.0680321793188341e-05
volunteers O 0 8.836304004944395e-06
having O 0 4.1199123188562226e-06
phenotype O 0 6.951820068934467e-06
Hp2 O 0 0.00013934214075561613
, O 0 1.7681129520497052e-06
whereas O 0 9.798550308914855e-07
the O 0 2.1455866772157606e-06
serum O 0 1.7896505596581846e-05
Hp O 0 1.1359166819602251e-05
level O 0 4.1700232031871565e-06
of O 0 1.7868320583147579e-06
an O 0 9.259199487132719e-07
individual O 0 7.772989079057879e-07
with O 0 3.193644715793198e-06
Hp1 O 1 0.9649351835250854
/ O 0 0.014065385796129704
Hpdel O 0 0.1560792326927185
was O 0 0.00012363743735477328
0 O 0 8.688976959092543e-05
. O 0 8.09918055892922e-05

50 O 0 0.0004221487615723163
mg O 0 0.002339312108233571
/ O 0 0.002580953063443303
ml O 0 0.00028726187883876264
, O 0 1.0042555004474707e-05
which O 0 1.4808603054916603e-06
was O 0 4.388698016555281e-06
approximately O 0 2.4065384423010983e-06
half O 0 1.0353189736633794e-06
the O 0 1.477429577789735e-06
level O 0 3.3878420708788326e-06
of O 0 4.4239800445211586e-06
Hp O 0 1.520183650427498e-05
in O 0 2.4455735001538415e-06
control O 0 8.005723429960199e-06
sera O 0 3.2141630072146654e-05
from O 0 2.575216058176011e-06
the O 0 4.347059984866064e-06
Hp1 O 0 0.00013228206080384552
phenotype O 0 6.5607778196863364e-06
( O 0 2.643402694957331e-06
1 O 0 4.693348728324054e-06
. O 0 1.3869112081010826e-06
26 O 0 6.281546120590065e-06
+ O 0 7.793425538693555e-06
/ O 0 9.102357580559328e-06
- O 0 5.7514907894073986e-06
0 O 0 2.6621180495567387e-06
. O 0 1.0215380825684406e-06
33 O 0 4.390515186969424e-06
mg O 0 1.45573267218424e-05
/ O 0 8.994255040306598e-06
ml O 0 1.1088301107520238e-05
; O 0 8.855740247781796e-07
n O 0 3.199250613761251e-06
= O 0 4.240784164721845e-06
9 O 0 4.500560407905141e-06
) O 0 9.577219088896527e-07
, O 0 6.389255418071116e-07
showing O 0 3.7249053548293887e-06
a O 0 6.7763880906568374e-06
gene O 0 1.9166587662766688e-05
- O 0 6.545901851495728e-05
dosage O 0 8.406222332268953e-05
effect O 0 0.00010272184590576217
. O 0 0.00011628611537162215

The O 0 9.470865916227922e-05
other O 0 1.282886751141632e-05
allele O 0 3.3369411539752036e-05
( O 0 3.335054498165846e-05
Hp2 O 0 0.0004938482888974249
) O 0 3.5575005767896073e-06
of O 0 2.2100516616774257e-06
individuals O 0 1.0011668791776174e-06
with O 0 4.020957476313924e-06
Hp2 O 1 0.9999735355377197
/ O 1 0.982030987739563
Hpdel O 1 0.9955607652664185
was O 0 2.9387161703198217e-05
found O 0 8.908418749342673e-07
to O 0 4.3455662535052397e-07
have O 0 1.6952338910414255e-07
, O 0 3.6965698768653965e-07
in O 0 5.254205461824313e-07
all O 0 5.548688477574615e-07
exons O 0 6.477155238826526e-06
, O 0 1.983843731068191e-06
no O 0 1.2609726809387212e-06
mutation O 0 1.7895691826197435e-06
, O 0 1.913182813950698e-06
by O 0 1.5572178426737082e-06
DNA O 0 2.543342088756617e-05
sequencing O 0 5.2915627748006955e-05
. O 0 6.37188131804578e-05

On O 0 8.194831752916798e-05
the O 0 9.891472473100293e-06
basis O 0 4.5398660404316615e-06
of O 0 5.293185495247599e-06
the O 0 3.4267338833160466e-06
present O 0 2.750271505647106e-06
study O 0 2.056679477391299e-06
, O 0 1.2655071941480855e-06
the O 0 1.4838291235719225e-06
mechanism O 0 3.845364517474081e-06
of O 0 3.522075303408201e-06
anhaptoglobinemia B-Disease 0 0.019637292250990868
and O 0 8.44286091705726e-07
the O 0 9.273347814087174e-07
mechanism O 0 3.265898840254522e-06
of O 0 2.6617069579515373e-06
anomalous O 0 4.615498619386926e-05
inheritance O 0 3.437028135522269e-05
of O 0 1.856286144175101e-05
Hp O 0 0.00022016235743649304
phenotypes O 0 1.127401537814876e-05
were O 0 6.711386049573775e-06
well O 0 1.0116957128047943e-05
explained O 0 7.601456309203058e-05
. O 0 5.64004440093413e-05

However O 0 8.88532231329009e-05
, O 0 1.6821210010675713e-05
the O 0 1.4111282325757202e-05
mechanism O 0 4.1483483073534444e-05
of O 0 7.327937055379152e-05
hypohaptoglobinemia B-Disease 1 0.9547897577285767
remains O 0 0.002309052273631096
unknown O 0 0.0007951163570396602

ATM O 0 0.004977097734808922
mutations O 0 0.00015094058471731842
and O 0 4.406853986438364e-05
phenotypes O 0 0.00013520791253540665
in O 0 0.0001434341393178329
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999964237213135
telangiectasia I-Disease 1 0.9999990463256836
families O 0 2.4837921955622733e-05
in O 0 4.171614364167908e-06
the O 0 5.204313310969155e-06
British O 0 9.217490514856763e-06
Isles O 0 1.3553775715990923e-05
: O 0 1.1648310191958444e-06
expression O 0 1.7575014226167696e-06
of O 0 1.9581307242333423e-06
mutant O 0 1.5101067219802644e-05
ATM O 0 1.937310298671946e-05
and O 0 5.543431029764179e-07
the O 0 8.468294367958151e-07
risk O 0 2.8212250526848948e-06
of O 0 7.137897046050057e-05
leukemia B-Disease 1 1.0
, O 1 0.9999529123306274
lymphoma B-Disease 1 1.0
, O 1 0.995402455329895
and O 1 0.5023354887962341
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999985694885254
. O 0 0.0010938908671960235

We O 0 2.7064679670729674e-05
report O 0 5.267086180538172e-06
the O 0 2.7983521704300074e-06
spectrum O 0 8.885434908734169e-06
of O 0 6.091723207646282e-06
59 O 0 4.8322694055968896e-05
ATM O 0 0.00017757606110535562
mutations O 0 6.649682745774044e-06
observed O 0 6.342590950225713e-06
in O 0 1.0042286703537684e-05
ataxia B-Disease 1 0.9999991655349731
- I-Disease 1 0.9998682737350464
telangiectasia I-Disease 1 0.9999994039535522
( O 0 0.0102747343480587
A B-Disease 1 0.9999918937683105
- I-Disease 1 0.9999319314956665
T I-Disease 1 0.9999933242797852
) O 0 5.842257905896986e-06
patients O 0 3.427586761972634e-06
in O 0 4.2628180381143466e-06
the O 0 9.438514098292217e-06
British O 0 5.732988574891351e-05
Isles O 0 0.00034820337896235287
. O 0 0.00011001777602359653

Of O 0 0.00018074919353239238
51 O 0 0.00034983575460501015
ATM O 0 0.0025501870550215244
mutations O 0 2.5639566956670024e-05
identified O 0 1.0634737918735482e-05
in O 0 2.5448766791669186e-06
families O 0 1.6398895468228147e-06
native O 0 3.1679242056270596e-06
to O 0 1.1018329360013013e-06
the O 0 2.048141823252081e-06
British O 0 4.744447778648464e-06
Isles O 0 1.1023668776033446e-05
, O 0 1.3375653225011774e-06
11 O 0 2.5424774321436416e-06
were O 0 2.0320014755270677e-06
founder O 0 4.045259629492648e-05
mutations O 0 1.6570965044593322e-06
, O 0 8.833463880364434e-07
and O 0 6.363034685819002e-07
2 O 0 2.5492149688943755e-06
of O 0 1.30144701415702e-06
these O 0 3.729693105469778e-07
11 O 0 2.7448945729702245e-06
conferred O 0 9.860656064120121e-06
a O 0 4.017208539153216e-06
milder O 0 9.597785719961394e-06
clinical O 0 8.465447535854764e-06
phenotype O 0 4.8430647439090535e-06
with O 0 1.4550181504091597e-06
respect O 0 2.52632003139297e-06
to O 0 2.899598257499747e-06
both O 0 3.929796002921648e-05
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 0 0.3559134304523468
cellular O 1 0.8177536129951477
features O 0 0.00016586249694228172
. O 0 0.00012447543849702924

We O 0 8.722449274500832e-05
report O 0 1.3356557246879674e-05
, O 0 4.712769168691011e-06
in O 0 4.334798177296761e-06
two O 0 5.910081199544948e-06
A B-Disease 1 0.5277430415153503
- I-Disease 0 0.28749382495880127
T I-Disease 1 0.7954180836677551
families O 0 2.0299833067838335e-06
, O 0 1.1518698102008784e-06
an O 0 9.90332637229585e-07
ATM O 0 2.962295366160106e-05
mutation O 0 2.2197343696461758e-06
( O 0 2.8175627448945306e-06
7271T O 0 0.00010482608195161447
- O 0 2.5478888346697204e-05
- O 0 2.565057366155088e-05
> O 0 3.763364293263294e-05
G O 0 4.786163481185213e-05
) O 0 8.405094149566139e-07
that O 0 2.016356290823751e-07
may O 0 3.444432081778359e-07
be O 0 2.0405057910011237e-07
associated O 0 3.874035030548839e-07
with O 0 2.2531824583893467e-07
an O 0 6.214461336639943e-07
increased O 0 3.7087065720697865e-06
risk O 0 9.761655746842735e-06
of O 0 0.00023657434212509543
breast B-Disease 1 0.9999986886978149
cancer I-Disease 1 0.9993383288383484
in O 0 4.354627890279517e-06
both O 0 3.0349756343639456e-06
homozygotes O 0 7.89143014117144e-05
and O 0 2.2836379685031716e-06
heterozygotes O 0 1.6985213733278215e-05
( O 0 2.718595396800083e-06
relative O 0 5.088383659312967e-06
risk O 0 2.05689548238297e-06
12 O 0 2.0268842035875423e-06
. O 0 9.277301273868943e-07
7 O 0 3.597379873099271e-06
; O 0 1.7509401004645042e-06
P O 0 4.746787089970894e-05
= O 0 7.253890544234309e-06
. O 0 2.8686740733974148e-06
0025 O 0 8.04753799457103e-05
) O 0 1.7024060525727691e-06
, O 0 7.934661425679224e-07
although O 0 3.3338830007778597e-07
there O 0 5.993650233904191e-07
is O 0 7.320623467421683e-07
a O 0 3.1268782549886964e-06
less O 0 5.622685876005562e-06
severe O 1 0.8095360994338989
A B-Disease 1 0.9999982118606567
- I-Disease 1 0.999991774559021
T I-Disease 1 0.9999865293502808
phenotype O 0 4.910918050882174e-06
in O 0 6.639972980337916e-07
terms O 0 5.866314722879906e-07
of O 0 2.0314919311203994e-06
the O 0 2.8285605822020443e-06
degree O 0 8.327711839228868e-05
of O 0 0.029596779495477676
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 0 0.2049565613269806

This O 0 0.00012211147986818105
mutation O 0 7.157118670875207e-05
( O 0 5.8171652199234813e-05
7271T O 0 0.0009145225631073117
- O 0 0.0002039692335529253
- O 0 9.254830365534872e-05
> O 0 6.868580385344103e-05
G O 0 8.12857470009476e-05
) O 0 1.9382396203582175e-06
also O 0 6.736412387908786e-07
allows O 0 3.395196017663693e-07
expression O 0 9.790386457098066e-07
of O 0 1.859702365436533e-06
full O 0 6.965497505007079e-06
- O 0 1.37634742713999e-05
length O 0 9.487644092587288e-06
ATM O 0 4.064098175149411e-05
protein O 0 2.157063590857433e-06
at O 0 3.2933157854131423e-06
a O 0 2.3948209673108067e-06
level O 0 3.2766745334811276e-06
comparable O 0 2.5797164653340587e-06
with O 0 9.131415481533622e-07
that O 0 1.0975612667607493e-06
in O 0 5.3187686717137694e-06
unaffected O 0 8.271362457890064e-05
individuals O 0 1.4645273950009141e-05
. O 0 6.590850534848869e-05

In O 0 8.890033495845273e-05
addition O 0 2.5000301320687868e-05
, O 0 6.143705377326114e-06
we O 0 1.753279434524302e-06
have O 0 6.149458045001666e-07
studied O 0 6.9130055635469034e-06
18 O 0 2.387578206253238e-05
A B-Disease 1 0.9997952580451965
- I-Disease 1 0.999976396560669
T I-Disease 1 0.9999994039535522
patients O 0 1.36667758852127e-05
, O 0 9.950748562914669e-07
in O 0 6.127107781139784e-07
15 O 0 1.2676318874582648e-06
families O 0 5.602702231044532e-07
, O 0 9.919406238623196e-07
who O 0 2.7249366212345194e-06
developed O 0 0.001808544504456222
leukemia B-Disease 1 1.0
, O 1 0.9864466190338135
lymphoma B-Disease 1 1.0
, O 1 0.997812032699585
preleukemic O 1 0.9999998807907104
T O 1 0.9999967813491821
- O 0 0.4696764647960663
cell O 0 0.012515455484390259
proliferation O 0 0.027952753007411957
, O 0 5.15711053594714e-06
or O 0 0.0001453765871701762
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 0.04362979531288147
mostly O 0 3.091945109190419e-05
in O 0 2.5159351935144514e-05
childhood O 0 0.4571717381477356
. O 0 0.0002252375998068601

A O 0 0.0003049425140488893
wide O 0 4.59428338217549e-05
variety O 0 8.96816527529154e-06
of O 0 1.0773835128929932e-05
ATM O 0 0.0017471135361120105
mutation O 0 3.2887769521039445e-06
types O 0 1.1602056702031405e-06
, O 0 7.162411748140585e-07
including O 0 9.628475936551695e-07
missense O 0 2.180906813009642e-05
mutations O 0 4.222482857585419e-06
and O 0 1.9946116935898317e-06
in O 0 5.073459306004224e-06
- O 0 0.0001148087321780622
frame O 0 4.204011202091351e-05
deletions O 0 8.896219696907792e-06
, O 0 1.9938452169299126e-06
were O 0 1.165323283203179e-06
seen O 0 2.356036020501051e-06
in O 0 2.4584958282503067e-06
these O 0 3.1619026685802964e-06
patients O 0 3.8036738260416314e-05
. O 0 5.6476492318324745e-05

We O 0 4.266088944859803e-05
also O 0 8.263577001343947e-06
show O 0 3.6903988984704483e-06
that O 0 7.090588951541577e-07
25 O 0 1.924796379171312e-06
% O 0 1.4203912996890722e-06
of O 0 2.6468128453416284e-06
all O 0 2.644186679390259e-06
A B-Disease 1 0.9997584223747253
- I-Disease 1 0.9999079704284668
T I-Disease 1 0.9999977350234985
patients O 0 1.44247696880484e-05
carried O 0 3.6940821246389532e-06
in O 0 1.991680619539693e-06
- O 0 2.307314753124956e-05
frame O 0 1.6492609574925154e-05
deletions O 0 4.044425168103771e-06
or O 0 1.5757783558001393e-06
missense O 0 1.8113418263965286e-05
mutations O 0 3.1841227610129863e-06
, O 0 1.6098331343528116e-06
many O 0 5.665756361850072e-07
of O 0 1.5869426306380774e-06
which O 0 1.2644877642742358e-06
were O 0 1.5431145357069909e-06
also O 0 1.2740881629724754e-06
associated O 0 1.0061143029815867e-06
with O 0 1.042804342432646e-06
expression O 0 4.087801244168077e-06
of O 0 1.6929889170569368e-05
mutant O 0 0.00033853278728201985
ATM O 0 0.0016361130401492119
protein O 0 0.00015956525749061257
. O 0 9.45894280448556e-05

The O 0 0.00020906180725432932
DMPK O 1 0.9987630844116211
gene O 0 6.601877248613164e-05
of O 0 0.0002678786404430866
severely O 1 0.9999803304672241
affected O 1 0.9999467134475708
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999806880950928
is O 0 0.0063494243659079075
hypermethylated O 1 0.997600257396698
proximal O 0 0.19196142256259918
to O 0 7.215460755105596e-06
the O 0 1.6402575056417845e-05
largely O 0 4.963092942489311e-05
expanded O 0 8.953424548963085e-05
CTG O 0 0.08764494210481644
repeat O 0 0.00034088818938471377
. O 0 0.00019757064001169056

Using O 0 0.00016151867748703808
methylation O 0 0.0001787272485671565
- O 0 0.00010271675273543224
sensitive O 0 2.9483337129931897e-05
restriction O 0 1.0050383025372867e-05
enzymes O 0 4.682342023443198e-06
, O 0 1.4308559457276715e-06
we O 0 7.438771945089684e-07
characterized O 0 2.2477963739220286e-06
the O 0 1.4459920976150897e-06
methylation O 0 3.827527962130262e-06
pattern O 0 3.5008677059522597e-06
on O 0 2.125231958416407e-06
the O 0 9.9151498034189e-07
5 O 0 2.054650622085319e-06
side O 0 1.4651775472884765e-06
of O 0 1.6859422657944378e-06
the O 0 4.466205609787721e-06
CTG O 0 0.29342061281204224
repeat O 0 4.074210210092133e-06
in O 0 1.7282159205933567e-06
the O 0 4.3622180783131626e-06
DMPK O 0 0.05050182342529297
gene O 0 1.7451588973926846e-06
of O 0 1.49215873079811e-06
normal O 0 1.5396394701383542e-06
individuals O 0 3.4694514283728495e-07
and O 0 6.439778417188791e-07
of O 0 8.575492756790482e-06
patients O 0 0.0025497358292341232
affected O 0 0.00036166675272397697
with O 1 0.9196613430976868
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.0004436462477315217
showing O 0 6.823371950304136e-05
expansions O 0 4.285967952455394e-05
of O 0 1.1941364391532261e-05
the O 0 2.1460456991917454e-05
repetitive O 0 0.00022784399334341288
sequence O 0 6.516846042359248e-05
. O 0 0.00013787188800051808

The O 0 0.00014496021321974695
gene O 0 8.474587957607582e-05
segment O 0 8.132947550620884e-05
analyzed O 0 1.981956302188337e-05
corresponds O 0 1.23406443890417e-05
to O 0 2.0659858819271903e-06
the O 0 9.387928002979606e-06
genomic O 0 5.765032983617857e-05
SacI O 0 0.014914390631020069
- O 0 9.531660180073231e-05
HindIII O 0 0.0002513784565962851
fragment O 0 4.642664498533122e-05
carrying O 0 2.2424337657867e-05
exons O 0 4.12730842072051e-05
11 O 0 7.342254684772342e-05
- O 0 9.664314711699262e-05
15 O 0 0.00010751152149168774
. O 0 0.00014241664030123502

There O 0 7.398530578939244e-05
is O 0 2.598891114757862e-05
constitutive O 0 5.391948070609942e-05
methylation O 0 1.4153114534565248e-05
in O 0 7.369850663963007e-06
intron O 0 0.00015685937250964344
12 O 0 8.123540283122566e-06
at O 0 6.043503617547685e-06
restriction O 0 3.6121689390711254e-06
sites O 0 1.6131111806316767e-06
of O 0 3.862657194986241e-06
SacII O 0 0.00010726851905928925
and O 0 3.6887906844640383e-06
HhaI O 0 6.99234296916984e-05
, O 0 2.195743036281783e-06
localized O 0 3.848299002129352e-06
1 O 0 5.593804417003412e-06
, O 0 2.3694274204899557e-06
159 O 0 3.6620988339564065e-06
- O 0 4.310435087973019e-06
1 O 0 6.018077783664921e-06
, O 0 2.3858710846980102e-06
232 O 0 6.634556939388858e-06
bp O 0 1.3634101378556807e-05
upstream O 0 7.199418632808374e-06
of O 0 2.8503648081823485e-06
the O 0 5.977848104521399e-06
CTG O 0 0.14531861245632172
repeat O 0 1.4034982086741365e-05
, O 0 2.1652706436725566e-06
whereas O 0 1.1108326134490198e-06
most O 0 4.476135018194327e-07
, O 0 4.4488942307907564e-07
if O 0 1.5966291755376005e-07
not O 0 1.1925810383672797e-07
all O 0 1.706076204754936e-07
, O 0 3.7426806898110954e-07
of O 0 8.210389523810591e-07
the O 0 9.951849051503814e-07
other O 0 3.461192932263657e-07
sites O 0 1.0058630550702219e-06
of O 0 3.4948034226545133e-06
SacII O 0 0.059992626309394836
, O 0 5.449122909340076e-06
HhaI O 0 0.004902766551822424
, O 0 2.018629629674251e-06
and O 0 1.4707885611642268e-06
HpaII O 0 0.00013493794540409
in O 0 2.2106819415057544e-06
this O 0 7.584967534057796e-07
region O 0 2.9583411560452078e-06
are O 0 3.2362444812861213e-07
unmethylated O 0 9.68485892371973e-06
, O 0 8.170499654625019e-07
in O 0 8.785802378952212e-07
normal O 0 1.1039164746762253e-06
individuals O 0 3.021158363480936e-07
and O 0 2.6318917889511795e-07
most O 0 4.4648626840171346e-07
of O 0 2.9403622647805605e-06
the O 0 2.2870792236062698e-05
patients O 0 0.000267747906036675
. O 0 0.0001076269181794487

In O 0 8.462320693070069e-05
a O 0 3.072896652156487e-05
number O 0 8.810397048364393e-06
of O 0 2.839281478372868e-05
young O 0 0.0001484389358665794
and O 0 1.0315421604900621e-05
severely O 0 0.16847611963748932
affected O 0 1.0458346878294833e-05
patients O 0 7.963477401062846e-06
, O 0 1.882156766441767e-06
however O 0 7.780753890074266e-07
, O 0 5.011031021240342e-07
complete O 0 1.8394374592389795e-06
methylation O 0 1.6994310954032699e-06
of O 0 1.3080567669021548e-06
these O 0 5.044445856583479e-07
restriction O 0 1.2084381069144001e-06
sites O 0 7.721434371887881e-07
was O 0 3.6257672491046833e-06
found O 0 8.941161695474875e-07
in O 0 1.8585853922559181e-06
the O 0 5.605958904197905e-06
mutated O 0 3.7019555747974664e-05
allele O 0 7.369717059191316e-05
. O 0 6.16476681898348e-05

In O 0 6.490853411378339e-05
most O 0 8.050211363297421e-06
of O 0 6.690948794130236e-06
these O 0 1.562495867801772e-06
patients O 0 3.935945642297156e-06
, O 0 1.6100756283776718e-06
the O 0 3.946179731428856e-06
onset O 1 0.9984638690948486
of O 0 0.020109182223677635
the O 1 0.9936203360557556
disease O 1 1.0
was O 1 0.9999988079071045
congenital O 1 1.0
. O 1 0.9042118191719055

Preliminary O 0 0.00025662127882242203
in O 0 9.445270552532747e-05
vivo O 0 0.0003914296976290643
footprinting O 0 0.0005872513283975422
data O 0 7.104137694113888e-06
gave O 0 4.489149432629347e-06
evidence O 0 2.544299150031293e-06
for O 0 1.4369137488756678e-06
protein O 0 5.508320555236423e-06
- O 0 6.06731373409275e-06
DNA O 0 3.2541779546590988e-06
contact O 0 1.2866086080975947e-06
in O 0 8.711929240234895e-07
normal O 0 1.2024303259750013e-06
genes O 0 8.978895493783057e-07
at O 0 2.825303909048671e-06
an O 0 2.6304464881832246e-06
Sp1 O 0 0.00014990470663178712
consensus O 0 4.596368398779305e-06
binding O 0 1.0835511830009636e-06
site O 0 3.88449961974402e-06
upstream O 0 5.413755388872232e-06
of O 0 2.456449692544993e-06
the O 0 4.4942853492102586e-06
CTG O 0 0.06073954701423645
repeat O 0 7.676092536712531e-06
and O 0 6.435474801946839e-07
for O 0 3.744562206975388e-07
a O 0 1.6935806570472778e-06
significant O 0 1.6283200920952368e-06
reduction O 0 2.029638835665537e-06
of O 0 1.3949962749393308e-06
this O 0 6.238570335881377e-07
interaction O 0 1.308765604335349e-06
in O 0 9.374904266223894e-07
cells O 0 1.6294898159685545e-06
with O 0 1.0078650802824995e-06
a O 0 1.4857427231618203e-05
hypermethylated O 1 0.6411516070365906
DMPK O 1 0.9956040382385254
gene O 0 2.9036382329650223e-05
. O 0 1.4270674910221715e-05
. O 0 4.2385381675558165e-05

The O 0 0.0013644405407831073
hemochromatosis B-Disease 1 1.0
gene O 0 0.00018103653565049171
product O 0 2.8877710064989515e-05
complexes O 0 3.695574923767708e-05
with O 0 4.608786184689961e-06
the O 0 1.3157638932170812e-05
transferrin O 0 0.0003409168275538832
receptor O 0 1.5126925973163452e-05
and O 0 1.8772379917209037e-06
lowers O 0 5.7757633840083145e-06
its O 0 1.4458170198849984e-06
affinity O 0 6.0785091591242235e-06
for O 0 3.289708729425911e-06
ligand O 0 4.9636702897259966e-05
binding O 0 2.7740190489566885e-05
. O 0 7.045386882964522e-05

We O 0 6.96924325893633e-05
recently O 0 4.288723721401766e-05
reported O 0 9.563725143379997e-06
the O 0 4.778938091476448e-06
positional O 0 3.1179512006929144e-05
cloning O 0 1.4385892427526414e-05
of O 0 4.211311079416191e-06
a O 0 6.009612206980819e-06
candidate O 0 9.601035344530828e-06
gene O 0 8.35860009829048e-06
for O 0 1.7125692465924658e-05
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999978542327881
HFE O 1 0.9999995231628418
. O 0 0.001075573032721877

The O 0 8.836297638481483e-05
gene O 0 3.226253102184273e-05
product O 0 5.542873168451479e-06
, O 0 2.4259197743958794e-06
a O 0 3.0316346055769827e-06
member O 0 3.3710314255586127e-06
of O 0 2.8162760372651974e-06
the O 0 1.0639679203450214e-05
major O 0 0.06094785034656525
histocompatibility O 1 0.9999998807907104
complex O 1 0.8333914279937744
class O 0 0.0009064391488209367
I O 0 0.0013081146171316504
- O 0 2.122403384419158e-05
like O 0 2.63748484030657e-06
family O 0 3.0566181976610096e-06
, O 0 9.288899605053302e-07
was O 0 2.8126257802796317e-06
found O 0 4.864139668825374e-07
to O 0 3.185855632636958e-07
have O 0 4.0389295463683084e-07
a O 0 2.5896797524183057e-06
mutation O 0 4.861403340328252e-06
, O 0 8.685617103765253e-06
Cys O 0 0.057482603937387466
- O 0 7.217536040116102e-05
282 O 0 0.00011416352208470926
- O 0 7.782263128319755e-05
- O 0 5.4611249652225524e-05
> O 0 8.002066897461191e-05
Tyr O 0 0.00012706156121566892
( O 0 4.354474640422268e-06
C282Y O 0 3.630058199632913e-05
) O 0 2.4397500055783894e-06
, O 0 1.6485390688103507e-06
in O 0 1.197707092615019e-06
85 O 0 6.74255761623499e-06
% O 0 9.715811756905168e-06
of O 0 3.220274447812699e-05
patient O 0 0.00020257840515114367
chromosomes O 0 0.00013396206486504525
. O 0 9.102623880608007e-05

This O 0 4.963665924151428e-05
mutation O 0 4.775554043590091e-05
eliminates O 0 5.9626421716529876e-05
the O 0 6.969637524889549e-06
ability O 0 4.809145139006432e-06
of O 0 6.715554263792001e-06
HFE O 0 0.017016563564538956
to O 0 4.960481874149991e-06
associate O 0 1.5053001334308647e-05
with O 0 3.3801452445914038e-06
beta2 O 1 0.7265654802322388
- O 0 0.0006709052831865847
microglobulin O 0 0.20639389753341675
( O 0 1.2186607818875927e-05
beta2m O 0 0.0006563953356817365
) O 0 2.686500010895543e-06
and O 0 2.8745896543114213e-06
prevents O 0 1.841194534790702e-05
cell O 0 5.7248271332355216e-05
- O 0 5.9516041801543906e-05
surface O 0 6.667600973742083e-05
expression O 0 7.974978507263586e-05
. O 0 9.330629836767912e-05

A O 0 0.0005264848587103188
second O 0 7.743768219370395e-05
mutation O 0 1.5245756003423594e-05
that O 0 2.2420713321480434e-06
has O 0 1.325107405136805e-06
no O 0 1.8872974578698631e-06
effect O 0 2.8440165351639735e-06
on O 0 5.115421117807273e-06
beta2m O 0 0.03749321028590202
association O 0 2.124108505086042e-05
, O 0 7.3492165029165335e-06
H63D O 1 0.8726900815963745
, O 0 3.536463736963924e-06
was O 0 8.192742825485766e-06
found O 0 1.251689809578238e-06
in O 0 1.0005884405472898e-06
eight O 0 1.508990521870146e-06
out O 0 9.764846709003905e-07
of O 0 2.194679609601735e-06
nine O 0 6.718001259287121e-06
patients O 0 5.781296749773901e-06
heterozygous O 0 4.982215159543557e-06
for O 0 3.4779066027113004e-06
the O 0 2.7283711460768245e-05
C282Y O 0 0.0016528882551938295
mutant O 0 0.0003851734509225935
. O 0 0.00014838078641332686

In O 0 6.157175084808841e-05
this O 0 6.864050646981923e-06
report O 0 3.5391494748182595e-06
, O 0 2.0697625586763024e-06
we O 0 1.4313403653432033e-06
demonstrate O 0 6.143177870399086e-06
in O 0 4.186807927908376e-06
cultured O 0 3.6650337278842926e-05
293 O 0 0.00011665440251817927
cells O 0 2.5377428755746223e-05
overexpressing O 0 0.00014519332034979016
wild O 0 9.110886821872555e-06
- O 0 1.1975840607192367e-05
type O 0 5.933789452683413e-06
or O 0 3.923888925783103e-06
mutant O 0 5.2439911087276414e-05
HFE O 0 0.012519946321845055
proteins O 0 1.463588318983966e-06
that O 0 3.929488059384312e-07
both O 0 4.986703743270482e-07
the O 0 2.04940579351387e-06
wild O 0 9.543862688587978e-06
- O 0 2.1586443835985847e-05
type O 0 2.428147490718402e-05
and O 0 8.087416972557548e-06
H63D O 1 0.9999740123748779
HFE O 1 0.9917833805084229
proteins O 0 3.97103622162831e-06
form O 0 2.168707396776881e-06
stable O 0 4.698126758739818e-06
complexes O 0 4.811791768588591e-06
with O 0 1.695907940302277e-06
the O 0 6.95008293405408e-06
transferrin O 0 0.0004206405719742179
receptor O 0 6.596049934159964e-05
( O 0 1.9074268493568525e-05
TfR O 0 0.000968198582995683
) O 0 2.5089271730394103e-05
. O 0 5.4570482461713254e-05

The O 0 0.0002132690860889852
C282Y O 0 0.0012215909082442522
mutation O 0 2.8053047572029755e-05
nearly O 0 1.261923898709938e-05
completely O 0 8.93154810910346e-06
prevents O 0 2.171693950003828e-06
the O 0 1.565472985021188e-06
association O 0 2.9289103622431867e-06
of O 0 3.080115448028664e-06
the O 0 9.533355296298396e-06
mutant O 0 0.0001698780688457191
HFE O 1 0.8805447220802307
protein O 0 8.233072549046483e-06
with O 0 3.0921828511054628e-06
the O 0 3.010458567587193e-05
TfR O 0 0.17911775410175323
. O 0 0.00017222996393684298

Studies O 0 0.0001643016585148871
on O 0 8.059672109084204e-05
cell O 0 0.0001668373733991757
- O 0 3.170698255416937e-05
associated O 0 7.539779744547559e-06
transferrin O 0 4.764301047543995e-05
at O 0 1.1489522876217961e-05
37 O 0 8.050173164519947e-06
degrees O 0 7.71359646023484e-06
C O 0 1.6699161278665997e-05
suggest O 0 2.4111559469019994e-06
that O 0 9.207652169607172e-07
the O 0 3.53860605173395e-06
overexpressed O 0 8.857067587086931e-05
wild O 0 1.1001950042555109e-05
- O 0 2.3318420062423684e-05
type O 0 2.2223346604732797e-05
HFE O 0 0.20031355321407318
protein O 0 4.384606654639356e-06
decreases O 0 2.9627512958541047e-06
the O 0 1.4950559261706076e-06
affinity O 0 4.619888841261854e-06
of O 0 5.222699655860197e-06
the O 0 1.96296186913969e-05
TfR O 0 0.006524733267724514
for O 0 5.677246008417569e-05
transferrin O 0 0.0013141512172296643
. O 0 0.0001695847895462066

The O 0 0.0005886387662030756
overexpressed O 1 0.9229826331138611
H63D O 1 0.9992151260375977
protein O 0 1.8474223907105625e-05
does O 0 1.10253506591107e-06
not O 0 3.4320117947572726e-07
have O 0 2.310027014118532e-07
this O 0 3.663433290057583e-07
effect O 0 1.062875071511371e-06
, O 0 6.263088607738609e-07
providing O 0 1.0073221119455411e-06
the O 0 9.487847023592622e-07
first O 0 2.0157729068159824e-06
direct O 0 9.379357948091638e-07
evidence O 0 2.392369424342178e-06
for O 0 1.3316964668774744e-06
a O 0 4.099028046766762e-06
functional O 0 7.926985745143611e-06
consequence O 0 1.873326618806459e-05
of O 0 1.8165817891713232e-05
the O 0 6.161539204185829e-05
H63D O 1 0.9998276233673096
mutation O 0 0.00019282041466794908
. O 0 0.00011356017785146832

Addition O 0 0.00025394978001713753
of O 0 0.00014728997484780848
soluble O 0 0.002712615765631199
wild O 0 0.00020971983030904084
- O 0 0.023249175399541855
type O 1 0.5244238376617432
HFE O 1 0.9999996423721313
/ O 1 0.9989583492279053
beta2m O 1 0.9884002208709717
heterodimers O 0 0.000839219952467829
to O 0 1.342791165370727e-05
cultured O 0 4.6341006964212283e-05
cells O 0 4.69857923235395e-06
also O 0 1.184676079901692e-06
decreased O 0 5.6966941883729305e-06
the O 0 2.4937273792602355e-06
apparent O 0 1.8359309251536615e-05
affinity O 0 8.133865776471794e-06
of O 0 5.728302767238347e-06
the O 0 7.837242264940869e-06
TfR O 0 0.00024413061328232288
for O 0 1.2268070577192702e-06
its O 0 1.3261604863146204e-06
ligand O 0 6.574970939254854e-06
under O 0 4.743936642626068e-06
steady O 0 5.051226617069915e-05
- O 0 6.619653959205607e-06
state O 0 1.4920847206667531e-06
conditions O 0 1.9569395135476952e-06
, O 0 6.651609396612912e-07
both O 0 2.696567378279724e-07
in O 0 8.927435715122556e-07
293 O 0 1.8854512745747343e-05
cells O 0 3.56312693838845e-06
and O 0 1.7245115486730356e-06
in O 0 7.199384526757058e-06
HeLa O 0 0.36172330379486084
cells O 0 3.967988595832139e-05
. O 0 5.122544462210499e-05

Furthermore O 0 0.00012243921810295433
, O 0 1.920755676110275e-05
at O 0 9.989484169636853e-06
4 O 0 6.386273071257165e-06
degrees O 0 4.331046056904597e-06
C O 0 1.82106887223199e-05
, O 0 2.039613946180907e-06
the O 0 2.6646632704796502e-06
added O 0 7.984664080140647e-06
soluble O 0 2.4650677005411126e-05
complex O 0 1.9910345145035535e-05
of O 0 5.8029036154039204e-05
HFE O 1 0.9999920129776001
/ O 0 0.4326082170009613
beta2m O 0 0.023043090477585793
inhibited O 0 3.5920274967793375e-05
binding O 0 4.232678747939644e-06
of O 0 4.4621147026191466e-06
transferrin O 0 8.377173799090087e-05
to O 0 5.912053893553093e-06
HeLa O 0 0.30268341302871704
cell O 0 2.6603251171763986e-05
TfR O 0 7.373449625447392e-05
in O 0 3.562107622201438e-06
a O 0 9.992085324483924e-06
concentration O 0 0.0010342888999730349
- O 0 8.493826317135245e-05
dependent O 0 2.4823266357998364e-05
manner O 0 3.44324107572902e-05
. O 0 7.917419861769304e-05

Scatchard O 0 0.0009720867965370417
plots O 0 5.183389293961227e-05
of O 0 1.1035712304874323e-05
these O 0 1.4064200968277873e-06
data O 0 1.3432473906505038e-06
indicate O 0 1.5454517097168718e-06
that O 0 5.242753218226426e-07
the O 0 1.3886608485336183e-06
added O 0 3.6829837881668936e-06
heterodimer O 0 2.5960100174415857e-05
substantially O 0 5.208190941630164e-06
reduced O 0 1.8768835161608877e-06
the O 0 1.5642283415218117e-06
affinity O 0 8.898002306523267e-06
of O 0 1.6060814232332632e-05
TfR O 0 0.02996225655078888
for O 0 3.9396465581376106e-05
transferrin O 0 0.0013820684980601072
. O 0 0.00012321455869823694

These O 0 1.5240900211210828e-05
results O 0 1.3820253116136882e-05
establish O 0 1.550126398797147e-05
a O 0 1.2523330042313319e-05
molecular O 0 2.1342202671803534e-05
link O 0 2.9567634555860423e-05
between O 0 2.6398094632895663e-05
HFE O 1 0.9056388139724731
and O 0 3.1316562854044605e-06
a O 0 4.01208581024548e-06
key O 0 1.7272770492127165e-05
protein O 0 4.029379397252342e-06
involved O 0 2.174180508518475e-06
in O 0 3.22707728628302e-06
iron O 1 0.6745163202285767
transport O 0 2.174284600187093e-05
, O 0 2.1443693185574375e-06
the O 0 2.5707549866638146e-06
TfR O 0 0.006579185836017132
, O 0 1.7715071862767218e-06
and O 0 4.46264493803028e-07
raise O 0 1.0154993788091815e-06
the O 0 7.342634376072965e-07
possibility O 0 1.6212590026043472e-06
that O 0 2.4684212007741735e-07
alterations O 0 3.2296543395204935e-06
in O 0 7.989896744220459e-07
this O 0 8.037340535338444e-07
regulatory O 0 3.1732095067127375e-06
mechanism O 0 4.271298621461028e-06
may O 0 1.8729141402218374e-06
play O 0 1.6177806401174166e-06
a O 0 2.1584050955425482e-06
role O 0 3.6446469948714366e-06
in O 0 3.1384163321490632e-06
the O 0 1.7258544176002033e-05
pathogenesis O 1 0.9999814033508301
of O 1 0.8766762018203735
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9650267362594604
. O 0 0.001125773647800088

Genomic O 0 0.0006415860261768103
organization O 0 0.00011270329559920356
of O 0 5.0130522140534595e-05
the O 0 6.55514668324031e-05
UBE3A O 1 0.9999369382858276
/ O 1 0.9880123138427734
E6 O 1 0.9997841715812683
- O 0 0.0004371447139419615
AP O 0 7.097627531038597e-05
gene O 0 6.670948550890898e-06
and O 0 4.6042478061281145e-06
related O 0 1.9692091882461682e-05
pseudogenes O 0 0.0002612717798911035
. O 0 0.00013615495117846876

The O 0 0.0002538955886848271
UBE3A O 0 0.016546478495001793
gene O 0 2.7251024221186526e-05
encodes O 0 2.1177713279030286e-05
the O 0 1.463404896639986e-05
E6 O 0 0.22730141878128052
- O 0 0.00010931389988400042
AP O 0 0.00013177079381421208
ubiquitin O 0 0.00012139861064497381
- O 0 4.822978371521458e-05
protein O 0 8.030207027331926e-06
ligase O 0 1.5859088307479396e-05
and O 0 1.1128131518489681e-06
has O 0 6.256253186620597e-07
recently O 0 1.5796857724126312e-06
been O 0 3.8436851923506765e-07
shown O 0 7.338700243053609e-07
to O 0 4.404772937505186e-07
be O 0 9.069664770322561e-07
mutated O 0 1.0435890544613358e-05
in O 0 0.0002540219575166702
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9996241331100464
who O 0 0.0002305618836544454
lack O 0 0.008280579000711441
15q11 O 1 0.9875512719154358
- O 0 0.0005265204817987978
q13 O 0 0.0002586771151982248
deletions O 0 1.3594165466201957e-05
or O 0 7.2046045715978835e-06
chromosome O 0 3.540382385835983e-05
15 O 0 5.625396079267375e-05
paternal O 0 0.001503914943896234
uniparental B-Disease 1 0.9998290538787842
disomy I-Disease 1 0.9904699325561523
. O 0 0.0005987640470266342

Previous O 0 0.0010173502378165722
UBE3A O 0 0.01009694766253233
cDNA O 0 0.00020137093088123947
analysis O 0 1.6064919691416435e-05
has O 0 6.437183401430957e-06
shown O 0 7.642979653610382e-06
a O 0 7.388105132122291e-06
coding O 0 1.5760182577650994e-05
region O 0 9.779265383258462e-06
of O 0 9.58415876084473e-06
approximately O 0 6.056742131477222e-05
2 O 0 0.00014578791160602123
. O 0 6.004071474308148e-05

6 O 0 0.0009157350286841393
kb O 0 0.0008049077005125582
and O 0 2.2487314708996564e-05
a O 0 2.3285578208742663e-05
3 O 0 8.061409607762471e-05
- O 0 7.911019201856107e-05
untranslated O 0 0.0003244228719267994
region O 0 5.237584628048353e-05
( O 0 1.8283340978086926e-05
UTR O 0 0.00029882698436267674
) O 0 3.611390638980083e-06
of O 0 3.955773081543157e-06
< O 0 2.8793368983315304e-05
50 O 0 7.5888988249062095e-06
bp O 0 1.9920184058719315e-05
, O 0 1.6335726513716509e-06
whereas O 0 1.409144147146435e-06
Northern O 0 1.3629270370074664e-06
analysis O 0 8.788936156634009e-07
has O 0 7.381742079815012e-07
indicated O 0 9.391046660311986e-07
mRNA O 0 1.7733090089677717e-06
sizes O 0 9.69756342783512e-07
of O 0 2.4063342607405502e-06
5 O 0 1.5445792087120935e-05
- O 0 4.944097963743843e-05
8 O 0 0.00013039288751315325
kb O 0 0.0011330497218295932
. O 0 0.00013016010052524507

We O 0 4.723441816167906e-05
have O 0 4.066043402417563e-06
analyzed O 0 5.618279828922823e-06
additional O 0 4.1151179175358266e-06
cDNA O 0 2.8409038350218907e-05
clones O 0 9.838703590503428e-06
and O 0 5.893775778531563e-07
provide O 0 4.6678687226631155e-07
evidence O 0 1.005857257041498e-06
for O 0 7.333970870604389e-07
an O 0 2.261826921312604e-06
additional O 0 9.696586857899092e-06
0 O 0 9.125254291575402e-05
. O 0 9.169025724986568e-05

5 O 0 0.00026511147734709084
kb O 0 0.0005749612464569509
of O 0 3.8135822251206264e-05
5 O 0 6.756072980351746e-05
- O 0 6.536937871715054e-05
UTR O 0 0.0002890054020099342
and O 0 3.7912498100922676e-06
> O 0 8.027106559893582e-06
2 O 0 1.2052294550812803e-05
kb O 0 4.793596235685982e-05
of O 0 1.1686001926136669e-05
3 O 0 8.466865256195888e-05
- O 0 0.00045024085557088256
UTR O 0 0.05710825324058533
. O 0 0.00012712943134829402

We O 0 5.219410013523884e-05
have O 0 5.865062121301889e-06
established O 0 8.548480764147826e-06
the O 0 3.9763417589711025e-06
genomic O 0 7.557734534202609e-06
organization O 0 4.049917151860427e-06
of O 0 6.422038040909683e-06
UBE3A O 0 0.0019921958446502686
and O 0 1.4242924635254894e-06
the O 0 1.7344536900054663e-06
sequence O 0 3.235582653360325e-06
of O 0 1.0826011930475943e-05
intron O 0 0.33251434564590454
- O 0 0.00024343862605746835
exon O 0 0.0002620461455080658
borders O 0 3.3967207855312154e-05
. O 0 4.823479685001075e-05

We O 0 4.815400461666286e-05
have O 0 5.367564881453291e-06
also O 0 2.8247111458767904e-06
mapped O 0 5.282197435008129e-06
two O 0 1.0390727993581095e-06
highly O 0 3.297901230325806e-06
homologous O 0 4.791122137248749e-06
processed O 0 4.131283276365139e-06
pseudogenes O 0 1.261881880054716e-05
, O 0 2.955738409582409e-06
UBE3AP1 O 0 0.005368857178837061
and O 0 3.907897735189181e-06
UBE3AP2 O 0 0.0009697380592115223
, O 0 1.9503625026118243e-06
to O 0 5.546270926970465e-07
chromosomes O 0 2.175810777771403e-06
2 O 0 2.674710003702785e-06
and O 0 1.0438541266921675e-06
21 O 0 3.6045332763023907e-06
, O 0 2.346286692045396e-06
respectively O 0 3.859402113448596e-06
, O 0 2.0209008653182536e-06
and O 0 1.2538498594949488e-06
determined O 0 3.4027591482299613e-06
their O 0 2.0690401925094193e-06
genomic O 0 2.3272525140782818e-05
organization O 0 2.703099380596541e-05
. O 0 4.4829303078586236e-05

These O 0 1.698340020084288e-05
results O 0 6.929692517587682e-06
will O 0 2.003010422413354e-06
form O 0 1.089076022253721e-06
the O 0 1.0277852879880811e-06
basis O 0 8.889824698599114e-07
for O 0 7.734589644314838e-07
studies O 0 2.0159920950391097e-06
of O 0 6.2503772824129555e-06
mutation O 0 6.086862413212657e-06
and O 0 7.252493560372386e-06
imprinting O 0 0.0001709104108158499
of O 0 0.00019056243763770908
UBE3A O 1 0.9995558857917786
. O 0 0.00025018295855261385

Mutation O 0 0.0003997177118435502
spectrum O 0 0.0001993265759665519
and O 0 3.2773295970400795e-05
genotype O 0 0.00017459427181165665
- O 0 0.0002722973295021802
phenotype O 0 3.187791662639938e-05
analyses O 0 1.4892976651026402e-05
in O 0 2.9310669560800306e-05
Cowden B-Disease 1 0.9999994039535522
disease I-Disease 1 0.9999943971633911
and O 0 0.0007228890317492187
Bannayan B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999990463256836
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 6.0297366871964186e-05
two O 0 4.332308890298009e-05
hamartoma B-Disease 1 0.9999985694885254
syndromes I-Disease 1 0.9999843835830688
with O 0 0.2657778561115265
germline O 1 0.9999985694885254
PTEN O 1 0.9999946355819702
mutation O 0 0.001698517007753253
. O 0 0.0004184847930446267

The O 0 0.0027377696242183447
tumour B-Disease 1 1.0
suppressor O 1 0.999666690826416
gene O 0 0.00037951458944007754
PTEN O 0 0.2681901156902313
, O 0 1.2236124348419253e-05
which O 0 5.151998266228475e-06
maps O 0 2.1697976990253665e-05
to O 0 1.957958738785237e-05
10q23 O 0 0.0009923686739057302
. O 0 9.607968968339264e-05

3 O 0 0.00020342481730040163
and O 0 2.2408772565540858e-05
encodes O 0 2.138572199328337e-05
a O 0 9.452684025745839e-06
403 O 0 1.3457152817863971e-05
amino O 0 4.6119821490719914e-06
acid O 0 6.145023689896334e-06
dual O 0 6.638449121965095e-06
specificity O 0 1.0930050848401152e-05
phosphatase O 0 9.353096538688987e-05
( O 0 5.913948371016886e-06
protein O 0 8.857152351993136e-06
tyrosine O 0 2.076601049338933e-05
phosphatase O 0 6.224512617336586e-05
; O 0 2.3066838821250712e-06
PTPase O 0 4.595549762598239e-05
) O 0 1.7521696236144635e-06
, O 0 1.17528986720572e-06
was O 0 3.937207111448515e-06
shown O 0 1.674942041063332e-06
recently O 0 2.366600028835819e-06
to O 0 1.0276735338266008e-06
play O 0 2.3897059691080358e-06
a O 0 3.834125891444273e-06
broad O 0 9.652605513110757e-06
role O 0 1.700333086773753e-05
in O 0 1.4038583685760386e-05
human O 0 5.1830134907504544e-05
malignancy B-Disease 1 0.9995294809341431
. O 0 0.00020481015963014215

Somatic O 1 0.9913374185562134
PTEN O 1 0.9991046786308289
deletions O 0 0.00043398383422754705
and O 0 1.8222935977973975e-05
mutations O 0 8.328777767019346e-06
were O 0 3.869713964377297e-06
observed O 0 3.851438577839872e-06
in O 0 1.8767296978694503e-06
sporadic B-Disease 0 4.062396692461334e-05
breast I-Disease 1 0.9918578267097473
, I-Disease 0 4.256575630279258e-05
brain I-Disease 1 0.9644714593887329
, I-Disease 0 4.686582542490214e-05
prostate I-Disease 1 0.9999998807907104
and I-Disease 1 0.9887616038322449
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9991084933280945
lines O 0 1.5131312466110103e-05
and O 0 1.4623744846176123e-06
in O 0 1.1922357998628286e-06
several O 0 1.7584604847797891e-06
primary O 0 0.003373056882992387
tumours B-Disease 1 0.9999972581863403
such O 0 3.823507540801074e-06
as O 0 0.019099311903119087
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 0.9999985694885254
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9999998807907104
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9975179433822632

In O 0 7.467861723853275e-05
addition O 0 3.135394581477158e-05
, O 0 2.3172799046733417e-05
PTEN O 1 0.6010056138038635
was O 0 3.7127781979506835e-05
identified O 0 2.36366099670704e-06
as O 0 1.0068322353617987e-06
the O 0 1.3949044159744517e-06
susceptibility O 0 2.241484253318049e-05
gene O 0 2.356901404709788e-06
for O 0 2.1857958927284926e-06
two O 0 1.4720370927534532e-05
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
( O 0 0.004211122635751963
CD B-Disease 0 0.1419772505760193
; O 0 1.3864186257706024e-05
MIM O 1 0.9508680105209351
158350 O 0 0.00022697432723362
) O 0 5.0133244258177e-06
and O 0 4.548820015770616e-06
Bannayan B-Disease 0 0.006606223061680794
- I-Disease 0 0.00016582896932959557
Zonana I-Disease 1 0.8719944357872009
( I-Disease 0 1.5631498172297142e-05
BZS I-Disease 0 0.07735750824213028
) I-Disease 0 5.635279649141012e-06
or I-Disease 0 5.477721970237326e-06
Ruvalcaba I-Disease 0 0.003511423245072365
- I-Disease 0 0.00014704049681313336
Riley I-Disease 0 0.004131935071200132
- I-Disease 0 0.05229263752698898
Smith I-Disease 1 0.8926690816879272
syndrome I-Disease 1 0.9999998807907104
( O 0 0.07665863633155823
MIM O 1 0.9999964237213135
153480 O 1 0.7728946208953857
) O 0 6.0377002228051424e-05
. O 0 7.785373600199819e-05

Constitutive O 0 0.0019140132935717702
DNA O 0 0.00022831022215541452
from O 0 4.2997395212296396e-05
37 O 0 7.728689524810761e-05
CD B-Disease 0 9.527054498903453e-05
families O 0 7.524300599470735e-06
and O 0 4.99604175274726e-06
seven O 0 1.7785505406209268e-05
BZS B-Disease 0 0.2613694369792938
families O 0 7.2481025199522264e-06
was O 0 3.76963616872672e-05
screened O 0 2.3519398382632062e-05
for O 0 1.8313283362658694e-05
germline O 1 0.7457048892974854
PTEN O 1 0.9866807460784912
mutations O 0 0.0002002668916247785
. O 0 0.00018538474978413433

PTEN O 0 0.2170449048280716
mutations O 0 6.524756463477388e-05
were O 0 1.4197414202499203e-05
identified O 0 6.2153308135748375e-06
in O 0 1.4528135352520621e-06
30 O 0 2.697199533940875e-06
of O 0 2.182687921958859e-06
37 O 0 4.426402483659331e-06
( O 0 1.4891295450070174e-06
81 O 0 4.882273969997186e-06
% O 0 3.0318572044052416e-06
) O 0 2.4411765480181202e-06
CD B-Disease 0 9.788120223674923e-06
families O 0 1.2388887853376218e-06
, O 0 9.065540211850021e-07
including O 0 1.0494999287402607e-06
missense O 0 1.564180274726823e-05
and O 0 2.4660473627591273e-06
nonsense O 0 2.972250513266772e-05
point O 0 1.6719239283702336e-05
mutations O 0 5.933235115662683e-06
, O 0 1.8120321101378067e-06
deletions O 0 3.7644269923475804e-06
, O 0 1.447445015401172e-06
insertions O 0 1.114752740249969e-05
, O 0 1.774833322087943e-06
a O 0 4.420980985742062e-06
deletion O 0 3.0161399990902282e-05
/ O 0 0.00011921668919967487
insertion O 0 6.668439891654998e-05
and O 0 1.9154638721374795e-05
splice O 0 0.00017431762535125017
site O 0 9.360288822790608e-05
mutations O 0 8.724487997824326e-05
. O 0 0.00010850768740056083

These O 0 3.169446426909417e-05
mutations O 0 4.120261291973293e-05
were O 0 1.59856954269344e-05
scattered O 0 1.6145293557201512e-05
over O 0 6.488809503935045e-06
the O 0 6.915062840562314e-06
entire O 0 1.3509822565538343e-05
length O 0 8.616563718533143e-06
of O 0 1.1805689609900583e-05
PTEN O 0 0.11018859595060349
, O 0 2.9430134418362286e-06
with O 0 6.350582566483354e-07
the O 0 1.539188701826788e-06
exception O 0 2.4717642190807965e-06
of O 0 2.47130697061948e-06
the O 0 3.958331944886595e-06
first O 0 7.387661298707826e-06
, O 0 3.156431830575457e-06
fourth O 0 1.3172803846828174e-05
and O 0 5.53007976122899e-06
last O 0 2.9887614800827578e-05
exons O 0 0.00018513217219151556
. O 0 9.100540773943067e-05

A O 0 0.0010230181505903602
hot O 0 0.00028171989833936095
spot O 0 7.897828618297353e-05
for O 0 2.6926818463834934e-05
PTEN O 0 0.04812053591012955
mutation O 0 1.0465580999152735e-05
in O 0 4.810406608157791e-06
CD B-Disease 0 3.8098492950666696e-05
was O 0 1.8666994947125204e-05
identified O 0 3.08310154650826e-06
in O 0 1.301124370911566e-06
exon O 0 1.0941429536615033e-05
5 O 0 2.557928382884711e-06
that O 0 4.862673677052953e-07
contains O 0 8.271755405075965e-07
the O 0 2.8130093596701045e-06
PTPase O 0 0.0019653863273561
core O 0 2.8781430955859832e-05
motif O 0 5.7154352361976635e-06
, O 0 8.708082646080584e-07
with O 0 8.383183853766241e-07
13 O 0 2.4107696390274214e-06
of O 0 2.3331290321948472e-06
30 O 0 4.171738055447349e-06
( O 0 1.8231952481073677e-06
43 O 0 5.043752025812864e-06
% O 0 3.7435374906635843e-06
) O 0 5.004825652576983e-06
CD B-Disease 0 2.2783542590332218e-05
mutations O 0 3.872435172525002e-06
identified O 0 3.81532299797982e-06
in O 0 4.26815495302435e-06
this O 0 1.349259491689736e-05
exon O 0 0.0004982109530828893
. O 0 0.0001974708284251392

Seven O 0 0.00012823005090467632
of O 0 3.416254185140133e-05
30 O 0 1.921210059663281e-05
( O 0 4.377984623715747e-06
23 O 0 9.01544808584731e-06
% O 0 1.927443463500822e-06
) O 0 1.1662137922030524e-06
were O 0 1.064664616023947e-06
within O 0 7.834543112039682e-07
the O 0 1.98739053303143e-06
core O 0 3.8251615478657186e-05
motif O 0 8.02361682872288e-06
, O 0 1.0539491768213338e-06
the O 0 8.304867264996574e-07
majority O 0 1.0215322845397168e-06
( O 0 7.242446145028225e-07
five O 0 5.102662612443964e-07
of O 0 9.299606631429924e-07
seven O 0 1.0695066521293484e-06
) O 0 3.9545142271890654e-07
of O 0 9.166403174276638e-07
which O 0 6.798303502364433e-07
were O 0 1.651325760576583e-06
missense O 0 1.6191874237847514e-05
mutations O 0 3.887186721840408e-06
, O 0 2.7523021799424896e-06
possibly O 0 6.398501682269853e-06
pointing O 0 5.794654043711489e-06
to O 0 5.895563504054735e-07
the O 0 1.4784189943384263e-06
functional O 0 4.037287908431608e-06
significance O 0 1.0335854312870651e-05
of O 0 1.0796894457598682e-05
this O 0 8.480615178996231e-06
region O 0 0.00011333505244692788
. O 0 9.181274799630046e-05

Germline O 1 0.9957436919212341
PTEN O 1 0.8405474424362183
mutations O 0 5.73850265936926e-05
were O 0 1.5029520909592975e-05
identified O 0 5.346011221263325e-06
in O 0 1.7396289422322297e-06
four O 0 1.2039139392072684e-06
of O 0 1.9616668396338355e-06
seven O 0 2.860505901480792e-06
( O 0 1.6597599596934742e-06
57 O 0 9.37009281187784e-06
% O 0 7.146117695810972e-06
) O 0 1.1545990673766937e-05
BZS B-Disease 0 0.026192443445324898
families O 0 1.3854853932571132e-05
studied O 0 9.294672781834379e-05
. O 0 8.256767614511773e-05

Interestingly O 0 0.000612513511441648
, O 0 2.693917485885322e-05
none O 0 1.4072683370613959e-05
of O 0 7.184617061284371e-06
these O 0 1.5131712416405207e-06
mutations O 0 4.280155280866893e-06
was O 0 1.7392958397977054e-05
observed O 0 4.3425438889244106e-06
in O 0 2.9577545319625642e-06
the O 0 1.1987357538600918e-05
PTPase O 1 0.9888610243797302
core O 0 0.003970314282923937
motif O 0 0.00020457810023799539
. O 0 9.177089668810368e-05

It O 0 7.337851275224239e-05
is O 0 1.699266431387514e-05
also O 0 5.492950549523812e-06
worthy O 0 1.2298092769924551e-05
of O 0 4.936085133522283e-06
note O 0 4.286724106350448e-06
that O 0 9.042856277119427e-07
a O 0 2.3357604277407518e-06
single O 0 3.0024734769540373e-06
nonsense O 0 2.6740757675725035e-05
point O 0 1.3658775060321204e-05
mutation O 0 4.159974196227267e-06
, O 0 4.304203230276471e-06
R233X O 0 4.170450120000169e-05
, O 0 1.8722068944043713e-06
was O 0 5.790820068796165e-06
observed O 0 1.2042435173498234e-06
in O 0 6.834929990873206e-07
the O 0 2.536855845391983e-06
germline O 0 4.742361852549948e-05
DNA O 0 6.006850526318885e-06
from O 0 1.8498427607482881e-06
two O 0 1.963190243259305e-06
unrelated O 0 1.0563769137661438e-05
CD B-Disease 0 4.889810224995017e-05
families O 0 4.936000550515018e-06
and O 0 4.66916935693007e-06
one O 0 2.1195191948208958e-05
BZS B-Disease 1 0.9884967803955078
family O 0 0.0001184778957394883
. O 0 7.890376582508907e-05

Genotype O 0 0.0019088764674961567
- O 0 0.0005901766126044095
phenotype O 0 3.7124842492630705e-05
studies O 0 5.729471922677476e-06
were O 0 2.0737891190947266e-06
not O 0 4.59263475249827e-07
performed O 0 2.0864270027232124e-06
on O 0 1.1689151051541558e-06
this O 0 9.373670195600425e-07
small O 0 2.116322775691515e-06
group O 0 3.562607162166387e-06
of O 0 2.7853915526065975e-05
BZS B-Disease 1 0.9987832903862
families O 0 7.015726441750303e-05
. O 0 7.487185939680785e-05

However O 0 8.158449782058597e-05
, O 0 2.3040256564854644e-05
genotype O 0 7.088543497957289e-05
- O 0 6.312900222837925e-05
phenotype O 0 1.5980331227183342e-05
analysis O 0 5.032624812884023e-06
inthe O 0 0.00011131374776596203
group O 0 4.3398445086495485e-06
of O 0 5.313379460858414e-06
CD B-Disease 0 3.684461989905685e-05
families O 0 2.063264901153161e-06
revealed O 0 2.6696209260990145e-06
two O 0 3.3007506772264605e-07
possible O 0 5.335746209311765e-07
associations O 0 9.444630677535315e-07
worthy O 0 4.1205134948540945e-06
of O 0 3.4105530630768044e-06
follow O 0 2.003789859372773e-06
- O 0 6.834846317360643e-06
up O 0 3.2972627650451614e-06
in O 0 4.303780315240147e-06
independent O 0 9.237141057383269e-06
analyses O 0 2.893703458539676e-05
. O 0 6.846967153251171e-05

The O 0 0.00013665181177202612
first O 0 9.24024498090148e-05
was O 0 0.000135503985802643
an O 0 1.274207988899434e-05
association O 0 1.5753164916532114e-05
noted O 0 5.630584382743109e-06
in O 0 2.7820724426419474e-06
the O 0 3.3607084333198145e-06
group O 0 2.686328343770583e-06
of O 0 4.2148108150286134e-06
CD B-Disease 0 0.00010461367492098361
families O 0 5.111003247293411e-06
with O 0 2.7387513910070993e-05
breast B-Disease 1 0.9999991655349731
disease I-Disease 1 0.9999991655349731
. O 0 0.0012840696144849062

A O 0 0.00026351833366788924
correlation O 0 7.528415153501555e-05
was O 0 4.753880784846842e-05
observed O 0 5.962231170997256e-06
between O 0 3.479233555481187e-06
the O 0 3.0349756343639456e-06
presence O 0 9.809922630665824e-06
/ O 0 3.565132283256389e-05
absence O 0 1.6716528989491053e-05
of O 0 8.001730748219416e-06
a O 0 2.9379654733929783e-05
PTEN O 0 0.4494017958641052
mutation O 0 2.8080532956664683e-06
and O 0 1.2473118431444163e-06
the O 0 1.799591473172768e-06
type O 0 4.312371402193094e-06
of O 0 1.1020788406312931e-05
breast O 1 0.857345700263977
involvement O 0 0.001893279841169715
( O 0 1.4445888155023567e-05
unaffected O 0 0.00012174894800409675
versus O 0 0.0019305961905047297
benign O 1 0.9834596514701843
versus O 1 0.9776954054832458
malignant O 1 0.9999988079071045
) O 0 0.0001822544727474451
. O 0 9.110370592679828e-05

Specifically O 0 9.596815652912483e-05
and O 0 9.568177119945176e-06
more O 0 1.8159174715037807e-06
directly O 0 2.9738537250523223e-06
, O 0 2.6257396257278742e-06
an O 0 2.165935711673228e-06
association O 0 1.0311536243534647e-05
was O 0 6.547681550728157e-05
also O 0 1.521362491985201e-06
observed O 0 1.045453132064722e-06
between O 0 9.679527011030586e-07
the O 0 1.3314906937011983e-06
presence O 0 1.8941800590255298e-06
of O 0 2.2129177068563877e-06
a O 0 1.4004834156366996e-05
PTEN O 1 0.9965736865997314
mutation O 0 2.0214045434840955e-05
and O 0 8.548309415346012e-05
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
. O 0 0.0016667337622493505

Secondly O 0 0.0013635173672810197
, O 0 2.5976694814744405e-05
there O 0 7.009631190157961e-06
appeared O 0 9.467218660574872e-06
to O 0 1.28775400298764e-06
be O 0 1.2551204235933255e-06
an O 0 3.3902888390002772e-06
interdependent O 0 4.4668075133813545e-05
association O 0 8.59020929055987e-06
between O 0 8.031110155570786e-06
mutations O 0 6.309349373623263e-06
upstream O 0 1.2919675100420136e-05
and O 0 9.338961035609827e-07
within O 0 1.7592018366485718e-06
the O 0 6.168357231217669e-06
PTPase O 1 0.7931838631629944
core O 0 0.00013931635476183146
motif O 0 2.214394771726802e-05
, O 0 2.061769919237122e-06
the O 0 2.049357135547325e-06
core O 0 1.723919740470592e-05
motif O 0 5.285397037368966e-06
containing O 0 9.85814381238015e-07
the O 0 7.87615817898768e-07
majority O 0 6.843839059911261e-07
of O 0 1.1802015933426446e-06
missense O 0 1.9419145246502012e-05
mutations O 0 1.9463973330857698e-06
, O 0 1.1426824357840815e-06
and O 0 5.380189236348087e-07
the O 0 1.5448077874680166e-06
involvement O 0 6.5633807935228106e-06
of O 0 2.6707591587182833e-06
all O 0 1.7257964373129653e-06
major O 0 0.008451715111732483
organ O 1 0.9999098777770996
systems O 0 0.0031897390726953745
( O 0 7.551329417765373e-06
central O 0 0.0001586965809110552
nervous O 0 0.01697676070034504
system O 0 6.9100856308068614e-06
, O 0 6.489131010312121e-06
thyroid O 1 0.9999996423721313
, O 0 0.03641539439558983
breast O 1 0.999998927116394
, O 0 0.4027423560619354
skin O 1 0.9999483823776245
and O 1 0.5365803241729736
gastrointestinal O 1 1.0
tract O 1 1.0
) O 1 0.6295686960220337
. O 0 0.00035674948594532907

However O 0 7.162082329159603e-05
, O 0 9.034116374095902e-06
these O 0 1.4067755955693428e-06
observations O 0 2.7869239147548797e-06
would O 0 1.1132483450637665e-06
need O 0 1.0098422080773162e-06
to O 0 5.587089617620222e-07
be O 0 6.322169383565779e-07
confirmed O 0 1.6967719602689613e-06
by O 0 1.7388293827025336e-06
studying O 0 4.548633114609402e-06
a O 0 3.829576144198654e-06
larger O 0 3.070987759201671e-06
number O 0 2.269203150717658e-06
of O 0 1.9118067939416505e-05
CD B-Disease 0 0.0002561644068919122
families O 0 7.002045458648354e-05
. O 0 0.00016468703688587993

Molecular O 0 0.46340107917785645
defects O 1 0.9632167816162109
leading O 0 0.00012695498298853636
to O 0 6.068176389817381e-06
human O 0 6.999210654612398e-06
complement B-Disease 0 0.0002191700041294098
component I-Disease 1 0.99998939037323
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 5.822515595355071e-05
an O 0 2.5509134502499364e-05
African O 0 0.00016690196935087442
- O 0 0.00024824903812259436
American O 0 8.79909930517897e-05
family O 0 0.00012113022239645943
. O 0 0.000120285723824054

Complement B-Disease 0 0.01617513597011566
component I-Disease 1 0.9999942779541016
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 0.4906328618526459
C6D B-Disease 1 0.9999924898147583
) O 0 3.205402026651427e-05
was O 0 8.9994166046381e-05
diagnosed O 0 0.003939313814043999
in O 0 6.419968030968448e-06
a O 0 1.4517509953293484e-05
16 O 0 2.5179562726407312e-05
- O 0 2.9301143513293937e-05
year O 0 8.741575584281236e-06
- O 0 3.0792158213444054e-05
old O 0 5.074255750514567e-05
African O 0 1.7972392015508376e-05
- O 0 3.875711627188139e-05
American O 0 1.1000554877682589e-05
male O 0 1.944082396221347e-05
with O 0 5.6258897529914975e-05
meningococcal B-Disease 1 0.9999998807907104
meningitis I-Disease 1 0.9999995231628418
. O 0 0.001715969992801547

The O 0 0.0002222310722572729
patients O 0 0.000247726944508031
father O 0 0.00015770822938065976
and O 0 7.626611932209926e-06
two O 0 5.128898465045495e-06
brothers O 0 0.00016187623259611428
also O 0 4.224456461088266e-06
had O 0 2.0048826627316885e-05
C6D B-Disease 1 0.9938018918037415
, O 0 2.53185771725839e-06
but O 0 1.0766558489194722e-06
gave O 0 2.554427737777587e-06
no O 0 1.6632902770652436e-06
history O 0 7.5321836447983515e-06
of O 0 4.9551290430827066e-05
meningitis B-Disease 1 0.9999890327453613
or O 0 5.2567938837455586e-05
other O 0 3.0255398087319918e-05
neisserial B-Disease 1 0.9999443292617798
infection I-Disease 1 0.9406989812850952
. O 0 0.00012489012442529202

By O 0 0.00010396716970717534
using O 0 3.427672709221952e-05
exon O 0 0.00017023789405357093
- O 0 3.150909105897881e-05
specific O 0 3.69464214600157e-06
polymerase O 0 3.945428761653602e-05
chain O 0 1.4771600035601296e-05
reaction O 0 3.783072997975978e-06
( O 0 3.1438771657121833e-06
PCR O 0 1.2725686246994883e-05
) O 0 3.6333376556285657e-06
/ O 0 1.6196197975659743e-05
single O 0 6.787564871046925e-06
- O 0 1.6564705219934694e-05
strand O 0 1.0394768651167396e-05
conformation O 0 2.874260644603055e-06
polymorphism O 0 3.674942263387493e-06
as O 0 7.143038942558633e-07
a O 0 1.169019924418535e-06
screening O 0 1.2430842843969003e-06
step O 0 1.9011785070688347e-06
and O 0 3.394833356651361e-07
nucleotide O 0 1.1633168242042302e-06
sequencing O 0 1.4031378441359266e-06
of O 0 9.380117944601807e-07
target O 0 1.423005414835643e-06
exons O 0 3.952518909500213e-06
, O 0 1.0760861641756492e-06
we O 0 3.8070615460128465e-07
determined O 0 6.622328783123521e-07
that O 0 2.4576701207479346e-07
the O 0 1.2395364592521219e-06
proband O 0 6.406440661521628e-05
was O 0 1.35487880470464e-05
a O 0 6.717732048855396e-06
compound O 0 1.3380296877585351e-05
heterozygote O 0 2.604836117825471e-05
for O 0 4.561691639537457e-06
two O 0 1.0320931323803961e-05
C6 O 1 0.9998441934585571
gene O 0 3.9770886360201985e-05
mutations O 0 5.5067313951440156e-05
. O 0 9.726647840579972e-05

The O 0 7.304577593458816e-05
first O 0 2.8544332963065244e-05
, O 0 9.158747161563952e-06
1195delC O 0 5.4395604820456356e-05
located O 0 1.221791171701625e-05
in O 0 2.4058315375441452e-06
exon O 0 1.8168244423577562e-05
7 O 0 9.63783259066986e-06
, O 0 1.1970823834417388e-06
is O 0 6.463928343691805e-07
a O 0 1.1879411658810568e-06
novel O 0 1.6272132370431791e-06
mutation O 0 6.692370106975432e-07
, O 0 3.256336924550851e-07
while O 0 2.294635521593591e-07
the O 0 3.8406656699407904e-07
second O 0 2.545007646403974e-06
, O 0 1.1187230484210886e-06
1936delG O 0 1.5908939531072974e-05
in O 0 2.759192966550472e-06
exon O 0 2.4460645363433287e-05
12 O 0 3.821961854555411e-06
, O 0 1.0567582648945972e-06
has O 0 8.21758135316486e-07
been O 0 7.905302936705993e-07
described O 0 1.4290326362242922e-06
before O 0 1.3193863424021401e-06
to O 0 1.4659769931313349e-06
cause O 0 1.551737113913987e-05
C6D B-Disease 1 0.7269057035446167
in O 0 5.762042292190017e-06
an O 0 4.609933057508897e-06
unrelated O 0 3.158978506689891e-05
African O 0 6.099471283960156e-05
- O 0 9.938796574715525e-05
American O 0 3.141245178994723e-05
individual O 0 1.3752151062362827e-05
. O 0 7.498896593460813e-05

Both O 0 7.248719339258969e-05
mutations O 0 8.40271168272011e-05
result O 0 3.595021917135455e-05
in O 0 2.6700292437453754e-05
premature O 0 0.00019365784828551114
termination O 0 0.0003975485742557794
codons O 0 0.00025011878460645676
and O 0 5.8302717661717907e-05
C6 O 1 0.9948105812072754
null O 0 0.0002617055724840611
alleles O 0 0.00015955323760863394
. O 0 0.00013176364882383496

Allele O 0 0.0004249787889420986
- O 0 0.0001296340487897396
specific O 0 8.415211596002337e-06
PCR O 0 3.0058690754231066e-05
indicated O 0 1.0631118129822426e-05
that O 0 1.0750594583441853e-06
the O 0 4.074513526575174e-06
probands O 0 0.00019359546422492713
two O 0 4.893629011348821e-06
brothers O 0 9.213919111061841e-05
also O 0 6.374371423589764e-06
inherited O 0 0.0009436964755877852
the O 0 1.0092884622281417e-05
1195delC O 0 0.00014700571773573756
mutation O 0 2.512319952074904e-06
from O 0 1.5546893337159418e-06
their O 0 7.491840392503946e-07
heterozygous O 0 3.5042148738284595e-06
mother O 0 7.213032404251862e-06
and O 0 7.849515668567619e-07
the O 0 2.223164301540237e-06
1936delG O 0 3.593401561374776e-05
mutation O 0 2.8020692752761533e-06
from O 0 2.0975676306989044e-06
their O 0 3.045258836209541e-06
homozygous O 0 4.02653131459374e-05
father O 0 8.039453678065911e-05
. O 0 3.257658318034373e-05
. O 0 0.00010920117347268388

PAX6 O 1 0.9720511436462402
mutations O 0 0.0016386633506044745
reviewed O 0 0.001355928834527731
. O 0 0.0008443253464065492

Mutations O 0 0.0005399732617661357
in O 0 0.00012261036317795515
PAX6 O 1 0.6765838861465454
are O 0 4.545532647171058e-06
responsible O 0 8.880039786163252e-06
for O 0 4.115408501093043e-06
human O 0 1.4570910934708081e-05
aniridia B-Disease 1 0.9999736547470093
and O 0 1.8884318251366494e-06
have O 0 4.4325810222289874e-07
also O 0 3.275485482845397e-07
been O 0 5.729847885049821e-07
found O 0 4.504144328620896e-07
in O 0 9.84520625024743e-07
patients O 0 3.555913281161338e-06
with O 0 6.81882374919951e-06
Peters B-Disease 1 0.9999991655349731
anomaly I-Disease 1 0.9999997615814209
, O 0 0.0032097140792757273
with O 1 0.9857441782951355
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.9998488426208496
with O 1 0.9299106001853943
autosomal B-Disease 1 0.9999992847442627
dominant I-Disease 1 0.9999995231628418
keratitis I-Disease 1 0.9999998807907104
, O 0 7.54657230572775e-05
and O 0 7.936266229080502e-06
with O 0 2.9647031624335796e-05
isolated B-Disease 1 0.9995125532150269
foveal I-Disease 1 0.9999998807907104
hypoplasia I-Disease 1 1.0
. O 0 0.0021156813018023968

No O 0 7.124528201529756e-05
locus O 0 6.921865860931575e-05
other O 0 3.217013954781578e-06
than O 0 3.3134367640741402e-06
chromosome O 0 2.6102694391738623e-05
11p13 O 0 0.00024385003780480474
has O 0 2.958166305688792e-06
been O 0 2.976055384351639e-06
implicated O 0 1.6599544323980808e-05
in O 0 1.0406811270513572e-05
aniridia B-Disease 1 0.9999926090240479
, O 0 7.517242465837626e-06
and O 0 4.232420451444341e-06
PAX6 O 1 0.9837913513183594
is O 0 3.128381649730727e-06
clearly O 0 2.210867478424916e-06
the O 0 1.0550563729339046e-06
major O 0 3.1029087494971463e-06
, O 0 6.027791528140369e-07
if O 0 2.139737205197889e-07
not O 0 1.581518631610379e-07
only O 0 4.7570571837241005e-07
, O 0 2.0262077669030987e-06
gene O 0 9.533227967040148e-06
responsible O 0 3.1735475204186514e-05
. O 0 9.377692185807973e-05

Twenty O 0 0.0008927291492000222
- O 0 0.0001532113819848746
eight O 0 1.748902832332533e-05
percent O 0 1.0924507478193846e-05
of O 0 9.712968676467426e-06
identified O 0 1.3650284927280154e-05
PAX6 O 0 0.019536662846803665
mutations O 0 5.527891516976524e-06
are O 0 1.5351851061495836e-06
C O 0 7.205714064184576e-05
- O 0 8.671222894918174e-05
T O 0 8.207398059312254e-05
changes O 0 1.6341086848115083e-06
at O 0 8.232781510741916e-06
CpG O 0 3.6646597436629236e-05
dinucleotides O 0 4.490186256589368e-05
, O 0 1.1902727692358894e-06
20 O 0 1.3948485957371304e-06
% O 0 9.069033808373206e-07
are O 0 2.8512980065897864e-07
splicing O 0 2.430521135465824e-06
errors O 0 2.6399561647849623e-06
, O 0 6.78854064517509e-07
and O 0 3.418964240609057e-07
more O 0 1.981961190722359e-07
than O 0 2.8734910983985174e-07
30 O 0 1.296789832849754e-06
% O 0 1.5736637806185172e-06
are O 0 6.1536178463939e-07
deletion O 0 1.0268182450090535e-05
or O 0 7.499770617869217e-06
insertion O 0 7.791173266014084e-05
events O 0 7.343031757045537e-05
. O 0 8.141685248119757e-05

There O 0 5.779278217232786e-05
is O 0 2.1999763703206554e-05
a O 0 2.4965898774098605e-05
noticeably O 0 0.0001255820388905704
elevated O 0 0.00020276721625123173
level O 0 1.0827580808836501e-05
of O 0 7.082619504217291e-06
mutation O 0 2.6207610517303692e-06
in O 0 1.277912815567106e-06
the O 0 2.5788212951738387e-06
paired O 0 4.53156508228858e-06
domain O 0 3.228296236557071e-06
compared O 0 1.1198171705473214e-06
with O 0 6.043102303010528e-07
the O 0 1.1964855275437003e-06
rest O 0 4.193065251456574e-06
of O 0 4.695085408457089e-06
the O 0 1.2410383533278946e-05
gene O 0 3.430566721362993e-05
. O 0 6.346969894366339e-05

Increased O 0 0.0001814388670027256
mutation O 0 3.6610970710171387e-05
in O 0 8.84805922396481e-06
the O 0 1.185731071018381e-05
homeodomain O 0 0.0002673818089533597
is O 0 5.824789241160033e-06
accounted O 0 5.152401627128711e-06
for O 0 1.6038308103816235e-06
by O 0 2.915005325121456e-06
the O 0 1.4742270650458522e-05
hypermutable O 0 0.05681515112519264
CpG O 0 0.0003997382300440222
dinucleotide O 0 0.00027427132590673864
in O 0 3.462533641140908e-05
codon O 0 0.00015497839194722474
240 O 0 0.00015764354611746967
. O 0 9.735907951835543e-05

Very O 0 4.6107685193419456e-05
nearly O 0 2.3916982172522694e-05
all O 0 2.5345368612761376e-06
mutations O 0 3.524813791955239e-06
appear O 0 2.040232629951788e-06
to O 0 1.0760892337202677e-06
cause O 0 5.303639682097128e-06
loss O 0 6.223545642569661e-05
of O 0 5.34725541001535e-06
function O 0 2.3885324935690733e-06
of O 0 2.631746156112058e-06
the O 0 3.774049901039689e-06
mutant O 0 8.441624231636524e-06
allele O 0 1.107830144064792e-06
, O 0 4.4551694600158953e-07
and O 0 2.2583108716389688e-07
more O 0 1.7914902628035634e-07
than O 0 2.1181107001666533e-07
80 O 0 1.4817587725701742e-06
% O 0 2.189309043387766e-06
of O 0 6.852579190308461e-06
exonic O 0 0.0002092554495902732
substitutions O 0 1.556994902784936e-05
result O 0 1.0091816875501536e-05
in O 0 1.6254209185717627e-05
nonsense O 0 0.00020748504903167486
codons O 0 0.00026521083782427013
. O 0 0.0001775092096067965

In O 0 8.186972263501957e-05
a O 0 3.142449713777751e-05
gene O 0 9.931787644745782e-06
with O 0 1.5418053180837887e-06
such O 0 1.8316162595510832e-06
extraordinarily O 0 5.762323780800216e-05
high O 0 1.3141913768777158e-05
sequence O 0 3.771412593778223e-06
conservation O 0 4.3804107008327264e-06
throughout O 0 1.7952031612367136e-06
evolution O 0 2.6899047043116298e-06
, O 0 6.570116966031492e-07
there O 0 6.352508989948547e-07
are O 0 5.244283443062159e-07
presumed O 0 1.3999118891661055e-05
undiscovered O 0 0.00038591455086134374
missense O 0 3.9617087168153375e-05
mutations O 0 7.157282198022585e-06
, O 0 1.5651594367227517e-06
these O 0 4.788326464222337e-07
are O 0 3.5468258374748984e-07
hypothesized O 0 4.550737685349304e-06
to O 0 6.086399366722617e-07
exist O 0 1.2308360055612866e-06
in O 0 2.1877083327126456e-06
as O 0 5.3792127800988965e-06
- O 0 2.457294067426119e-05
yet O 0 9.967445294023491e-06
unidentified O 0 4.1154507925966755e-05
phenotypes O 0 3.651184306363575e-05
. O 0 2.386526648479048e-05
. O 0 7.08913867129013e-05

Genetic O 0 0.001306813326664269
heterogeneity O 0 0.0005289926775731146
and O 0 3.283796104369685e-05
penetrance O 0 0.00017149678023997694
analysis O 0 1.1098764844064135e-05
of O 0 8.558432455174625e-06
the O 0 1.4906774595146999e-05
BRCA1 O 0 0.00014532767818309367
and O 0 7.961305527715012e-06
BRCA2 O 0 9.078170114662498e-05
genes O 0 6.181831395224435e-06
in O 0 1.2838929251302034e-05
breast B-Disease 1 0.9999401569366455
cancer I-Disease 1 0.9997101426124573
families O 0 7.694135274505243e-05
. O 0 0.00012554529530461878

The O 0 0.049729038029909134
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9999862909317017
Consortium O 1 0.627682089805603
. O 0 0.00046646216651424766

The O 0 8.355122554348782e-05
contribution O 0 8.484371210215613e-05
of O 0 4.164091660641134e-05
BRCA1 O 0 0.0009364830912090838
and O 0 1.8026359612122178e-05
BRCA2 O 0 0.0015343051636591554
to O 0 3.280196324340068e-05
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.949487030506134
assessed O 0 2.5398250727448612e-05
by O 0 3.756630349016632e-06
linkage O 0 2.8927266612299718e-05
and O 0 1.3245793297755881e-06
mutation O 0 9.181276823255757e-07
analysis O 0 4.919562002214661e-07
in O 0 5.524774451259873e-07
237 O 0 2.553989133957657e-06
families O 0 9.696805136627518e-07
, O 0 3.4590050290717045e-07
each O 0 8.424251518590609e-08
with O 0 1.4147590832180867e-07
at O 0 1.6663544784023543e-06
least O 0 5.129144824422838e-07
four O 0 5.694096785191505e-07
cases O 0 5.235428375272022e-07
of O 0 1.7530523109599017e-05
breast B-Disease 1 0.9999985694885254
cancer I-Disease 1 0.9994304776191711
, O 0 1.7031270544975996e-06
collected O 0 1.2740747479256243e-06
by O 0 1.0030638577518403e-06
the O 0 4.221644121571444e-05
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9999879598617554
Consortium O 0 0.3306659758090973
. O 0 0.00020375482563395053

Families O 0 0.00010755694529507309
were O 0 1.970885023183655e-05
included O 0 1.0062659384857398e-05
without O 0 4.306383743823972e-06
regard O 0 5.697987489838852e-06
to O 0 1.1640670436463552e-06
the O 0 2.7934086119785206e-06
occurrence O 0 1.5036788681754842e-05
of O 0 0.00029098388040438294
ovarian B-Disease 1 0.9999998807907104
or I-Disease 0 0.0005906822625547647
other I-Disease 0 5.762675209552981e-05
cancers I-Disease 1 0.9997357726097107
. O 0 0.0005054804496467113

Overall O 0 0.004888619761914015
, O 0 0.0004298029525671154
disease O 1 0.9994868040084839
was O 0 0.027756713330745697
linked O 0 4.1025865357369184e-05
to O 0 2.346557494092849e-06
BRCA1 O 0 1.1435347005317453e-05
in O 0 2.3245981992658926e-06
an O 0 2.20286165131256e-06
estimated O 0 4.132930371270049e-06
52 O 0 5.845390205649892e-06
% O 0 2.5465324142714962e-06
of O 0 2.9448212899296777e-06
families O 0 2.0549721284623956e-06
, O 0 1.520380692454637e-06
to O 0 8.202289905057114e-07
BRCA2 O 0 8.351476935786195e-06
in O 0 8.783288762970187e-07
32 O 0 1.4820668639003998e-06
% O 0 8.181930866157927e-07
of O 0 1.4370767758009606e-06
families O 0 9.904763373924652e-07
, O 0 7.172699270086014e-07
and O 0 3.0362298275576904e-07
to O 0 4.960469368597842e-07
neither O 0 1.223538902195287e-06
gene O 0 9.891169838738278e-07
in O 0 6.119947784100077e-07
16 O 0 1.2340435660007643e-06
% O 0 1.2000143669865793e-06
( O 0 1.0313573284292943e-06
95 O 0 3.786407887673704e-06
% O 0 3.107039674432599e-06
confidence O 0 1.437005448678974e-05
interval O 0 2.3700604288023897e-05
[ O 0 3.3792741305660456e-05
CI O 0 0.025085311383008957
] O 0 1.8628070392878726e-05
6 O 0 8.422382052231114e-06
% O 0 6.464596935984446e-06
- O 0 1.2227456863911357e-05
28 O 0 8.332654942933004e-06
% O 0 4.485691079025855e-06
) O 0 3.7721213175245794e-06
, O 0 3.399648676349898e-06
suggesting O 0 7.717879270785488e-06
other O 0 4.2537781155260745e-06
predisposition O 0 0.0012283769901841879
genes O 0 6.459485302912071e-05
. O 0 0.00012435218377504498

The O 0 6.983945786487311e-05
majority O 0 1.4407832168217283e-05
( O 0 6.021326043992303e-06
81 O 0 1.2156079719716217e-05
% O 0 2.5466756596870255e-06
) O 0 1.1987960988335544e-06
of O 0 3.970721991208848e-06
the O 0 3.569912223611027e-05
breast B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.2307959877944086e-05
were O 0 2.717581764954957e-06
due O 0 5.111120117362589e-06
to O 0 2.299613697687164e-06
BRCA1 O 0 2.1140971512068063e-05
, O 0 2.062672820102307e-06
with O 0 9.88607666840835e-07
most O 0 1.244805730493681e-06
others O 0 1.051915774041845e-06
( O 0 1.701501901152369e-06
14 O 0 5.3777866924065165e-06
% O 0 4.927403097099159e-06
) O 0 5.681676611857256e-06
due O 0 1.380068169964943e-05
to O 0 3.137479507131502e-05
BRCA2 O 0 0.0007490666466765106
. O 0 0.00015363063721451908

Conversely O 0 0.0004002648638561368
, O 0 2.6890867957263254e-05
the O 0 7.35878211344243e-06
majority O 0 4.0531476770411246e-06
of O 0 3.368592388142133e-06
families O 0 2.0816039523197105e-06
with O 0 2.219950374637847e-06
male B-Disease 0 1.1723463103407994e-05
and I-Disease 0 4.480688858166104e-06
female I-Disease 0 0.003687218762934208
breast I-Disease 1 0.9999819993972778
cancer I-Disease 1 0.998530387878418
were O 0 8.836489541863557e-06
due O 0 9.01632483873982e-06
to O 0 4.7624498620280065e-06
BRCA2 O 0 3.251239832025021e-05
( O 0 5.398340363171883e-06
76 O 0 2.3147091269493103e-05
% O 0 1.8023696611635387e-05
) O 0 3.0852173949824646e-05
. O 0 6.575619772775099e-05

The O 0 0.0001351635582977906
largest O 0 0.00012121040344936773
proportion O 0 1.7181329894810915e-05
( O 0 6.223082891665399e-06
67 O 0 1.0161649697693065e-05
% O 0 2.7554169719223864e-06
) O 0 1.0793309002110618e-06
of O 0 1.590874717294355e-06
families O 0 7.308946123885107e-07
due O 0 1.2187002766950172e-06
to O 0 4.128433772621065e-07
other O 0 3.0185807986526925e-07
genes O 0 6.017097007315897e-07
was O 0 4.398657893034397e-06
found O 0 5.97959399328829e-07
in O 0 5.62208867904701e-07
families O 0 6.824677143413282e-07
with O 0 5.128724183123268e-07
four O 0 5.499096005223691e-07
or O 0 5.390543265093584e-07
five O 0 6.416801170416875e-07
cases O 0 8.041978389883297e-07
of O 0 1.4002082025399432e-05
female O 0 0.4565834403038025
breast B-Disease 1 0.9999995231628418
cancer I-Disease 1 0.999968409538269
only O 0 0.0001362988696200773
. O 0 0.00015785792493261397

These O 0 2.4046796170296147e-05
estimates O 0 1.9513969164108858e-05
were O 0 7.508265298383776e-06
not O 0 1.8988193914992735e-06
substantially O 0 6.130257133918349e-06
affected O 0 1.858487848949153e-06
either O 0 1.0924735533990315e-06
by O 0 8.155404884746531e-07
changing O 0 1.723666400721413e-06
the O 0 2.007900775424787e-06
assumed O 0 1.681710455159191e-05
penetrance O 0 2.8430235033738427e-05
model O 0 2.472481128279469e-06
for O 0 1.0073538305732654e-06
BRCA1 O 0 1.5865229215705767e-05
or O 0 7.33794422558276e-07
by O 0 6.779281989111041e-07
including O 0 1.1932754659937927e-06
or O 0 2.8110437142458977e-06
excluding O 0 2.794045940390788e-05
BRCA1 O 0 0.00020976483938284218
mutation O 0 2.3563557988381945e-05
data O 0 2.6083709599333815e-05
. O 0 6.371117342496291e-05

Among O 0 0.00011285751679679379
those O 0 1.2091288226656616e-05
families O 0 1.879302908491809e-05
with O 0 1.9467817764962092e-05
disease O 1 0.9993519186973572
due O 0 0.0003969127719756216
to O 0 9.275760930904653e-06
BRCA1 O 0 0.00015407426690217108
that O 0 9.514422458778427e-07
were O 0 8.960487321019173e-07
tested O 0 9.925244057740201e-07
by O 0 2.919162511716422e-07
one O 0 3.4423831607455213e-07
of O 0 5.716557893720164e-07
the O 0 9.904422313411487e-07
standard O 0 1.0863531088034506e-06
screening O 0 1.136257992584433e-06
methods O 0 8.64184073634533e-07
, O 0 5.758278120993054e-07
mutations O 0 6.213904271135107e-07
were O 0 1.036077492244658e-06
detected O 0 2.987657580888481e-06
in O 0 1.2517398317868356e-06
the O 0 2.3600007352797547e-06
coding O 0 5.626644451695029e-06
sequence O 0 2.7450623747427016e-06
or O 0 1.8027623127636616e-06
splice O 0 7.727778211119585e-06
sites O 0 1.4447074363488355e-06
in O 0 8.290749065054115e-07
an O 0 9.660741397965467e-07
estimated O 0 2.2397716747946106e-06
63 O 0 4.174981313553872e-06
% O 0 2.4509715785825392e-06
( O 0 1.8721426613410586e-06
95 O 0 6.069883056625258e-06
% O 0 7.181130058597773e-06
CI O 0 0.001922702300362289
51 O 0 2.1132827896508388e-05
% O 0 9.215592399414163e-06
- O 0 2.820694680849556e-05
77 O 0 2.7393731215852313e-05
% O 0 2.294115438417066e-05
) O 0 3.7442634493345395e-05
. O 0 0.0001013338114717044

The O 0 0.00011166586045874283
estimated O 0 6.917036807863042e-05
sensitivity O 0 4.728981002699584e-05
was O 0 3.00758929370204e-05
identical O 0 2.679954377526883e-06
for O 0 1.2823469432987622e-06
direct O 0 3.183363787684357e-06
sequencing O 0 7.91890033724485e-06
and O 0 2.735111138463253e-06
other O 0 2.926416982518276e-06
techniques O 0 4.92460785608273e-05
. O 0 8.561051799915731e-05

The O 0 0.0003301001852378249
penetrance O 0 0.0012714904733002186
of O 0 0.00016545056132599711
BRCA2 O 0 0.000706590071786195
was O 0 6.491837848443538e-05
estimated O 0 1.102030546462629e-05
by O 0 3.5436007692624116e-06
maximizing O 0 1.995132515730802e-05
the O 0 8.163947313732933e-06
LOD O 0 0.014291576109826565
score O 0 1.0180235221923795e-05
in O 0 5.645014880428789e-06
BRCA2 O 0 0.00010177384683629498
- O 0 2.2668158635497093e-05
mutation O 0 3.8115733786980854e-06
families O 0 1.6034149439292378e-06
, O 0 1.5383435538751655e-06
over O 0 1.8348540606893948e-06
all O 0 1.4341989071908756e-06
possible O 0 7.747916242806241e-06
penetrance O 0 9.913562098518014e-05
functions O 0 1.992765101022087e-05
. O 0 5.777360638603568e-05

The O 0 6.291841418715194e-05
estimated O 0 3.544226638041437e-05
cumulative O 0 3.573655340005644e-05
risk O 0 1.857341339928098e-05
of O 0 4.313386671128683e-05
breast B-Disease 1 0.9998526573181152
cancer I-Disease 1 0.9754605889320374
reached O 0 4.016360981040634e-05
28 O 0 2.0301853510318324e-05
% O 0 5.837011485709809e-06
( O 0 2.9711750357819255e-06
95 O 0 8.188813808374107e-06
% O 0 8.579860150348395e-06
CI O 0 0.002611539326608181
9 O 0 1.369702113152016e-05
% O 0 3.4096362924174173e-06
- O 0 4.679029643739341e-06
44 O 0 2.9807022201566724e-06
% O 0 2.0935585780534893e-06
) O 0 9.74380441221001e-07
by O 0 9.446586091144127e-07
age O 0 3.1003530693851644e-06
50 O 0 2.383160335739376e-06
years O 0 1.8476584955351427e-06
and O 0 5.05534956118936e-07
84 O 0 3.5995587950310437e-06
% O 0 1.8024356904788874e-06
( O 0 2.299881089129485e-06
95 O 0 5.214114935370162e-06
% O 0 3.895373083651066e-06
CI O 0 0.0013948478735983372
43 O 0 9.477307685301639e-06
% O 0 2.898146931329393e-06
- O 0 6.303425379883265e-06
95 O 0 3.516715196383302e-06
% O 0 1.8462986872691545e-06
) O 0 1.51118683788809e-06
by O 0 1.7257717672691797e-06
age O 0 2.1152485714992508e-05
70 O 0 3.118323002126999e-05
years O 0 7.001744961598888e-05
. O 0 0.00011792549776146188

The O 0 0.00026809709379449487
corresponding O 0 0.4434051811695099
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9952709078788757
were O 0 0.0002702183264773339
0 O 0 0.000617458950728178
. O 0 0.00027744047110900283

4 O 0 0.0002030370815191418
% O 0 3.3253116271225736e-05
( O 0 1.4747951354365796e-05
95 O 0 2.68934563791845e-05
% O 0 1.4523658137477469e-05
CI O 0 0.0014672594843432307
0 O 0 1.597521077201236e-05
% O 0 5.947987574472791e-06
- O 0 5.343452357919887e-06
1 O 0 4.724684913526289e-06
% O 0 1.8947348507936113e-06
) O 0 5.294298830449407e-07
by O 0 4.069489705216256e-07
age O 0 1.233535272149311e-06
50 O 0 9.058798582373129e-07
years O 0 1.4509221273328876e-06
and O 0 6.881130047986517e-07
27 O 0 2.756484263954917e-06
% O 0 1.2391604968797765e-06
( O 0 9.893254855342093e-07
95 O 0 4.243381226842757e-06
% O 0 3.7022607557446463e-06
CI O 0 0.0003020110307261348
0 O 0 8.18195167084923e-06
% O 0 6.266970103752101e-06
- O 0 8.239519956987351e-06
47 O 0 5.7311117416247725e-06
% O 0 2.3716609121038346e-06
) O 0 1.393415345773974e-06
by O 0 1.546907128613384e-06
age O 0 8.067742783168796e-06
70 O 0 2.464080353092868e-05
years O 0 6.281230162130669e-05
. O 0 0.00012604513904079795

The O 0 0.00012711006274912506
lifetime O 0 0.000201117480173707
risk O 0 0.00018342846306040883
of O 0 0.03868837282061577
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999980926513672
appears O 0 2.3342116037383676e-05
similar O 0 9.186285865325772e-07
to O 0 7.246142104122555e-07
the O 0 2.2285175873548724e-06
risk O 0 5.859360044269124e-06
in O 0 3.4871461593866115e-06
BRCA1 O 0 0.00018695983453653753
carriers O 0 4.424241069500567e-06
, O 0 1.0491986586202984e-06
but O 0 3.2227731594502984e-07
there O 0 4.52819847396313e-07
was O 0 2.8728686629619915e-06
some O 0 2.414394941752107e-07
suggestion O 0 1.3876838238502387e-06
of O 0 7.110971864676685e-07
a O 0 1.2680974350587348e-06
lower O 0 3.668131967060617e-06
risk O 0 3.3281248761340976e-06
in O 0 3.578884388844017e-06
BRCA2 O 0 5.406374475569464e-05
carriers O 0 1.18398638733197e-05
< O 0 4.630646435543895e-05
50 O 0 1.3099120224069338e-05
years O 0 1.5691448425059207e-05
of O 0 3.553933493094519e-05
age O 0 0.0003159154439345002
. O 0 0.0002569508214946836

Eye B-Disease 1 0.9987452030181885
movement I-Disease 0 0.001709848060272634
abnormalities I-Disease 0 0.022795837372541428
correlate O 0 2.3012631572782993e-05
with O 0 6.837701675976859e-06
genotype O 0 0.00013330913498066366
in O 0 5.985121606499888e-05
autosomal O 1 0.9996845722198486
dominant O 1 0.9999982118606567
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 0.9999994039535522
I I-Disease 1 0.9999809265136719
. O 0 0.0007408083765767515

We O 0 0.00018003673176281154
compared O 0 0.00020311125263106078
horizontal O 0 0.0006066134083084762
eye O 0 0.0006903285393491387
movements O 0 4.0713752241572365e-05
( O 0 2.2422926122089848e-05
visually O 0 5.600111762760207e-05
guided O 0 8.656400314066559e-05
saccades O 0 0.000909786787815392
, O 0 1.789783527783584e-05
antisaccades O 0 0.0002142998855561018
, O 0 6.336357728287112e-06
and O 0 2.2527406144945417e-06
smooth O 0 9.736644642543979e-06
pursuit O 0 1.6699956177035347e-05
) O 0 2.348834641452413e-06
in O 0 1.0358118061049026e-06
control O 0 3.01532008961658e-06
subjects O 0 1.8294812207386713e-06
( O 0 1.4413041071748012e-06
n O 0 2.8715919597743778e-06
= O 0 2.9896129944972927e-06
14 O 0 2.1655184809787897e-06
) O 0 6.486944243988546e-07
and O 0 3.452588259733602e-07
patients O 0 6.480915430984169e-07
with O 0 4.0302919046553143e-07
three O 0 6.509675927190983e-07
forms O 0 1.4877483636155375e-06
of O 0 4.614309727912769e-05
autosomal O 1 0.9843429327011108
dominant O 1 0.9999171495437622
cerebellar B-Disease 1 1.0
ataxias I-Disease 1 0.9999994039535522
type I-Disease 1 0.940269947052002
I I-Disease 1 0.6015800833702087
spinocerebellar B-Disease 1 0.9999204874038696
ataxias I-Disease 0 0.0015412478242069483
1 I-Disease 0 1.7606520486879162e-05
and I-Disease 0 2.834733777490328e-06
2 I-Disease 0 1.1550495401024818e-05
( O 0 4.007917596027255e-06
SCA1 B-Disease 0 0.00022607410210184753
, O 0 1.1965643125222414e-06
n O 0 2.3969596441020258e-06
= O 0 3.802953415288357e-06
11 O 0 2.5595095394237433e-06
; O 0 9.153334872280539e-07
SCA2 B-Disease 0 7.939996430650353e-05
, O 0 1.4617581882703234e-06
n O 0 4.137792984693078e-06
= O 0 3.206128894817084e-06
10 O 0 2.5338479190395446e-06
) O 0 2.129403128492413e-06
and O 0 3.4266947750438703e-06
SCA3 B-Disease 1 0.9999604225158691
/ O 0 0.0008102838764898479
Machado B-Disease 0 0.0005591118824668229
- I-Disease 0 0.0001477389596402645
Joseph I-Disease 1 0.8311582803726196
disease I-Disease 1 0.9434332251548767
( O 0 2.5199236915796064e-05
MJD B-Disease 1 0.9999836683273315
) O 0 4.568866643239744e-06
( O 0 2.403249482085812e-06
n O 0 1.0142633982468396e-05
= O 0 1.6460946426377632e-05
16 O 0 2.0040644812979735e-05
) O 0 1.4052219739824068e-05
. O 0 3.853180169244297e-05

In O 0 0.0004003609938081354
SCA1 B-Disease 1 0.8940817713737488
, O 0 2.8836844649049453e-05
saccade O 0 8.962437277659774e-05
amplitude O 0 4.3925552745349705e-05
was O 0 2.4912527806009166e-05
significantly O 0 5.217472789809108e-06
increased O 0 4.616158093995182e-06
, O 0 3.615705281845294e-06
resulting O 0 1.512477592768846e-05
in O 0 3.6906898458255455e-05
hypermetria B-Disease 0 0.024856874719262123
. O 0 0.00035438817576505244

The O 0 0.0002547923068050295
smooth O 0 0.0003448035567998886
pursuit O 0 0.0005970271304249763
gain O 0 0.0003634951135609299
was O 0 0.0020308278035372496
decreased O 0 0.0009391140774823725
. O 0 0.00023245067859534174

In O 0 0.0005270808469504118
SCA2 B-Disease 1 0.9014553427696228
, O 0 9.760839748196304e-05
saccade O 0 0.0005868590669706464
velocity O 0 0.00018464031745679677
was O 0 0.00023168175539467484
markedly O 0 0.0002999195421580225
decreased O 0 0.0004156197246629745
. O 0 0.00013913474685978144

The O 0 0.0001250383647857234
percentage O 0 6.392173236235976e-05
of O 0 2.8801663574995473e-05
errors O 0 7.703407754888758e-05
in O 0 2.519318150007166e-05
antisaccades O 1 0.927693247795105
was O 0 0.00043081247713416815
greatly O 0 1.4863746400806122e-05
increased O 0 4.69504993816372e-06
and O 0 1.6272629181912635e-06
was O 0 8.627605893707369e-06
significantly O 0 2.287659526700736e-06
correlated O 0 2.4607497834949754e-06
with O 0 1.1378031103959074e-06
age O 0 2.6670082661439665e-05
at O 0 0.3436373770236969
disease O 1 0.9999842643737793
onset O 1 0.9999948740005493
. O 0 0.0018530276138335466

In O 0 0.00011380310024833307
addition O 0 2.8425734853954054e-05
, O 0 1.2643451555049978e-05
a O 0 5.971711743768537e-06
correlation O 0 8.16400188341504e-06
between O 0 7.360845756920753e-06
smooth O 0 3.9128786738729104e-05
pursuit O 0 7.230423943838105e-05
gain O 0 2.2301006538327783e-05
and O 0 2.4645335088280262e-06
the O 0 1.587485940035549e-06
number O 0 2.729560947045684e-06
of O 0 1.7585325622349046e-05
trinucleotide O 1 0.9953558444976807
repeats O 0 8.773209992796183e-05
was O 0 0.0001230186317116022
found O 0 3.723471672856249e-05
. O 0 7.1608395955991e-05

In O 0 0.0011941691627725959
SCA3 B-Disease 1 0.9999980926513672
, O 0 0.0002766507095657289
gaze B-Disease 0 0.03656880557537079
- I-Disease 0 0.006664854008704424
evoked I-Disease 0 0.05136801674962044
nystagmus I-Disease 0 0.1243266835808754
was O 0 0.00010163322440348566
often O 0 2.081800175801618e-06
present O 0 2.546984205764602e-06
as O 0 4.969137080479413e-06
was O 0 6.134610885055736e-05
saccade O 0 0.000199638117919676
hypometria O 0 0.00015567551599815488
and O 0 6.220680006663315e-06
smooth O 0 3.435192775214091e-05
pursuit O 0 6.22188308625482e-05
gain O 0 5.899983079871163e-05
was O 0 0.0002909042814280838
markedly O 0 0.00018527555221226066
decreased O 0 0.0002824094262905419
. O 0 0.00016737768601160496

Three O 0 9.585612133378163e-05
major O 0 8.587002957938239e-05
criteria O 0 2.5562807422829792e-05
, O 0 1.5067220374476165e-05
saccade O 0 9.020482684718445e-05
amplitude O 0 3.1975832825992256e-05
, O 0 5.609681011264911e-06
saccade O 0 4.1235864046029747e-05
velocity O 0 9.447979209653568e-06
, O 0 2.2893116238265065e-06
and O 0 1.300767053180607e-06
presence O 0 3.403719802008709e-06
of O 0 9.225713256455492e-06
gaze B-Disease 0 0.0005136810359545052
- I-Disease 0 0.00021561610628850758
evoked I-Disease 0 0.0003313701890874654
nystagmus I-Disease 0 6.620046769967303e-05
, O 0 1.933310613821959e-06
permitted O 0 1.514355062681716e-06
the O 0 8.5267873828343e-07
correct O 0 1.6983714203888667e-06
assignment O 0 3.6284513953432906e-06
of O 0 1.9940048332500737e-06
90 O 0 1.940584752446739e-06
% O 0 1.6215650475714938e-06
of O 0 2.851414137694519e-06
the O 0 3.998929969384335e-06
SCA1 B-Disease 0 0.13112427294254303
, O 0 1.7659070863373927e-06
90 O 0 2.1154166915948736e-06
% O 0 1.4542066537615028e-06
of O 0 1.9213082396163372e-06
the O 0 5.381342361943098e-06
SCA2 B-Disease 0 0.351881206035614
, O 0 1.780144316398946e-06
and O 0 5.946145051893836e-07
93 O 0 2.696577212191187e-06
% O 0 8.349465474566387e-07
of O 0 1.7612011333767441e-06
the O 0 3.7808908928127494e-06
patients O 0 7.2233774517371785e-06
with O 0 2.803312099786126e-06
SCA3 B-Disease 1 0.9999966621398926
to O 0 1.18629736789444e-06
their O 0 1.0115782060893252e-06
genetically O 0 2.6895659175352193e-06
confirmed O 0 3.568081410776358e-06
patient O 0 4.617915237759007e-06
group O 0 1.8560861008154461e-06
and O 0 8.829632065499027e-07
, O 0 1.1537100590430782e-06
therefore O 0 6.834642931607959e-07
, O 0 1.0025503343058517e-06
may O 0 1.130162900153664e-06
help O 0 2.866008117052843e-06
orient O 0 0.0002211576938861981
diagnoses O 0 4.302204615669325e-05
of O 0 7.034430745989084e-05
SCA1 B-Disease 1 0.9999982118606567
, O 0 7.322097371798009e-05
SCA2 B-Disease 1 0.9992924928665161
, O 0 1.0754392860690132e-05
and O 0 4.898293354926864e-06
SCA3 B-Disease 1 0.9998639822006226
at O 0 1.7235597624676302e-05
early O 0 1.0143321560462937e-05
clinical O 0 1.364878971799044e-05
stages O 0 4.9333084461977705e-05
of O 0 3.976557491114363e-05
the O 0 0.002040676074102521
diseases O 1 0.9999799728393555
. O 0 6.135371222626418e-05
. O 0 9.409330232301727e-05

Genetic O 0 0.0001596778747625649
basis O 0 1.7623049643589184e-05
and O 0 7.833355994080193e-06
molecular O 0 2.4669630874996074e-05
mechanism O 0 5.7828179706120864e-05
for O 0 0.00011232370889047161
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9943785071372986

Ventricular B-Disease 1 0.9999996423721313
fibrillation I-Disease 1 0.9999986886978149
causes O 0 0.007621199358254671
more O 0 1.349888952972833e-05
than O 0 4.973499017069116e-06
300 O 0 1.0159537850995548e-05
, O 0 3.2904963518376462e-06
000 O 0 1.2044941286148969e-05
sudden O 0 2.6034233087557368e-05
deaths O 0 4.152284873271128e-06
each O 0 7.202029905784002e-07
year O 0 3.4631848393473774e-06
in O 0 5.2276632231951226e-06
the O 0 2.0158760889898986e-05
USA O 0 0.0003612637228798121
alone O 0 9.322448750026524e-05
. O 0 7.391873805318028e-05

In O 0 6.601984205190092e-05
approximately O 0 9.576320735504851e-05
5 O 0 3.7239336961647496e-05
- O 0 1.665334275458008e-05
12 O 0 3.136997747787973e-06
% O 0 1.6979082602119888e-06
of O 0 1.024667312776728e-06
these O 0 2.2005551159054448e-07
cases O 0 3.4496952139306813e-07
, O 0 5.016945578972809e-07
there O 0 3.3621850548115617e-07
are O 0 1.8053914629945211e-07
no O 0 1.8448694163453183e-06
demonstrable O 1 0.9068310260772705
cardiac O 1 0.9999680519104004
or O 0 5.192987009650096e-05
non O 0 0.4329184293746948
- O 1 0.9999456405639648
cardiac O 1 0.9999982118606567
causes O 0 3.363487485330552e-05
to O 0 1.0686624136724276e-06
account O 0 7.545459652646969e-07
for O 0 3.8399480217776727e-07
the O 0 7.772959520480072e-07
episode O 0 1.0406711226096377e-05
, O 0 1.1122955356768216e-06
which O 0 2.883510887841112e-07
is O 0 3.389130256437056e-07
therefore O 0 3.867379234634427e-07
classified O 0 3.6604055821953807e-06
as O 0 2.564492024248466e-05
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 0.9999401569366455
IVF B-Disease 1 0.9999998807907104
) O 0 0.00028859515441581607
. O 0 0.0001890635467134416

A O 0 0.00027317600324749947
distinct O 0 4.673296643886715e-05
group O 0 2.47774751187535e-05
of O 0 8.549117046641186e-05
IVF B-Disease 1 0.9999996423721313
patients O 0 0.0029800902120769024
has O 0 3.527874241626705e-06
been O 0 1.6935580333665712e-06
found O 0 7.013349545559322e-07
to O 0 3.835172321942082e-07
present O 0 1.3068809039396e-06
with O 0 2.7954047254752368e-06
a O 0 3.2903913961490616e-05
characteristic O 0 0.001954183913767338
electrocardiographic O 1 0.9995473027229309
pattern O 0 0.0009899333817884326
. O 0 0.0002191758539993316

Because O 0 0.00013602571561932564
of O 0 5.992957085254602e-05
the O 0 3.1538369512418285e-05
small O 0 1.5181670278252568e-05
size O 0 5.519752448890358e-06
of O 0 4.080229700775817e-06
most O 0 1.9214787698729197e-06
pedigrees O 0 9.92498917185003e-06
and O 0 1.5435030036314856e-06
the O 0 2.915244522228022e-06
high O 0 2.3468674044124782e-05
incidence O 0 0.0006262818933464587
of O 0 1.4540010852215346e-05
sudden B-Disease 0 0.029506897553801537
death I-Disease 0 1.6717054677428678e-05
, O 0 8.619090863248857e-07
however O 0 3.969132365000405e-07
, O 0 3.6020790616930753e-07
molecular O 0 1.5648042790417094e-06
genetic O 0 1.5997217133190134e-06
studies O 0 1.2539981071313377e-06
of O 0 3.0869764486851636e-06
IVF B-Disease 1 0.9975185394287109
have O 0 9.666086953075137e-07
not O 0 5.6060270026137e-07
yet O 0 1.8405710306979017e-06
been O 0 3.2212903988693142e-06
done O 0 1.5158349924604408e-05
. O 0 4.073681702720933e-05

Because O 0 0.001997832441702485
IVF B-Disease 1 0.9999997615814209
causes O 1 0.9999827146530151
cardiac O 1 1.0
rhythm O 1 0.999990701675415
disturbance O 1 0.9997355341911316
, O 0 1.1744701623683795e-05
we O 0 2.434232555970084e-06
investigated O 0 5.3874114200880285e-06
whether O 0 2.0019372186652618e-06
malfunction O 0 0.0002002332912525162
of O 0 5.153187430551043e-06
ion O 0 2.6050149244838394e-05
channels O 0 4.868409178016009e-06
could O 0 1.9420474473008653e-06
cause O 0 2.4782268610579195e-06
the O 0 2.6687325771490578e-06
disorder O 1 0.9116170406341553
by O 0 3.1354543352790643e-06
studying O 0 8.503874596499372e-06
mutations O 0 2.9524505862355e-06
in O 0 1.0804194516822463e-06
the O 0 3.7819149838469457e-06
cardiac O 0 0.1511392742395401
sodium O 0 7.192848715931177e-05
channel O 0 0.00010505764657864347
gene O 0 7.031425047898665e-05
SCN5A O 0 0.0066660125739872456
. O 0 9.775772196007892e-05

We O 0 3.434311656747013e-05
have O 0 3.9991282392293215e-06
now O 0 4.086312401341274e-06
identified O 0 5.098156634630868e-06
a O 0 6.1434416238626e-06
missense O 0 2.0737335944431834e-05
mutation O 0 5.046451406087726e-06
, O 0 3.301938932054327e-06
a O 0 5.808103651361307e-06
splice O 0 9.074406261788681e-05
- O 0 1.9279752450529486e-05
donor O 0 5.967442120891064e-06
mutation O 0 1.8068416238747886e-06
, O 0 1.0820991747095832e-06
and O 0 6.693991281281342e-07
a O 0 3.2039006327977404e-06
frameshift O 0 1.8073316823574714e-05
mutation O 0 1.9094243270956213e-06
in O 0 8.064227472459606e-07
the O 0 2.355526021347032e-06
coding O 0 9.988798410631716e-06
region O 0 1.054721087712096e-05
of O 0 1.1638489922916051e-05
SCN5A O 1 0.913156270980835
in O 0 8.327252544404473e-06
three O 0 1.2528968909464311e-05
IVF B-Disease 1 0.9576020240783691
families O 0 4.341283056419343e-05
. O 0 0.00012031498044962063

We O 0 2.7353687983122654e-05
show O 0 9.864183084573597e-06
that O 0 1.6659859056744608e-06
sodium O 0 4.29786223321571e-06
channels O 0 1.6799635886854958e-06
with O 0 9.436186019229353e-07
the O 0 2.608667273307219e-06
missense O 0 3.506566645228304e-05
mutation O 0 5.84034660278121e-06
recover O 0 2.276076156704221e-05
from O 0 3.2445002489112085e-06
inactivation O 0 0.00011135196837130934
more O 0 8.701608180672338e-07
rapidly O 0 4.830854322790401e-06
than O 0 5.396767051024653e-07
normal O 0 9.016789590532426e-07
and O 0 3.137387807328196e-07
that O 0 1.9160152930908225e-07
the O 0 1.2584594060172094e-06
frameshift O 0 1.5391948181786574e-05
mutation O 0 1.1993964790235623e-06
causes O 0 1.5878326848906e-06
the O 0 1.3783471786155133e-06
sodium O 0 2.524761612221482e-06
channel O 0 2.548038537497632e-06
to O 0 6.206673219821823e-07
be O 0 1.0419812497275416e-06
non O 0 7.330862899834756e-06
- O 0 3.842978912871331e-05
functional O 0 4.774821354658343e-05
. O 0 5.167374183656648e-05

Our O 0 6.194353773025796e-05
results O 0 1.887178405013401e-05
indicate O 0 1.2136364603065886e-05
that O 0 2.8471617952163797e-06
mutations O 0 5.482441338244826e-06
in O 0 4.661503226088826e-06
cardiac O 1 0.5592562556266785
ion O 0 0.00013988101272843778
- O 0 3.1888434023130685e-05
channel O 0 7.848499080864713e-06
genes O 0 7.357171512012428e-07
contribute O 0 5.564458547269169e-07
to O 0 2.3124010795072536e-07
the O 0 9.025616805047321e-07
risk O 0 2.614707227621693e-06
of O 0 5.663532192556886e-06
developing O 0 9.726917051011696e-05
IVF B-Disease 1 0.9962588548660278
. O 0 3.055347042391077e-05
. O 0 4.8871526814764366e-05

Molecular O 0 0.00042638281593099236
heterogeneity O 0 0.00044265558244660497
in O 0 6.027667041053064e-05
mucopolysaccharidosis B-Disease 1 0.9951748847961426
IVA I-Disease 1 0.9998955726623535
in O 0 1.1556776371435262e-05
Australia O 0 6.587222287635086e-06
and O 0 1.1624406397459097e-06
Northern O 0 2.5706003725645132e-06
Ireland O 0 3.481161911622621e-06
: O 0 1.3422805977825192e-06
nine O 0 1.9539595541573362e-06
novel O 0 2.7931557724514278e-06
mutations O 0 1.0353012385166949e-06
including O 0 1.4939328139007557e-06
T312S O 0 4.8234844143735245e-05
, O 0 1.5322497119996115e-06
a O 0 1.4113660427028663e-06
common O 0 8.963393156591337e-07
allele O 0 1.2704579148703488e-06
that O 0 1.0354483492847066e-06
confers O 0 1.2997555131732952e-05
a O 0 1.9027536836802028e-05
mild O 0 0.008841457776725292
phenotype O 0 0.00030548666836693883
. O 0 0.0001038334085023962

Mucopolysaccharidosis B-Disease 1 0.9999699592590332
IVA I-Disease 1 0.9999995231628418
( O 0 0.21928559243679047
MPS B-Disease 1 0.9999380111694336
IVA I-Disease 1 1.0
) O 0 1.4778785953240003e-05
is O 0 2.256671223221929e-06
an O 0 2.5182641820720164e-06
autosomal B-Disease 1 0.5298471450805664
recessive I-Disease 1 0.9999980926513672
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9997422099113464
by O 0 2.3598055122420192e-05
a O 0 0.0001700158027233556
genetic B-Disease 1 0.9964120984077454
defect I-Disease 1 0.999868631362915
in O 0 3.2182757422560826e-05
N O 0 0.004626172594726086
- O 0 0.00023013669124338776
acetylgalactosamine O 0 0.057748280465602875
- O 0 7.131107850000262e-05
6 O 0 0.00014768855180591345
- O 0 0.0011720224283635616
sulfate O 0 0.40349632501602173
sulfatase O 1 0.8529841899871826
( O 0 7.161699613789096e-05
GALNS O 1 0.8292989730834961
) O 0 7.12361725163646e-05
. O 0 8.319292101077735e-05

Previous O 0 8.189144136849791e-05
studies O 0 2.749971281446051e-05
of O 0 1.354586856905371e-05
patients O 0 1.24480648082681e-05
from O 0 5.753279310738435e-06
a O 0 1.1018750228686258e-05
British O 0 2.2551423171535134e-05
- O 0 3.6245448427507654e-05
Irish O 0 2.4798253434710205e-05
population O 0 2.307610202478827e-06
showed O 0 2.468306320224656e-06
that O 0 2.987572997881216e-07
the O 0 1.260203362107859e-06
I113F O 0 3.1084891816135496e-05
mutation O 0 9.913494523061672e-07
is O 0 4.360361458566331e-07
the O 0 4.1951264506678854e-07
most O 0 3.626108764365199e-07
common O 0 7.260509846673813e-07
single O 0 1.057891608979844e-06
mutation O 0 1.8700335431276471e-06
among O 0 7.68345307733398e-06
MPS B-Disease 1 0.9999651908874512
IVA I-Disease 1 1.0
patients O 0 0.0051943776197731495
and O 0 4.744258149003144e-06
produces O 0 1.0311771802662406e-05
a O 0 1.6347588825738057e-05
severe O 0 0.28912782669067383
clinical O 0 0.4741739332675934
phenotype O 0 0.0028218799270689487
. O 0 0.00028069227118976414

We O 0 6.647063128184527e-05
studied O 0 7.710536010563374e-05
mutations O 0 1.6031832274165936e-05
in O 0 5.7095953707175795e-06
the O 0 8.661520951136481e-06
GALNS O 0 0.4316146969795227
gene O 0 3.976595962740248e-06
from O 0 2.672415348570212e-06
23 O 0 6.722698799421778e-06
additional O 0 1.083583447325509e-05
MPS B-Disease 0 0.23247738182544708
IVA I-Disease 1 0.9999998807907104
patients O 0 4.46966259914916e-05
( O 0 6.5241529227932915e-06
15 O 0 5.8763048400578555e-06
from O 0 2.6053505735035287e-06
Australia O 0 3.057014509977307e-06
, O 0 1.0862597719096811e-06
8 O 0 2.7207559014641447e-06
from O 0 1.1564982287382009e-06
Northern O 0 3.5289947390992893e-06
Ireland O 0 4.231775164953433e-06
) O 0 9.441407087251719e-07
, O 0 4.723873985312821e-07
with O 0 4.213819408960262e-07
various O 0 8.326342140207998e-07
clinical O 0 3.896048656315543e-05
phenotypes O 0 1.8753553376882337e-05
( O 0 7.078724138409598e-06
severe O 0 0.004250617232173681
, O 0 3.0313221941469237e-06
16 O 0 2.9163816179789137e-06
cases O 0 6.239510526029335e-07
; O 0 5.706986598852382e-07
intermediate O 0 4.945315595250577e-06
, O 0 1.2001470395262004e-06
4 O 0 2.3558181965199765e-06
cases O 0 7.631258540641284e-07
; O 0 1.1524070941959508e-06
mild O 0 1.2610480553121306e-05
, O 0 4.639819962903857e-06
3 O 0 9.990437320084311e-06
cases O 0 5.898842118767789e-06
) O 0 1.7664813640294597e-05
. O 0 6.0392438172129914e-05

We O 0 4.032587821711786e-05
found O 0 7.519135579059366e-06
two O 0 1.770223548192007e-06
common O 0 1.994980721065076e-06
mutations O 0 1.9531582893250743e-06
that O 0 1.0456554946358665e-06
together O 0 1.8640882899489952e-06
accounted O 0 4.44543911726214e-06
for O 0 1.5266181208062335e-06
32 O 0 4.496647761698114e-06
% O 0 2.255182607768802e-06
of O 0 2.861763732653344e-06
the O 0 4.4497146518551745e-06
44 O 0 8.690671165823005e-06
unrelated O 0 1.1988865480816457e-05
alleles O 0 5.501553914655233e-06
in O 0 6.785790901631117e-06
these O 0 7.98690234660171e-06
patients O 0 0.0001369537931168452
. O 0 0.00014309465768747032

One O 0 9.588310058461502e-05
is O 0 3.620633651735261e-05
the O 0 1.5455590983037837e-05
T312S O 0 0.00013135580229572952
mutation O 0 6.8745184762519784e-06
, O 0 2.88483329313749e-06
a O 0 4.273930699127959e-06
novel O 0 4.83998519484885e-06
mutation O 0 3.0596161195717286e-06
found O 0 2.49695904130931e-06
exclusively O 0 5.868912012374494e-06
in O 0 7.5875527727475855e-06
milder O 0 7.42825141060166e-05
patients O 0 0.00011864046973641962
. O 0 0.00010835899593075737

The O 0 9.688323189038783e-05
other O 0 6.63505034026457e-06
is O 0 6.246397333597997e-06
the O 0 4.823272774956422e-06
previously O 0 1.0425278560433071e-05
described O 0 1.8549624655861408e-05
I113F O 0 0.00011512685887282714
that O 0 5.520431841432583e-06
produces O 0 1.6749047063058242e-05
a O 0 4.3641048250719905e-05
severe O 0 0.49104544520378113
phenotype O 0 0.0017621422884985805
. O 0 0.0002769520797301084

The O 0 0.0002810647711157799
I113F O 0 0.000804864801466465
and O 0 1.5098073163244408e-05
T312S O 0 0.00016703108849469572
mutations O 0 7.909618034318555e-06
accounted O 0 7.734486644039862e-06
for O 0 1.971044639503816e-06
8 O 0 6.943332209630171e-06
( O 0 2.0387369659147225e-06
18 O 0 3.5312602904014057e-06
% O 0 1.876278588497371e-06
) O 0 7.60235479901894e-07
and O 0 3.9438970134142437e-07
6 O 0 2.243067910967511e-06
( O 0 7.734582254670386e-07
14 O 0 1.3786901718049194e-06
% O 0 6.62729519262939e-07
) O 0 4.5204578213997593e-07
of O 0 9.398501674695581e-07
44 O 0 5.5641739891143516e-06
unrelated O 0 6.428337201214163e-06
alleles O 0 4.992536105419276e-06
, O 0 7.350239684456028e-06
respectively O 0 4.278372580301948e-05
. O 0 6.505589408334345e-05

The O 0 9.024053724715486e-05
relatively O 0 5.345293538994156e-05
high O 0 9.569711255608127e-05
residual O 0 0.06082024425268173
GALNS O 1 0.9997649788856506
activity O 0 3.5431385185802355e-05
seen O 0 1.4404371540877037e-05
when O 0 2.4473465600749478e-06
the O 0 4.608869403455174e-06
T312S O 0 7.788923539919779e-05
mutant O 0 1.85839398909593e-05
cDNA O 0 2.789453174045775e-05
is O 0 3.108070814050734e-06
overexpressed O 0 1.8333799744141288e-05
in O 0 2.462766587996157e-06
mutant O 0 1.5597026504110545e-05
cells O 0 1.6980312693704036e-06
provides O 0 5.733198804591666e-07
an O 0 4.449844652754109e-07
explanation O 0 9.980914228435722e-07
for O 0 6.434952979361697e-07
the O 0 3.5111495435558027e-06
mild O 0 0.00018489771173335612
phenotype O 0 2.642816434672568e-05
in O 0 5.288871307129739e-06
patients O 0 1.2980436622456182e-05
with O 0 6.112329174357001e-06
this O 0 1.7646729247644544e-05
mutation O 0 9.6187497547362e-05
. O 0 0.00011148743942612782

The O 0 3.727298098965548e-05
distribution O 0 1.2763691302097868e-05
and O 0 2.055236564046936e-06
relative O 0 4.229499609209597e-06
frequencies O 0 2.0607005808415124e-06
of O 0 1.7974867887460277e-06
the O 0 5.031722139392514e-06
I113F O 0 0.00011908022861462086
and O 0 2.8420749913493637e-06
T312S O 0 5.416303247329779e-05
mutations O 0 2.3912903088785242e-06
in O 0 1.3428516467683949e-06
Australia O 0 1.9019111050511128e-06
corresponded O 0 4.595780865201959e-06
to O 0 7.640572334821627e-07
those O 0 7.300627657969017e-07
observed O 0 2.76395485343528e-06
in O 0 1.6511870626345626e-06
Northern O 0 3.0705427889188286e-06
Ireland O 0 4.420352979650488e-06
and O 0 8.68626045757992e-07
are O 0 2.4797395781206433e-07
unique O 0 3.0569049158657435e-07
to O 0 3.0622297231275297e-07
these O 0 2.575574455931928e-07
two O 0 3.9144148900049913e-07
populations O 0 7.268324679898797e-07
, O 0 6.286624625317927e-07
suggesting O 0 1.1727448736564838e-06
that O 0 2.3226959910971345e-07
both O 0 3.6045599927092553e-07
mutations O 0 1.085052645066753e-06
were O 0 1.3915348517912207e-06
probably O 0 2.946549102489371e-06
introduced O 0 1.5132997077671462e-06
to O 0 6.867441584290646e-07
Australia O 0 1.781739115358505e-06
by O 0 1.1724575870175613e-06
Irish O 0 8.899715794541407e-06
migrants O 0 6.130034762463765e-06
during O 0 1.2361633707769215e-05
the O 0 1.553589572722558e-05
19th O 0 0.0002534966915845871
century O 0 0.00028642831603065133
. O 0 0.00014140151324681938

Haplotype O 0 0.0007025171653367579
analysis O 0 4.441970668267459e-05
using O 0 1.793748015188612e-05
6 O 0 4.106609776499681e-05
RFLPs O 0 0.00016110431170091033
provides O 0 3.2228761028818553e-06
additional O 0 8.134191489261866e-07
data O 0 1.0168095059270854e-06
that O 0 3.8664978774249903e-07
the O 0 1.7345430478599155e-06
I113F O 0 5.9164351114304736e-05
mutation O 0 4.7561452447553165e-06
originated O 0 1.0335696970287245e-05
from O 0 3.466046109679155e-06
a O 0 1.2887311640952248e-05
common O 0 2.3464981495635584e-05
ancestor O 0 0.0002828190044965595
. O 0 0.00012746374704875052

The O 0 0.00010962507803924382
other O 0 1.4081356312090065e-05
9 O 0 4.867195457336493e-05
novel O 0 1.735991463647224e-05
mutations O 0 3.735285417860723e-06
identified O 0 1.6376046687582857e-06
in O 0 1.0896484354816494e-06
these O 0 6.181621188261488e-07
23 O 0 9.530201168672647e-06
patients O 0 2.3375428099825513e-06
were O 0 1.8169569102610694e-06
each O 0 5.703819851987646e-07
limited O 0 1.8151591802961775e-06
to O 0 1.7034112715919036e-06
a O 0 1.0112384188687429e-05
single O 0 2.851609133358579e-05
family O 0 8.738401083974168e-05
. O 0 8.725827501621097e-05

These O 0 1.9898347090929747e-05
data O 0 1.1074668691435363e-05
provide O 0 4.78629044664558e-06
further O 0 3.4770175716403173e-06
evidence O 0 3.5271038996143034e-06
for O 0 2.3936906927701784e-06
extensive O 0 2.281855086039286e-05
allelic O 0 0.00010339147411286831
heterogeneity O 0 0.00017926795408129692
in O 0 1.9836601495626383e-05
MPS B-Disease 1 0.9954302310943604
IVA I-Disease 1 0.9999997615814209
in O 0 1.6339919966412708e-05
British O 0 5.0793587433872744e-05
- O 0 0.00012027953198412433
Irish O 0 7.430093683069572e-05
patients O 0 4.311725660954835e-06
and O 0 8.796156407697708e-07
provide O 0 5.795178594780737e-07
evidence O 0 1.137300955633691e-06
for O 0 6.093694082665024e-07
their O 0 4.909794597551809e-07
transmission O 0 2.6301054276700597e-06
to O 0 8.676359470882744e-07
Australia O 0 2.1479511360666947e-06
by O 0 2.1892569748160895e-06
British O 0 9.260274964617565e-06
- O 0 3.0015204174560495e-05
Irish O 0 3.6070447094971314e-05
migrants O 0 2.2444617570727132e-05
. O 0 1.0631940313032828e-05
. O 0 3.872431261697784e-05

Identification O 0 0.00017364195082336664
of O 0 0.00011629067012108862
constitutional O 0 0.0005915696965530515
WT1 O 1 0.9997991919517517
mutations O 0 3.2879386708373204e-05
, O 0 9.940259587892797e-06
in O 0 4.7047492444107775e-06
patients O 0 1.9691189663717523e-05
with O 0 9.683316420705523e-06
isolated O 1 0.9999125003814697
diffuse B-Disease 1 0.9999997615814209
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 3.178229962941259e-05
and O 0 2.132168674506829e-06
analysis O 0 9.053962344296451e-07
of O 0 4.221874860377284e-06
genotype O 0 6.693682371405885e-05
/ O 0 0.0008332778816111386
phenotype O 0 8.08750974101713e-06
correlations O 0 7.64216292736819e-06
by O 0 1.2104658253520029e-06
use O 0 8.536144378012978e-07
of O 0 2.805882559187012e-06
a O 0 1.3074009075353388e-05
computerized O 0 8.528304169885814e-05
mutation O 0 3.265346822445281e-05
database O 0 6.922764441696927e-05
. O 0 6.327919982140884e-05

Constitutional O 0 0.0003373780637048185
mutations O 0 5.312936627888121e-05
of O 0 2.7587839213083498e-05
the O 0 3.429130447329953e-05
WT1 O 0 0.3243436813354492
gene O 0 7.116139840945834e-06
, O 0 2.121999614246306e-06
encoding O 0 4.7450544116145466e-06
a O 0 1.863805482571479e-05
zinc O 1 0.9871271848678589
- O 0 0.0009961132891476154
finger O 0 0.00011497677041916177
transcription O 0 2.9247345082694665e-05
factor O 0 7.385752269328805e-06
involved O 0 4.179539246251807e-06
in O 0 8.783224075159524e-06
renal O 1 0.9999998807907104
and O 0 0.0005050816107541323
gonadal O 1 0.9999988079071045
development O 0 0.0005119101260788739
, O 0 2.0792745090147946e-06
are O 0 2.291018859068572e-07
found O 0 5.786320684819657e-07
in O 0 8.361138839063642e-07
most O 0 1.3872947874915553e-06
patients O 0 3.44389763995423e-06
with O 0 6.3315615079773124e-06
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9930819869041443
DDS B-Disease 1 1.0
) O 0 1.3046834283159114e-05
, O 0 3.0764165330765536e-06
or O 0 1.2670876458287239e-05
diffuse B-Disease 1 0.9999840259552002
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 1 0.9994959831237793
DMS B-Disease 1 0.9999998807907104
) O 0 9.081306416192092e-06
associated O 0 2.9783097943436587e-06
with O 0 2.3561012767459033e-06
pseudohermaphroditism B-Disease 1 0.999976396560669
and O 0 1.6071018762886524e-05
/ O 1 0.8277317881584167
or O 0 0.0006551772239618003
Wilms B-Disease 1 1.0
tumor I-Disease 1 0.9999985694885254
( O 0 0.00027450284687802196
WT B-Disease 1 0.9999737739562988
) O 0 0.00013135279004927725
. O 0 0.00012778781820088625

Most O 0 9.822970605455339e-05
mutations O 0 0.00011679966701194644
in O 0 7.04447302268818e-05
DDS B-Disease 1 0.9999997615814209
patients O 0 0.00022464542416855693
lie O 0 9.811138443183154e-05
in O 0 6.938606475159759e-06
exon O 0 4.1574810893507674e-05
8 O 0 1.616804911463987e-05
or O 0 2.9064556201774394e-06
exon O 0 2.5514485969324596e-05
9 O 0 1.082669314200757e-05
, O 0 2.378587623752537e-06
encoding O 0 6.61161675452604e-06
zinc O 0 0.0002523201983422041
finger O 0 3.0615592550020665e-05
2 O 0 1.2762911865138449e-05
or O 0 3.2227715109911514e-06
zinc O 0 0.0040730806067585945
finger O 0 1.2265576515346766e-05
3 O 0 3.8716266317351256e-06
, O 0 7.791572897986043e-07
respectively O 0 1.4757031294720946e-06
, O 0 4.465211986826034e-07
with O 0 4.7283450044233177e-07
a O 0 4.0494192035112064e-06
hot O 0 1.8271033695782535e-05
spot O 0 1.746697489579674e-05
( O 0 6.901727374497568e-06
R394W O 0 9.935063280863687e-05
) O 0 4.599367457558401e-06
in O 0 1.0597561413305812e-05
exon O 0 0.00017628766363486648
9 O 0 0.000208253477467224
. O 0 0.0001469401322538033

We O 0 2.5399631340405904e-05
analyzed O 0 1.8173996068071574e-05
a O 0 7.61811406846391e-06
series O 0 3.821473455900559e-06
of O 0 3.833906703221146e-06
24 O 0 1.2914058061141986e-05
patients O 0 4.439719759830041e-06
, O 0 1.3138904932930018e-06
10 O 0 2.3020163553155726e-06
with O 0 3.0314263312902767e-06
isolated B-Disease 0 0.030635517090559006
DMS I-Disease 1 0.9999986886978149
( O 0 0.00011539141269167885
IDMS B-Disease 1 0.9991573095321655
) O 0 3.850938810501248e-06
, O 0 8.871852514857892e-07
10 O 0 9.104823561756348e-07
with O 0 1.547562192172336e-06
DDS B-Disease 1 0.9998980760574341
, O 0 2.7466726351121906e-06
and O 0 1.1640358934528194e-06
4 O 0 9.985027645598166e-06
with O 0 9.720872185425833e-06
urogenital B-Disease 1 0.9999994039535522
abnormalities I-Disease 1 0.9999668598175049
and O 0 0.00011898364027729258
/ O 1 0.9915623068809509
or O 0 0.000813773600384593
WT B-Disease 1 0.9999988079071045
. O 0 0.00038660020800307393

We O 0 0.00011983214062638581
report O 0 4.0309500036528334e-05
WT1 O 0 0.0012120356550440192
heterozygous O 0 1.910387072712183e-05
mutations O 0 6.004788247082615e-06
in O 0 5.490614512382308e-06
16 O 0 1.4021189599588979e-05
patients O 0 8.503939170623198e-06
, O 0 2.9952977911307244e-06
4 O 0 7.3416504164924845e-06
of O 0 8.527538739144802e-06
whom O 0 2.866914110200014e-05
presented O 0 6.017650957801379e-05
with O 0 6.672625750070438e-05
IDMS B-Disease 1 0.9999643564224243
. O 0 0.00034239102387800813

One O 0 0.0001061935763573274
male O 0 5.196574056753889e-05
and O 0 6.7567057158157695e-06
two O 0 6.020786713634152e-06
female O 0 0.0006579874898307025
IDMS B-Disease 1 0.9999980926513672
patients O 0 0.0011770989513024688
with O 0 7.195386569947004e-05
WT1 O 1 0.9999971389770508
mutations O 0 0.0012302246177569032
underwent O 1 0.9939520955085754
normal O 0 0.00036341819213703275
puberty O 0 0.0021314257755875587
. O 0 0.00017079849203582853

Two O 0 7.794339035172015e-05
mutations O 0 6.496557034552097e-05
associated O 0 3.108957753283903e-05
with O 0 1.9996563423774205e-05
IDMS B-Disease 1 0.9976528286933899
are O 0 1.65743142588326e-06
different O 0 4.988006594430772e-07
from O 0 3.501328592392383e-06
those O 0 2.903452468672185e-06
described O 0 3.3756856282707304e-05
in O 0 0.00010653110803104937
DDS B-Disease 1 1.0
patients O 0 0.23518557846546173
. O 0 0.0002465718425810337

No O 0 0.0003326796868350357
WT1 O 1 0.6344029903411865
mutations O 0 2.4137849322869442e-05
were O 0 6.3537545429426245e-06
detected O 0 7.333302619372262e-06
in O 0 2.7836940716952085e-06
the O 0 4.200501280138269e-06
six O 0 6.574080543941818e-06
other O 0 5.502408839674899e-06
IDMS B-Disease 1 0.999996542930603
patients O 0 0.00012908810458611697
, O 0 6.964839940337697e-06
suggesting O 0 1.5607947716489434e-05
genetic O 0 2.249398676212877e-05
heterogeneity O 0 4.5414060878101736e-05
of O 0 3.569935870473273e-05
this O 0 5.5615484598092735e-05
disease O 1 0.9998860359191895
. O 0 0.0005544250016100705

We O 0 8.995726238936186e-05
analyzed O 0 9.33181363507174e-05
genotype O 0 0.0001044072923832573
/ O 0 0.0009118836023844779
phenotype O 0 5.888853775104508e-05
correlations O 0 3.471735544735566e-05
, O 0 3.83420638172538e-06
on O 0 1.4074788623474888e-06
the O 0 1.6438714283140143e-06
basis O 0 1.4213683243724518e-06
of O 0 3.0835044526611455e-06
the O 0 4.627464477380272e-06
constitution O 0 2.3985990083019715e-06
of O 0 5.260680609353585e-06
a O 0 1.7799606212065555e-05
WT1 O 0 0.08238422125577927
mutation O 0 4.422916390467435e-06
database O 0 3.86037390853744e-06
of O 0 6.372031293722102e-06
84 O 0 0.0003109533281531185
germ O 1 0.9999594688415527
- O 0 0.00014754328003618866
line O 0 1.3848777598468587e-05
mutations O 0 1.6436049463663949e-06
, O 0 7.316435812754207e-07
to O 0 4.984668180441076e-07
compare O 0 1.0390211855337839e-06
the O 0 1.446644546376774e-06
distribution O 0 1.637939021748025e-06
and O 0 7.044519634291646e-07
type O 0 2.234595740446821e-06
of O 0 2.1846497020305833e-06
mutations O 0 2.49997538048774e-06
, O 0 8.751266022954951e-07
according O 0 4.7149219994935265e-07
to O 0 6.936588192729687e-07
the O 0 5.188157956581563e-06
different O 0 5.3236149142321665e-06
symptoms O 0 0.002954017836600542
. O 0 0.00024024624144658446

This O 0 7.251188071677461e-05
demonstrated O 0 0.00010368302173446864
( O 0 1.4861961062706541e-05
1 O 0 1.8866834579966962e-05
) O 0 3.028871788046672e-06
the O 0 1.8856513861464919e-06
association O 0 2.694161139515927e-06
between O 0 1.541331926091516e-06
mutations O 0 1.4544591522280825e-06
in O 0 2.172795802835026e-06
exons O 0 8.483623787469696e-06
8 O 0 4.634141987480689e-06
and O 0 1.1320290695948643e-06
9 O 0 6.892702913319226e-06
and O 0 2.7319545097270748e-06
DMS B-Disease 0 0.05048922449350357
; O 0 1.5393194416901679e-06
( O 0 1.250862851520651e-06
2 O 0 3.9655715227127075e-06
) O 0 1.927450739458436e-06
among O 0 1.2411853731464362e-06
patients O 0 1.8441852489559096e-06
with O 0 2.062322437268449e-06
DMS B-Disease 1 0.9972952008247375
, O 0 1.963465592780267e-06
a O 0 1.5732406382085173e-06
higher O 0 1.0757731843114016e-06
frequency O 0 9.877821867121384e-07
of O 0 2.1125922557985177e-06
exon O 0 1.661156420595944e-05
8 O 0 4.328976956458064e-06
mutations O 0 1.5527867844866705e-06
among O 0 1.200644987875421e-06
46 O 0 6.507052148663206e-06
, O 0 2.7278279048914555e-06
XY O 0 0.02692025899887085
patients O 0 3.602106971811736e-06
with O 0 1.6082803995232098e-06
female O 0 1.1376348993508145e-05
phenotype O 0 5.9976459851895925e-06
than O 0 1.1538223816387472e-06
among O 0 2.3984780455066357e-06
46 O 0 1.0705132808652706e-05
, O 0 3.6630103750212584e-06
XY O 0 0.19264808297157288
patients O 0 5.940295068285195e-06
with O 0 1.5332333305195789e-06
sexual O 0 1.7551499695400707e-05
ambiguity O 0 0.00013766984920948744
or O 0 1.6026251614675857e-05
male O 0 2.183095784857869e-05
phenotype O 0 8.090595656540245e-06
; O 0 1.031119381877943e-06
and O 0 6.898858373460826e-07
( O 0 1.0218079751211917e-06
3 O 0 2.1188066057220567e-06
) O 0 4.624727978352894e-07
statistically O 0 4.0774688159217476e-07
significant O 0 4.675665365994064e-07
evidence O 0 9.006013215184794e-07
that O 0 3.0133486461636494e-07
mutations O 0 6.395314358087489e-07
in O 0 7.80117943577352e-07
exons O 0 5.558329576160759e-06
8 O 0 2.8630495307879755e-06
and O 0 5.636734385916498e-07
9 O 0 2.58369027505978e-06
preferentially O 0 1.3603286106445012e-06
affect O 0 5.509889433596982e-07
amino O 0 7.289016821232508e-07
acids O 0 4.779575419888715e-07
with O 0 3.6889912280457793e-07
different O 0 2.164873080801044e-07
functions O 0 1.9902527128579095e-06
. O 0 5.424986284197075e-06
. O 0 3.184054367011413e-05

The O 0 0.00045694835716858506
185delAG O 0 0.00985278096050024
BRCA1 O 0 0.0007112428429536521
mutation O 0 3.213559102732688e-05
originated O 0 3.0045963285374455e-05
before O 0 7.0474957283295225e-06
the O 0 4.572702437144471e-06
dispersion O 0 1.97880817722762e-05
of O 0 7.0909600253799e-06
Jews O 0 1.3457564818963874e-05
in O 0 6.7545156525739e-06
the O 0 6.086438588681631e-06
diaspora O 0 1.1483991329441778e-05
and O 0 1.5852953083594912e-06
is O 0 1.2050270470354008e-06
not O 0 6.407732371371822e-07
limited O 0 2.504308667994337e-06
to O 0 8.637030987301841e-06
Ashkenazim O 0 0.0007613105699419975
. O 0 0.00015017423720564693

The O 0 0.0001757485733833164
185delAG O 0 0.0012116491561755538
mutation O 0 4.934380922350101e-05
in O 0 2.295820195286069e-05
BRCA1 O 0 9.610195411369205e-05
is O 0 3.2298360110871727e-06
detected O 0 4.076759978488553e-06
in O 0 9.563966614223318e-07
Ashkenazi O 0 5.720867193304002e-06
Jews O 0 3.589063226172584e-06
both O 0 7.491897235922806e-07
in O 0 2.1926082354184473e-06
familial B-Disease 1 0.9999890327453613
breast I-Disease 1 1.0
and I-Disease 1 0.9999973773956299
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 4.72335159429349e-05
in O 0 5.783606411569053e-06
the O 0 9.643303201301023e-06
general O 0 2.8601172743947245e-05
population O 0 2.777818008325994e-05
. O 0 0.00011428463767515495

All O 0 7.003119389992207e-05
tested O 0 0.0001022166688926518
Ashkenazi O 0 9.610645065549761e-05
mutation O 0 1.3482793292496353e-05
carriers O 0 8.601399713370483e-06
share O 0 2.9046238978480687e-06
the O 0 3.0488622542179655e-06
same O 0 2.8814458801207365e-06
allelic O 0 2.898254751926288e-05
pattern O 0 2.5016017389134504e-05
at O 0 3.565815495676361e-05
the O 0 4.5455228246282786e-05
BRCA1 O 0 0.0013833361444994807
locus O 0 0.0007240166887640953
. O 0 0.00024589855456724763

Our O 0 4.337989230407402e-05
previous O 0 8.876677384250797e-06
study O 0 6.54183486403781e-06
showed O 0 3.7816446365468437e-06
that O 0 5.467662731462042e-07
this O 0 5.861321596967173e-07
Ashkenazi O 0 8.426141903328244e-06
mutation O 0 2.425806314931833e-06
also O 0 1.4146930880087893e-06
occurs O 0 9.959140925275278e-07
in O 0 1.3219154197940952e-06
Iraqi O 0 3.353815145601402e-06
Jews O 0 3.7695210721722106e-06
with O 0 1.8160005765821552e-06
a O 0 9.351614608021919e-06
similar O 0 9.008752385852858e-06
allelic O 0 0.00036397294024936855
pattern O 0 0.0003531352849677205
. O 0 0.0002793038438539952

We O 0 6.727226718794554e-05
extended O 0 2.7866852178703994e-05
our O 0 4.608122253557667e-06
analysis O 0 2.03736090043094e-06
to O 0 1.8222149265056942e-06
other O 0 1.317639771514223e-06
non O 0 7.765692316752393e-06
- O 0 1.5477275155717507e-05
Ashkenazi O 0 1.8829770851880312e-05
subsets O 0 8.711067494004965e-06
354 O 0 9.127348675974645e-06
of O 0 3.469945340839331e-06
Moroccan O 0 1.819390308810398e-05
origin O 0 2.355656306463061e-06
, O 0 3.757049398700474e-06
200 O 0 7.591511803184403e-06
Yemenites O 0 8.773092849878594e-05
and O 0 7.004826784395846e-06
150 O 0 1.7767317331163213e-05
Iranian O 0 5.056403097114526e-05
Jews O 0 0.0001220396370626986
. O 0 0.0001516353222541511

Heteroduplex O 0 0.0028076195158064365
analysis O 0 4.563407856039703e-05
complemented O 0 5.6418251915602013e-05
by O 0 5.843846338393632e-06
direct O 0 5.994923867547186e-06
DNA O 0 8.564213203499094e-06
sequencing O 0 8.1662901720847e-06
of O 0 8.548285222786944e-06
abnormally O 0 6.145865336293355e-05
migrating O 0 2.0176146790618077e-05
bands O 0 2.5728575565153733e-05
were O 0 1.601463918632362e-05
employed O 0 0.00012055281695211306
. O 0 0.00012574884749483317

Four O 0 0.00011126812023576349
of O 0 4.445487866178155e-05
Moroccan O 0 0.00010632935300236568
origin O 0 1.025051278702449e-05
( O 0 3.4584879813337466e-06
1 O 0 5.101935130369384e-06
. O 0 5.9358279713706e-07
1 O 0 2.998107220264501e-06
% O 0 3.274572009104304e-06
) O 0 1.2805028291040799e-06
and O 0 9.025306439980341e-07
none O 0 1.7937092025022139e-06
of O 0 1.9261626675870502e-06
the O 0 4.40949406765867e-06
Yemenites O 0 0.00017242894682567567
or O 0 1.575597934788675e-06
Iranians O 0 5.137113021191908e-06
was O 0 7.827889930922538e-06
a O 0 3.850079792755423e-06
carrier O 0 9.1841648099944e-06
of O 0 7.06488481228007e-06
the O 0 1.9758304915740155e-05
185delAG O 0 0.0011385579127818346
mutation O 0 8.888490992831066e-05
. O 0 0.0001079904250218533

BRCA1 O 0 0.004522603936493397
allelic O 0 0.0006344969151541591
patterns O 0 4.864624861511402e-05
were O 0 9.411324754182715e-06
determined O 0 7.584571903862525e-06
for O 0 1.9483902633510297e-06
four O 0 1.5872634548941278e-06
of O 0 2.5744473077793373e-06
these O 0 5.352028438210255e-07
individuals O 0 5.162416982784634e-07
and O 0 6.910355523359613e-07
for O 0 6.454990284510131e-07
12 O 0 2.1633757114614127e-06
additional O 0 1.581381411597249e-06
non O 0 6.61930653222953e-06
- O 0 1.1949645340791903e-05
Ashkenazi O 0 1.6148018403328024e-05
185delAG O 0 3.476877463981509e-05
mutation O 0 3.2784837458166294e-06
carriers O 0 2.208086016253219e-06
who O 0 3.116289462923305e-06
had O 0 9.050984954228625e-05
breast B-Disease 1 0.9999996423721313
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.45250052213668823

Six O 0 0.0002496339729987085
non O 0 0.00024462828878313303
- O 0 0.00017246429342776537
Ashkenazi O 0 5.663818956236355e-05
individuals O 0 2.0196137029415695e-06
shared O 0 5.821762442792533e-06
the O 0 3.0012511160748545e-06
common O 0 3.118634822385502e-06
Ashkenazi O 0 7.85897282185033e-05
haplotype O 0 2.046535155386664e-05
, O 0 2.5090873805311276e-06
four O 0 1.2118933909732732e-06
had O 0 1.9152382719767047e-06
a O 0 2.0578295334416907e-06
closely O 0 1.5212305015666061e-06
related O 0 9.208301889884751e-07
pattern O 0 5.437198979052482e-06
, O 0 1.2209943633934017e-06
and O 0 8.642911666356667e-07
the O 0 1.9335668639541836e-06
rest O 0 4.9865311666508205e-06
( O 0 2.8027695861965185e-06
n O 0 7.744325557723641e-06
= O 0 7.374082997557707e-06
6 O 0 1.042607345880242e-05
) O 0 2.721129476412898e-06
displayed O 0 9.127809789788444e-06
a O 0 1.0223002391285263e-05
distinct O 0 2.493819920346141e-05
BRCA1 O 0 0.00033764640102162957
allelic O 0 0.0005428062286227942
pattern O 0 0.00045501539716497064
. O 0 0.00017328387184534222

We O 0 5.7526875025359914e-05
conclude O 0 3.446973641985096e-05
that O 0 2.358862047913135e-06
the O 0 1.1730565347534139e-05
185delAG O 0 0.0023243597242981195
BRCA1 O 0 0.00016545782273169607
mutation O 0 8.94708136911504e-06
occurs O 0 3.299168838566402e-06
in O 0 1.5989164694474312e-06
some O 0 1.0983255833707517e-06
non O 0 8.589628123445436e-06
- O 0 1.537627940706443e-05
Ashkenazi O 0 1.5991397958714515e-05
populations O 0 1.628922746021999e-06
at O 0 3.020774329343112e-06
rates O 0 1.8233673699796782e-06
comparable O 0 3.2816587918205187e-06
with O 0 1.0310988045603153e-06
that O 0 1.6846948938109563e-06
of O 0 2.1856916646356694e-05
Ashkenazim O 0 0.010341686196625233
. O 0 0.00014914607163518667

The O 0 0.00013617053627967834
majority O 0 3.769265822484158e-05
of O 0 2.4935987312346697e-05
Jewish O 0 6.718059012200683e-05
185delAG O 0 0.0032224811147898436
mutation O 0 1.2774615242960863e-05
carriers O 0 7.533908046752913e-06
have O 0 1.509557819190377e-06
a O 0 4.068595899298089e-06
common O 0 2.432042037980864e-06
allelic O 0 6.066835339879617e-05
pattern O 0 2.9216904295026325e-05
, O 0 4.3879363147425465e-06
supporting O 0 5.3915332500764634e-06
the O 0 7.231435574794887e-06
founder O 0 0.00042166633647866547
effect O 0 5.535134278034093e-06
notion O 0 6.814721473347163e-06
, O 0 7.514029221056262e-07
but O 0 3.8778679822826234e-07
dating O 0 2.6966954465024173e-06
the O 0 8.669650810588792e-07
mutations O 0 7.04566161857656e-07
origin O 0 6.865398631816788e-07
to O 0 7.307489227059705e-07
an O 0 1.3956681641502655e-06
earlier O 0 3.127638819933054e-06
date O 0 4.724256996269105e-06
than O 0 2.347069994357298e-06
currently O 0 7.946665391500574e-06
estimated O 0 2.9858614652766846e-05
. O 0 5.3359271987574175e-05

However O 0 9.668766870163381e-05
, O 0 2.04557891265722e-05
the O 0 5.364243861549767e-06
different O 0 1.4114332316239597e-06
allelic O 0 2.3721906472928822e-05
pattern O 0 1.6201327525777742e-05
at O 0 1.339859409199562e-05
the O 0 1.5148538295761682e-05
BRCA1 O 0 9.572961425874382e-05
locus O 0 1.447586873837281e-05
even O 0 1.7122192730312236e-06
in O 0 1.1209368722120416e-06
some O 0 6.972209121158812e-07
Jewish O 0 2.2767314931115834e-06
mutation O 0 2.029456709351507e-06
carriers O 0 2.3817153760319343e-06
, O 0 1.36390735860914e-06
might O 0 1.255848360415257e-06
suggest O 0 1.069017116606119e-06
that O 0 4.4120753273091395e-07
the O 0 2.6793488814291777e-06
mutation O 0 4.431901743373601e-06
arose O 0 2.69944139290601e-05
independently O 0 1.4411569281946868e-05
. O 0 1.6638323359075002e-05
. O 0 8.31595971249044e-05

Crystal O 0 0.004177575930953026
structure O 0 0.00029679122962988913
of O 0 0.00013506074901670218
the O 0 0.017672356218099594
hemochromatosis B-Disease 1 1.0
protein O 1 0.8990365266799927
HFE O 1 0.9995691180229187
and O 0 5.62278228244395e-06
characterization O 0 9.053358553501312e-06
of O 0 2.7905568913411116e-06
its O 0 2.478482201695442e-06
interaction O 0 1.0331213161407504e-05
with O 0 8.822192285151687e-06
transferrin O 0 0.0005997293046675622
receptor O 0 0.00028122132061980665
. O 0 0.00011506980081321672

HFE O 1 0.9780048727989197
is O 0 0.00024002647842280567
an O 0 9.590356785338372e-05
MHC O 1 0.9932681918144226
- O 0 0.002074094954878092
related O 0 3.427626870688982e-05
protein O 0 1.0093067430716474e-05
that O 0 1.6541928289370844e-06
is O 0 1.4018177125763032e-06
mutated O 0 2.4938105980254477e-06
in O 0 1.8851513914341922e-06
the O 0 1.1616267329372931e-05
iron B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999996423721313
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9998791217803955

HFE O 0 0.2692345678806305
binds O 0 0.00017746214871294796
to O 0 2.6226207410218194e-05
transferrin O 0 0.00035894307075068355
receptor O 0 7.120345253497362e-05
( O 0 1.1906965482921805e-05
TfR O 0 0.0003096120781265199
) O 0 2.3403244995279238e-06
and O 0 1.0219172281722422e-06
reduces O 0 2.035350917140022e-06
its O 0 1.6159719962161034e-06
affinity O 0 5.513523774425266e-06
for O 0 6.89044236423797e-06
iron O 1 0.7272011637687683
- O 0 0.00014891769387759268
loaded O 0 4.63812866655644e-05
transferrin O 0 0.0001502710802014917
, O 0 1.3559089893533383e-05
implicating O 0 0.0022496080491691828
HFE O 1 0.9992386102676392
in O 0 0.00014919627574272454
iron O 1 0.9999693632125854
metabolism O 0 0.06805916130542755
. O 0 0.00021999362797942013

The O 0 0.001230060588568449
2 O 0 0.0019603080581873655
. O 0 0.0006976058357395232

6 O 0 0.0017954191425815225
A O 0 0.0032457008492201567
crystal O 0 0.19883976876735687
structure O 0 0.00034677391522563994
of O 0 0.00019536673789843917
HFE O 1 0.999846339225769
reveals O 0 5.433395926957019e-05
the O 0 5.112631242809584e-06
locations O 0 5.782056632597232e-06
of O 0 1.643938958295621e-05
hemochromatosis B-Disease 1 1.0
mutations O 0 0.00010560524970060214
and O 0 8.9888699221774e-06
a O 0 3.822298822342418e-05
patch O 1 0.6197898983955383
of O 0 2.7497771952766925e-05
histidines O 0 0.1479301154613495
that O 0 8.912336397770559e-07
could O 0 4.528932606717717e-07
be O 0 3.632093239502865e-07
involved O 0 1.6913821809794172e-06
in O 0 2.1754790395789314e-06
pH O 0 8.342066576005891e-05
- O 0 5.341619180398993e-05
dependent O 0 2.523869989090599e-05
interactions O 0 2.071209564746823e-05
. O 0 3.256186028011143e-05

We O 0 5.823770334245637e-05
also O 0 1.479051661590347e-05
demonstrate O 0 1.4971025848353747e-05
that O 0 4.2416741052875295e-06
soluble O 0 0.001151606789790094
TfR O 1 0.9835703372955322
and O 0 1.2241318472661078e-05
HFE O 1 0.9982821941375732
bind O 0 1.0116821613337379e-05
tightly O 0 5.029208296036813e-06
at O 0 2.0238130673533306e-06
the O 0 9.05176989363099e-07
basic O 0 2.311848447789089e-06
pH O 0 5.44303566130111e-06
of O 0 2.322276031918591e-06
the O 0 4.577366325975163e-06
cell O 0 1.4974937585066073e-05
surface O 0 3.832481070276117e-06
, O 0 7.406719078062451e-07
but O 0 2.41228661934656e-07
not O 0 2.0642870879328257e-07
at O 0 1.7590274410395068e-06
the O 0 2.2869332951813703e-06
acidic O 0 1.5354078641394153e-05
pH O 0 3.0319521101773717e-05
of O 0 4.132065441808663e-05
intracellular O 0 0.000563693349249661
vesicles O 0 0.0011172291124239564
. O 0 0.00018174704746343195

TfR O 1 0.9839230179786682
HFE O 0 0.49381211400032043
stoichiometry O 0 0.0006024212343618274
( O 0 7.930809806566685e-05
2 O 0 7.639513933099806e-05
1 O 0 3.9178146835183725e-05
) O 0 1.2490147128119133e-05
differs O 0 7.048806764942128e-06
from O 0 7.248842393892119e-06
TfR O 0 0.0003892179811373353
transferrin O 0 9.114792919717729e-05
stoichiometry O 0 2.310029412910808e-05
( O 0 2.9278294277901296e-06
2 O 0 6.157865755085368e-06
2 O 0 7.454853403032757e-06
) O 0 1.6737636769903474e-06
, O 0 1.0303114095222554e-06
implying O 0 4.132918547838926e-06
a O 0 1.4110403299127938e-06
different O 0 2.7576149363994773e-07
mode O 0 2.018335180764552e-06
of O 0 1.4558038401446538e-06
binding O 0 1.588390091455949e-06
for O 0 3.1075196602614596e-06
HFE O 0 0.47033408284187317
and O 0 5.107446213514777e-06
transferrin O 0 6.49229550617747e-05
to O 0 2.7403616513765883e-06
TfR O 0 0.000240789056988433
, O 0 2.444734036544105e-06
consistent O 0 2.3204675017041154e-06
with O 0 8.429971103396383e-07
our O 0 2.7452140329842223e-06
demonstration O 0 1.9122278899885714e-05
that O 0 3.870308773912257e-06
HFE O 0 0.06662844121456146
, O 0 7.830689355614595e-06
transferrin O 0 7.798228034516796e-05
, O 0 4.384384737932123e-06
and O 0 3.737683528015623e-06
TfR O 0 0.0002526897587813437
form O 0 1.1036963769583963e-05
a O 0 3.836094765574671e-05
ternary O 0 0.0003988182288594544
complex O 0 0.000775273481849581
. O 0 0.00025744811864569783

Identification O 0 0.00010773328540381044
of O 0 4.429753971635364e-05
three O 0 1.46906522786594e-05
novel O 0 2.6177982363151386e-05
mutations O 0 7.388401172647718e-06
and O 0 1.7738672113409848e-06
a O 0 3.3620997328398516e-06
high O 0 6.3928787312761415e-06
frequency O 0 1.7472470972279552e-06
of O 0 3.3354745028191246e-06
the O 0 5.5589075600437354e-06
Arg778Leu O 0 0.0006947906804271042
mutation O 0 3.2183947951125447e-06
in O 0 2.9891198209952563e-06
Korean O 0 0.12831886112689972
patients O 0 2.2306643586489372e-05
with O 0 2.2468990209745243e-05
Wilson B-Disease 1 0.999462902545929
disease I-Disease 1 0.999974250793457
. O 0 0.000376877433154732

Four O 0 0.00020130682969465852
mutations O 0 0.00014819837815593928
- O 0 0.00023264889023266733
- O 0 0.0001965784904314205
R778L O 0 0.0005944748409092426
, O 0 1.1343783626216464e-05
A874V O 0 7.55956643843092e-05
, O 0 5.296240487950854e-06
L1083F O 0 4.230502599966712e-05
, O 0 3.351836085130344e-06
and O 0 1.9537078514986206e-06
2304delC O 0 4.79112786706537e-05
- O 0 2.3170545318862423e-05
- O 0 1.43719316838542e-05
in O 0 2.764742930594366e-06
the O 0 6.878171461721649e-06
copper O 0 0.013070366345345974
- O 0 2.0924146156175993e-05
transporting O 0 1.3762752132606693e-05
enzyme O 0 5.82463871978689e-06
, O 0 3.3578603506612126e-06
P O 0 8.080695988610387e-05
- O 0 1.2640269233088475e-05
type O 0 1.2356047591310926e-05
ATPase O 0 5.8451576478546485e-05
( O 0 3.4075947041856125e-06
ATP7B O 0 0.0034454779233783484
) O 0 6.392741624949849e-07
, O 0 3.7885899928369327e-07
were O 0 4.5268512849361286e-07
identified O 0 8.260254276137857e-07
in O 0 2.1689866116503254e-06
Korean O 0 0.08003474026918411
Patients O 0 3.8058002246543765e-05
with O 0 3.294721318525262e-05
Wilson B-Disease 1 0.9999325275421143
disease I-Disease 1 0.9999862909317017
. O 0 0.00044144497951492667

Arg778Leu O 1 0.5231474041938782
, O 0 3.3880831324495375e-05
the O 0 1.1981802344962489e-05
most O 0 2.2094257019489305e-06
frequently O 0 2.360065991524607e-06
reported O 0 1.782286290108459e-06
mutation O 0 9.314607041233103e-07
of O 0 1.6649852341288351e-06
this O 0 8.972579053079244e-07
enzyme O 0 3.0168732791935327e-06
, O 0 1.3668319525095285e-06
was O 0 3.769639761230792e-06
found O 0 6.211380991771875e-07
in O 0 5.87468491630716e-07
six O 0 8.287808554996445e-07
of O 0 1.4092113360675285e-06
eight O 0 3.158042773065972e-06
unrelated O 0 1.0340882909076754e-05
patients O 0 4.1786142901401035e-06
studied O 0 6.38697338217753e-06
, O 0 1.4792018419029773e-06
an O 0 9.372097338200547e-07
allele O 0 2.235271495010238e-06
frequency O 0 4.923372671328252e-06
of O 0 1.3642399608215783e-05
37 O 0 0.00012291099119465798
. O 0 9.85053920885548e-05

5 O 0 0.0001904853997984901
% O 0 6.366816523950547e-05
, O 0 1.133482965087751e-05
which O 0 2.9613220249302685e-06
is O 0 1.9443232304183766e-06
considerably O 0 2.9627910862473072e-06
higher O 0 1.16859405352443e-06
than O 0 6.05543050369306e-07
those O 0 1.3335912854017806e-06
in O 0 4.977237949788105e-06
other O 0 7.240827471832745e-06
Asian O 0 0.00012338164378888905
populations O 0 6.095936259953305e-05
. O 0 0.00010968018614221364

The O 0 0.00011937684030272067
novel O 0 0.00012420427810866386
single O 0 1.8243106751469895e-05
nucleotide O 0 1.927302400872577e-05
deletion O 0 3.969642784795724e-05
, O 0 1.50231726365746e-05
2304delC O 0 8.96354831638746e-05
, O 0 7.09855748937116e-06
was O 0 1.7001855667331256e-05
found O 0 5.1399310905253515e-06
in O 0 4.58361319033429e-06
one O 0 2.056318953691516e-05
patient O 0 0.00013615534408017993
. O 0 0.00011706772056641057

Since O 0 0.00016892087296582758
a O 0 2.2690112018608488e-05
mutation O 0 1.196756238641683e-05
at O 0 1.8046432160190307e-05
cDNA O 0 3.708315853145905e-05
nucleotide O 0 3.2748517696745694e-05
2302 O 0 0.0006224511307664216
( O 0 7.533864845754579e-06
2302insC O 0 3.610348721849732e-05
) O 0 1.9229544250265462e-06
had O 0 2.6090654046129202e-06
been O 0 2.0544939616229385e-06
previously O 0 1.5704374618508155e-06
described O 0 2.1918974653090117e-06
, O 0 5.890280476705811e-07
this O 0 3.6473448972174083e-07
region O 0 1.8413575162412599e-06
of O 0 1.5635378076694906e-06
the O 0 9.967558980861213e-06
ATP7B O 1 0.9999860525131226
gene O 0 6.205114459589822e-06
may O 0 1.7096623423640267e-06
be O 0 8.793237498139206e-07
susceptible O 0 4.047357379022287e-06
to O 0 2.477933776390273e-06
gene O 0 2.0914332708343863e-05
rearrangements O 0 0.0042674052529037
causing O 1 0.6703863143920898
Wilson B-Disease 1 0.9986188411712646
disease I-Disease 1 0.9998863935470581
. O 0 0.0004434056463651359

Disruption O 0 0.0012040649307891726
of O 0 0.000154847206431441
splicing O 0 0.00015064235776662827
regulated O 0 3.3136810088763013e-05
by O 0 9.291776223108172e-06
a O 0 3.71635178453289e-05
CUG O 1 0.9962679743766785
- O 0 0.00020918184600304812
binding O 0 2.2239053578232415e-05
protein O 0 8.663006883580238e-05
in O 0 0.00012322784459684044
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.010861377231776714

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999463558197021
DM B-Disease 1 1.0
) O 0 0.00018584793724585325
is O 0 1.2615015293704346e-05
caused O 0 2.6329806132707745e-05
by O 0 4.204950073471991e-06
a O 0 2.1091551388963126e-05
CTG O 1 0.7560958862304688
expansion O 0 2.3190661522676237e-05
in O 0 3.2489278964931145e-06
the O 0 3.925224973500008e-06
3 O 0 1.1226059541513678e-05
untranslated O 0 6.55449039186351e-05
region O 0 1.563205114507582e-05
of O 0 1.8081575035466813e-05
the O 0 6.674573523923755e-05
DM B-Disease 1 0.9999998807907104
gene O 0 0.00027148675872012973
. O 0 0.0001313630782533437

One O 0 0.00013976235641166568
model O 0 0.00012405571760609746
of O 0 0.0005373573512770236
DM B-Disease 1 1.0
pathogenesis O 1 0.9999970197677612
suggests O 0 6.130179099272937e-05
that O 0 4.431149136507884e-06
RNAs O 0 1.6254627553280443e-05
from O 0 3.2069515327748377e-06
the O 0 1.922085402839002e-06
expanded O 0 3.545625759215909e-06
allele O 0 9.899446240524412e-07
create O 0 1.102747432923934e-06
a O 0 2.2122342215880053e-06
gain O 0 7.638884198968299e-06
- O 0 7.446604740835028e-06
of O 0 4.293081474315841e-06
- O 0 1.3151768143870868e-05
function O 0 1.4148645277600735e-06
mutation O 0 7.181947125900479e-07
by O 0 3.687911203087424e-07
the O 0 1.0505502814339707e-06
inappropriate O 0 2.319427494512638e-06
binding O 0 9.055888199327455e-07
of O 0 1.8211047745353426e-06
proteins O 0 8.396753514716693e-07
to O 0 1.4165777884045383e-06
the O 0 1.0045543604064733e-05
CUG O 1 0.6218391060829163
repeats O 0 0.0003208052658010274
. O 0 0.00012372825585771352

Data O 0 0.00011940759577555582
presented O 0 7.326161721721292e-05
here O 0 1.7864957044366747e-05
indicate O 0 6.424782441172283e-06
that O 0 1.1193719728908036e-06
the O 0 2.579972488092608e-06
conserved O 0 1.7730024410411716e-05
heterogeneous O 0 4.216454181005247e-05
nuclear O 0 0.00044415524462237954
ribonucleoprotein O 1 0.6367020010948181
, O 0 1.0040592314908281e-05
CUG O 0 0.03340194746851921
- O 0 1.792250077414792e-05
binding O 0 2.8702120289381128e-06
protein O 0 4.8147389861696865e-06
( O 0 4.473716217034962e-06
CUG O 0 0.06897733360528946
- O 0 3.468750219326466e-05
BP O 0 5.1872462790925056e-05
) O 0 2.3214545308292145e-06
, O 0 1.7808387156037497e-06
may O 0 1.952554839590448e-06
mediate O 0 1.3578460311691742e-05
the O 0 1.3783108443021774e-05
trans O 0 0.00018588000966701657
- O 0 8.118830010062084e-05
dominant O 0 2.8453529012040235e-05
effect O 0 7.261995506269159e-06
of O 0 8.138023076753598e-06
the O 0 2.069168294838164e-05
RNA O 0 0.00016655937361065298
. O 0 5.132412115926854e-05

CUG O 1 0.9997648596763611
- O 0 0.007782812230288982
BP O 0 0.0007617568480782211
was O 0 2.951242095150519e-05
found O 0 1.2824386885768035e-06
to O 0 8.566366886952892e-07
bind O 0 8.241243563134049e-07
to O 0 7.251527449625428e-07
the O 0 3.6829417240369366e-06
human O 0 1.257485018868465e-05
cardiac O 1 0.9999357461929321
troponin O 1 0.9999772310256958
T O 0 0.08454891294240952
( O 0 9.724599294713698e-06
cTNT O 0 8.15138773759827e-05
) O 0 3.932719209842617e-06
pre O 0 2.523427247069776e-05
- O 0 2.1355803255573846e-05
messenger O 0 1.744954352034256e-05
RNA O 0 8.583666385675315e-06
and O 0 1.576984004714177e-06
regulate O 0 3.032186668860959e-06
its O 0 2.4093103547784267e-06
alternative O 0 1.4252477740228642e-05
splicing O 0 9.73764545051381e-05
. O 0 9.115062857745215e-05

Splicing O 0 0.0005479506799019873
of O 0 0.00022130493016447872
cTNT O 1 0.9095153212547302
was O 0 0.03496469929814339
disrupted O 0 0.027852734550833702
in O 0 0.00018170892144553363
DM B-Disease 1 1.0
striated O 1 0.999975323677063
muscle O 0 0.015403869561851025
and O 0 3.587040964703192e-06
in O 0 2.497552031854866e-06
normal O 0 4.810906375496415e-06
cells O 0 3.234925543438294e-06
expressing O 0 4.474919478525408e-06
transcripts O 0 1.0998624020430725e-05
that O 0 2.324015213162056e-06
contain O 0 1.825287108658813e-05
CUG O 0 0.04371948540210724
repeats O 0 0.00018629075202625245
. O 0 0.00016395453712902963

Altered O 0 0.00018312827160116285
expression O 0 2.5449264285271056e-05
of O 0 1.0727667358878534e-05
genes O 0 5.561399575526593e-06
regulated O 0 9.656296242610551e-06
posttranscriptionally O 0 0.00011317650933051482
by O 0 1.4303075658972375e-05
CUG O 1 0.9996629953384399
- O 0 0.00024471041979268193
BP O 0 0.00016431858239229769
therefore O 0 3.947632649214938e-06
may O 0 3.1443507850781316e-06
contribute O 0 9.410714483237825e-06
to O 0 2.0762170606758446e-05
DM B-Disease 1 0.9999998807907104
pathogenesis O 1 0.9999492168426514
. O 0 0.00013611925533041358
. O 0 0.00017605602624826133

Identification O 0 7.923189696157351e-05
of O 0 4.509187056100927e-05
a O 0 2.543528717069421e-05
novel O 0 2.1542391550610773e-05
nonsense O 0 3.221205042791553e-05
mutation O 0 4.290949163987534e-06
and O 0 1.8428966086503351e-06
a O 0 4.0107238419295754e-06
missense O 0 1.445532871002797e-05
substitution O 0 8.393388270633295e-06
in O 0 3.620204324761289e-06
the O 0 9.173939361062367e-06
vasopressin O 0 0.00011718097084667534
- O 0 0.00016039676847867668
neurophysin O 0 0.28221940994262695
II O 1 0.9996964931488037
gene O 0 3.957825811085058e-06
in O 0 1.35374511955888e-06
two O 0 7.704222184656828e-07
Spanish O 0 8.380166946153622e-06
kindreds O 0 5.097963730804622e-05
with O 0 1.565795173519291e-05
familial B-Disease 1 0.9999969005584717
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999995231628418
. O 0 0.001934449770487845

Familial B-Disease 1 0.9999983310699463
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9997486472129822
FNDI B-Disease 1 1.0
) O 0 3.6358615034259856e-05
is O 0 3.885081241605803e-06
an O 0 4.555462055577664e-06
autosomal B-Disease 1 0.9985212683677673
dominant I-Disease 1 0.9999991655349731
disease I-Disease 1 1.0
caused O 1 0.9999954700469971
by O 0 0.023087337613105774
deficiency O 1 1.0
in O 0 5.818075078423135e-05
the O 0 0.00016925751697272062
antidiuretic O 0 0.2283405363559723
hormone O 0 3.4658140066312626e-05
arginine O 0 1.9588849681895226e-05
vasopressin O 0 2.251557816634886e-05
( O 0 3.497784291539574e-06
AVP O 0 6.232329178601503e-05
) O 0 1.0818980626936536e-06
encoded O 0 1.3783353551843902e-06
by O 0 1.165263256552862e-06
the O 0 5.52257461094996e-06
AVP O 1 0.648968517780304
- O 0 0.00014124816516414285
neurophysin O 1 0.5365630984306335
II O 1 0.9999961853027344
( O 0 0.00014039079542271793
AVP O 1 0.9978487491607666
- O 0 0.00018637851462699473
NPII O 0 0.4922874867916107
) O 0 8.506543053954374e-06
gene O 0 6.234054126252886e-06
on O 0 9.750582648848649e-06
chromosome O 0 9.42736369324848e-05
20p13 O 0 0.0005493739154189825
. O 0 0.00013074323942419142

In O 0 5.700709516531788e-05
this O 0 7.673230356886052e-06
study O 0 7.144502887967974e-06
, O 0 2.1624352939397795e-06
we O 0 8.584006536693778e-07
analyzed O 0 1.0705393833632115e-06
two O 0 3.0549173857252754e-07
families O 0 9.004844514493016e-07
with O 0 1.5638404420315055e-06
FNDI B-Disease 1 0.9997366070747375
using O 0 2.4707085231057135e-06
direct O 0 2.924411091953516e-06
automated O 0 9.38890480028931e-06
fluorescent O 0 3.667708597276942e-06
, O 0 1.010462597150763e-06
solid O 0 4.013853867945727e-06
phase O 0 1.0609292075969279e-05
, O 0 1.6101892015285557e-06
single O 0 2.2021454242349137e-06
- O 0 4.2600463530106936e-06
stranded O 0 3.7870001960982336e-06
DNA O 0 1.6213887192861876e-06
sequencing O 0 1.6023876696635853e-06
of O 0 2.31721242016647e-06
PCR O 0 3.2121803087648004e-05
- O 0 3.719592859852128e-05
amplified O 0 0.00012923711619805545
AVP O 0 0.1325312703847885
- O 0 0.00022171108867041767
NPII O 0 0.24854983389377594
DNA O 0 0.00014098509564064443
. O 0 0.00010379579907748848

In O 0 5.928227255935781e-05
one O 0 1.154593610408483e-05
of O 0 1.414059352100594e-05
the O 0 7.504292170779081e-06
families O 0 5.466215498017846e-06
, O 0 3.5915525131713366e-06
affected O 0 3.3181293019879377e-06
individuals O 0 1.372430233459454e-06
presented O 0 9.446645890420768e-06
a O 0 1.42392727866536e-05
novel O 0 2.0786994355148636e-05
nonsense O 0 3.334596840431914e-05
mutation O 0 3.973483671870781e-06
in O 0 2.943086428786046e-06
exon O 0 2.2268297470873222e-05
3 O 0 4.25615598942386e-06
of O 0 2.710458829824347e-06
the O 0 2.2468959741672734e-06
gene O 0 2.770076889646589e-06
, O 0 8.592156177655852e-07
consisting O 0 1.467801212129416e-06
in O 0 1.127667246691999e-06
a O 0 3.1519377898803214e-06
G O 0 1.6505528037669137e-05
to O 0 2.7584196686802898e-06
T O 0 2.5890851247822866e-05
transition O 0 8.957412319432478e-06
at O 0 1.2474743925849907e-05
nucleotide O 0 1.6500443962286226e-05
2101 O 0 7.643244316568598e-05
, O 0 1.2906652955280151e-06
which O 0 6.857363246126624e-07
produces O 0 7.524333796027349e-07
a O 0 8.922694973989564e-07
stop O 0 1.8092658820023644e-06
signal O 0 2.623721911731991e-06
in O 0 9.121388870880764e-07
codon O 0 7.684419870201964e-06
82 O 0 2.5150426154141314e-05
( O 0 9.945294550561812e-06
Glu O 0 0.0009955381974577904
) O 0 1.0618584383337293e-05
of O 0 5.321607386576943e-05
NPII O 1 0.9607243537902832
. O 0 0.0002450723259244114

The O 0 0.00011766557872761041
premature O 0 0.0003792800416704267
termination O 0 0.00026033385074697435
eliminates O 0 9.272797615267336e-05
part O 0 1.9055503798881546e-05
of O 0 8.175127732101828e-06
the O 0 9.364893230667803e-06
C O 0 0.006631656549870968
- O 0 5.535880336537957e-05
terminal O 0 4.924462336930446e-05
domain O 0 6.0078991737100296e-06
of O 0 7.62599347581272e-06
NPII O 1 0.7504311800003052
, O 0 1.9339152004249627e-06
including O 0 8.344395041604002e-07
a O 0 2.186575784435263e-06
cysteine O 0 2.760588131422992e-06
residue O 0 3.2983195978886215e-06
in O 0 6.640714218519861e-07
position O 0 1.6007915064619738e-06
85 O 0 1.9758042526518693e-06
, O 0 6.929612368367088e-07
which O 0 2.5486068011559837e-07
could O 0 2.653692661169771e-07
be O 0 2.962820531138277e-07
involved O 0 8.353463840649056e-07
in O 0 6.8467511482595e-07
the O 0 2.6355864974902943e-06
correct O 0 9.27297423913842e-06
folding O 0 0.00022893147252034396
of O 0 3.9847116568125784e-05
the O 0 0.00012215944298077375
prohormone O 1 0.997444748878479
. O 0 0.00020067479636054486

In O 0 0.00012556409637909383
the O 0 5.0206403102492914e-05
second O 0 6.580556510016322e-05
family O 0 2.7874377337866463e-05
, O 0 4.839080702367937e-06
a O 0 8.283895112981554e-06
G279A O 0 5.39703578397166e-05
substitution O 0 6.746693543391302e-06
at O 0 7.841324077162426e-06
position O 0 5.3388680498756e-06
- O 0 4.211877694615396e-06
1 O 0 2.9951665965199936e-06
of O 0 1.781358491825813e-06
the O 0 2.78816287391237e-06
signal O 0 1.669874654908199e-05
peptide O 0 1.701909968687687e-05
was O 0 1.0964556167891715e-05
observed O 0 2.977747271870612e-06
in O 0 1.7720325331538334e-06
all O 0 1.929606241901638e-06
affected O 0 8.60306499816943e-06
individuals O 0 1.4999835912021808e-05
. O 0 7.72487255744636e-05

This O 0 7.358144648605958e-05
missense O 0 0.000213901192182675
mutation O 0 2.5980807549785823e-05
, O 0 9.382164535054471e-06
which O 0 6.301742359937634e-06
replaces O 0 0.00026701297610998154
Ala O 0 0.3235875368118286
with O 0 1.058340239978861e-05
Thr O 1 0.9998784065246582
, O 0 7.820450264262035e-06
is O 0 4.028810508316383e-06
frequent O 0 5.235765456745867e-06
among O 0 1.764777334756218e-05
FNDI B-Disease 1 1.0
patients O 0 9.722223330754787e-05
and O 0 2.0389468318171566e-06
is O 0 1.6724872011764091e-06
thought O 0 1.0339533673686674e-06
to O 0 3.252438887102471e-07
reduce O 0 8.2499332165753e-07
the O 0 1.1070654863942764e-06
efficiency O 0 5.476641035784269e-06
of O 0 4.3454479055071715e-06
cleavage O 0 4.618272214429453e-05
by O 0 1.02827843875275e-05
signal O 0 8.601975423516706e-05
peptidases O 0 0.00034483472700230777
. O 0 2.449124622216914e-05
. O 0 5.569775385083631e-05

Genetic O 0 0.0006139591569080949
heterogeneity O 0 0.000709890911821276
of O 0 0.0016485921805724502
Saethre B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999986886978149
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 2.7858455723617226e-05
due O 0 2.1003717847634107e-05
to O 0 7.845041182008572e-06
TWIST O 0 0.0007221106789074838
and O 0 4.058823105879128e-05
FGFR O 1 0.9996354579925537
mutations O 0 0.00018146721413359046
. O 0 0.0001535246119601652

Thirty O 0 0.0012668423587456346
- O 0 0.0001855989539762959
two O 0 6.147502972453367e-06
unrelated O 0 3.4405034966766834e-05
patients O 0 6.299290816969005e-06
with O 0 1.8627641793500516e-06
features O 0 5.985047209833283e-06
of O 0 0.0005422389949671924
Saethre B-Disease 1 1.0
- I-Disease 1 0.9999991655349731
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 4.921664367429912e-05
a O 0 4.267977055860683e-05
common O 0 2.014523124671541e-05
autosomal B-Disease 0 0.2246188074350357
dominant I-Disease 1 0.9487941861152649
condition I-Disease 1 0.9957180619239807
of O 1 0.9996672868728638
craniosynostosis B-Disease 1 1.0
and O 1 0.9969417452812195
limb B-Disease 1 0.9999996423721313
anomalies I-Disease 1 0.9936366081237793
, O 0 5.923092430748511e-06
were O 0 1.8604971501190448e-06
screened O 0 3.193452812411124e-06
for O 0 1.1078344641646254e-06
mutations O 0 2.0498066533036763e-06
in O 0 3.616798494476825e-06
TWIST O 0 0.0006975598516874015
, O 0 1.3874237993150018e-05
FGFR2 O 1 0.9784988760948181
, O 0 1.2852833606302738e-05
and O 0 2.0140831111348234e-05
FGFR3 O 1 0.9656594395637512
. O 0 0.00015115144196897745

Nine O 0 0.0005408218712545931
novel O 0 0.0002075282100122422
and O 0 1.5551016986137256e-05
three O 0 1.9676810552482493e-05
recurrent O 0 0.003392726182937622
TWIST O 0 0.0007433018181473017
mutations O 0 9.885334293358028e-06
were O 0 5.23237122251885e-06
found O 0 3.2574630495219026e-06
in O 0 5.681150923919631e-06
12 O 0 2.458585731801577e-05
families O 0 3.9656242734054103e-05
. O 0 0.00013892924471292645

Seven O 0 0.0001099549699574709
families O 0 1.826612242439296e-05
were O 0 8.6371637735283e-06
found O 0 3.4807469546649372e-06
to O 0 1.5522005014645401e-06
have O 0 9.496926622887258e-07
the O 0 4.397949396661716e-06
FGFR3 O 1 0.9998918771743774
P250R O 0 0.0020062203984707594
mutation O 0 4.8107181100931484e-06
, O 0 1.562840111546393e-06
and O 0 6.754282821930246e-07
one O 0 6.548735882461187e-07
individual O 0 4.831762225876446e-07
was O 0 5.42528096048045e-06
found O 0 6.650683417319669e-07
to O 0 4.1056063082578476e-07
have O 0 6.191143029354862e-07
an O 0 5.10010158905061e-06
FGFR2 O 1 0.9880465269088745
VV269 O 0 0.0012721051461994648
- O 0 7.973030733410269e-05
270 O 0 6.632216536672786e-05
deletion O 0 0.00020671103266067803
. O 0 0.00011396079207770526

To O 0 3.237168857594952e-05
date O 0 3.1537918403046206e-05
, O 0 4.759775492857443e-06
our O 0 1.5822835166545701e-06
detection O 0 2.4210269202740164e-06
rate O 0 1.810018261494406e-06
for O 0 1.2405428151396336e-06
TWIST O 0 4.1290168155683205e-05
or O 0 3.2254467896564165e-06
FGFR O 1 0.5731090307235718
mutations O 0 3.453501449257601e-06
is O 0 1.0719369356593234e-06
68 O 0 3.501889750623377e-06
% O 0 1.1517346365508274e-06
in O 0 2.808460521919187e-06
our O 0 6.9043539951962885e-06
Saethre B-Disease 1 0.9999361038208008
- I-Disease 1 0.9998255372047424
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.013790992088615894
, O 0 5.122768470755545e-06
including O 0 1.6981964563456131e-06
our O 0 2.5965348413592437e-06
five O 0 2.444181518512778e-06
patients O 0 4.615132638718933e-06
elsewhere O 0 3.850773737212876e-06
reported O 0 4.459043339011259e-06
with O 0 6.31482134849648e-06
TWIST O 0 0.003960775677114725
mutations O 0 9.286106796935201e-05
. O 0 9.07771973288618e-05

More O 0 2.593946373963263e-05
than O 0 3.6834685488429386e-06
35 O 0 8.609909855294973e-06
different O 0 1.153951075139048e-06
TWIST O 0 3.0561339372070506e-05
mutations O 0 3.6280778203945374e-06
are O 0 7.921188966975024e-07
now O 0 1.9291242097096983e-06
known O 0 3.206446990589029e-06
in O 0 2.9163845738366945e-06
the O 0 7.395909051410854e-06
literature O 0 5.8068562793778256e-05
. O 0 4.994285700377077e-05

The O 0 7.390894461423159e-05
most O 0 1.7364416635246016e-05
common O 0 9.004964340419974e-06
phenotypic O 0 2.2110652935225517e-05
features O 0 8.450097993772943e-06
, O 0 2.207298621215159e-06
present O 0 1.3072025240035146e-06
in O 0 1.272956296816119e-06
more O 0 2.3102674617803132e-07
than O 0 2.972975892134855e-07
a O 0 9.148866979558079e-07
third O 0 2.1749353891209466e-06
of O 0 2.3963150397321442e-06
our O 0 2.6726343094196636e-06
patients O 0 2.976330733872601e-06
with O 0 1.4591118997486774e-06
TWIST O 0 0.004860991612076759
mutations O 0 6.698227480228525e-06
, O 0 1.926454842759995e-06
are O 0 6.607769478250702e-07
coronal B-Disease 0 0.0005560661084018648
synostosis I-Disease 0 0.013099048286676407
, O 0 5.9225781114946585e-06
brachycephaly B-Disease 0 0.00047776431892998517
, O 0 4.172211447439622e-06
low B-Disease 0 4.4723576138494536e-05
frontal I-Disease 1 0.9985520243644714
hairline I-Disease 1 0.9999994039535522
, O 0 0.00016925558156799525
facial B-Disease 1 0.9929965138435364
asymmetry I-Disease 1 0.9991598129272461
, O 0 0.0008334112935699522
ptosis B-Disease 1 0.9999914169311523
, O 0 9.546615183353424e-05
hypertelorism B-Disease 1 0.9973313808441162
, O 0 1.4094483049120754e-05
broad B-Disease 0 0.00012057108688168228
great I-Disease 0 0.44252559542655945
toes I-Disease 0 0.12018854171037674
, O 0 9.89155796560226e-06
and O 0 1.7652233509579673e-05
clinodactyly B-Disease 0 0.1017337217926979
. O 0 0.00017717404989525676

Significant O 0 0.000891940901055932
intra O 0 0.011138645000755787
- O 0 0.0006239889189600945
and O 0 1.9708739273482934e-05
interfamilial O 0 0.0006647605332545936
phenotypic O 0 3.234756150050089e-05
variability O 0 3.0154526029946283e-05
is O 0 3.696513658724143e-06
present O 0 2.126543677150039e-06
for O 0 2.23419510803069e-06
either O 0 5.432342277345015e-06
TWIST O 0 0.0001531135058030486
mutations O 0 1.5314537449739873e-05
or O 0 1.6826377759571187e-05
FGFR O 1 0.9965115189552307
mutations O 0 0.00015809532487764955
. O 0 0.00011724959767889231

The O 0 8.988370245788246e-05
overlap O 0 4.2272677092114463e-05
in O 0 1.2491969755501486e-05
clinical O 0 3.9162721805041656e-05
features O 0 9.384221812069882e-06
and O 0 2.0396296349645127e-06
the O 0 2.8631038730964065e-06
presence O 0 4.0898444240156095e-06
, O 0 6.139449624242843e-07
in O 0 4.107329516500613e-07
the O 0 5.531638862521504e-07
same O 0 5.11466680563899e-07
genes O 0 3.9273714946830296e-07
, O 0 3.274923301432864e-07
of O 0 4.0092299968819134e-07
mutations O 0 3.0432249786827015e-07
for O 0 3.5560924516175874e-07
more O 0 2.7231132548877213e-07
than O 0 4.311033023896016e-07
one O 0 1.1529039056767942e-06
craniosynostotic B-Disease 0 0.0006520992028526962
condition I-Disease 0 1.6654914361424744e-05
- O 0 1.1255227036599535e-05
such O 0 1.970080575119937e-06
as O 0 1.2739538760797586e-05
Saethre B-Disease 1 0.9950413107872009
- I-Disease 0 0.0002526658936403692
Chotzen I-Disease 0 0.20364469289779663
, I-Disease 0 3.7210177197266603e-06
Crouzon I-Disease 0 0.0028091082349419594
, I-Disease 0 2.521323040127754e-06
and I-Disease 0 4.339757651905529e-06
Pfeiffer I-Disease 1 0.999974250793457
syndromes I-Disease 1 0.9998144507408142
- O 0 0.00025003173504956067
support O 0 5.315822363627376e-06
the O 0 5.214219527260866e-06
hypothesis O 0 6.34220987194567e-06
that O 0 1.1901819334525499e-06
TWIST O 0 1.2168235116405413e-05
and O 0 1.472106305300258e-06
FGFRs O 0 6.1448932683561e-05
are O 0 4.6505573436661507e-07
components O 0 1.5585163737341645e-06
of O 0 1.296162963626557e-06
the O 0 1.3672361092176288e-06
same O 0 1.263158424080757e-06
molecular O 0 5.598484676738735e-06
pathway O 0 4.716275725513697e-06
involved O 0 9.512163501312898e-07
in O 0 6.977251700845954e-07
the O 0 1.390537477163889e-06
modulation O 0 3.591284257709049e-05
of O 0 0.001245694700628519
craniofacial O 1 1.0
and O 0 0.14543694257736206
limb O 1 0.9999878406524658
development O 0 0.00016297446563839912
in O 0 2.008149203902576e-05
humans O 0 1.4146043213258963e-05
. O 0 9.18036403163569e-06
. O 0 3.8550697354367e-05

Mutation O 0 0.00013267480244394392
analysis O 0 3.4204953408334404e-05
of O 0 0.00012301030801609159
UBE3A O 1 0.9999985694885254
in O 1 0.99936443567276
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999967813491821
. O 0 0.09449614584445953

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9991554021835327
AS B-Disease 1 0.9999481439590454
) O 0 9.15034888748778e-06
is O 0 2.5395404463779414e-06
caused O 0 1.0038437721959781e-05
by O 0 5.630557552649407e-06
chromosome O 0 0.00024979060981422663
15q11 O 0 0.14081288874149323
- O 0 0.0001400411711074412
q13 O 0 0.0001367714867228642
deletions O 0 1.234459978149971e-05
of O 0 6.71488169246004e-06
maternal O 0 3.0625873478129506e-05
origin O 0 5.579099706665147e-06
, O 0 3.6144056139164604e-06
by O 0 3.1607301025360357e-06
paternal O 0 0.0014171049697324634
uniparental B-Disease 1 0.9999980926513672
disomy I-Disease 1 0.9999324083328247
( O 0 0.0002056658995570615
UPD B-Disease 1 0.9999786615371704
) O 0 7.940422619867604e-06
15 O 0 4.329571765993023e-06
, O 0 2.150166892533889e-06
by O 0 2.020222382270731e-06
imprinting O 0 0.0006010946817696095
defects O 0 0.04898068681359291
, O 0 2.208264959335793e-06
and O 0 7.538483259850182e-07
by O 0 8.700595799382427e-07
mutations O 0 2.6052612156490795e-06
in O 0 3.6348969842947554e-06
the O 0 2.6031179004348814e-05
UBE3A O 1 0.9996376037597656
gene O 0 9.30746246012859e-05
. O 0 6.674624455627054e-05

UBE3A O 0 0.12448449432849884
encodes O 0 0.0003312312765046954
a O 0 8.974717638920993e-05
ubiquitin O 0 0.0003208300331607461
- O 0 0.00011374994937796146
protein O 0 2.0309424144215882e-05
ligase O 0 3.8665490137645975e-05
and O 0 4.603615252563031e-06
shows O 0 1.3331461559573654e-05
brain O 0 0.00014283675409387797
- O 0 3.6243509384803474e-05
specific O 0 1.3652003872266505e-05
imprinting O 0 0.000539187400136143
. O 0 0.00019141341908834875

Here O 0 0.00023936395882628858
we O 0 4.705642277258448e-05
describe O 0 7.421976624755189e-05
UBE3A O 0 0.11744027584791183
coding O 0 0.00012875899847131222
- O 0 5.932473868597299e-05
region O 0 1.8504695617593825e-05
mutations O 0 6.074179964343784e-06
detected O 0 9.234824574377853e-06
by O 0 2.965640533147962e-06
SSCP O 0 0.0008585920440964401
analysis O 0 3.3098931453423575e-06
in O 0 3.4953400245285593e-06
13 O 0 2.0008999854326248e-05
AS B-Disease 0 0.00033414666540920734
individuals O 0 5.210431936575333e-06
or O 0 8.574020284868311e-06
families O 0 2.8877819204353727e-05
. O 0 5.845570194651373e-05

Two O 0 6.656687037320808e-05
identical O 0 5.017443254473619e-05
de O 0 0.00020088269957341254
novo O 0 0.00018259993521496654
5 O 0 8.146034087985754e-05
- O 0 9.77251838776283e-05
bp O 0 0.00010145777196157724
duplications O 0 8.45557005959563e-05
in O 0 1.0639628271746915e-05
exon O 0 5.864319246029481e-05
16 O 0 2.0287356164772063e-05
were O 0 1.963927934411913e-05
found O 0 3.098385423072614e-05
. O 0 7.708521297900006e-05

Among O 0 6.70083609293215e-05
the O 0 1.8147635273635387e-05
other O 0 3.1479364679398714e-06
11 O 0 5.698921995644923e-06
unique O 0 3.247246013415861e-06
mutations O 0 4.407463620736962e-06
, O 0 2.1850289613212226e-06
8 O 0 5.733342277380871e-06
were O 0 2.76509899777011e-06
small O 0 2.6472141598787857e-06
deletions O 0 8.224682460422628e-06
or O 0 2.986529580084607e-06
insertions O 0 2.006906652241014e-05
predicted O 0 8.29762029752601e-06
to O 0 2.163751332773245e-06
cause O 0 8.570390491513535e-06
frameshifts O 0 8.109752525342628e-05
, O 0 2.349042915739119e-06
1 O 0 5.702994258172112e-06
was O 0 9.718833098304458e-06
a O 0 2.159582891181344e-06
mutation O 0 1.1160016128997086e-06
to O 0 5.749937486143608e-07
a O 0 1.3891165053792065e-06
stop O 0 2.477768475728226e-06
codon O 0 2.2264102881308645e-06
, O 0 8.18099465504929e-07
1 O 0 1.4256188478611875e-06
was O 0 5.107407105242601e-06
a O 0 2.0525178570096614e-06
missense O 0 7.803332664479967e-06
mutation O 0 1.4312148550743586e-06
, O 0 9.700763712316984e-07
and O 0 6.159547751849459e-07
1 O 0 5.7580436987336725e-06
was O 0 1.6270229025394656e-05
predicted O 0 3.96022733184509e-06
to O 0 7.040409286673821e-07
cause O 0 3.35124150296906e-06
insertion O 0 6.544961252075154e-06
of O 0 4.041016836708877e-06
an O 0 3.6181957057124237e-06
isoleucine O 0 0.00013957802730146796
in O 0 3.5378704978938913e-06
the O 0 5.263967977953143e-06
hect O 0 0.00017332517018076032
domain O 0 6.382522315107053e-06
of O 0 5.028805389883928e-06
the O 0 7.720183020865079e-06
UBE3A O 0 0.2930072844028473
protein O 0 7.815544449840672e-06
, O 0 1.33363971599465e-06
which O 0 7.454878527823894e-07
functions O 0 2.1532778191613033e-06
in O 0 4.952559720550198e-06
E2 O 0 0.00047108856961131096
binding O 0 1.447716658731224e-05
and O 0 1.3648125786858145e-05
ubiquitin O 0 0.0001220560516230762
transfer O 0 0.00013876243610866368
. O 0 0.0002232719853054732

Eight O 0 0.00012391159543767571
of O 0 3.935493077733554e-05
the O 0 1.4874197404424194e-05
cases O 0 9.424751624464989e-06
were O 0 1.3909398148825858e-05
familial O 0 0.009564673528075218
, O 0 1.4634942999691702e-05
and O 0 5.028488885727711e-06
five O 0 6.8406693571887445e-06
were O 0 2.0854842659900896e-05
sporadic O 0 0.0002753022126853466
. O 0 0.00019294604135211557

In O 0 6.985844083828852e-05
two O 0 1.4660799934063107e-05
familial O 0 0.011515279300510883
cases O 0 1.1616422852966934e-05
and O 0 4.730582077172585e-06
one O 0 3.4762085761030903e-06
sporadic O 0 1.3622573533211835e-05
case O 0 7.352315151365474e-06
, O 0 3.5144357752869837e-06
mosaicism O 0 0.03878570720553398
for O 0 6.268906417972175e-06
UBE3A O 1 0.9979852437973022
mutations O 0 8.206036000046879e-06
was O 0 9.33491719479207e-06
detected O 0 3.5997409213450737e-06
in O 0 1.0174284170716419e-06
the O 0 1.5633186194463633e-06
mother O 0 5.00595251651248e-06
of O 0 2.636247700138483e-06
three O 0 2.5260596885345876e-06
AS B-Disease 0 0.07251919060945511
sons O 0 0.00013866998779121786
, O 0 1.712549078547454e-06
in O 0 1.0181360039496212e-06
the O 0 2.24654036173888e-06
maternal O 0 6.23800078756176e-05
grandfather O 0 0.00013003034109715372
of O 0 5.026791768614203e-06
two O 0 1.8725389736573561e-06
AS B-Disease 0 0.0006766652222722769
first O 0 4.891991011390928e-06
cousins O 0 5.535208401852287e-06
, O 0 1.1313318282191176e-06
and O 0 3.1329238936450565e-07
in O 0 5.664584250553162e-07
the O 0 1.6300183460771223e-06
mother O 0 8.554483429179527e-06
of O 0 5.600380518444581e-06
an O 0 1.72970521816751e-05
AS B-Disease 1 0.9770522117614746
daughter O 0 0.1058475524187088
. O 0 0.00016880898328963667

The O 0 3.3211912523256615e-05
frequencies O 0 1.2316038919379935e-05
with O 0 3.4630459140316816e-06
which O 0 1.4235523622119217e-06
we O 0 1.4503328884529765e-06
detected O 0 2.8582915092556505e-06
mutations O 0 1.11789017864794e-06
were O 0 1.3445123840938322e-06
5 O 0 3.52907204614894e-06
( O 0 1.3289826483742218e-06
14 O 0 2.3077818696037866e-06
% O 0 1.3412146699920413e-06
) O 0 8.740431667320081e-07
of O 0 1.122493472394126e-06
35 O 0 2.4369639959331835e-06
in O 0 1.2435372127583832e-06
sporadic O 0 3.543276307027554e-06
cases O 0 6.201271389727481e-07
and O 0 7.674962034798227e-07
8 O 0 4.450766937225126e-06
( O 0 1.3025770613239729e-06
80 O 0 1.981268496820121e-06
% O 0 1.4657981637355988e-06
) O 0 1.2731019296552404e-06
of O 0 1.5564814930257853e-06
10 O 0 3.6317853755463148e-06
in O 0 4.225073098496068e-06
familial O 0 0.00023705752391833812
cases O 0 1.6650275938445702e-05
. O 0 2.5530818675179034e-05
. O 0 7.410944817820564e-05

The O 0 0.0013716422254219651
hemochromatosis B-Disease 1 0.9999997615814209
845 O 1 0.9989563226699829
G O 1 0.9625670313835144
- O 0 0.0008862278191372752
- O 0 9.3731505330652e-05
> O 0 3.436241240706295e-05
A O 0 2.6382816940895282e-05
and O 0 3.276130883023143e-06
187 O 0 8.304713446705136e-06
C O 0 5.5580920161446556e-05
- O 0 2.725936792558059e-05
- O 0 2.088005749101285e-05
> O 0 2.9997750971233472e-05
G O 0 5.395785046857782e-05
mutations O 0 5.567565494857263e-06
: O 0 4.27581881012884e-06
prevalence O 0 2.4936653062468395e-05
in O 0 1.1154312232974917e-05
non O 0 5.245176362222992e-05
- O 0 0.00024621759075671434
Caucasian O 0 0.00591654609888792
populations O 0 8.017181971808895e-05
. O 0 9.135808068094775e-05

Hemochromatosis B-Disease 1 0.9999986886978149
, O 0 0.00031155243050307035
the O 0 0.06958918273448944
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 0.9999691247940063
, O 0 3.4654174669412896e-05
leads O 0 3.5050950828008354e-05
, O 0 3.740828788068029e-06
if O 0 2.1530208869080525e-06
untreated O 1 0.7161427736282349
, O 0 9.084961675398517e-06
to O 0 1.481085655541392e-05
progressive O 1 0.999994158744812
iron B-Disease 1 1.0
overload I-Disease 1 0.9999990463256836
and O 0 9.920370939653367e-05
premature B-Disease 0 0.06922664493322372
death I-Disease 0 0.0007719568093307316
. O 0 7.276303949765861e-05

The O 0 0.00360698951408267
hemochromatosis B-Disease 1 1.0
gene O 0 0.013429739512503147
, O 0 0.00017520948313176632
HFE O 1 0.9996084570884705
, O 0 1.982342109840829e-05
recently O 0 8.990893547888845e-06
has O 0 1.1662693850666983e-06
been O 0 1.2498886690082145e-06
identified O 0 1.4661727618658915e-06
, O 0 7.206247687463474e-07
and O 0 5.411765187091078e-07
characterization O 0 2.3563034119433723e-06
of O 0 1.1802803783211857e-06
this O 0 6.248776003303647e-07
gene O 0 1.128970438912802e-06
has O 0 4.935299671160465e-07
shown O 0 4.269252258382039e-07
that O 0 9.71735900634485e-08
it O 0 1.288018864897822e-07
contains O 0 3.1063828487276623e-07
two O 0 2.3049261699270573e-07
mutations O 0 4.752322979584278e-07
that O 0 2.353504555685504e-07
result O 0 7.058716278152133e-07
in O 0 9.511093139735749e-07
amino O 0 1.2567541034513852e-06
acid O 0 2.611213631098508e-06
substitutions O 0 6.047937858966179e-06
- O 0 1.545948180137202e-05
cDNA O 0 2.34098424698459e-05
nucleotides O 0 8.42179542814847e-06
845 O 0 4.269744022167288e-05
G O 0 5.750434138462879e-05
- O 0 2.0438359570107423e-05
- O 0 9.449375284020789e-06
> O 0 1.2440196769603062e-05
A O 0 1.2432536095730029e-05
( O 0 3.548172799128224e-06
C282Y O 0 2.7316487830830738e-05
) O 0 1.2720388440357056e-06
and O 0 7.050421118037775e-07
187 O 0 5.198430244490737e-06
C O 0 3.0501501896651462e-05
- O 0 2.0071440303581767e-05
- O 0 3.31314695358742e-05
> O 0 4.8706497182138264e-05
G O 0 0.00020540214609354734
( O 0 3.0460252673947252e-05
H63D O 0 0.09066999703645706
) O 0 4.781561074196361e-05
. O 0 7.148142321966588e-05

Although O 0 0.0022651238832622766
hemochromatosis B-Disease 1 1.0
is O 0 5.934749060543254e-05
common O 0 8.261779839813244e-06
in O 0 7.322464171011234e-06
Caucasians O 0 0.00013137597125023603
, O 0 5.224916549195768e-06
affecting O 0 7.20797834219411e-06
> O 0 1.6936977772274986e-05
= O 0 1.117850661103148e-05
1 O 0 1.0296208529325668e-05
/ O 0 8.52339235279942e-06
300 O 0 2.1498756268556463e-06
individuals O 0 4.851002017858264e-07
of O 0 1.5549813952020486e-06
northern O 0 2.6716404590843013e-06
European O 0 1.3697849681193475e-06
origin O 0 8.149487484843121e-07
, O 0 1.078386276276433e-06
it O 0 6.156053586892085e-07
has O 0 4.779903974849731e-07
not O 0 3.312121066301188e-07
been O 0 1.1405963959987275e-06
recognized O 0 2.041550487774657e-06
in O 0 3.1278207188734086e-06
other O 0 4.222334155201679e-06
populations O 0 2.48214892053511e-05
. O 0 7.241120329126716e-05

The O 0 6.57469718134962e-05
present O 0 1.8576425645733252e-05
study O 0 6.93737592882826e-06
used O 0 2.650687747518532e-06
PCR O 0 8.60695399751421e-06
and O 0 1.5082310937941656e-06
restriction O 0 4.407396318129031e-06
- O 0 7.287610060302541e-06
enzyme O 0 2.0934987787768478e-06
digestion O 0 2.072191819024738e-06
to O 0 2.835410839452379e-07
analyze O 0 6.817872986175644e-07
the O 0 3.160764379117609e-07
frequency O 0 4.935553761242772e-07
of O 0 1.0655595588104916e-06
the O 0 2.8256704354134854e-06
845 O 0 0.00011603170423768461
G O 0 0.00010542837117100134
- O 0 2.176493580918759e-05
- O 0 1.0115731129189953e-05
> O 0 1.5571016774629243e-05
A O 0 1.2413318472681567e-05
and O 0 2.6514360342844157e-06
187 O 0 1.3648880667460617e-05
C O 0 4.2928772018058226e-05
- O 0 2.6758409148897044e-05
- O 0 1.836106093833223e-05
> O 0 3.0268329282989725e-05
G O 0 6.172495341161266e-05
mutations O 0 6.43278326606378e-06
in O 0 1.2777636584360152e-05
HLA O 1 0.7241742014884949
- O 0 2.1546933567151427e-05
typed O 0 4.70405802843743e-06
samples O 0 1.0819330782396719e-06
from O 0 1.9320000319567043e-06
non O 0 1.0716347787820268e-05
- O 0 2.1226120225037448e-05
Caucasian O 0 4.723297752207145e-05
populations O 0 1.8828104657586664e-06
, O 0 1.0088891713166959e-06
comprising O 0 2.7099933959107148e-06
Australian O 0 6.125681011326378e-06
Aboriginal O 0 9.719454283185769e-06
, O 0 3.0399783099710476e-06
Chinese O 0 7.291078873095103e-06
, O 0 2.356355025767698e-06
and O 0 6.032798864907818e-06
Pacific O 0 0.00011569693015189841
Islanders O 0 0.00017259229207411408
. O 0 8.762976358411834e-05

Results O 0 8.107488247333094e-05
showed O 0 5.7687837397679687e-05
that O 0 3.0087423965596827e-06
the O 0 7.05233696862706e-06
845 O 0 0.0014757995959371328
G O 0 0.027735766023397446
- O 0 0.00027096515987068415
- O 0 4.3869538785656914e-05
> O 0 1.6445912478957325e-05
A O 0 8.675054232298862e-06
mutation O 0 1.8264216805619071e-06
was O 0 3.12252745970909e-06
present O 0 4.851760309065867e-07
in O 0 6.299972596934822e-07
these O 0 2.5193639885401353e-07
populations O 0 3.7414423559312127e-07
( O 0 3.7931161500637245e-07
allele O 0 4.654737040254986e-07
frequency O 0 4.7500938649136515e-07
0 O 0 1.1377434248061036e-06
. O 0 4.202967147648451e-07
32 O 0 1.065611286321655e-06
% O 0 9.996365406550467e-07
) O 0 1.1206740282432293e-06
, O 0 6.268963375077874e-07
and O 0 5.627055656987068e-07
, O 0 5.880767162125267e-07
furthermore O 0 9.170985322271008e-07
, O 0 3.0859294497531664e-07
it O 0 1.6995058160773624e-07
was O 0 2.7503554065333446e-06
always O 0 8.456584055238636e-07
seen O 0 5.68318682780955e-07
in O 0 4.837285700887151e-07
conjunction O 0 4.1763714762055315e-06
with O 0 7.0456817411468364e-06
HLA O 1 0.9999973773956299
haplotypes O 0 0.0003433107922319323
common O 0 5.249529749562498e-06
in O 0 4.6203290366975125e-06
Caucasians O 0 3.993183054262772e-05
, O 0 3.640117483882932e-06
suggesting O 0 5.713822247344069e-06
that O 0 1.6809716498755733e-06
845 O 0 9.82420751824975e-05
G O 0 0.0005740727647207677
- O 0 6.550466059707105e-05
- O 0 2.5840163289103657e-05
> O 0 1.262375371879898e-05
A O 0 1.4637734238931444e-05
may O 0 1.980592287509353e-06
have O 0 2.328442576526868e-07
been O 0 5.867451022822934e-07
introduced O 0 1.0416047189210076e-06
into O 0 4.795107884092431e-07
these O 0 2.1274676953453309e-07
populations O 0 7.867855060794682e-07
by O 0 2.9942068522359477e-06
Caucasian O 0 0.00021259016648400575
admixture O 0 0.0006548235542140901
. O 0 0.00016568577848374844

187 O 0 0.0016460142796859145
C O 0 0.0017013062024489045
- O 0 0.0003655526670627296
- O 0 0.00010555652261245996
> O 0 4.463486766326241e-05
G O 0 4.827552038477734e-05
was O 0 1.2422793588484637e-05
present O 0 2.0162074179097544e-06
at O 0 2.275715587529703e-06
an O 0 1.0027932830780628e-06
allele O 0 2.310715444764355e-06
frequency O 0 2.780459453788353e-06
of O 0 1.1532137250469532e-05
2 O 0 8.14329250715673e-05
. O 0 8.124846499413252e-05

68 O 0 0.0003327730228193104
% O 0 3.1960284104570746e-05
in O 0 1.2643054105865303e-05
the O 0 5.1963779696961865e-06
two O 0 1.71526073700079e-06
populations O 0 2.9350983368203742e-06
analyzed O 0 5.4295514928526245e-06
( O 0 3.986068804806564e-06
Australian O 0 1.5479901776416227e-05
Aboriginal O 0 2.0841538571403362e-05
and O 0 6.616573955398053e-06
Chinese O 0 4.6582528739236295e-05
) O 0 3.293989357189275e-05
. O 0 5.016993236495182e-05

In O 0 0.00011635911505436525
the O 0 3.324030330986716e-05
Australian O 0 3.797932367888279e-05
Aboriginal O 0 2.1028970877523534e-05
samples O 0 3.887950242642546e-06
, O 0 3.232045173717779e-06
187 O 0 1.1725319382094312e-05
C O 0 4.736030678031966e-05
- O 0 3.2352716516470537e-05
- O 0 2.2524105588672683e-05
> O 0 2.5664910936029628e-05
G O 0 4.3783988076029345e-05
was O 0 6.3899465203576256e-06
found O 0 4.809213578482741e-07
to O 0 2.5900405375978153e-07
be O 0 3.243183925860649e-07
associated O 0 1.7192026007251116e-06
with O 0 5.031088676332729e-06
HLA O 1 0.999998927116394
haplotypes O 0 0.014279390685260296
common O 0 8.451274879917037e-06
in O 0 5.048034836363513e-06
Caucasians O 0 0.0002762408403214067
, O 0 2.8406768706190633e-06
suggesting O 0 2.742505785136018e-06
that O 0 3.4686178196352557e-07
it O 0 4.101309230009065e-07
was O 0 4.151081157033332e-06
introduced O 0 2.4730657059990335e-06
by O 0 1.8874451370720635e-06
recent O 0 9.976137334888335e-06
admixture O 0 0.00024272248265333474
. O 0 0.00010946369729936123

In O 0 0.0001188911046483554
the O 0 3.293185363872908e-05
Chinese O 0 2.0164547095191665e-05
samples O 0 4.843521764996694e-06
analyzed O 0 8.006715688679833e-06
, O 0 4.215325134282466e-06
187 O 0 1.4671583812742028e-05
C O 0 8.000143861863762e-05
- O 0 5.014099588152021e-05
- O 0 3.7613230233546346e-05
> O 0 6.19229904259555e-05
G O 0 9.503281762590632e-05
was O 0 1.6296735338983126e-05
present O 0 2.392517671978567e-06
in O 0 1.8953293192680576e-06
association O 0 2.701509174585226e-06
with O 0 7.639967520844948e-07
a O 0 2.8110384846513625e-06
wide O 0 5.163823516340926e-06
variety O 0 2.3173624867922626e-06
of O 0 1.725204310787376e-05
HLA O 1 0.9999969005584717
haplotypes O 0 0.00011151581566082314
, O 0 2.021133923335583e-06
showing O 0 2.653292767718085e-06
this O 0 3.647348592039634e-07
mutation O 0 4.6785066842858214e-07
to O 0 3.3562872658876586e-07
be O 0 3.825280430191924e-07
widespread O 0 1.678946659922076e-06
and O 0 7.625409352840506e-07
likely O 0 1.6245213600996067e-06
to O 0 1.6468371768496581e-06
predate O 0 1.5017012628959492e-05
the O 0 3.053046384593472e-06
more O 0 1.4434968989007757e-06
genetically O 0 3.962637492804788e-06
restricted O 0 4.169645762885921e-06
845 O 0 6.968811067054048e-05
G O 0 0.00020410658908076584
- O 0 0.00010195374488830566
- O 0 7.555991760455072e-05
> O 0 7.198619277914986e-05
A O 0 8.412332681473345e-05
mutation O 0 4.3180829379707575e-05
. O 0 9.35869975364767e-05

Genotype O 0 0.003577320370823145
- O 0 0.0015567939262837172
phenotype O 0 0.00020458782091736794
correlations O 0 0.00022308067127596587
in O 0 0.00010783976904349402
attenuated B-Disease 1 0.9946058392524719
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
coli I-Disease 1 0.999996542930603
. O 0 0.002266061259433627

Germ O 1 0.9999611377716064
- O 0 0.0010855607688426971
line O 0 7.051045395201072e-05
mutations O 0 9.571773261995986e-06
of O 0 1.4284180906543043e-05
the O 0 0.00011034779163310304
tumor B-Disease 1 0.9999997615814209
suppressor O 1 0.9843791127204895
APC O 0 0.0005170226213522255
are O 0 1.2772962918461417e-06
implicated O 0 1.317455098615028e-05
in O 0 8.219853043556213e-06
attenuated B-Disease 1 0.9363097548484802
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999998807907104
( O 1 0.9510942101478577
AAPC B-Disease 1 0.9999997615814209
) O 0 5.282146958052181e-06
, O 0 2.0002462406409904e-06
a O 0 3.0257535854616435e-06
variant O 0 1.2229124877194408e-05
of O 0 3.725520946318284e-05
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999433755874634
FAP B-Disease 1 0.9999991655349731
) O 0 0.0003064519551116973
. O 0 0.00014713319251313806

AAPC B-Disease 1 0.999941349029541
is O 0 8.081051055341959e-05
recognized O 0 1.4305353033705615e-05
by O 0 2.788324991342961e-06
the O 0 3.5596592624642653e-06
occurrence O 0 5.389358648244524e-06
of O 0 1.0895573723246343e-05
< O 0 0.015500277280807495
100 O 0 7.197452214313671e-05
colonic B-Disease 1 0.9991239905357361
adenomas I-Disease 0 0.011784526519477367
and O 0 2.0330985535110813e-06
a O 0 2.3557888653158443e-06
later O 0 5.53973950445652e-06
onset O 1 0.9962670207023621
of O 1 0.9988541603088379
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.0007417804445140064
age O 0 0.00019912063726224005
> O 0 8.101049024844542e-05
40 O 0 2.162860255339183e-05
years O 0 2.1579877284239046e-05
) O 0 2.4802440748317167e-05
. O 0 7.822455518180504e-05

The O 0 0.00013494490121956915
aim O 0 9.566335211275145e-05
of O 0 1.5243182133417577e-05
this O 0 2.9193734008003958e-06
study O 0 3.7540451103268424e-06
was O 0 9.650700121710543e-06
to O 0 1.9013779137821984e-06
assess O 0 8.99012138688704e-06
genotype O 0 3.826354441116564e-05
- O 0 7.653908687643707e-05
phenotype O 0 4.442419594852254e-05
correlations O 0 6.877986015751958e-05
in O 0 6.776198279112577e-05
AAPC B-Disease 1 0.9999865293502808
families O 0 0.0001319522416451946
. O 0 0.0001241356076207012

By O 0 9.541628242004663e-05
protein O 0 6.511082756333053e-05
- O 0 3.146858580294065e-05
truncation O 0 3.65892265108414e-05
test O 0 6.007331649016123e-06
( O 0 4.5330048124014866e-06
PTT O 0 3.9098500565160066e-05
) O 0 1.572358655721473e-06
assay O 0 2.3241041162691545e-06
, O 0 7.767579859319085e-07
the O 0 7.522052101194276e-07
entire O 0 5.133263584866654e-06
coding O 0 5.429670181911206e-06
region O 0 4.4338335101201665e-06
of O 0 2.8818085411330685e-06
the O 0 5.9578887885436416e-06
APC B-Disease 0 0.00604541040956974
gene O 0 3.581428245524876e-06
was O 0 8.983188308775425e-06
screened O 0 3.327909098516102e-06
in O 0 8.122099188767606e-07
affected O 0 8.865847007655248e-07
individuals O 0 4.966674964634876e-07
from O 0 4.3513400669326074e-06
11 O 0 0.06157701835036278
AAPC B-Disease 1 1.0
kindreds O 0 0.00014490880130324513
, O 0 2.39557925851841e-06
and O 0 9.573584520694567e-07
their O 0 8.217275535571389e-07
phenotypic O 0 7.478522547899047e-06
differences O 0 1.0403020496596582e-05
were O 0 1.442785287508741e-05
examined O 0 0.00011424902186263353
. O 0 9.955614223144948e-05

Five O 0 0.00032590681803412735
novel O 0 0.0013055407907813787
germ O 1 0.9997875094413757
- O 0 0.0027021036949008703
line O 0 0.00021754484623670578
APC B-Disease 0 0.0007583368569612503
mutations O 0 9.393337677465752e-06
were O 0 5.268282166071003e-06
identified O 0 9.445744581171311e-06
in O 0 1.414368216501316e-05
seven O 0 7.542184175690636e-05
kindreds O 0 0.0012030366342514753
. O 0 0.00025148276472464204

Mutations O 0 0.00021339277736842632
were O 0 4.5897337258793414e-05
located O 0 2.9162147257011384e-05
in O 0 3.1281160772778094e-06
three O 0 7.976892675287672e-07
different O 0 2.5466849251643e-07
regions O 0 4.973125555807201e-07
of O 0 1.510332481302612e-06
the O 0 4.581559096550336e-06
APC B-Disease 0 0.00014628615463152528
gene O 0 3.0813437206234084e-06
( O 0 1.13502017029532e-06
1 O 0 3.439364945734269e-06
) O 0 8.327660339091381e-07
at O 0 2.0186528217891464e-06
the O 0 9.534569471725263e-07
5 O 0 1.5624050320184324e-06
end O 0 2.467374315529014e-06
spanning O 0 7.251974238897674e-06
exons O 0 5.475471425597789e-06
4 O 0 4.676660410041222e-06
and O 0 7.126715786398563e-07
5 O 0 1.689918235570076e-06
, O 0 5.490601324709132e-07
( O 0 4.163266282830591e-07
2 O 0 1.2564796634251252e-06
) O 0 7.312920047297666e-07
within O 0 1.0265539458487183e-06
exon O 0 6.127123924670741e-06
9 O 0 2.931363724201219e-06
, O 0 8.605449011156452e-07
and O 0 4.6000863562767336e-07
( O 0 8.296174769384379e-07
3 O 0 2.256916559417732e-06
) O 0 8.60480042774725e-07
at O 0 2.40922986449732e-06
the O 0 2.0167055936326506e-06
3 O 0 1.1042080586776137e-05
distal O 0 4.91424034407828e-05
end O 0 1.5226561117742676e-05
of O 0 1.0437762284709606e-05
the O 0 3.1329345802078024e-05
gene O 0 8.330063428729773e-05
. O 0 7.097885099938139e-05

Variability O 0 0.000317171448841691
in O 0 1.795267417037394e-05
the O 0 1.001035070657963e-05
number O 0 1.2098577826691326e-05
of O 1 0.8690372705459595
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 1 0.997783362865448
most O 0 6.037363164068665e-06
apparent O 0 1.1962439202761743e-05
in O 0 1.230041561939288e-06
individuals O 0 5.192135290599253e-07
with O 0 1.042243638949003e-06
mutations O 0 2.2642852854914963e-06
in O 0 3.89128172173514e-06
region O 0 1.0027817552327178e-05
1 O 0 1.663946568442043e-05
, O 0 3.681751195472316e-06
and O 0 4.562444701150525e-06
upper O 1 0.7429695129394531
- O 1 0.9921157956123352
gastrointestinal O 1 0.9999915361404419
manifestations O 1 0.5456786155700684
were O 0 2.9063254260108806e-05
more O 0 4.794998403667705e-06
severe O 0 0.0005737286992371082
in O 0 1.9309083654661663e-05
them O 0 1.3055608178547118e-05
. O 0 5.805527689517476e-05

In O 0 6.166989624034613e-05
individuals O 0 7.576929874630878e-06
with O 0 4.20363085140707e-06
mutations O 0 4.940276539855404e-06
in O 0 3.0144001357257366e-06
either O 0 3.559625156412949e-06
region O 0 6.534576641570311e-06
2 O 0 7.81433755037142e-06
or O 0 2.3088607576937648e-06
region O 0 5.26381245435914e-06
3 O 0 4.992602953279857e-06
, O 0 1.0671134305084706e-06
the O 0 8.018635639928107e-07
average O 0 1.0875005500565749e-06
number O 0 7.540539854744566e-07
of O 0 3.438587782511604e-06
adenomas B-Disease 0 0.002562001347541809
tended O 0 3.0248102120822296e-06
to O 0 4.0182715110859135e-07
be O 0 2.723643035551504e-07
lower O 0 8.071514230323373e-07
than O 0 1.6132098323851096e-07
those O 0 1.0440487585583469e-07
in O 0 3.71372863128272e-07
individuals O 0 2.310897428969838e-07
with O 0 5.548974399971485e-07
mutations O 0 1.618890451027255e-06
in O 0 1.2992334177397424e-06
region O 0 4.535685548034962e-06
1 O 0 8.5078900156077e-06
, O 0 1.6958821333901142e-06
although O 0 8.54726351917634e-07
age O 0 4.601421096595004e-06
at O 0 1.9706520106410608e-05
diagnosis O 0 0.0005090788472443819
was O 0 0.00018471197108738124
similar O 0 2.8800950531149283e-05
. O 0 7.282113074325025e-05

In O 0 0.0002230179525213316
all O 0 0.000104210150311701
AAPC B-Disease 1 0.9999982118606567
kindreds O 0 0.0008830823935568333
, O 0 1.162524404207943e-05
a O 0 9.040071745403111e-06
predominance O 0 0.00028923284844495356
of O 0 7.514924800489098e-05
right O 0 0.1219676062464714
- O 1 0.9999979734420776
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9995695948600769
rectal B-Disease 1 1.0
polyp I-Disease 1 0.9999994039535522
sparing O 0 0.02973129041492939
was O 0 0.0024427894968539476
observed O 0 0.00010471518180565909
. O 0 0.0001268082414753735

No O 0 0.0010084155946969986
desmoid B-Disease 1 0.9999817609786987
tumors I-Disease 1 0.9999979734420776
were O 0 3.729146919795312e-05
found O 0 1.1412173989810981e-05
in O 0 1.0036599633167498e-05
these O 0 1.0431114787934348e-05
kindreds O 0 0.0007239643018692732
. O 0 0.00012443758896552026

Our O 0 8.502595301251858e-05
data O 0 1.6751795556047e-05
suggest O 0 1.0558703252172563e-05
that O 0 2.230029167549219e-06
, O 0 3.708515578182414e-06
in O 0 1.0574231964710634e-05
AAPC B-Disease 1 0.9999911785125732
families O 0 4.61511081084609e-06
, O 0 1.607587250873621e-06
the O 0 1.1909698969247984e-06
location O 0 4.561774403555319e-06
of O 0 3.278443045928725e-06
the O 0 8.05421223049052e-06
APC B-Disease 0 0.1612195521593094
mutation O 0 1.0784423466247972e-05
may O 0 8.256321962107904e-06
partially O 0 1.7689122614683583e-05
predict O 0 8.036795406951569e-06
specific O 0 3.981358076998731e-06
phenotypic O 0 6.743560516042635e-05
expression O 0 0.0001089529978344217
. O 0 0.0001535489282105118

This O 0 4.628589522326365e-05
should O 0 1.0356436177971773e-05
help O 0 4.608034487318946e-06
in O 0 2.152210072381422e-06
the O 0 1.7933807612280361e-06
design O 0 6.299531378317624e-06
of O 0 7.600900062243454e-06
tailored O 0 1.1981242096226197e-05
clinical O 0 0.0007411875994876027
- O 0 0.001694360515102744
management O 0 3.2774296414572746e-05
protocols O 0 3.942824605474016e-06
in O 0 1.0207951390839298e-06
this O 0 1.033456555887824e-06
subset O 0 8.110527232929599e-06
of O 0 1.9399263692321256e-05
FAP B-Disease 1 0.9999005794525146
patients O 0 0.00023129287001211196
. O 0 3.1037798180477694e-05
. O 0 9.279874939238653e-05

Wilms B-Disease 1 0.999954104423523
' I-Disease 0 0.002906468231230974
tumor I-Disease 1 0.5383519530296326
1 O 0 0.00015011556388344616
and O 0 2.347997906326782e-05
Dax O 1 0.9912282228469849
- O 0 3.4608041460160166e-05
1 O 0 2.2157468265504576e-05
modulate O 0 1.5650577552150935e-05
the O 0 4.234164862282341e-06
orphan O 0 0.00010904227383434772
nuclear O 0 0.00012186579260742292
receptor O 0 5.6131357268895954e-05
SF O 0 0.022077741101384163
- O 0 1.4638864740845747e-05
1 O 0 8.124849045998417e-06
in O 0 3.297030161775183e-06
sex O 0 5.3768894758832175e-06
- O 0 1.0514109817449935e-05
specific O 0 2.4806174678815296e-06
gene O 0 1.3835048775945324e-05
expression O 0 2.882966691686306e-05
. O 0 5.391392551246099e-05

Products O 0 0.00012979422172065824
of O 0 8.390781295020133e-05
steroidogenic O 0 0.037166889756917953
factor O 0 5.6510001741116866e-05
1 O 0 4.250892379786819e-05
( O 0 1.7480306269135326e-05
SF O 1 0.8206050992012024
- O 0 1.9952276488766074e-05
1 O 0 1.5006604371592402e-05
) O 0 4.5697420318902005e-06
and O 0 7.12095970811788e-06
Wilms B-Disease 1 0.999964714050293
tumor I-Disease 0 0.41195106506347656
1 O 0 6.280667003011331e-05
( O 0 1.8748636648524553e-05
WT1 O 0 0.0018200062913820148
) O 0 2.9735558655374916e-06
genes O 0 1.204505451823934e-06
are O 0 2.519534518796718e-07
essential O 0 1.130900386669964e-06
for O 0 1.4754892845303402e-06
mammalian O 0 1.3380041309574153e-05
gonadogenesis O 0 6.07919973845128e-05
prior O 0 9.46921318245586e-06
to O 0 5.907827016926603e-06
sexual O 0 5.319765841704793e-05
differentiation O 0 0.0005970657803118229
. O 0 0.00022369685757439584

In O 0 0.0001601290568942204
males O 0 9.023907477967441e-05
, O 0 6.728741573169827e-05
SF O 1 0.9991909861564636
- O 0 0.00012674900062847883
1 O 0 3.530571484589018e-05
participates O 0 1.64142475114204e-05
in O 0 3.218704705432174e-06
sexual O 0 7.467511750292033e-06
development O 0 5.352719654183602e-06
by O 0 1.7988227227760945e-06
regulating O 0 3.214729076717049e-06
expression O 0 2.1074447431601584e-06
of O 0 2.504561962268781e-06
the O 0 1.0547350939305034e-05
polypeptide O 0 0.3050253093242645
hormone O 0 0.00019472750136628747
Mullerian O 1 0.9602848887443542
inhibiting O 0 0.00025329156778752804
substance O 0 0.0002000357781071216
( O 0 5.3303381719160825e-05
MIS O 1 0.8176459074020386
) O 0 5.2114326535956934e-05
. O 0 7.100639777490869e-05

Here O 0 0.00016700448759365827
, O 0 1.959613655344583e-05
we O 0 7.874559742049314e-06
show O 0 1.666870593908243e-05
that O 0 9.721428796183318e-06
WT1 O 1 0.7529975175857544
- O 0 0.0004001003981102258
KTS O 1 0.7702662944793701
isoforms O 0 1.217564113176195e-05
associate O 0 1.1394133252906613e-05
and O 0 3.3211747449968243e-06
synergize O 0 8.574164530728012e-05
with O 0 7.970687875058502e-06
SF O 1 0.9998416900634766
- O 0 6.508549995487556e-05
1 O 0 2.756863977992907e-05
to O 0 7.90237209002953e-06
promote O 0 4.8008194426074624e-05
MIS O 0 0.2740425765514374
expression O 0 7.662321149837226e-05
. O 0 7.849729445297271e-05

In O 0 0.00011357825860613957
contrast O 0 0.0001355425047222525
, O 0 6.252610182855278e-05
WT1 O 1 0.9536437392234802
missense O 0 0.00017635103722568601
mutations O 0 2.8260259568924084e-05
, O 0 8.10418714536354e-06
associated O 0 3.7060760860185837e-06
with O 0 4.621475000021746e-06
male B-Disease 0 0.00014901756367180496
pseudohermaphroditism I-Disease 1 0.9999791383743286
in O 0 0.00011492724297568202
Denys B-Disease 1 0.9999983310699463
- I-Disease 1 0.9999971389770508
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.2325602256169077e-05
fail O 0 8.845967386150733e-06
to O 0 2.4233877411461435e-06
synergize O 0 0.00019909995899070054
with O 0 3.4344851883361116e-05
SF O 1 0.999990701675415
- O 0 0.0017409339779987931
1 O 0 0.0003732000768650323
. O 0 0.00010428769019199535

Additionally O 0 0.00014425285917241126
, O 0 2.2284104488790035e-05
the O 0 1.1455299500084948e-05
X O 0 0.00020274730923119932
- O 0 5.007782601751387e-05
linked O 0 1.505183900007978e-05
, O 0 2.4804280656098854e-06
candidate O 0 8.294882718473673e-06
dosage O 0 1.185242672363529e-05
- O 0 1.4703716260555666e-05
sensitive O 0 6.916262918821303e-06
sex O 0 4.112125225219643e-06
- O 0 1.061447346728528e-05
reversal O 0 1.0608937373035587e-05
gene O 0 2.7127757675771136e-06
, O 0 2.868408955691848e-06
Dax O 0 0.15229009091854095
- O 0 1.2392737517075147e-05
1 O 0 1.1664712474157568e-05
, O 0 5.5397817959601525e-06
antagonizes O 0 9.46272411965765e-05
synergy O 0 0.00013841436884831637
between O 0 3.807800749200396e-05
SF O 1 0.9996968507766724
- O 0 5.799164136988111e-05
1 O 0 2.8630427550524473e-05
and O 0 6.656815003225347e-06
WT1 O 0 0.0032347762025892735
, O 0 1.6252326986432308e-06
most O 0 8.190206131075684e-07
likely O 0 6.356424364639679e-07
through O 0 4.73429224712163e-07
a O 0 1.9699002677953104e-06
direct O 0 1.5602682879034546e-06
interaction O 0 6.105122793087503e-06
with O 0 1.1394350622140337e-05
SF O 1 0.9998716115951538
- O 0 0.0004302308661863208
1 O 0 0.0003307181759737432
. O 0 0.00017169705824926496

We O 0 7.801909669069573e-05
propose O 0 4.203069329378195e-05
that O 0 1.2077354767825454e-05
WT1 O 0 0.0046315621584653854
and O 0 1.5813266145414673e-05
Dax O 1 0.9988987445831299
- O 0 5.1987997721880674e-05
1 O 0 1.6905463780858554e-05
functionally O 0 1.3533458513848018e-05
oppose O 0 2.0345960365375504e-06
each O 0 5.592004299614928e-07
other O 0 7.570253615085676e-07
in O 0 3.7678712487831945e-06
testis O 0 8.696943405084312e-05
development O 0 1.1664757039397955e-05
by O 0 6.1981008911971e-06
modulating O 0 0.0004983249818906188
SF O 1 0.9998483657836914
- O 0 0.00014292953710537404
1 O 0 0.00020913477055728436
- O 0 0.0002984591410495341
mediated O 0 0.0002571789955254644
transactivation O 0 0.0009552265983074903
. O 0 3.707841824507341e-05
. O 0 9.642212535254657e-05

A O 0 0.0008750044507905841
mouse O 0 0.000239792003412731
model O 0 4.881707354797982e-05
for O 0 3.609594932640903e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9999997615814209
- O 1 0.9999886751174927
centre O 1 0.9993146657943726
mutations O 0 0.0002555800892878324
. O 0 0.00012022963346680626

Imprinting O 0 0.0013104970566928387
in O 0 6.618550105486065e-05
the O 0 6.280433444771916e-05
15q11 O 0 0.0692477598786354
- O 0 0.00024450261844322085
q13 O 0 0.0003235666372347623
region O 0 1.9867517039529048e-05
involves O 0 1.2327401236689184e-05
an O 0 6.025128641340416e-06
imprinting O 0 0.00014198085409589112
centre O 0 0.00014353921869769692
( O 0 1.1962439202761743e-05
IC O 0 0.0037995437160134315
) O 0 2.3686839085712563e-06
, O 0 1.052052198247111e-06
mapping O 0 2.0340739865787327e-06
in O 0 7.935335020192724e-07
part O 0 2.1317805476428475e-06
to O 0 1.710543074295856e-06
the O 0 4.077343419339741e-06
promoter O 0 8.413824980380014e-05
and O 0 3.836148607661016e-06
first O 0 1.37144834297942e-05
exon O 0 0.00017082667909562588
of O 0 8.796682232059538e-05
SNRPN O 1 0.9989898800849915
. O 0 0.00019088904082309455

Deletion O 0 0.0007011943962424994
of O 0 0.00014444928092416376
this O 0 4.0912484109867364e-05
IC O 0 0.4263235926628113
abolishes O 0 0.00018346731667406857
local O 0 1.1598513083299622e-05
paternally O 0 3.82890211767517e-05
derived O 0 5.019610398449004e-06
gene O 0 2.0868528736173175e-06
expression O 0 1.3938193887952366e-06
and O 0 7.935516919133079e-07
results O 0 2.7478438369143987e-06
in O 0 2.3767672246322036e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999974966049194
PWS B-Disease 1 1.0
) O 0 0.0009540646569803357
. O 0 0.00021125355851836503

We O 0 6.777968519600108e-05
have O 0 6.8666558945551515e-06
created O 0 1.4258975170378108e-05
two O 0 2.4199466679419857e-06
deletion O 0 2.8474241844378412e-05
mutations O 0 1.319883631367702e-05
in O 0 8.86543421074748e-06
mice O 0 1.7711621694616042e-05
to O 0 2.307394652234507e-06
understand O 0 2.628950824146159e-05
PWS B-Disease 1 0.999998927116394
and O 0 5.793360742245568e-06
the O 0 5.445013357530115e-06
mechanism O 0 1.539592631161213e-05
of O 0 1.8560293028713204e-05
this O 0 2.1784102500532754e-05
IC O 0 0.37279537320137024
. O 0 0.0001438395556760952

Mice O 0 0.4242349863052368
harbouring O 0 0.13498444855213165
an O 0 9.289118315791711e-05
intragenic O 0 0.16744038462638855
deletion O 0 0.00019815190171357244
in O 0 3.785530134337023e-05
Snrpn O 0 0.11580502241849899
are O 0 2.6111538318218663e-06
phenotypically O 0 3.0860443075653166e-05
normal O 0 5.29439694219036e-06
, O 0 1.9924025309592253e-06
suggesting O 0 5.3142462093092036e-06
that O 0 7.156990591283829e-07
mutations O 0 2.4355747427762253e-06
of O 0 5.5576456361450255e-06
SNRPN O 1 0.6894817352294922
are O 0 7.058837354634306e-07
not O 0 8.019392794267333e-07
sufficient O 0 8.004180926945992e-06
to O 0 1.1246343092352618e-05
induce O 0 0.001609085244126618
PWS B-Disease 1 0.9999992847442627
. O 0 0.0007381270988844335

Mice O 0 0.0005480193649418652
with O 0 1.7839794963947497e-05
a O 0 2.241189213236794e-05
larger O 0 1.1741399248421658e-05
deletion O 0 3.242634920752607e-05
involving O 0 1.660974339756649e-05
both O 0 6.614593985432293e-06
Snrpn O 0 0.08212769031524658
and O 0 3.6447793263505446e-06
the O 0 1.4033470506547019e-05
putative O 1 0.9994369149208069
PWS O 1 1.0
- O 1 0.9875735640525818
IC O 1 0.9984099864959717
lack O 0 2.7467922336654738e-05
expression O 0 5.157425675861305e-06
of O 0 2.844672962964978e-06
the O 0 6.904110705363564e-06
imprinted O 0 0.00011682261538226157
genes O 0 8.446584615739994e-06
Zfp127 O 0 0.0008504822617396712
( O 0 1.3390252206590958e-05
mouse O 0 2.6845515094464645e-05
homologue O 0 4.061230720253661e-05
of O 0 9.184882401314098e-06
ZNF127 O 0 0.2042013704776764
) O 0 1.22832407214446e-05
, O 0 8.5244082583813e-06
Ndn O 0 0.002733432687819004
and O 0 5.972725375613663e-06
Ipw O 0 0.00014243728946894407
, O 0 4.2974443204002455e-06
and O 0 1.6064930150605505e-06
manifest O 0 1.3820253116136882e-05
several O 0 4.673152034229133e-06
phenotypes O 0 3.134802682325244e-05
common O 0 2.7201043849345297e-05
to O 0 0.00011632638779701665
PWS B-Disease 1 1.0
infants O 1 0.9987702965736389
. O 0 0.0005658697336912155

These O 0 2.7487467377795838e-05
data O 0 1.6352829334209673e-05
demonstrate O 0 1.428301038686186e-05
that O 0 1.1128111054858891e-06
both O 0 5.425474682851927e-07
the O 0 1.3147139270586194e-06
position O 0 3.709827751663397e-06
of O 0 2.3376967419608263e-06
the O 0 4.907298716716468e-06
IC O 1 0.5828307271003723
and O 0 1.4607213643103023e-06
its O 0 7.196592264335777e-07
role O 0 1.986316192414961e-06
in O 0 7.73015756294626e-07
the O 0 1.2073046491423156e-06
coordinate O 0 1.8548031448517577e-06
expression O 0 8.812496048449248e-07
of O 0 1.771839947650733e-06
genes O 0 1.007352807391726e-06
is O 0 7.53560073007975e-07
conserved O 0 3.0960482035879977e-06
between O 0 2.8964363991690334e-06
mouse O 0 4.609744337358279e-06
and O 0 5.905799866923189e-07
human O 0 1.0969417871820042e-06
, O 0 7.011296929704258e-07
and O 0 5.311194399837404e-07
indicate O 0 1.3859751106792828e-06
that O 0 3.7843253153369005e-07
the O 0 1.286447968595894e-06
mouse O 0 3.678539997054031e-06
is O 0 7.947066364977218e-07
a O 0 1.1573224583116826e-06
suitable O 0 1.6747918607507017e-06
model O 0 9.32335183279065e-07
system O 0 7.154697527766984e-07
in O 0 3.913993111837044e-07
which O 0 1.6771464572684636e-07
to O 0 1.8182225858254242e-07
investigate O 0 9.738424751049024e-07
the O 0 7.362407359323697e-07
molecular O 0 2.6216059723083163e-06
mechanisms O 0 2.3491995762014994e-06
of O 0 2.6167376745434012e-06
imprinting O 0 1.7256699720746838e-05
in O 0 2.8833701435360126e-06
this O 0 1.1936397186218528e-06
region O 0 6.811875664425315e-06
of O 0 3.693937742355047e-06
the O 0 7.460699634975754e-06
genome O 0 2.2020818505552597e-05
. O 0 8.739391887502279e-06
. O 0 2.8326903702691197e-05

Mutations O 0 0.00014208853826858103
of O 0 5.433136902865954e-05
the O 0 2.6683184842113405e-05
ATM O 0 0.0006838906556367874
gene O 0 7.762627319607418e-06
detected O 0 6.403415682143532e-06
in O 0 3.4624713407538366e-06
Japanese O 0 0.25458070635795593
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
telangiectasia I-Disease 1 1.0
patients O 0 0.00039930062484927475
: O 0 3.005716507686884e-06
possible O 0 2.7526803023647517e-06
preponderance O 0 6.903712346684188e-05
of O 0 5.784483619208913e-06
the O 0 8.584976058045868e-06
two O 0 5.711403446184704e-06
founder O 0 0.0019521575886756182
mutations O 0 5.145074464962818e-05
4612del165 O 0 0.0010550793958827853
and O 0 6.002898226142861e-05
7883del5 O 0 0.0013890431728214025
. O 0 0.0001523631945019588

The O 0 0.00022010505199432373
ATM O 0 0.002073853276669979
( O 0 0.00010046422539744526
A O 1 0.9960440397262573
- O 1 0.9896266460418701
T O 1 0.9997228980064392
, O 0 8.13959923107177e-06
mutated O 0 6.1187506616988685e-06
) O 0 1.5901892993497313e-06
gene O 0 1.7617554703974747e-06
on O 0 4.10403890782618e-06
human O 0 6.214619588718051e-06
chromosome O 0 8.607835479779169e-05
11q22 O 0 0.0006579323089681566
. O 0 7.076250767568126e-05

3 O 0 0.00025642389664426446
has O 0 2.1685895262635313e-05
recently O 0 1.5967960280249827e-05
been O 0 2.2479568997368915e-06
identified O 0 1.5367993455583928e-06
as O 0 6.023935270604852e-07
the O 0 6.785679715903825e-07
gene O 0 1.090981527340773e-06
responsible O 0 1.028318706630671e-06
for O 0 5.967994525235554e-07
the O 0 4.252646249369718e-06
human O 0 3.143576759612188e-05
recessive B-Disease 1 0.9999376535415649
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.960338294506073
A B-Disease 1 0.9999985694885254
- I-Disease 1 0.9999687671661377
T I-Disease 1 0.9999872446060181
) O 0 5.5381289712386206e-05
. O 0 6.101740291342139e-05

In O 0 4.4090607843827456e-05
order O 0 7.74134969105944e-06
to O 0 2.380929799983278e-06
define O 0 4.123352027818328e-06
the O 0 4.217472451273352e-06
types O 0 5.103039711684687e-06
of O 0 7.241527055157349e-05
disease O 1 0.9999988079071045
- O 1 0.7012228965759277
causing O 0 0.02333425171673298
ATM O 0 0.07953377068042755
mutations O 0 2.2959759462537477e-06
in O 0 1.751223976498295e-06
Japanese O 0 0.00021425717568490654
A B-Disease 1 0.9999146461486816
- I-Disease 1 0.9999018907546997
T I-Disease 1 0.9999979734420776
patients O 0 7.31932277631131e-06
as O 0 7.713875334047771e-07
well O 0 6.307156468210451e-07
as O 0 4.985571990800963e-07
to O 0 2.7850458650391374e-07
look O 0 5.956525797046197e-07
for O 0 5.56603026780067e-07
possible O 0 2.3639245227968786e-06
mutational O 0 8.352542499778792e-05
hotspots O 0 3.0638871976407245e-05
, O 0 3.2432874377263943e-06
reverse O 0 9.215750651492272e-06
- O 0 1.199575126520358e-05
transcribed O 0 9.182185749523342e-06
RNA O 0 9.578859135217499e-06
derived O 0 1.3454948657454224e-06
from O 0 8.562968787373393e-07
ten O 0 3.634938821051037e-06
patients O 0 2.8291597118368372e-06
belonging O 0 3.4720872008620063e-06
to O 0 1.2368558373054839e-06
eight O 0 2.6911875465884805e-06
unrelated O 0 9.05467095435597e-06
Japanese O 0 0.00018305353296454996
A B-Disease 1 0.9985883831977844
- I-Disease 1 0.9773335456848145
T I-Disease 1 0.9953363537788391
families O 0 2.954630872409325e-06
was O 0 6.381293133017607e-06
analyzed O 0 2.3212553514895262e-06
for O 0 7.281936404979206e-07
mutations O 0 1.7966762015930726e-06
by O 0 1.1996229432043037e-06
the O 0 5.005637376598315e-06
restriction O 0 1.3792825484415516e-05
endonuclease O 0 9.393631626153365e-05
fingerprinting O 0 8.047238952713087e-05
method O 0 4.373987394501455e-05
. O 0 8.467850420856848e-05

As O 0 0.00013403029879555106
has O 0 1.8885411918745376e-05
been O 0 8.377505764656235e-06
reported O 0 4.036136942886515e-06
by O 0 1.2442964134606882e-06
others O 0 1.7918933963301242e-06
, O 0 1.3798661484543118e-06
mutations O 0 1.7564912013767753e-06
that O 0 8.85317376742023e-07
lead O 0 4.256221018295037e-06
to O 0 2.74702892966161e-06
exon O 0 6.883851892780513e-05
skipping O 0 2.4539593141525984e-05
or O 0 3.1731763101561228e-06
premature O 0 1.6883437638171017e-05
protein O 0 5.875161150470376e-06
truncation O 0 1.9425755453994498e-05
were O 0 3.1122708605835214e-06
also O 0 2.039221044469741e-06
predominant O 0 1.0534644388826564e-05
in O 0 7.66908942750888e-06
our O 0 1.661456008150708e-05
mutants O 0 0.00020210823277011514
. O 0 8.009685552679002e-05

Six O 0 9.589095861883834e-05
different O 0 5.555748430197127e-06
mutations O 0 9.140266229223926e-06
were O 0 4.9447639867139515e-06
identified O 0 5.800757662655087e-06
on O 0 3.5658122214954346e-06
12 O 0 4.683967290475266e-06
of O 0 5.469057214213535e-06
the O 0 1.1407702004362363e-05
16 O 0 3.391910286154598e-05
alleles O 0 2.796860644593835e-05
examined O 0 0.00012147619418101385
. O 0 5.995443643769249e-05

Four O 0 0.00012094093835912645
were O 0 6.0768168623326346e-05
deletions O 0 9.11033566808328e-05
involving O 0 3.869570355163887e-05
a O 0 3.3713036827975884e-05
loss O 0 0.00011159794667037204
of O 0 2.3341113774222322e-05
a O 0 2.5586998162907548e-05
single O 0 8.725568477530032e-06
exon O 0 6.077356374589726e-05
exon O 0 3.965242285630666e-05
7 O 0 1.515368239779491e-05
, O 0 4.343256023275899e-06
exon O 0 2.460966607031878e-05
16 O 0 1.1217625797144137e-05
, O 0 5.746578153775772e-06
exon O 0 5.717281237593852e-05
33 O 0 1.7994068912230432e-05
or O 0 1.2270115803403314e-05
exon O 0 0.00017760366608854383
35 O 0 0.00011816075129900128
. O 0 8.364801033167168e-05

The O 0 0.00013754810788668692
others O 0 1.929064092109911e-05
were O 0 7.861877747927792e-06
minute O 0 1.6926416719798e-05
deletions O 0 2.2156242266646586e-05
, O 0 7.588913376821438e-06
4649delA O 0 5.1216993597336113e-05
in O 0 7.78696994530037e-06
exon O 0 9.453470556763932e-05
33 O 0 2.9550779800047167e-05
and O 0 9.900136319629382e-06
7883del5 O 0 0.00015749092563055456
in O 0 2.4381086404900998e-05
exon O 0 0.0004241349524818361
55 O 0 0.00027286051772534847
. O 0 0.00020694291742984205

The O 0 0.0001912523148348555
mutations O 0 9.915348346112296e-05
4612del165 O 0 0.00040077074663713574
and O 0 8.488641469739377e-06
7883del5 O 0 5.182874883757904e-05
were O 0 2.916262246799306e-06
found O 0 1.2984036175112124e-06
in O 0 4.6667113906551094e-07
more O 0 2.217205121723964e-07
than O 0 3.0024796160432743e-07
two O 0 2.049957856797846e-07
unrelated O 0 1.2307315273574204e-06
families O 0 6.598486947950732e-07
; O 0 4.847607328883896e-07
44 O 0 2.0498985122685554e-06
% O 0 1.502134637121344e-06
( O 0 1.6647962866045418e-06
7 O 0 2.9907821499364218e-06
of O 0 2.149447254851111e-06
16 O 0 3.4068959848809754e-06
) O 0 8.917369882510684e-07
of O 0 7.48095942526561e-07
the O 0 2.2297124360193266e-06
mutant O 0 8.945818990468979e-06
alleles O 0 1.6508265616721474e-06
had O 0 1.863187094386376e-06
one O 0 6.817060125285934e-07
of O 0 2.404556198598584e-06
the O 0 6.286573807301465e-06
two O 0 7.88533543527592e-06
mutations O 0 5.678317756974138e-05
. O 0 7.542392995674163e-05

The O 0 0.00033918663393706083
4612del165 O 0 0.001360694644972682
mutations O 0 2.183095784857869e-05
in O 0 5.244145995675353e-06
three O 0 1.43002921504376e-06
different O 0 3.020000463038741e-07
families O 0 8.715784929336223e-07
were O 0 8.54047641496436e-07
all O 0 4.048034156767244e-07
ascribed O 0 6.898917945363792e-06
to O 0 1.1963634278799873e-06
the O 0 3.943268438888481e-06
same O 0 5.627996870316565e-06
T O 0 0.00048833031905815
- O 0 3.450153599260375e-05
- O 0 2.204861812060699e-05
> O 0 1.5120334865059704e-05
A O 0 9.005334504763596e-06
substitution O 0 4.8619176595821045e-06
at O 0 6.473270786955254e-06
the O 0 3.2969105632219e-06
splice O 0 2.532670805521775e-05
donor O 0 6.560345809702994e-06
site O 0 1.2694511497102212e-05
in O 0 1.1706660188792739e-05
intron O 0 0.0007833741256035864
33 O 0 0.00021881316206417978
. O 0 9.390927152708173e-05

Microsatellite O 0 0.21428442001342773
genotyping O 0 0.0009746188879944384
around O 0 4.933760283165611e-05
the O 0 1.7284964997088537e-05
ATM O 0 0.00024425098672509193
locus O 0 2.445880090817809e-05
also O 0 1.952054162757122e-06
indicated O 0 1.2796654118574224e-06
that O 0 3.8897053400432924e-07
a O 0 1.2752284419548232e-06
common O 0 1.2219624068166013e-06
haplotype O 0 1.1319165423628874e-05
was O 0 1.0726489563239738e-05
shared O 0 2.0471222796913935e-06
by O 0 1.415288238604262e-06
the O 0 3.490626568236621e-06
mutant O 0 1.7954351278604008e-05
alleles O 0 6.229014616110362e-06
in O 0 5.941360086580971e-06
both O 0 1.3457461136567872e-05
mutations O 0 8.492239430779591e-05
. O 0 0.0001454915473004803

This O 0 4.392354458104819e-05
suggests O 0 2.7260615752311423e-05
that O 0 1.668160848566913e-06
these O 0 8.714488330952008e-07
two O 0 1.6625527905489434e-06
founder O 0 0.00016503884398844093
mutations O 0 4.269234068488004e-06
may O 0 4.537148015515413e-06
be O 0 2.0321951978985453e-06
predominant O 0 1.1149005331390072e-05
among O 0 7.859666766307782e-06
Japanese O 0 7.76902015786618e-05
ATM O 0 0.0003534980642143637
mutant O 0 0.00014132818614598364
alleles O 0 8.986519242171198e-05
. O 0 9.265479457098991e-05

W474C O 0 0.0023787389509379864
amino O 0 8.71727752382867e-05
acid O 0 4.312382952775806e-05
substitution O 0 2.0687755750259385e-05
affects O 0 8.408697794948239e-06
early O 0 4.068029284098884e-06
processing O 0 4.7184312279568985e-06
of O 0 2.799000867526047e-06
the O 0 4.0386203181697056e-06
alpha O 0 1.8241784346173517e-05
- O 0 3.964973984693643e-06
subunit O 0 3.826447482424555e-06
of O 0 2.732608209043974e-06
beta O 0 1.3654008398589212e-05
- O 0 1.3942094483354595e-05
hexosaminidase O 0 5.472656630445272e-05
A O 0 1.0644855137798004e-05
and O 0 7.858511139602342e-07
is O 0 8.54189352139656e-07
associated O 0 1.8247851585329045e-06
with O 0 5.6025010053417645e-06
subacute O 1 0.9999707937240601
G B-Disease 1 0.9991433620452881
( I-Disease 0 0.0006944056949578226
M2 I-Disease 1 0.9994577765464783
) I-Disease 0 7.35834109946154e-05
gangliosidosis I-Disease 0 0.0008920863037928939
. O 0 0.00010533741442486644

Mutations O 0 0.00019109794811811298
in O 0 3.7125053495401517e-05
the O 0 3.869625652441755e-05
HEXA O 0 0.15037132799625397
gene O 0 9.242100531992037e-06
, O 0 3.4898475860245526e-06
encoding O 0 2.685352455955581e-06
the O 0 4.071778676006943e-06
alpha O 0 2.6076695576193742e-05
- O 0 9.635112292016856e-06
subunit O 0 7.266311968123773e-06
of O 0 5.32157491761609e-06
beta O 0 2.9139659091015346e-05
- O 0 2.4027403924264945e-05
hexosaminidase O 0 9.632609726395458e-05
A O 0 1.5947520296322182e-05
( O 0 4.696223186329007e-06
Hex O 0 4.228663237881847e-05
A O 0 9.620127457310446e-06
) O 0 9.031384706759127e-07
, O 0 5.172707346901007e-07
that O 0 5.523273216567759e-07
abolish O 0 4.129416083742399e-06
Hex O 0 1.7583966837264597e-05
A O 0 3.846468189294683e-06
enzyme O 0 2.4623016088298755e-06
activity O 0 8.452007932646666e-06
cause O 0 0.001408355892635882
Tay B-Disease 1 1.0
- I-Disease 1 0.9999994039535522
Sachs I-Disease 1 1.0
disease I-Disease 1 0.9999990463256836
( O 0 0.00012155823787907138
TSD B-Disease 1 0.9998490810394287
) O 0 3.97860276279971e-06
, O 0 1.4731454029970337e-06
the O 0 3.055979732380365e-06
fatal O 0 0.0008644891786389053
infantile B-Disease 0 0.0332629457116127
form I-Disease 0 6.1093860495020635e-06
of I-Disease 0 8.116769458865747e-05
G I-Disease 1 0.8630123734474182
( I-Disease 0 2.3678756406297907e-05
M2 I-Disease 1 0.904870867729187
) I-Disease 0 3.851820110867266e-06
gangliosidosis I-Disease 0 2.9236301998025738e-05
, I-Disease 0 3.577093139028875e-06
Type I-Disease 0 1.5231833458528854e-05
1 I-Disease 0 7.113395258784294e-05
. O 0 5.9472073189681396e-05

Less O 0 0.000453537970315665
severe O 1 0.9779089689254761
, O 0 0.0003633997985161841
subacute O 1 0.999993085861206
( O 0 0.197594553232193
juvenile O 1 0.9999911785125732
- O 1 0.9973170161247253
onset O 1 0.9999995231628418
) O 0 0.0002808239951264113
and O 0 2.2742557121091522e-05
chronic O 1 0.9999997615814209
( O 0 0.0005452862824313343
adult O 0 8.18155676824972e-05
- O 0 0.005089210346341133
onset O 1 0.9987278580665588
) O 0 3.4651075111469254e-06
variants O 0 1.6945483594099642e-06
are O 0 3.088591142841324e-07
characterized O 0 1.7415444517610013e-06
by O 0 6.243802204153326e-07
a O 0 4.347035428509116e-06
broad O 0 1.0877788554353174e-05
spectrum O 0 1.4834873582003638e-05
of O 0 1.7658765500527807e-05
clinical O 0 0.010843618772923946
manifestations O 0 0.0019058744655922055
and O 0 3.4360605241090525e-06
are O 0 5.124275617163221e-07
associated O 0 7.133270401027403e-07
with O 0 1.0270758821206982e-06
residual O 0 7.106228440534323e-05
levels O 0 8.51761615194846e-06
of O 0 1.360088208457455e-05
Hex O 0 0.000180198359885253
A O 0 6.293053593253717e-05
enzyme O 0 3.243132960051298e-05
activity O 0 5.2618699555750936e-05
. O 0 5.6395980209345e-05

We O 0 9.106044308282435e-05
identified O 0 5.91409407206811e-05
a O 0 5.601681550615467e-05
1422 O 0 0.35045722126960754
G O 0 0.0076011307537555695
- O 0 0.0002136863477062434
- O 0 5.79567022214178e-05
> O 0 4.432035711943172e-05
C O 0 4.843281567445956e-05
( O 0 3.900655883626314e-06
amino O 0 3.1075846891326364e-06
acid O 0 5.879835498490138e-06
W474C O 0 1.805259489628952e-05
) O 0 1.2002820994894137e-06
substitution O 0 1.2106435178793618e-06
in O 0 8.911605959838198e-07
the O 0 5.866264700671309e-07
first O 0 1.907043952087406e-06
position O 0 3.839717010123422e-06
of O 0 4.1268335735367145e-06
exon O 0 3.183392618666403e-05
13 O 0 8.228103069995996e-06
of O 0 1.3457179193210322e-05
HEXA O 0 0.10894858092069626
of O 0 1.2710790542769246e-05
a O 0 1.935283034981694e-05
non O 0 2.4578657757956535e-05
- O 0 3.602490323828533e-05
Jewish O 0 2.443043194944039e-05
proband O 0 0.00281016924418509
who O 0 5.737696028518258e-06
manifested O 0 3.719195592566393e-05
a O 0 1.1024878403986804e-05
subacute O 0 0.3153237998485565
variant O 0 3.0163701012497768e-05
of O 0 3.591965651139617e-05
G B-Disease 0 0.4820798635482788
( I-Disease 0 6.76732452120632e-05
M2 I-Disease 1 0.9803692698478699
) I-Disease 0 4.755195914185606e-05
gangliosidosis I-Disease 0 0.0006654466269537807
. O 0 0.0001096870910259895

On O 0 8.716787124285474e-05
the O 0 2.6979692847817205e-05
second O 0 6.92915782565251e-05
maternally O 0 0.0017581592546775937
inherited O 0 0.1062266007065773
allele O 0 9.48365413933061e-06
, O 0 2.093275270453887e-06
we O 0 1.029869281410356e-06
identified O 0 2.149367219317355e-06
the O 0 2.6490552045288496e-06
common O 0 3.6095363611821085e-05
infantile O 1 0.9999996423721313
disease O 1 0.9999998807907104
- O 1 0.9722651839256287
causing O 0 0.10876546055078506
4 O 0 0.00024409104662481695
- O 0 3.116016887361184e-05
bp O 0 1.6065991076175123e-05
insertion O 0 1.0540353287069593e-05
, O 0 5.669811343977926e-06
+ O 0 4.512326995609328e-05
TATC O 0 0.03180479258298874
1278 O 0 0.0006801344570703804
, O 0 1.0528638995310757e-05
in O 0 9.459303328185342e-06
exon O 0 0.00020109963952563703
11 O 0 8.743510261410847e-05
. O 0 0.00011117203393951058

Pulse O 0 0.016810066998004913
- O 0 0.0004225471639074385
chase O 0 0.00011968573380727321
analysis O 0 1.1397914931876585e-05
using O 0 1.0722921615524683e-05
proband O 0 0.0002488438331056386
fibroblasts O 0 2.4336442947969772e-05
revealed O 0 6.048808700143127e-06
that O 0 7.843402158869139e-07
the O 0 1.8073395722240093e-06
W474C O 0 3.440050932113081e-05
- O 0 7.713302693446167e-06
containing O 0 4.457011073100148e-06
alpha O 0 1.2670828255068045e-05
- O 0 6.7343321461521555e-06
subunit O 0 3.70766701962566e-06
precursor O 0 1.2799125215678941e-05
was O 0 8.770584827288985e-06
normally O 0 2.3228919872053666e-06
synthesized O 0 4.474769866646966e-06
, O 0 1.3016580169278313e-06
but O 0 6.893307613609068e-07
not O 0 3.9780985616744147e-07
phosphorylated O 0 6.403409315680619e-06
or O 0 2.6473580874153413e-06
secreted O 0 5.397130735218525e-06
, O 0 2.219156385763199e-06
and O 0 1.3198432498029433e-06
the O 0 4.187837930658134e-06
mature O 0 1.4897337678121403e-05
lysosomal O 0 0.004343773704022169
alpha O 0 5.6588571169413626e-05
- O 0 1.937463639478665e-05
subunit O 0 1.3772282727586571e-05
was O 0 2.1745914636994712e-05
not O 0 3.7151421565795317e-06
detected O 0 6.64094986859709e-05
. O 0 5.782972220913507e-05

When O 0 0.0001705229951767251
the O 0 5.624704135698266e-05
W474C O 0 0.0003790232294704765
- O 0 4.5582844904856756e-05
containing O 0 1.3212285921326838e-05
alpha O 0 3.559200558811426e-05
- O 0 1.190939474327024e-05
subunit O 0 6.353312073770212e-06
was O 0 1.7097414456657134e-05
transiently O 0 3.2586212910246104e-05
co O 0 1.4480383470072411e-05
- O 0 4.040130079374649e-06
expressed O 0 1.2319152347117779e-06
with O 0 5.398342182161286e-07
the O 0 1.5864553688516025e-06
beta O 0 1.1377260307199322e-05
- O 0 5.945345037616789e-06
subunit O 0 3.0144001357257366e-06
to O 0 6.453543619500124e-07
produce O 0 1.2976336165593239e-06
Hex O 0 1.6967936971923336e-05
A O 0 7.255488526425324e-06
( O 0 2.3975951535248896e-06
alphabeta O 0 7.59372633183375e-05
) O 0 3.300405751360813e-06
in O 0 5.284676262817811e-06
COS O 1 0.5716398358345032
- O 0 2.959522680612281e-05
7 O 0 1.3013182979193516e-05
cells O 0 2.306184569533798e-06
, O 0 6.418888460757444e-07
the O 0 1.2445409538486274e-06
mature O 0 4.550372977973893e-06
alpha O 0 9.13637995836325e-06
- O 0 2.325624791410519e-06
subunit O 0 2.749482064245967e-06
was O 0 2.740620629992918e-06
present O 0 8.464475058644894e-07
, O 0 6.665306386821612e-07
but O 0 2.7628058774098463e-07
its O 0 4.4874445848108735e-07
level O 0 4.316103058954468e-06
was O 0 6.9249490479705855e-06
much O 0 1.325319772149669e-06
lower O 0 1.3645396848005475e-06
than O 0 2.1050374243714032e-07
that O 0 1.4824752270214958e-07
from O 0 6.363410989251861e-07
normal O 0 1.6341756463589263e-06
alpha O 0 1.0539689355937298e-05
- O 0 5.6031262829492334e-06
subunit O 0 6.596526418434223e-06
transfections O 0 1.6582249372731894e-05
, O 0 7.13096426352422e-07
although O 0 4.1787870941334404e-07
higher O 0 6.95141523010534e-07
than O 0 2.4351140837097773e-07
in O 0 6.786333415220724e-07
those O 0 4.074658477293269e-07
cells O 0 1.9476972283882787e-06
transfected O 0 8.445610546914395e-06
with O 0 4.215636408844148e-07
an O 0 1.0981883633576217e-06
alpha O 0 2.4535847842344083e-05
- O 0 1.4802355508436449e-05
subunit O 0 1.7093501810450107e-05
associated O 0 1.1680007446557283e-05
with O 0 4.231959246681072e-05
infantile O 1 0.9966844916343689
TSD B-Disease 1 0.9999668598175049
. O 0 0.0005820589140057564

Furthermore O 0 0.0002884026034735143
, O 0 2.7996335120406002e-05
the O 0 1.0867150194826536e-05
precursor O 0 2.394884722889401e-05
level O 0 1.1512489436427131e-05
of O 0 5.04094396092114e-06
the O 0 6.691669568681391e-06
W474C O 0 0.0001188659225590527
alpha O 0 2.308566945430357e-05
- O 0 3.961020865972387e-06
subunit O 0 2.906439021899132e-06
was O 0 2.3555980988021474e-06
found O 0 4.303557261664537e-07
to O 0 3.2922216064434906e-07
accumulate O 0 1.1458579365353216e-06
in O 0 6.362889166666719e-07
comparison O 0 1.1748090855689952e-06
to O 0 6.576736950592021e-07
the O 0 1.8846930061044986e-06
normal O 0 4.486512352741556e-06
alpha O 0 2.99534422083525e-05
- O 0 1.336120749328984e-05
subunit O 0 1.6337737179128453e-05
precursor O 0 6.99669835739769e-05
levels O 0 4.706364779849537e-05
. O 0 6.522615876747295e-05

We O 0 6.833132647443563e-05
conclude O 0 5.1386025006650016e-05
that O 0 4.842625457968097e-06
the O 0 7.52760206523817e-06
1422 O 1 0.8560115694999695
G O 0 0.18954557180404663
- O 0 0.00048249802784994245
- O 0 6.669673166470602e-05
> O 0 2.6713585612014867e-05
C O 0 3.815601303358562e-05
mutation O 0 2.506578539396287e-06
is O 0 7.963483881212596e-07
the O 0 1.0980365914292634e-06
cause O 0 3.024121042471961e-06
of O 0 5.9810477068822365e-06
Hex B-Disease 1 0.6944268345832825
A I-Disease 1 0.7972614765167236
enzyme I-Disease 1 0.9983239769935608
deficiency I-Disease 1 0.9999997615814209
in O 0 5.606769991572946e-05
the O 0 0.00010235566151095554
proband O 0 0.46516379714012146
. O 0 0.00017896940698847175

The O 0 0.00020448837312869728
resulting O 0 0.00025529079721309245
W474C O 0 0.0008267821976915002
substitution O 0 7.541522063547745e-05
clearly O 0 3.3257332688663155e-05
interferes O 0 1.5105749298527371e-05
with O 0 3.094879275522544e-06
alpha O 0 2.175842018914409e-05
- O 0 6.840356036263984e-06
subunit O 0 4.350946710474091e-06
processing O 0 2.5755523438419914e-06
, O 0 6.072716018934443e-07
but O 0 3.4137642046516703e-07
because O 0 3.238118324588868e-07
the O 0 7.096203376022459e-07
base O 0 4.665920187107986e-06
substitution O 0 6.209939328982728e-06
falls O 0 2.0611545551219024e-05
at O 0 3.1973595469025895e-06
the O 0 9.61376827035565e-07
first O 0 1.4640742165283882e-06
position O 0 1.7084008732126676e-06
of O 0 1.787672431419196e-06
exon O 0 1.717733175610192e-05
13 O 0 4.022549092042027e-06
, O 0 1.8146640741178999e-06
aberrant O 0 5.878008323634276e-06
splicing O 0 6.255369044083636e-06
may O 0 1.8494158666726435e-06
also O 0 1.0707191222536494e-06
contribute O 0 2.378340241193655e-06
to O 0 3.924206794181373e-06
Hex B-Disease 0 0.0007330113439820707
A I-Disease 0 0.0064778574742376804
deficiency I-Disease 1 0.9999103546142578
in O 0 2.0572349967551418e-05
this O 0 2.0876850612694398e-05
proband O 0 0.004306777846068144
. O 0 4.526972770690918e-05
. O 0 0.0001006272213999182

Two O 0 7.735258259344846e-05
frequent O 0 9.980774484574795e-05
missense O 0 0.00051399867516011
mutations O 0 0.00014561090210918337
in O 0 0.0004379560414236039
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.551591694355011

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 0.2430805265903473
an O 1 0.9277569651603699
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 1.0
by O 1 0.986428439617157
early O 1 0.9999949932098389
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999984502792358
goiter B-Disease 1 1.0
. O 1 0.9975582361221313

A O 0 0.0005638336297124624
century O 0 0.00016123738896567374
after O 0 2.4308908905368298e-05
its O 0 5.141013843967812e-06
recognition O 0 1.075958334695315e-05
as O 0 9.435643733013421e-06
a O 0 8.063016866799444e-05
syndrome O 1 0.9999946355819702
by O 0 2.1781610485049896e-05
Vaughan O 1 0.7844202518463135
Pendred O 1 0.9942795038223267
, O 0 6.5259755501756445e-06
the O 0 9.985684300772846e-06
disease O 1 0.9889100790023804
gene O 0 1.5538371371803805e-05
( O 0 1.6315894754370674e-05
PDS O 1 0.996685802936554
) O 0 7.132541213650256e-06
was O 0 1.3928911357652396e-05
mapped O 0 1.3298041267262306e-05
to O 0 1.1918245945707895e-05
chromosome O 0 0.00012131540279369801
7q22 O 0 0.001114669139496982
- O 0 0.00046849215868860483
q31 O 0 0.0018489521462470293
. O 0 0.00021345277491491288

1 O 0 0.00038053299067541957
and O 0 4.302549496060237e-05
, O 0 1.605485704203602e-05
recently O 0 2.032909105764702e-05
, O 0 1.6468151216031401e-06
found O 0 6.912932803970762e-07
to O 0 6.68328823394404e-07
encode O 0 2.9571594950539293e-06
a O 0 1.2153634997957852e-05
putative O 0 0.0003362461575306952
sulfate O 0 0.32638680934906006
transporter O 1 0.9599087238311768
. O 0 0.00030254072044044733

We O 0 3.1000818125903606e-05
performed O 0 2.5160623408737592e-05
mutation O 0 6.824678621342173e-06
analysis O 0 2.393375552856014e-06
of O 0 3.689195182232652e-06
the O 0 7.66927951190155e-06
PDS B-Disease 1 0.9999305009841919
gene O 0 4.666516360884998e-06
in O 0 2.0407094325491926e-06
patients O 0 2.982778141813469e-06
from O 0 2.557625748522696e-06
14 O 0 1.7886215573525988e-05
Pendred B-Disease 0 0.0029198890551924706
families O 0 2.8185977498651482e-06
originating O 0 3.4782713100867113e-06
from O 0 1.3191158814152004e-06
seven O 0 1.4251986613089684e-06
countries O 0 4.539985809515201e-07
and O 0 1.196389689539501e-06
identified O 0 4.239137979311636e-06
all O 0 4.9177319851878565e-06
mutations O 0 4.4451957364799455e-05
. O 0 0.00012951111420989037

The O 0 9.654864697949961e-05
mutations O 0 2.8158032364444807e-05
include O 0 9.088687875191681e-06
three O 0 5.813584266434191e-06
single O 0 6.374310487444745e-06
base O 0 2.0178187696728855e-05
deletions O 0 1.575540409248788e-05
, O 0 4.103393166587921e-06
one O 0 4.009978056274122e-06
splice O 0 3.1519281037617475e-05
site O 0 1.3689420484297443e-05
mutation O 0 5.311333097779425e-06
and O 0 2.2854985672893235e-06
10 O 0 1.248157332156552e-05
missense O 0 0.0001427818788215518
mutations O 0 5.9575322666205466e-05
. O 0 7.731601363047957e-05

One O 0 0.00018036218534689397
missense O 0 0.00035402114735916257
mutation O 0 4.977715070708655e-05
( O 0 3.317010487080552e-05
L236P O 0 0.0001226709719048813
) O 0 3.875755737681175e-06
was O 0 6.808985290263081e-06
found O 0 7.113997071428457e-07
in O 0 4.266716757683753e-07
a O 0 8.489690230817359e-07
homozygous O 0 1.6780293208285002e-06
state O 0 6.648470503023418e-07
in O 0 7.194265663201804e-07
two O 0 8.289531479022116e-07
consanguineous O 0 2.2218409867491573e-05
families O 0 1.8721284504863434e-06
and O 0 6.641835170739796e-07
in O 0 8.083646889645024e-07
a O 0 2.3879883883637376e-06
heterozygous O 0 1.9378071556275245e-06
state O 0 8.804674394014e-07
in O 0 8.505817845616548e-07
five O 0 2.307467184436973e-06
additional O 0 6.494864464912098e-06
non O 0 4.159003583481535e-05
- O 0 0.00018048568745143712
consanguineous O 0 0.0014546432066708803
families O 0 5.9114605392096564e-05
. O 0 9.204452362610027e-05

Another O 0 0.0005367936682887375
missense O 0 0.0011710128746926785
mutation O 0 0.00012207537656649947
( O 0 3.5600733099272475e-05
T416P O 0 0.00021649016707669944
) O 0 4.569925295072608e-06
was O 0 7.80115897214273e-06
found O 0 1.053359369507234e-06
in O 0 9.509251981398847e-07
a O 0 2.3447857984137954e-06
homozygous O 0 3.5717207538255025e-06
state O 0 1.4212367887012078e-06
in O 0 1.7433989114579163e-06
one O 0 1.8448308765073307e-06
family O 0 3.88913713322836e-06
and O 0 1.187806333291519e-06
in O 0 1.2389170933602145e-06
a O 0 2.9935331440356094e-06
heterozygous O 0 4.766720849147532e-06
state O 0 2.6092793632415123e-06
in O 0 3.5235837003710913e-06
four O 0 7.368500973825576e-06
families O 0 2.7535847038961947e-05
. O 0 0.0001087438577087596

Pendred B-Disease 1 0.9351925253868103
patients O 0 0.00013936006871517748
in O 0 2.13139701372711e-05
three O 0 1.046183842845494e-05
non O 0 4.62428288301453e-05
- O 0 9.458682325202972e-05
consanguineous O 0 0.0001858739706221968
families O 0 2.337899786652997e-06
were O 0 1.4276187130235485e-06
shown O 0 1.0582941740722163e-06
to O 0 8.236474400291627e-07
be O 0 1.3918109971200465e-06
compound O 0 1.5983348930603825e-05
heterozygotes O 0 3.640486465883441e-05
for O 0 1.5124661331356037e-05
L236P O 0 0.0008348977426066995
and O 0 7.195797661552206e-05
T416P O 0 0.0018018775153905153
. O 0 0.00023281155154109

In O 0 6.93431356921792e-05
total O 0 2.7833310014102608e-05
, O 0 8.669197995914146e-06
one O 0 1.8262231833432452e-06
or O 0 8.889044806892343e-07
both O 0 7.012118885540986e-07
of O 0 1.396253992425045e-06
these O 0 4.054331839142833e-07
mutations O 0 9.79184278548928e-07
were O 0 1.2029108802380506e-06
found O 0 1.0724932053562952e-06
in O 0 1.1752887303373427e-06
nine O 0 2.645581389515428e-06
of O 0 2.740965783232241e-06
the O 0 8.497713679389562e-06
14 O 0 1.851600973168388e-05
families O 0 1.0198492418567184e-05
analyzed O 0 5.6186145229730755e-05
. O 0 6.257973291212693e-05

The O 0 7.487492985092103e-05
identification O 0 4.6830933570163324e-05
of O 0 2.3372409486910328e-05
two O 0 1.0722584192990325e-05
frequent O 0 4.727528721559793e-05
PDS B-Disease 1 0.9997314810752869
mutations O 0 6.742917321389541e-06
will O 0 1.051246840688691e-06
facilitate O 0 1.7175818811665522e-06
the O 0 1.888539827632485e-06
molecular O 0 1.3572504940384533e-05
diagnosis O 0 0.010301485657691956
of O 1 0.9853491187095642
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.801590085029602

Insertional O 0 0.007631444837898016
mutation O 0 0.00013229101023171097
by O 0 2.3105802029022016e-05
transposable O 0 0.0009557391749694943
element O 0 8.934208744904026e-05
, O 0 1.5548272131127305e-05
L1 O 0 0.029298927634954453
, O 0 3.815599484369159e-06
in O 0 2.3533862076874357e-06
the O 0 7.5699094850278925e-06
DMD B-Disease 1 0.9999538660049438
gene O 0 4.231036655255593e-06
results O 0 2.0375628082547337e-06
in O 0 4.816052296519047e-06
X B-Disease 0 0.009105687029659748
- I-Disease 1 0.8598682284355164
linked I-Disease 1 0.9901573657989502
dilated I-Disease 1 0.999910831451416
cardiomyopathy I-Disease 1 0.9999997615814209
. O 0 0.0008038304513320327

X B-Disease 1 0.9853149652481079
- I-Disease 1 0.999030351638794
linked I-Disease 1 0.9994497895240784
dilated I-Disease 1 0.9999982118606567
cardiomyopathy I-Disease 1 1.0
( O 1 0.8630552887916565
XLDCM B-Disease 1 0.9999973773956299
) O 0 5.568436790781561e-06
is O 0 1.7138643215730553e-06
a O 0 2.5156716674246127e-06
clinical O 0 1.5078993783390615e-05
phenotype O 0 8.304143193527125e-06
of O 0 1.337366302323062e-05
dystrophinopathy B-Disease 1 0.9807354807853699
which O 0 2.4104065232677385e-06
is O 0 1.7086713341996074e-06
characterized O 0 4.554176030069357e-06
by O 0 2.2216615889192326e-06
preferential O 0 0.0007153578335419297
myocardial B-Disease 1 1.0
involvement I-Disease 1 0.5691378116607666
without O 0 7.856684533180669e-06
any O 0 3.453827275734511e-06
overt O 0 8.97906647878699e-05
clinical O 0 0.06024466082453728
signs O 1 0.7238802313804626
of O 1 0.9990750551223755
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.773428201675415

To O 0 5.420907473308034e-05
date O 0 3.70577399735339e-05
, O 0 9.35967909754254e-06
several O 0 2.890081759687746e-06
mutations O 0 4.738402367365779e-06
in O 0 8.798691851552576e-06
the O 0 0.02964623086154461
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9866757988929749
, O 0 0.008004596456885338
DMD O 1 0.9999998807907104
, O 0 6.271872734942008e-06
have O 0 5.92891410633456e-07
been O 0 1.3275284800329246e-06
identified O 0 1.585157747285848e-06
in O 0 1.1412536196075962e-06
patients O 0 5.187168881093385e-06
with O 0 5.130420049681561e-06
XLDCM B-Disease 1 0.999997615814209
, O 0 4.313634235586505e-06
but O 0 6.218030534910213e-07
a O 0 1.4079701031732839e-06
pathogenic O 0 1.348671844425553e-06
correlation O 0 1.5361737268904108e-06
of O 0 1.6320964277838357e-06
these O 0 7.844943183954456e-07
cardiospecific O 0 0.0008445614366792142
mutations O 0 4.699744295066921e-06
in O 0 7.236706096591661e-06
DMD O 1 0.9999808073043823
with O 0 5.265675099508371e-06
the O 0 4.941123916069046e-05
XLDCM B-Disease 1 0.9999903440475464
phenotype O 0 2.813521678035613e-05
has O 0 8.891639481589664e-06
remained O 0 2.6549872927716933e-05
to O 0 4.119170171179576e-06
be O 0 1.2518828043539543e-05
elucidated O 0 0.0006030819495208561
. O 0 0.00016174862685147673

We O 0 5.6334218243137e-05
report O 0 1.0731892871262971e-05
here O 0 5.462640729092527e-06
the O 0 1.528975531073229e-06
identification O 0 1.5390551197924651e-06
of O 0 2.3474574391002534e-06
a O 0 6.527706318593118e-06
unique O 0 4.28599651058903e-06
de O 0 3.2382002245867625e-05
novo O 0 5.6445580412400886e-05
L1 O 0 0.00046921439934521914
insertion O 0 2.3659076759940945e-05
in O 0 4.820040430786321e-06
the O 0 6.759051757398993e-06
muscle O 0 5.3993677283870056e-05
exon O 0 6.32697920082137e-05
1 O 0 2.6526944566285238e-05
in O 0 1.503099610999925e-05
DMD O 1 0.9999651908874512
in O 0 6.941213541722391e-06
three O 0 8.724636245460715e-06
XLDCM B-Disease 1 0.998996913433075
patients O 0 6.866145668027457e-06
from O 0 2.8916394967382075e-06
two O 0 2.6597176656650845e-06
unrelated O 0 1.580292337166611e-05
Japanese O 0 0.00012119029997847974
families O 0 2.7418196623330005e-05
. O 0 7.192059274530038e-05

The O 0 0.0002029494207818061
insertion O 0 0.00028399459552019835
was O 0 0.00013528850104194134
a O 0 3.222631130483933e-05
5 O 0 2.5722196369315498e-05
- O 0 1.7125121303251944e-05
truncated O 0 1.891150895971805e-05
form O 0 1.5252995808623382e-06
of O 0 3.863438450935064e-06
human O 0 4.8503907237318344e-06
L1 O 0 0.012039314024150372
inversely O 0 3.970509715145454e-05
integrated O 0 1.2962425898876972e-05
in O 0 1.7363570350426016e-06
the O 0 2.916028734034626e-06
5 O 0 1.3554603356169537e-05
- O 0 2.1297593775670975e-05
untranslated O 0 0.00012734626943711191
region O 0 7.1900185503182e-06
in O 0 1.764639364409959e-06
the O 0 5.120326022733934e-06
muscle O 0 3.335551082273014e-05
exon O 0 2.735295674938243e-05
1 O 0 7.44431781640742e-06
, O 0 1.2581882629092433e-06
which O 0 3.836880466678849e-07
affected O 0 6.938539627299178e-07
the O 0 8.984720807347912e-07
transcription O 0 3.826878128165845e-06
or O 0 7.741120384707756e-07
the O 0 1.3675346508534858e-06
stability O 0 5.285764927975833e-06
of O 0 2.1937357814749703e-06
the O 0 4.771123258251464e-06
muscle O 0 2.678879172890447e-05
form O 0 1.2563215250338544e-06
of O 0 3.983139322372153e-06
dystrophin O 0 0.00015304361295420676
transcripts O 0 7.002462098171236e-06
but O 0 5.145655563865148e-07
not O 0 1.9831502129363798e-07
that O 0 2.064739845764052e-07
of O 0 9.802259910429711e-07
the O 0 1.2268747923371848e-05
brain O 1 0.9600437879562378
or O 0 3.791252675000578e-05
Purkinje O 1 0.9999258518218994
cell O 0 5.3386553190648556e-05
form O 0 3.2688622013665736e-06
, O 0 2.9829998311470263e-06
probably O 0 2.6508648716117023e-06
due O 0 1.8694379377848236e-06
to O 0 1.0422327250125818e-06
its O 0 1.537143930363527e-06
unique O 0 2.35585844166053e-06
site O 0 1.1469773198768962e-05
of O 0 2.0216899429215118e-05
integration O 0 0.00016941835929173976
. O 0 0.00012177053577033803

We O 0 0.00012777344090864062
speculate O 0 5.921865158597939e-05
that O 0 3.868430212605745e-06
this O 0 1.7931995444087079e-06
insertion O 0 1.9878811144735664e-05
of O 0 8.393876669288147e-06
an O 0 8.325386261276435e-06
L1 O 1 0.8856548070907593
sequence O 0 1.4324329640658107e-05
in O 0 9.815041266847402e-06
DMD O 1 0.9999285936355591
is O 0 2.3307181891141227e-06
responsible O 0 1.3427851399683277e-06
for O 0 3.865351345666568e-07
some O 0 5.026691383136495e-07
of O 0 1.392918306919455e-06
the O 0 1.5914711184450425e-06
population O 0 1.1478791748231743e-06
of O 0 3.6388958051247755e-06
Japanese O 0 6.456954724853858e-05
patients O 0 9.29273392102914e-06
with O 0 1.0315588042431045e-05
XLDCM B-Disease 1 0.9999352693557739
. O 0 5.095733285997994e-05
. O 0 9.52317423070781e-05

Severe O 1 0.9975277781486511
early O 0 0.4215317666530609
- O 1 0.9999876022338867
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999884366989136
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9956387877464294
red O 1 0.9999673366546631
hair O 1 0.9580855369567871
pigmentation O 1 0.9828675985336304
caused O 1 0.912286639213562
by O 0 5.28236705577001e-05
POMC O 1 0.9999946355819702
mutations O 0 3.537058364599943e-05
in O 0 1.3863234016753267e-05
humans O 0 3.111001569777727e-05
. O 0 5.825325206387788e-05

Sequential O 0 0.0004957806668244302
cleavage O 0 0.0003897151327691972
of O 0 5.305321610649116e-05
the O 0 2.4910485080908984e-05
precursor O 0 0.00022532735601998866
protein O 0 3.54265866917558e-05
pre O 0 9.877166303340346e-05
- O 0 0.00012959759624209255
pro O 0 0.0003004177997354418
- O 0 0.00032981199910864234
opiomelanocortin O 0 0.09138213843107224
( O 0 2.6704085030360147e-05
POMC O 0 0.0015901988372206688
) O 0 2.4079204195004422e-06
generates O 0 3.108355485892389e-06
the O 0 4.081186943949433e-06
melanocortin O 0 0.00044783102930523455
peptides O 0 2.6308594897272997e-05
adrenocorticotrophin O 0 0.00015380361583083868
( O 0 1.6159447113750502e-05
ACTH O 0 0.00020757608581334352
) O 0 9.92566128843464e-06
, O 0 1.0620842658681795e-05
melanocyte O 0 0.002218495588749647
- O 0 9.780349500942975e-05
stimulating O 0 0.00011926124716410413
hormones O 0 2.300185769854579e-05
( O 0 1.1490465112728998e-05
MSH O 0 0.0007200776017270982
) O 0 3.474975756034837e-06
alpha O 0 1.124919617723208e-05
, O 0 1.372451038150757e-06
beta O 0 3.412466412555659e-06
and O 0 7.971097488734813e-07
gamma O 0 3.137961130050826e-06
as O 0 1.2425864497345174e-06
well O 0 7.399312949019077e-07
as O 0 7.370852017629659e-07
the O 0 2.7150765617989236e-06
opioid O 0 8.447316940873861e-05
- O 0 6.962633779039606e-05
receptor O 0 6.40221405774355e-05
ligand O 0 5.732939098379575e-05
beta O 0 0.0001297590642934665
- O 0 0.00020387861877679825
endorphin O 0 0.0009898922871798277
. O 0 8.754507143748924e-05

While O 0 0.00016710133058950305
a O 0 4.075383913004771e-05
few O 0 7.844801984902006e-06
cases O 0 3.271797140769195e-06
of O 0 4.812567567569204e-05
isolated O 1 0.9999257326126099
ACTH B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999997615814209
have O 0 7.729569006187376e-06
been O 0 7.459568678314099e-06
reported O 0 8.512263775628526e-06
( O 0 1.39461499202298e-05
OMIM O 1 0.9959757924079895
201400 O 0 0.0007829272071830928
) O 0 4.482372787606437e-06
, O 0 1.952037337105139e-06
an O 0 4.5307701839192305e-06
inherited O 1 0.9999995231628418
POMC O 1 1.0
defect O 1 0.9995859265327454
has O 0 4.73719182991772e-06
not O 0 1.3352776022657054e-06
been O 0 3.197015075784293e-06
described O 0 7.2837337938835844e-06
so O 0 5.052821961726295e-06
far O 0 1.8908875063061714e-05
. O 0 4.8459281970281154e-05

Recent O 0 0.0001231108617503196
studies O 0 2.112269248755183e-05
in O 0 1.0259373084409162e-05
animal O 0 7.56468580220826e-06
models O 0 5.932963176746853e-06
elucidated O 0 3.319459574413486e-05
a O 0 4.361852006695699e-06
central O 0 7.134126462915447e-06
role O 0 7.055324203975033e-06
of O 0 1.419935142621398e-05
alpha O 0 0.00028222319087944925
- O 0 0.00012426194734871387
MSH O 0 0.018065176904201508
in O 0 1.8563445109975873e-06
the O 0 2.7389901333663147e-06
regulation O 0 1.8123863583241473e-06
of O 0 2.2143153728393372e-06
food O 0 1.8929900988950976e-06
intake O 0 1.9594306195358513e-06
by O 0 6.591342298634117e-07
activation O 0 4.203947810310638e-06
of O 0 4.573892965709092e-06
the O 0 8.234454980993178e-06
brain O 0 0.00020751968258991838
melanocortin O 0 0.050114139914512634
- O 0 4.888486000709236e-05
4 O 0 3.224472311558202e-05
- O 0 3.654190368251875e-05
receptor O 0 2.405560553597752e-05
( O 0 1.1015808013326023e-05
MC4 O 0 0.004861641675233841
- O 0 2.3433694877894595e-05
R O 0 3.127251329715364e-05
; O 0 2.277341764056473e-06
refs O 0 1.8235488823847845e-05
3 O 0 1.246691681444645e-05
- O 0 8.478204108541831e-06
5 O 0 5.104986939841183e-06
) O 0 8.78713478869031e-07
and O 0 4.788558953805477e-07
the O 0 1.5749594695080305e-06
linkage O 0 1.027202233672142e-05
of O 0 4.5520223466155585e-06
human O 0 6.763868896086933e-06
obesity B-Disease 1 0.858401894569397
to O 0 2.3731020064587938e-06
chromosome O 0 7.452884347003419e-06
2 O 0 2.897500053222757e-06
in O 0 1.1305282896501012e-06
close O 0 3.2749062484072056e-06
proximity O 0 2.877005726986681e-06
to O 0 1.7703231378618511e-06
the O 0 7.3557093855924904e-06
POMC O 0 0.24128016829490662
locus O 0 2.002495966735296e-05
, O 0 2.1881755856156815e-06
led O 0 2.7630271688394714e-06
to O 0 6.331533768388908e-07
the O 0 1.4358288353832904e-06
proposal O 0 1.7405100152245723e-06
of O 0 2.0870081698376453e-06
an O 0 1.846587565523805e-06
association O 0 8.022905603866093e-06
of O 0 2.6933417757390998e-05
POMC O 1 0.9999865293502808
with O 0 3.077384099015035e-05
human O 0 0.00023032196622807533
obesity B-Disease 1 0.999993085861206
. O 0 0.00024298134667333215

The O 0 0.000140830161399208
dual O 0 0.00012673134915530682
role O 0 0.00010053283767774701
of O 0 0.0001597730879439041
alpha O 0 0.0653485432267189
- O 0 0.015029960311949253
MSH O 1 0.9979420304298401
in O 0 1.0032006684923545e-05
regulating O 0 2.2977827029535547e-05
food O 0 6.2236822486738674e-06
intake O 0 1.3435046639642678e-05
and O 0 4.486846592044458e-06
influencing O 0 4.65080956928432e-05
hair O 0 5.713531936635263e-05
pigmentation O 0 0.00010321593435946852
predicts O 0 1.1538692888279911e-05
that O 0 4.937186872666643e-07
the O 0 1.1969020761171123e-06
phenotype O 0 3.7224053812678903e-06
associated O 0 1.2162097391410498e-06
with O 0 1.2665576605286333e-06
a O 0 2.1049152564955875e-05
defect O 1 0.9288780093193054
in O 0 2.0626372133847326e-05
POMC O 1 0.9999527931213379
function O 0 3.5307923553773435e-06
would O 0 1.151341507465986e-06
include O 0 7.2475013439543545e-06
obesity B-Disease 1 0.9999181032180786
, O 0 9.390704690304119e-06
alteration O 0 0.0011827951529994607
in O 0 3.904912591679022e-05
pigmentation O 1 0.9983890056610107
and O 0 0.13844113051891327
ACTH B-Disease 1 0.9999995231628418
deficiency I-Disease 1 1.0
. O 0 0.0015680888900533319

The O 0 0.00011858843936352059
observation O 0 0.0001313758548349142
of O 0 2.4131521058734506e-05
these O 0 4.5304982450034e-06
symptoms O 0 0.0006865210016258061
in O 0 9.930736268870533e-06
two O 0 4.537615495792124e-06
probands O 0 0.009540393017232418
prompted O 0 8.302923561132047e-06
us O 0 1.5100285963853821e-06
to O 0 5.018927140554297e-07
search O 0 1.518340468464885e-06
for O 0 9.067701398635108e-07
mutations O 0 2.1214918888290413e-06
within O 0 4.186041223874781e-06
their O 0 8.065503607213032e-06
POMC O 1 0.9568673372268677
genes O 0 4.423965947353281e-05
. O 0 7.398432353511453e-05

Patient O 0 0.00027002798742614686
1 O 0 8.430377783952281e-05
was O 0 6.340097024803981e-05
found O 0 2.5641659249231452e-06
to O 0 1.1421573162806453e-06
be O 0 8.075779760474688e-07
a O 0 1.9929345853597624e-06
compound O 0 8.26622544991551e-06
heterozygote O 0 1.0303644558007363e-05
for O 0 8.894573397810746e-07
two O 0 7.275661459971161e-07
mutations O 0 1.4579545677406713e-06
in O 0 1.935081400006311e-06
exon O 0 2.3239921574713662e-05
3 O 0 9.60269335337216e-06
( O 0 6.9032680585223716e-06
G7013T O 0 3.809140616795048e-05
, O 0 3.0415094443014823e-06
C7133delta O 0 5.3712450608145446e-05
) O 0 9.604246997696464e-07
which O 0 4.7558231131006323e-07
interfere O 0 1.4685854239360197e-06
with O 0 6.691068392683519e-07
appropriate O 0 1.3991732430440607e-06
synthesis O 0 8.06301977718249e-06
of O 0 1.0571367965894751e-05
ACTH O 0 0.0004625821893569082
and O 0 1.700693064776715e-05
alpha O 0 0.00034080390469171107
- O 0 0.000529502984136343
MSH O 1 0.8810536861419678
. O 0 0.000141275639180094

Patient O 0 0.00046854757238179445
2 O 0 0.0001357366272713989
was O 0 6.717239011777565e-05
homozygous O 0 1.2320196219661739e-05
for O 0 2.483166781530599e-06
a O 0 5.223387233854737e-06
mutation O 0 3.7738952869403875e-06
in O 0 3.922863470506854e-06
exon O 0 5.071513442089781e-05
2 O 0 2.8316693715169095e-05
( O 0 1.13272326416336e-05
C3804A O 0 0.0001277276169275865
) O 0 1.0576662134553771e-05
which O 0 1.3627628504764289e-05
abolishes O 0 0.00034890943788923323
POMC O 0 0.2319335788488388
translation O 0 0.00021473594824783504
. O 0 0.00017847385606728494

These O 0 2.341493200219702e-05
findings O 0 1.7545593436807394e-05
represent O 0 9.837568541115616e-06
the O 0 5.151802270120243e-06
first O 0 5.539274752663914e-06
examples O 0 4.349121354607632e-06
of O 0 8.37930383568164e-06
a O 0 0.00011017536598956212
genetic B-Disease 1 0.9999339580535889
defect I-Disease 1 0.9999916553497314
within O 0 2.3228776626638137e-05
the O 0 4.618967795977369e-05
POMC O 1 0.9998130202293396
gene O 0 3.208780981367454e-06
and O 0 7.267457817761169e-07
define O 0 1.85037208666472e-06
a O 0 3.2593989089946263e-06
new O 0 9.607126230548602e-06
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
resulting O 0 0.250050812959671
in O 0 3.47862187481951e-05
early O 0 0.32576704025268555
- O 1 0.9999094009399414
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9998010993003845
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.886525571346283
red O 1 0.9992436170578003
hair O 0 0.0648282840847969
pigmentation O 0 0.04147994518280029
. O 0 3.3528714993735775e-05
. O 0 6.646537076449022e-05

A O 0 0.0002434045309200883
European O 0 7.715258107054979e-05
multicenter O 0 0.0011840735096484423
study O 0 1.8698925487115048e-05
of O 0 0.0001154839774244465
phenylalanine B-Disease 1 0.9999880790710449
hydroxylase I-Disease 1 0.9999905824661255
deficiency I-Disease 1 1.0
: O 0 1.604431054147426e-05
classification O 0 1.0704908163461369e-05
of O 0 8.098453690763563e-06
105 O 0 1.934244210133329e-05
mutations O 0 2.6887864805758e-06
and O 0 8.054843192439876e-07
a O 0 1.330616100858606e-06
general O 0 2.312944388904725e-06
system O 0 2.73406294581946e-06
for O 0 1.4921986348781502e-06
genotype O 0 1.5304171029129066e-05
- O 0 1.7006072084768675e-05
based O 0 5.190691808820702e-06
prediction O 0 1.6540978322154842e-05
of O 0 3.360211121616885e-05
metabolic O 1 0.9959540367126465
phenotype O 0 0.0006010299548506737
. O 0 0.00018338403606321663

Phenylketonuria B-Disease 1 0.9999641180038452
( O 1 0.5353634357452393
PKU B-Disease 1 0.9999983310699463
) O 0 9.05075139598921e-05
and O 0 2.7936968763242476e-05
mild B-Disease 1 0.9996957778930664
hyperphenylalaninemia I-Disease 1 1.0
( O 1 0.9969224333763123
MHP B-Disease 1 1.0
) O 0 1.9762697775149718e-05
are O 0 1.891243300633505e-06
allelic B-Disease 0 0.06908313930034637
disorders I-Disease 1 0.9999942779541016
caused O 0 0.026513373479247093
by O 0 4.767102836922277e-06
mutations O 0 4.02351997763617e-06
in O 0 1.1531062682479387e-06
the O 0 2.982067144330358e-06
gene O 0 4.579689630190842e-06
encoding O 0 1.1797799743362702e-05
phenylalanine O 0 0.0001072953236871399
hydroxylase O 0 0.0008582599693909287
( O 0 0.0001080289512174204
PAH O 1 0.9999992847442627
) O 0 0.00016197860531974584
. O 0 0.00016732915537431836

Previous O 0 0.00011240203457418829
studies O 0 2.9667196940863505e-05
have O 0 3.381944452485186e-06
suggested O 0 4.378297489893157e-06
that O 0 4.4523110886984796e-07
the O 0 1.1946543736485182e-06
highly O 0 4.521675236901501e-06
variable O 0 6.735731403750833e-06
metabolic O 0 0.08841340243816376
phenotypes O 0 0.0003888686478603631
of O 1 0.9755021333694458
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.9982650876045227
with O 1 0.9426475167274475
PAH O 1 1.0
genotypes O 1 0.9984812140464783
. O 0 0.0005215505370870233

We O 0 5.806479384773411e-05
identified O 0 2.3243623218149878e-05
both O 0 7.179124168033013e-06
causative O 0 0.00013970826694276184
mutations O 0 1.1987380275968462e-05
in O 0 9.919576768879779e-06
686 O 0 0.031159888952970505
patients O 0 1.7655887859291397e-05
from O 0 9.716461136122234e-06
seven O 0 2.140802280337084e-05
European O 0 2.4927358026616275e-05
centers O 0 9.369253530167043e-05
. O 0 9.635788592277095e-05

On O 0 5.146566400071606e-05
the O 0 7.769670446577948e-06
basis O 0 5.13149143444025e-06
of O 0 4.766298388858559e-06
the O 0 4.931252988171764e-06
phenotypic O 0 1.225343112309929e-05
characteristics O 0 5.807195066154236e-06
of O 0 8.675765457155649e-06
297 O 0 0.0006129371467977762
functionally O 0 0.0031487708911299706
hemizygous O 0 0.07179278135299683
patients O 0 7.665214070584625e-06
, O 0 2.306650912942132e-06
105 O 0 4.272463684173999e-06
of O 0 2.7601538477028953e-06
the O 0 1.7594200016901596e-06
mutations O 0 1.9199126199964667e-06
were O 0 9.954630968422862e-07
assigned O 0 1.924181788126589e-06
to O 0 8.917642162487027e-07
one O 0 9.111825534091622e-07
of O 0 3.197228579665534e-06
four O 0 3.97968005927396e-06
arbitrary O 0 1.0033251783170272e-05
phenotype O 0 3.4582535590743646e-05
categories O 0 3.518991434248164e-05
. O 0 9.789353498490527e-05

We O 0 7.027068204479292e-05
proposed O 0 3.2416577596450225e-05
and O 0 5.43991154700052e-06
tested O 0 8.539394912077114e-06
a O 0 2.928709363914095e-06
simple O 0 1.6609760677965824e-06
model O 0 1.003014176603756e-06
for O 0 5.376147669267084e-07
correlation O 0 1.971674464584794e-06
between O 0 2.5787253434828017e-06
genotype O 0 8.41228393255733e-06
and O 0 4.8236270231427625e-06
phenotypic O 0 3.6515117244562134e-05
outcome O 0 0.0001031678038998507
. O 0 0.00011124955926788971

The O 0 7.581454701721668e-05
observed O 0 4.6734301577089354e-05
phenotype O 0 3.201714571332559e-05
matched O 0 1.4860841474728659e-05
the O 0 4.223687483317917e-06
predicted O 0 8.00339512352366e-06
phenotype O 0 2.5036208626261214e-06
in O 0 1.4079728316573892e-06
79 O 0 4.8317297114408575e-06
% O 0 1.6752743476899923e-06
of O 0 2.0785071228601737e-06
the O 0 2.5873569029499777e-06
cases O 0 1.43707131883275e-06
, O 0 1.437263222214824e-06
and O 0 6.034705393176409e-07
in O 0 6.744672873537638e-07
only O 0 3.534612460498465e-07
5 O 0 1.1021207910744124e-06
of O 0 2.0467241483856924e-06
184 O 0 1.1642473509709816e-05
patients O 0 4.769485713040922e-06
was O 0 1.208679168485105e-05
the O 0 2.421765884719207e-06
observed O 0 1.8972842781295185e-06
phenotype O 0 2.1690548237529583e-06
more O 0 3.8909223576411023e-07
than O 0 3.846428171527805e-07
one O 0 7.655911531401216e-07
category O 0 1.7929856994669535e-06
away O 0 2.555419314376195e-06
from O 0 1.973679900402203e-06
that O 0 1.89068418876559e-06
expected O 0 1.8514667317504063e-05
. O 0 5.0395537982694805e-05

Among O 0 8.47921910462901e-05
the O 0 1.9082746803178452e-05
seven O 0 1.3670100088347681e-05
contributing O 0 1.7885568013298325e-05
centers O 0 4.479176368477056e-06
, O 0 8.810899316813448e-07
the O 0 8.060506502260978e-07
proportion O 0 1.3848572280039662e-06
of O 0 4.478377832128899e-06
patients O 0 5.920867351960624e-06
for O 0 1.6555499087189673e-06
whom O 0 3.6996559629187686e-06
the O 0 1.2714772310573608e-06
observed O 0 1.6443402728327783e-06
phenotype O 0 2.4804471649986226e-06
did O 0 7.071208187880984e-07
not O 0 2.117413941959967e-07
match O 0 9.868782626654138e-07
the O 0 1.8302212083654013e-06
predicted O 0 7.283267677848926e-06
phenotype O 0 5.676238743035356e-06
was O 0 7.549961537733907e-06
4 O 0 6.999951438046992e-06
% O 0 3.8085827327449806e-06
- O 0 6.450826731452253e-06
23 O 0 4.695255938713672e-06
% O 0 2.050117473118007e-06
( O 0 2.8894701245008036e-06
P O 0 5.263947241473943e-05
< O 0 2.6041931050713174e-05
. O 0 1.5392489558507805e-06
0001 O 0 3.754406498046592e-05
) O 0 1.1756787898775656e-06
, O 0 7.717915195826208e-07
suggesting O 0 1.4931239320503664e-06
that O 0 1.8001803425704566e-07
differences O 0 7.174128882070363e-07
in O 0 6.767358513570798e-07
methods O 0 6.903221674292581e-07
used O 0 5.238499625193072e-07
for O 0 6.655974971181422e-07
mutation O 0 2.6146772142965347e-06
detection O 0 7.891459972597659e-06
or O 0 2.4196951926569454e-06
phenotype O 0 6.503850727312965e-06
classification O 0 7.2812540565792006e-06
may O 0 3.820347501459764e-06
account O 0 1.7103506024795934e-06
for O 0 1.594289187778486e-06
a O 0 6.276887233980233e-06
considerable O 0 2.3065471395966597e-05
proportion O 0 1.7373875380144455e-05
of O 0 2.5002540496643633e-05
genotype O 0 0.00035539676900953054
- O 0 0.0033532555680722
phenotype O 0 0.0002717908064369112
inconsistencies O 0 0.0009371842606924474
. O 0 0.00024182279594242573

Our O 0 8.527083991793916e-05
data O 0 1.8120035747415386e-05
indicate O 0 1.5712519598309882e-05
that O 0 4.362159870652249e-06
the O 0 2.9424403692246415e-05
PAH O 1 1.0
- O 0 0.009685096330940723
mutation O 0 4.524997166299727e-06
genotype O 0 3.779564167416538e-06
is O 0 8.098222679109313e-07
the O 0 7.929193088784814e-07
main O 0 2.382937736911117e-06
determinant O 0 1.2746017091558315e-05
of O 0 6.335940270218998e-06
metabolic O 0 0.19337479770183563
phenotype O 0 1.0015927728090901e-05
in O 0 2.5987396838900167e-06
most O 0 4.664709649659926e-06
patients O 0 0.0007966270204633474
with O 1 0.8095276355743408
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.9985584616661072

In O 0 8.307716780109331e-05
the O 0 2.243481867481023e-05
present O 0 8.512986823916435e-06
study O 0 6.066596597520402e-06
, O 0 2.2169394924276276e-06
the O 0 1.5118470173547394e-06
classification O 0 9.255189979739953e-06
of O 0 2.9540551622631028e-05
105 O 1 0.9795610308647156
PAH O 1 1.0
mutations O 0 1.647275530558545e-05
may O 0 2.2541462385561317e-06
allow O 0 5.704070531464822e-07
the O 0 7.571683795504214e-07
prediction O 0 3.6520161756925518e-06
of O 0 1.4710900586578646e-06
the O 0 2.911612909883843e-06
biochemical O 0 2.021076943492517e-05
phenotype O 0 7.146076768549392e-06
in O 0 2.278056399518391e-06
> O 0 1.5019361853774171e-05
10 O 0 3.865502094413387e-06
, O 0 2.3109755602490623e-06
000 O 0 7.062958047754364e-06
genotypes O 0 5.29096996615408e-06
, O 0 8.819877734822512e-07
which O 0 4.7582460638295743e-07
may O 0 9.65351205195475e-07
be O 0 4.332200944645592e-07
useful O 0 8.196957423933782e-07
for O 0 1.3502328783943085e-06
the O 0 4.6957211452536285e-06
management O 0 2.7986965505988337e-05
of O 0 6.364193541230634e-05
hyperphenylalaninemia B-Disease 1 0.9999591112136841
in O 0 9.834254888119176e-05
newborns O 0 0.0006773123168386519
. O 0 0.00014716053556185216

Somatic O 0 0.004506646655499935
instability O 0 0.0029390514828264713
of O 0 0.00014595341053791344
the O 0 0.00011481944966362789
CTG O 1 0.9984214305877686
repeat O 0 0.00011132946383440867
in O 0 1.660378802625928e-05
mice O 0 4.387213630252518e-05
transgenic O 0 3.6279234336689115e-05
for O 0 5.185793725104304e-06
the O 0 0.011655179783701897
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 0.24780477583408356
is O 0 1.5150561011978425e-05
age O 0 1.0079120329464786e-05
dependent O 0 1.8129413774659042e-06
but O 0 3.4176960639342724e-07
not O 0 1.8083466102325474e-07
correlated O 0 8.654921543893579e-07
to O 0 3.4601632137309934e-07
the O 0 1.3684662008017767e-06
relative O 0 9.000636964628939e-06
intertissue O 0 0.00019731515203602612
transcription O 0 4.259247725713067e-05
levels O 0 2.0646799384849146e-05
and O 0 1.9318293198011816e-05
proliferative O 1 0.9868659377098083
capacities O 0 0.001303680706769228
. O 0 0.00022868887754157186

A O 0 0.0019229071913287044
( O 0 0.00046181314974091947
CTG O 0 0.4842956066131592
) O 0 4.87270335725043e-05
nexpansion O 0 0.00019040658662561327
in O 0 7.777306564094033e-06
the O 0 7.944323442643508e-06
3 O 0 3.5405915696173906e-05
- O 0 5.161217995919287e-05
untranslated O 0 0.0003700460074469447
region O 0 2.3036014681565575e-05
( O 0 4.647994956030743e-06
UTR O 0 0.00011573886149562895
) O 0 1.3369110547500895e-06
of O 0 1.8598850601847516e-06
the O 0 6.449731699831318e-06
DM O 1 0.9999994039535522
protein O 0 2.2302730940282345e-05
kinase O 0 1.827842424972914e-05
gene O 0 4.196817371848738e-06
( O 0 2.679151975826244e-06
DMPK O 0 0.00018252248992212117
) O 0 1.2388923096295912e-06
is O 0 4.910065740659775e-07
responsible O 0 1.8518213664719951e-06
for O 0 4.6011314225324895e-06
causing O 1 0.9999408721923828
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999314546585083
DM B-Disease 1 1.0
) O 0 0.0005745238158851862
. O 0 0.000232265010708943

Major O 0 0.00561119569465518
instability O 0 0.35877329111099243
, O 0 2.1942585590295494e-05
with O 0 5.804061402159277e-06
very O 0 5.697400865756208e-06
large O 0 4.331310265115462e-06
expansions O 0 1.4491821275441907e-05
between O 0 5.2165769375278614e-06
generations O 0 6.436569947254611e-06
and O 0 1.7718331264404696e-06
high O 0 5.7910688155971e-06
levels O 0 2.264177282995661e-06
of O 0 5.615312147710938e-06
somatic O 0 0.00039699370972812176
mosaicism O 1 0.6120492219924927
, O 0 5.86765281695989e-06
is O 0 3.7255342704156647e-06
observed O 0 5.014337602915475e-06
in O 0 1.10995160866878e-05
patients O 0 5.172412420506589e-05
. O 0 8.260775939561427e-05

There O 0 0.00010749593639047816
is O 0 3.319235111121088e-05
a O 0 9.961571777239442e-06
good O 0 5.588205567619298e-06
correlation O 0 6.133677743491717e-06
between O 0 6.387369012372801e-06
repeat O 0 1.5782621630933136e-05
size O 0 4.242442628310528e-06
( O 0 8.229085892708099e-07
at O 0 1.929015752466512e-06
least O 0 8.761704179960361e-07
in O 0 1.6461400491607492e-06
leucocytes O 0 0.00012032931408612058
) O 0 2.155145011784043e-06
, O 0 2.2687099772156216e-06
clinical O 0 9.580193363945e-06
severity O 0 2.2458407329395413e-05
and O 0 6.301135272224201e-06
age O 0 6.399735866580158e-05
of O 0 0.00019160661031492054
onset O 1 0.999984860420227
. O 0 0.0008806561236269772

The O 0 0.0007873406866565347
trinucleotide O 1 0.9996718168258667
repeat O 0 0.0032375259324908257
instability O 1 0.8373721837997437
mechanisms O 0 6.830369966337457e-05
involved O 0 2.6444602553965524e-05
in O 0 2.6305986466468312e-05
DM B-Disease 1 1.0
and O 0 9.405869604961481e-06
other O 0 3.301047854620265e-06
human O 0 4.625588553608395e-05
genetic B-Disease 1 0.9999887943267822
diseases I-Disease 1 0.9999997615814209
are O 0 1.3924395716458093e-05
unknown O 0 0.00021327032300177962
. O 0 0.00010648430179571733

We O 0 0.00010690315684769303
studied O 0 0.00013775547267869115
somatic O 0 0.0002998932613991201
instability O 0 0.0004296734987292439
by O 0 2.1858375475858338e-05
measuring O 0 0.0003117728920187801
the O 0 3.020397161890287e-05
CTG O 1 0.8596963882446289
repeat O 0 1.446492660761578e-05
length O 0 3.031241249118466e-06
at O 0 3.4858594517572783e-06
several O 0 6.312469622571371e-07
ages O 0 1.7219281289726496e-06
in O 0 1.1345038046783884e-06
various O 0 1.0042411986432853e-06
tissues O 0 4.36066238762578e-06
of O 0 6.191572538227774e-06
transgenic O 0 0.00013801422028336674
mice O 0 9.719575245981105e-06
carrying O 0 4.797056590177817e-06
a O 0 4.627799626177875e-06
( O 0 1.105537830881076e-05
CTG O 0 0.06800060719251633
) O 0 8.7021080616978e-06
55expansion O 0 5.6926903198473155e-05
surrounded O 0 1.4007236131874379e-05
by O 0 1.2203622645756695e-06
45 O 0 2.576957740529906e-06
kb O 0 2.094504816341214e-05
of O 0 4.433313733898103e-06
the O 0 7.620686119480524e-06
human O 0 1.0860384463740047e-05
DM B-Disease 1 0.9999980926513672
region O 0 3.314446075819433e-05
, O 0 4.802251623914344e-06
using O 0 2.958287495857803e-06
small O 0 1.04134433058789e-05
- O 0 5.830750160384923e-05
pool O 0 0.00021543793263845146
PCR O 0 0.00022357104171533138
. O 0 7.41479016141966e-05

These O 0 6.31135335424915e-05
mice O 0 6.307015428319573e-05
have O 0 1.4352880270962487e-06
been O 0 1.4584218206437072e-06
shown O 0 1.1223650062675006e-06
to O 0 1.034469278238248e-06
reproduce O 0 2.143510755558964e-06
the O 0 1.9468577647785423e-06
intergenerational O 0 5.463302295538597e-05
and O 0 4.811309736396652e-06
somatic O 0 5.777459955425002e-05
instability O 0 7.590049062855542e-05
of O 0 9.69149186857976e-06
the O 0 6.5171316236956045e-06
55 O 0 3.735204882104881e-05
CTG O 0 0.3771059215068817
repeat O 0 1.4809062122367322e-05
suggesting O 0 4.665545930038206e-06
that O 0 7.666681085538585e-07
surrounding O 0 2.0371430764498655e-06
sequences O 0 1.442874804524763e-06
and O 0 6.988752261349873e-07
the O 0 2.17273372982163e-06
chromatin O 0 1.9324890672578476e-05
environment O 0 2.9744437597400974e-06
are O 0 6.152966420813755e-07
involved O 0 2.636564659042051e-06
in O 0 1.0191366527578793e-05
instability O 0 0.03549754619598389
mechanisms O 0 0.0001928860874613747
. O 0 0.00012994059943594038

As O 0 9.402638534083962e-05
observed O 0 2.0168337869108655e-05
in O 0 3.6572023418557364e-06
some O 0 1.041194536810508e-06
of O 0 3.4989386676897993e-06
the O 0 6.590313660126412e-06
tissues O 0 2.7675743694999255e-05
of O 0 0.010342922061681747
DM B-Disease 1 1.0
patients O 0 0.03664030134677887
, O 0 3.973256298195338e-06
there O 0 1.6454196156701073e-06
is O 0 1.0851954357349314e-06
a O 0 2.2905171590537066e-06
tendency O 0 2.855272896340466e-06
for O 0 9.373509897159238e-07
repeat O 0 6.81264236845891e-06
length O 0 5.807715751871001e-06
and O 0 2.5422009457543027e-06
somatic O 0 2.369626599829644e-05
mosaicism O 0 0.00016872673586476594
to O 0 2.0423642581590684e-06
increase O 0 2.4751279852353036e-06
with O 0 1.8137280903829378e-06
the O 0 7.275465122802416e-06
age O 0 3.126822048216127e-05
of O 0 3.333547283546068e-05
the O 0 6.648787530139089e-05
mouse O 0 0.00022533487936016172
. O 0 5.631853855447844e-05

Furthermore O 0 0.0002489183098077774
, O 0 2.1419622498797253e-05
we O 0 4.297612122172723e-06
observed O 0 2.5671558887552237e-06
no O 0 1.524018557574891e-06
correlation O 0 3.413507783989189e-06
between O 0 3.980272140324814e-06
the O 0 6.261169346544193e-06
somatic O 0 4.845244620810263e-05
mutation O 0 8.783005796431098e-06
rate O 0 1.3861568731954321e-05
and O 0 1.3862148989574052e-05
tissue O 0 0.002381465397775173
proliferation O 0 0.0695364698767662
capacity O 0 0.0007481213542632759
. O 0 0.0002801575465127826

The O 0 0.00016683497233316302
somatic O 0 0.00034309516195207834
mutation O 0 3.490238668746315e-05
rates O 0 6.8051940615987405e-06
in O 0 2.3140521534514846e-06
different O 0 8.04559135758609e-07
tissues O 0 2.892784323194064e-06
were O 0 8.879826509655686e-07
also O 0 9.60738930189109e-07
not O 0 2.795271427658008e-07
correlated O 0 1.1887912023667013e-06
to O 0 4.890615628028172e-07
the O 0 1.0561537919784314e-06
relative O 0 1.118767886509886e-05
inter O 0 0.4092475175857544
- O 0 0.020880071446299553
tissue O 0 1.9859939129673876e-05
difference O 0 1.853105800364574e-06
in O 0 8.844102126204234e-07
transcriptional O 0 3.191281848557992e-06
levels O 0 8.017099162316299e-07
of O 0 5.18833871865354e-07
the O 0 6.589934287148935e-07
three O 0 5.528342512661766e-07
genes O 0 1.3207460369812907e-06
( O 0 3.935499080398586e-06
DMAHP O 0 0.26927560567855835
, O 0 6.475938334915554e-06
DMPK O 0 0.0027676615864038467
and O 0 3.0201665595086524e-06
59 O 0 1.566232822369784e-05
) O 0 3.1896815926302224e-06
surrounding O 0 1.0298997949576005e-05
the O 0 1.007643913908396e-05
repeat O 0 9.668149141361937e-05
. O 0 2.2497719328384846e-05
. O 0 8.227553189499304e-05

A O 0 0.0004407536762300879
novel O 0 0.00011818711209343746
missense O 0 0.00014559397823177278
mutation O 0 1.8262917365063913e-05
in O 0 7.75860098656267e-06
patients O 0 1.0225635378446896e-05
from O 0 4.7061312216101214e-06
a O 0 7.985311822267249e-05
retinoblastoma B-Disease 1 0.9989744424819946
pedigree O 0 0.0001795575808500871
showing O 0 1.6277877875836566e-05
only O 0 1.8993246158061083e-06
mild O 0 1.4102132809057366e-05
expression O 0 5.523438630916644e-06
of O 0 1.1426462151575834e-05
the O 0 6.579063483513892e-05
tumor B-Disease 1 0.9999723434448242
phenotype O 0 0.00023362092906609178
. O 0 8.143650484271348e-05

We O 0 6.981268961681053e-05
have O 0 9.917363968270365e-06
used O 0 7.305110557354055e-06
single O 0 1.0495986316527706e-05
strand O 0 1.6354137187590823e-05
conformation O 0 8.690174581715837e-06
polymorphism O 0 4.598718533088686e-06
analysis O 0 1.6250327234956785e-06
to O 0 1.0753198012025678e-06
study O 0 1.2304733445489546e-06
the O 0 2.6047543997265166e-06
27 O 0 9.437100743525662e-06
exons O 0 1.145252554124454e-05
of O 0 5.960650469205575e-06
the O 0 1.1671088941511698e-05
RB1 O 1 0.8708315491676331
gene O 0 2.666015461727511e-06
in O 0 1.0453484264871804e-06
individuals O 0 8.014637273845437e-07
from O 0 2.113454684149474e-06
a O 0 5.518341822607908e-06
family O 0 6.445906819863012e-06
showing O 0 1.0400729479442816e-05
mild O 0 2.0601974028977565e-05
expression O 0 3.2058935630630003e-06
of O 0 7.538392765127355e-06
the O 0 4.143780824961141e-05
retinoblastoma B-Disease 1 0.9950119256973267
phenotype O 0 0.0006437156698666513
. O 0 0.00029602061840705574

In O 0 6.929335359018296e-05
this O 0 1.3869937902200036e-05
family O 0 2.0376239262986928e-05
affected O 0 1.1198545507795643e-05
individuals O 0 3.735121708814404e-06
developed O 0 0.0001350764650851488
unilateral B-Disease 0 0.000884775654412806
tumors I-Disease 1 0.9999992847442627
and O 0 6.1571136029670015e-06
, O 0 1.8085308965964941e-06
as O 0 1.1603052598729846e-06
a O 0 1.6478379620821215e-06
result O 0 1.0776378758237115e-06
of O 0 3.3738681395334424e-06
linkage O 0 5.4239531891653314e-05
analysis O 0 3.2089340038510272e-06
, O 0 2.111003141180845e-06
unaffected O 0 4.991231890016934e-06
mutation O 0 3.226461785743595e-06
carriers O 0 2.2851215817354387e-06
were O 0 1.7716371303322376e-06
also O 0 2.1577548068307806e-06
identified O 0 4.380519840196939e-06
within O 0 6.42760733171599e-06
the O 0 2.2423395421355963e-05
pedigree O 0 0.000384283484891057
. O 0 0.00012978196900803596

A O 0 0.00034439287264831364
single O 0 4.671224451158196e-05
band O 0 6.535691500175744e-05
shift O 0 2.5708437533467077e-05
using O 0 5.445382612379035e-06
SSCP O 0 0.0005969525664113462
was O 0 1.6345094991265796e-05
identified O 0 3.462134600340505e-06
in O 0 2.9267966965562664e-06
exon O 0 1.9781666196649894e-05
21 O 0 7.022417321422836e-06
which O 0 1.2349146345513873e-06
resulted O 0 2.79924620372185e-06
in O 0 1.2797850104107056e-06
a O 0 3.688931656142813e-06
missense O 0 1.9142018572892994e-05
mutation O 0 5.965199761703843e-06
converting O 0 2.205913551733829e-05
a O 0 3.5124663554597646e-05
cys O 0 0.11312802881002426
- O 0 8.615865954197943e-05
- O 0 4.9509348173160106e-05
> O 0 3.555560761014931e-05
arg O 0 2.711330307647586e-05
at O 0 8.878006156010088e-06
nucleotide O 0 5.07804816152202e-06
position O 0 5.3884491535427514e-06
28 O 0 7.507284863095265e-06
in O 0 3.567693511286052e-06
the O 0 2.3150225388235413e-05
exon O 0 0.000418203417211771
. O 0 0.00012010199861833826

The O 0 0.00018266818369738758
mutation O 0 0.00015016910037957132
destroyed O 0 0.00037172550219111145
an O 0 3.731651304406114e-05
NdeI O 0 0.004929141607135534
restriction O 0 0.00010958912753267214
enzyme O 0 9.18311343411915e-05
site O 0 0.00018121444736607373
. O 0 0.00010152599134016782

Analysis O 0 5.0796352297766134e-05
of O 0 2.183964170399122e-05
all O 0 5.2153632168483455e-06
family O 0 6.9961879489710554e-06
members O 0 2.432914243399864e-06
demonstrated O 0 6.416528322006343e-06
that O 0 5.986926225887146e-07
the O 0 1.8995655182152404e-06
missense O 0 3.987470699939877e-05
mutation O 0 1.6707332179066725e-05
co O 0 0.00045640140888281167
- O 0 4.905648165731691e-05
segregated O 0 3.84666673198808e-05
with O 0 3.776188577830908e-06
patients O 0 0.0040061743929982185
with O 0 0.0018109349766746163
tumors B-Disease 1 1.0
or O 0 2.941778438980691e-05
who O 0 9.28934878174914e-06
, O 0 1.8892080788646126e-06
as O 0 1.1264515933362418e-06
a O 0 1.3289610478750546e-06
result O 0 9.659589750299347e-07
of O 0 3.1007937195681734e-06
linkage O 0 4.68075813842006e-05
analysis O 0 2.69354973170266e-06
had O 0 3.5258024126960663e-06
been O 0 2.0193961063341703e-06
predicted O 0 2.2610570340475533e-06
to O 0 9.210725693264976e-07
carry O 0 2.13269754567591e-06
the O 0 8.516356501786504e-06
predisposing O 0 0.0002788437996059656
mutation O 0 8.704825449967757e-05
. O 0 0.00011724433716153726

These O 0 4.406442167237401e-05
observations O 0 3.753247074200772e-05
point O 0 2.1412739442894235e-05
to O 0 2.997040837726672e-06
another O 0 5.231982413533842e-06
region O 0 8.066735063039232e-06
of O 0 5.263882485451177e-06
the O 0 1.7304790162597783e-05
RB1 O 1 0.9987159967422485
gene O 0 2.720828433666611e-06
where O 0 1.35315133320546e-06
mutations O 0 4.633725438907277e-07
only O 0 2.6179407086601714e-07
modify O 0 3.1527417831966886e-07
the O 0 4.626924976491864e-07
function O 0 3.469600642347359e-07
of O 0 9.079020060198673e-07
the O 0 1.8885901909015956e-06
gene O 0 2.407759666311904e-06
and O 0 1.012434267977369e-06
raise O 0 2.0993447833461687e-06
important O 0 9.919017429638188e-07
questions O 0 8.88458657755109e-07
for O 0 5.879476816517126e-07
genetic O 0 3.009057991221198e-06
counseling O 0 1.0116319572262e-05
in O 0 3.101879428868415e-06
families O 0 2.4540495360270143e-06
with O 0 2.165679688914679e-06
these O 0 3.04776926896011e-06
distinctive O 0 2.98378654406406e-05
phenotypes O 0 9.086320642381907e-05
. O 0 3.488295624265447e-05
. O 0 0.00011416091001592577

Maternal B-Disease 1 0.9160093069076538
disomy I-Disease 1 0.9988338351249695
and O 0 0.0054326653480529785
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 0.4174315333366394
with O 0 3.7899801100138575e-05
gamete O 0 0.18471135199069977
complementation O 0 0.07990211993455887
in O 0 4.756067937705666e-06
a O 0 3.0998712645669e-06
case O 0 2.7075600428361213e-06
of O 0 2.7210230655327905e-06
familial O 0 0.005715118255466223
translocation O 0 0.0003855496470350772
( O 0 4.135315521125449e-06
3 O 0 4.98367853651871e-06
; O 0 9.060173056241183e-07
15 O 0 2.2933543277758872e-06
) O 0 9.038131452143716e-07
( O 0 1.251732669516059e-06
p25 O 0 3.3330386941088364e-05
; O 0 1.6501576283189934e-06
q11 O 0 3.460751031525433e-05
. O 0 3.0028775199753e-06
2 O 0 2.384192521276418e-05
) O 0 2.5143568564089946e-05
. O 0 4.543637260212563e-05

Maternal B-Disease 1 0.998763918876648
uniparental I-Disease 1 0.999996542930603
disomy I-Disease 1 0.9998781681060791
( I-Disease 0 0.0016665488947182894
UPD I-Disease 1 0.9999861717224121
) I-Disease 0 1.0989281690854114e-05
for I-Disease 0 3.279853672211175e-06
chromosome I-Disease 0 1.0464153092470951e-05
15 I-Disease 0 3.8446710277639795e-06
is O 0 9.189914180751657e-07
responsible O 0 6.110873869147326e-07
for O 0 3.691447716391849e-07
an O 0 6.595976742573839e-07
estimated O 0 1.9942083326895954e-06
30 O 0 9.959929911929066e-07
% O 0 1.187952534564829e-06
of O 0 1.9029779423362925e-06
cases O 0 2.712454943321063e-06
of O 0 0.0004187854938209057
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999964237213135
PWS B-Disease 1 1.0
) O 0 0.0005520777776837349
. O 0 0.00015439224080182612

We O 0 4.8934158257907256e-05
report O 0 7.595472652610624e-06
on O 0 2.2457350041804602e-06
an O 0 1.73517503299081e-06
unusual O 0 2.6894454094872344e-06
case O 0 3.7562217585218605e-06
of O 0 3.9950950849743094e-06
maternal B-Disease 0 0.02535136789083481
disomy I-Disease 1 0.9741849303245544
15 I-Disease 0 1.5152814739849418e-05
in O 0 8.263041308964603e-06
PWS B-Disease 1 0.9999995231628418
that O 0 1.8041141629510093e-06
is O 0 1.205760440825543e-06
most O 0 4.848453158956545e-07
consistent O 0 1.8208945675723953e-06
with O 0 9.092849495573319e-07
adjacent O 0 2.1695099349017255e-05
- O 0 2.0392877559061162e-05
1 O 0 2.3730346583761275e-05
segregation O 0 5.252784467302263e-05
of O 0 5.523828349396354e-06
a O 0 1.0761595149233472e-05
paternal O 0 3.345818549860269e-05
t O 0 1.1331499990774319e-05
( O 0 2.0529466837615473e-06
3 O 0 4.772497959493194e-06
; O 0 8.060068239501561e-07
15 O 0 3.670095111374394e-06
) O 0 1.4945627526685712e-06
( O 0 2.7456958378024865e-06
p25 O 0 5.4201576858758926e-05
; O 0 1.6483330682603992e-06
q11 O 0 2.723494435485918e-05
. O 0 1.4996469417383196e-06
2 O 0 4.67827521788422e-06
) O 0 1.4563647710019723e-06
with O 0 8.968780207396776e-07
simultaneous O 0 7.562918199255364e-06
maternal O 0 7.633179484400898e-05
meiotic O 0 0.11281993985176086
nondisjunction O 0 0.01544148474931717
for O 0 2.76477567240363e-05
chromosome O 0 9.496876737102866e-05
15 O 0 6.466967897722498e-05
. O 0 8.189205982489511e-05

The O 0 0.000176388886757195
patient O 0 0.00015659035125281662
( O 0 3.0045019229874015e-05
J O 0 0.0005681082257069647
. O 0 4.527422788669355e-06
B O 0 2.218288318545092e-05
. O 0 1.3579190181189915e-06
) O 0 6.970082040425041e-07
, O 0 3.879828796016227e-07
a O 0 1.9873716610163683e-06
17 O 0 9.445069736102596e-06
- O 0 1.6102008885354735e-05
year O 0 8.314127626363188e-06
- O 0 7.90568083175458e-05
old O 0 0.00015805597649887204
white O 0 2.3612170480191708e-05
male O 0 1.562540273880586e-05
with O 0 9.748574484547134e-06
PWS B-Disease 1 1.0
, O 0 7.624648333148798e-06
was O 0 8.347964467247948e-06
found O 0 5.201725912229449e-07
to O 0 1.6081223463970673e-07
have O 0 2.5111771151387074e-07
47 O 0 1.9792460079770535e-06
chromosomes O 0 9.889679404295748e-07
with O 0 7.407284101645928e-07
a O 0 5.19972945767222e-06
supernumerary O 0 0.0006199248600751162
, O 0 7.742738489469048e-06
paternal O 0 7.552720489911735e-05
der O 0 0.0100976238027215
( O 0 5.460281045088777e-06
15 O 0 3.5819678032567026e-06
) O 0 1.1528467211974203e-06
consisting O 0 1.7416755326848943e-06
of O 0 2.05950414056133e-06
the O 0 2.676345502550248e-06
short O 0 8.962385436461773e-06
arm O 0 2.3114487703423947e-05
and O 0 1.1876579719682923e-06
the O 0 4.468647148314631e-06
proximal O 1 0.9184601306915283
long O 0 5.568670530919917e-05
arm O 0 5.990768477204256e-05
of O 0 1.3511163160728756e-05
chromosome O 0 3.3468048059148714e-05
15 O 0 8.80843072081916e-06
, O 0 5.141013843967812e-06
and O 0 1.0139984624402132e-05
distal O 1 0.9989138841629028
chromosome O 1 0.933271050453186
arm O 1 0.9046935439109802
3p O 1 0.9977046847343445
. O 0 0.0002913483767770231

The O 0 0.00029364481451921165
t O 0 0.00023613919620402157
( O 0 2.6082938347826712e-05
3 O 0 2.055617187579628e-05
; O 0 2.753066155491979e-06
15 O 0 5.850861271028407e-06
) O 0 2.5323067802673904e-06
was O 0 6.267902335821418e-06
present O 0 1.2976632888239692e-06
in O 0 1.1606482530623907e-06
the O 0 1.4928134532965487e-06
balanced O 0 1.8478804122423753e-06
state O 0 6.566459092027799e-07
in O 0 1.085083681573451e-06
the O 0 3.955765805585543e-06
patients O 0 1.8222222934127785e-05
father O 0 7.636644295416772e-05
and O 0 1.2616508684004657e-05
a O 0 6.130816473159939e-05
sister O 0 0.0004170747415628284
. O 0 0.00013344926992431283

Fluorescent O 0 0.00036864320281893015
in O 0 2.744299308687914e-05
situ O 0 0.00011184340110048652
hybridization O 0 1.3831975593348034e-05
analysis O 0 4.5653519009647425e-06
demonstrated O 0 1.301473457715474e-05
that O 0 1.788693793969287e-06
the O 0 1.0235157787974458e-05
PWS B-Disease 1 0.9999996423721313
critical O 0 4.728137355414219e-05
region O 0 2.1582614863291383e-05
resided O 0 2.5573606762918644e-05
on O 0 2.3504344426328316e-06
the O 0 2.6665675250114873e-06
derivative O 0 7.383913725789171e-06
chromosome O 0 6.183346613397589e-06
3 O 0 3.3218843782378826e-06
and O 0 5.701525083168235e-07
that O 0 4.0076895402307855e-07
there O 0 4.1390617866454704e-07
was O 0 3.725555416167481e-06
no O 0 7.279944043148134e-07
deletion O 0 5.840759058628464e-06
of O 0 8.7741318566259e-06
the O 0 7.506780821131542e-05
PWS B-Disease 1 1.0
region O 0 2.316215068276506e-05
on O 0 3.3783983326429734e-06
the O 0 1.607013928150991e-06
normal O 0 3.3897035791596863e-06
pair O 0 3.910865416401066e-06
of O 0 4.5788419811287895e-06
15s O 0 5.8630892453948036e-05
present O 0 1.6427196896984242e-05
in O 0 3.2504554837942123e-05
J O 1 0.8905395865440369
. O 0 0.0001757586287567392

B O 0 0.3229908049106598
. O 0 0.0036428773310035467

Methylation O 0 0.00022862917103338987
analysis O 0 2.979140481329523e-05
at O 0 7.232955249492079e-05
exon O 0 0.00015990565589163452
alpha O 0 5.5966625950532034e-05
of O 0 9.205788046529051e-06
the O 0 9.506499736744445e-06
small O 0 2.1444702724693343e-05
nuclear O 0 0.00021035107783973217
ribonucleoprotein O 0 0.15685327351093292
- O 0 5.291038178256713e-05
associated O 0 8.777780749369413e-06
polypeptide O 0 6.372641655616462e-05
N O 0 9.028056228999048e-05
( O 0 1.2006556062260643e-05
SNRPN O 0 0.028034821152687073
) O 0 3.171306616422953e-06
gene O 0 2.5619151529099327e-06
showed O 0 3.3709159197314875e-06
a O 0 3.2985115012706956e-06
pattern O 0 4.284165697754361e-06
characteristic O 0 2.875834525184473e-06
of O 0 3.1082281566341408e-06
only O 0 1.6598673937551212e-06
the O 0 4.193676886643516e-06
maternal O 0 7.818458834663033e-05
chromosome O 0 4.0965107473311946e-05
15 O 0 2.6305535357096232e-05
in O 0 3.3487875043647364e-05
J O 0 0.1611059606075287
. O 0 0.000227906130021438

B O 0 0.18607743084430695
. O 0 0.001851846231147647

Maternal B-Disease 0 0.09983780980110168
disomy I-Disease 0 0.041236571967601776
was O 0 0.00019978130876552314
confirmed O 0 1.5062680176924914e-05
by O 0 5.012750534660881e-06
polymerase O 0 3.372786159161478e-05
chain O 0 7.818317499186378e-06
reaction O 0 2.00443969333719e-06
analysis O 0 1.0928642950602807e-06
of O 0 2.7893809146917192e-06
microsatellite O 0 3.321121766930446e-05
repeats O 0 7.588826065330068e-06
at O 0 6.876393854327034e-06
the O 0 2.679297722352203e-06
gamma O 0 4.256429383531213e-05
- O 0 4.10355678468477e-05
aminobutyric O 0 0.00016628119919914752
acid O 0 1.9907440218958072e-05
receptor O 0 3.11608164338395e-05
beta3 O 0 0.00012482608144637197
subunit O 0 2.5080084014916793e-05
( O 0 1.932723171194084e-05
GABRB3 O 0 0.000804250652436167
) O 0 2.8753529477398843e-05
locus O 0 0.00015378072566818446
. O 0 0.00010471319546923041

A O 0 0.0012194132432341576
niece O 0 0.0016843596240505576
( O 0 6.647944246651605e-05
B O 0 0.0001518874050816521
. O 0 5.831558610225329e-06
B O 0 2.7823252821690403e-05
. O 0 1.283076016989071e-06
) O 0 7.294885904229886e-07
with O 0 4.6015082943995367e-07
45 O 0 1.972488689716556e-06
chromosomes O 0 1.191343699247227e-06
and O 0 2.504293945548852e-07
the O 0 6.355181767503382e-07
derivative O 0 2.036313844655524e-06
3 O 0 2.3928714654175565e-06
but O 0 3.623125905960478e-07
without O 0 5.051349489804124e-07
the O 0 2.4516730263712816e-06
der O 0 0.0013475494924932718
( O 0 1.9434926343819825e-06
15 O 0 3.5877594655175926e-06
) O 0 1.3948113064543577e-06
demonstrated O 0 5.719759883504594e-06
a O 0 2.5236420242435997e-06
phenotype O 0 5.821728791488567e-06
consistent O 0 3.0809615054749884e-06
with O 0 1.0961272209897288e-06
that O 0 1.1282568266324233e-06
reported O 0 3.0169942419888685e-06
for O 0 3.9131336961872876e-06
haploinsufficiency O 0 0.00036032989737577736
of O 0 3.0356439310708083e-05
distal O 0 0.2129860520362854
3 O 0 0.0007666992605663836
p O 0 0.0013517031911760569
. O 0 0.00018885325698647648

Uniparental B-Disease 1 0.9999997615814209
disomy I-Disease 1 0.9999740123748779
associated O 0 0.0001106045237975195
with O 0 2.7513613531482406e-05
unbalanced O 0 0.003037086920812726
segregation O 0 0.09994728118181229
of O 0 0.00019901624182239175
non O 0 0.16792207956314087
- O 1 0.9283848404884338
Robertsonian O 1 0.9999147653579712
translocations O 0 3.754106000997126e-05
has O 0 1.2817771448681015e-06
been O 0 9.816480996960308e-07
reported O 0 1.1182686421307153e-06
previously O 0 1.1557727930266992e-06
but O 0 4.6901888595130004e-07
has O 0 6.463151862590166e-07
not O 0 2.4811589582895976e-07
, O 0 4.340840007444058e-07
to O 0 3.254266403018846e-07
our O 0 7.467572800123889e-07
knowledge O 0 1.7868371742224554e-06
, O 0 1.2577252164192032e-06
been O 0 1.0020389709097799e-06
observed O 0 1.0937578736047726e-06
in O 0 1.2550461860882933e-06
a O 0 5.852792128280271e-06
case O 0 1.9356668417458422e-05
of O 0 0.0002520432462915778
PWS B-Disease 1 0.9999998807907104
. O 0 0.0006652589654549956

Furthermore O 0 0.000328060268657282
, O 0 1.8173719581682235e-05
our O 0 4.371671820990741e-06
findings O 0 3.3270905532845063e-06
are O 0 6.550285434059333e-07
best O 0 1.6861785070432234e-06
interpreted O 0 2.3840332232794026e-06
as O 0 2.0575350845319917e-06
true O 0 6.614391622861149e-06
gamete O 0 7.00557793607004e-05
complementation O 0 0.0010967160342261195
resulting O 0 2.558282903919462e-05
in O 0 2.7370908355806023e-05
maternal B-Disease 1 0.8572396039962769
UPD I-Disease 1 0.9999995231628418
15 I-Disease 0 0.0005796623299829662
and O 0 0.00039460419793613255
PWS B-Disease 1 0.999998927116394

Schwartz B-Disease 1 0.9567505717277527
- I-Disease 1 0.998946487903595
Jampel I-Disease 1 0.9999978542327881
syndrome I-Disease 1 0.9999998807907104
type I-Disease 0 0.010507523082196712
2 I-Disease 0 0.0027142828330397606
and O 0 3.0147797588142566e-05
Stuve B-Disease 1 0.9999970197677612
- I-Disease 1 0.9999277591705322
Wiedemann I-Disease 1 0.9999992847442627
syndrome I-Disease 1 0.9999997615814209
: O 0 1.8685324903344736e-05
a O 0 1.3007636880502105e-05
case O 0 7.777499376970809e-06
for O 0 4.073091531608952e-06
" O 0 2.7112240786664188e-05
lumping O 0 0.00013504659000318497
" O 0 0.00010772435052786022
. O 0 8.079917461145669e-05

Recent O 0 0.00014721584739163518
studies O 0 3.309531166451052e-05
demonstrated O 0 3.0044244340388104e-05
the O 0 5.288881311571458e-06
existence O 0 9.663417586125433e-06
of O 0 8.770994099904783e-06
a O 0 1.4429640941671096e-05
genetically O 0 8.125794010993559e-06
distinct O 0 2.804531504807528e-06
, O 0 1.95202233044256e-06
usually O 0 6.592618433387543e-07
lethal O 0 1.6310725641233148e-06
form O 0 6.140327855064243e-07
of O 0 2.9107022783136927e-06
the O 0 1.1237477337999735e-05
Schwartz B-Disease 1 0.9961395859718323
- I-Disease 1 0.9998942613601685
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.37355685234069824
SJS B-Disease 1 0.9999992847442627
) O 0 7.845954314689152e-06
of O 0 3.455490877968259e-05
myotonia B-Disease 1 0.9999969005584717
and O 0 0.0003042136668227613
skeletal B-Disease 1 0.9999994039535522
dysplasia I-Disease 1 0.9999986886978149
, O 0 1.2694087672571186e-05
which O 0 2.332697476958856e-06
we O 0 2.3831241833249805e-06
called O 0 1.601280746399425e-05
SJS B-Disease 1 0.9448940753936768
type I-Disease 0 0.00010270177153870463
2 I-Disease 0 0.00023868911375757307
. O 0 0.00011050585453631356

This O 0 0.000221664784476161
disorder O 1 0.9999934434890747
is O 0 9.862852311925963e-05
reminiscent O 0 0.0005234630079939961
of O 0 2.3871707526268438e-05
another O 0 2.7867226890521124e-05
rare O 0 2.026689617196098e-05
condition O 0 2.421076897007879e-05
, O 0 3.4243003028677776e-06
the O 0 1.776367389538791e-05
Stuve B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999994039535522
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9417158365249634
SWS B-Disease 1 0.9999912977218628
) O 0 9.499077350483276e-06
, O 0 1.8808809727488551e-06
which O 0 1.0436838238092605e-06
comprises O 0 5.547267392103095e-06
campomelia B-Disease 0 6.92380708642304e-05
at O 0 1.2398790204315446e-05
birth O 0 3.368199759279378e-05
with O 0 0.00010844220378203318
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 0.40899819135665894
contractures B-Disease 1 0.9999865293502808
, O 0 1.5225254173856229e-05
and O 0 5.7594056670495775e-06
early B-Disease 0 4.687409455073066e-05
death I-Disease 0 0.00025445997016504407
. O 0 9.627595136407763e-05

To O 0 4.0171573346015066e-05
test O 0 1.834385511756409e-05
for O 0 5.392721050156979e-06
possible O 0 6.312906407401897e-06
nosologic O 0 0.0118116345256567
identity O 0 7.626240858371602e-06
between O 0 8.794153472990729e-06
these O 0 3.0854780561639927e-06
disorders O 1 0.9999949932098389
, O 0 1.1395894034649245e-05
we O 0 1.5475179679924622e-06
reviewed O 0 1.750636329234112e-06
the O 0 1.0836048431883682e-06
literature O 0 1.9884921584889526e-06
and O 0 6.10146344115492e-07
obtained O 0 1.144199359259801e-06
a O 0 1.5790622001077281e-06
follow O 0 1.1906995496246964e-06
- O 0 2.47259185925941e-06
up O 0 1.2900316050945548e-06
of O 0 1.0591594445941155e-06
the O 0 1.1942818218813045e-06
only O 0 6.846985911579395e-07
two O 0 6.686960318802448e-07
surviving O 0 2.1851310521014966e-05
patients O 0 3.259330469518318e-06
, O 0 1.3028466128162108e-06
one O 0 9.418950526196568e-07
with O 0 3.955788088205736e-06
SJS B-Disease 1 0.9988873600959778
type I-Disease 0 1.2306292774155736e-05
2 I-Disease 0 1.0802249562402721e-05
at O 0 6.620562999160029e-06
age O 0 4.674257070291787e-06
10 O 0 2.0550639874272747e-06
years O 0 2.1424050373752834e-06
and O 0 1.0150860134672257e-06
another O 0 4.465417987375986e-06
with O 0 5.139891527505824e-06
SWS B-Disease 1 0.7258533835411072
at O 0 5.758351835538633e-05
age O 0 7.729824574198574e-05
7 O 0 0.00010636100341798738
years O 0 0.00015459433780051768
. O 0 0.00016126231639645994

Patients O 0 0.0004602365370374173
reported O 0 4.973743489244953e-05
as O 0 1.1389233804948162e-05
having O 0 1.2734207302855793e-05
either O 0 2.911030242103152e-05
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 0.0010097143240272999
SWS B-Disease 1 0.9994025230407715
presented O 0 1.0305030627932865e-05
a O 0 4.5721531023446005e-06
combination O 0 2.659606025190442e-06
of O 0 3.063400072278455e-06
a O 0 9.255012628273107e-06
severe O 1 0.9354434609413147
, O 0 0.0001094482431653887
prenatal O 1 0.9999130964279175
- O 1 0.9999988079071045
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9999843835830688
with O 1 0.999991774559021
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.9999958276748657
respiratory O 1 1.0
and O 0 0.012396072968840599
feeding O 0 0.09343214333057404
difficulties O 1 0.8460729122161865
, O 0 7.340810498135397e-06
tendency O 0 1.5306581190088764e-05
to O 0 4.487193109525833e-06
hyperthermia B-Disease 1 0.9998308420181274
, O 0 4.913592874800088e-06
and O 0 1.6704148038115818e-06
frequent O 0 5.8693317441793624e-06
death O 0 1.27024050016189e-05
in O 0 4.899583018413978e-06
infancy O 0 0.0001540422672405839
) O 0 3.1739691621623933e-06
with O 0 1.5807723912075744e-06
a O 0 8.929351679398678e-06
distinct O 0 2.5956191166187637e-05
campomelic B-Disease 1 0.9998822212219238
- I-Disease 1 0.9999157190322876
metaphyseal I-Disease 1 0.9999990463256836
skeletal I-Disease 1 0.9999998807907104
dysplasia I-Disease 1 0.9999997615814209
. O 0 0.0012449227506294847

The O 0 4.973207614966668e-05
similarity O 0 3.9140057197073475e-05
of O 0 9.351899279863574e-06
the O 0 1.2706015695584938e-05
clinical O 0 0.00014344070223160088
and O 0 3.9915462366479915e-06
radiographic O 0 0.00021169352112337947
findings O 0 4.532658749667462e-06
is O 0 1.903195766317367e-06
so O 0 5.332657906365057e-07
extensive O 0 3.0442051865975372e-06
that O 0 5.221641572461522e-07
these O 0 7.401818606922461e-07
disorders O 1 0.9728769063949585
appear O 0 4.382031875138637e-06
to O 0 1.6789850860732258e-06
be O 0 2.168213313780143e-06
a O 0 9.730490091897082e-06
single O 0 2.2449969037552364e-05
entity O 0 0.00014680960157420486
. O 0 0.00014422986714635044

The O 0 9.591811249265447e-05
follow O 0 5.649454033118673e-05
- O 0 3.306402140879072e-05
up O 0 3.7673110000469023e-06
observation O 0 1.0175139323109761e-05
of O 0 3.4588276776048588e-06
an O 0 2.8281019694986753e-06
identical O 0 1.858257519415929e-06
and O 0 8.634311257083027e-07
unique O 0 1.5290863757400075e-06
pattern O 0 8.859805348038208e-06
of O 0 0.0001588201121194288
progressive O 1 0.9999997615814209
bone B-Disease 1 1.0
dysplasia I-Disease 1 0.9999991655349731
in O 0 9.812748430704232e-06
the O 0 4.894030553259654e-06
two O 0 1.4419752005778719e-06
patients O 0 5.70116708331625e-06
( O 0 2.66923893832427e-06
one O 0 2.1477319478435675e-06
with O 0 4.1770604184421245e-06
SJS B-Disease 1 0.9999862909317017
type I-Disease 0 1.8174654542235658e-05
2 I-Disease 0 1.1876911230501719e-05
, O 0 1.353859943264979e-06
one O 0 8.308788324029592e-07
with O 0 1.2731213701044908e-06
SWS B-Disease 1 0.960799515247345
) O 0 4.404862465889892e-06
surviving O 0 3.5724046028917655e-05
beyond O 0 1.114929182222113e-05
infancy O 0 1.9956216419814155e-05
adds O 0 1.6597471130808117e-06
to O 0 8.14485701994272e-07
the O 0 1.773882218003564e-06
evidence O 0 3.5796592783299275e-06
in O 0 3.0089433948887745e-06
favor O 0 1.0718003977672197e-05
of O 0 2.1663221559720114e-05
identity O 0 0.00014993602235335857
. O 0 0.00016245547158177942

The O 0 0.00021708194981329143
hypothesis O 0 0.00019270242773927748
that O 0 2.0966972442693077e-05
SWS B-Disease 1 0.9286592602729797
and O 0 2.683937236724887e-05
SJS B-Disease 1 0.9996805191040039
type I-Disease 0 3.2599920814391226e-05
2 I-Disease 0 1.531575071567204e-05
are O 0 4.866543008574808e-07
the O 0 1.4393167475645896e-06
same O 0 3.221680572096375e-06
disorder O 1 0.9741267561912537
should O 0 2.4983237381093204e-06
be O 0 1.7670407714831526e-06
testable O 0 8.131841241265647e-06
by O 0 2.5985764295910485e-06
molecular O 0 1.1325449122523423e-05
methods O 0 1.0668718459783122e-05
. O 0 1.6194715499295853e-05
. O 0 8.907048322726041e-05

A O 0 0.0010988147696480155
mouse O 0 0.00018019354320131242
model O 0 2.1709154680138454e-05
of O 0 5.692125705536455e-05
severe O 1 0.9999947547912598
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.8038416504859924
defects O 1 0.9999955892562866
in O 0 0.08457670360803604
hemostasis O 1 0.9999998807907104
and O 0 0.36943724751472473
thrombosis B-Disease 1 0.9999996423721313
. O 0 0.004590350203216076

von B-Disease 1 0.9964367151260376
Willebrand I-Disease 1 0.9999920129776001
factor I-Disease 0 0.0469185896217823
( I-Disease 0 0.008507376536726952
vWf I-Disease 1 0.9998382329940796
) I-Disease 0 0.14752915501594543
deficiency I-Disease 1 1.0
causes O 1 0.9999654293060303
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 0.0007187191513366997
humans O 0 0.00022121149231679738
. O 0 7.235749217215925e-05

We O 0 7.67028977861628e-05
generated O 0 5.886517828912474e-05
a O 0 2.533433689677622e-05
mouse O 0 1.339510617981432e-05
model O 0 3.8090115594968665e-06
for O 0 1.909633510877029e-06
this O 0 2.4821154056553496e-06
disease O 0 0.00022220036771614105
by O 0 5.468144991027657e-06
using O 0 8.968216206994839e-06
gene O 0 2.551195393607486e-05
targeting O 0 5.8990601246478036e-05
. O 0 6.218330236151814e-05

vWf B-Disease 1 0.9961442947387695
- I-Disease 1 0.9851394295692444
deficient I-Disease 1 0.992639422416687
mice O 0 0.00017066711734514683
appeared O 0 2.0992783902329393e-05
normal O 0 5.626381607726216e-06
at O 0 1.2030740435875487e-05
birth O 0 9.149074685410596e-06
; O 0 2.2002329842507606e-06
they O 0 1.2923810572829098e-06
were O 0 4.438533778738929e-06
viable O 0 2.8555710741784424e-05
and O 0 1.6332565792254172e-05
fertile O 0 0.000397257215809077
. O 0 0.00011151252692798153

Neither O 0 0.0012491012457758188
vWf O 0 0.004898167680948973
nor O 0 0.00021766767895314842
vWf O 0 0.0017611125949770212
propolypeptide O 0 0.003113141981884837
( O 0 5.221441460889764e-05
von B-Disease 1 0.8745414018630981
Willebrand I-Disease 1 0.999995231628418
antigen O 0 0.00629489915445447
II O 1 0.9999860525131226
) O 0 4.9153409236168955e-06
were O 0 1.8371619034951436e-06
detectable O 0 7.480455678887665e-06
in O 0 1.4740969618287636e-06
plasma O 0 1.1722981980710756e-05
, O 0 2.0775241864612326e-06
platelets O 0 1.123968559113564e-05
, O 0 1.8606336880111485e-06
or O 0 2.1496953195310198e-06
endothelial O 0 5.086905730422586e-05
cells O 0 2.004441739700269e-06
of O 0 2.6511252144700848e-06
the O 0 8.145641004375648e-06
homozygous O 0 8.203893230529502e-05
mutant O 0 0.00029745351639576256
mice O 0 0.00012278986105229706
. O 0 6.342618871713057e-05

The O 0 0.0006278054788708687
mutant O 0 0.3400782346725464
mice O 0 0.019756797701120377
exhibited O 0 0.009868601337075233
defects O 1 0.9746006727218628
in O 0 7.187596202129498e-05
hemostasis O 1 0.9997813105583191
with O 0 2.771784784272313e-05
a O 0 0.000157096452312544
highly O 0 0.007235907018184662
prolonged O 1 0.999992847442627
bleeding O 1 0.999991774559021
time O 0 2.2879386960994452e-05
and O 0 9.042632882483304e-06
spontaneous O 0 0.0004045597743242979
bleeding O 1 0.6783381104469299
events O 0 4.429856744536664e-06
in O 0 2.6952479856845457e-06
approximately O 0 8.54148038342828e-06
10 O 0 6.485481208073907e-06
% O 0 8.611050361650996e-06
of O 0 5.31503428646829e-05
neonates O 0 0.001427888055332005
. O 0 0.00023318985768128186

As O 0 7.294297392945737e-05
in O 0 1.2162376151536591e-05
the O 0 1.40475167427212e-05
human O 0 3.290890163043514e-05
disease O 1 0.9177512526512146
, O 0 4.4679227357846685e-06
the O 0 4.633337539416971e-06
factor O 0 2.7450951165519655e-05
VIII O 1 0.9807553887367249
level O 0 2.0933766791131347e-05
in O 0 2.966059128084453e-06
these O 0 1.0565828461039928e-06
mice O 0 6.449805368902162e-06
was O 0 5.034698460804066e-06
reduced O 0 1.63148945375724e-06
strongly O 0 9.961125897461898e-07
as O 0 7.809933890712273e-07
a O 0 9.238903544428467e-07
result O 0 7.995964210749662e-07
of O 0 2.1322603060980327e-06
the O 0 2.693950364118791e-06
lack O 0 7.112339972081827e-06
of O 0 7.577089036203688e-06
protection O 0 3.5908902646042407e-05
provided O 0 1.7345069863949902e-05
by O 0 2.1096942873555236e-05
vWf O 0 0.000887970847543329
. O 0 0.0001125847120420076

Defective O 1 0.9998915195465088
thrombosis B-Disease 1 0.9999973773956299
in O 0 0.000417921895859763
mutant O 1 0.7070186734199524
mice O 0 0.0002944291918538511
was O 0 3.2087940780911595e-05
also O 0 2.416104962321697e-06
evident O 0 6.890382792335004e-06
in O 0 1.574831799189269e-06
an O 0 1.3138553640601458e-06
in O 0 3.6402111618372146e-06
vivo O 0 6.085283530410379e-05
model O 0 2.136888178938534e-05
of O 0 0.0001919562346301973
vascular B-Disease 1 0.9999998807907104
injury I-Disease 1 0.9999620914459229
. O 0 0.002641451545059681

In O 0 6.82289683027193e-05
this O 0 1.22566680147429e-05
model O 0 1.427587449143175e-05
, O 0 4.484557848627446e-06
the O 0 9.354584108223207e-06
exteriorized O 0 0.044876690953969955
mesentery O 0 0.001716986414976418
was O 0 0.00012300196976866573
superfused O 0 0.0011957729002460837
with O 0 6.9394004640344065e-06
ferric O 1 0.9998714923858643
chloride O 0 0.004548816010355949
and O 0 5.44604199603782e-06
the O 0 6.682416824332904e-06
accumulation O 0 0.00018220757192466408
of O 0 4.643789361580275e-05
fluorescently O 0 0.20959696173667908
labeled O 0 7.889910193625838e-05
platelets O 0 5.1043367420788854e-05
was O 0 2.6386085664853454e-05
observed O 0 8.344645721081179e-06
by O 0 9.45524425333133e-06
intravital O 0 0.0004014299192931503
microscopy O 0 0.00015353970229625702
. O 0 0.00013249603216536343

We O 0 7.628157618455589e-05
conclude O 0 5.708836761186831e-05
that O 0 4.251932750776177e-06
these O 0 1.9001724922418362e-06
mice O 0 9.406677236256655e-06
very O 0 2.304397412444814e-06
closely O 0 4.95433550895541e-06
mimic O 0 0.00010636344086378813
severe O 1 0.9818499684333801
human O 0 0.1876293271780014
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 7.060506959533086e-06
will O 0 5.899607344872493e-07
be O 0 4.291638617814897e-07
very O 0 4.768585313286167e-07
useful O 0 6.833599854871863e-07
for O 0 5.781824938821956e-07
investigating O 0 2.2907029233465437e-06
the O 0 2.5858546450763242e-06
role O 0 7.400812592095463e-06
of O 0 5.35207209395594e-06
vWf O 0 6.103736814111471e-05
in O 0 1.7484438785686507e-06
normal O 0 3.1409192615683423e-06
physiology O 0 1.9939019693993032e-05
and O 0 1.6729784420022042e-06
in O 0 6.465324531745864e-06
disease O 1 0.6178152561187744
models O 0 1.1635736882453784e-05
. O 0 1.1564615306269843e-05
. O 0 3.834108429145999e-05

Oral O 0 0.28254520893096924
contraceptives O 0 0.0019111514557152987
and O 0 9.948984370566905e-06
the O 0 1.2540658644866198e-05
risk O 0 7.078923954395577e-05
of O 1 0.7052436470985413
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9997209906578064

Hereditary B-Disease 1 0.9999998807907104
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9999861717224121
Study O 0 0.03006434254348278
Group O 0 0.0007790542440488935
. O 0 0.00028465414652600884

BACKGROUND O 0 0.0008499228279106319
Women O 0 4.612009070115164e-05
with O 0 7.473268397006905e-06
mutations O 0 8.86608540895395e-06
in O 0 4.540125701169018e-06
either O 0 2.579376996436622e-06
the O 0 6.388447673089104e-06
BRCA1 O 0 4.379071106086485e-05
or O 0 1.5502832866332028e-06
the O 0 4.034928224427858e-06
BRCA2 O 0 3.4296932426514104e-05
gene O 0 2.987811512866756e-06
have O 0 5.748029821006639e-07
a O 0 1.7244672108063241e-06
high O 0 8.139700184983667e-06
lifetime O 0 1.6427196896984242e-05
risk O 0 4.490297578740865e-05
of O 1 0.5961276888847351
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.11538515239953995

Oral O 1 0.9926725029945374
contraceptives O 1 0.9953005313873291
protect O 0 0.007103453855961561
against O 1 0.9998629093170166
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0003865298058371991
general O 0 0.000470250059152022
, O 0 3.108331839030143e-06
but O 0 5.1095867092954e-07
it O 0 3.796970702296676e-07
is O 0 4.0391108768744743e-07
not O 0 2.529487517222151e-07
known O 0 9.378194363307557e-07
whether O 0 4.900761041426449e-07
they O 0 4.59263475249827e-07
also O 0 6.253569608816179e-07
protect O 0 1.975369059437071e-06
against O 0 3.928441856260179e-06
hereditary B-Disease 1 0.9898436069488525
forms I-Disease 0 0.005003312136977911
of I-Disease 1 0.9999983310699463
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.8925914168357849

METHODS O 0 0.0003695327031891793
We O 0 4.745080877910368e-05
enrolled O 0 0.0001116255225497298
207 O 0 9.284681436838582e-05
women O 0 1.3148081961844582e-05
with O 0 4.097260898561217e-05
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.0022813938558101654
161 O 0 0.00011446504504419863
of O 0 1.5122412150958553e-05
their O 0 3.19678019877756e-06
sisters O 0 1.743884786264971e-05
as O 0 1.5122651575438795e-06
controls O 0 2.416713414277183e-06
in O 0 1.8449363778927363e-06
a O 0 7.03479781805072e-06
case O 0 9.649355888541322e-06
- O 0 4.972539682057686e-05
control O 0 2.0328974642325193e-05
study O 0 2.244335519208107e-05
. O 0 3.912949614459649e-05

All O 0 3.486463538138196e-05
the O 0 2.662149927346036e-05
patients O 0 1.6205207430175506e-05
carried O 0 8.158546734193806e-06
a O 0 4.996722964278888e-06
pathogenic O 0 5.413001872511813e-06
mutation O 0 2.409376747891656e-06
in O 0 2.432672999930219e-06
either O 0 3.5262328310636804e-06
BRCA1 O 0 2.6080699171870947e-05
( O 0 7.0521823545277584e-06
179 O 0 1.3449096513795666e-05
women O 0 4.457639988686424e-06
) O 0 2.645117092470173e-06
or O 0 2.574913878561347e-06
BRCA2 O 0 3.0029921617824584e-05
( O 0 8.156725925800856e-06
28 O 0 3.0432671337621287e-05
women O 0 1.3319579920789693e-05
) O 0 3.117341475444846e-05
. O 0 6.241713708732277e-05

The O 0 0.00013874232536181808
control O 0 6.388071778928861e-05
women O 0 8.27082203613827e-06
were O 0 3.991957783000544e-06
enrolled O 0 9.791705451789312e-06
regardless O 0 2.0959757875971263e-06
of O 0 2.0314607809268637e-06
whether O 0 1.252946049135062e-06
or O 0 8.138528642120946e-07
not O 0 4.424931887569983e-07
they O 0 3.413761078263633e-07
had O 0 3.802891797022312e-06
either O 0 1.025208712235326e-05
mutation O 0 2.6017800337285735e-05
. O 0 9.531315299682319e-05

Lifetime O 0 0.0005166791961528361
histories O 0 0.00017088369349949062
of O 0 0.00018371728947386146
oral O 1 0.987300455570221
- O 1 0.5294908285140991
contraceptive O 0 0.00042498038965277374
use O 0 2.011340939134243e-06
were O 0 2.197617959609488e-06
obtained O 0 1.6015198980312562e-06
by O 0 1.4179388472257415e-06
interview O 0 2.6099462502315873e-06
or O 0 5.518944590221508e-07
by O 0 5.52757285277039e-07
written O 0 5.517513841368782e-07
questionnaire O 0 1.6707431313989218e-06
and O 0 1.0456644758960465e-06
were O 0 1.7771859575077542e-06
compared O 0 2.9434988846333e-06
between O 0 1.0142653991351835e-05
patients O 0 1.5629933841410093e-05
and O 0 2.617301788632176e-06
control O 0 1.0604062481434084e-05
women O 0 1.7382026271661744e-06
, O 0 1.5921376643746044e-06
after O 0 3.0731616789125837e-06
adjustment O 0 9.53934886638308e-06
for O 0 1.529223368379462e-06
year O 0 2.9376856218732428e-06
of O 0 8.45250815473264e-06
birth O 0 7.547055429313332e-05
and O 0 2.731849417614285e-05
parity O 0 0.0015205619856715202
. O 0 0.0002541329013183713

RESULTS O 0 0.0001454751763958484
The O 0 4.0275874198414385e-05
adjusted O 0 6.146686064312235e-05
odds O 0 6.454491813201457e-05
ratio O 0 3.519357051118277e-05
for O 0 0.00010104240936925635
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 1.8200913473265246e-05
with O 0 1.5574228200421203e-06
any O 0 1.2524204748842749e-06
past O 0 3.047897052965709e-06
use O 0 7.384339824056951e-07
of O 0 6.39297559246188e-06
oral O 0 0.0019054943695664406
contraceptives O 0 0.011296719312667847
was O 0 0.00044855225132778287
0 O 0 0.00023409297864418477
. O 0 0.00024805337307043374

5 O 0 0.00011700030881911516
( O 0 2.5965993700083345e-05
95 O 0 1.4694295714434702e-05
percent O 0 7.990056474227458e-06
confidence O 0 1.6103605958051048e-05
interval O 0 1.1935113434446976e-05
, O 0 2.082328592223348e-06
0 O 0 3.427142473810818e-06
. O 0 1.183804215543205e-06
3 O 0 2.1973330603941577e-06
to O 0 1.8689245280256728e-06
0 O 0 9.688128557172604e-06
. O 0 4.441574674274307e-06
8 O 0 2.7726704502128996e-05
) O 0 2.2414629711420275e-05
. O 0 5.460676766233519e-05

The O 0 0.0001720641739666462
risk O 0 8.712914132047445e-05
decreased O 0 7.678764086449519e-05
with O 0 5.79680408918648e-06
increasing O 0 9.12882842385443e-06
duration O 0 1.6212979971896857e-05
of O 0 6.81008259562077e-06
use O 0 2.6649274786905153e-06
( O 0 5.143436737853335e-06
P O 0 4.0395887481281534e-05
for O 0 2.6166553652728908e-06
trend O 0 4.71695966552943e-06
, O 0 8.813252065920096e-07
< O 0 6.889923042763257e-06
0 O 0 3.9744836612953804e-06
. O 0 8.187620323951705e-07
001 O 0 1.9609669834608212e-05
) O 0 8.636402526462916e-07
; O 0 1.99380792764714e-07
use O 0 1.498014512435475e-07
for O 0 2.841425441602041e-07
six O 0 1.0633809779392323e-06
or O 0 7.400441859317652e-07
more O 0 4.0372546550315747e-07
years O 0 2.3612524273630697e-06
was O 0 8.612521014583763e-06
associated O 0 1.5673762163714855e-06
with O 0 6.376192231982714e-07
a O 0 3.0610053727286868e-06
60 O 0 5.933025477133924e-06
percent O 0 8.76968988450244e-06
reduction O 0 2.234914427390322e-05
in O 0 2.0240628145984374e-05
risk O 0 0.00010495539754629135
. O 0 0.00011657578579615802

Oral O 1 0.5705755949020386
- O 0 0.059948425740003586
contraceptive O 0 0.0015210811980068684
use O 0 8.5892506831442e-06
protected O 0 0.00019793947285506874
against O 1 0.6540408730506897
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 8.865256859280635e-06
for O 0 4.622546384780435e-06
carriers O 0 3.958094112022081e-06
of O 0 1.9004189653060166e-06
the O 0 4.793973857886158e-06
BRCA1 O 0 6.325482536340132e-05
mutation O 0 3.702162075569504e-06
( O 0 2.850370265150559e-06
odds O 0 7.658974027435761e-06
ratio O 0 2.0988723008485977e-06
, O 0 5.069601343166141e-07
0 O 0 1.1302124676149106e-06
. O 0 2.601993571715866e-07
5 O 0 5.384608812164515e-07
; O 0 2.8475261615312775e-07
95 O 0 7.924966780592513e-07
percent O 0 8.377317612939805e-07
confidence O 0 1.9599353890953353e-06
interval O 0 3.1107458653423237e-06
, O 0 7.973903279889782e-07
0 O 0 1.9422845980443526e-06
. O 0 5.039608481638425e-07
3 O 0 1.5079059494382818e-06
to O 0 6.848559905847651e-07
0 O 0 2.999871867359616e-06
. O 0 8.934334800869692e-07
9 O 0 3.4232684811286163e-06
) O 0 7.251078386616427e-07
and O 0 4.941539373248816e-07
for O 0 5.519655132957269e-07
carriers O 0 1.3567851055995561e-06
of O 0 1.4308722029454657e-06
the O 0 2.150749196516699e-06
BRCA2 O 0 1.832023735914845e-05
mutation O 0 1.7927499129655189e-06
( O 0 1.3301466879056534e-06
odds O 0 3.4263321140315384e-06
ratio O 0 9.762089803189156e-07
, O 0 5.500129418578581e-07
0 O 0 7.517290327996307e-07
. O 0 2.6999742885891465e-07
4 O 0 1.329452970821876e-06
; O 0 3.159149173370679e-07
95 O 0 1.432800445400062e-06
percent O 0 1.3288317859405652e-06
confidence O 0 3.6686672046926105e-06
interval O 0 4.033793175040046e-06
, O 0 9.136781500274083e-07
0 O 0 1.240846927430539e-06
. O 0 4.076248103501712e-07
2 O 0 1.539336949463177e-06
to O 0 1.0879082310566446e-06
1 O 0 7.388704034383409e-06
. O 0 4.027923296234803e-06
1 O 0 4.341316525824368e-05
) O 0 5.083419819129631e-05
. O 0 0.0001028978222166188

CONCLUSIONS O 0 0.000511825957801193
Oral O 0 0.08599543571472168
- O 0 0.010129478760063648
contraceptive O 0 0.00033186626387760043
use O 0 2.858269681382808e-06
may O 0 2.475505652910215e-06
reduce O 0 1.8432692741043866e-06
the O 0 1.4795855349802878e-06
risk O 0 1.558094118081499e-05
of O 0 0.4756452143192291
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 8.528190664947033e-05
women O 0 2.8430131351342425e-06
with O 0 8.650993095216108e-07
pathogenic O 0 3.167721843055915e-06
mutations O 0 2.271554649269092e-06
in O 0 2.483479192960658e-06
the O 0 1.1482732588774525e-05
BRCA1 O 0 0.0007772367680445313
or O 0 6.809065234847367e-05
BRCA2 O 0 0.0031920624896883965
gene O 0 0.0005641760653816164

A O 0 0.0007992374012246728
Japanese O 0 0.0008735907031223178
family O 0 7.016141171334311e-05
with O 0 2.5033366910065524e-05
adrenoleukodystrophy B-Disease 1 0.9999996423721313
with O 0 1.5411527783726342e-05
a O 0 1.8790518879541196e-05
codon O 0 2.2456073565990664e-05
291 O 0 1.0277617548126727e-05
deletion O 0 9.783967470866628e-06
: O 0 1.7822251265897648e-06
a O 0 3.572487003111746e-06
clinical O 0 1.657556276768446e-05
, O 0 4.8261945266858675e-06
biochemical O 0 2.9687207643291913e-05
, O 0 8.653752047393937e-06
pathological O 0 0.0014572259970009327
, O 0 4.763649030792294e-06
and O 0 4.370692295196932e-06
genetic O 0 6.25592001597397e-05
report O 0 2.9843469746992923e-05
. O 0 7.599246600875631e-05

We O 0 6.821673741796985e-05
report O 0 1.2752607290167361e-05
a O 0 1.4835722140560392e-05
Japanese O 0 6.847071927040815e-05
family O 0 3.03650667774491e-05
with O 0 2.682655212993268e-05
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.9885351061820984
ALD B-Disease 1 1.0
) O 0 8.845250704325736e-06
with O 0 1.885548840618867e-06
a O 0 2.967055024782894e-06
three O 0 1.1882561921083834e-06
base O 0 5.617133410851238e-06
pair O 0 4.305652510083746e-06
deletion O 0 1.550173692521639e-05
( O 0 1.1965371413680259e-05
delGAG O 0 0.0002384229883318767
291 O 0 2.5829394871834666e-05
) O 0 4.054713372170227e-06
in O 0 3.015363290614914e-06
the O 0 2.6958963644574396e-05
ALD B-Disease 1 0.9999998807907104
gene O 0 0.0002015862992266193
. O 0 0.00012499306467361748

A O 0 0.0003378027176950127
variety O 0 2.4453345758956857e-05
of O 0 1.4658619875262957e-05
phenotypes O 0 2.2682734197587706e-05
were O 0 6.470937933045207e-06
observed O 0 4.728236945084063e-06
within O 0 5.7095953707175795e-06
this O 0 6.591495548491366e-06
family O 0 5.60081607545726e-05
. O 0 7.600724347867072e-05

While O 0 8.308445831062272e-05
the O 0 4.83416770293843e-05
proband O 0 0.0038219518028199673
( O 0 2.3678328943788074e-05
patient O 0 2.2623064069193788e-05
1 O 0 1.4490439752989914e-05
) O 0 4.923711003357312e-06
was O 0 1.8968747099279426e-05
classified O 0 3.452730879871524e-06
as O 0 1.845524138843757e-06
having O 0 2.180064484491595e-06
a O 0 2.4354537799808895e-06
rare O 0 3.5832456433126936e-06
intermediate O 0 1.8817561795003712e-05
type O 0 1.284265181311639e-05
of O 0 2.1518513676710427e-05
adult O 0 5.138641790836118e-05
cerebral O 1 0.862291157245636
and O 0 3.613590160966851e-05
cerebello O 1 0.9999918937683105
- O 1 0.9966490864753723
brain O 1 0.9428425431251526
stem O 0 2.7020838388125412e-05
forms O 0 3.1169818157650298e-06
, O 0 1.4965937680244679e-06
his O 0 6.143001883174293e-06
younger O 0 1.4718222701048944e-05
brother O 0 2.2920796254766174e-05
( O 0 2.2300844193523517e-06
patient O 0 5.635295565298293e-06
2 O 0 7.805891982570756e-06
) O 0 1.9011658878298476e-06
and O 0 1.4103702596912626e-06
nephew O 0 6.449046486523002e-05
( O 0 3.430389597269823e-06
patient O 0 4.550273388304049e-06
3 O 0 5.537277957046172e-06
) O 0 1.8304968989468762e-06
had O 0 6.8183553594280966e-06
a O 0 2.7459016564534977e-05
childhood O 1 0.999976634979248
ALD B-Disease 1 1.0
type O 1 0.9953294992446899
. O 0 0.0003513769479468465

Another O 0 0.000613569573033601
nephew O 0 0.021612275391817093
( O 0 2.2949992853682488e-05
patient O 0 2.4950115403044038e-05
4 O 0 1.236497064383002e-05
) O 0 1.942632707141456e-06
of O 0 3.0770504508836893e-06
patient O 0 6.001662768539973e-06
1 O 0 1.4177024240780156e-05
was O 0 4.2909534386126325e-05
classified O 0 8.000334673852194e-06
as O 0 3.4069903449562844e-06
having O 0 9.189543561660685e-06
an O 0 1.3097671399009414e-05
adolescent O 0 0.004813001491129398
form O 0 0.00010436965385451913
. O 0 0.00021090857626404613

The O 0 0.0001434325095033273
tau O 0 0.0002525753516238183
level O 0 2.35512234212365e-05
in O 0 4.586971499520587e-06
the O 0 9.234207936970051e-06
cerebrospinal O 1 0.9488493204116821
fluid O 0 0.08887085318565369
( O 0 0.00011036379873985425
CSF O 1 0.9997665286064148
) O 0 4.284770056983689e-06
in O 0 1.6005228644644376e-06
patient O 0 3.536312306096079e-06
1 O 0 7.381653631455265e-06
was O 0 2.028874951065518e-05
as O 0 1.2430226661308552e-06
high O 0 1.5735678289274802e-06
as O 0 4.0517497268410807e-07
that O 0 2.226076247779929e-07
of O 0 1.78475420398172e-06
patients O 0 2.2370317310560495e-05
with O 0 0.0008585540344938636
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.007789376191794872
AD B-Disease 0 0.014207703992724419
) O 0 4.8023441195255145e-05
. O 0 5.552783113671467e-05

His O 0 0.0006879816064611077
brain O 0 0.03748863935470581
magnetic O 0 0.0001321204617852345
resonance O 0 8.280105248559266e-05
image O 0 4.511191218625754e-05
( O 0 9.299808880314231e-06
MRI O 0 0.0006962429033592343
) O 0 9.730852070788387e-06
showed O 0 3.362708230270073e-05
abnormalities B-Disease 0 0.000589093950111419
in I-Disease 0 4.616770638676826e-06
the I-Disease 0 1.2913244972878601e-05
bilateral I-Disease 1 0.7629768252372742
cerebellar I-Disease 1 0.9999991655349731
hemispheres I-Disease 0 0.005919379647821188
and O 0 4.451864515431225e-05
brain O 1 0.9972739815711975
stem O 0 0.0001641309936530888
, O 0 1.4940724213374779e-06
but O 0 3.438832720803475e-07
not O 0 3.3633205021033064e-07
in O 0 1.6135587657117867e-06
the O 0 1.2204285667394288e-05
cerebral O 1 0.9955058097839355
white O 0 4.156398426857777e-05
matter O 0 5.0538728828541934e-06
, O 0 1.0957990070892265e-06
where O 0 1.1553066769920406e-06
marked O 0 5.0611220103746746e-06
reductions O 0 3.069822241741349e-06
of O 0 1.6170557728401036e-06
the O 0 5.708386652258923e-06
cerebral O 1 0.8749533891677856
blood O 0 1.697960942692589e-05
flow O 0 4.461067874217406e-06
and O 0 1.4762774753762642e-06
oxygen O 0 7.19752370059723e-06
metabolism O 0 5.369197879190324e-06
were O 0 1.5554397805317421e-06
clearly O 0 2.1504129108507186e-06
demonstrated O 0 4.569916654872941e-06
by O 0 2.1121068130014464e-06
positron O 0 3.533521885401569e-05
emission O 0 1.2146578228566796e-05
tomography O 0 4.112880924367346e-05
( O 0 2.1048874259577133e-05
PET O 0 0.0001340998278465122
) O 0 2.6106379664270207e-05
. O 0 5.452226832858287e-05

In O 0 0.0001352873514406383
patients O 0 4.07959523727186e-05
2 O 0 3.7420679291244596e-05
and O 0 7.229387392726494e-06
3 O 0 1.2913553291582502e-05
, O 0 2.2160941171023296e-06
the O 0 1.956291953320033e-06
autopsy O 0 8.570406862418167e-06
findings O 0 4.5777683226333465e-06
showed O 0 3.389379344298504e-05
massive O 0 0.06409438699483871
demyelination B-Disease 1 0.9999971389770508
of I-Disease 0 7.34276618459262e-05
the I-Disease 0 0.00024486001348122954
cerebral I-Disease 1 0.999182403087616
white I-Disease 0 4.9076086725108325e-05
matter I-Disease 0 3.0015917218406685e-06
with O 0 1.4409550885829958e-06
sparing O 0 1.1131572136946488e-05
of O 0 7.959285539982375e-06
the O 0 8.210286614485085e-05
U O 1 0.9999985694885254
- O 1 0.9388872981071472
fibers O 0 0.00041187903843820095
, O 0 2.7160531317349523e-06
compatible O 0 3.756297019208432e-06
with O 0 5.328230372469989e-07
the O 0 1.7891595689434325e-06
findings O 0 5.3456037676369306e-06
of O 0 4.993837865185924e-05
childhood O 1 0.9999947547912598
ALD B-Disease 1 1.0
. O 0 0.0037388873752206564

Oleic O 0 0.03340907022356987
and O 0 0.00036134570837020874
erucic O 1 0.8668071627616882
acids O 0 7.101405208231881e-05
( O 0 4.411260306369513e-05
Lorenzos O 0 0.00031302706338465214
Oil O 0 1.5798204913153313e-05
) O 0 1.2831177400585148e-06
were O 0 6.760533324268181e-07
administered O 0 1.5580170611428912e-06
to O 0 8.470353805023478e-07
patients O 0 1.7979565427594935e-06
1 O 0 4.439405984157929e-06
and O 0 1.1773462347264285e-06
4 O 0 5.006396349926945e-06
, O 0 1.281495997318416e-06
but O 0 5.89260082506371e-07
sufficient O 0 3.011997932844679e-06
effectiveness O 0 8.619193067715969e-06
was O 0 1.3642451449413784e-05
not O 0 3.587068249544245e-06
obtained O 0 3.095493957516737e-05
. O 0 8.733335562283173e-05

The O 0 8.549312769901007e-05
findings O 0 2.4492321244906634e-05
in O 0 7.076907877490157e-06
this O 0 2.7987791781924898e-06
family O 0 5.095273991173599e-06
suggest O 0 3.2313578230969142e-06
that O 0 6.874001314827183e-07
delGAG291 O 0 2.2446050934377126e-05
is O 0 1.3714856095248251e-06
part O 0 1.8549870901551913e-06
of O 0 2.6656343834474683e-06
the O 0 5.222859272180358e-06
cause O 0 2.0240704543539323e-05
of O 0 3.0027258617337793e-05
Japanese O 1 0.8296346664428711
ALD B-Disease 1 0.9999997615814209
with O 0 3.9130987715907395e-05
phenotypic O 0 0.00021295453188940883
variations O 0 0.00018131537945009768
. O 0 0.0001987178111448884

Moreover O 0 0.0002636075369082391
, O 0 1.9678818716784008e-05
although O 0 3.83873612008756e-06
the O 0 2.816826736307121e-06
scale O 0 7.358445600402774e-06
of O 0 3.35740242007887e-06
the O 0 2.782594947348116e-06
study O 0 1.4418155842577107e-06
is O 0 8.030482945287076e-07
limited O 0 9.80060690380924e-07
, O 0 5.649359309245483e-07
there O 0 7.196879892035213e-07
is O 0 1.4288145848695422e-06
a O 0 2.396287754891091e-06
possibility O 0 7.872126843722071e-06
that O 0 2.1269979697535746e-06
PET O 0 1.9251736375736073e-05
can O 0 7.652976705685433e-07
detect O 0 5.9017224884883035e-06
an O 0 5.607729235634906e-06
insidious B-Disease 1 0.9306195974349976
lesion I-Disease 1 0.9800618290901184
which O 0 2.4616956579848193e-06
is O 0 1.4407902426682995e-06
undetectable O 0 5.923109256400494e-06
by O 0 5.311022164278256e-07
computed O 0 3.953917257604189e-06
tomogram O 0 8.896768122212961e-05
( O 0 4.117414391657803e-06
CT O 0 0.00012074539699824527
) O 0 1.3526945394914947e-06
or O 0 5.627125574392267e-07
MRI O 0 8.310980774695054e-06
analysis O 0 1.114533688451047e-06
, O 0 5.744840336774359e-07
and O 0 3.426207229040301e-07
that O 0 2.4569482093284023e-07
the O 0 8.121928658511024e-07
higher O 0 8.463828748972446e-07
level O 0 2.925811486420571e-06
of O 0 4.399773843033472e-06
tau O 0 2.6900896045845002e-05
reflects O 0 4.044556135340827e-06
the O 0 1.520483579042775e-06
process O 0 3.760088929993799e-06
of O 0 2.243054041173309e-05
neuronal B-Disease 1 0.9907687306404114
degeneration I-Disease 1 0.9999998807907104
in O 0 0.27881330251693726
ALD B-Disease 1 1.0
. O 0 0.0027357395738363266

Lorenzos O 0 0.013235483318567276
Oil O 0 0.0002271507546538487
should O 0 7.65974800742697e-06
be O 0 1.064785465132445e-06
given O 0 1.324197910435032e-06
in O 0 2.0307616068748757e-06
the O 0 3.5210275655117584e-06
early O 0 2.0297071387176402e-05
stage O 0 7.041483331704512e-05
. O 0 2.3843947928980924e-05
. O 0 8.236282883444801e-05

Nonsense O 0 0.0009452659287489951
mutation O 0 3.5420642234385014e-05
in O 0 1.6615476852166466e-05
exon O 0 8.557451656088233e-05
4 O 0 2.0369301637401804e-05
of O 0 1.0883225513680372e-05
human O 0 5.398067514761351e-06
complement O 0 1.511502887296956e-05
C9 O 1 0.975233793258667
gene O 0 4.432138211996062e-06
is O 0 1.427820279786829e-06
the O 0 1.5535613329120679e-06
major O 0 6.774643225071486e-06
cause O 0 9.80165623332141e-06
of O 0 1.4175916476233397e-05
Japanese O 1 0.6992341876029968
complement B-Disease 1 0.6170908212661743
C9 I-Disease 1 0.9999996423721313
deficiency I-Disease 1 0.9999997615814209
. O 0 0.0008161491714417934

Deficiency B-Disease 1 0.9999990463256836
of I-Disease 0 0.00034166485420428216
the I-Disease 0 0.00013550101721193641
ninth I-Disease 1 0.7988867163658142
component I-Disease 0 0.0001947095151990652
of I-Disease 0 8.051217264437582e-06
human I-Disease 0 3.8693156056979205e-06
complement I-Disease 0 9.053237590705976e-06
( O 0 8.770250133238733e-06
C9 O 1 0.9738561511039734
) O 0 1.5709018725829083e-06
is O 0 7.569676654384239e-07
the O 0 8.39918868678069e-07
most O 0 1.0922474302788032e-06
common O 0 8.157317097357009e-06
complement B-Disease 1 0.9984970092773438
deficiency I-Disease 1 1.0
in O 0 4.230474223732017e-05
Japan O 0 0.001964257564395666
but O 0 1.98532575268473e-06
is O 0 1.9575741134758573e-06
rare O 0 2.5821509552770294e-06
in O 0 2.008741603276576e-06
other O 0 2.3676293494645506e-06
countries O 0 7.828159141354263e-06
. O 0 6.444528116844594e-05

We O 0 4.635418008547276e-05
studied O 0 4.6384073357330635e-05
the O 0 6.037490038579563e-06
molecular O 0 7.520713097619591e-06
basis O 0 5.973921815893846e-06
of O 0 5.303601938067004e-05
C9 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999986886978149
in O 0 3.148761607008055e-05
four O 0 2.8840391678386368e-05
Japanese O 1 0.9931116104125977
C9 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9989132881164551
deficient I-Disease 1 0.9949108958244324
patients O 0 7.926076068542898e-05
who O 0 1.632138628337998e-05
had O 0 0.00037113309372216463
suffered O 1 0.9999961853027344
from O 1 0.9972846508026123
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 0.01490466296672821

Direct O 0 0.00017870341253001243
sequencing O 0 0.00014823312812950462
of O 0 9.368450992042199e-05
amplified O 0 0.00026555953081697226
C9 O 0 0.0012111697578802705
cDNA O 0 4.5019041863270104e-05
and O 0 3.0487894946418237e-06
DNA O 0 4.8957108447211795e-06
revealed O 0 7.3918049565691035e-06
a O 0 5.7604711400927044e-06
nonsense O 0 2.060541373793967e-05
substitution O 0 1.4249894775275607e-05
( O 0 1.424814217898529e-05
CGA O 0 0.0002245131036033854
- O 0 3.287342769908719e-05
- O 0 3.0758081265958026e-05
> O 0 3.956226646550931e-05
TGA O 0 0.00011959516268689185
) O 0 2.4325174763362156e-06
at O 0 5.150888227944961e-06
codon O 0 4.566841198538896e-06
95 O 0 4.9464379117125645e-06
in O 0 3.558332082320703e-06
exon O 0 2.2018297386239283e-05
4 O 0 6.124821993580554e-06
in O 0 4.799765520147048e-06
the O 0 8.857751709001604e-06
four O 0 2.0004345060442574e-05
C9 B-Disease 1 0.9997016787528992
- I-Disease 0 0.018136247992515564
deficient I-Disease 0 0.002432323759421706
individuals O 0 1.5220477507682517e-05
. O 0 6.798288086429238e-05

An O 0 8.591204095864668e-05
allele O 0 4.136611460126005e-05
- O 0 2.8112579457229003e-05
specific O 0 3.2922323498496553e-06
polymerase O 0 6.010728611727245e-05
chain O 0 9.430461432202719e-06
reaction O 0 2.805614940371015e-06
system O 0 3.682162059703842e-06
designed O 0 2.457534719724208e-06
to O 0 8.768759585109365e-07
detect O 0 2.7462720026960596e-06
exclusively O 0 1.21103380479326e-06
only O 0 5.814959536110109e-07
one O 0 4.810452196579718e-07
of O 0 9.293701737078663e-07
the O 0 1.1426322998886462e-06
normal O 0 2.3830195914342767e-06
and O 0 9.765125241756323e-07
mutant O 0 4.567276846501045e-06
alleles O 0 7.568543196612154e-07
indicated O 0 9.327887369181553e-07
that O 0 1.5971303923834057e-07
all O 0 1.5284636845080968e-07
the O 0 6.259512019823887e-07
four O 0 8.852625228428224e-07
patients O 0 1.5070060044308775e-06
were O 0 9.429097076463222e-07
homozygous O 0 1.703425823507132e-06
for O 0 4.3618007339318865e-07
the O 0 1.1785054994106758e-06
mutation O 0 1.451666889806802e-06
in O 0 1.7709649000607897e-06
exon O 0 1.4718686543346848e-05
4 O 0 3.7698805499530863e-06
and O 0 6.256551614569617e-07
that O 0 2.2431910906561825e-07
the O 0 6.75421176765667e-07
parents O 0 7.202957021945622e-07
of O 0 1.89856757515372e-06
patient O 0 6.952927378733875e-06
2 O 0 1.9440229152678512e-05
were O 0 1.7608768757781945e-05
heterozygous O 0 5.878563388250768e-05
. O 0 6.620286876568571e-05

The O 0 5.996604522806592e-05
common O 0 1.1724067007889971e-05
mutation O 0 1.0211640983470716e-05
at O 0 1.0639241736498661e-05
codon O 0 6.131858754088171e-06
95 O 0 3.411451189094805e-06
in O 0 1.7242747389900615e-06
exon O 0 1.5784713468747213e-05
4 O 0 5.039655661676079e-06
might O 0 1.2814899719160167e-06
be O 0 4.5237010226628627e-07
responsible O 0 1.4170088888931787e-06
for O 0 1.4269504617914208e-06
most O 0 4.922748303215485e-06
Japanese O 1 0.8375216126441956
C9 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
. O 0 6.702650716761127e-05
. O 0 0.0001441541244275868

BRCA1 O 0 0.0003495172131806612
required O 0 1.802551923901774e-05
for O 0 1.3675601621798705e-05
transcription O 0 0.00025516768801026046
- O 0 0.00045971633517183363
coupled O 0 0.0003868606872856617
repair O 0 0.0012110481038689613
of O 0 4.596768121700734e-05
oxidative O 0 0.09444759786128998
DNA O 0 0.0002547796757426113
damage O 0 0.0017611442599445581
. O 0 0.00011622038437053561

The O 0 0.0003246499691158533
breast B-Disease 1 0.9999750852584839
and I-Disease 1 0.9516987800598145
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9999970197677612
gene O 0 0.004292183555662632
BRCA1 O 0 0.002496069995686412
encodes O 0 1.8995140635524876e-05
a O 0 9.80312324827537e-06
zinc O 0 0.04137469083070755
finger O 0 2.3987566237337887e-05
protein O 0 3.7719414649473038e-06
of O 0 4.215666649542982e-06
unknown O 0 1.6453535863547586e-05
function O 0 1.540697121527046e-05
. O 0 3.3447882742621005e-05

Association O 0 0.00016693744692020118
of O 0 4.7270736104110256e-05
the O 0 2.600911830086261e-05
BRCA1 O 0 0.00013869443500880152
protein O 0 9.892567504721228e-06
with O 0 1.8189438151239301e-06
the O 0 4.580650511343265e-06
DNA O 0 1.4289944374468178e-05
repair O 0 0.0004562436952255666
protein O 0 1.1100574738520663e-05
Rad51 O 0 4.159550735494122e-05
and O 0 6.219430019882566e-07
changes O 0 3.354066677729861e-07
in O 0 3.5476412563184567e-07
the O 0 7.014306788732938e-07
phosphorylation O 0 2.2598003397433786e-06
and O 0 9.500014925833966e-07
cellular O 0 4.079762675246457e-06
localization O 0 5.347168553271331e-06
of O 0 2.1679320525436196e-06
the O 0 2.371138407397666e-06
protein O 0 2.8900101369799813e-06
after O 0 3.038743670913391e-06
exposure O 0 5.151576260686852e-06
to O 0 1.527807967249828e-06
DNA O 0 9.263826541427989e-06
- O 0 1.2491004781622905e-05
damaging O 0 6.843122719146777e-06
agents O 0 1.1285214895906392e-06
are O 0 2.1055875265574286e-07
consistent O 0 6.97722498443909e-07
with O 0 4.611616759575554e-07
a O 0 2.4564731120335637e-06
role O 0 6.151949037302984e-06
for O 0 5.160859927855199e-06
BRCA1 O 0 9.255659824702889e-05
in O 0 2.0975852748961188e-05
DNA O 0 0.00011587779590627179
repair O 0 0.002663516905158758
. O 0 0.0001696161925792694

Here O 0 0.00012529641389846802
, O 0 1.1728316167136654e-05
it O 0 1.2696559679170605e-06
is O 0 1.8335579170525307e-06
shown O 0 3.6458220620261272e-06
that O 0 1.574924908709363e-06
mouse O 0 1.759050792315975e-05
embryonic O 0 5.0744252803269774e-05
stem O 0 7.740063301753253e-05
cells O 0 8.345442438439932e-06
deficient B-Disease 0 1.6780288206064142e-05
in I-Disease 0 2.5821877898124512e-06
BRCA1 I-Disease 0 3.7385329051176086e-05
are O 0 6.017177156536491e-07
defective O 0 5.507942660187837e-06
in O 0 1.1008140745616402e-06
the O 0 9.093101311918872e-07
ability O 0 5.97374594235589e-07
to O 0 3.7959279097776744e-07
carry O 0 7.449988856933487e-07
out O 0 9.506767355560442e-07
transcription O 0 1.404592148901429e-05
- O 0 1.6873458662303165e-05
coupled O 0 2.145157486665994e-05
repair O 0 3.75173294742126e-05
of O 0 6.086670964577934e-06
oxidative O 0 8.813795284368098e-05
DNA O 0 1.0457907592353877e-05
damage O 0 1.7587555703357793e-05
, O 0 1.281738150282763e-06
and O 0 1.022954620566452e-06
are O 0 6.095123694649374e-07
hypersensitive O 0 2.050023977062665e-05
to O 0 3.233201368857408e-06
ionizing O 0 0.00017287064110860229
radiation O 0 0.0001203249630634673
and O 0 1.0671005838958081e-05
hydrogen O 0 8.408973371842876e-05
peroxide O 0 0.0002887974842451513
. O 0 0.00014825660036876798

These O 0 2.0004668840556405e-05
results O 0 9.844147825788241e-06
suggest O 0 1.1941136108362116e-05
that O 0 2.707260364331887e-06
BRCA1 O 0 2.6674075343180448e-05
participates O 0 8.806120604276657e-06
, O 0 2.107848786181421e-06
directly O 0 1.2920630751978024e-06
or O 0 9.856178166955942e-07
indirectly O 0 3.5589225717558293e-06
, O 0 1.3210647011874244e-06
in O 0 2.021240106842015e-06
transcription O 0 5.632089960272424e-05
- O 0 6.591321289306507e-05
coupled O 0 5.0972343160538e-05
repair O 0 8.291088306577876e-05
of O 0 1.7352993381791748e-05
oxidative O 0 0.00021890393691137433
DNA O 0 4.641885607270524e-05
damage O 0 9.110527025768533e-05
. O 0 1.730630719976034e-05
. O 0 4.2558207496767864e-05

Truncation O 0 0.0018224935047328472
mutations O 0 0.00012133263953728601
in O 0 4.0110866393661126e-05
the O 0 2.380498335696757e-05
transactivation O 0 0.0004620733670890331
region O 0 2.930566915892996e-05
of O 0 2.504528129065875e-05
PAX6 O 1 0.9710960984230042
result O 0 1.7308255337411538e-05
in O 0 7.49768923924421e-06
dominant O 0 0.00016356183914467692
- O 0 7.858897879486904e-05
negative O 0 2.6182624424109235e-05
mutants O 0 0.0002692780690267682
. O 0 0.00011749358236556873

PAX6 O 0 0.1564180850982666
is O 0 5.667541699949652e-05
a O 0 1.8905160686699674e-05
transcription O 0 3.476996789686382e-05
factor O 0 9.245361070497893e-06
with O 0 1.653352114772133e-06
two O 0 1.8019389926848817e-06
DNA O 0 9.560506441630423e-06
- O 0 6.2014350987738e-06
binding O 0 2.023822617047699e-06
domains O 0 6.2532931224268395e-06
( O 0 3.040760930161923e-06
paired O 0 1.269925542146666e-05
box O 0 2.183289689128287e-05
and O 0 4.208849986753194e-06
homeobox O 0 0.0002104379382217303
) O 0 3.3941482797672506e-06
and O 0 2.0718539417430293e-06
a O 0 8.353666999028064e-06
proline O 0 5.670519749401137e-05
- O 0 3.164315057802014e-05
serine O 0 4.098511271877214e-05
- O 0 2.3955652068252675e-05
threonine O 0 3.4303309803362936e-05
( O 0 1.36019843921531e-05
PST O 0 0.0011837690835818648
) O 0 1.7198313798871823e-05
- O 0 3.453619865467772e-05
rich O 0 2.8339927666820586e-05
transactivation O 0 0.00042116717668250203
domain O 0 0.00014250248204916716
. O 0 0.00012796973169315606

PAX6 O 1 0.9998225569725037
regulates O 0 0.004818495828658342
eye O 0 0.002129285130649805
development O 0 7.145253039197996e-05
in O 0 1.099992459785426e-05
animals O 0 4.257414275343763e-06
ranging O 0 6.5112917582155205e-06
from O 0 5.245306056167465e-06
jellyfish O 0 1.0064242815133184e-05
to O 0 1.921297325679916e-06
Drosophila O 0 1.2285068805795163e-05
to O 0 3.460401558186277e-06
humans O 0 1.6008576494641602e-05
. O 0 3.273690163041465e-05

Heterozygous O 0 0.0002786014520097524
mutations O 0 5.071068517281674e-05
in O 0 1.5018674275779631e-05
the O 0 1.14417834993219e-05
human O 0 1.3062881407677196e-05
PAX6 O 1 0.9643224477767944
gene O 0 5.410627636592835e-06
result O 0 1.6383843330913805e-06
in O 0 8.710200631867338e-07
various O 0 9.486833505434333e-07
phenotypes O 0 7.022792487987317e-06
, O 0 1.5240897255353048e-06
including O 0 4.881156655756058e-06
aniridia B-Disease 1 0.9999991655349731
, O 0 0.00011069156607845798
Peters B-Disease 1 0.9999784231185913
anomaly I-Disease 1 0.9999954700469971
, O 0 4.302881643525325e-05
autosomal B-Disease 1 0.7074779868125916
dominant I-Disease 1 0.9986087679862976
keratitis I-Disease 1 0.9999935626983643
, O 0 9.116713044932112e-05
and O 0 5.4495289077749476e-05
familial B-Disease 1 0.9999986886978149
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.12837766110897064

It O 0 4.907093898509629e-05
is O 0 1.4314701729745138e-05
believed O 0 1.3003481399209704e-05
that O 0 1.2389301673465525e-06
the O 0 1.938339437401737e-06
mutated O 0 5.973511633783346e-06
allele O 0 5.1485062613210175e-06
of O 0 1.0161029422306456e-05
PAX6 O 1 0.5244358777999878
produces O 0 4.878029358224012e-06
an O 0 1.571071038597438e-06
inactive O 0 3.377163739060052e-05
protein O 0 8.726831765670795e-06
and O 0 2.9367586193984607e-06
aniridia B-Disease 1 0.8731778860092163
is O 0 3.978663244197378e-06
caused O 0 1.12809093479882e-05
due O 0 6.26620521870791e-06
to O 0 3.420859911784646e-06
genetic O 0 0.00020112530910409987
haploinsufficiency O 1 0.7898886799812317
. O 0 8.025436545722187e-05

However O 0 0.00011665630154311657
, O 0 1.5408675608341582e-05
several O 0 5.576487637881655e-06
truncation O 0 4.493163214647211e-05
mutations O 0 6.658148322458146e-06
have O 0 8.443794854429143e-07
been O 0 1.0754552022262942e-06
found O 0 4.849234755965881e-07
to O 0 4.2998647131753387e-07
occur O 0 4.1163406194755225e-07
in O 0 1.0215312613581773e-06
the O 0 5.674853582604555e-06
C O 0 0.004961480386555195
- O 0 7.255925447680056e-05
terminal O 0 0.00017890663002617657
half O 0 5.673013674822869e-06
of O 0 7.055324203975033e-06
PAX6 O 1 0.6176273226737976
in O 0 3.087509185206727e-06
patients O 0 3.583706984500168e-06
with O 0 2.4349383238586597e-06
Aniridia B-Disease 1 0.9999674558639526
resulting O 0 8.395525583182462e-06
in O 0 1.8786886357702315e-06
mutant O 0 4.6752379603276495e-06
proteins O 0 4.1535420791660727e-07
that O 0 1.9666141781726765e-07
retain O 0 1.054440758707642e-06
the O 0 1.4734897604284924e-06
DNA O 0 6.4902760641416535e-06
- O 0 6.300751010712702e-06
binding O 0 8.595287113166705e-07
domains O 0 1.9000203792529646e-06
but O 0 5.763245098933112e-07
have O 0 4.526756356426631e-07
lost O 0 6.7912678787251934e-06
most O 0 7.209794716800388e-07
of O 0 3.7193110529187834e-06
the O 0 1.6381845853175037e-05
transactivation O 0 0.006568386219441891
domain O 0 0.00011722792260115966
. O 0 7.984230614965782e-05

It O 0 3.758461753022857e-05
is O 0 6.957297955523245e-06
not O 0 1.3312443343238556e-06
clear O 0 3.482768988760654e-06
whether O 0 7.868050033721374e-07
such O 0 8.91065383257228e-07
mutants O 0 1.2989004972041585e-05
really O 0 4.3095924411318265e-06
behave O 0 2.235930196547997e-06
as O 0 1.754329787218012e-06
loss O 0 2.7401256375014782e-05
- O 0 2.2345479010255076e-05
of O 0 1.2162376151536591e-05
- O 0 5.0215643568662927e-05
function O 0 5.841611255164025e-06
mutants O 0 1.6749398128013127e-05
as O 0 3.5372734146221774e-06
predicted O 0 1.167308073490858e-05
by O 0 6.996674528636504e-06
haploinsufficiency O 0 0.0007417118176817894
. O 0 0.00011479273962322623

Contrary O 0 0.00012647300900425762
to O 0 5.620348474622006e-06
this O 0 2.8902747999381972e-06
theory O 0 6.0306133491394576e-06
, O 0 1.3932186675447156e-06
our O 0 8.030368121580977e-07
data O 0 7.841300657673855e-07
showed O 0 1.8335701952310046e-06
that O 0 3.0727994726476027e-07
these O 0 3.0073772450123215e-07
mutants O 0 3.3378705666109454e-06
are O 0 6.059098609512148e-07
dominant O 0 8.03884267952526e-06
- O 0 9.13596977625275e-06
negative O 0 2.7805392619484337e-06
in O 0 2.935985776275629e-06
transient O 0 3.8149537431309e-05
transfection O 0 3.436234692344442e-05
assays O 0 3.3965993679885287e-06
when O 0 1.994524154724786e-06
they O 0 6.993079182393558e-07
are O 0 5.506511797648272e-07
coexpressed O 0 3.49046167684719e-05
with O 0 7.164446742535802e-06
wild O 0 5.1668077503563836e-05
- O 0 0.000613186857663095
type O 0 0.01023809053003788
PAX6 O 1 0.9996030926704407
. O 0 0.0002538183471187949

We O 0 3.270376691943966e-05
found O 0 8.763126970734447e-06
that O 0 2.4945788936747704e-06
the O 0 3.4161130315624177e-06
dominant O 0 8.6314081272576e-05
- O 0 4.037405233248137e-05
negative O 0 3.284379772594548e-06
effects O 0 3.7860468182771e-06
result O 0 1.1749738177968538e-06
from O 0 8.327898513016407e-07
the O 0 1.3616823935080902e-06
enhanced O 0 5.03594219480874e-06
DNA O 0 2.0617897007468855e-06
binding O 0 6.605160365324991e-07
ability O 0 9.177897482004482e-07
of O 0 3.765407200262416e-06
these O 0 3.824831310339505e-06
mutants O 0 0.0001011789427138865
. O 0 8.087619789876044e-05

Kinetic O 0 0.0006340725813060999
studies O 0 3.3949818316614255e-05
of O 0 1.650445665291045e-05
binding O 0 7.6081523729953915e-06
and O 0 3.522622819218668e-06
dissociation O 0 2.2983351300354116e-05
revealed O 0 1.1341728168190457e-05
that O 0 7.319450787690585e-07
various O 0 7.391745384666137e-07
truncation O 0 1.2913097634736914e-05
mutants O 0 8.742442332732026e-06
have O 0 1.2619182143680518e-06
3 O 0 4.809176516573643e-06
- O 0 9.130369107879233e-06
5 O 0 6.984634183027083e-06
- O 0 5.399421752372291e-06
fold O 0 2.765357521639089e-06
higher O 0 7.058029609652294e-07
affinity O 0 9.699746215119376e-07
to O 0 2.846950621915312e-07
various O 0 4.861180968873668e-07
DNA O 0 3.296545855846489e-06
- O 0 2.5437532258365536e-06
binding O 0 5.677932222170057e-07
sites O 0 8.172962111530069e-07
when O 0 8.517359901816235e-07
compared O 0 1.3373268075156375e-06
with O 0 1.0438451454319875e-06
the O 0 5.454478014144115e-06
wild O 0 2.852212855941616e-05
- O 0 0.00017789042613003403
type O 0 0.00041831983253359795
PAX6 O 1 0.9935844540596008
. O 0 0.00010054741142084822

These O 0 1.4224425285647158e-05
results O 0 5.983391929476056e-06
provide O 0 4.565569724945817e-06
a O 0 4.143368641962297e-06
new O 0 2.0162997316219844e-06
insight O 0 6.2625013015349396e-06
into O 0 1.6724040960980346e-06
the O 0 1.375492274746648e-06
role O 0 5.1930096560681704e-06
of O 0 9.509953997621778e-06
mutant O 0 0.00019376534328330308
PAX6 O 1 0.9125324487686157
in O 0 1.4572356121789198e-05
causing O 0 0.0006557863671332598
aniridia B-Disease 1 0.9997634291648865
. O 0 4.995323979528621e-05
. O 0 8.786815305938944e-05

Reversal O 0 0.017252234742045403
of O 0 0.07841522991657257
severe O 1 0.9999998807907104
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 0.009711016900837421
excellent O 0 0.001721456297673285
neuropsychologic O 0 0.04073481634259224
outcome O 0 2.4241773644462228e-05
in O 0 7.292615919141099e-06
very B-Disease 0 1.0342125278839376e-05
- I-Disease 0 2.661649887159001e-05
long I-Disease 0 3.6172968975733966e-05
- I-Disease 0 9.156337910098955e-05
chain I-Disease 0 3.567253952496685e-05
acyl I-Disease 0 5.735646846005693e-05
- I-Disease 0 0.00010108067363034934
coenzyme I-Disease 0 7.89816040196456e-05
A I-Disease 0 0.008550748229026794
dehydrogenase I-Disease 1 0.5253476500511169
deficiency I-Disease 1 0.9999841451644897
. O 0 0.00034135213354602456

Very B-Disease 0 0.0002841490204446018
- I-Disease 0 0.00044598785461857915
long I-Disease 0 0.0001879468181869015
- I-Disease 0 0.00022758866543881595
chain I-Disease 0 8.065314614214003e-05
acyl I-Disease 0 5.9760193835245445e-05
- I-Disease 0 3.6335288314148784e-05
coenzyme I-Disease 0 1.668093682383187e-05
A I-Disease 0 3.9826787542551756e-05
dehydrogenase I-Disease 0 4.976472337148152e-05
( I-Disease 0 1.2206195606268011e-05
VLCAD I-Disease 1 0.9999510049819946
) I-Disease 0 2.41982579609612e-05
deficiency I-Disease 1 0.9985306262969971
is O 0 2.889023562602233e-06
a O 0 6.254850177356275e-06
disorder O 1 0.9987679123878479
of O 0 0.0033543554600328207
fatty O 0 0.3665512204170227
acid O 0 0.00021201750496402383
beta O 0 3.434075915720314e-05
oxidation O 0 6.714677056152141e-06
that O 0 1.4062673017178895e-06
reportedly O 0 8.479223652102519e-06
has O 0 1.2784444152202923e-06
high O 0 4.871873898082413e-06
rates O 0 3.3999856441369047e-06
of O 0 7.946361620270181e-06
morbidity O 0 0.00021959379955660552
and O 0 1.6423531633336097e-05
mortality O 0 0.00026621785946190357
. O 0 0.00010504943202249706

We O 0 5.886427970835939e-05
describe O 0 3.331120024085976e-05
the O 0 5.930598945269594e-06
outcome O 0 8.725451152713504e-06
of O 0 1.426357266609557e-05
a O 0 1.9159990188200027e-05
5 O 0 2.529262565076351e-05
- O 0 3.7969763070577756e-05
year O 0 1.072818849934265e-05
- O 0 6.382646824931726e-05
old O 0 0.0002350049326196313
girl O 0 0.00020199880236759782
with O 0 0.00010641323024174199
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 0.00016267776663880795
was O 0 9.339566895505413e-05
first O 0 3.5151465453964192e-06
seen O 0 2.2099525267549325e-06
at O 0 2.0814111394429347e-06
5 O 0 1.2117201322325855e-06
months O 0 1.254986273124814e-06
of O 0 2.1781590930913808e-06
age O 0 2.3464221158064902e-05
with O 0 4.1032395529327914e-05
severe O 1 0.9999998807907104
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 0.9999911785125732
hepatomegaly B-Disease 1 1.0
, O 1 0.99977046251297
encephalopathy B-Disease 1 1.0
, O 0 0.001037301030009985
and O 0 0.0002684638893697411
hypotonia B-Disease 1 0.9976668357849121
. O 0 0.00038897577906027436

Biochemical O 0 0.012527666054666042
studies O 0 0.0005338022019714117
indicated O 1 0.9969678521156311
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.9987086057662964
by O 0 3.1386647606268525e-05
a O 0 6.182574725244194e-05
stable O 0 0.00013535056496039033
yet O 0 1.895936111395713e-05
inactive O 0 0.00011674533016048372
enzyme O 0 9.889682405628264e-05
. O 0 0.00010549312719376758

Molecular O 0 0.0003389933262951672
genetic O 0 7.63957214076072e-05
analysis O 0 1.6235509974649176e-05
of O 0 2.2432122932514176e-05
her O 0 3.4373686503386125e-05
VLCAD O 1 0.9991543292999268
gene O 0 1.7478439986007288e-05
revealed O 0 1.5716521374997683e-05
a O 0 9.859058081929106e-06
T1372C O 0 8.920197433326393e-05
( O 0 7.294097486010287e-06
F458L O 0 6.049941657693125e-05
) O 0 4.41354131908156e-06
missense O 0 2.7542571842786856e-05
mutation O 0 6.2208459894463886e-06
and O 0 5.293826689012349e-06
a O 0 3.231580194551498e-05
1668 O 1 0.9990481734275818
ACAG O 1 0.9999310970306396
1669 O 1 0.7737826108932495
splice O 0 0.000662166450638324
site O 0 0.0002121999568771571
mutation O 0 0.00012110851093893871
. O 0 0.000133741763420403

After O 0 0.0002621088642627001
initial O 0 0.00011878852819791064
treatment O 0 0.00011610674118855968
with O 0 2.7582789698499255e-05
intravenous O 1 0.9987508058547974
glucose O 0 0.11593423783779144
and O 0 2.5872241167235188e-05
carnitine O 1 0.8757002949714661
, O 0 4.848725438932888e-06
the O 0 4.00008184442413e-06
patient O 0 1.383990456815809e-05
has O 0 3.2605803426122293e-06
thrived O 0 2.018923441937659e-05
on O 0 3.4965235045092413e-06
a O 0 7.014867605903419e-06
low O 0 1.7431448213756084e-05
- O 0 2.2694091967423446e-05
fat O 0 1.9031058400287293e-05
diet O 0 3.821116479230113e-06
supplemented O 0 3.219889777028584e-06
with O 0 1.4868916196064674e-06
medium O 0 1.4979480511101428e-05
- O 0 1.9621624232968315e-05
chain O 0 1.838564276113175e-05
triglyceride O 0 3.085461867158301e-05
oil O 0 1.1145603821205441e-05
and O 0 3.957743047067197e-06
carnitine O 0 0.00023609506024513394
and O 0 5.170081749383826e-06
avoidance O 0 8.071779302554205e-05
of O 0 4.9196085456060246e-05
fasting O 0 0.00026226809131912887
. O 0 0.00010629083408275619

Her O 0 0.005392118822783232
ventricular O 1 0.9999771118164062
hypertrophy O 1 0.9976835250854492
resolved O 0 0.00015684665413573384
significantly O 0 1.094648087018868e-05
over O 0 5.595169568550773e-06
1 O 0 9.953416338248644e-06
year O 0 3.485397201075102e-06
, O 0 1.8752410824163235e-06
and O 0 1.7926780628840788e-06
cognitively O 0 4.096964039490558e-05
, O 0 1.4694805940962397e-06
she O 0 2.0579509509843774e-06
is O 0 7.990307722138823e-07
in O 0 9.86537543212762e-07
the O 0 3.7115512441232568e-06
superior O 0 2.3543119823443703e-05
range O 0 9.879047865979373e-06
for O 0 9.33225510379998e-06
age O 0 0.00013413232227321714
. O 0 0.0001423434732714668

Clinical O 0 0.001389455865137279
recognition O 0 0.0006525452481582761
of O 1 0.9999667406082153
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.05846406891942024
important O 0 1.3435213077173103e-05
because O 0 1.548315253785404e-06
it O 0 5.209718665355467e-07
is O 0 5.09510527990642e-07
one O 0 2.6817440357262967e-07
of O 0 8.575260039833665e-07
the O 0 1.9914014046662487e-06
few O 0 3.2106911476148525e-06
directly O 0 9.969935490516946e-06
treatable O 1 0.999562680721283
causes O 0 0.008589544333517551
of O 1 0.7859417796134949
cardiomyopathy B-Disease 1 1.0
in O 0 0.02488323673605919
children O 0 0.00018061583978123963
. O 0 3.508500230964273e-05
. O 0 8.544959564460441e-05

Cloning O 0 0.00023403963132295758
of O 0 2.752342879830394e-05
a O 0 1.6140551451826468e-05
novel O 0 1.7511807527625933e-05
member O 0 4.2159199438174255e-06
of O 0 3.602969400162692e-06
the O 0 8.372929187316913e-06
low O 0 2.996518560394179e-05
- O 0 5.081248309579678e-05
density O 0 3.577457391656935e-05
lipoprotein O 0 0.009369375184178352
receptor O 0 0.00013609368761535734
family O 0 7.093824387993664e-05
. O 0 7.565710984636098e-05

A O 0 0.00034364446764811873
gene O 0 3.2233008823823184e-05
encoding O 0 1.6252053683274426e-05
a O 0 1.3389026207732968e-05
novel O 0 2.6978457754012197e-05
transmembrane O 0 6.943292828509584e-05
protein O 0 6.925582965777721e-06
was O 0 7.608421128679765e-06
identified O 0 1.061110879163607e-06
by O 0 4.2400137090226053e-07
DNA O 0 8.656613772473065e-07
sequence O 0 4.914741111861076e-07
analysis O 0 4.242351394623256e-07
within O 0 4.955258532390872e-07
the O 0 1.2194884675409412e-06
insulin B-Disease 0 3.570007538655773e-05
- I-Disease 0 0.0006381617859005928
dependent I-Disease 0 0.00134762073867023
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 0.28177914023399353
IDDM B-Disease 1 0.9999924898147583
) O 0 1.3352952919376548e-05
locus O 0 5.7173794630216435e-05
IDDM4 O 0 0.007669615093618631
on O 0 3.875586116919294e-05
chromosome O 0 0.0002570478536654264
11q13 O 0 0.0009692461462691426
. O 0 0.00012621519272215664

Based O 0 8.265418000519276e-05
on O 0 2.6287603759556077e-05
its O 0 1.0855870641535148e-05
chromosomal O 0 3.257639764342457e-05
position O 0 8.079892722889781e-06
, O 0 1.920808017530362e-06
this O 0 7.93625133610476e-07
gene O 0 1.376586737933394e-06
is O 0 6.24034953489172e-07
a O 0 1.0699524182200548e-06
candidate O 0 2.4009402750380104e-06
for O 0 1.5797655805727118e-06
conferring O 0 7.01058452250436e-05
susceptibility O 0 0.022566216066479683
to O 0 0.000155089539475739
diabetes B-Disease 1 0.9999971389770508
. O 0 0.0007654089131392539

The O 0 0.00010892994032474235
gene O 0 4.1219354898203164e-05
, O 0 7.644838660780806e-06
termed O 0 2.747745566011872e-05
low O 0 2.6486350179766305e-05
- O 0 2.9182929210946895e-05
density O 0 9.040933946380392e-06
lipoprotein O 0 6.52145390631631e-05
receptor O 0 9.119005881075282e-06
related O 0 3.558868002073723e-06
protein O 0 2.5067413389479043e-06
5 O 0 3.4298236641916446e-06
( O 0 2.682964122868725e-06
LRP5 O 0 0.00015435500245075673
) O 0 1.084661448658153e-06
, O 0 4.139732823205122e-07
encodes O 0 9.94686843114323e-07
a O 0 9.213888461090392e-07
protein O 0 1.4263748653320363e-06
of O 0 1.0940698302874807e-06
1615 O 0 2.514433435862884e-05
amino O 0 9.869515906757442e-07
acids O 0 5.15229487518809e-07
that O 0 2.4923716068769863e-07
contains O 0 9.632076398702338e-07
conserved O 0 2.605203917482868e-06
modules O 0 3.1091499295143876e-06
which O 0 2.1858949139641481e-07
are O 0 1.2619456413176522e-07
characteristic O 0 9.076526907847438e-07
of O 0 1.6810870420158608e-06
the O 0 3.4570603020256385e-06
low O 0 1.8691080185817555e-05
- O 0 3.375524829607457e-05
density O 0 2.129844688170124e-05
lipoprotein O 0 0.0003104920906480402
( O 0 1.8990811440744437e-05
LDL O 0 0.01285882480442524
) O 0 1.4825581274635624e-05
receptor O 0 4.536117194220424e-05
family O 0 3.188168921042234e-05
. O 0 4.020894630230032e-05

These O 0 3.126026058453135e-05
modules O 0 6.316874350886792e-05
include O 0 9.602317732060328e-06
a O 0 1.2232927474542521e-05
putative O 0 3.308265877421945e-05
signal O 0 2.1839725377503783e-05
peptide O 0 1.2562252777570393e-05
for O 0 1.298882807532209e-06
protein O 0 3.2340803954866715e-06
export O 0 2.377274313403177e-06
, O 0 7.915819537629432e-07
four O 0 2.3346692614722997e-06
epidermal O 0 0.0006048681680113077
growth O 0 9.64123410085449e-06
factor O 0 6.111629772931337e-06
( O 0 3.836236373899737e-06
EGF O 0 0.0001817751326598227
) O 0 1.6176634289877256e-06
repeats O 0 2.4914595542213647e-06
with O 0 1.2205694019939983e-06
associated O 0 2.682588046809542e-06
spacer O 0 2.3581205823575146e-05
domains O 0 1.0438100616738666e-05
, O 0 3.9450360418413766e-06
three O 0 2.748619635895011e-06
LDL O 0 0.077965147793293
- O 0 9.213286102749407e-05
receptor O 0 3.280415330664255e-05
( O 0 1.5827718016225845e-05
LDLR O 0 0.0057569812051951885
) O 0 4.272468231647508e-06
repeats O 0 5.167222752788803e-06
, O 0 1.4562980368282297e-06
a O 0 3.7939444155199453e-06
single O 0 5.5914943004609086e-06
transmembrane O 0 9.911434608511627e-05
spanning O 0 7.189611642388627e-05
domain O 0 2.093316834361758e-05
, O 0 7.024768365226919e-06
and O 0 2.959924358947319e-06
a O 0 1.951836202351842e-05
cytoplasmic O 0 9.342213161289692e-05
domain O 0 0.00015657574112992734
. O 0 6.899328582221642e-05

The O 0 5.9034784499090165e-05
encoded O 0 3.055387787753716e-05
protein O 0 1.3263756954984274e-05
has O 0 1.9685480765474495e-06
a O 0 1.8044100897895987e-06
unique O 0 1.931290853462997e-06
organization O 0 3.1004537959233858e-06
of O 0 9.039494216267485e-06
EGF O 1 0.9998705387115479
and O 0 1.188040005217772e-05
LDLR O 1 0.9911903142929077
repeats O 0 1.805958709155675e-05
; O 0 1.7960542209038977e-06
therefore O 0 2.1189603103266563e-06
, O 0 1.7365192661600304e-06
LRP5 O 0 0.0010983585380017757
likely O 0 3.480275381662068e-06
represents O 0 3.418068217797554e-06
a O 0 2.627525645948481e-06
new O 0 1.8858797830034746e-06
category O 0 3.3512380923639284e-06
of O 0 6.5650269789330196e-06
the O 0 5.925378354731947e-05
LDLR O 1 0.9998855590820312
family O 0 0.00028482163907028735
. O 0 0.0001583646226208657

Both O 0 9.104811033466831e-05
human O 0 6.402507278835401e-05
and O 0 2.9111299227224663e-05
mouse O 0 0.0004681770224124193
LRP5 O 1 0.9990378618240356
cDNAs O 0 0.0024658357724547386
have O 0 2.100967094520456e-06
been O 0 1.97578924598929e-06
isolated O 0 2.4351193133043125e-06
and O 0 4.902125851913297e-07
the O 0 1.2412907608450041e-06
encoded O 0 1.866374077508226e-06
mature O 0 1.7516483694635099e-06
proteins O 0 3.2541575478717277e-07
are O 0 1.2726864895284962e-07
95 O 0 6.639352250203956e-07
% O 0 9.304556556344323e-07
identical O 0 8.271621254607453e-07
, O 0 7.890751021477627e-07
indicating O 0 3.0756305022805464e-06
a O 0 2.405446139164269e-06
high O 0 6.65540574118495e-06
degree O 0 8.936840458773077e-06
of O 0 6.946988378331298e-06
evolutionary O 0 3.6032735806657e-05
conservation O 0 3.4974393201991916e-05
. O 0 1.5048623936309014e-05
. O 0 4.8533373046666384e-05

The O 0 0.0005362377851270139
APC B-Disease 0 0.04381968453526497
variants O 0 0.00013767930795438588
I1307K O 0 0.0005899378447793424
and O 0 7.766796443320345e-06
E1317Q O 0 8.773519220994785e-05
are O 0 1.3143842352292268e-06
associated O 0 1.0768349966383539e-05
with O 0 0.2910481095314026
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.0004281619330868125
but O 0 1.3372081184570561e-06
not O 0 6.936687100278505e-07
always O 0 1.4965852415116387e-06
with O 0 1.8212246004623012e-06
a O 0 1.0414793905511033e-05
family O 0 3.0187298762029968e-05
history O 0 0.0001994794001802802
. O 0 0.00014173790987115353

Classical O 0 0.1330435574054718
familial B-Disease 1 0.9999997615814209
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.999529242515564
FAP B-Disease 1 0.999990701675415
) O 0 4.0788017940940335e-05
is O 0 7.5045068115286995e-06
a O 0 9.257705642085057e-06
high O 0 0.00034150885767303407
- O 1 0.8052056431770325
penetrance O 1 0.9999604225158691
autosomal B-Disease 1 0.9998307228088379
dominant I-Disease 1 0.9999969005584717
disease I-Disease 1 0.9999994039535522
that O 0 5.420652541943127e-06
predisposes O 0 0.0006399828707799315
to O 0 1.8842995359591441e-06
hundreds O 0 2.4229948394349776e-06
or O 0 1.2564305507112294e-06
thousands O 0 9.35816115088528e-06
of O 1 0.7787190675735474
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999423027038574
carcinoma I-Disease 1 1.0
and O 0 2.683960337890312e-05
that O 0 1.6597693957010051e-06
results O 0 1.4606754348278628e-06
from O 0 1.8045511751552112e-06
truncating O 0 3.9140242733992636e-05
mutations O 0 5.037954906583764e-06
in O 0 5.244050953479018e-06
the O 0 2.2378233552444726e-05
APC B-Disease 0 0.06444019079208374
gene O 0 7.618125528097153e-05
. O 0 6.778479291824624e-05

A O 0 0.0005641954485327005
variant O 0 0.00032235472463071346
of O 0 0.0001441383210476488
FAP B-Disease 1 0.9997739195823669
is O 0 5.6872864661272615e-05
attenuated B-Disease 0 0.4206518232822418
adenomatous I-Disease 1 0.9999995231628418
polyposis I-Disease 1 0.9999997615814209
coli I-Disease 1 0.998991072177887
, O 0 9.401725947100203e-06
which O 0 1.5140502682697843e-06
results O 0 2.9628306492668344e-06
from O 0 9.216101716447156e-06
germ O 1 0.9998142123222351
- O 0 0.00011422450188547373
line O 0 1.2022584996884689e-05
mutations O 0 2.273246991535416e-06
in O 0 1.1214256119274069e-06
the O 0 2.5458718937443336e-06
5 O 0 4.729490683530457e-06
and O 0 1.7894070651891525e-06
3 O 0 4.314358193369117e-06
regions O 0 1.9961187263106694e-06
of O 0 3.817044216702925e-06
the O 0 1.7172187654068694e-05
APC B-Disease 0 0.025345807895064354
gene O 0 4.908886330667883e-05
. O 0 6.853479135315865e-05

Attenuated B-Disease 1 0.9994891881942749
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999997615814209
patients O 1 0.670221745967865
have O 0 1.1497984814923257e-05
" O 0 1.4020613889442757e-05
multiple O 0 1.633495048736222e-05
" O 1 0.6544143557548523
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 2.279477848787792e-05
typically O 0 1.2629595858015819e-06
fewer O 0 6.181267622196174e-07
than O 0 3.9865489043222624e-07
100 O 0 1.5907246506685624e-06
) O 0 1.0351511718909023e-06
without O 0 1.2535676887637237e-06
the O 0 4.2858491724473424e-06
florid O 0 0.00022070670092944056
phenotype O 0 6.336640217341483e-05
of O 0 9.359591786051169e-05
classical O 0 0.0015570393297821283
FAP B-Disease 1 0.998051643371582
. O 0 0.00032354966970160604

Another O 0 0.00019914495351258665
group O 0 3.366375676705502e-05
of O 0 2.72356210189173e-05
patients O 0 4.449568223208189e-05
with O 0 7.0662727011949755e-06
multiple O 0 0.0002133445377694443
adenomas B-Disease 1 0.9999854564666748
has O 0 6.153990852908464e-06
no O 0 1.9626866105681984e-06
mutations O 0 1.3083562180327135e-06
in O 0 2.282512241436052e-06
the O 0 6.7211667555966415e-06
APC B-Disease 0 0.15585611760616302
gene O 0 4.409346729516983e-06
, O 0 8.065966312642558e-07
and O 0 5.482904725795379e-07
their O 0 6.547236921505828e-07
phenotype O 0 3.508508370941854e-06
probably O 0 2.0841323475906393e-06
results O 0 5.894258947591879e-07
from O 0 7.173410949690151e-07
variation O 0 1.6972574030660326e-06
at O 0 4.002135028713383e-06
a O 0 3.6777121295017423e-06
locus O 0 9.217051228915807e-06
, O 0 2.088927658405737e-06
or O 0 1.1386889582354343e-06
loci O 0 2.6268442070431774e-06
, O 0 1.4161145145408227e-06
elsewhere O 0 1.797135496417468e-06
in O 0 2.2993503989710007e-06
the O 0 7.188195013441145e-06
genome O 0 4.496073961490765e-05
. O 0 6.28811030765064e-05

Recently O 0 0.000319554063025862
, O 0 1.5961961253196932e-05
however O 0 5.235500793787651e-06
, O 0 2.592091504993732e-06
a O 0 5.478265848068986e-06
missense O 0 1.8038414054899476e-05
variant O 0 1.4447706234932411e-05
of O 0 1.5675221220590174e-05
APC B-Disease 1 0.6186755299568176
( O 0 1.4085506336414255e-05
I1307K O 0 0.0003276368079241365
) O 0 2.607714577607112e-06
was O 0 6.878847216285067e-06
described O 0 1.8722605545917759e-06
that O 0 4.872645718023705e-07
confers O 0 2.2619844912696863e-06
an O 0 1.2559094102471136e-06
increased O 0 4.84923430121853e-06
risk O 0 3.9752721932018176e-05
of O 1 0.9801539182662964
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.0011019196826964617
including O 0 2.28965454880381e-05
multiple O 0 6.888442294439301e-05
adenomas B-Disease 1 0.9982208609580994
, O 0 2.204096563218627e-05
in O 0 3.7959667679388076e-05
Ashkenazim O 0 0.10125011205673218
. O 0 0.00021924523753114045

We O 0 5.057676389697008e-05
have O 0 3.472769321888336e-06
studied O 0 8.54134214023361e-06
a O 0 2.4504151951987296e-06
set O 0 2.0068689536856255e-06
of O 0 2.279308091601706e-06
164 O 0 1.775210512278136e-05
patients O 0 8.791151230980176e-06
with O 0 7.712176739005372e-06
multiple O 1 0.9873148202896118
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9337764978408813
/ I-Disease 1 0.9999829530715942
or I-Disease 0 0.028531529009342194
carcinoma I-Disease 1 1.0
and O 0 2.6887046260526404e-05
analyzed O 0 2.1615633158944547e-05
codons O 0 3.8289530493784696e-05
1263 O 0 0.0017177697736769915
- O 0 8.886271098162979e-05
1377 O 0 0.0017914019990712404
( O 0 1.549848457216285e-05
exon O 0 6.712936738040298e-05
15G O 0 5.443057671072893e-05
) O 0 1.5103886426004465e-06
of O 0 2.044059556283173e-06
the O 0 8.018912012630608e-06
APC B-Disease 0 0.00012466621410567313
gene O 0 1.0666876733012032e-05
for O 0 1.5152814739849418e-05
germ O 1 0.999875545501709
- O 0 0.0018378201639279723
line O 0 0.0003215628385078162
variants O 0 0.0001370372629025951
. O 0 0.00016835855785757303

Three O 0 0.00011585977335926145
patients O 0 3.494108750601299e-05
with O 0 5.9240869632049e-06
the O 0 1.8741235180641524e-05
I1307K O 0 0.0003645186370704323
allele O 0 4.768685357703362e-06
were O 0 3.1003264666651376e-06
detected O 0 5.046080332249403e-06
, O 0 1.44392231504753e-06
each O 0 8.11291727131902e-07
of O 0 9.46267755352892e-06
Ashkenazi O 0 0.00017203579773195088
descent O 0 0.00031444785417988896
. O 0 0.000176372064743191

Four O 0 0.0001527373242424801
patients O 0 0.00013730436330661178
had O 0 7.345806079683825e-05
a O 0 0.0004250819038134068
germ O 1 0.9999986886978149
- O 0 0.4249330461025238
line O 0 0.00042860457324422896
E1317Q O 0 0.0007090862491168082
missense O 0 4.517640627454966e-05
variant O 0 1.572370092617348e-05
of O 0 1.0679496881493833e-05
APC O 0 0.0002588782226666808
that O 0 1.0187254702032078e-06
was O 0 4.420926416059956e-06
not O 0 2.0949057955022e-07
present O 0 5.756060659223294e-07
in O 0 7.29398209387e-07
controls O 0 1.256844029740023e-06
; O 0 3.125018963601178e-07
one O 0 2.981066700158408e-07
of O 0 6.499985829577781e-07
these O 0 2.469414539518766e-07
individuals O 0 3.5924321650782076e-07
had O 0 2.18292939280218e-06
an O 0 1.996093942580046e-06
unusually O 0 1.006860111374408e-05
large O 0 2.8329502583801514e-06
number O 0 1.4725877690580091e-06
of O 0 1.0881067282753065e-05
metaplastic B-Disease 1 0.5159063935279846
polyps I-Disease 0 0.00013151172606740147
of I-Disease 0 1.7377438780386e-05
the I-Disease 0 5.20460816915147e-05
colorectum I-Disease 0 0.354218989610672
. O 0 0.00014219329750631005

There O 0 6.176670285640284e-05
is O 0 1.2218447409395594e-05
increasing O 0 5.744019290432334e-06
evidence O 0 4.25467851528083e-06
that O 0 1.487807821831666e-06
there O 0 2.6803379569173558e-06
exist O 0 1.1258855010964908e-05
germ O 1 0.9916778802871704
- O 0 3.801690399996005e-05
line O 0 8.966248969954904e-06
variants O 0 2.827498065016698e-06
of O 0 2.9870766411477234e-06
the O 0 6.619464784307638e-06
APC B-Disease 0 0.011729948222637177
gene O 0 1.2200573564769002e-06
that O 0 3.912518877768889e-07
predispose O 0 3.010045475093648e-06
to O 0 6.216204155862215e-07
the O 0 1.2799350770364981e-06
development O 0 3.940509031963302e-06
of O 0 1.634693398955278e-05
multiple O 1 0.9977521300315857
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.999996542930603
carcinoma I-Disease 1 1.0
, O 0 0.0010129139991477132
but O 0 2.573035999375861e-06
without O 0 1.6129680489029852e-06
the O 0 3.707221139848116e-06
florid O 0 0.0005965885356999934
phenotype O 0 1.9380329831619747e-05
of O 0 1.4306049706647173e-05
classical O 0 0.0024545721244066954
FAP B-Disease 1 0.999201238155365
, O 0 2.5989529603975825e-06
and O 0 7.627132845300366e-07
possibly O 0 1.5048460682010045e-06
with O 0 6.309099376267113e-07
importance O 0 2.7627143936115317e-05
for O 0 0.008710132911801338
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.5111111998558044
in O 0 1.0341464985685889e-05
the O 0 1.0460541489010211e-05
general O 0 2.05745473067509e-05
population O 0 8.651952157379128e-06
. O 0 2.3410957510350272e-05
. O 0 7.03664481989108e-05

Genomic O 0 0.0003507718211039901
structure O 0 6.080353705328889e-05
of O 0 1.688187512627337e-05
the O 0 5.203302498557605e-05
human O 1 0.9266914129257202
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.999997615814209
CLD B-Disease 1 1.0
) O 0 0.0002794407482724637
gene O 0 0.00011991512292297557
. O 0 0.00010979214130202308

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999980926513672
CLD B-Disease 1 1.0
) O 0 7.84221847425215e-05
is O 0 6.188396582729183e-06
caused O 0 5.710695404559374e-06
by O 0 8.667096267345187e-07
mutations O 0 9.421798949915683e-07
in O 0 6.973672270760289e-07
a O 0 2.46100103140634e-06
gene O 0 2.1144162474229233e-06
which O 0 1.3963285709905904e-06
encodes O 0 8.025308488868177e-06
an O 0 9.563725143379997e-06
intestinal O 1 0.9998156428337097
anion O 1 0.970146656036377
transporter O 1 0.9971863627433777
. O 0 0.00021123483020346612

We O 0 4.402213016874157e-05
report O 0 8.600119144830387e-06
here O 0 4.816231012227945e-06
the O 0 2.049663862635498e-06
complete O 0 7.489921244996367e-06
genomic O 0 8.223129952966701e-06
organization O 0 3.069649892495363e-06
of O 0 3.3094197533500846e-06
the O 0 4.8663760026101954e-06
human O 0 5.764779416495003e-06
CLD B-Disease 1 0.9965168237686157
gene O 0 5.519726073544007e-06
which O 0 1.3282339068609872e-06
spans O 0 1.0513929737498984e-05
approximately O 0 9.942818905983586e-06
39kb O 0 7.930628635222092e-05
, O 0 3.3516187158966204e-06
and O 0 4.162998720858013e-06
comprises O 0 2.04223433684092e-05
21 O 0 7.879835175117478e-05
exons O 0 0.00021473062224686146
. O 0 0.00012591683480422944

All O 0 0.00011547120084287599
exon O 0 0.0009933921974152327
/ O 0 0.00046779331751167774
intron O 0 0.0005181745509617031
boundaries O 0 1.6945508832577616e-05
conform O 0 6.607847353734542e-06
to O 0 4.713614089268958e-06
the O 0 1.651872298680246e-05
GT O 0 0.4134517312049866
/ O 1 0.9313056468963623
AG O 1 0.9999451637268066
rule O 0 0.0003676191554404795
. O 0 0.00032539269886910915

An O 0 3.573127105482854e-05
analysis O 0 1.2760880053974688e-05
of O 0 1.3962905541120563e-05
the O 0 2.280380249430891e-05
putative O 0 0.001243575126864016
promoter O 0 0.006517436821013689
region O 0 1.3119535651640035e-05
sequence O 0 3.887883394781966e-06
shows O 0 4.288703166821506e-06
a O 0 9.9679109553108e-06
putative O 0 0.00040397170232608914
TATA O 1 0.9912550449371338
box O 0 3.3294621971435845e-05
and O 0 3.373089612068725e-06
predicts O 0 1.0371005373599473e-05
multiple O 0 3.086679043917684e-06
transcription O 0 2.191433304687962e-05
factor O 0 1.9166058336850256e-05
binding O 0 1.2834816516260616e-05
sites O 0 3.478024882497266e-05
. O 0 7.652047497685999e-05

The O 0 0.0001076517510227859
genomic O 0 0.00013970694271847606
structure O 0 4.9280235543847084e-05
was O 0 3.468465729383752e-05
determined O 0 4.398293185658986e-06
using O 0 1.9381805032026023e-06
DNA O 0 2.9672048640350113e-06
from O 0 7.635269980710291e-07
several O 0 6.969138439671951e-07
sources O 0 9.275549928133842e-07
including O 0 6.288855729508214e-07
multiple O 0 2.6848556444747373e-06
large O 0 1.5344650819315575e-05
- O 0 7.762992026982829e-05
insert O 0 3.5913184547098354e-05
libaries O 0 6.904909969307482e-05
and O 0 1.4217356465451303e-06
genomic O 0 4.95487938678707e-06
DNA O 0 5.576376224780688e-06
from O 0 4.672670911531895e-06
Finnish O 0 0.31234586238861084
CLD B-Disease 1 0.999991774559021
patients O 0 0.00019282336870674044
and O 0 2.8976359317312017e-05
controls O 0 0.00012052569218212739
. O 0 0.0001345322234556079

Exon O 0 0.014760561287403107
- O 0 0.00017341379134450108
specific O 0 8.769538908381946e-06
primers O 0 2.7710158974514343e-05
developed O 0 7.5210364229860716e-06
in O 0 1.3232699984655483e-06
this O 0 4.711182270966674e-07
study O 0 6.375037173711462e-07
will O 0 3.8056060702729155e-07
facilitate O 0 8.290535902233387e-07
mutation O 0 8.051832764977007e-07
screening O 0 1.246884835381934e-06
studies O 0 9.459901662012271e-07
of O 0 3.1088534342416096e-06
patients O 0 8.330088348884601e-06
with O 0 7.955734872666653e-06
the O 0 0.006119807716459036
disease O 1 0.9999960660934448
. O 0 0.0006519401795230806

Genomic O 0 0.00017933599883690476
sequencing O 0 7.275811367435381e-05
of O 0 3.0352992325788364e-05
a O 0 5.957401299383491e-05
BAC O 1 0.9997088313102722
clone O 1 0.5728724002838135
H O 1 0.9998315572738647
_ O 0 1.533464455860667e-05
RG364P16 O 0 4.204031574772671e-05
revealed O 0 5.293715730658732e-06
the O 0 1.4085154589338345e-06
presence O 0 2.1326752630557166e-06
of O 0 1.5649445685994579e-06
another O 0 2.5033391466422472e-06
, O 0 1.062736259882513e-06
highly O 0 1.356524990114849e-06
homologous O 0 1.3729695638176054e-06
gene O 0 6.658743245679943e-07
3 O 0 1.6939748093136586e-06
of O 0 1.3825743963025161e-06
the O 0 6.079465492803138e-06
CLD B-Disease 1 0.9982258677482605
gene O 0 2.3311984023166588e-06
, O 0 5.742868438574078e-07
with O 0 3.8011592096154345e-07
a O 0 1.3529913758247858e-06
similar O 0 6.608928515561274e-07
genomic O 0 4.5382039388641715e-06
structure O 0 3.6653029837907525e-06
, O 0 9.423370670447184e-07
recently O 0 2.714742777243373e-06
identified O 0 1.2556207593661384e-06
as O 0 1.3598084933619248e-06
the O 0 1.3804498848912772e-05
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 0.1142163798213005
( O 0 0.00024310138542205095
PDS B-Disease 1 0.9998509883880615
) O 0 4.231777711538598e-05
. O 0 2.293653778906446e-05
. O 0 8.069900650298223e-05

The O 0 0.0003545453364495188
APCI1307K O 1 0.9993003606796265
allele O 0 0.00010106178524438292
and O 0 2.3648632122785784e-05
cancer B-Disease 1 0.9575541615486145
risk O 0 2.66772312897956e-05
in O 0 3.860337074002018e-06
a O 0 7.1667900556349196e-06
community O 0 6.0950233091716655e-06
- O 0 6.542046776303323e-06
based O 0 1.3496226074494189e-06
study O 0 2.670265075721545e-06
of O 0 8.138760676956736e-06
Ashkenazi O 0 0.0001830645342124626
Jews O 0 0.00020738400053232908
. O 0 0.00019849151431117207

Mutations O 0 0.0003908775106538087
in O 0 0.0001170969771919772
APC O 0 0.08282819390296936
are O 0 8.334562153322622e-06
classically O 0 0.00019111814617644995
associated O 0 1.0897299034695607e-05
with O 0 2.9245364203234203e-05
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999903440475464
FAP B-Disease 1 0.9999994039535522
) O 0 1.467337460780982e-05
, O 0 4.139786597079365e-06
a O 0 8.880521818355191e-06
highly O 0 0.00012788276944775134
penetrant O 1 0.9999933242797852
autosomal B-Disease 1 0.9999997615814209
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9999984502792358
by O 1 0.5093350410461426
multiple O 1 0.9999485015869141
intestinal O 1 1.0
polyps B-Disease 1 0.9999924898147583
and O 0 1.4904641830071341e-05
, O 0 3.7191516639722977e-06
without O 0 2.373672487010481e-06
surgical O 0 0.007074619177728891
intervention O 0 4.118701326660812e-05
, O 0 1.5220504110402544e-06
the O 0 1.9339761365699815e-06
development O 0 3.091526377829723e-05
of O 1 0.9436876773834229
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9995399713516235
CRC B-Disease 1 0.9999690055847168
) O 0 9.172216959996149e-05
. O 0 9.128684177994728e-05

APC B-Disease 0 0.03107968159019947
is O 0 0.0001134911144617945
a O 0 0.0007919121999293566
tumour O 1 1.0
- O 1 0.9987326264381409
suppressor O 1 0.7831827998161316
gene O 0 1.6045245502027683e-05
, O 0 5.59803584110341e-06
and O 0 4.898059614788508e-06
somatic O 0 7.929266575956717e-05
loss O 0 0.03716588765382767
occurs O 0 3.9496713725384325e-05
in O 0 0.00011076855298597366
tumours B-Disease 1 0.9999991655349731
. O 0 0.0004925329121761024

The O 0 0.0008430880843661726
germline O 1 0.9939536452293396
T O 1 0.7042457461357117
- O 0 0.00018317086505703628
to O 0 1.6583753676968627e-05
- O 0 6.0127295000711456e-05
A O 0 4.775395063916221e-05
transversion O 0 0.00021301080414559692
responsible O 0 4.99851967106224e-06
for O 0 2.221036538685439e-06
the O 0 8.145795618474949e-06
APC O 0 0.000603469496127218
I1307K O 0 6.720846431562677e-05
allele O 0 4.411416739458218e-06
converts O 0 2.5320750864921138e-06
the O 0 1.9546973817341495e-06
wild O 0 4.17541150454781e-06
- O 0 4.205146524327574e-06
type O 0 2.1087919321871595e-06
sequence O 0 1.4401953194465023e-06
to O 0 1.4920605053703184e-06
a O 0 1.7449294318794273e-05
homopolymer O 1 0.9998213648796082
tract O 1 0.9999779462814331
( O 0 0.00019062950741499662
A8 O 1 0.9990252256393433
) O 0 3.4440422496118117e-06
that O 0 1.5046651924421894e-06
is O 0 3.7071363294671755e-06
genetically O 0 7.150214514695108e-06
unstable O 0 2.882086846511811e-05
and O 0 4.5145525291445665e-06
prone O 0 0.0001279917050851509
to O 0 1.4610035577788949e-05
somatic O 0 0.00041193916695192456
mutation O 0 0.00010345834016334265
. O 0 0.0001324409677181393

The O 0 0.00032817755709402263
I1307K O 0 0.0016752730589359999
allele O 0 0.0001406586670782417
was O 0 9.971100371330976e-05
found O 0 2.4765000489423983e-05
in O 0 3.883217868860811e-05
6 O 0 0.00030827190494164824
. O 0 0.00021941820159554482

1 O 0 0.00022790266666561365
% O 0 8.627392526250333e-05
of O 0 8.295114093925804e-05
unselected O 0 0.1560722291469574
Ashkenazi O 0 0.0002672465343493968
Jews O 0 5.834009425598197e-05
and O 0 5.707662694476312e-06
higher O 0 7.50361959944712e-06
proportions O 0 1.2044103641528636e-05
of O 0 1.0216978807875421e-05
Ashkenazim O 0 0.0005789572023786604
with O 0 6.386607765307417e-06
family O 0 1.0092913726111874e-05
or O 0 2.6752304620458744e-06
personal O 0 1.1703122254402842e-05
histories O 0 2.6892150344792753e-05
of O 0 0.00015844135486986488
CRC B-Disease 1 0.9996678829193115
( O 0 4.6705605200259015e-05
ref O 0 0.0007175078499130905
. O 0 1.4365793504111934e-05
2 O 0 6.720891542499885e-05
) O 0 4.70502745884005e-05
. O 0 6.017398482072167e-05

To O 0 4.28899766120594e-05
evaluate O 0 2.7210799089516513e-05
the O 0 1.0318008207832463e-05
role O 0 2.025118919846136e-05
of O 0 2.005611349886749e-05
I1307K O 0 0.05174378305673599
in O 0 1.4881135030009318e-05
cancer B-Disease 0 0.2534872889518738
, O 0 4.848365279030986e-06
we O 0 1.853552930697333e-06
genotyped O 0 5.906305159442127e-05
5 O 0 9.651969776314218e-06
, O 0 5.23258131579496e-06
081 O 0 0.00020130662596784532
Ashkenazi O 0 3.102276605204679e-05
volunteers O 0 1.2311294085520785e-05
in O 0 2.8726383334287675e-06
a O 0 1.3002922969462816e-05
community O 0 2.3408681954606436e-05
survey O 0 5.894472633372061e-05
. O 0 9.803927969187498e-05

Risk O 0 0.00037179692299105227
of O 0 0.00024315633345395327
developing O 1 0.9738854169845581
colorectal B-Disease 1 1.0
, I-Disease 0 0.4321361482143402
breast I-Disease 1 0.9995552897453308
and I-Disease 0 1.1283254934824072e-05
other I-Disease 0 2.7291964670439484e-06
cancers I-Disease 0 0.08979401737451553
were O 0 6.731828307238175e-06
compared O 0 7.4543559094308876e-06
between O 0 1.7271122487727553e-05
genotyped O 1 0.8309019207954407
I1307K O 0 0.0022824304178357124
carriers O 0 8.212659849959891e-06
and O 0 3.2766276945039863e-06
non O 0 1.0835535249498207e-05
- O 0 2.685122672119178e-05
carriers O 0 4.299473403079901e-06
and O 0 1.8521021729611675e-06
their O 0 1.3638475593324983e-06
first O 0 8.150558642228134e-06
- O 0 2.6074854758917354e-05
degree O 0 5.604866601061076e-05
relatives O 0 7.068050763336942e-05
. O 0 5.780292485724203e-05

Sperm O 0 0.0001383007620461285
DNA O 0 4.241611168254167e-05
analysis O 0 7.781482963764574e-06
in O 0 8.507930033374578e-06
a O 0 4.858546526520513e-05
Friedreich B-Disease 1 0.9999794960021973
ataxia I-Disease 1 0.999998927116394
premutation O 1 0.9999529123306274
carrier O 0 0.001551239867694676
suggests O 0 2.71405642706668e-05
both O 0 4.9650066102913115e-06
meiotic O 0 0.00021594055579043925
and O 0 6.9393599915201776e-06
mitotic O 0 8.103065920295194e-05
expansion O 0 5.002703255740926e-05
in O 0 9.362804121337831e-06
the O 0 2.102273538184818e-05
FRDA B-Disease 1 0.995668888092041
gene O 0 7.628070306964219e-05
. O 0 7.854821888031438e-05

Friedreich B-Disease 1 0.9999973773956299
ataxia I-Disease 1 0.9999961853027344
is O 0 0.000325475528370589
usually O 0 1.7944679711945355e-05
caused O 0 3.136824307148345e-05
by O 0 2.819379915308673e-06
an O 0 2.5709289275255287e-06
expansion O 0 2.877758743125014e-05
of O 0 1.002753106149612e-05
a O 0 2.9993514544912614e-05
GAA O 0 0.005099184811115265
trinucleotide O 0 0.16529786586761475
repeat O 0 2.9900813387939706e-05
in O 0 1.1307049135211855e-05
intron O 0 0.0002861078828573227
1 O 0 3.582598583307117e-05
of O 0 2.2150179574964568e-05
the O 0 5.578216223511845e-05
FRDA B-Disease 1 0.9994611144065857
gene O 0 0.00018404742877464741
. O 0 0.00012169159890618175

Occasionally O 0 0.00021713100431952626
, O 0 2.1335692508728243e-05
a O 0 1.3606655556941405e-05
fully O 0 1.7721422409522347e-05
expanded O 0 7.716208529018331e-06
allele O 0 2.9653972433152376e-06
has O 0 1.4655046243206016e-06
been O 0 7.8411886761387e-07
found O 0 4.3390645032559405e-07
to O 0 4.115312037811236e-07
arise O 0 2.6423715553391958e-06
from O 0 2.306985379618709e-06
a O 0 6.630255938944174e-06
premutation O 0 0.0001385527430102229
of O 0 9.256839803128969e-06
100 O 0 9.480218068347313e-06
or O 0 3.413826789255836e-06
less O 0 1.5449002603418194e-05
triplet O 0 0.00028852198738604784
repeats O 0 0.0003556268638931215
. O 0 0.0001686633622739464

We O 0 4.6015622501727194e-05
have O 0 5.93480854149675e-06
examined O 0 1.1102215466962662e-05
the O 0 5.24009146829485e-06
sperm O 0 9.870582289295271e-06
DNA O 0 6.7051614678348415e-06
of O 0 7.990665835677646e-06
a O 0 3.065225973841734e-05
premutation O 0 0.02317001484334469
carrier O 0 0.0003407917101867497
. O 0 0.0001333550171693787

This O 0 5.786563633591868e-05
mans O 0 0.00022288551554083824
leucocyte O 0 0.00042222245247103274
DNA O 0 2.443439188937191e-05
showed O 0 7.857411219447386e-06
one O 0 2.1421476503746817e-06
normal O 0 1.6117395489345654e-06
allele O 0 9.653750794313964e-07
and O 0 5.474408908412443e-07
one O 0 5.180823450245953e-07
allele O 0 1.1595330988711794e-06
of O 0 2.5246581571991555e-06
approximately O 0 1.6761960068834014e-05
100 O 0 3.4586162655614316e-05
repeats O 0 7.973403990035877e-05
. O 0 6.448720523621887e-05

His O 0 0.00024921257863752544
sperm O 0 7.606721919728443e-05
showed O 0 2.7947013222728856e-05
an O 0 3.3842609354906017e-06
expanded O 0 1.3117021808284335e-05
allele O 0 3.935176209779456e-06
in O 0 2.7060832508141175e-06
a O 0 6.175343969516689e-06
tight O 0 1.3071155080979224e-05
range O 0 4.694611106970115e-06
centering O 0 1.8069265934173018e-05
on O 0 6.330993983283406e-06
a O 0 7.695962267462164e-06
size O 0 4.331079253461212e-06
of O 0 7.879488293838222e-06
approximately O 0 6.302927067736164e-05
320 O 0 0.00017096861847676337
trinucleotide O 0 0.018173586577177048
repeats O 0 0.000526748422998935
. O 0 0.00019060459453612566

His O 0 0.0006075351848267019
affected O 0 0.00017914868658408523
son O 0 0.0022248916793614626
has O 0 1.340090784651693e-05
repeat O 0 2.3146980311139487e-05
sizes O 0 7.773784091114067e-06
of O 0 1.4289631508290768e-05
1040 O 0 0.0001483417145209387
and O 0 3.5386139643378556e-05
540 O 0 0.000506423762999475
. O 0 0.00016139537910930812

These O 0 4.2789397411979735e-05
data O 0 2.588381539680995e-05
suggest O 0 1.1897043805220164e-05
that O 0 3.409531927900389e-06
expansion O 0 1.306812646362232e-05
occurs O 0 1.9238973436586093e-06
in O 0 1.1779167152781156e-06
two O 0 6.674688961538777e-07
stages O 0 4.715677732747281e-06
, O 0 1.3691307003682596e-06
the O 0 1.1111928870377596e-06
first O 0 2.3360009890893707e-06
during O 0 5.047606464358978e-06
meiosis O 0 2.032573684118688e-05
followed O 0 6.171952463773778e-06
by O 0 2.4986238713609055e-06
a O 0 9.006751497508958e-06
second O 0 2.974274684675038e-05
mitotic O 0 0.0007019498734734952
expansion O 0 0.00046843214659020305
. O 0 0.00010522687807679176

We O 0 5.1726245146710426e-05
also O 0 1.1246535905229393e-05
show O 0 2.8449117053241935e-06
that O 0 5.948289185653266e-07
in O 0 1.1998597528872779e-06
all O 0 7.713867944403319e-07
informative O 0 7.2147381615650374e-06
carrier O 0 1.2000751667073928e-05
father O 0 1.714953759801574e-05
to O 0 2.958939376185299e-06
affected O 0 5.442770543595543e-06
child O 0 8.538003385183401e-06
transmissions O 0 5.000254986953223e-06
, O 0 1.1508541319926735e-06
with O 0 3.974526237016107e-07
the O 0 1.3070741715637268e-06
notable O 0 2.9299133075255668e-06
exception O 0 2.0624720491468906e-06
of O 0 2.8385238692862913e-06
the O 0 4.849696779274382e-06
premutation O 0 0.004799822811037302
carrier O 0 1.584800520504359e-05
, O 0 1.7145657693617977e-06
the O 0 2.64709569819388e-06
expansion O 0 2.2273736249189824e-05
size O 0 9.06092463992536e-06
decreases O 0 3.724466296262108e-05
. O 0 1.5133534361666534e-05
. O 0 4.9867096095113084e-05

The O 0 0.00016120942018460482
R496H O 0 0.0007875290466472507
mutation O 0 2.896033583965618e-05
of O 0 3.525712600094266e-05
arylsulfatase O 0 0.469784140586853
A O 0 0.00015847200120333582
does O 0 6.697147455270169e-06
not O 0 7.729959179414436e-06
cause O 0 0.0016927231336012483
metachromatic B-Disease 1 0.9999971389770508
leukodystrophy I-Disease 1 0.9999995231628418
. O 0 0.0006895257392898202

Deficiency B-Disease 1 0.9999980926513672
of I-Disease 0 0.06694408506155014
arylsulfatase I-Disease 1 0.9999088048934937
A I-Disease 0 0.1546517163515091
( O 0 0.00016754485841374844
ARSA O 1 0.9995978474617004
) O 0 1.1181822628714144e-05
enzyme O 0 1.5414909285027534e-05
activity O 0 2.3452474124496803e-05
causes O 0 0.00022243587591219693
metachromatic B-Disease 1 0.9999954700469971
leukodystrophy I-Disease 1 0.9999998807907104
( O 0 0.0010127848945558071
MLD B-Disease 1 0.9999974966049194
) O 0 0.00011776975588873029
. O 0 9.415719978278503e-05

A O 0 0.00023529147438239306
number O 0 1.6109486750792712e-05
of O 0 5.957674147794023e-05
ARSA O 1 0.9995719790458679
gene O 0 2.5348646886413917e-05
mutations O 0 1.2615870218724012e-05
responsible O 0 1.2249083738424815e-05
for O 0 1.233109287568368e-05
MLD B-Disease 1 0.9999964237213135
have O 0 8.983180123323109e-06
been O 0 2.0142924768151715e-05
identified O 0 5.322053766576573e-05
. O 0 6.51260997983627e-05

Recently O 0 0.0004463640507310629
, O 0 2.3215310648083687e-05
the O 0 1.7159729395643808e-05
R496H O 0 0.0002614885743241757
mutation O 0 1.8767599613056518e-05
of O 0 2.404908991593402e-05
ARSA O 1 0.9982233643531799
was O 0 2.1846142772119492e-05
proposed O 0 1.709796151772025e-06
to O 0 4.034187099932751e-07
be O 0 6.252776074688882e-07
a O 0 2.5023891794262454e-06
cause O 0 1.1430429367464967e-05
of O 0 2.9862969313398935e-05
MLD B-Disease 1 1.0
( O 0 7.050144631648436e-05
Draghia O 0 0.046642255038022995
et O 0 5.478964521898888e-05
al O 0 2.4630044208606705e-05
. O 0 4.303156856622081e-06
, O 0 5.000937562726904e-06
1997 O 0 2.2959582565817982e-05
) O 0 2.6567602617433295e-05
. O 0 6.910897354828194e-05

We O 0 6.751823093509302e-05
have O 0 6.908800514793256e-06
investigated O 0 2.2338703274726868e-05
the O 0 7.666076271561906e-06
R496H O 0 0.00017112142813857645
mutation O 0 5.471185431815684e-06
and O 0 1.8234926528748474e-06
found O 0 9.656532711233012e-07
this O 0 3.793792586748168e-07
mutation O 0 1.1186376696059597e-06
at O 0 2.2247845663514454e-06
a O 0 1.4278065236794646e-06
relatively O 0 1.0072990335174836e-06
high O 0 9.289590252592461e-07
frequency O 0 5.158017870598997e-07
in O 0 4.237115547311987e-07
an O 0 8.119519634419703e-07
African O 0 3.327306330902502e-06
American O 0 1.8898549569712486e-06
population O 0 9.451604796595348e-07
( O 0 1.3418250546237687e-06
f O 0 4.271147645340534e-06
= O 0 4.179562893114053e-06
0 O 0 3.983423994213808e-06
. O 0 9.712899782243767e-07
09 O 0 1.6275875168503262e-05
, O 0 3.2073551210487494e-06
n O 0 1.194385731650982e-05
= O 0 2.417007453914266e-05
61 O 0 4.2511110223131254e-05
subjects O 0 4.438663745531812e-05
) O 0 4.3375919631216675e-05
. O 0 0.0001038490590872243

The O 0 0.0004331778618507087
ARSA O 1 0.9994315505027771
enzyme O 0 6.960183964110911e-05
activity O 0 1.0443477549415547e-05
in O 0 2.1121288682479644e-06
subjects O 0 3.6383960377861513e-06
with O 0 1.5567455875498126e-06
and O 0 1.2598547982634045e-06
without O 0 1.1540149671418476e-06
the O 0 4.101581453141989e-06
R496H O 0 0.00015592436830047518
mutation O 0 4.202909167361213e-06
was O 0 6.772382221242879e-06
determined O 0 1.5812563560757553e-06
and O 0 6.922214765836543e-07
found O 0 4.967512836628885e-07
to O 0 8.6081411154737e-07
be O 0 2.5141007427009754e-06
normal O 0 1.344122392765712e-05
. O 0 3.24963366438169e-05

It O 0 3.070058301091194e-05
is O 0 1.3803076399199199e-05
therefore O 0 7.78045978222508e-06
concluded O 0 1.1350924978614785e-05
that O 0 1.7358404420519946e-06
the O 0 5.782939297205303e-06
R496H O 0 0.00012174708535894752
mutation O 0 5.95767232880462e-06
of O 0 1.1406331395846792e-05
ARSA O 1 0.9991078972816467
does O 0 1.5620936437699129e-06
not O 0 6.192802857185598e-07
negatively O 0 2.038799266301794e-06
influence O 0 2.6854343104787404e-06
the O 0 2.017222868744284e-06
activity O 0 7.670522791158874e-06
of O 0 1.0298742381564807e-05
ARSA O 1 0.9144548773765564
and O 0 2.9373941288213246e-06
is O 0 1.9834426439047093e-06
not O 0 1.4084965869187727e-06
a O 0 1.1632941095740534e-05
cause O 0 0.00019675381190609187
of O 0 0.003100342582911253
MLD B-Disease 1 0.9999998807907104

Down O 0 0.0007815511198714375
- O 0 0.00016966309340205044
regulation O 0 3.6590095987776294e-05
of O 0 3.058349102502689e-05
transmembrane O 0 0.44304123520851135
carbonic O 1 0.9637235403060913
anhydrases O 1 0.9981377124786377
in O 0 0.006387972738593817
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9984612464904785
lines O 0 3.230766742490232e-05
by O 0 7.565010037069442e-06
wild O 0 2.6847614208236337e-05
- O 0 6.982347986195236e-05
type O 0 9.16381468414329e-05
von B-Disease 1 0.927295982837677
Hippel I-Disease 1 0.9996401071548462
- I-Disease 1 0.5513009428977966
Lindau I-Disease 1 0.9997492432594299
transgenes O 0 0.003513445844873786
. O 0 0.00022791441006120294

To O 0 6.236039189388976e-05
discover O 0 6.236663466552272e-05
genes O 0 9.569345820636954e-06
involved O 0 1.0493194167793263e-05
in O 0 8.677486221131403e-06
von B-Disease 0 0.03871897608041763
Hippel I-Disease 1 0.9990878105163574
- I-Disease 1 0.5949866771697998
Lindau I-Disease 1 0.9999887943267822
( O 0 7.0510184741579e-05
VHL B-Disease 1 0.993238091468811
) O 0 1.3297559235070366e-05
- O 0 2.8034299248247407e-05
mediated O 0 4.416593219502829e-05
carcinogenesis O 0 0.013658479787409306
, O 0 2.189290171372704e-06
we O 0 1.2590176083904225e-06
used O 0 1.8423657820676453e-05
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999150037765503
lines O 0 0.00019444848294369876
stably O 0 0.0004830312973354012
transfected O 0 8.715257717994973e-05
with O 0 4.611137683241395e-06
wild O 0 2.979424607474357e-05
- O 0 0.00014053331688046455
type O 0 0.0008963454747572541
VHL O 1 0.9998168349266052
- O 0 0.0009996192529797554
expressing O 0 0.00023202750890050083
transgenes O 0 0.0009610270499251783
. O 0 0.00012074239930370823

Large O 0 0.0003905012854374945
- O 0 0.00026912178145721555
scale O 0 9.15817217901349e-05
RNA O 0 9.70383916865103e-05
differential O 0 2.432152359688189e-05
display O 0 1.649400837777648e-05
technology O 0 1.0972245036100503e-05
applied O 0 1.2796788269042736e-06
to O 0 4.564062123790791e-07
these O 0 5.072870976619015e-07
cell O 0 5.372507075662725e-06
lines O 0 2.7596984182309825e-06
identified O 0 1.2454931948013837e-06
several O 0 1.0012880693466286e-06
differentially O 0 1.3652029338118155e-05
expressed O 0 3.3865985642478336e-06
genes O 0 1.385134623888007e-06
, O 0 6.47137937903608e-07
including O 0 4.967508289155376e-07
an O 0 2.6723716928245267e-06
alpha O 0 8.908092422643676e-05
carbonic O 0 0.00034433379187248647
anhydrase O 0 0.0010883366921916604
gene O 0 1.6420335668954067e-05
, O 0 1.2478717508201953e-05
termed O 0 0.00011906398867722601
CA12 O 0 0.45248687267303467
. O 0 0.00016378080181311816

The O 0 9.45872743614018e-05
deduced O 0 0.000161958989338018
protein O 0 1.6281868738587946e-05
sequence O 0 6.520849638036452e-06
was O 0 1.8265704056830145e-05
classified O 0 5.052658707427327e-06
as O 0 2.2036033442418557e-06
a O 0 2.9242437449283898e-06
one O 0 5.070044153399067e-06
- O 0 5.12335573148448e-05
pass O 0 3.987949821748771e-05
transmembrane O 0 0.013744182884693146
CA O 0 0.00011472597543615848
possessing O 0 1.7036491044564173e-05
an O 0 3.4383319871267304e-06
apparently O 0 1.9019465980818495e-05
intact O 0 1.2852956388087478e-05
catalytic O 0 7.346469374169828e-06
domain O 0 6.08303207627614e-06
in O 0 2.0224238141963724e-06
the O 0 8.166781299223658e-06
extracellular O 0 0.00019218573288526386
CA O 0 0.0009306281572207808
module O 0 0.0015337025979533792
. O 0 0.00010194285277975723

Reintroduced O 0 0.0009758207015693188
wild O 0 0.00030917642288841307
- O 0 0.000958514166995883
type O 0 0.0004207771271467209
VHL B-Disease 1 0.9951992630958557
strongly O 0 7.626124897797126e-06
inhibited O 0 1.5731620806036517e-05
the O 0 3.0164273994159885e-06
overexpression O 0 9.022225640364923e-06
of O 0 1.9554377104213927e-06
the O 0 3.822523012786405e-06
CA12 O 1 0.7464228868484497
gene O 0 2.1780010683869477e-06
in O 0 1.4674513977297465e-06
the O 0 5.325240181264235e-06
parental O 0 0.005904815625399351
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999933242797852
lines O 0 0.003658316796645522
. O 0 0.00021056376863270998

Similar O 0 3.768478927668184e-05
results O 0 7.4631116149248555e-06
were O 0 3.693810640470474e-06
obtained O 0 5.820196747663431e-06
with O 0 4.4372218326316215e-06
CA9 O 1 0.9334510564804077
, O 0 7.028688742138911e-06
encoding O 0 7.309989086934365e-06
another O 0 1.7280135580222122e-05
transmembrane O 0 0.0007444976945407689
CA O 0 3.087101140408777e-05
with O 0 2.3292072910408024e-06
an O 0 6.231272436707513e-06
intact O 0 9.123185009229928e-05
catalytic O 0 6.704767292831093e-05
domain O 0 8.284750947495922e-05
. O 0 0.00010022882634075359

Although O 0 3.6678135074907914e-05
both O 0 8.283586794277653e-06
domains O 0 2.2278389224084094e-05
of O 0 1.3334921277419198e-05
the O 0 2.2126385374576785e-05
VHL B-Disease 1 0.9995808005332947
protein O 0 1.0889081750065088e-05
contribute O 0 3.3698875085974578e-06
to O 0 1.8107348296325654e-06
regulation O 0 4.987553438695613e-06
of O 0 9.711921848065685e-06
CA12 O 1 0.9605237245559692
expression O 0 5.11150028614793e-06
, O 0 1.6072652897491935e-06
the O 0 2.118794554917258e-06
elongin O 0 5.8243476814823225e-05
binding O 0 1.9164185687259305e-06
domain O 0 5.485516794578871e-06
alone O 0 3.7321626678021858e-06
could O 0 2.9068050935165957e-06
effectively O 0 1.4376099898072425e-05
regulate O 0 3.9301485230680555e-05
CA9 O 0 0.07292605936527252
expression O 0 9.397557005286217e-05
. O 0 8.092842472251505e-05

We O 0 0.0002010363677982241
mapped O 0 0.0006921840831637383
CA12 O 1 0.9457449316978455
and O 0 8.81390442373231e-05
CA9 O 1 0.9903102517127991
loci O 0 9.538116864860058e-05
to O 0 1.5849229384912178e-05
chromosome O 0 0.00010788544750539586
bands O 0 6.674414180452004e-05
15q22 O 0 0.0007774166879244149
and O 0 6.465198384830728e-05
17q21 O 0 0.0012302023824304342
. O 0 0.0001815187861211598

2 O 0 0.0004997586365789175
respectively O 0 0.0001521480007795617
, O 0 2.3809865524526685e-05
regions O 0 1.1761984751501586e-05
prone O 0 3.586379170883447e-05
to O 0 5.053015229350422e-06
amplification O 0 3.0107086786301807e-05
in O 0 4.8118836275534704e-06
some O 0 7.206040663731983e-06
human O 0 4.035003803437576e-05
cancers B-Disease 1 0.7084031701087952
. O 0 0.00035242902231402695

Additional O 0 8.162939775502309e-05
experiments O 0 3.921073948731646e-05
are O 0 1.555229118821444e-06
needed O 0 3.505334461806342e-06
to O 0 1.1922471685466007e-06
define O 0 4.6322729758685455e-06
the O 0 3.6417286537471227e-06
role O 0 1.4068953532841988e-05
of O 0 4.857124440604821e-05
CA O 1 0.5767174363136292
IX O 1 0.9997010827064514
and O 0 2.1636855308315717e-05
CA O 0 0.0004704935126937926
XII O 1 0.9268131256103516
enzymes O 0 3.160904725518776e-06
in O 0 9.113702503782406e-07
the O 0 8.161154596564302e-07
regulation O 0 1.6764793144830037e-06
of O 0 1.581135620654095e-06
pH O 0 9.449600838706829e-06
in O 0 1.2028799574181903e-06
the O 0 2.6607933705236064e-06
extracellular O 0 3.432978701312095e-05
microenvironment O 0 3.556259616743773e-05
and O 0 9.919623380483245e-07
its O 0 9.851011100181495e-07
potential O 0 4.998548774892697e-06
impact O 0 9.703062460175715e-06
on O 0 2.2506668756250292e-05
cancer B-Disease 1 0.9999077320098877
cell O 0 0.017342673614621162
growth O 0 0.00010297182598151267
. O 0 0.00011350507702445611

A O 0 9.90914850262925e-05
gene O 0 1.2269473700143863e-05
encoding O 0 8.811270163278095e-06
a O 0 1.0003470379160717e-05
transmembrane O 0 0.00012519824667833745
protein O 0 4.072881438332843e-06
is O 0 9.131503020398668e-07
mutated O 0 1.5537096942352946e-06
in O 0 7.561725396953989e-07
patients O 0 1.3716955436393619e-05
with O 0 0.0014525846345350146
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.999998927116394
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 0.004770325496792793
. O 0 0.0002430114836897701

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999303817749023
WFS B-Disease 1 0.9999998807907104
; O 0 0.0004067069967277348
OMIM O 1 0.9999957084655762
222300 O 0 0.484677791595459
) O 0 6.24063295617816e-06
is O 0 2.4795128865662264e-06
an O 0 4.78085257782368e-06
autosomal B-Disease 1 0.999887228012085
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 1 0.965112030506134
by O 0 0.0021689909044653177
young O 0 0.3797885477542877
- O 1 0.5451364517211914
onset O 1 0.9999990463256836
non O 1 0.9796055555343628
- O 1 0.9992376565933228
immune O 1 0.9990130662918091
insulin B-Disease 1 0.6651468873023987
- I-Disease 1 0.9803988337516785
dependent I-Disease 1 0.8910502195358276
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999128580093384
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 0 0.015027325600385666

Linkage O 0 0.0013648283202201128
to O 0 5.169685391592793e-05
markers O 0 0.0001260944118257612
on O 0 5.449129093904048e-05
chromosome O 0 0.00035621592542156577
4p O 1 0.9932720065116882
was O 0 8.38790147099644e-05
confirmed O 0 1.4189008652465418e-05
in O 0 6.0975985434197355e-06
five O 0 1.0361811291659251e-05
families O 0 1.6705915186321363e-05
. O 0 7.523464591940865e-05

On O 0 3.2321720937034115e-05
the O 0 8.156818694260437e-06
basis O 0 8.043589332373813e-06
of O 0 1.9251092453487217e-05
meiotic O 1 0.99997878074646
recombinants O 1 0.9999938011169434
and O 0 0.0012586620869114995
disease O 1 0.9999960660934448
- O 0 0.11811097711324692
associated O 0 1.2954887097293977e-05
haplotypes O 0 2.3520835384260863e-05
, O 0 2.8905119506816845e-06
the O 0 5.5388572945958e-06
WFS B-Disease 1 0.9585586190223694
gene O 0 3.5904290598409716e-06
was O 0 6.485332960437518e-06
localized O 0 4.342162810644368e-06
to O 0 1.5704299585195258e-06
a O 0 9.598297765478492e-06
BAC O 1 0.7366116046905518
/ O 0 0.0017037822399288416
P1 O 0 0.12337436527013779
contig O 0 0.00012737687211483717
of O 0 9.94198489934206e-06
less O 0 3.770732973862323e-06
than O 0 3.2812051813380094e-06
250 O 0 1.7997244867729023e-05
kb O 0 0.00042435131035745144
. O 0 9.987410885514691e-05

Mutations O 0 0.00012570639955811203
in O 0 3.448492498137057e-05
a O 0 2.09394365811022e-05
novel O 0 1.535976116429083e-05
gene O 0 4.9095128815679345e-06
( O 0 3.329010496599949e-06
WFS1 O 0 0.0002533125807531178
) O 0 1.503122120993794e-06
encoding O 0 1.7513042394057265e-06
a O 0 4.608724339050241e-06
putative O 0 2.1852623831364326e-05
transmembrane O 0 3.5275021218694746e-05
protein O 0 2.600522520879167e-06
were O 0 9.366914923703007e-07
found O 0 6.462116175498522e-07
in O 0 4.541943212643673e-07
all O 0 3.1471722650167067e-07
affected O 0 9.336511652691115e-07
individuals O 0 3.27080641682187e-07
in O 0 1.511858613412187e-06
six O 0 7.559572622994892e-06
WFS B-Disease 1 0.9988328814506531
families O 0 1.5157810366872582e-06
, O 0 8.964256608123833e-07
and O 0 4.2274970724065497e-07
these O 0 1.8074224783504178e-07
mutations O 0 7.388686640297237e-07
were O 0 8.401831905757717e-07
associated O 0 2.0631487132050097e-06
with O 0 3.128286152787041e-06
the O 0 0.00019482204515952617
disease O 1 0.9999933242797852
phenotype O 0 0.037232860922813416
. O 0 0.00027293182210996747

WFS1 O 1 0.963566243648529
appears O 0 7.759765139780939e-05
to O 0 6.26881137577584e-06
function O 0 5.437655545392772e-06
in O 0 4.43943190475693e-06
survival O 0 3.619535709731281e-05
of O 0 1.2323733244556934e-05
islet O 0 0.08330945670604706
beta O 0 0.0006234867032617331
- O 0 0.00025754558737389743
cells O 0 9.429058081877884e-06
and O 0 5.143681846675463e-06
neurons O 0 3.376587119419128e-05
. O 0 2.0379484340082854e-05
. O 0 6.727426080033183e-05

Stable O 0 0.0005072691710665822
interaction O 0 4.854365033679642e-05
between O 0 1.5360317775048316e-05
the O 0 7.221036412374815e-06
products O 0 3.73633292838349e-06
of O 0 3.4654908631637227e-06
the O 0 8.703594176040497e-06
BRCA1 O 0 0.0031443736515939236
and O 0 1.6827629224280827e-05
BRCA2 O 0 0.3221941292285919
tumor B-Disease 1 0.9822384119033813
suppressor O 0 0.00011163306044181809
genes O 0 3.6058602290722774e-06
in O 0 3.7864440400880994e-06
mitotic O 0 0.00010287967597832903
and O 0 3.3574371627764776e-05
meiotic O 1 0.9206589460372925
cells O 0 0.0002395995834376663
. O 0 0.00014104439469520003

BRCA1 O 0 0.034498199820518494
and O 0 6.350043986458331e-05
BRCA2 O 0 8.717676973901689e-05
account O 0 6.001954261591891e-06
for O 0 1.4836988384558936e-06
most O 0 5.731323540203448e-07
cases O 0 5.645998726322432e-07
of O 0 3.6869305404252373e-06
familial O 0 0.13709379732608795
, O 0 9.66470815910725e-06
early O 0 0.00026711507234722376
onset O 1 0.999998927116394
breast B-Disease 1 0.9999798536300659
and I-Disease 0 0.00025413220282644033
/ I-Disease 1 0.9999897480010986
or I-Disease 1 0.9992102384567261
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.4837717571936082e-05
encode O 0 3.441733952058712e-06
products O 0 1.8107572259395965e-06
that O 0 5.2701335562233e-07
each O 0 6.697592880300363e-07
interact O 0 4.896196514891926e-06
with O 0 1.115752547775628e-05
hRAD51 O 0 0.0008674145792610943
. O 0 0.00010844551434274763

Results O 0 8.863725088303909e-05
presented O 0 6.14031232544221e-05
here O 0 1.2733758012473118e-05
show O 0 4.616374098986853e-06
that O 0 1.5361326859419933e-06
BRCA1 O 0 4.374450509203598e-05
and O 0 4.4982430154050235e-06
BRCA2 O 0 6.745997234247625e-05
coexist O 0 9.950540516001638e-06
in O 0 3.2366228879254777e-06
a O 0 9.404739103047177e-06
biochemical O 0 5.169813448446803e-05
complex O 0 5.87323447689414e-05
and O 0 7.97499069449259e-06
colocalize O 0 0.014215152710676193
in O 0 7.459027983713895e-06
subnuclear O 0 0.03474733978509903
foci O 0 0.00010812768596224487
in O 0 4.843438546231482e-06
somatic O 0 7.162793190218508e-05
cells O 0 4.093188181286678e-06
and O 0 6.488868393716984e-07
on O 0 9.624978929423378e-07
the O 0 1.4909311403243919e-06
axial O 0 3.5342084174772026e-06
elements O 0 3.2154587188415462e-06
of O 0 1.4362973161041737e-05
developing O 0 0.0001533467002445832
synaptonemal O 0 0.03988657146692276
complexes O 0 0.0005874696071259677
. O 0 0.0001428823743481189

Like O 0 0.0003657268243841827
BRCA1 O 0 0.0023915350902825594
and O 0 7.141758396755904e-05
RAD51 O 1 0.9929516911506653
, O 0 3.7517511373152956e-05
BRCA2 O 0 0.0001167202863143757
relocates O 0 4.7379777242895216e-05
to O 0 5.260600573819829e-06
PCNA O 0 0.00032370671397075057
+ O 0 1.304939723922871e-05
replication O 0 6.096069682826055e-06
sites O 0 7.966705197759438e-07
following O 0 1.4161253147904063e-06
exposure O 0 4.829942099604523e-06
of O 0 6.237271463760408e-06
S O 0 0.00015084432379808277
phase O 0 5.2916690037818626e-05
cells O 0 7.265362910402473e-06
to O 0 3.665138592623407e-06
hydroxyurea O 0 0.000147325947182253
or O 0 1.652218634262681e-05
UV O 0 0.0020420572254806757
irradiation O 0 0.00021872034994885325
. O 0 0.00017153212684206665

Thus O 0 0.0001692505757091567
, O 0 4.340430677984841e-05
BRCA1 O 0 0.00013325879990588874
and O 0 6.889089036121732e-06
BRCA2 O 0 3.391706559341401e-05
participate O 0 2.8917718282173155e-06
, O 0 1.2999287264392478e-06
together O 0 9.166980134978076e-07
, O 0 6.83755047248269e-07
in O 0 7.123875320758088e-07
a O 0 2.9365066893660696e-06
pathway O 0 1.2192153008072637e-05
( O 0 2.275669885420939e-06
s O 0 6.968061825318728e-06
) O 0 5.171405064174905e-07
associated O 0 4.3512514480426034e-07
with O 0 2.1819958817559382e-07
the O 0 9.933690989782917e-07
activation O 0 5.959666850685608e-06
of O 0 5.58590363652911e-06
double O 0 2.2794452888774686e-05
- O 0 0.00010485676466487348
strand O 0 1.682621586951427e-05
break O 0 6.860523171781097e-06
repair O 0 3.855201794067398e-05
and O 0 2.7973087526333984e-06
/ O 0 3.3445106964791194e-05
or O 0 8.026639989111573e-06
homologous O 0 4.8891342885326594e-05
recombination O 0 0.00016174771008081734
. O 0 0.00011032927432097495

Dysfunction O 1 0.999933123588562
of O 0 0.0004808803787454963
this O 0 4.382567567517981e-05
pathway O 0 0.00077478913590312
may O 0 6.112573828431778e-06
be O 0 1.1087222446803935e-06
a O 0 2.3399607016472146e-06
general O 0 4.264680228516227e-06
phenomenon O 0 5.090383183414815e-06
in O 0 6.837589694441704e-07
the O 0 1.1269254400758655e-06
majority O 0 8.700877742739976e-07
of O 0 9.220613605975814e-07
cases O 0 8.280097745227977e-07
of O 0 2.7272863007965498e-05
hereditary B-Disease 1 0.9999998807907104
breast I-Disease 1 0.9999996423721313
and I-Disease 1 0.5412493944168091
/ I-Disease 1 0.9999997615814209
or I-Disease 1 0.9999904632568359
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0007789291557855904
. O 0 0.00012717708887066692

A O 0 0.0005842711543664336
novel O 0 0.00018005460151471198
Arg362Ser O 0 0.00039057983667589724
mutation O 0 1.002135468297638e-05
in O 0 4.418751359480666e-06
the O 0 8.658424121676944e-06
sterol O 0 7.245166489155963e-05
27 O 0 4.140356759307906e-05
- O 0 5.458532177726738e-05
hydroxylase O 0 4.931840521749109e-05
gene O 0 5.27386691828724e-06
( O 0 3.301652213849593e-06
CYP27 O 0 0.00047739240108057857
) O 0 1.4925843743185396e-06
: O 0 4.885347948402341e-07
its O 0 6.131164127509692e-07
effects O 0 2.438856654407573e-06
on O 0 4.0913346310844645e-06
pre O 0 3.196735633537173e-05
- O 0 3.0134402550174855e-05
mRNA O 0 1.4673947589471936e-05
splicing O 0 1.49406323544099e-05
and O 0 5.7719144024304114e-06
enzyme O 0 2.0018220311612822e-05
activity O 0 4.740128497360274e-05
. O 0 7.219234976219013e-05

A O 0 0.0006645271205343306
novel O 0 0.00013607589062303305
C O 0 0.0001016389433061704
to O 0 6.992225280555431e-06
A O 0 1.30716043713619e-05
mutation O 0 2.798819195959368e-06
in O 0 1.7485305079389946e-06
the O 0 5.1263850764371455e-06
sterol O 0 4.2185372876701877e-05
27 O 0 3.0324497856781818e-05
- O 0 4.8057478124974295e-05
hydroxylase O 0 4.8876794608077034e-05
gene O 0 4.068250291311415e-06
( O 0 2.9001735128986184e-06
CYP27 O 0 0.0004910366260446608
) O 0 1.3094771702526486e-06
was O 0 3.325834086354007e-06
identified O 0 1.136862806561112e-06
by O 0 9.325984251518094e-07
sequencing O 0 7.018507403699914e-06
amplified O 0 2.0716699509648606e-05
CYP27 O 0 0.0007881626370362937
gene O 0 2.790517100947909e-06
products O 0 7.185427080003137e-07
from O 0 9.382864618601161e-07
a O 0 3.0873884497850668e-06
patient O 0 1.2624680493900087e-05
with O 0 1.398078711645212e-05
cerebrotendinous B-Disease 1 0.9999996423721313
xanthomatosis I-Disease 1 0.999998927116394
( O 0 0.001197200850583613
CTX B-Disease 1 0.9999275207519531
) O 0 7.824216299923137e-05
. O 0 0.0001348205260001123

The O 0 0.000130974585772492
mutation O 0 5.0887840188806877e-05
changed O 0 2.6002471713582054e-05
the O 0 1.0199455573456362e-05
adrenodoxin O 0 0.00032305187778547406
cofactor O 0 7.881457713665441e-05
binding O 0 9.798776773095597e-06
residue O 0 2.6294799681636505e-05
362Arg O 0 6.396867684088647e-05
to O 0 5.4760612329118885e-06
362Ser O 0 0.00019582867389544845
( O 0 3.5504137485986575e-05
CGT O 1 0.7198348641395569
362Arg O 0 0.000263271969743073
to O 0 1.8910028302343562e-05
AGT O 1 0.9999831914901733
362Ser O 0 0.0005838518845848739
) O 0 4.776085916091688e-06
, O 0 1.57577233039774e-06
and O 0 7.926637408672832e-07
was O 0 1.0443328392284457e-05
responsible O 0 3.91528419640963e-06
for O 0 4.555879058898427e-06
deficiency O 1 0.9999364614486694
in O 0 1.3070955901639536e-05
the O 0 3.0754094041185454e-05
sterol O 0 0.00013437811867333949
27 O 0 4.894461380899884e-05
- O 0 2.6550735128694214e-05
hydroxylase O 0 2.3821879949537106e-05
activity O 0 2.778696853056317e-06
, O 0 8.435962968178501e-07
as O 0 6.766422302462161e-07
confirmed O 0 9.294835763284937e-07
by O 0 4.5460603814717615e-07
expression O 0 9.192332868224184e-07
of O 0 2.946436779893702e-06
mutant O 0 2.4490311261615716e-05
cDNA O 0 4.401940168463625e-05
into O 0 9.95312166196527e-06
COS O 0 0.0010378911392763257
- O 0 7.729456410743296e-05
1 O 0 0.00014651523088105023
cells O 0 7.157999061746523e-05
. O 0 8.020065433811396e-05

Quantitative O 0 0.0001465022360207513
analysis O 0 1.8189843103755265e-05
showed O 0 1.6323439922416583e-05
that O 0 1.75602042418177e-06
the O 0 2.3311561108130263e-06
expression O 0 4.329456260165898e-06
of O 0 6.616416158067295e-06
CYP27 O 1 0.5485700368881226
gene O 0 1.0374299563409295e-05
mRNA O 0 1.0106754416483454e-05
in O 0 2.2708723008690868e-06
the O 0 5.2519035307341255e-06
patient O 0 1.688382326392457e-05
represented O 0 2.276269151479937e-05
52 O 0 0.00014097339590080082
. O 0 0.00011068089952459559

5 O 0 0.00017800884961616248
% O 0 6.129337270976976e-05
of O 0 4.810567043023184e-05
the O 0 5.0684044254012406e-05
normal O 0 8.401318336836994e-05
level O 0 0.00026863571838475764
. O 0 0.00013705450692214072

As O 0 0.00011051965702790767
the O 0 2.8934715373907238e-05
mutation O 0 2.2152629753691144e-05
occurred O 0 3.78013719455339e-05
at O 0 1.5275474652298726e-05
the O 0 7.305180133698741e-06
penultimate O 0 6.96737552061677e-05
nucleotide O 0 1.3147378922440112e-05
of O 0 1.4892579201841727e-05
exon O 0 6.636112811975181e-05
6 O 0 2.070397931674961e-05
( O 0 5.8559858189255465e-06
- O 0 5.069672170066042e-06
2 O 0 3.606971176850493e-06
position O 0 2.8478675631049555e-06
of O 0 4.09106542065274e-06
exon O 0 5.319750198395923e-05
6 O 0 3.0460429115919396e-05
- O 0 3.2668045605532825e-05
intron O 0 0.0002023766573984176
6 O 0 1.645516931603197e-05
splice O 0 1.812843584048096e-05
site O 0 4.804766831512097e-06
) O 0 6.804361873946618e-07
of O 0 6.359115900522738e-07
the O 0 1.2209815167807392e-06
gene O 0 1.0806749060066068e-06
, O 0 6.823948979217676e-07
we O 0 6.10177778526122e-07
hypothesized O 0 1.9041307268707897e-06
that O 0 2.3125774362142693e-07
the O 0 6.550322950715781e-07
mutation O 0 1.7515413901492138e-06
may O 0 2.1393302631622646e-06
partially O 0 7.970588740136009e-06
affect O 0 6.340307550090074e-07
the O 0 7.386136076092953e-07
normal O 0 9.262060416403983e-07
splicing O 0 2.234237854281673e-06
efficiency O 0 1.941549271577969e-06
in O 0 1.335227921117621e-06
exon O 0 1.0576017302810214e-05
6 O 0 5.638494258164428e-06
and O 0 1.0660068028300884e-06
cause O 0 2.531611471567885e-06
alternative O 0 1.7769791611499386e-06
splicing O 0 3.186337153238128e-06
elsewhere O 0 1.494976118010527e-06
, O 0 8.428411888417031e-07
which O 0 5.495897994478582e-07
resulted O 0 3.3563014767423738e-06
in O 0 1.8088536535287858e-06
decreased O 0 2.7281057555228472e-05
transcript O 0 2.7054877136833966e-05
in O 0 6.9818970587220974e-06
the O 0 2.7075369871454313e-05
patient O 0 0.0001687859621597454
. O 0 7.322655437747017e-05

Transfection O 0 0.0034053188282996416
of O 0 0.00013450669939629734
constructed O 0 0.0027981449384242296
minigenes O 0 0.0021885253954678774
, O 0 5.865252660441911e-06
with O 0 1.3642794556290028e-06
or O 0 1.3487991736838012e-06
without O 0 1.8179033531851019e-06
the O 0 3.4727727324934676e-06
mutation O 0 4.952210019837366e-06
, O 0 3.1181352824205533e-06
into O 0 5.010255790693918e-06
COS O 1 0.9931061863899231
- O 0 2.1649693735525943e-05
1 O 0 1.134622834797483e-05
cells O 0 1.436224692952237e-06
confirmed O 0 5.01039494338329e-07
that O 0 1.9560106068183813e-07
the O 0 9.559516911394894e-07
mutant O 0 1.3376647984841838e-05
minigene O 0 5.4210886446526274e-05
was O 0 9.0472994997981e-06
responsible O 0 1.8962966805702308e-06
for O 0 1.0498512210688205e-06
a O 0 2.0291045075282454e-06
mRNA O 0 4.102019374840893e-06
species O 0 3.516074400522484e-07
alternatively O 0 2.6067423277709167e-06
spliced O 0 4.7485355025855824e-06
at O 0 4.1425864765187725e-06
an O 0 3.887156708515249e-06
activated O 0 5.862418038304895e-05
cryptic O 0 2.226927608717233e-05
5 O 0 1.0438418939884286e-05
splice O 0 2.052668969554361e-05
site O 0 1.1888061635545455e-05
88 O 0 9.470893019170035e-06
bp O 0 1.6595635315752588e-05
upstream O 0 9.938259609043598e-06
from O 0 2.5761100914678536e-06
the O 0 2.8999659207329387e-06
3 O 0 8.128376066451892e-06
end O 0 1.775125929270871e-05
of O 0 3.712112447828986e-05
exon O 0 0.000541452958714217
6 O 0 0.00023281799803953618
. O 0 0.00016444646462332457

Our O 0 0.00010292599472450092
data O 0 2.6532610718277283e-05
suggest O 0 1.2072310710209422e-05
that O 0 1.4070211591388215e-06
the O 0 2.7728813165595056e-06
C O 0 1.648587749514263e-05
to O 0 1.9071347878707456e-06
A O 0 1.2343150956439786e-05
mutation O 0 3.563779500836972e-06
at O 0 7.827471563359722e-06
the O 0 4.677842753153527e-06
penultimate O 0 7.145621930249035e-05
nucleotide O 0 1.0767271305667236e-05
of O 0 6.723647857143078e-06
exon O 0 4.396259828354232e-05
6 O 0 1.2341232832113747e-05
of O 0 4.416560841491446e-06
the O 0 7.626633305335417e-06
CYP27 O 1 0.8733682632446289
gene O 0 2.629661366881919e-06
not O 0 3.7184489087849215e-07
only O 0 6.505400165224273e-07
causes O 0 2.5604788334021578e-06
the O 0 5.889387466595508e-06
deficiency B-Disease 1 0.999967098236084
in I-Disease 0 9.032350135385059e-06
the I-Disease 0 1.806199725251645e-05
sterol I-Disease 0 0.00010504182137083262
27 I-Disease 0 3.4913075069198385e-05
- I-Disease 0 2.1452167857205495e-05
hydroxylase I-Disease 0 2.024082095886115e-05
activity I-Disease 0 3.586288357837475e-06
, O 0 5.999323207106499e-07
but O 0 4.2695901925071666e-07
also O 0 7.060614848342084e-07
partially O 0 4.52054109700839e-06
leads O 0 2.0625016077246983e-06
to O 0 6.766841806893353e-07
alternative O 0 1.603511236680788e-06
pre O 0 1.2150795555498917e-05
- O 0 6.03597527515376e-06
mRNA O 0 4.032981905766064e-06
splicing O 0 3.866597126034321e-06
of O 0 2.0340332866908284e-06
the O 0 9.765119102667086e-06
gene O 0 3.737919541890733e-05
. O 0 5.5711403547320515e-05

To O 0 5.549511479330249e-05
our O 0 1.760739178280346e-05
knowledge O 0 1.2822715689253528e-05
, O 0 2.1328623915906064e-06
this O 0 5.964409979242191e-07
is O 0 7.202633582892304e-07
the O 0 6.208555305420305e-07
first O 0 1.5607743080181535e-06
report O 0 9.390608397552569e-07
regarding O 0 1.6664785107423086e-06
effects O 0 5.543512088479474e-06
on O 0 5.9030289776274e-06
pre O 0 2.9262355383252725e-05
- O 0 1.1125978744530585e-05
mRNA O 0 3.7674510622309754e-06
splicing O 0 1.822333047130087e-06
of O 0 5.133745162311243e-07
a O 0 1.0114556516782613e-06
mutation O 0 7.518494840041967e-07
at O 0 2.4111698166962015e-06
the O 0 2.4695541469554882e-06
- O 0 6.533455234603025e-06
2 O 0 7.711508260399569e-06
position O 0 4.43099315816653e-06
of O 0 4.477809852687642e-06
a O 0 1.2335762221482582e-05
5 O 0 4.3996191379847005e-05
splice O 0 0.0002117817202815786
site O 0 0.00015682615048717707
. O 0 9.173948637908325e-05

ATM O 0 0.05489771440625191
germline O 0 0.005343222990632057
mutations O 0 8.628331124782562e-05
in O 0 4.9897727876668796e-05
classical O 0 0.2917949855327606
ataxia B-Disease 1 1.0
- I-Disease 1 0.999998927116394
telangiectasia I-Disease 1 0.9999998807907104
patients O 0 0.004764623939990997
in O 0 1.767121830198448e-05
the O 0 1.968431934074033e-05
Dutch O 0 0.000254803744610399
population O 0 4.6307217417052016e-05
. O 0 9.247992420569062e-05

Germline O 0 0.005735029932111502
mutations O 0 8.738575706956908e-05
in O 0 1.787402288755402e-05
the O 0 1.3076378309051506e-05
ATM O 0 0.0009901653975248337
gene O 0 3.009608917636797e-06
are O 0 4.974358489562292e-07
responsible O 0 1.7337872577627422e-06
for O 0 1.3513665635400685e-06
the O 0 3.2197494874708354e-05
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9992127418518066
A B-Disease 1 0.9999992847442627
- I-Disease 1 0.9999713897705078
T I-Disease 1 0.999963641166687
) O 0 7.249839836731553e-05
. O 0 0.00011467305012047291

In O 0 0.00010053571895696223
our O 0 2.1840100089320913e-05
study O 0 1.2137476005591452e-05
, O 0 4.878308573097456e-06
we O 0 1.3521631672119838e-06
have O 0 5.522082915376814e-07
determined O 0 1.4605681144530536e-06
the O 0 2.3425707240676275e-06
ATM O 0 5.267472079140134e-05
mutation O 0 4.129459284740733e-06
spectrum O 0 5.5039622566255275e-06
in O 0 2.04894672606315e-06
19 O 0 9.883486200124025e-06
classical O 0 3.595622183638625e-05
A B-Disease 1 0.999829888343811
- I-Disease 1 0.999966025352478
T I-Disease 1 0.9999985694885254
patients O 0 9.112728548643645e-06
, O 0 1.4156621546135284e-06
including O 0 5.485723590936686e-07
some O 0 4.246172693456174e-07
immigrant O 0 4.165913196629845e-06
populations O 0 1.0734530633271788e-06
, O 0 9.553209565638099e-07
as O 0 1.2979887742403662e-06
well O 0 1.2002237781416625e-06
as O 0 1.408593220730836e-06
12 O 0 2.3258332930709003e-06
of O 0 8.030222488741856e-06
Dutch O 0 6.212681910255924e-05
ethnic O 0 2.435387796140276e-05
origin O 0 2.986165782203898e-05
. O 0 6.874333485029638e-05

Both O 0 3.2123276469064876e-05
the O 0 1.568410334584769e-05
protein O 0 7.745264156255871e-06
truncation O 0 2.6300718673155643e-05
test O 0 4.623322183761047e-06
( O 0 3.361667040735483e-06
PTT O 0 1.8402466594125144e-05
) O 0 1.0334367743780604e-06
and O 0 3.399631793854496e-07
the O 0 7.416473408738966e-07
restriction O 0 2.046489953499986e-06
endonuclease O 0 2.6785264708450995e-05
fingerprinting O 0 2.085428604914341e-05
( O 0 8.858546607370954e-06
REF O 0 0.00029813521541655064
) O 0 1.5523603451583767e-06
method O 0 9.756756753631635e-07
were O 0 5.657976203110593e-07
used O 0 6.246243628993398e-07
and O 0 3.5902195349990507e-07
compared O 0 6.856879508632119e-07
for O 0 4.1157085206577904e-07
their O 0 6.52620428809314e-07
detection O 0 5.575897375820205e-06
efficiency O 0 6.022853540343931e-06
, O 0 1.0655260211933637e-06
identifying O 0 2.2140154669614276e-06
76 O 0 3.96424411519547e-06
% O 0 1.5213654478429817e-06
and O 0 7.340975116676418e-07
60 O 0 1.7170480077766115e-06
% O 0 1.5745795280963648e-06
of O 0 2.2776653167966288e-06
the O 0 5.436923856905196e-06
mutations O 0 9.27557448449079e-06
, O 0 8.639272891741712e-06
respectively O 0 3.935947097488679e-05
. O 0 4.3813182855956256e-05

Most O 0 7.630945037817582e-05
patients O 0 4.824390634894371e-05
were O 0 1.0018621651397552e-05
found O 0 4.522571998677449e-06
to O 0 2.7701350973075023e-06
be O 0 7.619414645887446e-06
compound O 0 0.00015897024422883987
heterozygote O 0 0.0007712582591921091
. O 0 0.0001335116394329816

Seventeen O 0 0.0005367324920371175
mutations O 0 3.836734686046839e-05
were O 0 9.73254100244958e-06
distinct O 0 5.649721970257815e-06
, O 0 2.769509137579007e-06
of O 0 2.73079263024556e-06
which O 0 1.271180281037232e-06
10 O 0 2.907148882513866e-06
were O 0 3.1990339266485535e-06
not O 0 2.1475477751664585e-06
reported O 0 1.7505062714917585e-05
previously O 0 6.381624552886933e-05
. O 0 0.0001280444412259385

Mutations O 0 0.00020539939578156918
are O 0 1.6236654118984006e-05
small O 0 1.1201590496057179e-05
deletions O 0 2.9516530048567802e-05
or O 0 7.851920599932782e-06
point O 0 3.635050234152004e-05
mutations O 0 1.611104016774334e-05
frequently O 0 1.7159598428406753e-05
affecting O 0 3.5022254451178014e-05
splice O 0 0.0001959272922249511
sites O 0 8.876573701854795e-05
. O 0 9.424433665117249e-05

Moreover O 0 0.0010780231095850468
, O 0 0.00023074705677572638
a O 0 0.00025975913740694523
16 O 0 0.0004503773816395551
. O 0 0.0002851923054549843

7 O 0 0.0008524269214831293
- O 0 0.0003080668393522501
kb O 0 0.00031357997795566916
genomic O 0 2.7611682526185177e-05
deletion O 0 1.4674731573904864e-05
of O 0 5.940130904491525e-06
the O 0 4.548824108496774e-06
3 O 0 6.805161774536828e-06
end O 0 4.089719368494116e-06
of O 0 1.8280668427905766e-06
the O 0 2.7830860744870733e-06
gene O 0 1.746597490637214e-06
, O 0 6.332240332085348e-07
most O 0 3.595914677134715e-07
likely O 0 7.661506629119685e-07
a O 0 7.713014724686218e-07
result O 0 5.363459081308974e-07
of O 0 1.4718352758791298e-06
recombination O 0 8.316871571878437e-06
between O 0 5.0273574743187055e-06
two O 0 2.6567768145469017e-06
LINE O 0 8.278353925561532e-05
elements O 0 9.99971143755829e-06
, O 0 7.99101690063253e-06
was O 0 5.1527153118513525e-05
identified O 0 3.062306859646924e-05
. O 0 6.652802403550595e-05

The O 0 8.111623901640996e-05
most O 0 7.918561095721088e-06
frequently O 0 8.009022167243529e-06
found O 0 2.769976390482043e-06
mutation O 0 1.8260751630805316e-06
, O 0 1.0482734751349199e-06
identified O 0 1.7173575770357274e-06
in O 0 1.1097239394075586e-06
three O 0 1.607748231435835e-06
unrelated O 0 7.3912765401473735e-06
Turkish O 0 3.779758480959572e-05
A B-Disease 1 0.9997459053993225
- I-Disease 1 0.9984172582626343
T I-Disease 1 0.999852180480957
individuals O 0 1.7456649175073835e-06
, O 0 1.6322488818332204e-06
was O 0 8.40904249344021e-06
previously O 0 2.2418703338189516e-06
described O 0 1.0986136658175383e-06
to O 0 2.999205719333986e-07
be O 0 4.2580705894579296e-07
a O 0 2.106777628796408e-06
Turkish O 0 2.2038380848243833e-05
A B-Disease 1 0.9957072734832764
- I-Disease 1 0.9996738433837891
T I-Disease 1 0.9999940395355225
founder O 0 0.048279643058776855
mutation O 0 5.06187388964463e-05
. O 0 5.266578227747232e-05

The O 0 6.885289622005075e-05
presence O 0 3.388270488358103e-05
of O 0 2.6700698072090745e-05
a O 0 4.012264616903849e-05
founder O 0 0.004484806675463915
mutation O 0 1.0612661753839348e-05
among O 0 4.122081918467302e-06
relatively O 0 4.5874094212194905e-06
small O 0 1.6412789136666106e-06
ethnic O 0 1.2390813708407222e-06
population O 0 5.8748526043928e-07
groups O 0 2.3600540544066462e-07
in O 0 4.899233090327471e-07
Western O 0 1.9802334918495035e-06
Europe O 0 1.8296835833098157e-06
could O 0 4.3675115080077376e-07
indicate O 0 1.0529515748203266e-06
a O 0 2.0593606677721255e-06
high O 0 5.013137979403837e-06
carrier O 0 6.8480389927572105e-06
frequency O 0 3.407311851333361e-06
in O 0 4.981179245078238e-06
such O 0 4.728750809590565e-06
communities O 0 2.3999924451345578e-05
. O 0 9.760419925441965e-05

In O 0 0.00012546090874820948
patients O 0 4.729657302959822e-05
of O 0 3.2763015042291954e-05
Dutch O 0 0.0003707225259859115
ethnic O 0 1.4777433534618467e-05
origin O 0 4.459625870367745e-06
, O 0 2.4623909666843247e-06
however O 0 1.8380872006673599e-06
, O 0 1.414200710314617e-06
no O 0 1.1697960644596606e-06
significant O 0 5.5455534493376035e-06
founder O 0 0.00022290315246209502
effect O 0 5.493191565619782e-06
could O 0 2.381558715569554e-06
be O 0 4.409952452988364e-06
identified O 0 2.6625586542650126e-05
. O 0 6.121800834080204e-05

The O 0 0.00012907713244203478
observed O 0 8.913938654586673e-05
genetic O 0 4.566629650071263e-05
heterogeneity O 0 6.38010969851166e-05
including O 0 5.504880846274318e-06
the O 0 9.435931133339182e-06
relative O 0 1.425054779247148e-05
high O 0 1.4291947991296183e-05
percentage O 0 1.1154738785990048e-05
of O 0 1.0883381037274376e-05
splice O 0 0.00014913569611962885
- O 0 3.2052401365945116e-05
site O 0 1.2812437489628792e-05
mutations O 0 4.3517884478205815e-06
had O 0 4.9941936595132574e-06
no O 0 2.266599267386482e-06
reflection O 0 1.0710217793530319e-05
on O 0 5.4955912673904095e-06
the O 0 2.0173836674075574e-05
phenotype O 0 0.00018886802718043327
. O 0 0.00014284206554293633

All O 0 0.00010643526184139773
patients O 0 0.00010416066652396694
manifested O 0 0.0002150254586013034
classical O 0 0.0003017557319253683
A B-Disease 1 0.9992818236351013
- I-Disease 1 0.9696816205978394
T I-Disease 1 0.9989653825759888
and O 0 5.5649170462857e-06
increased O 0 2.1244853996904567e-05
cellular O 0 5.581164077739231e-05
radioresistant O 0 0.000354380055796355
DNA O 0 9.649837738834321e-05
synthesis O 0 0.00017897947691380978
. O 0 0.00012001246795989573

Determination O 0 0.0006824331940151751
of O 0 0.0001075572581612505
the O 0 2.9317016014829278e-05
genomic O 0 5.037718437961303e-05
structure O 0 2.8350848879199475e-05
of O 0 1.1454961168055888e-05
the O 0 1.7689779269858263e-05
COL4A4 O 1 0.9993578791618347
gene O 0 4.566283678286709e-06
and O 0 1.2604976973307203e-06
of O 0 3.751557414943818e-06
novel O 0 1.9340450307936408e-05
mutations O 0 2.7431535272626206e-05
causing O 0 0.05468824878334999
autosomal B-Disease 1 0.9999452829360962
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9996838569641113

Autosomal B-Disease 1 0.999998927116394
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.9973304271697998
a O 1 0.9875060319900513
progressive O 1 0.9999995231628418
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.9942573308944702
by O 0 0.0003755975340027362
glomerular B-Disease 1 1.0
basement I-Disease 1 0.9999997615814209
membrane I-Disease 1 0.9928353428840637
abnormalities I-Disease 1 0.8539947867393494
and O 0 2.246733174615656e-06
associated O 0 2.1113476122991415e-06
with O 0 8.55989071624208e-07
mutations O 0 1.9292012893856736e-06
in O 0 9.48554827573389e-07
either O 0 1.3812565384796471e-06
the O 0 3.1646538900531596e-06
COL4A3 O 1 0.9897896647453308
or O 0 1.5004580973254633e-06
the O 0 3.5467689940560376e-06
COL4A4 O 1 0.9693965315818787
gene O 0 3.0387029710254865e-06
, O 0 8.971431952886633e-07
which O 0 2.95971972263942e-07
encode O 0 8.678229050929076e-07
the O 0 1.8479383925296133e-06
alpha3 O 0 5.8332079788669944e-05
and O 0 4.3630916479742154e-06
alpha4 O 1 0.7689143419265747
type O 0 0.32173216342926025
IV O 1 1.0
collagen O 1 0.9998888969421387
chains O 0 4.660060949390754e-05
, O 0 1.3003704225411639e-05
respectively O 0 3.7907320802332833e-05
. O 0 6.0402169765438884e-05

To O 0 4.166764483670704e-05
date O 0 2.4043631128733978e-05
, O 0 4.573622391035315e-06
mutation O 0 3.243092805860215e-06
screening O 0 2.3522934498032555e-06
in O 0 1.4029170642970712e-06
the O 0 1.9794856598309707e-06
two O 0 1.2584570185936172e-06
genes O 0 1.9150154457747703e-06
has O 0 1.2414327557053184e-06
been O 0 1.4438465996136074e-06
hampered O 0 7.584145350847393e-06
by O 0 7.333075018323143e-07
the O 0 1.8181910945713753e-06
lack O 0 5.870518180017825e-06
of O 0 9.998558198276442e-06
genomic O 0 3.7581070500891656e-05
structure O 0 4.8893296479946e-05
information O 0 2.2550433641299605e-05
. O 0 6.891872180858627e-05

We O 0 7.044586527626961e-05
report O 0 1.4552162610925734e-05
here O 0 6.556811513291905e-06
the O 0 5.310562755767023e-06
complete O 0 1.0135035154235084e-05
characterization O 0 1.7292368283960968e-05
of O 0 5.4300121519190725e-06
the O 0 5.1885394896089565e-06
48 O 0 1.0721970284066629e-05
exons O 0 2.0261522877262905e-05
of O 0 6.313647190836491e-06
the O 0 1.4814302630838938e-05
COL4A4 O 1 0.9886183738708496
gene O 0 6.242698418645887e-06
, O 0 1.4521681350743165e-06
a O 0 2.800253014356713e-06
comprehensive O 0 6.827217475802172e-06
gene O 0 2.325913101230981e-06
screen O 0 2.2700992303725798e-06
, O 0 6.323556362985983e-07
and O 0 3.1702981573289435e-07
the O 0 5.328677161742235e-07
subsequent O 0 1.9660533325804863e-06
detection O 0 3.0482342481263913e-06
of O 0 2.087780558213126e-06
10 O 0 2.9438388082780875e-06
novel O 0 2.960494839499006e-06
mutations O 0 1.0168794233322842e-06
in O 0 1.0897294941969449e-06
eight O 0 6.52198741590837e-06
patients O 0 0.00014994159573689103
diagnosed O 1 0.9999929666519165
with O 0 0.03390803560614586
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999039173126221

Furthermore O 0 0.00028024890343658626
, O 0 3.759562605409883e-05
we O 0 5.365973265725188e-06
identified O 0 5.114191935717827e-06
a O 0 7.134813586162636e-06
glycine O 0 2.8979229682590812e-05
to O 0 3.482566398815834e-06
alanine O 0 1.7909325833898038e-05
substitution O 0 1.0236524758511223e-05
in O 0 5.96559812038322e-06
the O 0 1.4533356988977175e-05
collagenous O 0 0.21925055980682373
domain O 0 1.2318387234699912e-05
that O 0 1.6656601928843884e-06
is O 0 2.396552872596658e-06
apparently O 0 5.075433819001773e-06
silent O 0 8.557241017115302e-06
in O 0 1.029602231028548e-06
the O 0 1.716157498776738e-06
heterozygous O 0 6.661133284069365e-06
carriers O 0 4.691307822213275e-06
, O 0 4.33573632108164e-06
in O 0 6.72285887048929e-06
11 O 0 0.00011794730380643159
. O 0 0.00010139064397662878

5 O 0 0.00014050424215383828
% O 0 4.604108107741922e-05
of O 0 1.1034385352104437e-05
all O 0 3.4808431337296497e-06
control O 0 6.2877311393094715e-06
individuals O 0 1.3476445701599005e-06
, O 0 1.8961194427902228e-06
and O 0 9.672035048424732e-07
in O 0 1.1963634278799873e-06
one O 0 1.3014445130465901e-06
control O 0 2.4200205643865047e-06
individual O 0 9.072078341887391e-07
homozygous O 0 2.9956465823488543e-06
for O 0 1.1104937129857717e-06
this O 0 2.1498756268556463e-06
glycine O 0 4.5945333113195375e-05
substitution O 0 6.808739999542013e-05
. O 0 6.803120049880818e-05

There O 0 7.812690455466509e-05
has O 0 1.9054450604016893e-05
been O 0 4.665821961680194e-06
no O 0 1.6522818668818218e-06
previous O 0 2.051341880360269e-06
finding O 0 2.0936026885465253e-06
of O 0 2.2047656784707215e-06
a O 0 3.3559108487679623e-06
glycine O 0 1.154141136794351e-05
substitution O 0 3.4656493426155066e-06
that O 0 7.379897510872979e-07
is O 0 6.376970418386918e-07
not O 0 2.6186174295617093e-07
associated O 0 7.499746743633295e-07
with O 0 9.264623486160417e-07
any O 0 2.366047056057141e-06
obvious O 0 2.5657764126663096e-05
phenotype O 0 2.558558298915159e-05
in O 0 7.10490303390543e-06
homozygous O 0 3.8834587030578405e-05
individuals O 0 2.5644409106462263e-05
. O 0 0.00012676978076342493

Founder O 1 0.9539437294006348
BRCA1 O 0 0.0037913748528808355
and O 0 2.9683074899367057e-05
BRCA2 O 0 0.00014753850700799376
mutations O 0 9.487218449066859e-06
in O 0 3.6573351280821953e-06
French O 0 2.093500370392576e-05
Canadian O 0 0.00011653388355625793
breast B-Disease 1 0.9999665021896362
and I-Disease 1 0.8548822999000549
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.1934591829776764
. O 0 0.0005172798410058022

We O 0 6.11335999565199e-05
have O 0 4.91158289150917e-06
identified O 0 5.316664100973867e-06
four O 0 1.827129040066211e-06
mutations O 0 1.2231761274961173e-06
in O 0 5.127462827658746e-07
each O 0 3.7151312426431105e-07
of O 0 2.073255245704786e-06
the O 0 3.078334702877328e-05
breast B-Disease 1 0.9999991655349731
cancer I-Disease 1 0.9999994039535522
- O 1 0.987555205821991
susceptibility O 0 0.4627566933631897
genes O 0 6.180558102641953e-06
, O 0 4.338383860158501e-06
BRCA1 O 0 2.3494114429922774e-05
and O 0 1.5754776541143656e-06
BRCA2 O 0 7.401384209515527e-06
, O 0 7.339064040934318e-07
in O 0 6.658412985416362e-07
French O 0 4.995693871023832e-06
Canadian O 0 3.8354504795279354e-05
breast B-Disease 1 0.9999762773513794
cancer I-Disease 1 0.9999898672103882
and O 0 0.012337506748735905
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0005261484766378999
from O 0 0.00012318415974732488
Quebec O 0 0.005207146983593702
. O 0 0.00026417840854264796

To O 0 0.00015815622464288026
identify O 0 0.00017356300668325275
founder O 0 0.0020350844133645296
effects O 0 6.815300730522722e-05
, O 0 6.250801106943982e-06
we O 0 3.0387377591978293e-06
examined O 0 3.156618731736671e-06
independently O 0 1.3349554137676023e-06
ascertained O 0 8.00686848378973e-06
French O 0 1.3887662134948187e-05
Canadian O 0 1.9982646335847676e-05
cancer B-Disease 0 0.0007475202437490225
families O 0 1.5304576663766056e-06
for O 0 8.523323913323111e-07
the O 0 2.082241280731978e-06
distribution O 0 1.5975614360286272e-06
of O 0 3.8919533835724e-06
these O 0 1.981725972655113e-06
eight O 0 1.4771359929000027e-05
mutations O 0 3.8256246625678614e-05
. O 0 7.948897837195545e-05

Mutations O 0 0.0002621400635689497
were O 0 3.432474477449432e-05
found O 0 1.1366371836629696e-05
in O 0 5.43563828614424e-06
41 O 0 1.80247807293199e-05
of O 0 2.1384785213740543e-05
97 O 0 0.00012665499525610358
families O 0 4.194624489173293e-05
. O 0 0.00011918690142920241

Six O 0 0.0001088146964320913
of O 0 3.779311737162061e-05
eight O 0 1.795870230125729e-05
mutations O 0 1.2879399037046824e-05
were O 0 5.000675173505442e-06
observed O 0 8.264546522696037e-06
at O 0 1.904881719383411e-05
least O 0 1.573906592966523e-05
twice O 0 5.3542979003395885e-05
. O 0 8.9782610302791e-05

The O 0 0.00020675358246080577
BRCA1 O 0 0.01556535717099905
C4446T O 0 0.001532090245746076
mutation O 0 1.0390904208179563e-05
was O 0 1.960230656550266e-05
the O 0 2.938719489975483e-06
most O 0 1.4605681144530536e-06
common O 0 1.3634210063173668e-06
mutation O 0 2.217502014900674e-06
found O 0 1.246151327904954e-06
, O 0 8.582442774240917e-07
followed O 0 1.67189386957034e-06
by O 0 2.5996321255661314e-06
the O 0 2.183822653023526e-05
BRCA2 O 0 0.00034216471249237657
8765delAG O 0 0.0006435358664020896
mutation O 0 0.00010701239079935476
. O 0 7.523349631810561e-05

Together O 0 0.00014367439143825322
, O 0 1.3425196812022477e-05
these O 0 1.3051983387413202e-06
mutations O 0 2.3462130229745526e-06
were O 0 2.1721041321143275e-06
found O 0 1.5678157296861173e-06
in O 0 1.5352056834672112e-06
28 O 0 4.92851677336148e-06
of O 0 3.4358897664787946e-06
41 O 0 7.203511813713703e-06
families O 0 1.6104380620163283e-06
identified O 0 1.5026433857201482e-06
to O 0 9.451001119487046e-07
have O 0 9.13848964501085e-07
a O 0 1.0019004548666999e-05
mutation O 0 2.574006066424772e-05
. O 0 6.0550213675014675e-05

The O 0 8.775151218287647e-05
odds O 0 6.686925917165354e-05
of O 0 1.6717422113288194e-05
detection O 0 1.6950260032899678e-05
of O 0 4.622092092176899e-06
any O 0 1.8891864783654455e-06
of O 0 5.699368102796143e-06
the O 0 7.338815521507058e-06
four O 0 1.5571416952298023e-05
BRCA1 O 0 0.00013972212036605924
mutations O 0 3.3937059924937785e-05
was O 0 0.0002209846570622176
18 O 0 0.000207052260520868
. O 0 0.00019646550936158746

7x O 0 0.012184935621917248
greater O 0 4.097639612155035e-05
if O 0 3.3698422612360446e-06
one O 0 1.6863972405189998e-06
or O 0 7.088614779604541e-07
more O 0 4.1937263972613437e-07
cases O 0 1.5623617173332605e-06
of O 0 0.3008149266242981
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.0008747247629798949
also O 0 8.40329630591441e-06
present O 0 4.5439637688104995e-06
in O 0 4.41354131908156e-06
the O 0 1.5067651474964805e-05
family O 0 6.838190165581182e-05
. O 0 5.664715718012303e-05

The O 0 0.00017469267186243087
odds O 0 0.00019132217857986689
of O 0 2.3643829990760423e-05
detection O 0 2.039050559687894e-05
of O 0 6.737305739079602e-06
any O 0 2.4967207536974456e-06
of O 0 4.891310254606651e-06
the O 0 9.982884876080789e-06
four O 0 1.2355871149338782e-05
BRCA2 O 0 0.0001402753114234656
mutations O 0 2.0072702682227828e-05
was O 0 0.00012641609646379948
5 O 0 0.00010522427328396589
. O 0 0.000126699946122244

3x O 0 0.0009788312017917633
greater O 0 5.429263546830043e-05
if O 0 4.015787908429047e-06
there O 0 1.8939922483696137e-06
were O 0 1.5576218856949708e-06
at O 0 2.0571856111928355e-06
least O 0 9.678142305347137e-07
five O 0 6.584343736903975e-07
cases O 0 7.758200126772863e-07
of O 0 3.759060564334504e-05
breast B-Disease 1 0.9999984502792358
cancer I-Disease 1 0.9999842643737793
in O 0 3.616141475504264e-05
the O 0 8.876801439328119e-05
family O 0 0.00024063391902018338
. O 0 8.583407907281071e-05

Interestingly O 0 0.0006555294385179877
, O 0 3.1307452445616946e-05
the O 0 7.911587090347894e-06
presence O 0 4.809089659829624e-06
of O 0 7.830211870896164e-06
a O 0 0.00017002099775709212
breast B-Disease 1 0.999991774559021
cancer I-Disease 1 0.999833345413208
case O 0 2.6932211767416447e-05
< O 0 0.00011169972276547924
36 O 0 6.1726823332719505e-06
years O 0 3.5740990824706387e-06
of O 0 4.2336032493039966e-06
age O 0 1.2389405128487851e-05
was O 0 2.5107146939262748e-05
strongly O 0 3.393193310330389e-06
predictive O 0 1.9829133179882774e-06
of O 0 1.5469159961867263e-06
the O 0 1.3111429097989458e-06
presence O 0 1.7683945543467416e-06
of O 0 1.029796635521052e-06
any O 0 5.651407377627038e-07
of O 0 1.7699314867059002e-06
the O 0 2.9999864636920393e-06
eight O 0 1.0418499186926056e-05
mutations O 0 1.821923433453776e-05
screened O 0 7.871964044170454e-05
. O 0 0.00012159127072663978

Carriers O 0 0.00010499094787519425
of O 0 2.4189974283217452e-05
the O 0 8.27285839477554e-06
same O 0 2.9563896077888785e-06
mutation O 0 2.8204124191688607e-06
, O 0 9.487367265137436e-07
from O 0 5.867120762559352e-07
different O 0 1.2767674206770607e-07
families O 0 6.614666290261084e-07
, O 0 8.076087851804914e-07
shared O 0 1.4713216387463035e-06
similar O 0 1.0074911642732332e-06
haplotypes O 0 8.714207979210187e-06
, O 0 1.298498887081223e-06
indicating O 0 3.053687123610871e-06
that O 0 3.140213777896861e-07
the O 0 1.132829197558749e-06
mutant O 0 5.460166903503705e-06
alleles O 0 7.05517663845967e-07
were O 0 5.818060344608966e-07
likely O 0 5.937175160397601e-07
to O 0 2.3137687321650446e-07
be O 0 1.7345485048281262e-07
identical O 0 3.0749100687899045e-07
by O 0 4.4666899157164153e-07
descent O 0 3.870991349685937e-06
for O 0 8.023639566090424e-07
a O 0 3.937736892112298e-06
mutation O 0 2.3286163468583254e-06
in O 0 1.954378603841178e-06
the O 0 8.103027539618779e-06
founder O 0 0.00023812630388420075
population O 0 2.3495345885748975e-05
. O 0 6.706907879561186e-05

The O 0 6.684917752863839e-05
identification O 0 2.7433992727310397e-05
of O 0 3.38374957209453e-05
common O 0 4.375881690066308e-05
BRCA1 O 0 0.004887756425887346
and O 0 1.269777840207098e-05
BRCA2 O 0 8.312844147440046e-05
mutations O 0 3.853344878734788e-06
will O 0 9.514966450296924e-07
facilitate O 0 2.5043564164661802e-06
carrier O 0 3.648632628028281e-06
detection O 0 2.7661487820296315e-06
in O 0 9.194787935484783e-07
French O 0 4.855102361034369e-06
Canadian O 0 2.958238655992318e-05
breast B-Disease 1 0.999890923500061
cancer I-Disease 1 0.9999873638153076
and O 0 0.003965779673308134
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.012181014753878117
. O 0 0.00038502897950820625

Are O 0 0.00012216968752909452
Dp71 O 0 0.15502743422985077
and O 0 5.872612746316008e-05
Dp140 O 1 0.9182471036911011
brain O 0 0.07645972818136215
dystrophin O 0 0.00021197000751271844
isoforms O 0 9.955047062248923e-06
related O 0 5.513828909897711e-06
to O 0 5.42410134585225e-06
cognitive B-Disease 1 0.9552522897720337
impairment I-Disease 1 0.9999996423721313
in O 1 0.9999916553497314
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9997240900993347

Molecular O 0 0.0004579785745590925
study O 0 4.577669460559264e-05
and O 0 1.066169988916954e-05
neuropsychological O 0 4.3560678022913635e-05
analysis O 0 3.3858618735393975e-06
were O 0 1.7014695004036184e-06
performed O 0 3.0962341952545103e-06
concurrently O 0 4.401641490403563e-06
on O 0 2.8499571271822788e-06
49 O 0 2.154867979697883e-05
patients O 0 0.00016242449055425823
with O 0 0.3078596293926239
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999979734420776
DMD B-Disease 1 1.0
) O 0 7.675418601138517e-06
in O 0 1.2241667946000234e-06
order O 0 5.01456838719605e-07
to O 0 3.1712536951999937e-07
find O 0 1.1468157481431263e-06
a O 0 1.175927764052176e-06
molecular O 0 1.8187807881986373e-06
explanation O 0 1.1485186632853583e-06
for O 0 7.228996992125758e-07
the O 0 3.014216190422303e-06
cognitive B-Disease 0 0.1985209882259369
impairment I-Disease 1 0.9854676127433777
observed O 0 2.280252010677941e-05
in O 0 1.1948597602895461e-05
most O 0 3.7375735701061785e-05
DMD B-Disease 1 1.0
patients O 0 0.010151275433599949
. O 0 0.00019181483366992325

Complete O 0 0.00012048109783791006
analysis O 0 2.2378360881702974e-05
of O 0 1.561018143547699e-05
the O 0 1.384910774504533e-05
dystrophin O 0 0.0008754388545639813
gene O 0 9.822579158935696e-06
was O 0 1.989379416045267e-05
performed O 0 3.907643986167386e-06
to O 0 7.327168418669316e-07
define O 0 1.686278324086743e-06
the O 0 1.594871491761296e-06
localization O 0 1.1905330211448018e-05
of O 0 4.705978426500224e-06
deletions O 0 2.0161491192993708e-05
and O 0 3.3569288007129217e-06
duplications O 0 1.823016646085307e-05
in O 0 3.49294737134187e-06
relation O 0 5.471336862683529e-06
to O 0 3.071409537369618e-06
the O 0 8.28544216346927e-06
different O 0 1.750359297147952e-05
DMD B-Disease 1 0.9999985694885254
promoters O 0 0.07153420150279999
. O 0 0.0002653840638231486

Qualitative O 0 0.00019437153241597116
analysis O 0 2.3691927708568983e-05
of O 0 2.0925763237755746e-05
the O 0 1.8102107787854038e-05
Dp71 O 0 0.11525224149227142
transcript O 0 3.346843004692346e-05
and O 0 1.7434854271414224e-06
testing O 0 9.388306807522895e-07
for O 0 6.132193561825261e-07
the O 0 1.5876722727625747e-06
specific O 0 8.590705533606524e-07
first O 0 3.9191618270706385e-06
exon O 0 3.8080368540249765e-05
of O 0 1.0949645002256148e-05
Dp140 O 0 0.0001508887653471902
were O 0 5.843394774274202e-06
also O 0 2.37127642321866e-06
carried O 0 1.0744314749899786e-05
out O 0 1.3392627806751989e-05
. O 0 6.622015644097701e-05

Neuropsychological O 0 0.001040199538692832
analysis O 0 4.374546551844105e-05
assessed O 0 3.6617500882130116e-05
verbal O 0 4.8297075409209356e-05
and O 0 1.079036792361876e-05
visuospatial O 0 0.043170664459466934
intelligence O 0 1.8327278667129576e-05
, O 0 3.8226617107284255e-06
verbal O 0 1.5001210158516187e-05
memory O 0 0.04447224363684654
, O 0 1.3260468222142663e-05
and O 0 1.2801639968529344e-05
reading O 0 0.00015882191655691713
skills O 0 0.00037175556644797325
. O 0 0.00014910865866113454

Comparison O 0 0.00012258760398253798
of O 0 4.626965164788999e-05
molecular O 0 5.0308535719523206e-05
and O 0 9.688341378932819e-06
psychometric O 0 8.279600297100842e-05
findings O 0 6.449608463299228e-06
demonstrated O 0 9.840111488301773e-06
that O 0 9.801316309676622e-07
deletions O 0 6.780428066122113e-06
and O 0 1.8389148408459732e-06
duplications O 0 1.4239191841625143e-05
that O 0 8.616304967290489e-07
were O 0 2.1072478375572246e-06
localized O 0 5.154893187864218e-06
in O 0 2.8802562610508176e-06
the O 0 4.696616997534875e-06
distal O 0 0.000743069511372596
part O 0 7.96245876699686e-06
of O 0 4.1605062506278045e-06
the O 0 4.473583885555854e-06
gene O 0 4.134148639423074e-06
seemed O 0 5.495628101925831e-06
to O 0 6.634282954109949e-07
be O 0 8.890706340025645e-07
preferentially O 0 2.447843826303142e-06
associated O 0 3.0403928121813806e-06
with O 0 5.745712314819684e-06
cognitive B-Disease 1 0.9221615195274353
impairment I-Disease 1 0.9999502897262573
. O 0 0.002637329511344433

Two O 0 0.00010094726167153567
altered O 0 0.00012624359806068242
Dp71 O 0 0.00036849002935923636
transcripts O 0 4.830380203202367e-05
and O 0 5.516626515600365e-06
two O 0 2.4029814085224643e-06
deleted O 0 1.68084297911264e-05
Dp140 O 0 4.3277250370010734e-05
DNA O 0 3.916075456800172e-06
sequences O 0 1.476076249673497e-06
were O 0 1.5376085684692953e-06
found O 0 1.091524723051407e-06
in O 0 1.437397600057011e-06
four O 0 3.2039954476204002e-06
patients O 0 1.996919854718726e-05
with O 0 8.379219798371196e-05
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.9948652386665344

These O 0 3.562504571164027e-05
findings O 0 2.7967245841864496e-05
suggest O 0 1.371883899992099e-05
that O 0 1.524662593510584e-06
some O 0 1.206563297273533e-06
sequences O 0 1.6576955204072874e-06
located O 0 6.985993422858883e-06
in O 0 2.1836726773472037e-06
the O 0 3.4817628602468176e-06
distal O 0 0.0001433850557077676
part O 0 8.227302714658435e-06
of O 0 3.923226358892862e-06
the O 0 3.541252908689785e-06
gene O 0 2.6743095986603294e-06
and O 0 1.027007328957552e-06
, O 0 9.432874890080711e-07
in O 0 5.071584041616006e-07
particular O 0 1.212138499795401e-06
, O 0 1.2832180118493852e-06
some O 0 1.4521708635584218e-06
DMD B-Disease 1 0.9991397857666016
isoforms O 0 2.8028148335579317e-06
expressed O 0 2.4252581170003396e-06
in O 0 1.0530891358939698e-06
the O 0 2.903048198277247e-06
brain O 0 0.00024478044360876083
may O 0 2.1751511667389423e-06
be O 0 6.184769745232188e-07
related O 0 7.234990562210442e-07
to O 0 8.530431045983278e-07
the O 0 5.698726454284042e-06
cognitive B-Disease 0 0.13540995121002197
impairment I-Disease 1 0.9992607235908508
associated O 0 0.0001728745992295444
with O 0 0.0016055636806413531
DMD B-Disease 1 1.0
. O 0 0.00010325885523343459
. O 0 0.00010658995597623289

I1307K O 0 0.08834902942180634
APC O 0 0.004602209199219942
and O 0 4.8167457862291485e-05
hMLH1 O 0 0.0002450760512147099
mutations O 0 1.5987829101504758e-05
in O 0 5.832170700159622e-06
a O 0 1.3439633221423719e-05
non O 0 1.891183273983188e-05
- O 0 1.3020780897932127e-05
Jewish O 0 7.092176929290872e-06
family O 0 3.278690201113932e-06
with O 0 2.590453050288488e-06
hereditary B-Disease 1 0.9999500513076782
non I-Disease 1 0.9999895095825195
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9908728003501892

We O 0 5.6718829000601545e-05
describe O 0 3.072451363550499e-05
a O 0 1.764959051797632e-05
French O 0 3.715487036970444e-05
Canadian O 0 5.993860031594522e-05
hereditary B-Disease 1 0.9999189376831055
non I-Disease 1 0.9999052286148071
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999998807907104
HNPCC B-Disease 1 1.0
) O 0 0.0009848562767729163
kindred O 0 0.00037948816316202283
which O 0 2.324392198715941e-06
carries O 0 4.6059340093052015e-06
a O 0 6.54886298434576e-06
novel O 0 1.2507419342000503e-05
truncating O 0 5.0065264076692984e-05
mutation O 0 1.6508251064806245e-05
in O 0 2.3256661734194495e-05
hMLH1 O 0 0.0010779040167108178
. O 0 9.333014895673841e-05

Interestingly O 0 0.000547584961168468
, O 0 5.608299397863448e-05
the O 0 3.049990118597634e-05
I1307K O 0 0.018266109749674797
APC O 0 0.00036961655132472515
polymorphism O 0 1.5558251106995158e-05
, O 0 2.8018446300848154e-06
associated O 0 1.10266330466402e-06
with O 0 3.6020276183990063e-07
an O 0 7.519857376792061e-07
increased O 0 9.18006662686821e-06
risk O 0 8.82634412846528e-05
of O 1 0.9974076151847839
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.0009748608572408557
is O 0 4.482945769268554e-06
also O 0 1.1851529961859342e-06
present O 0 1.359873294859426e-06
in O 0 2.304513827766641e-06
this O 0 5.400209374784026e-06
family O 0 4.7724588512210175e-05
. O 0 7.404403731925413e-05

The O 0 0.0002862653345800936
I1307K O 0 0.0019319170387461782
polymorphism O 0 7.94244188000448e-05
has O 0 7.513078799092909e-06
previously O 0 3.911133717338089e-06
only O 0 6.970959134378063e-07
been O 0 1.111042479351454e-06
identified O 0 1.36582593768253e-06
in O 0 1.0346360568291857e-06
individuals O 0 6.713971174576727e-07
of O 0 1.0869222933251876e-05
self O 0 0.00017471000319346786
- O 0 0.0002153483801521361
reported O 0 1.7571162970853038e-05
Ashkenazi O 0 7.681496208533645e-05
Jewish O 0 3.9390564779751e-05
origins O 0 0.00011583336890907958
. O 0 8.772205910645425e-05

In O 0 8.56932601891458e-05
addition O 0 2.822120768541936e-05
, O 0 8.163137863448355e-06
in O 0 3.188668642906123e-06
this O 0 1.8746545720205177e-06
family O 0 5.456829512695549e-06
, O 0 1.4309036941995146e-06
there O 0 1.2077146038791398e-06
appears O 0 1.932547320393496e-06
to O 0 4.7239100808837975e-07
be O 0 5.879241484763043e-07
no O 0 9.257495321435272e-07
relationship O 0 2.4660571398271713e-06
between O 0 3.3443420761614107e-06
the O 0 5.455976406665286e-06
I1307K O 0 0.00016560476797167212
polymorphism O 0 6.923429737071274e-06
and O 0 9.505362186246202e-07
the O 0 1.2423755606505438e-06
presence O 0 3.2965615446300944e-06
or O 0 1.1741987009372679e-06
absence O 0 1.807066291803494e-05
of O 0 0.0001295279071200639
cancer B-Disease 1 0.9998641014099121
. O 0 5.0325135816819966e-05
. O 0 6.618524639634416e-05

Identification O 0 0.00010992079478455707
of O 0 4.168103987467475e-05
a O 0 3.223349995096214e-05
novel O 0 1.919601891131606e-05
mutation O 0 3.350167844473617e-06
of O 0 4.0740355871093925e-06
the O 0 1.1103687938884832e-05
CPO O 0 0.002416277304291725
gene O 0 3.2825009839143604e-06
in O 0 1.6735369854359305e-06
a O 0 8.798867384030018e-06
Japanese O 0 0.0004799107264261693
hereditary B-Disease 1 0.9998821020126343
coproporphyria I-Disease 1 0.9999474287033081
family O 0 0.0007179127424024045
. O 0 0.00011842468666145578

Hereditary B-Disease 1 0.9999924898147583
coproporphyria I-Disease 1 0.9999942779541016
( O 1 0.8316187262535095
HCP B-Disease 1 0.9999974966049194
) O 0 2.5735887902555987e-05
is O 0 7.013215054030297e-06
an O 0 1.1304515282972716e-05
autosomal B-Disease 1 0.9993950128555298
dominant I-Disease 1 0.999996542930603
disease I-Disease 1 0.9999998807907104
characterized O 1 0.8862659335136414
by O 0 1.7209322322742082e-05
a O 0 0.039745308458805084
deficiency B-Disease 1 0.9999998807907104
of I-Disease 1 0.8479869961738586
coproporphyrinogen I-Disease 1 0.9999969005584717
oxidase I-Disease 0 0.0005606413469649851
( O 0 2.007496186706703e-05
CPO O 0 0.00026031225570477545
) O 0 2.444985966576496e-06
caused O 0 4.254061877873028e-06
by O 0 1.2584403066284722e-06
a O 0 6.279665285546798e-06
mutation O 0 6.008821856084978e-06
in O 0 5.819664238515543e-06
the O 0 4.0080507460515946e-05
CPO O 0 0.03386542573571205
gene O 0 7.480925705749542e-05
. O 0 5.761153079220094e-05

Only O 0 6.77106945659034e-05
11 O 0 3.279420707258396e-05
mutations O 0 8.396085831918754e-06
of O 0 6.8911845119146165e-06
the O 0 6.986892913118936e-06
gene O 0 3.584930936995079e-06
have O 0 7.622835482834489e-07
been O 0 2.559880840635742e-06
reported O 0 7.68201698519988e-06
in O 0 1.831511690397747e-05
HCP B-Disease 1 0.999984622001648
patients O 0 0.0021679147612303495
. O 0 0.00020381352805998176

We O 0 5.408292781794444e-05
report O 0 2.2532181901624426e-05
another O 0 1.9762490410357714e-05
mutation O 0 1.424598212906858e-05
in O 0 9.154486178886145e-06
a O 0 3.378561814315617e-05
Japanese O 0 0.0005353517481125891
family O 0 0.00020088520250283182
. O 0 0.00020642048912122846

Polymerase O 0 0.0031379293650388718
chain O 0 0.00035374765866436064
reaction O 0 5.865309140062891e-05
- O 0 7.148550503188744e-05
single O 0 9.688332283985801e-06
strand O 0 1.7651846064836718e-05
conformational O 0 5.17699891133816e-06
polymorphism O 0 4.175964932073839e-06
and O 0 6.728412245138315e-07
direct O 0 7.027054493846663e-07
sequence O 0 9.756365670909872e-07
analyses O 0 1.1676338544930331e-06
demonstrated O 0 4.128120508539723e-06
a O 0 3.1112797387322644e-06
C O 0 1.2691158190136775e-05
to O 0 2.429042751828092e-06
T O 0 1.4551302228937857e-05
substitution O 0 3.116503421551897e-06
in O 0 1.8283352574144374e-06
exon O 0 1.4408945389732253e-05
1 O 0 4.944641204929212e-06
of O 0 3.339408294777968e-06
the O 0 3.614788056438556e-06
CPO O 0 3.103673589066602e-05
gene O 0 1.120012598221365e-06
at O 0 2.01507145902724e-06
nucleotide O 0 2.126322669937508e-06
position O 0 1.6410832586188917e-06
85 O 0 2.3807388060959056e-06
, O 0 1.0232512295260676e-06
which O 0 6.1324510625127e-07
lies O 0 4.815010015590815e-06
in O 0 9.438040251552593e-07
the O 0 4.206173343845876e-06
putative O 0 5.688805686077103e-05
presequence O 0 9.343647252535447e-05
for O 0 4.137927589908941e-06
targeting O 0 1.4860217561363243e-05
to O 0 1.284293375647394e-05
mitochondria O 0 9.365144796902314e-05
. O 0 8.425097621511668e-05

This O 0 3.907680365955457e-05
mutation O 0 1.92837615031749e-05
changes O 0 5.37479763806914e-06
the O 0 3.872309662256157e-06
codon O 0 4.849928245675983e-06
for O 0 1.5027967492642347e-06
glutamine O 0 3.743002253031591e-06
to O 0 1.1751048987207469e-06
a O 0 2.4440603283437667e-06
termination O 0 7.553591331088683e-06
codon O 0 7.734907740086783e-06
at O 0 9.623100595490541e-06
amino O 0 9.25045878830133e-06
acid O 0 1.4971511518524494e-05
position O 0 4.87706383864861e-05
29 O 0 0.0001777049619704485
. O 0 0.00013805502385366708

MaeI O 0 0.003646901808679104
restriction O 0 9.635824972065166e-05
analysis O 0 1.7025802662828937e-05
showed O 0 2.200695962528698e-05
two O 0 1.993499154195888e-06
other O 0 1.9339115624461556e-06
carriers O 0 7.222772183013149e-06
in O 0 6.0563238548638765e-06
the O 0 3.302040931885131e-05
family O 0 0.0001693269150564447
. O 0 0.00013170925376471132

The O 0 0.00037125693052075803
C O 1 0.8656976819038391
- O 0 0.1377319097518921
T O 0 0.010000097565352917
mutation O 0 7.2994344009202905e-06
is O 0 3.753493501790217e-06
located O 0 7.557366643595742e-06
within O 0 1.317670012213057e-06
a O 0 2.7798153041658225e-06
recently O 0 5.376448370952858e-06
proposed O 0 3.712195621119463e-06
putative O 0 1.1580132195376791e-05
alternative O 0 3.7749930470454274e-06
translation O 0 5.5760142458893824e-06
initiation O 0 1.555064409330953e-05
codon O 0 1.4925294635759201e-05
( O 0 7.730585821263958e-06
TIC O 0 0.0006411630311049521
- O 0 8.234069355239626e-06
1 O 0 5.481385414896067e-06
) O 0 1.1977082294833963e-06
, O 0 7.393987289106008e-07
supporting O 0 1.6280482668662444e-06
that O 0 1.1085435289714951e-06
TIC O 0 0.04238824173808098
- O 0 8.414650437771343e-06
1 O 0 8.294107828987762e-06
is O 0 2.052341642411193e-06
the O 0 1.4142466397970566e-06
real O 0 1.2225346836203244e-05
TIC O 0 0.01685713604092598
rather O 0 2.800624088195036e-06
than O 0 3.7358340705395676e-06
TIC O 0 0.0681372880935669
- O 0 5.1012906624237075e-05
2 O 0 3.103957715211436e-05
. O 0 1.4734976502950303e-05
. O 0 4.018081017420627e-05

Human B-Disease 0 0.00012874721141997725
complement I-Disease 0 0.0002871197648346424
factor I-Disease 1 0.771549642086029
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 1 0.8936794400215149
with O 1 0.999940037727356
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999715089797974

This O 0 4.3941850890405476e-05
study O 0 1.7987893443205394e-05
reports O 0 7.297409410966793e-06
on O 0 6.9853335844527464e-06
six O 0 3.274628397775814e-06
cases O 0 1.8812309008353623e-06
of O 0 9.426051110494882e-05
deficiency B-Disease 1 0.9999998807907104
in I-Disease 0 2.7836626031785272e-05
the I-Disease 0 7.562384325865423e-06
human I-Disease 0 1.7004085748340003e-06
complement I-Disease 0 2.9420843929983675e-06
regulatory I-Disease 0 3.7234915453154827e-06
protein I-Disease 0 6.379698788805399e-06
Factor I-Disease 0 1.8690689103095792e-05
H I-Disease 0 0.29800379276275635
( O 0 8.482248631480616e-06
FH O 0 0.0005167429335415363
) O 0 1.8106192101186025e-06
in O 0 9.173223816105747e-07
the O 0 1.3373612546274671e-06
context O 0 1.9239651010138914e-06
of O 0 5.828228495374788e-06
an O 0 0.004548330791294575
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9999239444732666

Five O 0 8.045527647482231e-05
of O 0 2.676555232028477e-05
the O 0 1.0581061360426247e-05
cases O 0 2.5901490516844206e-06
were O 0 2.2767726477468386e-06
observed O 0 1.7983699081014493e-06
in O 0 8.9253677515444e-07
children O 0 1.8278715288033709e-06
presenting O 0 2.1920979634160176e-05
with O 0 0.0214268509298563
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
HUS B-Disease 1 1.0
) O 0 0.27548518776893616
. O 0 0.0003337156376801431

Two O 0 3.314414425403811e-05
of O 0 3.34100732288789e-05
the O 0 1.9158384020556696e-05
children O 0 1.4222131540009286e-05
exhibited O 0 0.00023563855211250484
a O 0 0.00010831756662810221
homozygous O 1 0.8560683131217957
deficiency O 1 0.9999997615814209
characterized O 0 0.004634506534785032
by O 0 7.902816832938697e-06
the O 0 6.766752903786255e-06
absence O 0 1.192521540360758e-05
of O 0 5.773174962087069e-06
the O 0 4.647799869417213e-06
150 O 0 1.031411284202477e-05
- O 0 2.7311773010296747e-05
kD O 0 0.0001296942646149546
form O 0 2.099853418258135e-06
of O 0 4.775502475240501e-06
Factor O 0 4.236279710312374e-05
H O 0 0.3517260253429413
and O 0 1.1617889867920894e-06
the O 0 1.4743527572136372e-06
presence O 0 1.8833474086932256e-06
, O 0 1.2128739399486221e-06
upon O 0 1.7208577673955006e-06
immunoblotting O 0 3.050024861295242e-05
, O 0 1.2466138059608056e-06
of O 0 2.180276851504459e-06
the O 0 4.524267751548905e-06
42 O 0 3.754238423425704e-05
- O 0 5.720962872146629e-05
kD O 0 0.0008545608725398779
Factor O 0 3.897330680047162e-05
H O 0 0.003020857460796833
- O 0 1.7271453543798998e-05
like O 0 2.0585753190971445e-06
protein O 0 1.5406779994009412e-06
1 O 0 5.728854830522323e-06
( O 0 3.892625045409659e-06
FHL O 0 0.0001593619817867875
- O 0 9.352541383123025e-06
1 O 0 7.167152489273576e-06
) O 0 2.057778374364716e-06
and O 0 1.1333446536809788e-06
other O 0 1.1013191851816373e-06
FH O 0 0.01738072745501995
- O 0 3.068176738452166e-05
related O 0 6.642064363404643e-06
protein O 0 1.1645637641777284e-05
( O 0 1.0946419024548959e-05
FHR O 0 0.05562825873494148
) O 0 1.3419987226370722e-05
bands O 0 4.545830233837478e-05
. O 0 4.384047133498825e-05

Southern O 0 0.00028179591754451394
blot O 0 0.00017632600793149322
and O 0 6.591369583475171e-06
PCR O 0 8.572498700232245e-06
analysis O 0 1.5709348417658475e-06
of O 0 2.4600294636911713e-06
DNA O 0 2.9499371976271505e-06
of O 0 1.883922209344746e-06
one O 0 2.1437172108562663e-06
patient O 0 7.72189196140971e-06
with O 0 3.168818466292578e-06
homozygous O 0 0.0024753024335950613
deficiency O 1 0.9999957084655762
ruled O 0 8.24861490400508e-05
out O 0 2.696212050068425e-06
the O 0 2.6487546165299136e-06
presence O 0 1.6299063645419665e-06
of O 0 2.081437060041935e-06
a O 0 3.0571050047001336e-06
large O 0 3.0331498237501364e-06
deletion O 0 5.497022357303649e-06
of O 0 6.291996214713436e-06
the O 0 1.2792877896572463e-05
FH O 1 0.9991543292999268
gene O 0 5.166788923816057e-06
as O 0 2.023014076257823e-06
the O 0 4.186671958450461e-06
underlying O 0 0.0012142626801505685
defect O 0 0.0868227630853653
for O 0 1.9928145775338635e-05
the O 0 0.04176268354058266
deficiency O 1 1.0
. O 0 0.06646955013275146

The O 0 8.767923281993717e-05
other O 0 6.302469955699053e-06
four O 0 3.957825811085058e-06
children O 0 6.2699832596990746e-06
presented O 0 8.23329173726961e-06
with O 0 1.5101961253094487e-05
heterozygous O 0 0.05871657282114029
deficiency O 1 0.9999994039535522
and O 0 2.9116297810105607e-05
exhibited O 0 0.004086413886398077
a O 0 1.528707616671454e-05
normal O 0 9.438990673515946e-06
immunoblotting O 0 0.00015519176668021828
pattern O 0 3.852948339044815e-06
of O 0 4.874564638157608e-06
proteins O 0 2.5752724468475208e-06
of O 0 5.7986894717032555e-06
the O 0 3.6536956031341106e-05
FH O 1 0.9995587468147278
family O 0 0.00024108770594466478
. O 0 0.00012180944031570107

Factor B-Disease 1 0.9998217225074768
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
is O 0 2.196737659687642e-05
the O 0 1.0239336006634403e-05
only O 0 1.276118382520508e-05
complement B-Disease 1 0.9943301677703857
deficiency I-Disease 1 1.0
associated O 0 0.010016151703894138
with O 0 0.011269559152424335
HUS B-Disease 1 1.0
. O 0 0.001892591593787074

These O 0 1.5442596122738905e-05
observations O 0 1.852314562711399e-05
suggest O 0 1.3014933756494429e-05
a O 0 7.959369213494938e-06
role O 0 8.98936741577927e-06
for O 0 9.70365454122657e-06
FH O 1 0.9998542070388794
and O 0 2.1031617507105693e-05
/ O 0 0.01344272866845131
or O 0 1.651031016081106e-05
FH O 1 0.9990218877792358
receptors O 0 1.2770583452947903e-05
in O 0 4.943783096678089e-06
the O 0 1.448644616175443e-05
pathogenesis O 1 0.9996259212493896
of O 0 0.06958797574043274
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 0 0.0005795236211270094
. O 0 0.0002653830742929131

Further O 0 0.00014242451288737357
evidence O 0 3.922278483514674e-05
for O 0 1.029380382533418e-05
a O 0 1.4647342140960973e-05
major O 0 3.439958891249262e-05
ancient O 0 0.00023549413890577853
mutation O 0 0.32052189111709595
underlying O 1 0.9999997615814209
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 0.431597501039505
linkage O 1 0.9997801184654236
disequilibrium O 1 0.9952569603919983
studies O 0 8.200177035178058e-06
in O 0 3.2572982036072062e-06
the O 0 6.5414478740422055e-06
Japanese O 0 0.00010079614003188908
population O 0 1.5648458429495804e-05
. O 0 5.731321653001942e-05

The O 1 0.9852044582366943
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.999834418296814
DM B-Disease 1 1.0
) O 0 5.319643969414756e-05
mutation O 0 9.454739483771846e-06
is O 0 3.0705807603226276e-06
an O 0 5.598735697276425e-06
unstable O 0 0.0006244952674023807
( O 0 2.0930414393660612e-05
CTG O 0 0.3518288731575012
) O 0 4.5177007450547535e-06
n O 0 5.293952654028544e-06
repeat O 0 4.703008926298935e-06
, O 0 9.973815622288384e-07
present O 0 7.724498232164478e-07
at O 0 2.0896809473924804e-06
a O 0 2.318445694982074e-06
copy O 0 2.0643788047891576e-06
number O 0 4.1955425444939465e-07
of O 0 2.024120021815179e-06
5 O 0 1.1363468729541637e-05
- O 0 9.572065209795255e-06
37 O 0 5.4075221669336315e-06
repeats O 0 3.3104138310591225e-06
on O 0 1.3242117802292341e-06
normal O 0 9.319973628407752e-07
chromosomes O 0 9.545195780447102e-07
but O 0 5.24441361449135e-07
amplified O 0 3.7916693145234603e-06
to O 0 9.935671414496028e-07
50 O 0 5.409543973655673e-06
- O 0 1.5708534192526713e-05
3000 O 0 2.562582812970504e-05
copies O 0 1.3774883882433642e-05
on O 0 2.7430802219896577e-05
DM B-Disease 1 0.9998912811279297
chromosomes O 0 0.0002585807233117521
. O 0 0.0001430999836884439

Previous O 0 0.00011366351827746257
findings O 0 4.526066186372191e-05
in O 0 1.7877160644275136e-05
Caucasian O 0 0.000178004804183729
populations O 0 1.0185731298406608e-05
of O 0 1.9055394659517333e-05
a O 0 0.029910840094089508
DM B-Disease 1 1.0
founder O 1 0.999666690826416
chromosome O 0 5.041515396442264e-05
raise O 0 4.550321136775892e-06
a O 0 1.9994013200630434e-06
question O 0 1.6092945998025243e-06
about O 0 9.150961091108911e-07
the O 0 1.3313116369317868e-06
molecular O 0 3.2817310966493096e-06
events O 0 2.459682491462445e-06
involved O 0 5.1271376833028626e-06
in O 0 4.5633491936314385e-06
the O 0 9.639321433496661e-06
expansion O 0 0.00014458900841418654
mutation O 0 6.48331842967309e-05
. O 0 5.2321775001473725e-05

To O 0 6.0880876844748855e-05
investigate O 0 3.754309727810323e-05
whether O 0 1.4066243238630705e-05
a O 0 2.483254502294585e-05
founder O 0 0.000426145939854905
chromosome O 0 1.6465201042592525e-05
for O 0 3.896213002008153e-06
the O 0 3.0210423574317247e-05
DM B-Disease 1 1.0
mutation O 0 1.0753120477602351e-05
exists O 0 5.2967002375226e-06
in O 0 9.997881988965673e-07
the O 0 1.6653154943924164e-06
Japanese O 0 8.325251656060573e-06
population O 0 1.3462238257488934e-06
, O 0 8.722495294932742e-07
we O 0 4.891286948804918e-07
genotyped O 0 8.553096449759323e-06
families O 0 7.221038345051056e-07
using O 0 9.051061624631984e-07
polymorphic O 0 4.253048246027902e-06
markers O 0 7.500243100366788e-06
near O 0 1.374470411974471e-05
the O 0 4.402875674713869e-06
( O 0 6.665212822554167e-06
CTG O 0 0.0007705747848376632
) O 0 2.2651363451586803e-06
n O 0 6.51876052870648e-06
repeat O 0 1.220065496454481e-05
region O 0 1.7801370631786995e-05
and O 0 1.12394600364496e-05
constructed O 0 0.0002598827122710645
haplotypes O 0 0.00031565199606120586
. O 0 0.00011918872041860595

Six O 0 9.431249054614455e-05
different O 0 7.823374289728235e-06
haplotypes O 0 4.5917826355434954e-05
were O 0 1.267684820049908e-05
found O 0 1.0716563338064589e-05
and O 0 1.1054176866309717e-05
DM B-Disease 1 0.999997615814209
alleles O 0 3.054140688618645e-05
were O 0 1.6657137166475877e-05
always O 0 3.7146295653656125e-05
haplotype O 0 0.00019595719641074538
A O 0 0.00020190022769384086
. O 0 0.00014314120926428586

To O 0 4.435951268533245e-05
find O 0 9.794665857043583e-06
an O 0 1.5265306956280256e-06
origin O 0 1.4772267604712397e-06
of O 0 2.603150051072589e-06
the O 0 6.2464800976158585e-06
( O 0 1.3291183677210938e-05
CTG O 1 0.71868497133255
) O 0 2.133462430720101e-06
n O 0 3.264114639023319e-06
repeat O 0 4.1571820474928245e-06
mutation O 0 1.0976460771416896e-06
and O 0 5.750420086769736e-07
to O 0 4.5435288598127954e-07
investigate O 0 1.699029212431924e-06
the O 0 1.1205393093405291e-06
mechanism O 0 2.2275064566201763e-06
of O 0 1.6849664916662732e-06
the O 0 2.6275481559423497e-06
expansion O 0 1.0498349183762912e-05
mutation O 0 1.356192569801351e-06
in O 0 9.020694733408163e-07
the O 0 1.2063539998052875e-06
Japanese O 0 7.716759682807606e-06
population O 0 8.25079098376591e-07
we O 0 5.139829113431915e-07
have O 0 3.606712652981514e-07
studied O 0 4.52194672106998e-06
90 O 0 6.446386123570846e-06
Japanese O 0 5.616830458166078e-05
DM B-Disease 1 0.9994986057281494
families O 0 5.347786100173835e-06
comprising O 0 1.002471981337294e-05
190 O 0 7.938680937513709e-06
affected O 0 3.904976892954437e-06
and O 0 2.5990473204728914e-06
130 O 0 1.9833971236948855e-05
unaffected O 0 4.6159388148225844e-05
members O 0 1.9901726773241535e-05
. O 0 5.6881544878706336e-05

The O 0 7.299210119526833e-05
results O 0 1.3308545931067783e-05
suggest O 0 8.771103239268996e-06
that O 0 1.1495839089548099e-06
a O 0 3.4156830679421546e-06
few O 0 1.7687706304059247e-06
common O 0 2.4127384676830843e-06
ancestral O 0 7.02704128343612e-05
mutations O 0 3.382070190127706e-06
in O 0 2.4890371150831925e-06
both O 0 3.554245040504611e-06
Caucasian O 0 8.843319665174931e-05
and O 0 2.8603394639503676e-06
Japanese O 0 2.7010737539967522e-05
populations O 0 8.140081604324223e-07
have O 0 2.714981235385494e-07
originated O 0 1.3451394806907047e-06
by O 0 3.6625738175644074e-07
expansion O 0 4.159998297836864e-06
of O 0 1.8663811260921648e-06
an O 0 2.1845539777132217e-06
ancestral O 0 1.3981506526761223e-05
n O 0 6.481882337538991e-06
= O 0 4.5723490984528325e-06
5 O 0 2.305340331076877e-06
repeat O 0 3.1181621125142556e-06
to O 0 1.0088872386404546e-06
n O 0 3.1927677355270134e-06
= O 0 7.707647455390543e-06
19 O 0 1.580097887199372e-05
- O 0 1.380007597617805e-05
37 O 0 1.9478200556477532e-05
copies O 0 2.250842771900352e-05
. O 0 8.308643737109378e-05

These O 0 1.739926119626034e-05
data O 0 1.5867059119045734e-05
support O 0 7.93774233898148e-06
multistep O 0 3.873638343065977e-05
models O 0 7.417056167469127e-06
of O 0 8.63361401570728e-06
triplet O 0 9.484124893788248e-05
repeat O 0 1.5991809050319716e-05
expansion O 0 1.391304704156937e-05
that O 0 5.477699005496106e-07
have O 0 3.036475959561358e-07
been O 0 6.009578896737366e-07
proposed O 0 1.0214261010332848e-06
for O 0 9.13810595193354e-07
both O 0 5.495690857060254e-06
DM B-Disease 1 1.0
and O 0 0.00015921569138299674
Friedreichs B-Disease 1 0.9999666213989258
ataxia I-Disease 1 0.999923586845398
. O 0 0.0001010880951071158
. O 0 0.00016499085177201778

The O 0 8.124537271214649e-05
molecular O 0 7.38236412871629e-05
basis O 0 4.699565761256963e-05
of O 1 0.7695081830024719
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.00011723327043000609
the O 0 2.2378382709575817e-05
western O 0 2.0626765035558492e-05
Cape O 0 9.496224083704874e-05
, O 0 8.833137144392822e-06
South O 0 5.707067612092942e-05
Africa O 0 7.535039185313508e-05
. O 0 5.8208388509228826e-05

Deficiency B-Disease 1 0.9999915361404419
of I-Disease 0 0.00023523133131675422
the I-Disease 0 5.564789898926392e-05
sixth I-Disease 0 0.0026857657358050346
component I-Disease 0 3.973449202021584e-05
of I-Disease 0 6.3276197579398286e-06
human I-Disease 0 2.4062721877271542e-06
complement I-Disease 0 9.590457921149209e-06
( O 0 1.886848986032419e-05
C6 O 1 0.999953031539917
) O 0 2.947004304587608e-06
has O 0 1.0168163271373487e-06
been O 0 9.191263643515413e-07
reported O 0 1.5083805919857696e-06
in O 0 6.561344889632892e-07
a O 0 8.648873404126789e-07
number O 0 5.886596454729442e-07
of O 0 1.4607115872422582e-06
families O 0 1.1372824246791424e-06
from O 0 2.1558255411946448e-06
the O 0 3.385655418242095e-06
western O 0 1.7185227989102714e-05
Cape O 0 9.236808546120301e-05
, O 0 8.841530870995484e-06
South O 0 6.646961264777929e-05
Africa O 0 0.00011324711522320285
. O 0 7.812794501660392e-05

Meningococcal B-Disease 1 0.9999996423721313
disease I-Disease 1 0.9999991655349731
is O 0 0.00014615731197409332
endemic O 0 0.00014341992209665477
in O 0 7.704098607064225e-06
the O 0 5.8395116866449825e-06
Cape O 0 5.4300187912303954e-05
and O 0 9.58873442868935e-07
almost O 0 1.054205540640396e-06
all O 0 5.476267688209191e-07
pedigrees O 0 3.828776698355796e-06
of O 0 9.541723557049409e-06
total O 1 0.9980541467666626
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.8750040531158447
C6Q0 O 1 0.9999921321868896
) O 0 3.1287486308428925e-06
have O 0 4.242076556693064e-07
been O 0 1.1527334891070495e-06
ascertained O 0 5.6493554438930005e-06
because O 0 1.9230130874348106e-06
of O 0 1.8687695046537556e-05
recurrent O 1 0.9999948740005493
disease O 1 0.9999983310699463
. O 0 0.0012795024085789919

We O 0 6.764525460312143e-05
have O 0 5.736372258979827e-06
sequenced O 0 1.0309551726095378e-05
the O 0 2.570791593825561e-06
expressed O 0 2.7423357096267864e-06
exons O 0 7.926456419227179e-06
of O 0 3.625276121965726e-06
the O 0 6.720551482430892e-06
C6 O 1 0.9999648332595825
gene O 0 1.5279595118045108e-06
from O 0 7.603312042192556e-07
selected O 0 8.757227192290884e-07
cases O 0 2.8789634143322473e-07
and O 0 3.5253611940788687e-07
have O 0 2.218990431401835e-07
found O 0 3.698001478369406e-07
three O 0 6.938169008208206e-07
molecular O 0 3.417059269850142e-05
defects O 0 0.035869717597961426
leading O 0 2.133324960595928e-05
to O 0 2.2641427221969934e-06
total O 0 0.0007373972912319005
deficiency O 1 1.0
879delG O 1 0.9959779977798462
, O 0 4.647170499083586e-06
which O 0 8.117839911392366e-07
is O 0 7.50391052406485e-07
the O 0 1.3809615211357595e-06
common O 0 4.270325462130131e-06
defect O 0 0.0013071210123598576
in O 0 5.578940090344986e-06
the O 0 8.388146852666978e-06
Cape O 0 0.0011358991032466292
and O 0 3.916657988156658e-06
hitherto O 0 4.116294803679921e-05
unreported O 0 1.1178005479450803e-05
, O 0 1.7716760112307384e-06
and O 0 1.145587020801031e-06
1195delC O 0 4.7010988055262715e-05
and O 0 2.5402500796189997e-06
1936delG O 0 3.173093864461407e-05
, O 0 1.5002464124336257e-06
which O 0 3.7870333358114294e-07
have O 0 3.1880406936579675e-07
been O 0 9.555942597216927e-07
previously O 0 2.1137750536581734e-06
reported O 0 2.4544615371269174e-06
in O 0 5.683594736183295e-06
African O 0 4.9821224820334464e-05
- O 0 0.00022031184926163405
Americans O 0 8.281890768557787e-05
. O 0 8.83891771081835e-05

We O 0 4.9215701437788084e-05
also O 0 1.388366217724979e-05
show O 0 6.901543201820459e-06
that O 0 1.0082832204716397e-06
the O 0 4.1397547647648025e-06
879delG O 0 0.00018042373994830996
and O 0 4.9379309530195314e-06
1195delC O 1 0.8524647951126099
defects O 0 0.22326292097568512
are O 0 7.138027626751864e-07
associated O 0 2.044328766714898e-06
with O 0 4.482560598262353e-06
characteristic O 1 0.9897552132606506
C6 O 1 1.0
/ O 1 0.9999825954437256
C7 O 1 0.9999929666519165
region O 0 6.0571466747205704e-05
DNA O 0 3.193633892806247e-05
marker O 0 4.156655995757319e-05
haplotypes O 0 2.831836900440976e-05
, O 0 3.40797805620241e-06
although O 0 2.4471062261000043e-06
small O 0 2.6197865281574195e-06
variations O 0 4.5578740355267655e-06
were O 0 7.487521543225739e-06
observed O 0 3.4117776522180066e-05
. O 0 5.2694518672069535e-05

The O 0 0.0004974213661625981
1936delG O 1 0.9466251730918884
defect O 1 0.8938741683959961
was O 0 0.0002580017317086458
observed O 0 7.957661182445008e-06
only O 0 1.7578518054506276e-06
once O 0 3.4032168514386285e-06
in O 0 1.3704514003620716e-06
the O 0 2.5867498152365442e-06
Cape O 0 3.616945105022751e-05
, O 0 1.893271701192134e-06
but O 0 4.111977602860861e-07
its O 0 6.545089945575455e-07
associated O 0 2.498016328900121e-06
haplotype O 0 1.0698315236368217e-05
could O 0 3.9363249015877955e-06
be O 0 4.167824954492971e-06
deduced O 0 9.839938866207376e-05
. O 0 6.831203791080043e-05

The O 0 9.83139470918104e-05
data O 0 2.9954184356029145e-05
from O 0 7.864938197599258e-06
the O 0 5.3529497563431505e-06
haplotypes O 0 1.1653149158519227e-05
indicate O 0 3.856616785924416e-06
that O 0 6.761939062016609e-07
these O 0 2.8018050102218695e-07
three O 0 1.1670738331304165e-06
molecular O 0 1.5585012079100125e-05
defects O 0 0.00016043502546381205
account O 0 1.9872163647960406e-06
for O 0 1.181019001705863e-06
the O 0 7.248067959153559e-06
defects O 0 0.004881387576460838
in O 0 3.2186064800043823e-06
all O 0 1.0301404245183221e-06
the O 0 5.294892162055476e-06
38 O 0 2.5920769985532388e-05
unrelated O 0 2.6485617127036676e-05
C6Q0 O 0 0.41778305172920227
individuals O 0 1.6358144421246834e-06
we O 0 1.1500575283207581e-06
have O 0 7.45015938719007e-07
studied O 0 8.810674444248434e-06
from O 0 4.0719728531257715e-06
the O 0 1.8654878658708185e-05
Cape O 0 0.0010848958045244217
. O 0 0.0001226401946041733

We O 0 5.502133353729732e-05
have O 0 6.508169462904334e-06
also O 0 5.512740244739689e-06
observed O 0 6.08342679697671e-06
the O 0 8.394476026296616e-06
879delG O 0 0.0004448489344213158
defect O 0 0.0002847467258106917
in O 0 1.1255313438596204e-05
two O 0 1.480273567722179e-05
Dutch O 1 0.9999194145202637
C6 B-Disease 1 1.0
- I-Disease 1 0.9999446868896484
deficient I-Disease 1 0.999972939491272
kindreds O 0 0.00015816451923456043
, O 0 3.004567361131194e-06
but O 0 8.14941017779347e-07
the O 0 3.2109912808664376e-06
879delG O 0 0.002270108088850975
defect O 0 0.0021173469722270966
in O 0 5.873693680769065e-06
the O 0 1.0411178664071485e-05
Cape O 0 0.00029777357121929526
probably O 0 5.9532708291953895e-06
did O 0 1.3745141131948913e-06
not O 0 3.2205213074121275e-07
come O 0 1.0270994152961066e-06
from O 0 2.2359558897733223e-06
The O 0 9.6987969300244e-06
Netherlands O 0 6.420843419618905e-05
. O 0 2.667766239028424e-05
. O 0 8.064945723162964e-05

Complement B-Disease 1 0.9999830722808838
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 5.778804552392103e-05
seven O 0 1.8087008356815204e-05
further O 0 1.131578756030649e-05
molecular O 0 7.727105548838153e-05
defects O 0 0.0026962982956320047
and O 0 3.3667295156192267e-06
their O 0 3.524908152030548e-06
associated O 0 1.7304591892752796e-05
marker O 0 0.0011862998362630606
haplotypes O 0 0.00055221829097718
. O 0 0.00011589314817683771

Seven O 0 0.00011638786236289889
further O 0 3.447535709710792e-05
molecular O 0 2.903726817748975e-05
bases O 0 3.4605167456902564e-05
of O 0 0.4139871299266815
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 8.515059016644955e-05
described O 0 0.00025806351914070547
. O 0 0.0001464051747461781

All O 0 3.396228566998616e-05
these O 0 5.055285328126047e-06
new O 0 5.660745955538005e-06
molecular O 0 4.6338576794369146e-05
defects O 0 0.0020654378458857536
involve O 0 1.0140100130229257e-05
single O 0 1.1470692697912455e-05
- O 0 2.8188072974444367e-05
nucleotide O 0 4.641669875127263e-06
events O 0 2.5464498776273103e-06
, O 0 1.225258984050015e-06
deletions O 0 2.0831109850405483e-06
and O 0 9.869592076938716e-07
substitutions O 0 1.937851493494236e-06
, O 0 6.75253772897122e-07
some O 0 2.07952922437471e-07
of O 0 8.567494091948902e-07
which O 0 7.064973033266142e-07
alter O 0 3.094032308581518e-06
splice O 0 9.145341209659819e-06
sites O 0 2.1363944142649416e-06
, O 0 1.727499125081522e-06
and O 0 1.9341957795404596e-06
others O 0 6.09175776844495e-06
codons O 0 4.0572514990344644e-05
. O 0 4.640694533009082e-05

They O 0 2.46955496550072e-05
are O 0 4.170452939433744e-06
distributed O 0 3.403878963581519e-06
along O 0 5.806408807984553e-06
the O 0 9.498262443230487e-06
C7 O 1 0.9989653825759888
gene O 0 7.2240941335621756e-06
, O 0 1.681543949416664e-06
but O 0 7.338686032198893e-07
predominantly O 0 2.58214345194574e-06
towards O 0 6.078236310713692e-06
the O 0 4.3789445953734685e-06
3 O 0 3.4327102184761316e-05
end O 0 8.11074351076968e-05
. O 0 8.034165512071922e-05

All O 0 4.565018025459722e-05
were O 0 1.9185736164217815e-05
found O 0 1.203902684210334e-05
in O 0 1.3300298633112106e-05
compound O 0 5.546220927499235e-05
heterozygous O 0 3.352977000758983e-05
individuals O 0 2.249741919513326e-05
. O 0 9.975618013413623e-05

The O 0 0.004313814919441938
C6 O 1 1.0
/ O 1 0.9999940395355225
C7 O 1 0.9999992847442627
marker O 1 0.5865275859832764
haplotypes O 0 9.187246178044006e-05
associated O 0 5.101433998788707e-06
with O 0 3.6373726288729813e-06
most O 0 2.4489940187777393e-05
C7 B-Disease 1 0.9999998807907104
defects I-Disease 1 0.9953951239585876
are O 0 6.170280812511919e-06
tabulated O 0 7.60066686780192e-05
. O 0 3.0774044716963544e-05
. O 0 6.50522270007059e-05

A O 0 0.0010055365273728967
genome O 0 0.00023422000231221318
- O 0 5.092677383800037e-05
wide O 0 1.8495589756639674e-05
search O 0 7.967579222167842e-06
for O 0 4.194725079287309e-06
chromosomal O 0 0.0003049407678190619
loci O 0 9.725404379423708e-05
linked O 0 8.675795834278688e-05
to O 0 1.3626873624161817e-05
mental O 1 0.9999854564666748
health O 0 0.3413437306880951
wellness O 0 0.36198052763938904
in O 0 7.321563316509128e-06
relatives O 0 8.312478712468874e-06
at O 0 1.47430291690398e-05
high O 0 3.623089651227929e-05
risk O 0 5.0182232371298596e-05
for O 0 0.0013863154454156756
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 1 0.9195452928543091
the O 0 0.0026069048326462507
Old O 0 0.19421549141407013
Order O 0 5.323774166754447e-05
Amish O 0 0.00023171403154265136
. O 0 4.099911166122183e-05

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9999994039535522
BPAD B-Disease 1 1.0
; O 1 0.9999626874923706
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 0.0339960902929306
is O 0 1.1642351637419779e-05
characterized O 0 7.5045068115286995e-06
by O 0 1.3336015172171756e-06
episodes O 0 7.933095730550122e-06
of O 0 8.426439308095723e-05
mania B-Disease 1 0.9999988079071045
and O 0 4.30828113167081e-05
/ O 1 0.8357526063919067
or O 0 2.2973927116254345e-05
hypomania B-Disease 1 0.9999681711196899
interspersed O 0 0.00012553295528050512
with O 0 4.576009359880118e-06
periods O 0 5.3532457968685776e-05
of O 0 0.0003102482296526432
depression B-Disease 1 0.9999973773956299
. O 0 0.0008594589307904243

Compelling O 0 0.00024072661472018808
evidence O 0 5.618095019599423e-05
supports O 0 1.5702691598562524e-05
a O 0 5.891555701964535e-06
significant O 0 5.96167365074507e-06
genetic O 0 8.209182851715013e-06
component O 0 1.1730038750101812e-05
in O 0 2.1032685708632926e-06
the O 0 3.659686626633629e-06
susceptibility O 0 7.076925976434723e-05
to O 0 1.9443252313067205e-05
develop O 0 0.000489740923512727
BPAD B-Disease 1 0.9999974966049194
. O 0 0.00033432416967116296

To O 0 3.518800076562911e-05
date O 0 3.531177208060399e-05
, O 0 1.2054490071022883e-05
however O 0 4.982362497685244e-06
, O 0 3.2819937132444466e-06
linkage O 0 2.488042628101539e-05
studies O 0 2.3703989882051246e-06
have O 0 3.9588422851011273e-07
attempted O 0 2.757020411081612e-06
only O 0 4.5634092771251744e-07
to O 0 4.901841066384804e-07
identify O 0 2.367922888879548e-06
chromosomal O 0 3.521811595419422e-05
loci O 0 1.3323988241609186e-05
that O 0 1.7236762914762949e-06
cause O 0 6.623632089031162e-06
or O 0 1.8993645198861486e-06
increase O 0 2.1370544800447533e-06
the O 0 4.739848918688949e-06
risk O 0 1.933322346303612e-05
of O 0 3.636406108853407e-05
developing O 0 0.0035329521633684635
BPAD B-Disease 1 0.9999995231628418
. O 0 0.0001999940286623314

To O 0 2.0100591427762993e-05
determine O 0 6.868935543025145e-06
whether O 0 4.262362836016109e-06
there O 0 3.2432690204586834e-06
could O 0 1.291944840886572e-06
be O 0 9.671452971815597e-07
protective O 0 6.142240636108909e-06
alleles O 0 1.5802748976057046e-06
that O 0 7.322187798308732e-07
prevent O 0 2.4623791432532016e-06
or O 0 1.0479845968802692e-06
reduce O 0 2.45557612288394e-06
the O 0 3.087326604145346e-06
risk O 0 6.517815563711338e-06
of O 0 1.427347888238728e-05
developing O 0 0.0007594577036798
BPAD B-Disease 1 0.9999978542327881
, O 0 1.9946762677136576e-06
similar O 0 4.5109146640243125e-07
to O 0 3.638132000105543e-07
what O 0 2.1488474999387108e-07
is O 0 4.600284171374369e-07
observed O 0 4.0835746517586813e-07
in O 0 4.350617075488117e-07
other O 0 1.794330273696687e-06
genetic B-Disease 1 0.9999990463256836
disorders I-Disease 1 1.0
, O 0 0.001717787585221231
we O 0 3.6198591715219663e-06
used O 0 5.669628080795519e-06
mental O 1 0.9999841451644897
health O 1 0.9303392767906189
wellness O 1 0.9985306262969971
( O 0 1.0031395504483953e-05
absence O 0 1.81481555046048e-05
of O 0 8.517599781043828e-06
any O 0 1.5724001059425063e-05
psychiatric B-Disease 1 0.9999998807907104
disorder I-Disease 1 1.0
) O 0 0.0006121023325249553
as O 0 1.1105911653430667e-05
the O 0 5.60487387701869e-06
phenotype O 0 1.0727810149546713e-05
in O 0 2.746853397184168e-06
our O 0 4.064338099851739e-06
genome O 0 1.5419936971738935e-05
- O 0 1.588313898537308e-05
wide O 0 1.2092902579752263e-05
linkage O 0 3.176278551109135e-05
scan O 0 6.541060884046601e-06
of O 0 3.768255737668369e-06
several O 0 3.1489903449255507e-06
large O 0 1.1342290235916153e-05
multigeneration O 0 0.00043257829383946955
Old O 0 3.3728923881426454e-05
Order O 0 6.580441095138667e-06
Amish O 0 2.1432679204735905e-05
pedigrees O 0 1.0357898645452224e-05
exhibiting O 0 9.176110324915498e-06
an O 0 4.4914017962582875e-06
extremely O 0 2.580472755653318e-05
high O 0 8.510300540365279e-05
incidence O 0 0.006218309514224529
of O 0 0.0024817148223519325
BPAD B-Disease 1 0.9999998807907104
. O 0 0.0005383877432905138

We O 0 5.243285704636946e-05
have O 0 4.793356765731005e-06
found O 0 4.907668426312739e-06
strong O 0 2.7038493044528877e-06
evidence O 0 1.8070104488288052e-06
for O 0 1.3340199984668288e-06
a O 0 4.013942088931799e-06
locus O 0 1.264029287995072e-05
on O 0 6.72519308864139e-06
chromosome O 0 4.06977633247152e-05
4p O 0 0.21348163485527039
at O 0 2.6388275728095323e-05
D4S2949 O 0 8.689805690664798e-05
( O 0 5.105069703859044e-06
maximum O 0 1.9162183889420703e-05
GENEHUNTER O 0 0.001327713136561215
- O 0 1.970764969883021e-05
PLUS O 0 2.1839101464138366e-05
nonparametric O 0 2.3588965632370673e-05
linkage O 0 1.180219987872988e-05
score O 0 3.7231225178402383e-06
= O 0 4.364356755104382e-06
4 O 0 2.758753680609516e-06
. O 0 7.963932375787408e-07
05 O 0 2.0142617358942516e-05
, O 0 1.8280562699146685e-06
P O 0 1.8590995750855654e-05
= O 0 3.5112263958581025e-06
5 O 0 2.0129355107201263e-06
. O 0 5.758910219810787e-07
22 O 0 1.8527045995142544e-06
x O 0 2.280129820064758e-06
10 O 0 1.7612985629966715e-06
( O 0 2.4576236228313064e-06
- O 0 7.600965091114631e-06
4 O 0 7.812004696461372e-06
) O 0 3.151631290165824e-06
; O 0 1.747827127474011e-06
SIBPAL O 0 0.00013896211748942733
Pempirical O 0 5.318847615853883e-05
value O 0 3.9135666156653315e-06
< O 0 1.373309441987658e-05
3 O 0 4.595294740283862e-06
x O 0 4.667869234253885e-06
10 O 0 2.3941129256854765e-06
( O 0 2.2183480723469984e-06
- O 0 6.335185389616527e-06
5 O 0 3.394870191186783e-06
) O 0 1.5663690646761097e-06
) O 0 7.603109111187223e-07
and O 0 3.7753568449261365e-07
suggestive O 0 1.6113013998619863e-06
evidence O 0 9.415511499355489e-07
for O 0 4.666368624839379e-07
a O 0 2.3017726107354974e-06
locus O 0 1.1957659808103926e-05
on O 0 6.380757440638263e-06
chromosome O 0 4.205129880574532e-05
4q O 0 9.300533565692604e-05
at O 0 2.0161585780442692e-05
D4S397 O 0 6.791063788114116e-05
( O 0 7.141116839193273e-06
maximum O 0 2.0192526790197007e-05
GENEHUNTER O 0 0.001261664554476738
- O 0 4.529935176833533e-05
PLUS O 0 2.9082635592203587e-05
nonparametric O 0 2.3707385480520315e-05
linkage O 0 1.5122035620152019e-05
score O 0 4.44989700554288e-06
= O 0 4.6947275222919416e-06
3 O 0 3.2405359888798557e-06
. O 0 8.412776537625177e-07
29 O 0 5.089121259516105e-06
, O 0 2.1511962131626206e-06
P O 0 1.852982495620381e-05
= O 0 3.970123543695081e-06
2 O 0 2.9138129775674315e-06
. O 0 6.004978558848961e-07
57 O 0 2.3494571905757766e-06
x O 0 2.33824744100275e-06
10 O 0 2.072120651064324e-06
( O 0 1.6907661120058037e-06
- O 0 4.267829353921115e-06
3 O 0 4.7227931645466015e-06
) O 0 1.6369380091418861e-06
; O 0 9.332711101706082e-07
SIBPAL O 0 6.156530434964225e-05
Pempirical O 0 1.866806451289449e-05
value O 0 1.672011876507895e-06
< O 0 7.428432127198903e-06
1 O 0 3.8055113691370934e-06
x O 0 3.995986844529398e-06
10 O 0 1.8611482346386765e-06
( O 0 2.1822029339091387e-06
- O 0 5.084779331809841e-06
3 O 0 3.6694439131679246e-06
) O 0 1.1897212743861019e-06
) O 0 6.380486752277648e-07
that O 0 1.9162162345764955e-07
are O 0 2.465031059273315e-07
linked O 0 7.303438906092197e-06
to O 0 6.576620307896519e-06
mental O 1 0.9999239444732666
health O 1 0.9694189429283142
wellness O 1 0.99931800365448
. O 0 0.00035839559859596193

These O 0 1.3011767805437557e-05
findings O 0 6.338339971989626e-06
are O 0 7.274482527463988e-07
consistent O 0 2.797340812321636e-06
with O 0 1.0327274821975152e-06
the O 0 2.9910902412666474e-06
hypothesis O 0 3.1906490676192334e-06
that O 0 2.637683564898907e-07
certain O 0 1.9584017252327612e-07
alleles O 0 6.381551997947099e-07
could O 0 9.366414701617032e-07
prevent O 0 1.6342941080438322e-06
or O 0 6.30948477464699e-07
modify O 0 1.706520151856239e-06
the O 0 2.570073320384836e-06
clinical O 0 3.243151513743214e-05
manifestations O 0 0.0005000214441679418
of O 0 0.04605536907911301
BPAD B-Disease 1 1.0
and O 0 1.4153869415167719e-05
perhaps O 0 1.4099349755269941e-05
other O 0 2.5678709789644927e-06
related O 0 0.00035414841840974987
affective B-Disease 1 0.9999998807907104
disorders I-Disease 1 1.0
. O 1 0.9760674834251404

Segregation O 1 0.9992920160293579
distortion O 1 0.9999017715454102
in O 1 0.9993676543235779
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.960273027420044

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999953508377075
DM B-Disease 1 1.0
) O 0 0.0004260264977347106
is O 0 8.435411473328713e-06
an O 0 8.629506737634074e-06
autosomal B-Disease 1 0.9721109867095947
dominant I-Disease 1 0.9999819993972778
disease I-Disease 1 0.9999988079071045
which O 0 8.88989325176226e-06
, O 0 2.2327126316668e-06
in O 0 1.1512712490002741e-06
the O 0 2.6626462386047933e-06
typical O 0 7.911232387414202e-06
pedigree O 0 1.6062576833064668e-05
, O 0 1.5648072348994901e-06
shows O 0 1.8216900343759335e-06
a O 0 4.801775503437966e-06
three O 0 5.557174063142156e-06
generation O 0 0.00016934242739807814
anticipation O 0 0.0003576375893317163
cascade O 0 0.0026557534001767635
. O 0 0.00024469499476253986

This O 0 3.364822259754874e-05
results O 0 1.8946620912174694e-05
in O 0 6.829002086305991e-05
infertility B-Disease 1 1.0
and O 1 0.9999997615814209
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
CDM B-Disease 1 0.9999977350234985
) O 0 3.4523095564509276e-06
with O 0 3.591150914417085e-07
the O 0 1.276916350434476e-06
disappearance O 0 1.9196679204469547e-05
of O 0 4.615348734660074e-05
DM B-Disease 1 1.0
in O 0 4.503355376073159e-05
that O 0 1.1553998774616048e-05
pedigree O 0 0.00021595701400656253
. O 0 6.109309470048174e-05

The O 0 0.0001138798616011627
concept O 0 6.697800563415512e-05
of O 0 4.805060234502889e-05
segregation O 1 0.9027761816978455
distortion O 1 0.6025446653366089
, O 0 7.857426680857316e-06
where O 0 3.838717475446174e-06
there O 0 1.7411624639862566e-06
is O 0 1.5452690149686532e-06
preferential O 0 4.002692094218219e-06
transmission O 0 4.774118679051753e-06
of O 0 2.356707909711986e-06
the O 0 1.6591174016866717e-06
larger O 0 1.6834711686897208e-06
allele O 0 1.3009420172238606e-06
at O 0 3.0918524771550437e-06
the O 0 7.310002729354892e-06
DM B-Disease 1 0.9999997615814209
locus O 0 4.633906064555049e-05
, O 0 1.1995257409580518e-06
has O 0 8.308447263516427e-07
been O 0 9.629440000935574e-07
put O 0 1.2519367373897694e-06
forward O 0 1.5892946976237e-06
to O 0 8.098971875369898e-07
explain O 0 3.0700155093654757e-06
partially O 0 5.578274794970639e-06
the O 0 1.9596138827182585e-06
maintenance O 0 7.466231181751937e-05
of O 0 7.035610906314105e-05
DM B-Disease 1 0.9999998807907104
in O 0 2.608497925393749e-05
the O 0 2.3511729523306713e-05
population O 0 3.128838216071017e-05
. O 0 9.209667041432112e-05

In O 0 7.468409603461623e-05
a O 0 4.069771966896951e-05
survey O 0 3.2491007004864514e-05
of O 0 4.5838107325835153e-05
DM B-Disease 1 0.9999978542327881
in O 0 2.103759652527515e-05
Northern O 0 3.5909692087443545e-05
Ireland O 0 1.914066706376616e-05
, O 0 5.15795682076714e-06
59 O 0 2.8262820706004277e-05
pedigrees O 0 6.202494842000306e-05
were O 0 2.9764736609649844e-05
ascertained O 0 0.00034038617741316557
. O 0 0.0001468285045120865

Sibships O 0 0.008991137146949768
where O 0 4.072019874001853e-05
the O 0 9.271904673369136e-06
status O 0 5.102991508465493e-06
of O 0 4.106215328647522e-06
all O 0 1.0300323083356488e-06
the O 0 1.8885001509261201e-06
members O 0 1.217330691360985e-06
had O 0 2.4637088245071936e-06
been O 0 9.5682537448738e-07
identified O 0 8.185606361621467e-07
were O 0 7.925223712845764e-07
examined O 0 1.5934986095089698e-06
to O 0 3.6819159277001745e-07
determine O 0 8.276048220068333e-07
the O 0 3.123108172076172e-06
transmission O 0 6.048260729585309e-06
of O 0 3.265752638981212e-06
the O 0 1.638153480598703e-05
DM B-Disease 1 1.0
expansion O 0 0.00016567834245506674
from O 0 4.377512595965527e-06
affected O 0 3.443799187152763e-06
parents O 0 1.911814706545556e-06
to O 0 1.3810563359584194e-06
their O 0 6.119194040365983e-06
offspring O 0 0.00010053610458271578
. O 0 8.792396693024784e-05

Where O 0 0.00017363567894790322
the O 0 6.386731547536328e-05
transmitting O 0 0.00048187567153945565
parent O 0 8.202758908737451e-05
was O 0 0.00019203497504349798
male O 0 3.5128181480104104e-05
, O 0 1.7048761947080493e-05
58 O 0 8.970576163847e-05
. O 0 0.00010713746451074257

3 O 0 0.00012390603660605848
% O 0 3.039142939087469e-05
of O 0 1.7027703506755643e-05
the O 0 1.2247168342582881e-05
offspring O 0 1.230406360264169e-05
were O 0 4.066268502356252e-06
affected O 0 3.2274003842758248e-06
, O 0 1.152788399849669e-06
and O 0 4.5684862470807275e-07
in O 0 6.01010015088832e-07
the O 0 1.2878386996817426e-06
case O 0 2.0068077901669312e-06
of O 0 2.159547875635326e-06
a O 0 6.990585006860783e-06
female O 0 1.7325362932751887e-05
transmitting O 0 0.00016053172294050455
parent O 0 3.228616697015241e-05
, O 0 2.9916644052718766e-05
68 O 0 0.000201143542653881
. O 0 9.525046334601939e-05

7 O 0 0.0006116416188888252
% O 0 0.0001754803379299119
were O 0 0.00017854092584457248
affected O 0 0.00023369934933725744
. O 0 0.00024156352446880192

Studies O 0 0.0002523214207030833
on O 0 0.00012396018428262323
meiotic O 0 0.3305448293685913
drive O 0 0.00022213574266061187
in O 0 3.374704101588577e-05
DM B-Disease 1 0.9999985694885254
have O 0 4.699852070189081e-06
shown O 0 2.450483179927687e-06
increased O 0 1.9718718249350786e-06
transmission O 0 1.8221193158751703e-06
of O 0 7.73719420976704e-07
the O 0 1.3698712564291782e-06
larger O 0 9.601636747902376e-07
allele O 0 1.1868088449773495e-06
at O 0 3.5824596125166863e-06
the O 0 2.983477770612808e-06
DM B-Disease 1 0.9999899864196777
locus O 0 3.104972711298615e-05
in O 0 9.024231076182332e-06
non O 0 6.437176489271224e-05
- O 0 0.03450939431786537
DM O 1 0.9999997615814209
heterozygotes O 0 0.0012713681207969785
for O 0 7.865397492423654e-05
CTGn O 0 0.03866305947303772
. O 0 0.0002523281436879188

This O 0 2.7214016881771386e-05
study O 0 1.2509400221460965e-05
provides O 0 5.5974383030843455e-06
further O 0 5.6986286836036015e-06
evidence O 0 7.146076768549392e-06
that O 0 2.303358087374363e-06
the O 0 1.5006660760263912e-05
DM B-Disease 1 0.9999997615814209
expansion O 0 0.0003389025223441422
tends O 0 9.19560989132151e-06
to O 0 2.088101155095501e-06
be O 0 3.0263106509664794e-06
transmitted O 0 1.6763156963861547e-05
preferentially O 0 5.657988367602229e-05
. O 0 4.3185769754927605e-05

Diagnosis O 1 0.9981340765953064
of O 1 0.9812260866165161
hemochromatosis B-Disease 1 1.0
. O 1 0.781375527381897

If O 0 0.0003702937683556229
untreated O 1 0.9999982118606567
, O 1 0.9648177623748779
hemochromatosis B-Disease 1 1.0
can O 0 0.004166268277913332
cause O 1 0.9997958540916443
serious O 1 0.9999756813049316
illness O 1 0.9999988079071045
and O 0 2.932037205027882e-05
early B-Disease 0 0.00010990150622092187
death I-Disease 0 0.00026499497471377254
, O 0 2.435079977658461e-06
but O 0 1.11948941139417e-06
the O 0 4.8249885367113166e-06
disease O 1 0.9945992231369019
is O 0 8.989487469079904e-06
still O 0 9.465727998758666e-06
substantially O 0 2.487043821020052e-05
under O 0 6.88673389959149e-05
- O 1 0.8275744915008545
diagnosed O 1 0.9999854564666748
. O 0 0.0007667540921829641

The O 0 0.0002682185440789908
cornerstone O 0 0.287636399269104
of O 0 5.579455682891421e-05
screening O 0 2.3416318072122522e-05
and O 0 3.5598866361397086e-06
case O 0 3.455672413110733e-06
detection O 0 3.8593066165049095e-06
is O 0 9.291787250731431e-07
the O 0 1.293742457164626e-06
measurement O 0 5.491735009854892e-06
of O 0 6.9245461418177e-06
serum O 0 5.515140219358727e-05
transferrin O 0 5.9057925682282075e-05
saturation O 0 2.4967897843453102e-05
and O 0 2.5373396965733264e-06
the O 0 1.4933894817659166e-05
serum O 0 0.0002333557786187157
ferritin O 0 0.000564836198464036
level O 0 0.0001654358784435317
. O 0 8.694796269992366e-05

Once O 0 0.00028348551131784916
the O 0 4.477064067032188e-05
diagnosis O 0 0.009193625301122665
is O 0 1.4084579561313149e-05
suspected O 0 3.249420115025714e-05
, O 0 4.002035439043539e-06
physicians O 0 5.262984359433176e-06
must O 0 1.4755989923287416e-06
use O 0 1.460796624996874e-06
serum O 0 4.369135058368556e-05
ferritin O 0 0.0006945701315999031
levels O 0 8.60406544234138e-06
and O 0 7.326110790017992e-06
hepatic O 1 0.9995512366294861
iron O 1 0.9998722076416016
stores O 0 1.3512786608771421e-05
on O 0 1.0155226846109144e-05
liver O 0 0.012677746824920177
biopsy O 0 6.175286398502067e-05
specimens O 0 4.6862728595442604e-06
to O 0 7.515791935475136e-07
assess O 0 2.764432110780035e-06
patients O 0 2.565012209743145e-06
for O 0 1.2894056453660596e-06
the O 0 5.354409950086847e-06
presence O 0 1.8945518604596145e-05
of O 0 0.00023259432055056095
iron B-Disease 1 0.9999982118606567
overload I-Disease 1 0.9999686479568481
. O 0 0.00022024655481800437

Liver O 1 0.9999583959579468
biopsy O 1 0.545279860496521
is O 0 1.4578639820683748e-05
also O 0 1.6325244587278576e-06
used O 0 5.393500259742723e-07
to O 0 3.182506134180585e-07
establish O 0 1.0569034429863677e-06
the O 0 7.943800710563664e-07
presence O 0 1.5905546888461686e-06
or O 0 8.864443543643574e-07
absence O 0 1.071647147909971e-05
of O 0 7.229892798932269e-05
cirrhosis B-Disease 1 1.0
, O 0 1.7556791135575622e-05
which O 0 1.2536203257695888e-06
can O 0 7.931196819299657e-07
affect O 0 3.8732805478503e-06
prognosis O 0 0.0034083977807313204
and O 0 1.6663749192957766e-05
management O 0 0.0008398143108934164
. O 0 0.000162411030032672

A O 0 0.0004582302935887128
DNA O 0 7.951240695547312e-05
- O 0 1.6125226466101594e-05
based O 0 2.0060194856341695e-06
test O 0 1.546786279504886e-06
for O 0 1.1637184798019007e-06
the O 0 7.011737579887267e-06
HFE O 1 0.9777657389640808
gene O 0 3.0423825592151843e-06
is O 0 8.119976655507344e-07
commercially O 0 9.478504239268659e-07
available O 0 1.6381579825974768e-07
, O 0 2.62461014699511e-07
but O 0 1.1412063827265229e-07
its O 0 2.4930278641477344e-07
place O 0 8.529577257831988e-07
in O 0 8.915685612009838e-07
the O 0 2.0541667709039757e-06
diagnosis O 0 0.004245759919285774
of O 0 0.051787134259939194
hemochromatosis B-Disease 1 1.0
is O 0 0.00039718946209177375
still O 0 1.9211769540561363e-05
being O 0 1.5928901120787486e-05
evaluated O 0 8.776858885539696e-05
. O 0 7.630893378518522e-05

Currently O 0 7.912890578154474e-05
, O 0 1.139776395575609e-05
the O 0 3.1591177958034677e-06
most O 0 9.454715268475411e-07
useful O 0 1.2995320730624371e-06
role O 0 8.981756423054321e-07
for O 0 3.7998577795406163e-07
this O 0 4.706018330580264e-07
test O 0 1.4812940207775682e-06
is O 0 1.0537431762713823e-06
in O 0 5.391694912759704e-07
the O 0 1.5176353826973354e-06
detection O 0 1.2616134881682228e-05
of O 0 3.743613342521712e-05
hemochromatosis B-Disease 1 1.0
in O 0 2.5682367777335458e-05
the O 0 7.614736205141526e-06
family O 0 3.2789214401418576e-06
members O 0 8.344896400558355e-07
of O 0 1.3888384273741394e-06
patients O 0 2.52980839832162e-06
with O 0 1.2056914329150459e-06
a O 0 1.3329809007700533e-05
proven O 0 7.536073826486245e-05
case O 0 7.991474376467522e-06
of O 0 8.266894838016015e-06
the O 0 0.00013406261859927326
disease O 1 0.9998741149902344
. O 0 0.00017453485634177923

It O 0 4.018583058496006e-05
is O 0 1.1861043276439887e-05
crucial O 0 2.8659165764111094e-05
to O 0 1.2119825441914145e-05
diagnose O 1 0.9999871253967285
hemochromatosis B-Disease 1 1.0
before O 1 0.9999982118606567
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.9999905824661255
because O 0 0.003547340864315629
phlebotomy O 1 0.9999959468841553
therapy O 1 0.6192293167114258
can O 0 3.5980283428216353e-06
avert O 1 0.9776034355163574
serious O 1 0.9999992847442627
chronic O 1 1.0
disease O 1 1.0
and O 0 0.00011959322728216648
can O 0 1.516428824288596e-06
even O 0 1.8674813873076346e-06
lead O 0 4.175793947069906e-06
to O 0 1.9999333744635805e-06
normal O 0 8.050050382735208e-06
life O 0 2.0067382138222456e-05
expectancy O 0 0.0001072574668796733
. O 0 3.077507426496595e-05
. O 0 7.48263846617192e-05

Prevalence O 0 0.00146683887578547
of O 0 0.00013519734784495085
the O 0 0.00016683099966030568
I1307K O 1 0.9781559705734253
APC B-Disease 0 0.04236761853098869
gene O 0 1.2034515748382546e-05
variant O 0 9.90026819636114e-06
in O 0 1.8595337678561918e-06
Israeli O 0 4.161855486017885e-06
Jews O 0 2.47562365984777e-06
of O 0 1.0022396281783585e-06
differing O 0 4.401472324389033e-07
ethnic O 0 9.072138595911383e-07
origin O 0 9.855662028712686e-07
and O 0 1.51225515310216e-06
risk O 0 3.789344191318378e-05
for O 0 0.009675159119069576
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9493119120597839

BACKGROUND O 0 0.0021577770821750164
& O 0 0.0010734729003161192
AIMS O 0 0.00012437091208994389
Israeli O 0 2.5207024009432644e-05
Jews O 0 1.4575719433196355e-05
of O 0 5.894838068343233e-06
European O 0 4.9721520554157905e-06
birth O 0 1.278352465305943e-05
, O 0 4.076413915754529e-06
i O 0 3.491918278086814e-06
. O 0 5.689401518793602e-07
e O 0 1.700663119663659e-06
. O 0 5.134538128004351e-07
, O 0 8.731742013878829e-07
Ashkenazim O 0 1.4299515896709636e-05
, O 0 1.2953252053193864e-06
have O 0 4.998258873456507e-07
the O 0 3.056180730709457e-06
highest O 1 0.9851515889167786
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9975135326385498
of O 0 3.6260833439882845e-05
any O 0 5.412331120169256e-06
Israeli O 0 2.307972863491159e-05
ethnic O 0 2.8232028853381053e-05
group O 0 8.33999874885194e-05
. O 0 0.00010100282088387758

The O 0 0.0007869004039093852
I1307K O 0 0.2658421993255615
APC B-Disease 0 0.013998148962855339
gene O 0 6.369124457705766e-05
variant O 0 5.73005381738767e-05
was O 0 6.619554187636822e-05
found O 0 1.3398402188613545e-05
in O 0 1.5507326679653488e-05
6 O 0 0.00016002554912120104
. O 0 0.00011177004489582032

1 O 0 0.0001685537281446159
% O 0 3.9931488572619855e-05
of O 0 2.2020796677679755e-05
American O 0 1.2518720723164733e-05
Jews O 0 1.3412770385912154e-05
, O 0 1.4723518688697368e-06
28 O 0 2.423813157292898e-06
% O 0 8.192603786483232e-07
of O 0 2.251572141176439e-06
their O 0 7.276978067238815e-06
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 0.0012152964482083917
, O 0 5.283991413307376e-06
but O 0 8.390917969336442e-07
not O 0 5.134601792633475e-07
in O 0 2.110638888552785e-06
non O 0 2.320818202861119e-05
- O 0 0.00014887154975440353
Jews O 0 0.0002526492753531784
. O 0 0.00015404152509290725

We O 0 7.808831287547946e-05
assessed O 0 7.254154479596764e-05
the O 0 2.1795742213726044e-05
I1307K O 0 0.0005158146377652884
prevalence O 0 9.235451580025256e-05
in O 0 5.252950359135866e-06
Israeli O 0 9.035175935423467e-06
Jews O 0 7.169681794039207e-06
of O 0 2.6676814286474837e-06
differing O 0 8.319571520587488e-07
ethnic O 0 1.823299612624396e-06
origin O 0 2.0624975149985403e-06
and O 0 2.711710067160311e-06
risk O 0 9.209754352923483e-05
for O 0 0.031206313520669937
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9396065473556519

METHODS O 0 0.00015910991351120174
DNA O 0 4.375472781248391e-05
samples O 0 6.002527243254008e-06
from O 0 3.1328243039752124e-06
500 O 0 9.541505278320983e-06
unrelated O 0 1.0207347258983646e-05
Jews O 0 7.252458544826368e-06
of O 0 3.7844044982193736e-06
European O 0 5.291050456435187e-06
or O 0 3.2532780096516944e-06
non O 0 1.4300442671810742e-05
- O 0 1.4597700101148803e-05
European O 0 1.884362518467242e-06
origin O 0 1.064585376298055e-06
, O 0 7.043565801723162e-07
with O 0 2.8760655368387233e-07
or O 0 6.18982085143216e-07
without O 0 9.552708206683747e-07
a O 0 2.270469622089877e-06
personal O 0 1.0176604519074317e-05
and O 0 3.5571240459830733e-06
/ O 0 0.002484483178704977
or O 0 3.314106606921996e-06
family O 0 5.583709025813732e-06
history O 0 5.0659364205785096e-06
of O 0 1.3235363439889625e-05
neoplasia B-Disease 1 0.9501157402992249
, O 0 2.846398729161592e-06
were O 0 1.1693722399286344e-06
examined O 0 1.7504977449789294e-06
for O 0 7.504697236981883e-07
the O 0 2.5247495614166837e-06
I1307K O 0 5.351699292077683e-05
variant O 0 2.8960303097846918e-06
by O 0 9.943975101123215e-07
the O 0 2.0373668121465016e-06
allele O 0 4.26189126301324e-06
- O 0 6.2734638959227595e-06
specific O 0 1.820102852434502e-06
oligonucleotide O 0 5.537379183806479e-05
( O 0 1.787545443221461e-05
ASO O 0 0.028591031208634377
) O 0 1.4175700016494375e-05
method O 0 3.5901710361940786e-05
. O 0 7.809806993464008e-05

RESULTS O 0 0.00014087610179558396
In O 0 1.5260709915310144e-05
persons O 0 1.0215108886768576e-05
at O 0 1.5534502381342463e-05
average O 0 9.988227247959003e-06
risk O 0 3.619438939495012e-05
for O 0 0.0002726750972215086
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.008513121865689754
I1307K O 0 0.23578451573848724
was O 0 4.3698015360860154e-05
found O 0 3.272592948633246e-06
in O 0 6.7916439547843765e-06
5 O 0 6.973072595428675e-05
. O 0 0.00010936726903310046

0 O 0 0.0001426378876203671
% O 0 4.452496432350017e-05
of O 0 3.3355954656144604e-05
120 O 0 4.576084756990895e-05
European O 0 2.110495370288845e-05
and O 0 2.484121432644315e-05
1 O 0 0.00021037415717728436
. O 0 0.0001791702234186232

6 O 0 0.00034997917828150094
% O 0 7.923265366116539e-05
of O 0 6.680483056697994e-05
188 O 0 0.00011656611604848877
non O 0 4.215453009237535e-05
- O 0 4.070920840604231e-05
European O 0 8.587375305069145e-06
Jews O 0 1.788224108167924e-05
( O 0 1.1743156392185483e-05
P O 0 7.110519800335169e-05
= O 0 1.721061926218681e-05
0 O 0 1.0564222975517623e-05
. O 0 6.621952252316987e-06
08 O 0 0.00011877449287567288
) O 0 3.472321623121388e-05
. O 0 7.032599387457594e-05

It O 0 0.00015351935871876776
occurred O 0 0.0005697860033251345
in O 0 9.670620784163475e-05
15 O 0 0.00029491379973478615
. O 0 0.0002821986854542047

4 O 0 0.00014066777657717466
% O 0 2.5784333047340624e-05
of O 0 1.9705394151969813e-05
52 O 0 4.735854236059822e-05
Ashkenazi O 0 3.806570020969957e-05
Israelis O 0 1.274373153137276e-05
with O 0 6.402725830412237e-06
familial O 1 0.998875081539154
cancer B-Disease 1 0.9999736547470093
( O 0 5.496941594174132e-05
P O 0 0.0353907011449337
= O 0 1.457152120565297e-05
0 O 0 5.734386377298506e-06
. O 0 1.7531724552100059e-06
02 O 0 2.8470576580730267e-05
) O 0 1.452934043300047e-06
and O 0 6.146069608803373e-07
was O 0 4.571921635942999e-06
not O 0 5.720140734410961e-07
detected O 0 1.8645807813300053e-06
in O 0 8.447040613646095e-07
51 O 0 6.280216439336073e-06
non O 0 5.215840701566776e-06
- O 0 5.789113856735639e-06
European O 0 2.1056830519228242e-06
Jews O 0 6.433832368202275e-06
at O 0 2.291034979862161e-05
increased O 0 0.0001584022247698158
cancer B-Disease 1 0.9876450896263123
risk O 0 0.00023541803238913417
. O 0 0.0001649417681619525

Colorectal B-Disease 1 0.9999995231628418
neoplasia I-Disease 1 0.9999971389770508
occurred O 1 0.6591395735740662
personally O 0 0.000370292691513896
or O 0 6.300372660916764e-06
in O 0 3.3769713354558917e-06
the O 0 3.1583651889377506e-06
families O 0 1.8215703221358126e-06
of O 0 3.53266818819975e-06
13 O 0 5.529209374799393e-06
of O 0 4.228370471537346e-06
20 O 0 1.3765955372946337e-05
Ashkenazi O 0 7.640475814696401e-05
I1307K O 0 0.00013568396389018744
carriers O 0 7.291538167919498e-06
, O 0 2.0964498617104255e-06
8 O 0 4.796251232619397e-06
of O 0 4.225927568768384e-06
whom O 0 5.373726708057802e-06
also O 0 2.490224460416357e-06
had O 0 2.8559727525134804e-06
a O 0 4.66386018160847e-06
personal O 0 7.389683105429867e-06
or O 0 3.877167728205677e-06
family O 0 1.452138621971244e-05
history O 0 3.873982132063247e-05
of O 0 0.00017422839300706983
noncolonic O 1 0.9998987913131714
neoplasia B-Disease 1 0.9997969269752502
. O 0 0.0004986970452591777

CONCLUSIONS O 0 0.0005901263211853802
The O 0 0.00022208069276530296
I1307K O 1 0.8348869681358337
APC O 0 0.041765596717596054
variant O 0 4.58312060800381e-05
may O 0 7.184439255070174e-06
represent O 0 2.1698763248423347e-06
a O 0 4.886745500698453e-06
susceptibility O 0 3.712144462042488e-05
gene O 0 6.228230631677434e-06
for O 0 5.762130513176089e-06
colorectal B-Disease 1 1.0
, I-Disease 0 1.501646784163313e-05
or I-Disease 0 2.6643838282325305e-06
other I-Disease 0 1.2057615776939201e-06
, I-Disease 0 8.613745194452349e-06
cancers I-Disease 0 0.11265300214290619
in O 0 6.033524186932482e-06
Ashkenazi O 0 0.0005986539181321859
Jews O 0 5.1669754611793905e-05
, O 0 2.8394688342814334e-06
and O 0 1.3540575309889391e-06
partially O 0 1.0541659321461339e-05
explains O 0 1.9331519069964997e-06
the O 0 1.0767174671855173e-06
higher O 0 2.425496404612204e-06
incidence O 0 0.0013302305014804006
of O 1 0.6894274950027466
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 9.754559869179502e-05
European O 0 4.2296393075957894e-05
Israelis O 0 0.00010741458390839398
. O 0 9.001691068988293e-05

Systematic O 0 0.00040584022644907236
analysis O 0 7.01598692103289e-05
of O 0 6.448136264225468e-05
coproporphyrinogen O 1 0.996067225933075
oxidase O 0 0.0006402854924090207
gene O 0 7.865210500312969e-05
defects O 0 0.00746065704151988
in O 0 3.2192703656619415e-05
hereditary B-Disease 1 0.9999723434448242
coproporphyria I-Disease 1 0.9998724460601807
and O 0 4.102203092770651e-05
mutation O 0 6.98192889103666e-05
update O 0 0.000125846840091981
. O 0 0.0001077749184332788

Hereditary B-Disease 1 0.9999947547912598
coproporphyria I-Disease 1 0.9999909400939941
( O 1 0.686804473400116
HC B-Disease 1 1.0
) O 0 0.0003590793057810515
is O 0 1.7354401279590093e-05
an O 0 6.292825855780393e-05
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9997945427894592
autosomal O 1 0.9999991655349731
dominant O 1 0.9999982118606567
inheritance O 1 0.9999648332595825
caused O 1 0.9993828535079956
by O 0 2.00526301341597e-05
deficient B-Disease 0 0.017306726425886154
activity I-Disease 0 1.2445584616216365e-05
of I-Disease 0 1.461009287595516e-05
coproporphyrinogen I-Disease 1 0.966571569442749
III I-Disease 1 0.9999693632125854
oxidase I-Disease 0 0.0001467152760596946
( O 0 2.8273037969483994e-05
CPO O 0 0.00031521564233116806
) O 0 3.0329470973811112e-05
. O 0 5.7830278819892555e-05

Clinical O 0 0.04803656414151192
manifestations O 0 0.03526177629828453
of O 0 0.01035501342266798
the O 1 0.9552448987960815
disease O 1 0.9999994039535522
are O 0 1.6013564163586125e-06
characterized O 0 0.00016961360233835876
by O 0 4.9459054025646765e-06
acute O 1 0.999998927116394
attacks O 0 0.10680321604013443
of O 1 0.9999250173568726
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 0.18196652829647064
precipitated O 1 0.9996763467788696
by O 0 1.1253831871727016e-05
drugs O 0 1.5831221389817074e-05
, O 0 2.709308773773955e-06
fasting O 0 1.1070782420574687e-05
, O 0 3.6730502870341297e-06
cyclical O 0 0.004346674308180809
hormonal O 0 0.0025440615136176348
changes O 0 6.058155122445896e-06
, O 0 1.3051998394075781e-05
or O 0 0.0023088082671165466
infectious B-Disease 1 0.9999998807907104
diseases I-Disease 1 0.9999997615814209
. O 0 0.06196528673171997

Skin O 1 0.9998749494552612
photosensitivity O 1 0.9996792078018188
may O 0 0.00019665797299239784
also O 0 2.606105772429146e-05
be O 0 1.8234826711704955e-05
present O 0 5.257244629319757e-05
. O 0 0.0001533396716695279

The O 0 8.711344707990065e-05
seven O 0 4.3151721911272034e-05
exons O 0 5.987975964671932e-05
, O 0 5.957854682492325e-06
the O 0 5.897649771213764e-06
exon O 0 9.945926285581663e-05
/ O 0 7.646845915587619e-05
intron O 0 0.00011912475747521967
boundaries O 0 1.7086648540498572e-06
and O 0 7.066731200211507e-07
part O 0 1.421570345883083e-06
of O 0 1.8766008906823117e-06
3 O 0 5.810602033307077e-06
noncoding O 0 1.152938693849137e-05
sequence O 0 1.2464330438888283e-06
of O 0 1.5448019894392928e-06
the O 0 3.3998819617409026e-06
CPO O 0 4.6668654249515384e-05
gene O 0 1.7023735381371807e-06
were O 0 1.0577119837762439e-06
systematically O 0 2.3408579181705136e-06
analyzed O 0 1.3586339946414228e-06
by O 0 7.253491958181257e-07
an O 0 2.5774590994842583e-06
exon O 0 7.16888825991191e-05
- O 0 1.6479763871757314e-05
by O 0 5.662716375809396e-06
- O 0 4.776406058226712e-05
exon O 0 7.919231575215235e-05
denaturing O 0 0.00012252552551217377
gradient O 0 0.00013673001376446337
gel O 0 0.00019854317361023277
electrophoresis O 0 9.872647206066176e-05
( O 0 1.3952550034446176e-05
DGGE O 0 0.0027149287052452564
) O 0 4.517881734500406e-06
strategy O 0 3.359804850333603e-06
followed O 0 1.8085585224980605e-06
by O 0 4.604765422300261e-07
direct O 0 6.187666485857335e-07
sequencing O 0 1.9520559817465255e-06
in O 0 7.81055177867529e-07
seven O 0 1.7844820376922144e-06
unrelated O 0 4.967649147147313e-06
heterozygous O 0 8.223569238907658e-06
HC B-Disease 1 0.9999773502349854
patients O 0 5.655820496031083e-05
from O 0 8.32934892969206e-06
France O 0 2.0147515897406265e-05
, O 0 6.316592589428183e-06
Holland O 0 4.096627890248783e-05
, O 0 4.771687599713914e-06
and O 0 4.328423983679386e-06
Czech O 0 0.00014842917153146118
Republic O 0 0.00018611515406519175
. O 0 0.00010543619282543659

Seven O 0 0.0002830464218277484
novel O 0 0.0001358188601443544
mutations O 0 3.404991002753377e-05
and O 0 5.704338036593981e-06
two O 0 3.1562874482915504e-06
new O 0 6.652816864516353e-06
polymorphisms O 0 4.7272988012991846e-05
were O 0 2.9472372261807323e-05
detected O 0 0.00012738681107293814
. O 0 8.877936488715932e-05

Among O 0 5.636769492411986e-05
these O 0 5.8421073845238425e-06
mutations O 0 5.559744749916717e-06
two O 0 1.5109059177120798e-06
are O 0 1.4292983223640476e-06
missense O 0 2.220048918388784e-05
( O 0 7.849254870961886e-06
G197W O 0 0.00013063619553577155
, O 0 5.560370482271537e-06
W427R O 0 4.0961906051961705e-05
) O 0 1.0919912938334164e-06
, O 0 4.840123892790871e-07
two O 0 2.7703779892362945e-07
are O 0 4.7268707703551627e-07
nonsense O 0 1.2349320968496613e-05
( O 0 4.748001174448291e-06
Q306X O 0 8.41864020912908e-05
, O 0 2.3438244625140214e-06
Q385X O 0 1.6788260836619884e-05
) O 0 9.046298146131448e-07
, O 0 4.837585265704547e-07
two O 0 2.6427923671690223e-07
are O 0 2.2463423476892785e-07
small O 0 2.244501729364856e-06
deletions O 0 5.381167738960357e-06
( O 0 6.396866410796065e-06
662de14bp O 0 5.7699173339642584e-05
; O 0 1.907462092276546e-06
1168del3bp O 0 3.0436009183176793e-05
removing O 0 6.970508366066497e-06
a O 0 1.8490807178750401e-06
glycine O 0 6.042229870217852e-06
at O 0 3.3341864309477387e-06
position O 0 4.264533799869241e-06
390 O 0 7.249022019095719e-06
) O 0 1.1834723636638955e-06
, O 0 6.523143269987486e-07
and O 0 4.1114364535133063e-07
one O 0 3.433118251905398e-07
is O 0 5.359071906241297e-07
a O 0 1.2878361985713127e-06
splicing O 0 4.903074568574084e-06
mutation O 0 3.1491676963923965e-06
( O 0 8.488892490277067e-06
IVS1 O 0 0.0460091196000576
- O 0 5.716414307244122e-05
15c O 0 0.00019112907466478646
- O 0 2.8890272005810402e-05
- O 0 1.8628194084158167e-05
> O 0 1.2678564417001326e-05
g O 0 6.4770501921884716e-06
) O 0 9.43897646266123e-07
which O 0 4.108136124614248e-07
creates O 0 2.2171805085235974e-06
a O 0 2.0779759779543383e-06
new O 0 3.4931840673380066e-06
acceptor O 0 2.0558209143928252e-05
splice O 0 0.00014606257900595665
site O 0 0.00010424463107483461
. O 0 9.107590449275449e-05

The O 0 0.00020285444043111056
pathological O 0 0.0010693141957744956
significance O 0 6.695648335153237e-05
of O 0 2.1586854927591048e-05
the O 0 1.0696652680053376e-05
point O 0 5.758363113272935e-05
mutations O 0 1.1527496099006385e-05
G197W O 0 8.865610288921744e-05
, O 0 4.0578584048489574e-06
W427R O 0 3.21956213156227e-05
, O 0 1.6678744714226923e-06
and O 0 7.282964702426398e-07
the O 0 1.3172602848499082e-06
in O 0 4.527164037426701e-06
- O 0 4.011430428363383e-05
frame O 0 2.1895446479902603e-05
deletion O 0 1.1122859177703504e-05
390delGly O 0 1.8623612049850635e-05
were O 0 1.346360022580484e-06
assessed O 0 1.2352008980087703e-06
by O 0 4.1473833789495984e-07
their O 0 4.518522587204643e-07
respective O 0 1.1003332929249154e-06
expression O 0 1.3870831025997177e-06
in O 0 8.774565003477619e-07
a O 0 3.118474296570639e-06
prokaryotic O 0 5.666633114742581e-06
system O 0 7.399789410555968e-06
using O 0 5.263455932436045e-06
site O 0 2.7010686608264223e-05
- O 0 4.5871518523199484e-05
directed O 0 6.436194234993309e-05
mutagenesis O 0 0.000503856863360852
. O 0 0.0001696459366939962

These O 0 2.8313832444837317e-05
mutations O 0 2.4545866835978813e-05
resulted O 0 3.1960709748091176e-05
in O 0 9.70416294876486e-06
the O 0 6.514254437206546e-06
absence O 0 2.1849851691513322e-05
or O 0 3.510001079121139e-06
a O 0 9.268766007153317e-06
dramatic O 0 4.6806952013866976e-05
decrease O 0 6.688220310024917e-05
of O 0 9.10458475118503e-05
CPO O 0 0.30390068888664246
activity O 0 0.00015928936772979796
. O 0 7.970385195221752e-05

The O 0 0.0001472228905186057
two O 0 1.7519543689559214e-05
polymorphisms O 0 7.642851414857432e-05
were O 0 9.467642485105898e-06
localized O 0 2.2160997104947455e-05
in O 0 4.444497790245805e-06
noncoding O 0 5.195939593249932e-05
part O 0 6.5123294916702434e-06
of O 0 4.157333023613319e-06
the O 0 3.553563828972983e-06
gene O 0 2.4307785224664258e-06
1 O 0 4.170246484136442e-06
) O 0 1.7421059510525083e-06
a O 0 3.398494527573348e-06
C O 0 6.887325434945524e-05
/ O 0 3.7287059967638925e-05
G O 0 3.520176323945634e-05
polymorphism O 0 7.730328434263356e-06
in O 0 1.7274793435717584e-06
the O 0 3.268712589488132e-06
promotor O 0 0.00036130266380496323
region O 0 1.2062574569426943e-05
, O 0 2.2196029476617696e-06
142 O 0 5.331093689164845e-06
bp O 0 7.664884833502583e-06
upstream O 0 3.461771257207147e-06
from O 0 8.887620310815691e-07
the O 0 1.3753284520134912e-06
transcriptional O 0 1.2796002010873053e-05
initiation O 0 1.2328294360486325e-05
site O 0 1.4868325706629548e-05
( O 0 6.092013336456148e-06
- O 0 1.655129926803056e-05
142C O 0 8.052065822994336e-05
/ O 0 2.7179419703315943e-05
G O 0 2.5951017960323952e-05
) O 0 1.4355249504660605e-06
, O 0 5.447083708531864e-07
and O 0 3.606196514738258e-07
2 O 0 2.002517476284993e-06
) O 0 9.628320185584016e-07
a O 0 2.401879328317591e-06
6 O 0 5.897070423088735e-06
bp O 0 1.17799463623669e-05
deletion O 0 7.367657872237032e-06
polymorphism O 0 6.7082573877996765e-06
in O 0 1.830739506658574e-06
the O 0 1.4364602520799963e-06
3 O 0 5.494187007570872e-06
noncoding O 0 1.581729156896472e-05
part O 0 2.96576786240621e-06
of O 0 2.928592039097566e-06
the O 0 6.875174221931957e-06
CPO O 0 0.000499068817589432
gene O 0 4.8933957259578165e-06
, O 0 2.108220769514446e-06
574 O 0 2.411054083495401e-05
bp O 0 1.3362863683141768e-05
downstream O 0 1.1520507541717961e-05
of O 0 2.3095874439604813e-06
the O 0 3.43568990501808e-06
last O 0 4.660036665882217e-06
base O 0 5.213155418459792e-06
of O 0 2.19801404455211e-06
the O 0 3.87625095754629e-06
normal O 0 7.148980330384802e-06
termination O 0 1.9378368961042725e-05
codon O 0 2.0199671780574135e-05
( O 0 1.224530024046544e-05
+ O 0 6.526225479319692e-05
574 O 0 0.0002918640966527164
delATTCTT O 0 0.0005174169782549143
) O 0 6.780192779842764e-05
. O 0 5.008202788303606e-05

Five O 0 0.000415675196563825
intragenic O 1 0.9311280250549316
dimorphisms O 0 0.01184102427214384
are O 0 6.4163696151808836e-06
now O 0 5.278189291857416e-06
well O 0 2.8033841772412416e-06
characterized O 0 8.472966328554321e-06
and O 0 1.3470727253661607e-06
the O 0 2.330384859305923e-06
high O 0 1.1091686246800236e-05
degree O 0 1.6203259292524308e-05
of O 0 8.290754522022326e-06
allelic O 0 0.00017266567738261074
heterogeneity O 0 0.00010132038005394861
in O 0 1.55923862621421e-05
HC B-Disease 1 0.9999796152114868
is O 0 1.5687215636717156e-05
demonstrated O 0 1.1604486644500867e-05
with O 0 9.2060889755885e-07
seven O 0 1.6133465123857604e-06
new O 0 5.33565412297321e-07
different O 0 2.167137012065723e-07
mutations O 0 5.041050599174923e-07
making O 0 7.508857038374117e-07
a O 0 8.997943155009125e-07
total O 0 2.13963835449249e-06
of O 0 5.677581611962523e-06
nineteen O 0 0.0006428092019632459
CPO O 1 0.8756917119026184
gene B-Disease 0 3.4438322472851723e-05
defects I-Disease 0 0.00023912351753097028
reported O 0 9.725155905471183e-06
so O 0 4.831047590414528e-06
far O 0 1.592305488884449e-05
. O 0 1.5493238606723025e-05
. O 0 7.295527757378295e-05

Coincidence O 0 0.00035540491808205843
of O 0 4.1566403524484485e-05
two O 0 7.215749519673409e-06
novel O 0 2.1105335690663196e-05
arylsulfatase O 0 8.967659960035235e-05
A O 0 1.1388809980417136e-05
alleles O 0 2.178568138333503e-06
and O 0 1.3383449868342723e-06
mutation O 0 3.575988102966221e-06
459 O 0 6.605567614315078e-05
+ O 0 0.00010156608914257959
1G O 0 0.00024347251746803522
> O 0 1.1648726285784505e-05
A O 0 4.364835604064865e-06
within O 0 1.3362584923015675e-06
a O 0 2.154165031242883e-06
family O 0 4.1613475332269445e-06
with O 0 5.342647455108818e-06
metachromatic B-Disease 1 0.999998927116394
leukodystrophy I-Disease 1 0.9999951124191284
: O 0 5.452007371786749e-06
molecular O 0 3.840640147245722e-06
basis O 0 3.110882062173914e-06
of O 0 5.628555300063454e-06
phenotypic O 0 8.011825411813334e-05
heterogeneity O 0 0.0010130545124411583
. O 0 0.0001938056229846552

In O 0 0.00011597527918638662
a O 0 5.736975799663924e-05
family O 0 2.142699850082863e-05
with O 0 4.125483428651933e-06
three O 0 3.3882815841934644e-06
siblings O 0 2.010250864259433e-05
, O 0 2.3296736344491364e-06
one O 0 2.0574486825353233e-06
developed O 0 7.1843978730612434e-06
classical O 0 1.444683857698692e-05
late O 0 0.012942853383719921
infantile O 1 0.9999995231628418
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 0.07840713858604431
MLD B-Disease 1 0.9999998807907104
) O 0 1.4079785614740103e-05
, O 0 5.332690307113808e-06
fatal O 0 2.976942232635338e-05
at O 0 1.4735285731148906e-05
age O 0 1.2000236893072724e-05
5 O 0 8.16773172118701e-06
years O 0 6.8713857217517216e-06
, O 0 2.0848460735578556e-06
with O 0 3.2472025850438513e-06
deficient O 0 0.03216284140944481
arylsulfatase O 1 0.5476886630058289
A O 0 0.00017906297580339015
( O 0 1.2556743058667053e-05
ARSA O 0 0.48024696111679077
) O 0 1.5110413187358063e-06
activity O 0 2.014496885749395e-06
and O 0 8.53886319873709e-07
increased O 0 4.826922122447286e-06
galactosylsulfatide O 0 0.00037233243347145617
( O 0 1.5962630641297437e-05
GS O 1 0.9998699426651001
) O 0 1.983442598429974e-05
excretion O 0 0.0001012251668726094
. O 0 5.456897633848712e-05

The O 0 8.601204899605364e-05
two O 0 1.864481055235956e-05
other O 0 6.150851731945295e-06
siblings O 0 4.546389391180128e-05
, O 0 6.860693247290328e-06
apparently O 0 1.0244591067021247e-05
healthy O 0 4.386128694022773e-06
at O 0 5.054576377006015e-06
12 O 0 3.8056637094996404e-06
( O 0 1.7803429273044458e-06
1 O 0 1.0853531421162188e-05
/ O 0 1.3598417353932746e-05
2 O 0 6.629788003920112e-06
) O 0 1.318108616032987e-06
and O 0 4.067510985805711e-07
15 O 0 1.4293460708358907e-06
years O 0 1.3083737258057226e-06
, O 0 1.185098767564341e-06
respectively O 0 1.959628889380838e-06
, O 0 8.875067578628659e-07
and O 0 5.641725238092477e-07
their O 0 1.2893956409243401e-06
father O 0 3.21262123179622e-05
, O 0 3.6926976463291794e-06
apparently O 0 9.520372259430587e-06
healthy O 0 3.3578603506612126e-06
as O 0 1.3194555776863126e-06
well O 0 1.3576652690971969e-06
, O 0 1.74964645793807e-06
presented O 0 1.095348852686584e-05
ARSA O 1 0.9953063130378723
and O 0 3.920911240129499e-06
GS O 1 0.8290612697601318
values O 0 1.4474849194812123e-06
within O 0 1.5000746316218283e-06
the O 0 2.3829832116462057e-06
range O 0 8.805046491033863e-06
of O 0 5.5450364015996456e-05
MLD B-Disease 1 0.9999998807907104
patients O 0 0.0034705568104982376
. O 0 0.0003011556691490114

Mutation O 0 0.00018630639533512294
screening O 0 5.304047226672992e-05
and O 0 6.876302450109506e-06
sequence O 0 5.2726149988302495e-06
analysis O 0 2.4186385871871607e-06
disclosed O 0 6.4016144278866705e-06
the O 0 1.3344081253308104e-06
involvement O 0 5.596253231487935e-06
of O 0 1.7776334289010265e-06
three O 0 1.1636718681984348e-06
different O 0 1.0886585641856072e-06
ARSA O 0 0.24865640699863434
mutations O 0 4.177630216872785e-06
being O 0 2.7224846235185396e-06
the O 0 2.4777257294772426e-06
molecular O 0 3.1099625630304217e-06
basis O 0 2.0082627543160925e-06
of O 0 1.310789320996264e-05
intrafamilial O 0 0.002203064039349556
phenotypic O 0 0.00024186336668208241
heterogeneity O 0 0.000908559828530997
. O 0 0.00025619639200158417

The O 0 0.00023480203526560217
late O 0 0.0022725891321897507
infantile O 1 0.9999375343322754
patient O 0 0.4250034987926483
inherited O 1 0.9998049139976501
from O 0 8.919814717955887e-05
his O 0 0.0001030873681884259
mother O 0 3.740815009223297e-05
the O 0 6.381445018632803e-06
frequent O 0 6.698156994389137e-06
0 O 0 1.6675687220413238e-05
- O 0 1.7002050299197435e-05
type O 0 6.170504548208555e-06
mutation O 0 4.173015440755989e-06
459 O 0 3.369465412106365e-05
+ O 0 4.340422310633585e-05
1G O 0 0.00017453452164772898
> O 0 1.0178594493481796e-05
A O 0 1.284757672692649e-05
, O 0 1.3128133105055895e-06
and O 0 7.142889444367029e-07
from O 0 1.4717202247993555e-06
his O 0 7.284128969331505e-06
father O 0 1.750588126014918e-05
a O 0 4.059066213812912e-06
novel O 0 4.9632644731900655e-06
, O 0 1.6099328377094935e-06
single O 0 2.061854502244387e-06
basepair O 0 5.240136306383647e-05
microdeletion O 0 2.319063787581399e-05
of O 0 5.114948180562351e-06
guanine O 0 8.830929800751619e-06
at O 0 4.827299108001171e-06
nucleotide O 0 4.717783212981885e-06
7 O 0 6.333880719466833e-06
in O 0 3.427488763918518e-06
exon O 0 5.0979833758901805e-05
1 O 0 3.1832954846322536e-05
( O 0 1.9837187210214324e-05
7delG O 0 0.00022478662140201777
) O 0 4.080120561411604e-05
. O 0 6.0483038396341726e-05

The O 0 0.0001455560850445181
two O 0 3.9086382457753643e-05
clinically O 0 0.0654202252626419
unaffected O 0 0.00015237742627505213
siblings O 0 2.4666267563588917e-05
carried O 0 6.934531484148465e-06
the O 0 3.830957211903296e-06
maternal O 0 2.112434412993025e-05
mutation O 0 1.2968829651072156e-05
459 O 0 9.194346785079688e-05
+ O 0 7.997794455150142e-05
1G O 0 0.0002023045381065458
> O 0 1.0700283382902853e-05
A O 0 6.198898518050555e-06
and O 0 8.55904943364294e-07
, O 0 4.795327868123422e-07
on O 0 5.443770305646467e-07
their O 0 4.4284061573307554e-07
paternal O 0 5.924561264691874e-06
allele O 0 3.6512085443973774e-06
, O 0 2.3075617718859576e-06
a O 0 2.65237190433254e-06
novel O 0 4.182298198429635e-06
cytosine O 0 3.1293961910705548e-06
to O 0 9.41257496833714e-07
thymidine O 0 9.010823305288795e-06
transition O 0 9.842918188951444e-06
at O 0 1.5363848433480598e-05
nucleotide O 0 2.3374952434096485e-05
2435 O 0 0.0002055468939943239
in O 0 5.6702874644543044e-06
exon O 0 2.7038418920710683e-05
8 O 0 9.079652954824269e-06
, O 0 1.6989675941658788e-06
resulting O 0 2.189929318774375e-06
in O 0 1.3572781654147548e-06
substitution O 0 4.337817244959297e-06
of O 0 8.008327313291375e-06
alanine O 0 3.602648212108761e-05
464 O 0 8.954064833233133e-05
by O 0 1.4773037037230097e-05
valine O 0 0.00027652279823087156
( O 0 3.685203773784451e-05
A464V O 0 0.0010221393313258886
) O 0 8.091769996099174e-05
. O 0 0.00010458675387781113

The O 0 0.0004333488177508116
fathers O 0 0.00038096398930065334
genotype O 0 0.00035783948260359466
thus O 0 0.00013932352885603905
was O 0 0.0006302259862422943
7delG O 0 0.008994204923510551
/ O 0 0.012626814655959606
A464V O 0 0.007592891342937946
. O 0 0.0003893634711857885

Mutation O 0 0.0007301396690309048
A464V O 0 0.0011378477793186903
was O 0 7.375974382739514e-05
not O 0 2.272115807500086e-06
found O 0 2.066612523776712e-06
in O 0 2.6190571134065976e-06
18 O 0 2.20770434680162e-05
unrelated O 0 0.008975286968052387
MLD B-Disease 1 1.0
patients O 0 0.0002298873441759497
and O 0 9.132232662523165e-06
50 O 0 3.233861571061425e-05
controls O 0 4.23298442910891e-05
. O 0 5.1206396165071055e-05

A464V O 0 0.005305915139615536
, O 0 6.473527173511684e-05
although O 0 1.5223759874061216e-05
clearly O 0 3.19222999678459e-05
modifying O 0 6.9623944000341e-05
ARSA O 1 0.9996328353881836
and O 0 3.1225783459376544e-05
GS O 1 0.9999926090240479
levels O 0 3.7982586945872754e-05
, O 0 6.1533924053946976e-06
apparently O 0 1.2581650480569806e-05
bears O 0 1.422390869265655e-05
little O 0 7.244778316817246e-06
significance O 0 8.902770787244663e-06
for O 0 3.005220833074418e-06
clinical O 0 0.00012362588313408196
manifestation O 0 0.37782999873161316
of O 0 0.06943538784980774
MLD B-Disease 1 1.0
, O 0 6.012981975800358e-05
mimicking O 0 9.884384780889377e-05
the O 0 3.147812822135165e-05
frequent O 0 8.130443166010082e-05
ARSA O 1 0.9992876648902893
pseudodeficiency O 0 0.013581612147390842
allele O 0 0.00011310023546684533
. O 0 0.0001176462828880176

Our O 0 5.041933400207199e-05
results O 0 7.120022473827703e-06
demonstrate O 0 8.636437996756285e-06
that O 0 7.686637673032237e-07
in O 0 1.4407860362553038e-06
certain O 0 1.6936711517701042e-06
genetic O 0 6.312286132015288e-05
conditions O 0 0.025483792647719383
MLD B-Disease 1 1.0
- O 1 0.9990401864051819
like O 0 0.00010057847975986078
ARSA O 1 0.9999885559082031
and O 0 8.282576345663983e-06
GS O 1 0.9997426867485046
values O 0 2.597092134237755e-06
need O 0 7.920932034721773e-07
not O 0 3.08924199998728e-07
be O 0 3.5388958963267214e-07
paralleled O 0 6.137978743936401e-06
by O 0 1.6034010741350357e-06
clinical O 0 0.11505739390850067
disease O 1 0.9988293051719666
, O 0 6.051121999917086e-06
a O 0 6.288210897764657e-06
finding O 0 3.062544465137762e-06
with O 0 1.5857248172324034e-06
serious O 0 0.0006243119714781642
diagnostic O 0 0.0006846888572908938
and O 0 4.4748321670340374e-05
prognostic O 1 0.9996917247772217
implications O 0 0.019968142732977867
. O 0 0.00019682475249283016

Moreover O 0 0.0004306779883336276
, O 0 5.878748561372049e-05
further O 0 6.306546129053459e-05
ARSA O 1 0.5210533142089844
alleles O 0 2.4985616619233042e-05
functionally O 0 3.403662776690908e-05
similar O 0 2.868187266358291e-06
to O 0 2.671446964086499e-06
A464V O 0 6.194927118485793e-05
might O 0 1.814369966268714e-06
exist O 0 6.461980319727445e-07
which O 0 3.373053232280654e-07
, O 0 5.474899467117211e-07
together O 0 7.432744837387872e-07
with O 0 6.758225481462432e-07
0 O 0 1.200328188133426e-05
- O 0 5.583644815487787e-05
type O 0 1.5783645721967332e-05
mutations O 0 5.267699179967167e-06
, O 0 2.153240757252206e-06
may O 0 4.471229658520315e-06
cause O 0 0.0005054952926002443
pathological O 1 0.999840259552002
ARSA O 1 0.9999991655349731
and O 0 2.8402049792930484e-05
GS O 1 0.9999960660934448
levels O 0 7.982151146279648e-06
, O 0 1.1575223197723972e-06
but O 0 3.1805640787752054e-07
not O 0 3.168895545968553e-07
clinical O 0 5.718134161725175e-06
outbreak O 0 4.6783174184383824e-05
of O 0 2.4089327780529857e-05
the O 0 0.0016955544706434011
disease O 1 0.9999779462814331
. O 0 5.983164373901673e-05
. O 0 9.336700895801187e-05

Human O 1 0.9209750294685364
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 1 0.9999511241912842
to O 0 0.0005738424370065331
hematological B-Disease 1 0.9999980926513672
malignancy I-Disease 1 0.9999997615814209
and O 0 0.010838638991117477
neurofibromatosis B-Disease 1 0.9999998807907104
type I-Disease 1 0.8517174124717712
1 I-Disease 1 0.7585078477859497
. O 0 0.0003525148786138743

Heterozygous O 0 0.002842437941581011
germ O 1 0.9998235106468201
- O 0 0.0006909950752742589
line O 0 7.819040183676407e-05
mutations O 0 9.159918590739835e-06
in O 0 2.932566076196963e-06
the O 0 6.628466053371085e-06
DNA O 0 2.7809617677121423e-05
mismatch O 1 0.8940019607543945
repair O 0 0.024463888257741928
genes O 0 4.955720214638859e-06
lead O 0 1.2570857506943867e-05
to O 0 1.0493194167793263e-05
hereditary B-Disease 1 0.9999994039535522
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9874351024627686

The O 0 0.0015448079211637378
disease O 1 0.9999710321426392
susceptibility O 0 0.10261072963476181
of O 0 0.0001401782501488924
individuals O 0 1.2489957043726463e-05
who O 0 1.6838221199577674e-05
constitutionally O 0 2.1245705283945426e-05
lack O 0 9.064235200639814e-06
both O 0 3.222654868295649e-06
wild O 0 1.8973143596667796e-05
- O 0 3.6620818718802184e-05
type O 0 1.6896226952667348e-05
alleles O 0 1.0648763236531522e-05
is O 0 1.1087360689998604e-05
unknown O 0 4.051703217555769e-05
. O 0 3.561668927432038e-05

We O 0 6.762951670680195e-05
have O 0 8.105980668915436e-06
identified O 0 7.761072993162088e-06
three O 0 3.182085947628366e-06
offspring O 0 7.248275323945563e-06
in O 0 3.221689894417068e-06
a O 0 7.212354830699041e-05
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9999746084213257
who O 0 0.007971861399710178
developed O 1 0.7896713018417358
hematological B-Disease 1 0.9999773502349854
malignancy I-Disease 1 0.9999815225601196
at O 0 0.00013401138130575418
a O 0 5.681855327566154e-06
very O 0 1.204393925036129e-06
early O 0 3.1979602681531105e-06
age O 0 3.228096147722681e-06
, O 0 1.0564035619609058e-06
and O 0 4.213007969156024e-07
at O 0 1.5684842082919204e-06
least O 0 5.638212883241067e-07
two O 0 2.637816862716136e-07
of O 0 1.3234291600383585e-06
them O 0 8.795074109002599e-07
displayed O 0 9.39935944188619e-06
signs O 0 1.6653135389788076e-05
of O 0 1.4703926353831775e-05
neurofibromatosis B-Disease 1 0.9999653100967407
type I-Disease 0 0.00015139405149966478
1 I-Disease 0 0.000700775533914566
( O 0 7.131570600904524e-05
NF1 B-Disease 0 0.30270686745643616
) O 0 7.165976421674713e-05
. O 0 7.484537491109222e-05

DNA O 0 0.00011665217607514933
sequence O 0 1.7264650523429736e-05
analysis O 0 6.680339083686704e-06
and O 0 3.3199273730133427e-06
allele O 0 5.490797775564715e-06
- O 0 9.97951519821072e-06
specific O 0 2.088947667289176e-06
amplification O 0 2.0876592316199094e-05
in O 0 3.672027560241986e-06
two O 0 2.3705347302893642e-06
siblings O 0 1.8799912140821107e-05
revealed O 0 1.1918780728592537e-05
a O 0 8.077181519183796e-06
homozygous O 0 2.1247486074571498e-05
MLH1 O 0 0.005722264759242535
mutation O 0 2.362721716053784e-05
( O 0 1.6921916540013626e-05
C676T O 0 0.0003669870784506202
- O 0 0.00010503741214051843
- O 0 0.0001419812615495175
> O 0 0.0003137124585919082
Arg226Stop O 0 0.03278578072786331
) O 0 6.338102684821934e-05
. O 0 7.493363227695227e-05

Thus O 0 0.00017030557501129806
, O 0 3.3464730222476646e-05
a O 0 4.055913086631335e-05
homozygous O 0 0.00040515183354727924
germ O 1 0.999987006187439
- O 0 0.36039999127388
line O 0 0.00905291922390461
MLH1 O 1 0.9998242259025574
mutation O 0 2.5309396733064204e-05
and O 0 1.2742420040012803e-05
consequent O 1 0.999915599822998
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 5.608822903013788e-05
in O 0 1.9265340597485192e-05
a O 0 6.301917892415076e-05
mutator O 1 0.9953952431678772
phenotype O 0 6.125258369138464e-05
characterized O 0 4.3856991396751255e-05
by O 0 1.671636891842354e-05
leukemia B-Disease 1 1.0
and O 0 0.011997715570032597
/ O 1 0.9999938011169434
or O 1 0.9624370336532593
lymphoma B-Disease 1 1.0
associated O 0 0.14613322913646698
with O 0 0.0006351963966153562
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.5953524708747864
1 I-Disease 0 0.028760427609086037
. O 0 3.9502669096691534e-05
. O 0 8.78913706401363e-05

Missense O 0 0.0016239191172644496
mutations O 0 9.449089702684432e-05
in O 0 1.5521292880293913e-05
the O 0 1.0934618330793455e-05
most O 0 3.814780484390212e-06
ancient O 0 7.720382200204767e-06
residues O 0 5.412640348367859e-06
of O 0 5.570710072788643e-06
the O 0 1.8261662262375467e-05
PAX6 O 1 0.9998542070388794
paired O 0 2.958633740490768e-05
domain O 0 1.4708568414789625e-05
underlie O 0 4.788281876244582e-05
a O 0 1.0699875929276459e-05
spectrum O 0 6.645630492130294e-05
of O 0 0.0023692212998867035
human O 1 0.9993308782577515
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 1 0.8989238142967224

Mutations O 0 0.00011595294927246869
of O 0 3.2268959330394864e-05
the O 0 2.5967183319153264e-05
human O 0 3.860473589156754e-05
PAX6 O 1 0.999963641166687
gene O 0 0.0010614197235554457
underlie O 1 0.9998302459716797
aniridia B-Disease 1 1.0
( O 1 0.994672954082489
congenital B-Disease 1 1.0
absence I-Disease 1 0.658355176448822
of I-Disease 0 0.005356656387448311
the I-Disease 0 0.0010317714186385274
iris I-Disease 0 0.10462862998247147
) O 0 4.236151653458364e-06
, O 0 2.3988302473298972e-06
a O 0 6.094198397477157e-06
rare O 0 3.0294146199594252e-05
dominant O 0 0.27448809146881104
malformation B-Disease 1 0.999995231628418
of I-Disease 0 0.018524903804063797
the I-Disease 0 0.13785943388938904
eye I-Disease 1 0.992249608039856
. O 0 0.00010157392534893006

The O 0 0.00018542575708124787
spectrum O 0 0.0003586013917811215
of O 0 0.00019238317327108234
PAX6 O 1 0.999873161315918
mutations O 0 7.498024206142873e-05
in O 0 4.793303378392011e-05
aniridia B-Disease 1 0.9999983310699463
patients O 0 4.0942693885881454e-05
is O 0 2.3683069230173714e-06
highly O 0 2.826473519235151e-06
biased O 0 1.941660457305261e-06
, O 0 3.943600006550696e-07
with O 0 3.2809441563586006e-07
92 O 0 5.194416189624462e-06
% O 0 1.801232770048955e-06
of O 0 1.8339549114898546e-06
all O 0 8.054889235609153e-07
reported O 0 1.985236849577632e-06
mutations O 0 1.0022205287896213e-06
leading O 0 3.0399316983675817e-06
to O 0 9.158766260952689e-07
premature O 0 5.614589554170379e-06
truncation O 0 1.1801254004240036e-05
of O 0 3.3377398267475655e-06
the O 0 3.0897476790414657e-06
protein O 0 4.076029199495679e-06
( O 0 1.7545942228025524e-06
nonsense O 0 8.099210390355438e-06
, O 0 1.0263904641760746e-06
splicing O 0 3.5271643810119713e-06
, O 0 1.1474370467112749e-06
insertions O 0 5.094540483696619e-06
and O 0 1.3861707657270017e-06
deletions O 0 4.913279099127976e-06
) O 0 1.5941993751766859e-06
and O 0 1.0136803894056357e-06
just O 0 1.5359320286734146e-06
2 O 0 3.5739865325012943e-06
% O 0 2.168297896787408e-06
leading O 0 4.3713343984563835e-06
to O 0 1.0519017905608052e-06
substitution O 0 3.4647073334781453e-06
of O 0 2.7208518531551817e-06
one O 0 2.396975560259307e-06
amino O 0 2.4074474822555203e-06
acid O 0 4.463365712581435e-06
by O 0 1.665409172346699e-06
another O 0 1.0578114597592503e-05
( O 0 1.0331931662221905e-05
missense O 0 9.365056030219421e-05
) O 0 3.898419890902005e-05
. O 0 6.671938172075897e-05

The O 0 0.00010064180969493464
extraordinary O 0 6.158655014587566e-05
conservation O 0 2.2708964024786837e-05
of O 0 7.358263246715069e-06
the O 0 9.818111720960587e-06
PAX6 O 0 0.34362220764160156
protein O 0 7.404921234410722e-06
at O 0 4.989071385352872e-06
the O 0 2.7569180929276627e-06
amino O 0 5.6453377510479186e-06
acid O 0 1.0465230843692552e-05
level O 0 1.1173134225828107e-05
amongst O 0 1.4934550563339144e-05
vertebrates O 0 2.1371715774876066e-05
predicts O 0 8.119605809042696e-06
that O 0 7.5322600423533e-07
pathological O 0 2.927083733084146e-05
missense O 0 3.422450026846491e-05
mutations O 0 3.0065339160501026e-06
should O 0 1.072546410796349e-06
in O 0 7.742427214907366e-07
fact O 0 1.4465852018474834e-06
be O 0 5.172880150894343e-07
common O 0 6.294195600275998e-07
even O 0 4.467124483653606e-07
though O 0 5.016060526941146e-07
they O 0 3.4827348827093374e-07
are O 0 3.180333578711725e-07
hardly O 0 4.136972620472079e-06
ever O 0 4.759066996484762e-06
seen O 0 1.2749141205858905e-05
in O 0 2.069497713819146e-05
aniridia B-Disease 1 0.9999790191650391
patients O 0 0.0011917873052880168
. O 0 0.00020546303130686283

This O 0 3.0234979931265116e-05
indicates O 0 3.6309793358668685e-05
that O 0 2.551910029069404e-06
there O 0 3.3860010262287688e-06
is O 0 2.52887980423111e-06
a O 0 5.661577688442776e-06
heavy O 0 0.00011775996972573921
ascertainment O 0 0.10984981060028076
bias O 0 1.348778278043028e-05
in O 0 1.6489100289618364e-06
the O 0 1.5340787058448768e-06
selection O 0 1.4950330751162255e-06
of O 0 3.342916670590057e-06
patients O 0 5.903507371840533e-06
for O 0 3.1574495551467407e-06
PAX6 O 1 0.9405688643455505
mutation O 0 2.7553435302252183e-06
analysis O 0 1.0654173365765018e-06
and O 0 5.202599027143151e-07
that O 0 3.7870978530918364e-07
the O 0 1.7630967477089143e-06
missing O 0 1.7286827642237768e-05
PAX6 O 1 0.9665974378585815
missense O 0 8.200225420296192e-05
mutations O 0 9.497954124526586e-06
frequently O 0 6.00001476414036e-06
may O 0 6.517181645904202e-06
underlie O 0 0.00010425844084238634
phenotypes O 0 4.85565178678371e-05
distinct O 0 2.8256325094844215e-05
from O 0 8.150906069204211e-05
textbook O 1 0.7459210753440857
aniridia B-Disease 1 0.9999746084213257
. O 0 0.000529093318618834

Here O 0 0.00012214359594509006
we O 0 1.283346955460729e-05
present O 0 8.960334525909275e-06
four O 0 7.055740752548445e-06
novel O 0 4.1442552173975855e-05
PAX6 O 1 0.5563692450523376
missense O 0 7.275020470842719e-05
mutations O 0 7.397164608846651e-06
, O 0 1.463998728468141e-06
two O 0 8.128956778818974e-07
in O 0 1.488037696617539e-06
association O 0 3.893044777214527e-06
with O 0 3.2982661650748923e-06
atypical O 1 0.9835230708122253
phenotypes O 0 0.4649319052696228
ectopia B-Disease 1 0.9999666213989258
pupillae I-Disease 1 0.9985641837120056
( O 0 1.2024936040688772e-05
displaced B-Disease 0 2.3385075110127218e-05
pupils I-Disease 0 3.034914334421046e-05
) O 0 8.014287232072093e-06
and O 0 1.403312217007624e-05
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9995569586753845
( O 0 3.670717705972493e-05
searching B-Disease 0 1.3785356713924557e-05
gaze I-Disease 0 1.6514595699845813e-05
) O 0 1.1346304518156103e-06
, O 0 4.269867304174113e-07
and O 0 3.0240352089094813e-07
two O 0 4.976802188139118e-07
in O 0 1.4096549421083182e-06
association O 0 5.758686256740475e-06
with O 0 2.5410861326236045e-06
more O 0 6.732624115102226e-06
recognizable O 0 0.0008747639367356896
aniridia B-Disease 1 0.9999812841415405
phenotypes O 0 0.0005850032903254032
. O 0 0.0001530801091575995

Strikingly O 0 0.00043377495603635907
, O 0 1.730467556626536e-05
all O 0 2.426558239676524e-06
four O 0 3.5753059819398914e-06
mutations O 0 3.831603862636257e-06
are O 0 7.264277428475907e-07
located O 0 5.697177584806923e-06
within O 0 1.977170768441283e-06
the O 0 3.1086460694496054e-06
PAX6 O 0 0.26274582743644714
paired O 0 7.218805421871366e-06
domain O 0 4.2242068047926296e-06
and O 0 1.189971953863278e-06
affect O 0 1.770475137163885e-06
amino O 0 1.2760215213347692e-06
acids O 0 5.426178404377424e-07
which O 0 2.908189458139532e-07
are O 0 1.2638233215511718e-07
highly O 0 9.876239346340299e-07
conserved O 0 1.961677980943932e-06
in O 0 7.97499069449259e-07
all O 0 1.0157434644497698e-06
known O 0 9.795077858143486e-06
paired O 0 1.973710095626302e-05
domain O 0 2.377785131102428e-05
proteins O 0 2.2082751456764527e-05
. O 0 3.933673360734247e-05

Our O 0 0.00012005860480712727
results O 0 1.4506077604892198e-05
support O 0 8.462889127258677e-06
the O 0 4.798946520168101e-06
hypothesis O 0 6.754759851901326e-06
that O 0 3.995633903741691e-07
the O 0 9.689316584626795e-07
under O 0 3.505210770526901e-06
- O 0 5.294654329190962e-06
representation O 0 2.6276209155184915e-06
of O 0 4.860753961111186e-06
missense O 0 0.00014038664812687784
mutations O 0 1.0046405805042014e-05
is O 0 4.508305210038088e-06
caused O 0 1.2495866030803882e-05
by O 0 4.18092622567201e-06
ascertainment O 0 0.07938683032989502
bias O 0 2.6042474928544834e-05
and O 0 2.38956454268191e-06
suggest O 0 2.531773134251125e-06
that O 0 6.285437734732113e-07
a O 0 2.5378287773492048e-06
substantial O 0 1.1931130757147912e-05
burden O 0 5.878787487745285e-05
of O 0 0.00022429315140470862
PAX6 B-Disease 1 0.9999997615814209
- I-Disease 1 0.9937439560890198
related I-Disease 0 0.005215982906520367
disease I-Disease 1 0.9966080188751221
remains O 0 7.518558413721621e-05
to O 0 2.1557639229285996e-06
be O 0 3.978374934376916e-06
uncovered O 0 5.3788317018188536e-05
. O 0 1.3431791558105033e-05
. O 0 5.504815635504201e-05

The O 0 0.00016038271132856607
chromosomal O 0 0.00024536202545277774
order O 0 2.0926661818521097e-05
of O 0 1.8535727576818317e-05
genes O 0 1.2904110008093994e-05
controlling O 0 6.95991184329614e-05
the O 0 1.4405085494217928e-05
major O 0 0.05201594904065132
histocompatibility O 1 0.9999995231628418
complex O 0 0.015080728568136692
, O 0 6.073722488508793e-06
properdin O 0 0.024024611338973045
factor O 0 9.666496225690935e-06
B O 0 0.00019409430387895554
, O 0 1.883923914647312e-06
and O 0 1.6820877135614865e-06
deficiency B-Disease 1 0.9127947092056274
of I-Disease 0 1.2649240488826763e-05
the I-Disease 0 1.1530124538694508e-05
second I-Disease 0 5.335357127478346e-05
component I-Disease 0 5.944553413428366e-05
of I-Disease 0 2.770785977190826e-05
complement I-Disease 0 9.647152182878926e-05
. O 0 6.591220881091431e-05

The O 0 7.56674271542579e-05
relationship O 0 3.818921322817914e-05
of O 0 1.1479556633275934e-05
the O 0 1.1473362064862158e-05
genes O 0 5.6244984989461955e-06
coding O 0 9.733339538797736e-06
for O 0 4.403867023938801e-06
HLA O 0 0.031490057706832886
to O 0 1.4811639630352147e-06
those O 0 5.651251058225171e-07
coding O 0 3.797223826040863e-06
for O 0 2.2975882529863156e-06
properdin O 0 0.0740785226225853
Factor O 0 6.275081977946684e-05
B O 0 0.001978646032512188
allotypes O 0 0.00027924845926463604
and O 0 1.7750804772731499e-06
for O 0 2.273472773595131e-06
deficiency B-Disease 1 0.9973161816596985
of I-Disease 0 1.2130602044635452e-05
the I-Disease 0 5.552803486352786e-06
second I-Disease 0 1.2450878784875385e-05
component I-Disease 0 1.3455883163260296e-05
of I-Disease 0 3.919535629393067e-06
complement I-Disease 0 1.2301717106311116e-05
( O 0 8.687820809427649e-06
C2 O 0 0.1757899969816208
) O 0 2.4661276256665587e-06
was O 0 5.599119958787924e-06
studied O 0 2.083069375657942e-06
in O 0 3.923032636521384e-07
families O 0 6.399195058293117e-07
of O 0 2.6288314529665513e-06
patients O 0 0.000184458534931764
with O 0 0.0348459929227829
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 1 0.999065101146698

Patients O 0 0.00027414687792770565
were O 0 1.6688511095708236e-05
selected O 0 8.151678230206016e-06
because O 0 1.9240221718064277e-06
they O 0 8.453696977994696e-07
were O 0 1.364815602755698e-06
heterozygous O 0 3.5366695101402e-06
or O 0 2.6095381144841667e-06
homozygous O 0 5.7400069636059925e-05
for O 0 0.0006676840712316334
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.9951654672622681

12 O 0 0.00019333498494233936
families O 0 2.7070127543993294e-05
with O 0 7.532363270001952e-06
15 O 0 3.557300806278363e-05
matings O 0 0.00011395426554372534
informative O 0 9.75990915321745e-05
for O 0 0.00029037115746177733
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.015130543150007725
found O 0 0.00012429514026734978
. O 0 0.00012184835941297933

Of O 0 0.0002470780455041677
57 O 0 0.0003116258012596518
informative O 0 0.0001220352205564268
meioses O 0 0.0003123220812994987
, O 0 6.637518254137831e-06
two O 0 1.4638646916864673e-06
crossovers O 0 5.1938263823103625e-06
were O 0 1.3300185628395411e-06
noted O 0 3.0511487238982227e-06
between O 0 8.200638148991857e-06
the O 0 0.0006956105353310704
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 4.589606760418974e-05
and O 0 5.0673424993874505e-06
the O 0 2.1866695533390157e-05
HLA O 1 0.9999896287918091
- O 0 0.002633337862789631
B O 0 0.0009535317658446729
gene O 0 2.7131250135425944e-06
, O 0 9.095008977055841e-07
with O 0 5.014946395931474e-07
a O 0 2.504103349565412e-06
recombinant O 0 1.4059431123314425e-05
fraction O 0 9.61513796937652e-06
of O 0 1.52922366396524e-05
0 O 0 0.00018093145627062768
. O 0 0.0001086204283637926

035 O 1 0.6267629861831665
. O 0 0.005054280627518892

A O 0 0.0006566763040609658
lod O 0 0.0013268496841192245
score O 0 5.5192231229739264e-05
of O 0 2.362712621106766e-05
13 O 0 2.4062119337031618e-05
was O 0 1.0888447832257953e-05
calculated O 0 4.64849108539056e-06
for O 0 2.1201408344495576e-06
linkage O 0 0.0006673220777884126
between O 1 0.9691241979598999
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.9972400665283203
HLA O 1 0.9999998807907104
- O 0 0.3963492810726166
B O 0 0.0004479375493247062
at O 0 8.210122359741945e-06
a O 0 2.2039480427338276e-06
maximum O 0 1.6633537143206922e-06
likelihood O 0 1.3097993587507517e-06
value O 0 6.036605100234738e-07
of O 0 6.567686341441004e-07
the O 0 1.231592136718973e-06
recombinant O 0 6.952754574740538e-06
fraction O 0 5.046715614298591e-06
of O 0 8.868267286743503e-06
0 O 0 4.7592518967576325e-05
. O 0 5.712376514566131e-05

04 O 1 0.6560407280921936
. O 0 0.0035620504058897495

18 O 0 0.0002539224224165082
families O 0 3.920976450899616e-05
with O 0 1.1946204722335096e-05
21 O 0 4.162332697887905e-05
informative O 0 3.0154984415275976e-05
matings O 0 2.938929173978977e-05
for O 0 2.827476464517531e-06
both O 0 3.4173706353612943e-06
properdin O 0 0.0003155791782774031
Factor O 0 4.8529393097851425e-05
B O 0 0.00032264378387480974
allotype O 0 0.012752359732985497
and O 0 2.1415313312900253e-05
HLA O 1 0.9996905326843262
- O 0 0.0016015724977478385
B O 0 0.008181468583643436
were O 0 1.9078233890468255e-05
found O 0 2.2838557924842462e-05
. O 0 5.455893187900074e-05

Of O 0 0.0003819697303697467
72 O 0 0.0005592765519395471
informative O 0 0.00024259132624138147
meioses O 0 0.0007892320863902569
, O 0 1.272949612030061e-05
three O 0 6.139464858279098e-06
recombinants O 0 6.864225724712014e-05
were O 0 3.4985448564839317e-06
found O 0 2.1551800273300614e-06
, O 0 1.3136673260305542e-06
giving O 0 1.7897672250910546e-06
a O 0 2.5370929961354705e-06
recombinant O 0 7.477617145923432e-06
fraction O 0 7.578079475933919e-06
of O 0 9.899578799377196e-06
0 O 0 6.286012649070472e-05
. O 0 7.40844989195466e-05

042 O 0 0.2988760769367218
. O 0 0.004884881433099508

A O 0 0.0003807031607721001
lod O 0 0.0005732520949095488
score O 0 3.5802491765934974e-05
of O 0 2.5540293790982105e-05
16 O 0 4.557354623102583e-05
between O 0 0.00012800928379874676
HLA O 1 0.9999969005584717
- O 0 0.02215246856212616
B O 0 0.0020391265861690044
and O 0 3.1317249522544444e-06
Factor O 0 1.004217210720526e-05
B O 0 3.686884156195447e-05
allotypes O 0 3.0655297450721264e-05
was O 0 5.3076619224157184e-06
calculated O 0 1.5292117723220144e-06
at O 0 2.694114982659812e-06
a O 0 1.1132102599731297e-06
maximum O 0 1.5530384871453862e-06
likelihood O 0 2.047600673904526e-06
value O 0 8.598139515925141e-07
of O 0 1.247717477781407e-06
the O 0 2.8291567559790565e-06
recombinant O 0 1.2603579307324253e-05
fraction O 0 1.0767096682684496e-05
of O 0 1.075970612873789e-05
0 O 0 6.923814362380654e-05
. O 0 6.515740096801892e-05

04 O 1 0.5967274904251099
. O 0 0.003772181225940585

A O 0 0.0003791486087720841
crossover O 0 0.00017638065037317574
was O 0 4.5107353798812255e-05
shown O 0 4.821562015422387e-06
to O 0 8.435970926257141e-07
have O 0 4.772306283484795e-07
occurred O 0 3.322876182210166e-06
between O 0 1.6264560827039531e-06
genes O 0 8.565313009967213e-07
for O 0 1.065717015080736e-06
Factor O 0 5.556559244723758e-06
B O 0 3.343053685966879e-05
and O 0 4.91848277306417e-06
HLA O 1 0.9991089701652527
- O 0 0.00048672326374799013
D O 0 0.04206841066479683
, O 0 2.227922777819913e-06
in O 0 2.036958676399081e-06
which O 0 3.865664439217653e-06
HLA O 1 0.9843154549598694
- O 0 0.000905283959582448
D O 1 0.7835895419120789
segregared O 0 0.002121239434927702
with O 0 1.7142898286692798e-05
HLA O 1 0.9994280934333801
- O 0 0.0004931450821459293
A O 0 0.00019656913354992867
and O 0 2.894045610446483e-05
B O 0 0.0011356280883774161
. O 0 0.00011744161747628823

These O 0 2.1145086066098884e-05
studies O 0 1.0474067494214978e-05
suggest O 0 4.285575414542109e-06
that O 0 6.560380825249013e-07
the O 0 1.259540113096591e-06
genes O 0 7.161708026615088e-07
for O 0 6.292586931522237e-07
Factor O 0 2.2015210561221465e-05
B O 1 0.985721230506897
and O 0 0.038605134934186935
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 3.6493809147941647e-06
located O 0 1.2430497008608654e-05
outside O 0 2.3132047317631077e-06
those O 0 6.023894911777461e-07
for O 0 1.5235984847095096e-06
HLA O 1 0.9768774509429932
, O 0 1.4586206589228823e-06
that O 0 2.446128348765342e-07
the O 0 4.6676106535414874e-07
order O 0 6.819889222242637e-07
of O 0 2.1323355667846045e-06
genese O 0 0.0011333286529406905
is O 0 1.2269075341464486e-05
HLA O 1 0.7070428133010864
- O 0 3.6186593206366524e-05
A O 0 2.9910796001786366e-05
, O 0 6.161713372421218e-06
- O 0 1.129546308220597e-05
B O 0 4.456383976503275e-05
, O 0 5.659158887283411e-06
- O 0 2.5478257157374173e-05
D O 0 0.00047871432616375387
, O 0 3.1214556202030508e-06
Factor O 0 7.301683581317775e-06
B O 0 0.000637509860098362
allotype O 1 0.9805279970169067
, O 0 0.0002084570878650993
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 4.321638698456809e-06
that O 0 4.98662700465502e-07
the O 0 1.01607577107643e-06
genes O 0 8.01793987648125e-07
coding O 0 4.921307208860526e-06
for O 0 1.0344680049456656e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 2.753773696895223e-05
Factor O 0 6.148462853161618e-05
B O 0 5.08176235598512e-05
allotypes O 0 1.9472032363410108e-05
are O 0 3.3471260962869565e-07
approximately O 0 1.8548986417954438e-06
3 O 0 3.699673698065453e-06
- O 0 9.344304089609068e-06
- O 0 8.719462130102329e-06
5 O 0 5.338379651220748e-06
centimorgans O 0 4.16170951211825e-05
from O 0 2.6328909825679148e-06
the O 0 9.877890079224017e-06
HLA O 1 0.9993019104003906
- O 0 0.00011600050493143499
A O 0 0.00020491973555181175
and O 0 1.353243897028733e-05
HLA O 1 0.9999954700469971
- O 0 0.023988161236047745
B O 0 0.057380907237529755
loci O 0 5.903602868784219e-06
, O 0 8.33274498290848e-07
and O 0 2.2691158108045784e-07
that O 0 1.322785152524375e-07
the O 0 8.965787401393754e-07
apparent O 0 9.326178769697435e-06
lack O 0 7.618222753080772e-06
of O 0 9.752880032465328e-06
recombinants O 0 0.0007692236686125398
between O 0 4.445379545359174e-06
the O 0 4.859276032220805e-06
Factor O 0 2.48298001679359e-05
B O 0 0.00291461031883955
gene O 0 2.5981526050600223e-05
and O 0 5.871073153684847e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 9.960456372937188e-05
suggests O 0 6.1101554820197634e-06
that O 0 3.4370623325230554e-07
these O 0 1.39606612492571e-07
two O 0 4.6979513967926323e-07
genes O 0 1.1427183608248015e-06
lie O 0 5.264901574264513e-06
in O 0 1.2404457265802193e-06
close O 0 6.920564828760689e-06
proximity O 0 9.368475730298087e-06
to O 0 2.440797288727481e-06
one O 0 8.383899512409698e-06
another O 0 4.9688416766002774e-05
. O 0 0.00011522570275701582

Distribution O 0 0.0002407624269835651
of O 0 0.00013987196143716574
emerin O 1 0.5251436829566956
and O 0 3.4284636058146134e-05
lamins O 0 0.0015746032586321235
in O 0 1.023314780468354e-05
the O 0 1.9873199562425725e-05
heart O 0 0.01600823737680912
and O 0 8.424366569670383e-06
implications O 0 4.283577800379135e-05
for O 0 3.316842776257545e-05
Emery B-Disease 1 0.9978876709938049
- I-Disease 1 0.9999932050704956
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.06501659005880356

Emerin O 0 0.007361702620983124
is O 0 7.865727820899338e-05
a O 0 2.8315020244917832e-05
nuclear O 0 0.0002961795253213495
membrane O 0 3.055894921999425e-05
protein O 0 3.3896067179739475e-06
which O 0 4.959049988428887e-07
is O 0 7.185105346252385e-07
missing O 0 2.699103788472712e-06
or O 0 1.2780482165908325e-06
defective O 0 2.0813711671507917e-05
in O 0 1.1802751032519154e-05
Emery B-Disease 1 0.9491482973098755
- I-Disease 1 0.9999736547470093
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9902442097663879
EDMD B-Disease 1 1.0
) O 0 0.0002621753083076328
. O 0 0.00018614338478073478

It O 0 4.5603625039802864e-05
is O 0 1.1566401553864125e-05
one O 0 3.1522806693828898e-06
member O 0 6.350077455863357e-06
of O 0 3.3701253414619714e-06
a O 0 7.79176116338931e-06
family O 0 8.67019025463378e-06
of O 0 1.4111523341853172e-05
lamina O 1 0.9999537467956543
- O 0 0.00041176326340064406
associated O 0 2.9741374873992754e-06
proteins O 0 8.964795483734633e-07
which O 0 8.324460623043706e-07
includes O 0 2.706349278014386e-06
LAP1 O 0 0.0342627577483654
, O 0 5.673716714227339e-06
LAP2 O 0 0.004314962308853865
and O 0 6.312280675047077e-06
lamin O 0 0.00019829081429634243
B O 0 0.00041598561801947653
receptor O 0 9.103673801291734e-05
( O 0 3.220548023818992e-05
LBR O 0 0.061062004417181015
) O 0 2.972298716485966e-05
. O 0 8.699498721398413e-05

A O 0 0.00026313294074498117
panel O 0 2.955697891593445e-05
of O 0 1.2523437362688128e-05
16 O 0 3.982690395787358e-05
monoclonal O 0 3.134889266220853e-05
antibodies O 0 8.531409548595548e-06
( O 0 7.148489203245845e-06
mAbs O 0 4.215521039441228e-05
) O 0 2.3289585442398675e-06
has O 0 1.192914737657702e-06
been O 0 1.4086820101510966e-06
mapped O 0 2.8254360131541034e-06
to O 0 7.39149129458383e-07
six O 0 1.1776808150898432e-06
specific O 0 3.603294942422508e-07
sites O 0 1.1676070243993308e-06
throughout O 0 1.4901039548931294e-06
the O 0 3.2082671168609522e-06
emerin O 0 7.238910620799288e-05
molecule O 0 4.75351043860428e-06
using O 0 1.702669123915257e-06
phage O 0 3.422251029405743e-05
- O 0 1.1452470971562434e-05
displayed O 0 1.2875984793936368e-05
peptide O 0 6.874020527902758e-06
libraries O 0 2.3136990421335213e-06
and O 0 7.49444836856128e-07
has O 0 5.059077352598251e-07
been O 0 5.757729013566859e-07
used O 0 5.110069309921528e-07
to O 0 6.888805614835292e-07
localize O 0 3.754639328690246e-05
emerin O 0 8.456182695226744e-05
in O 0 3.9578976611664984e-06
human O 0 6.817087523813825e-06
and O 0 1.5656010873499326e-05
rabbit O 0 0.00084917206550017
heart O 0 0.01677096076309681
. O 0 0.00011709876707755029

Several O 0 0.00018249427375849336
mAbs O 0 0.0005867225700058043
against O 0 4.328038630774245e-05
different O 0 1.0611021934892051e-05
emerin O 0 0.062191471457481384
epitopes O 0 0.00011723259376594797
did O 0 7.83485756983282e-06
not O 0 2.0375669009808917e-06
recognize O 0 5.9408221204648726e-06
intercalated O 0 0.00039598153671249747
discs O 0 3.3815234928624704e-05
in O 0 2.5259487301809713e-06
the O 0 6.224453954928322e-06
heart O 0 0.03621344640851021
, O 0 1.1717253300957964e-06
though O 0 7.103665211616317e-07
they O 0 4.2692198576332885e-07
recognized O 0 1.7608031157578807e-06
cardiomyocyte O 0 0.0001263560843653977
nuclei O 0 1.1417050700401887e-05
strongly O 0 2.1546311472775415e-06
, O 0 9.208249593939399e-07
both O 0 6.537229637615383e-07
at O 0 4.776185960508883e-06
the O 0 5.297472853271756e-06
rim O 0 3.390759229660034e-05
and O 0 1.6624466070425115e-06
in O 0 4.457780505617848e-06
intranuclear O 0 0.00033980191801674664
spots O 0 2.080952253891155e-05
or O 0 7.839611498638988e-06
channels O 0 3.030992411368061e-05
. O 0 4.7755722334841266e-05

A O 0 0.006037043873220682
polyclonal O 0 0.019035382196307182
rabbit O 0 0.0011809050338342786
antiserum O 0 0.0006172206485643983
against O 0 4.69632213935256e-05
emerin O 0 0.0010767719941213727
did O 0 1.1537505088199396e-05
recognize O 0 5.028316081734374e-06
both O 0 3.2484445000591222e-06
nuclear O 0 6.482916796812788e-05
membrane O 0 1.6909752957872115e-05
and O 0 2.404923407084425e-06
intercalated O 0 0.00010323344758944586
discs O 0 1.830734618124552e-05
but O 0 1.0090489013236947e-06
, O 0 1.0263063359161606e-06
after O 0 3.941474915336585e-06
affinity O 0 8.567350050725508e-06
purification O 0 2.345077518839389e-05
against O 0 8.491613698424771e-06
a O 0 2.201298593718093e-05
pure O 0 0.00019701512064784765
- O 0 0.00020386523101478815
emerin O 0 0.0006457545096054673
band O 0 3.619884228101e-05
on O 0 7.646741323696915e-06
a O 0 7.424911927955691e-06
western O 0 9.584971849108115e-06
blot O 0 4.5098924601916224e-05
, O 0 3.659093408714398e-06
it O 0 1.6656093748679268e-06
stained O 0 3.7504203646676615e-05
only O 0 3.188875552950776e-06
the O 0 1.5406178135890514e-05
nuclear O 0 0.0005830636364407837
membrane O 0 0.0002388548746239394
. O 0 7.446080417139456e-05

These O 0 2.3571468773297966e-05
results O 0 1.1570120477699675e-05
would O 0 3.763116637856001e-06
not O 0 8.449433721580135e-07
be O 0 6.407164505617402e-07
expected O 0 1.841554308157356e-06
if O 0 1.2267146303202026e-06
immunostaining O 0 6.138298340374604e-05
at O 0 2.561050860094838e-05
intercalated O 0 0.0014828036073595285
discs O 0 1.9427923689363524e-05
were O 0 2.0605375539162196e-06
due O 0 1.1741627758965478e-06
to O 0 3.4083510058735556e-07
a O 0 7.619710231665522e-07
product O 0 5.829751899000257e-07
of O 0 8.206921506825893e-07
the O 0 2.9393024760793196e-06
emerin O 0 0.19306296110153198
gene O 0 1.985554945349577e-06
and O 0 5.988873681417317e-07
, O 0 5.687080033567327e-07
therefore O 0 7.565490705019329e-07
, O 0 2.729886432462081e-07
cast O 0 7.90108970250003e-07
some O 0 3.041794514047069e-07
doubt O 0 1.5970190361258574e-06
upon O 0 1.1946668792006676e-06
the O 0 1.2050994655510294e-06
hypothesis O 0 8.603137757745571e-06
that O 0 2.6710240490501747e-06
cardiac B-Disease 1 0.9999872446060181
defects I-Disease 1 0.9999127388000488
in O 0 0.015393149107694626
EDMD B-Disease 1 1.0
are O 0 4.021340828330722e-06
caused O 0 1.65728124557063e-05
by O 0 2.6119480480701895e-06
absence O 0 1.2134640201111324e-05
of O 0 2.1190706320339814e-05
emerin O 1 0.8480092287063599
from O 0 5.115808380651288e-05
intercalated O 1 0.7679681777954102
discs O 0 0.0008287461241707206
. O 0 9.692935418570414e-05

Although O 0 0.00044729941873811185
emerin O 0 0.011743737384676933
was O 0 0.00020734562713187188
abundant O 0 2.2343581804307178e-05
in O 0 4.181436906947056e-06
the O 0 5.710237928724382e-06
membranes O 0 1.0881067282753065e-05
of O 0 1.0737338925537188e-05
cardiomyocyte O 0 0.3915161192417145
nuclei O 0 4.050177085446194e-05
, O 0 2.6133186565857613e-06
it O 0 7.323312161133799e-07
was O 0 6.941955234651687e-06
absent O 0 4.421908670337871e-06
from O 0 1.1583626928768354e-06
many O 0 1.4524271136906464e-06
non O 0 2.012487493630033e-05
- O 0 0.004076594952493906
myocyte O 1 0.9984478950500488
cells O 0 1.0105221917910967e-05
in O 0 4.404543233249569e-06
the O 0 2.6225981855532154e-05
heart O 0 0.012343009933829308
. O 0 0.00019173143664374948

This O 0 3.9433631172869354e-05
distribution O 0 1.5276275007636286e-05
of O 0 1.839874494180549e-05
emerin O 0 0.006427490618079901
was O 0 1.566237369843293e-05
similar O 0 5.02523960221879e-07
to O 0 5.480144409375498e-07
that O 0 4.1002650164045917e-07
of O 0 2.845367589543457e-06
lamin O 0 9.033041715156287e-05
A O 0 1.190678358398145e-05
, O 0 9.66205902841466e-07
a O 0 1.1765986300815712e-06
candidate O 0 2.003098188652075e-06
gene O 0 7.98790779299452e-07
for O 0 9.627070767237456e-07
an O 0 2.44412103711511e-06
autosomal O 0 5.809216236229986e-05
form O 0 6.406097963918e-05
of O 0 0.47658148407936096
EDMD B-Disease 1 1.0
. O 0 0.0014802726218476892

In O 0 0.0002791403967421502
contrast O 0 0.00029659716528840363
, O 0 0.00016250736371148378
lamin O 1 0.9591817855834961
B1 O 1 0.9999856948852539
was O 0 0.0023360492195934057
absent O 0 0.00010395269055152312
from O 0 1.6402307664975524e-05
cardiomyocyte O 0 0.0020884154364466667
nuclei O 0 3.45226981153246e-05
, O 0 4.357997568149585e-06
showing O 0 1.0199785720033105e-05
that O 0 3.6949734294466907e-06
lamin O 0 0.0018564739730209112
B1 O 1 0.9966545104980469
is O 0 2.695533339647227e-06
not O 0 6.17957027770899e-07
essential O 0 2.00643262360245e-06
for O 0 8.742198929212464e-07
localization O 0 1.5694038665969856e-05
of O 0 7.636582267878111e-06
emerin O 0 0.0001458706392440945
to O 0 7.553857813036302e-06
the O 0 2.0829736968153156e-05
nuclear O 0 0.0018179942853748798
lamina O 1 0.5179796814918518
. O 0 0.00015536883438471705

Lamin O 1 0.9996033310890198
B1 O 1 0.9999752044677734
is O 0 7.128797005861998e-05
also O 0 1.3892401511839125e-05
almost O 0 1.5343450286309235e-05
completely O 0 3.250966619816609e-05
absent O 0 6.86357743688859e-05
from O 0 8.03395887487568e-05
skeletal O 1 0.9999340772628784
muscle O 1 0.9809384346008301
nuclei O 0 0.1909807324409485
. O 0 0.00036565118352882564

In O 0 0.00035404376103542745
EDMD B-Disease 1 0.9999585151672363
, O 0 1.4544753867085092e-05
the O 0 4.495545908866916e-06
additional O 0 3.5233622384112095e-06
absence O 0 2.1790192477055825e-05
of O 0 6.749253952875733e-05
lamin O 1 0.9999414682388306
B1 O 1 0.9999997615814209
from O 0 0.0009964881464838982
heart O 1 0.9999738931655884
and O 0 0.0014282403280958533
skeletal O 1 0.9999997615814209
muscle O 1 0.9995587468147278
nuclei O 0 0.00524476682767272
which O 0 2.248297732876381e-06
already O 0 4.080101007275516e-06
lack O 0 6.343540462694364e-06
emerin O 0 0.0001534119510324672
may O 0 2.38942334362946e-06
offer O 0 9.367718689645699e-07
an O 0 6.796126399422064e-07
alternative O 0 1.1613857395786908e-06
explanation O 0 1.501334168096946e-06
of O 0 2.3643440272280714e-06
why O 0 3.4778204280883074e-06
these O 0 7.637746080035868e-07
tissues O 0 3.6586047826858703e-06
are O 0 7.437594149450888e-07
particularly O 0 5.222859272180358e-06
affected O 0 1.0583533367025666e-05
. O 0 1.3928033695265185e-05
. O 0 6.80995435686782e-05

Genetic O 0 0.0004885416710749269
mapping O 0 0.00020391616271808743
of O 0 0.000111478402686771
the O 0 0.00013661597040481865
copper B-Disease 1 0.9998419284820557
toxicosis I-Disease 1 0.9998019337654114
locus O 0 0.00011976736277574673
in O 0 2.4798586309771053e-05
Bedlington O 0 0.03401364013552666
terriers O 0 0.00028929102700203657
to O 0 6.786554877180606e-06
dog O 0 1.6967049305094406e-05
chromosome O 0 4.060711489728419e-06
10 O 0 1.563454361530603e-06
, O 0 1.1268028856648016e-06
in O 0 9.447657589589653e-07
a O 0 4.507845460466342e-06
region O 0 1.5524919945164584e-05
syntenic O 0 6.322449917206541e-05
to O 0 1.8764361584544531e-06
human O 0 2.9632431051140884e-06
chromosome O 0 1.621662886464037e-05
region O 0 2.881545697164256e-05
2p13 O 0 0.0016945645911619067
- O 0 0.0003050544182769954
p16 O 0 0.00044256445835344493
. O 0 9.330719331046566e-05

Abnormal O 1 0.9999903440475464
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999991655349731
accumulation I-Disease 1 0.9996967315673828
is O 0 2.3542739654658362e-05
recognized O 0 5.803723524877569e-06
as O 0 5.054277607996482e-06
an O 0 2.4356897483812645e-05
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9987695813179016
man O 1 0.9995394945144653
, O 0 6.391716306097806e-05
mouse O 0 7.292738882824779e-05
, O 0 1.0044231203210074e-05
rat O 0 0.0002698920725379139
and O 0 1.4616613952966873e-05
dog O 0 0.00012140345643274486
. O 0 5.493796925293282e-05

The O 0 0.00021882339206058532
major O 0 0.0008015216444619
cause O 0 0.029082195833325386
of O 1 0.697936475276947
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999998807907104
accumulation I-Disease 1 0.99993896484375
in O 0 2.34745821217075e-05
man O 0 3.620723509811796e-05
is O 0 3.0204978429537732e-06
a O 0 8.382165106013417e-06
dysfunctional O 0 0.001676923013292253
ATP7B O 1 0.9997885823249817
gene O 0 1.2577895176946186e-05
, O 0 6.212901098479051e-06
causing O 0 0.0018292729509994388
Wilson B-Disease 1 0.9817719459533691
disease I-Disease 1 0.9999344348907471
( O 0 0.0006012946832925081
WD B-Disease 1 0.9999769926071167
) O 0 0.00023564687580801547
. O 0 0.00020412429876159877

Mutations O 0 0.00014865040429867804
in O 0 2.4602839403087273e-05
the O 0 2.7303753086016513e-05
ATP7B O 1 0.9995974898338318
genes O 0 5.238152880338021e-06
have O 0 9.166359404844115e-07
also O 0 1.5108770412552985e-06
been O 0 2.610374394862447e-06
demonstrated O 0 1.3246905837149825e-05
in O 0 9.241643056157045e-06
mouse O 0 5.5579908803338185e-05
and O 0 2.32747224799823e-05
rat O 0 0.000950208748690784
. O 0 0.00013337904238142073

The O 0 0.000413518282584846
ATP7B O 1 0.9997263550758362
gene O 0 4.477448237594217e-05
has O 0 8.505398909619544e-06
been O 0 3.5035732253163587e-06
excluded O 0 5.657772362610558e-06
in O 0 1.1705169526976533e-06
the O 0 3.1064766972122015e-06
much O 0 6.943239895917941e-06
rarer O 0 0.00016308794147334993
human O 0 3.550166366039775e-05
copper B-Disease 1 0.9999946355819702
overload I-Disease 1 0.9999997615814209
disease O 1 0.9999972581863403
non B-Disease 0 0.006900216452777386
- I-Disease 0 0.047878049314022064
Indian I-Disease 0 0.0002082520950352773
childhood I-Disease 1 0.9983140230178833
cirrhosis I-Disease 1 0.9999984502792358
, O 0 2.1752344764536247e-05
indicating O 0 8.38107371237129e-05
genetic O 0 0.00011457249638624489
heterogeneity O 0 0.0009441451984457672
. O 0 0.0001698657579254359

By O 0 6.924811168573797e-05
investigating O 0 4.845290823141113e-05
the O 0 1.6237336240010336e-05
common O 0 5.5735632486175746e-05
autosomal O 1 0.9954421520233154
recessive O 1 0.9999967813491821
copper B-Disease 1 1.0
toxicosis I-Disease 1 1.0
( O 0 0.00508024450391531
CT B-Disease 1 0.9878867864608765
) O 0 7.335519967455184e-06
in O 0 5.653009793604724e-06
Bedlington O 0 0.1284627914428711
terriers O 0 0.0002435203641653061
, O 0 1.8255213944939896e-06
we O 0 4.649523930311261e-07
have O 0 2.654062143392366e-07
identified O 0 8.368621706722479e-07
a O 0 8.821938877190405e-07
new O 0 9.89082991509349e-07
locus O 0 8.571910257160198e-06
involved O 0 9.178228538075928e-06
in O 0 4.814408384845592e-05
progressive O 1 0.9999998807907104
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.8856273293495178

We O 0 7.306765473913401e-05
examined O 0 4.090222137165256e-05
whether O 0 5.968272944301134e-06
the O 0 8.968507245299406e-06
WD B-Disease 1 0.9999123811721802
gene O 0 3.9726004615658894e-05
ATP7B O 1 0.9614537358283997
was O 0 3.777481470024213e-05
also O 0 2.520077941881027e-06
causative O 0 1.440877986169653e-05
for O 0 3.650522558018565e-06
CT B-Disease 0 0.00011765144154196605
by O 0 3.4533595680841245e-06
investigating O 0 1.021574189508101e-05
the O 0 9.944279554474633e-06
chromosomal O 0 0.060461077839136124
co O 0 0.018320638686418533
- O 0 0.00013474612205754966
localization O 0 0.00012746217544190586
of O 0 4.799871749128215e-05
ATP7B O 1 0.998367965221405
and O 0 7.332155291805975e-06
C04107 O 0 4.440589691512287e-05
, O 0 1.6670347804392804e-06
using O 0 6.766912861166929e-07
fluorescence O 0 3.953397481382126e-06
in O 0 3.3835476642707363e-06
situ O 0 6.090154420235194e-05
hybridization O 0 3.7059257010696456e-05
( O 0 1.2400801097101066e-05
FISH O 0 2.5001778340083547e-05
) O 0 1.0782160643429961e-05
. O 0 3.5740235034609213e-05

C04107 O 0 0.0039012455381453037
is O 0 5.6814209528965876e-05
an O 0 1.1486871699162293e-05
anonymous O 0 2.9113798518665135e-05
microsatellite O 0 0.00029765660292468965
marker O 0 9.824010339798406e-05
closely O 0 1.9032748241443187e-05
linked O 0 3.462296081124805e-05
to O 0 2.9865077522117645e-05
CT B-Disease 0 0.28497061133384705
. O 0 0.00017605250468477607

However O 0 0.00014370190910995007
, O 0 8.756593888392672e-05
BAC O 1 0.9398753046989441
clones O 0 0.0003021745942533016
containing O 0 3.066579665755853e-05
ATP7B O 0 0.08776894956827164
and O 0 4.959450507158181e-06
C04107 O 0 2.9995289878570475e-05
mapped O 0 5.5964292187127285e-06
to O 0 1.184550683319685e-06
the O 0 3.1787160423846217e-06
canine O 0 8.854415500536561e-05
chromosome O 0 1.9938903278671205e-05
regions O 0 5.694586434401572e-06
CFA22q11 O 0 0.0007343859761022031
and O 0 4.134574282943504e-06
CFA10q26 O 0 0.0007180615793913603
, O 0 2.904754410337773e-06
respectively O 0 2.983904551001615e-06
, O 0 1.244562326974119e-06
demonstrating O 0 5.816828434035415e-06
that O 0 1.4172547935231705e-06
WD B-Disease 0 0.0005669802776537836
cannot O 0 2.855670345525141e-06
be O 0 2.688170980036375e-06
homologous O 0 1.5106311366253067e-05
to O 0 1.708367381070275e-05
CT B-Disease 0 0.004107472952455282
. O 0 0.0002277890598634258

The O 0 0.0006166020757518709
copper O 0 0.35038548707962036
transport O 0 0.00023580709239467978
genes O 0 4.1962528484873474e-05
CTR1 O 1 0.9158039689064026
and O 0 1.4011538951308466e-05
CTR2 O 1 0.8211237788200378
were O 0 4.890022410108941e-06
also O 0 2.0205479813739657e-06
excluded O 0 3.430991455388721e-06
as O 0 1.0370215477450984e-06
candidate O 0 3.161336053381092e-06
genes O 0 8.064989174272341e-07
for O 0 1.4360027762450045e-06
CT B-Disease 0 0.0001663458824623376
since O 0 2.830298399203457e-06
they O 0 3.45015934044568e-07
both O 0 5.586509246313653e-07
mapped O 0 5.8126083786191884e-06
to O 0 4.167224687989801e-06
canine O 0 0.00024632958229631186
chromosome O 0 0.00015553203411400318
region O 0 0.0001472227304475382
CFA11q22 O 0 0.0383889302611351
. O 0 0.00024018077237997204

2 O 0 0.003164303256198764
- O 0 0.0028002052567899227
22 O 0 0.0015037618577480316
. O 0 0.0006296277279034257

5 O 0 0.0049246326088905334
. O 0 0.0016145232366397977

A O 0 0.00022416081628762186
transcribed O 0 8.393374446313828e-05
sequence O 0 1.5385607184725814e-05
identified O 0 5.478062121255789e-06
from O 0 2.77564345196879e-06
the O 0 5.696422704204451e-06
C04107 O 0 0.00029372714925557375
- O 0 2.6111709303222597e-05
containing O 0 6.431648216675967e-06
BAC O 0 0.0008582056616432965
was O 0 7.104489668563474e-06
found O 0 4.6481406457132834e-07
to O 0 2.3772058455051592e-07
be O 0 1.7644495642343827e-07
homologous O 0 6.023538503541204e-07
to O 0 2.90741013486695e-07
a O 0 1.2399466413626214e-06
gene O 0 9.861012131295865e-07
expressed O 0 1.2297836065044976e-06
from O 0 1.1120949920950807e-06
human O 0 2.7843045700137736e-06
chromosome O 0 4.247642573318444e-05
2p13 O 0 0.005173887591809034
- O 0 5.1139737479388714e-05
p16 O 0 2.897486774600111e-05
, O 0 1.5599766811646987e-06
a O 0 3.2473171813762747e-06
region O 0 9.95921618596185e-06
devoid O 0 1.537078060209751e-05
of O 0 4.267336862540105e-06
any O 0 7.824724889360368e-06
positional O 0 9.016020339913666e-05
candidate O 0 7.010008994257078e-05
genes O 0 6.707727152388543e-05
. O 0 0.00012374098878353834

Molecular O 0 0.00012381722626741976
analysis O 0 8.542368959751911e-06
of O 0 1.1883630577358417e-05
the O 0 1.4657262909167912e-05
APC B-Disease 0 0.0004981012898497283
gene O 0 4.900690328213386e-06
in O 0 3.7997124309185892e-06
205 O 0 9.616247552912682e-06
families O 0 2.571257482486544e-06
: O 0 1.4079190577831469e-06
extended O 0 7.788774382788688e-06
genotype O 0 3.1466755899600685e-05
- O 0 5.2607407269533724e-05
phenotype O 0 1.843353675212711e-05
correlations O 0 1.7069944078684784e-05
in O 0 4.168878149357624e-06
FAP B-Disease 0 0.00880154874175787
and O 0 1.2781200666722725e-06
evidence O 0 1.5353900835179957e-06
for O 0 4.914235205433215e-07
the O 0 1.120185743275215e-06
role O 0 4.059027105540736e-06
of O 0 5.593739842879586e-06
APC B-Disease 0 0.0013442524941638112
amino O 0 4.001009074272588e-06
acid O 0 6.805271823395742e-06
changes O 0 5.256006716081174e-06
in O 0 0.0001389084500260651
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.9999996423721313
. O 0 0.02034538798034191

BACKGROUND O 0 0.003369014710187912
/ O 0 0.025028755888342857
AIMS O 0 0.00019924902881029993
The O 0 1.4114162695477717e-05
development O 0 7.58184542064555e-05
of O 1 0.8998628854751587
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.8603657736093737e-05
a O 0 1.1639532203844283e-05
variable O 0 4.049087237945059e-06
range O 0 3.833851678791689e-06
of O 0 9.266282177122775e-06
extracolonic O 0 0.2596643269062042
manifestations O 0 0.0003644601092673838
in O 0 6.621467036893591e-05
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9998145699501038
FAP B-Disease 1 0.9999969005584717
) O 0 1.376222735416377e-05
is O 0 2.7967378173343604e-06
the O 0 1.1500060281832702e-06
result O 0 1.560665509714454e-06
of O 0 2.447043016218231e-06
the O 0 4.910468305752147e-06
dominant O 0 3.86521132895723e-05
inheritance O 0 8.320678898598999e-05
of O 0 0.0022267214953899384
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999966621398926
( O 0 0.010152698494493961
APC B-Disease 1 0.8329164981842041
) O 0 3.4571192372823134e-05
gene O 0 4.9460737500339746e-05
mutations O 0 7.76900487835519e-05
. O 0 0.00012965394125785679

In O 0 5.4212538088904694e-05
this O 0 7.974086656759027e-06
study O 0 5.658846021106001e-06
, O 0 1.5222450429064338e-06
direct O 0 1.121605237131007e-06
mutation O 0 7.939369766063464e-07
analysis O 0 6.705710120513686e-07
of O 0 1.729247742332518e-06
the O 0 5.338409664545907e-06
APC B-Disease 0 0.0017872746102511883
gene O 0 4.54087057732977e-06
was O 0 8.505245205014944e-06
performed O 0 2.1599826141027734e-06
to O 0 5.899944994780526e-07
determine O 0 1.3759345165453851e-06
genotype O 0 1.704833994153887e-05
- O 0 1.9430925021879375e-05
phenotype O 0 8.293498467537574e-06
correlations O 0 8.081958185357507e-06
for O 0 2.1107916836626828e-06
nine O 0 1.0517068403714802e-05
extracolonic O 0 0.0025319214910268784
manifestations O 0 1.718603198241908e-05
and O 0 1.4958947076593176e-06
to O 0 1.1057339861508808e-06
investigate O 0 4.147167601331603e-06
the O 0 2.496435172361089e-06
incidence O 0 2.6485744456294924e-05
of O 0 2.028867311310023e-05
APC B-Disease 0 0.07670702785253525
mutations O 0 7.033999736449914e-06
in O 0 1.086479733203305e-05
non O 0 0.007076552137732506
- O 1 0.999985933303833
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.026983771473169327

METHODS O 0 0.0002157495910068974
The O 0 0.00010336890409234911
APC B-Disease 0 0.0010066857794299722
gene O 0 2.4889872292988002e-05
was O 0 2.6094257918884978e-05
analysed O 0 1.3074733033135999e-05
in O 0 3.051061185033177e-06
190 O 0 1.1781091416196432e-05
unrelated O 0 1.4633183127443772e-05
FAP B-Disease 0 0.005168353207409382
and O 0 5.09133496962022e-06
15 O 0 1.5914187315502204e-05
non O 0 0.0011050987523049116
- O 1 0.9999898672103882
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 0.002853382145985961
using O 0 8.746478670218494e-06
denaturing O 0 0.00016977766063064337
gradient O 0 0.00018972429097630084
gel O 0 5.207438152865507e-05
electrophoresis O 0 1.817314841900952e-05
, O 0 1.319495822826866e-06
the O 0 1.8025904182650265e-06
protein O 0 3.876694790960755e-06
truncation O 0 8.982015060610138e-06
test O 0 3.125047669527703e-06
, O 0 2.572380935816909e-06
and O 0 2.0190648228890495e-06
direct O 0 1.0748629392764997e-05
sequencing O 0 4.961678132531233e-05
. O 0 5.698507811757736e-05

RESULTS O 0 0.0003599277406465262
Chain O 0 0.00015263305976986885
terminating O 0 7.71861377870664e-05
signals O 0 2.466351361363195e-05
were O 0 4.935011929774191e-06
only O 0 3.288626430730801e-06
identified O 0 5.43096484761918e-06
in O 0 2.8069771360605955e-06
patients O 0 6.696828222629847e-06
belonging O 0 9.95141363091534e-06
to O 0 3.948382072849199e-06
the O 0 1.3782661881123204e-05
FAP B-Disease 1 0.8618067502975464
group O 0 9.230227988155093e-06
( O 0 5.751337084802799e-06
105 O 0 4.205402728985064e-05
patients O 0 2.454464993206784e-05
) O 0 2.8020560421282426e-05
. O 0 4.403392813401297e-05

Amino O 0 0.00017952796770259738
acid O 0 7.76707092882134e-05
changes O 0 6.7316486820345744e-06
were O 0 4.770104624185478e-06
identified O 0 3.899625426129205e-06
in O 0 1.6789721257737256e-06
four O 0 2.4527018922526622e-06
patients O 0 3.475708354017115e-06
, O 0 1.3593520407084725e-06
three O 0 9.33534579417028e-07
of O 0 2.092584736601566e-06
whom O 0 3.7294089452188928e-06
belonged O 0 1.6022935596993193e-05
to O 0 7.879741588112665e-07
the O 0 2.4772439246589784e-06
non O 0 3.2174040825339034e-05
- O 0 0.014791909605264664
FAP O 1 0.9995512366294861
group O 0 3.519625897752121e-05
of O 1 0.9457711577415466
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999538660049438
. O 0 0.001401195302605629

Genotype O 0 0.021203693002462387
- O 0 0.017773820087313652
phenotype O 0 0.00011748685938073322
correlations O 0 5.836079071741551e-05
identified O 0 1.1357963558111805e-05
significant O 0 7.436619398504263e-06
differences O 0 5.380844413593877e-06
in O 0 3.868821295327507e-06
the O 0 3.38186691806186e-06
nature O 0 5.047225840826286e-06
of O 0 5.125749794387957e-06
certain O 0 4.1625694393587764e-06
extracolonic O 1 0.8137239813804626
manifestations O 0 0.001203562831506133
in O 0 3.2507716241525486e-05
FAP B-Disease 1 0.9999537467956543
patients O 0 3.2725911296438426e-05
belonging O 0 7.153174465202028e-06
to O 0 2.049056092801038e-06
three O 0 5.487034286488779e-06
mutation O 0 3.049867882509716e-05
subgroups O 0 0.00021411322813946754
. O 0 0.00014572299551218748

CONCLUSIONS O 0 0.0004215628432575613
Extended O 0 0.0002420763048576191
genotype O 0 0.0003498544392641634
- O 0 0.0002238942397525534
phenotype O 0 2.7487887564348057e-05
correlations O 0 1.8048498532152735e-05
made O 0 5.5195632739923894e-06
in O 0 1.9703097677847836e-06
this O 0 1.1896327123395167e-06
study O 0 1.9415920178289525e-06
may O 0 1.502167719991121e-06
have O 0 4.306660912334337e-07
the O 0 1.2718811603917857e-06
potential O 0 2.3478110051655676e-06
to O 0 6.919323709553282e-07
determine O 0 5.206599098528386e-07
the O 0 1.2347710480753449e-06
most O 0 6.368741765072627e-07
appropriate O 0 1.4107630477155908e-06
surveillance O 0 5.7887605180440005e-06
and O 0 2.5047029339475557e-06
prophylactic O 0 0.0005097502144053578
treatment O 0 0.00020320538897067308
regimens O 0 3.4782769944285974e-05
for O 0 1.8031732906820253e-06
those O 0 1.5837327964618453e-06
patients O 0 4.48869968749932e-06
with O 0 2.3454276742995717e-06
mutations O 0 7.719469067524187e-06
associated O 0 8.082929525699e-06
with O 0 6.608818239328684e-06
life O 0 9.812129428610206e-05
threatening O 0 0.00021368492161855102
conditions O 0 0.00017698830924928188
. O 0 0.0001290867367060855

This O 0 5.472990596899763e-05
study O 0 2.243417657155078e-05
also O 0 2.992842382809613e-06
provided O 0 2.150835371139692e-06
evidence O 0 1.9882227206835523e-06
for O 0 6.257267841647263e-07
the O 0 2.773539563349914e-06
pathological O 0 0.0017334123840555549
nature O 0 5.004372269468149e-06
of O 0 6.6701345531328116e-06
amino O 0 5.155192866368452e-06
acid O 0 3.6712499422719702e-06
changes O 0 1.5340290246967925e-06
in O 0 2.4716348434594693e-06
APC O 0 6.935967394383624e-05
associated O 0 2.1467571968969423e-06
with O 0 1.3558227465182426e-06
both O 0 3.893768734997138e-06
FAP B-Disease 1 0.9834670424461365
and O 0 1.5828896721359342e-05
non O 0 0.468777596950531
- O 1 0.9999982118606567
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9992910623550415
. O 0 9.352587949251756e-05
. O 0 0.00016528939886484295

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.999941349029541
cancer B-Disease 1 0.9999998807907104
risk O 0 0.19234779477119446
of O 0 0.0005270432448014617
the O 0 0.001620337599888444
APC O 1 0.9995909333229065
I1307K O 0 0.34803345799446106
polymorphism O 0 0.00044563281699083745
. O 0 0.0001514246832812205

Germ O 1 0.9999905824661255
- O 0 0.012770610861480236
line O 0 0.00010359645239077508
and O 0 6.468167612183606e-06
somatic O 0 4.267948315828107e-05
truncating O 0 5.3669344197260216e-05
mutations O 0 4.373227056930773e-06
of O 0 4.225532393320464e-06
the O 0 4.69220276499982e-06
APC B-Disease 0 0.0024243281222879887
gene O 0 1.572956989548402e-06
are O 0 2.3937082005431876e-07
thought O 0 1.0754408776847413e-06
to O 0 1.4784642416998395e-06
initiate O 0 5.062916534370743e-05
colorectal B-Disease 1 1.0
tumor I-Disease 1 0.9999979734420776
formation O 1 0.9549170136451721
in O 0 0.0177032258361578
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.9998776912689209
sporadic O 1 0.9999992847442627
colorectal O 1 1.0
carcinogenesis O 1 0.9999998807907104
, O 0 0.0007109789294190705
respectively O 0 0.0004924137028865516
. O 0 0.0001457257749279961

Recently O 0 0.0006965575157664716
, O 0 3.663541792775504e-05
an O 0 1.9706370949279517e-05
isoleucine O 0 0.003223678795620799
- O 0 0.00048713828437030315
- O 0 0.0003802566498052329
> O 0 0.00018675727187655866
lysine O 0 6.0312380810501054e-05
polymorphism O 0 2.1274780010571703e-05
at O 0 2.2876485672895797e-05
codon O 0 3.0732953746337444e-05
1307 O 0 0.00016008569218683988
( O 0 6.782834589103004e-06
I1307K O 0 2.152518391085323e-05
) O 0 1.4085045449974132e-06
of O 0 2.232570068372297e-06
the O 0 5.46274486623588e-06
APC B-Disease 0 0.00014376455510500818
gene O 0 2.530571009629057e-06
has O 0 8.752267603995278e-07
been O 0 7.630188747498323e-07
identified O 0 1.1056496305172914e-06
in O 0 8.440147212240845e-07
6 O 0 4.900017302134074e-06
% O 0 3.864045993395848e-06
- O 0 8.591684490966145e-06
7 O 0 6.772628239559708e-06
% O 0 2.848590156645514e-06
of O 0 4.486392754188273e-06
the O 0 1.004158730211202e-05
Ashkenazi O 0 5.858790973434225e-05
Jewish O 0 2.7895435778191313e-05
population O 0 2.0265273633413017e-05
. O 0 4.4896853069076315e-05

To O 0 4.126351996092126e-05
assess O 0 3.850469147437252e-05
the O 0 1.15455613922677e-05
risk O 0 6.709524313919246e-06
of O 0 3.832364200206939e-06
this O 0 2.217311703134328e-06
common O 0 6.753291472705314e-06
APC B-Disease 0 0.053014032542705536
allelic O 0 0.0002849938755389303
variant O 0 0.00011395143519621342
in O 0 0.00011836135672638193
colorectal O 1 1.0
carcinogenesis O 1 0.9999979734420776
, O 0 6.292350462899776e-06
we O 0 7.998053774826985e-07
have O 0 2.7353985387890134e-07
analyzed O 0 1.3773366163150058e-06
a O 0 2.656855485838605e-06
large O 0 4.460595391719835e-06
cohort O 0 3.564295911928639e-05
of O 0 6.470752396126045e-06
unselected O 0 0.0018651301506906748
Ashkenazi O 0 2.9231370717752725e-05
Jewish O 0 8.82485164765967e-06
subjects O 0 7.3691549005161505e-06
with O 0 5.737630090152379e-06
adenomatous B-Disease 1 0.9998859167098999
polyps I-Disease 0 0.12644705176353455
and O 0 5.6835888244677335e-06
. O 0 4.962142156728078e-06
or O 0 0.016217760741710663
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 7.901731441961601e-05
for O 0 1.3561998457589652e-05
the O 0 5.9080393839394674e-05
APC O 1 0.8258780837059021
I1307K O 0 0.006417446304112673
polymorphism O 0 0.0003940123424399644
. O 0 0.00021371325419750065

The O 0 0.0002626807545311749
APC O 0 0.0032266376074403524
I1307K O 0 0.00027644739020615816
allele O 0 1.2306034477660432e-05
was O 0 1.7779975678422488e-05
identified O 0 3.605801566664013e-06
in O 0 1.3812248198519228e-06
48 O 0 4.100267688045278e-06
( O 0 9.609698281565215e-07
10 O 0 1.370637050968071e-06
. O 0 7.320190889004152e-07
1 O 0 3.4598438105604146e-06
% O 0 4.5615788621944375e-06
) O 0 4.371459453977877e-06
of O 0 2.3723083359072916e-05
476 O 0 0.0005775242461822927
patients O 0 0.00021900184219703078
. O 0 0.0001452161668566987

Compared O 0 0.00013052189024165273
with O 0 1.5204172086669132e-05
the O 0 7.885741979407612e-06
frequency O 0 5.83962855671416e-06
in O 0 1.4249649211706128e-06
two O 0 6.965902343836206e-07
separate O 0 1.0127509995072614e-06
population O 0 1.6259505173366051e-06
control O 0 3.4283127661183244e-06
groups O 0 1.0271915016346611e-06
, O 0 1.5147176100072102e-06
the O 0 4.306170012569055e-06
APC O 0 0.0023539585527032614
I1307K O 0 0.00011156644904986024
allele O 0 3.3220935620192904e-06
is O 0 1.0507887964195106e-06
associated O 0 1.0380417734268121e-06
with O 0 5.375922000894207e-07
an O 0 1.2824386885768035e-06
estimated O 0 7.473510777344927e-06
relative O 0 2.0525594663922675e-05
risk O 0 1.0958347047562711e-05
of O 0 1.5399422409245744e-05
1 O 0 0.00024526682682335377
. O 0 9.115722787100822e-05

5 O 0 0.001633913372643292
- O 0 0.0011655965354293585
1 O 0 0.000772979692555964
. O 0 0.0005257973098196089

7 O 0 0.0009824993321672082
for O 0 0.00018940941663458943
colorectal B-Disease 1 0.9999998807907104
neoplasia I-Disease 1 0.9999063014984131
( O 0 5.472886186907999e-05
both O 0 1.666514617681969e-05
P O 0 0.002103490987792611
= O 0 6.7718188802246e-05
. O 0 9.828248039411847e-06
01 O 0 0.0004874173610005528
) O 0 6.811740604462102e-05
. O 0 0.00010236972593702376

Furthermore O 0 0.00024174118880182505
, O 0 2.3620683350600302e-05
compared O 0 1.2575966138683725e-05
with O 0 8.306329618790187e-06
noncarriers O 1 0.6334121823310852
, O 0 3.372152423253283e-05
APC O 0 0.13809721171855927
I1307K O 0 0.0004123120161239058
carriers O 0 4.887803697783966e-06
had O 0 2.1967107386444695e-06
increased O 0 1.127262976297061e-06
numbers O 0 6.275136001931969e-07
of O 0 4.048291430081008e-06
adenomas B-Disease 1 0.9904481768608093
and O 0 4.9388250772608444e-05
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999372959136963
per O 0 8.279977009806316e-06
patient O 0 2.3757971575832926e-05
( O 0 4.785532837559003e-06
P O 0 0.00016500533092767
= O 0 8.70804342412157e-06
. O 0 8.143614422806422e-07
03 O 0 2.2592492314288393e-05
) O 0 9.775841363079962e-07
, O 0 3.3920144915100536e-07
as O 0 4.1933344618882984e-07
well O 0 4.4717316427522746e-07
as O 0 6.702979362671613e-07
a O 0 2.6249558686686214e-06
younger O 0 9.553688869345933e-06
age O 0 1.8551003449829295e-05
at O 0 0.00012880614667665213
diagnosis O 0 0.01622925139963627
. O 0 0.00017985745216719806

We O 0 4.6687880967510864e-05
conclude O 0 5.34487517143134e-05
that O 0 3.3703886401781347e-06
the O 0 9.78276329988148e-06
APC O 0 0.009695365093648434
I1307K O 0 0.0005163468304090202
variant O 0 1.6911251805140637e-05
leads O 0 1.0017895874625538e-05
to O 0 2.6152383725275286e-06
increased O 0 3.369510523043573e-05
adenoma B-Disease 1 0.9999943971633911
formation O 0 7.818495942046866e-05
and O 0 1.5886521396168973e-06
directly O 0 2.0547386156977154e-06
contributes O 0 2.0554189177346416e-06
to O 0 4.833605657950102e-07
3 O 0 2.19099888454366e-06
% O 0 2.149082320102025e-06
- O 0 4.164094207226299e-06
4 O 0 2.6292502752767177e-06
% O 0 1.1366155376890674e-06
of O 0 2.22717494580138e-06
all O 0 2.038266302406555e-06
Ashkenazi O 0 0.0002984525926876813
Jewish O 1 0.7415379881858826
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.009675409644842148

The O 0 0.00016708970360923558
estimated O 0 8.361993241123855e-05
relative O 0 4.809512392967008e-05
risk O 0 1.9317722035339102e-05
for O 0 4.111089765501674e-06
carriers O 0 5.396795586420922e-06
may O 0 1.7873006754598464e-06
justify O 0 2.5792639917199267e-06
specific O 0 4.143998921790626e-07
clinical O 0 2.2529811758431606e-06
screening O 0 2.132943791366415e-06
for O 0 1.1894330782524776e-06
the O 0 3.319275037938496e-06
360 O 0 8.478051313431934e-06
, O 0 1.358531790174311e-06
000 O 0 3.4142501590395113e-06
Americans O 0 9.141514283328434e-07
expected O 0 8.284544605885458e-07
to O 0 7.241327466545044e-07
harbor O 0 1.4941815607016906e-05
this O 0 6.334590239021054e-07
allele O 0 8.846017180985655e-07
, O 0 5.518981538443768e-07
and O 0 3.315088292765722e-07
genetic O 0 1.468317805120023e-06
testing O 0 1.1043301810786943e-06
in O 0 7.086755431373604e-07
the O 0 1.8164475932280766e-06
setting O 0 2.779216401904705e-06
of O 0 3.1537599625153234e-06
long O 0 8.734767106943764e-06
- O 0 1.77964993781643e-05
term O 0 1.1607641681621317e-05
- O 0 9.696568668005057e-06
outcome O 0 3.39591269948869e-06
studies O 0 1.5900404832791537e-06
may O 0 1.5880190176176257e-06
impact O 0 5.597923973255092e-06
significantly O 0 5.514843451237539e-06
on O 0 0.00014119091792963445
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 0.9951246380805969
in O 0 2.72399811365176e-05
this O 0 1.6069945559138432e-05
population O 0 3.346517769386992e-05
. O 0 6.922645115992054e-05

Localization O 0 0.0011339691700413823
of O 0 0.00010217817907687277
human O 0 2.8867358196293935e-05
BRCA1 O 0 0.00012131065886933357
and O 0 4.041429292556131e-06
its O 0 1.9449814772087848e-06
loss O 0 3.559587639756501e-05
in O 0 5.328801307769027e-06
high O 0 5.088163015898317e-05
- O 0 5.2158371545374393e-05
grade O 0 0.0002897666417993605
, O 0 5.476338174048578e-06
non B-Disease 0 4.4618438550969586e-05
- I-Disease 1 0.8144490122795105
inherited I-Disease 1 0.9999997615814209
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.003290570341050625

Although O 0 5.3017913160147145e-05
the O 0 1.9587747374316677e-05
link O 0 3.0197463274816982e-05
between O 0 1.3485210729413666e-05
the O 0 6.828116602264345e-05
BRCA1 O 1 0.9999843835830688
tumour B-Disease 1 1.0
- O 1 0.9971376657485962
suppressor O 0 0.28004157543182373
gene O 0 7.364433713519247e-06
and O 0 1.9836545561702223e-06
hereditary B-Disease 1 0.9999864101409912
breast I-Disease 1 1.0
and I-Disease 1 0.9999911785125732
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 0.000412613560911268
established O 0 1.3510480130207725e-05
, O 0 1.1426377568568569e-06
the O 0 1.0660393172656768e-06
role O 0 1.986717961699469e-06
, O 0 7.268706099239353e-07
if O 0 2.134053573854544e-07
any O 0 2.621720796014415e-07
, O 0 5.809593517369649e-07
of O 0 2.5062606709980173e-06
BRCA1 O 0 7.958992500789464e-05
in O 0 1.4134311641100794e-05
non B-Disease 0 0.0003826118481811136
- I-Disease 1 0.8168013095855713
familial I-Disease 1 0.9999768733978271
cancers I-Disease 1 0.9999500513076782
is O 0 7.447407551808283e-05
unclear O 0 6.022611341904849e-05
. O 0 5.995529500069097e-05

BRCA1 O 0 0.013914013281464577
mutations O 0 7.311896479222924e-05
are O 0 5.820329988637241e-06
rare O 0 1.2918308129883371e-05
in O 0 7.886855200922582e-06
sporadic B-Disease 0 0.004822638351470232
cancers I-Disease 1 0.9825910925865173
, O 0 5.616983344225446e-06
but O 0 1.5749188833069638e-06
loss O 0 0.00018387289310339838
of O 0 4.0543003706261516e-05
BRCA1 O 0 0.008989234454929829
resulting O 0 1.9884802895830944e-05
from O 0 6.5062331486842595e-06
reduced O 0 9.127165867539588e-06
expression O 0 3.5375906008994207e-06
or O 0 2.2206595531315543e-06
incorrect O 0 3.260785433667479e-06
subcellular O 0 1.647523822612129e-05
localization O 0 1.6871879779500887e-05
is O 0 1.6343393554052454e-06
postulated O 0 6.104959084041184e-06
to O 0 7.00899704497715e-07
be O 0 5.12946257913427e-07
important O 0 1.7563086203153944e-06
in O 0 3.1628435408492805e-06
non B-Disease 0 3.0034132578293793e-05
- I-Disease 0 0.18604719638824463
familial I-Disease 1 0.9999949932098389
breast I-Disease 1 1.0
and I-Disease 1 0.9999908208847046
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.985607385635376

Epigenetic O 0 0.29240116477012634
loss O 0 0.29476505517959595
, O 0 3.976185689680278e-05
however O 0 8.064734174695332e-06
, O 0 2.229824985988671e-06
has O 0 7.87620308528858e-07
not O 0 3.309815781449288e-07
received O 0 1.4514952226818423e-06
general O 0 4.358949354354991e-06
acceptance O 0 1.27749935927568e-05
due O 0 9.824864719121251e-06
to O 0 2.7131768547405954e-06
controversy O 0 1.818753662519157e-05
regarding O 0 3.1329557259596186e-06
the O 0 3.5996106362290448e-06
subcellular O 0 1.971127676370088e-05
localization O 0 2.5422701583011076e-05
of O 0 1.153785615315428e-05
BRCA1 O 0 6.971330003580078e-05
proteins O 0 2.396353920630645e-06
, O 0 8.548934715690848e-07
reports O 0 4.613292503563571e-07
of O 0 8.445196044704062e-07
which O 0 6.344444614114764e-07
have O 0 3.4960595485244994e-07
ranged O 0 4.8825813792063855e-06
from O 0 1.8222845028503798e-06
exclusively O 0 4.589058789861156e-06
nuclear O 0 1.7169781131087802e-05
, O 0 1.4102841987551074e-06
to O 0 9.253055850422243e-07
conditionally O 0 6.839025900262641e-06
nuclear O 0 4.895939582638675e-06
, O 0 5.057234488958784e-07
to O 0 6.5324934439559e-07
the O 0 6.864227088954067e-06
ER O 1 0.9983589053153992
/ O 0 0.0002930656191892922
golgi O 0 0.00020459330698940903
, O 0 2.9598368200822733e-06
to O 0 2.8737042612192454e-06
cytoplasmic O 0 3.264157203375362e-05
invaginations O 0 0.00014166493201628327
into O 0 7.895742783148307e-06
the O 0 1.5008879927336238e-05
nucleus O 0 0.0002613375545479357
. O 0 9.584560029907152e-05

In O 0 8.144473395077512e-05
an O 0 1.909902312036138e-05
attempt O 0 2.3781769414199516e-05
to O 0 3.4346026041021105e-06
resolve O 0 1.106934723793529e-05
this O 0 1.7852325981948525e-06
issue O 0 2.952579961856827e-06
, O 0 9.510920904176601e-07
we O 0 7.326853506128828e-07
have O 0 9.590690979166538e-07
comprehensively O 0 3.333773202029988e-05
characterized O 0 1.742936910886783e-05
19 O 0 6.546045915456489e-05
anti O 0 0.002827995689585805
- O 0 0.026963762938976288
BRCA1 O 0 0.001526273088529706
antibodies O 0 5.7369648857275024e-05
. O 0 6.350250623654574e-05

These O 0 4.647776222554967e-05
reagents O 0 0.00011832197196781635
detect O 0 5.205770139582455e-05
a O 0 3.1768358894623816e-05
220 O 0 8.970019553089514e-05
- O 0 0.0001142814799095504
kD O 0 0.009991312399506569
protein O 0 6.335499620035989e-06
localized O 0 3.485989054752281e-06
in O 0 5.578007176154642e-07
discrete O 0 1.6999870240397286e-06
nuclear O 0 1.206847809953615e-05
foci O 0 2.043927634076681e-05
in O 0 1.5036152944958303e-06
all O 0 1.3730166301684221e-06
epithelial O 0 0.36853402853012085
cell O 0 6.548043893417343e-05
lines O 0 2.657694267327315e-06
, O 0 8.613487239017559e-07
including O 0 5.289902560434712e-07
those O 0 7.3499626296325e-07
derived O 0 4.7236621867341455e-06
from O 0 3.086818469455466e-05
breast B-Disease 1 0.9999066591262817
malignancies I-Disease 1 0.9997941851615906
. O 0 0.00033232755959033966

Immunohistochemical O 0 0.009542330168187618
staining O 0 0.0009317264775745571
of O 0 0.00017955433577299118
human O 0 0.00012595886073540896
breast O 1 0.7983569502830505
specimens O 0 2.4088201826089062e-05
also O 0 4.898288807453355e-06
revealed O 0 2.6565146981738508e-05
BRCA1 O 0 9.308759035775438e-05
nuclear O 0 0.00012484488252084702
foci O 0 0.0005058966344222426
in O 0 1.0579517038422637e-05
benign O 1 0.9993131160736084
breast O 1 0.9999533891677856
, O 0 0.013894823379814625
invasive B-Disease 1 0.9998829364776611
lobular I-Disease 1 1.0
cancers I-Disease 1 0.9999208450317383
and O 0 5.210353992879391e-05
low B-Disease 1 0.5465192198753357
- I-Disease 1 0.998917818069458
grade I-Disease 1 0.9999986886978149
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.0010418577585369349

Conversely O 0 0.0009395562228746712
, O 0 7.953887688927352e-05
BRCA1 O 0 0.00028377212584018707
expression O 0 2.6461810193723068e-05
was O 0 3.329624450998381e-05
reduced O 0 8.29274722491391e-06
or O 0 2.2033195818949025e-06
undetectable O 0 1.5908453860902227e-05
in O 0 1.6727152569728787e-06
the O 0 1.707234787318157e-06
majority O 0 2.1564876533375354e-06
of O 0 1.0317969099560287e-05
high O 0 0.00033911046921275556
- O 0 0.004998220596462488
grade O 1 0.9889615178108215
, O 0 0.0012582174967974424
ductal B-Disease 1 1.0
carcinomas I-Disease 1 0.9999998807907104
, O 0 7.417997039738111e-06
suggesting O 0 5.789102942799218e-06
that O 0 7.942823572193447e-07
absence O 0 3.967720203945646e-06
of O 0 7.900239324953873e-06
BRCA1 O 0 0.0006730268942192197
may O 0 3.5525338262232253e-06
contribute O 0 2.271710627610446e-06
to O 0 6.547100497300562e-07
the O 0 1.343720214208588e-06
pathogenesis O 0 0.0005394834442995489
of O 0 2.1523949271795573e-06
a O 0 2.2632275431533344e-06
significant O 0 2.457539267197717e-06
percentage O 0 6.469487288995879e-06
of O 0 1.4103236935625318e-05
sporadic B-Disease 0 0.1157151386141777
breast I-Disease 1 0.9999827146530151
cancers I-Disease 1 0.9996142387390137
. O 0 6.0033104091417044e-05
. O 0 0.0001174922363134101

